	ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)
S84-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S84-BMJ_2010_Apr_29_340_c1640	['we could not examine the Vitamin D status of the fetus directly but INSTEAD chose the ambient ultraviolet radiation level experienced by the mother during Gestation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 68)]	1	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 155, 'gestation')]
S87-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S87-BMJ_2010_Apr_29_340_c1640	['RECENT work by sayers et al also INDICATES that ambient erythemal ultraviolet radiation levels during Pregnancy, EVEN in a single location, CAN be used to INDICATE Vitamin D status.29further work COULD CONFIRM the timing of the OBSERVED EFFECT of Prenatal ultraviolet radiation.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 33), ('ANOMALY_CURIOUS_FINDING', 113), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 155), ('INCOMPLETE_EVIDENCE', 196), ('INCOMPLETE_EVIDENCE', 202), ('INCOMPLETE_EVIDENCE', 228), ('SUPERFICIAL_RELATIONSHIP', 237)]	9	[('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007565', 'female pregnancy', 247, 'prenatal')]
S103-BMJ_2010_Apr_29_340_c1640	BMJ_2010_Apr_29_340_c1640	4/2010	S103-BMJ_2010_Apr_29_340_c1640	['overall, epidemiological studies SUPPORT a PROTECTIVE ROLE for Vitamin D in Autoimmune disease, PARTICULARLY in childhood and Adolescence, and Vitamin D supplementation in early Adulthood EFFECTIVELY reduces the risk of multiple sclerosis; THEREFORE, supplementation of adolescents and young Adults COULD BE effectively used for PREVENTION.6the FINDINGS HERE provide the FIRST population BASED evidence beyond month of Birth PATTERNS to INDICATE that Vitamin D supplementation for the PREVENTION of multiple sclerosis MIGHT also NEED to be CONSIDERED during in utero development.14they are CONSISTENT with a multi-hit causal cascade for multiple sclerosis, with PUTATIVE adverse environmental FACTORS, such as low Vitamin D concentrations, acting at more than one stage of Life.53\n\nwhat is already known on this topic\nin the northern hemisphere, there are more cases of multiple sclerosis in People Born in may and fewer in those Born in november\nmaternal exposure to ambient ultraviolet radiation in Pregnancy can be used as an instrumental variable for Vitamin D status during Pregnancy\nlow Vitamin D concentrations HAVE BEEN ASSOCIATED with a higher risk of multiple sclerosis\n\nwhat THIS STUDY adds\nin australia there is a reciprocal PATTERN of month of Birth and risk of multiple sclerosis, with a higher risk for those Born in november-december compared with may-june\nthis PATTERN was accounted FOR by maternal exposure to ambient ultraviolet radiation in the first trimester\nlow maternal exposure to Ultraviolet Radiation in the first trimester was inversely RELATED to risk of multiple sclerosis in the offspring after adjustment for either month of Birth or place of Birth\n\npubmed central:']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 54), ('IMPORTANT_CONSIDERATION', 96), ('IMPORTANT_CONSIDERATION', 188), ('PROBABLE_UNDERSTANDING', 240), ('INCOMPLETE_EVIDENCE', 299), ('SUPERFICIAL_RELATIONSHIP', 329), ('INCOMPLETE_EVIDENCE', 345), ('QUESTION_ANSWERED_BY_THIS_WORK', 354), ('INCOMPLETE_EVIDENCE', 371), ('QUESTION_ANSWERED_BY_THIS_WORK', 388), ('SUPERFICIAL_RELATIONSHIP', 425), ('INCOMPLETE_EVIDENCE', 437), ('SUPERFICIAL_RELATIONSHIP', 485), ('INCOMPLETE_EVIDENCE', 518), ('FUTURE_WORK', 529), ('IMPORTANT_CONSIDERATION', 529), ('FUTURE_WORK', 540), ('IMPORTANT_CONSIDERATION', 540), ('INCOMPLETE_EVIDENCE', 590), ('SUPERFICIAL_RELATIONSHIP', 590), ('PROBABLE_UNDERSTANDING', 662), ('SUPERFICIAL_RELATIONSHIP', 693), ('INCOMPLETE_EVIDENCE', 1118), ('SUPERFICIAL_RELATIONSHIP', 1128), ('QUESTION_ANSWERED_BY_THIS_WORK', 1186), ('SUPERFICIAL_RELATIONSHIP', 1237), ('SUPERFICIAL_RELATIONSHIP', 1378), ('QUESTION_ANSWERED_BY_THIS_WORK', 1400), ('SUPERFICIAL_RELATIONSHIP', 1565)]	31	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 76, 'autoimmune'), ('GO_0048848', 'neurohypophysis morphogenesis', 126, 'adolescence'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('UBERON_0000113', 'post-juvenile adult stage', 178, 'adulthood'), ('UBERON_0007023', 'adult organism', 292, 'adults'), ('GO_0007567', 'parturition', 419, 'birth'), ('CHEBI_27300', 'vitamin D', 451, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 714, 'vitamin D'), ('UBERON_0000104', 'life cycle', 773, 'life'), ('NCBITaxon_10088', 'Mus <genus>', 892, 'people'), ('GO_0007567', 'parturition', 899, 'born'), ('GO_0007567', 'parturition', 930, 'born'), ('GO_0007565', 'female pregnancy', 1001, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1055, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1079, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1093, 'vitamin D'), ('GO_0007567', 'parturition', 1257, 'birth'), ('GO_0007567', 'parturition', 1324, 'born'), ('CHEBI_52927', 'To-Pro-1(2+)', 1506, 'ultraviolet radiation'), ('GO_0007567', 'parturition', 1657, 'birth'), ('GO_0007567', 'parturition', 1675, 'birth')]
S176-PMC2151954	PMC2151954	10/2007	S176-PMC2151954	['FUTURE STUDIES would ideally examine the RELATIONSHIP between maternal Vitamin D status and neonatal anthropometry across time (e.g.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 41)]	2	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
S77-PMC2290997	PMC2290997	4/2008	S77-PMC2290997	['a swedish epidemiologic study published in the december 2006 issue of diabetologia FOUND that sufficient Vitamin D status in early Life was ASSOCIATED with a lower risk of developing type 1 diabetes.']	[('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 140)]	2	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0000104', 'life cycle', 131, 'life')]
S95-PMC2290997	PMC2290997	4/2008	S95-PMC2290997	['in addition, 25(Oh)D levels are inversely ASSOCIATED with the clinical status of ra patients, and greater intake of Vitamin D HAS BEEN LINKED with lower ra RISK, AS REPORTED in january 2004 in arthritis & rheumatism .']	[('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 135), ('IMPORTANT_CONSIDERATION', 156), ('PROBABLE_UNDERSTANDING', 162), ('INCOMPLETE_EVIDENCE', 165)]	6	[('CHEBI_71657', 'versiconol acetate', 13, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
S107-PMC2290997	PMC2290997	4/2008	S107-PMC2290997	['studies by bruce hollis, director of pediatric nutritional sciences at the medical university of south carolina, and colleagues SUGGEST that a maternal Vitamin D3Intake of 4,000 iu per day is SAFE and sufficient to ensure adequate Vitamin D status for both mother and nursing infant.']	[('INCOMPLETE_EVIDENCE', 128), ('IMPORTANT_CONSIDERATION', 192)]	2	[('CHEBI_63635', 'valganciclovir', 152, 'vitamin D3intake'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D')]
S193-PMC2290997	PMC2290997	4/2008	S193-PMC2290997	['NONETHELESS, says lucas, “there are DRAWBACKS to INFERRING that a RELATIONSHIP with any PROXY for the exposure of interest is a RELATIONSHIP with personal uv dose or Vitamin D status.” on the bright side, she adds, our ability to ACCURATELY gauge an Individual’s uv dose history HAS BEEN ENHANCED with the use of silicone rubber casts of the Back of subjects’ Hands.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 36), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 66), ('SUPERFICIAL_RELATIONSHIP', 88), ('SUPERFICIAL_RELATIONSHIP', 128), ('SUPERFICIAL_RELATIONSHIP', 230), ('INCOMPLETE_EVIDENCE', 279), ('FUTURE_WORK', 288)]	9	[('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('NCBITaxon_1', 'root', 250, 'individual'), ('UBERON_0001137', 'dorsum', 342, 'back'), ('UBERON_0002398', 'manus', 360, 'hands')]
S79-PMC2582131	PMC2582131	11/2008	S79-PMC2582131	['the risk for gdm was highest for overweight women who were classified as being deficient for Vitamin D (25-[Oh] D<20 ng/ml in Pregnancy); they experienced an APPROXIMATELY 5-fold increased risk as compared with lean women of higher Plasma 25-[Oh] D levels (adjusted or\u200a=\u200a4.93, 95% ci 1.63–14.9) ( table 3 ).10.1371/journal.pone.0003753.t003\n\ncaption (table-wrap): table 3\nodds ratios (or) and 95% confidence intervals (ci) for Gestational diabetes (gdm) according to both maternal Plasma 25-Hydroxyvitamin D deficient status and pre-Pregnancy overweight status.Vitamin D deficiency*overweight**gdm casescontrolsunadjusted or (95% ci)adjusted1or (95% ci)(n\u200a=\u200a57)(n\u200a=\u200a114)nono22751.00 (referent)1.00 (referent)yesno792.65 (0.89–7.93)2.36 (0.75–7.43)noyes16232.37 (1.07–5.25)2.24 (0.99–5.08)yesyes1275.84 (2.05–16.6)4.93 (1.63–14.9) p value for interaction term0.930.93\nVitamin D deficiency is DEFINED as maternal Plasma 25-Hydroxyvitamin D concentrations <20 ng/ml (holick mf,[reference 1]).']	[('INCOMPLETE_EVIDENCE', 158), ('PROBABLE_UNDERSTANDING', 891)]	2	"[('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_34300', '2-naphthoyl-CoA', 104, '25-[OH] D'), ('GO_0007565', 'female pregnancy', 126, 'pregnancy'), ('UBERON_0001969', 'blood plasma', 232, 'plasma'), ('CHEBI_34300', '2-naphthoyl-CoA', 239, '25-[OH] D'), ('GO_0007565', 'female pregnancy', 427, 'gestational'), ('UBERON_0001969', 'blood plasma', 481, 'plasma'), ('CHEBI_27844', ""2',3'-cyclic AMP"", 488, '25-Hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 533, 'pregnancy'), ('CHEBI_28384', 'vitamin K', 561, 'Vitamin D'), ('CHEBI_28384', 'vitamin K', 867, 'Vitamin D'), ('UBERON_0001969', 'blood plasma', 911, 'plasma'), ('CHEBI_27844', ""2',3'-cyclic AMP"", 918, '25-Hydroxyvitamin D')]"
S85-PMC2582131	PMC2582131	11/2008	S85-PMC2582131	['the biologically active form of Vitamin D is 1,25-[Oh] D. HOWEVER, 25-[Oh] D is REGARDED AS the BEST INDICATOR of Vitamin D status in the body because it is the substrate for the Renal and Nonrenal Production Of 1,25-[Oh] D and has a longer biological half-life and higher concentrations in circulation than 1,25-[Oh] D. Plasma 25-[Oh] D REFLECTS Vitamin D from both endogenous and exogenous sources.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 58), ('PROBABLE_UNDERSTANDING', 80), ('PROBABLE_UNDERSTANDING', 89), ('IMPORTANT_CONSIDERATION', 96), ('SUPERFICIAL_RELATIONSHIP', 101), ('PROBABLE_UNDERSTANDING', 338), ('SUPERFICIAL_RELATIONSHIP', 338)]	7	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_34300', '2-naphthoyl-CoA', 47, '25-[OH] D'), ('CHEBI_34300', '2-naphthoyl-CoA', 67, '25-[OH] D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0006260', 'DNA replication', 179, 'renal ...'), ('UBERON_0002113', 'kidney', 179, 'renal'), ('UBERON_0000970', 'eye', 189, 'nonrenal'), ('GO_0030164', 'protein denaturation', 198, 'production of ... OH] D'), ('CHEBI_84441', '13(S)-HOTrE', 212, '1,25-[OH] D'), ('CHEBI_34300', '2-naphthoyl-CoA', 310, '25-[OH] D'), ('UBERON_0001969', 'blood plasma', 321, 'Plasma'), ('CHEBI_34300', '2-naphthoyl-CoA', 328, '25-[OH] D'), ('CHEBI_27300', 'vitamin D', 347, 'vitamin D')]
S114-PMC2582131	PMC2582131	11/2008	S114-PMC2582131	['first, a single measurement of Plasma 25-[Oh] D concentrations is not LIKELY to provide a time-integrated measure of maternal Vitamin D status during the entire study Pregnancy.']	[('PROBABLE_UNDERSTANDING', 70)]	1	[('UBERON_0001969', 'blood plasma', 31, 'plasma'), ('CHEBI_34300', '2-naphthoyl-CoA', 38, '25-[OH] D'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('GO_0007565', 'female pregnancy', 167, 'pregnancy')]
S118-PMC2582131	PMC2582131	11/2008	S118-PMC2582131	['HOWEVER, DUE TO the PREDISPOSITION of asian, black, and hispanic women for Insulin resistance and Vitamin D deficiency, IT IS POSSIBLE that adequate Vitamin D status MAY BE even more IMPORTANT in these populations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 120), ('INCOMPLETE_EVIDENCE', 166), ('IMPORTANT_CONSIDERATION', 183)]	6	[('PR_000045358', 'insulin family protein', 75, 'insulin'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
S121-PMC2582131	PMC2582131	11/2008	S121-PMC2582131	['such EVIDENCE is valuable in view of the LIMITED prospective DATA on the RELATION of circulating Vitamin D status to impaired Glucose tolerance in either Pregnant or non-Pregnant Individuals.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 73)]	3	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_17234', 'glucose', 126, 'glucose'), ('GO_0007565', 'female pregnancy', 154, 'pregnant'), ('GO_0007565', 'female pregnancy', 170, 'pregnant'), ('NCBITaxon_1', 'root', 179, 'individuals')]
S17-PMC2685863	PMC2685863	5/2009	S17-PMC2685863	['“many obstetricians are oblivious to their patients’ Vitamin D status and FALSELY ASSUME that the miniscule amount of Vitamin D contained in Prenatal Vitamins will meet the needs of their patients,” hollis says.']	[('PROBLEM_COMPLICATION', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82)]	2	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007565', 'female pregnancy', 141, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 150, 'vitamins')]
S122-PMC2722583	PMC2722583	1/2009	S122-PMC2722583	['for example, the fact that Prenatal Folate supplementation substantially reduces the risk of Neural Tube defect ONLY IF it is taken Preconceptually is WELL KNOWN BUT improving Vitamin A status before Pregnancy HAS also BEEN SHOWN to have a dramatic and AS YET UNEXPLAINED EFFECT on maternal morbidity and mortality (west et al 1999).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 112), ('INCOMPLETE_EVIDENCE', 151), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 162), ('INCOMPLETE_EVIDENCE', 210), ('INCOMPLETE_EVIDENCE', 224), ('INCOMPLETE_EVIDENCE', 253), ('INCOMPLETE_EVIDENCE', 260), ('SUPERFICIAL_RELATIONSHIP', 272)]	8	[('GO_0007565', 'female pregnancy', 27, 'prenatal'), ('CHEBI_30863', '5-azaorotic acid', 36, 'folate'), ('UBERON_0001049', 'neural tube', 93, 'neural tube'), ('GO_0007608', 'sensory perception of smell', 132, 'preconceptually'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin A'), ('GO_0007565', 'female pregnancy', 200, 'pregnancy')]
S1-PMC2798111	PMC2798111	12/2010	S1-PMC2798111	['TO EXAMINE the EFFECTIVENESS of oral Vitamin D3(400\u2009iu) supplementation on the nutritional Vitamin D status of breastfeeding infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 15)]	2	[('CHEBI_33279', 'vitamin D5', 37, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 37, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
S17-PMC2798111	PMC2798111	12/2010	S17-PMC2798111	['THEREFORE, Oral supplementation or sufficient sun exposure is NECESSARY to ensure adequate Vitamin D status for proper calcium absorption and bone mineralization [3–6].RECENT RESEARCH has also LINKED Vitamin D to Innate Immunity [7–9].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 62), ('INCOMPLETE_EVIDENCE', 168), ('SUPERFICIAL_RELATIONSHIP', 193)]	4	[('UBERON_0000165', 'mouth', 11, 'oral'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('GO_0045087', 'innate immune response', 213, 'innate immunity')]
S20-PMC2798111	PMC2798111	12/2010	S20-PMC2798111	['the revised statement by the american academy of pediatrics [26] brings forth the QUESTION of WHETHER OR NOT Vitamin D-only preparations are as effective as the time-honored use of infant multivitamin preparations in achieving adequate Vitamin D status in breastfed infants.']	[('EXPLICIT_QUESTION', 82), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 94)]	2	[('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D')]
S97-PMC2798111	PMC2798111	12/2010	S97-PMC2798111	['infant Vitamin D levels in exclusively breastfed infants REFLECT maternal Vitamin D status, and GIVEN that the majority of the mothers in this cohort present with circulating 25(Oh)D levels <30\u2009ng/ml, it is NOT SURPRISING that the infants who are almost solely DEPENDENT on the mother for their Vitamin D have corresponding deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 57), ('PROBABLE_UNDERSTANDING', 96), ('PROBABLE_UNDERSTANDING', 207), ('ANOMALY_CURIOUS_FINDING', 211), ('SUPERFICIAL_RELATIONSHIP', 261)]	5	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 178, 'OH)D'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D')]
S98-PMC2798111	PMC2798111	12/2010	S98-PMC2798111	['UNTIL it can be determined WHAT amount of Vitamin D supplementation in mothers will effectively and SAFELY increase and/or maintain the Vitamin D status in her breastfed infant, we MUST rely on Vitamin D supplementation of the infant to prevent deficiency.']	[('FUTURE_WORK', 0), ('EXPLICIT_QUESTION', 27), ('IMPORTANT_CONSIDERATION', 100), ('IMPORTANT_CONSIDERATION', 181)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
S105-PMC2798111	PMC2798111	12/2010	S105-PMC2798111	['WHILE prescription of a Vitamin or medication and changes in Blood levels of that vitamin or medication, in this case, Vitamin D does NOT prove direct causality, the change in circulating 25(Oh)D status was INDEPENDENT of season.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 134), ('SUPERFICIAL_RELATIONSHIP', 207)]	3	[('CHEBI_33229', 'vitamin (role)', 24, 'vitamin'), ('UBERON_0000178', 'blood', 61, 'blood'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 188, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 188, '25(OH ... D')]
S106-PMC2798111	PMC2798111	12/2010	S106-PMC2798111	['in addition, DESPITE the normal growth of the infants during this six-month period, on a per kilogram basis, the 400\u2009iu/day dose was adequate in helping the infant maintain adequate Vitamin D status during the six-month study period.']	[('ANOMALY_CURIOUS_FINDING', 13)]	1	[('CHEBI_27300', 'vitamin D', 182, 'vitamin D')]
S116-PMC2798111	PMC2798111	12/2010	S116-PMC2798111	['clearly, the 400\u2009iu/day group of infants (presented HERE) had improved Vitamin D status BASED ON their therapy that was not seen in the 2400\u2009iu group of infants, who were receiving placebo and whose only source of Vitamin D was maternal Breast Milk that has significantly lower levels than that of the 6400 iu group.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 52), ('SUPERFICIAL_RELATIONSHIP', 88)]	2	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D'), ('UBERON_0001348', 'brown adipose tissue', 237, 'breast milk')]
S19-PMC2821652	PMC2821652	2/2010	S19-PMC2821652	['at the time of Birth, Cord Blood AS a direct reflection of fetal Vitamin D status will contain APPROXIMATELY 50–60% of the maternal circulating levels of 25(Oh)D. this RELATIONSHIP APPEARS TO BE linear EVEN at Pharmacological intakes of Vitamin D [12].']	[('PROBABLE_UNDERSTANDING', 33), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 168), ('ANOMALY_CURIOUS_FINDING', 181), ('ANOMALY_CURIOUS_FINDING', 202)]	5	[('GO_0007567', 'parturition', 15, 'birth'), ('UBERON_0009472', 'axilla', 22, 'cord blood'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 154, '25(OH)D'), ('CHEBI_52217', 'pharmaceutical', 210, 'pharmacological'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
S23-PMC2821652	PMC2821652	2/2010	S23-PMC2821652	['THUS, in the Human fetus, Vitamin D Metabolism in all LIKELIHOOD begins with 25(Oh)D. as a result, the nutritional Vitamin D status of the Human fetus/neonate is totally DEPENDENT on the Vitamin D stores of the mother [11]; THUS, IF the mother is hypovitaminotic D, her fetus will experience depleted Vitamin D exposure throughout Gestation [14].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 54), ('SUPERFICIAL_RELATIONSHIP', 170), ('PROBABLE_UNDERSTANDING', 224), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 230)]	5	[('NCBITaxon_9606', 'Homo sapiens', 13, 'human'), ('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 26, 'vitamin D metabolism'), ('CHEBI_71657', 'versiconol acetate', 77, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 139, 'human'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 263, 'D'), ('CHEBI_27300', 'vitamin D', 301, 'vitamin D'), ('GO_0007565', 'female pregnancy', 331, 'gestation')]
S29-PMC2821652	PMC2821652	2/2010	S29-PMC2821652	['DESPITE an expanding Intravascular volume during Pregnancy, maternal Vitamin D status SHOWS seasonal variation but beyond the typical FACTORS that INFLUENCE Vitamin D status in Adults (such as sunlight exposure and bmi), Vitamin D status does not fluctuate during Pregnancy and once supplemented, maternal Blood levels reach steady-state within 2 months [15].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 86), ('SUPERFICIAL_RELATIONSHIP', 134), ('SUPERFICIAL_RELATIONSHIP', 147)]	4	[('GO_0005622', 'intracellular anatomical structure', 21, 'intravascular'), ('GO_0007565', 'female pregnancy', 49, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('UBERON_0007023', 'adult organism', 177, 'adults'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D'), ('GO_0007565', 'female pregnancy', 264, 'pregnancy'), ('UBERON_0000178', 'blood', 306, 'blood')]
S57-PMC2821652	PMC2821652	2/2010	S57-PMC2821652	['at each study visit, AS a MARKER of Vitamin D status, circulating levels of 25(Oh)D and Vitamin D3Were measured in patient Serum.']	[('PROBABLE_UNDERSTANDING', 21), ('SUPERFICIAL_RELATIONSHIP', 26)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 76, '25(OH)D'), ('CHEBI_73706', 'bromosuccinate', 88, 'vitamin D3were'), ('UBERON_0001977', 'blood serum', 123, 'serum')]
S503-PMC2841444	PMC2841444	2/2010	S503-PMC2841444	['DUE TO ethical REASONS RECENT RCTS DID NOT include a placebo group, but compared DIFFERENT treatment modes, using Vitamin K status as the primary outcome.']	[('PROBLEM_COMPLICATION', 0), ('PROBABLE_UNDERSTANDING', 15), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81)]	5	[('CHEBI_27300', 'vitamin D', 114, 'vitamin K')]
S3-PMC2872349	PMC2872349	4/2010	S3-PMC2872349	['maternal lifestyle, body build and 25(Oh) Vitamin D status PREDICT offspring bone mass.']	[('SUPERFICIAL_RELATIONSHIP', 59)]	1	[('CHEBI_30778', 'gallic acid', 35, '25(OH)'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
S91-PMC2872349	PMC2872349	4/2010	S91-PMC2872349	['maternal Vitamin D status was statistically significantly ASSOCIATED with childhood bone area, and areal bmd.']	[('SUPERFICIAL_RELATIONSHIP', 58)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
S93-PMC2872349	PMC2872349	4/2010	S93-PMC2872349	['ADDITIONAL EVIDENCE SUPPORTING a ROLE for maternal Vitamin D status was obtained in the southampton women’s survey, when maternal Vitamin D concentrations again CORRELATED with neonatal bone mass [41].']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 161)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
S141-PMC2889879	PMC2889879	5/2010	S141-PMC2889879	['our results of a PROTECTIVE EFFECT of Vitamin D intake MUST BE CONSIDERED AS ROUGH, SINCE we ONLY measure the dietary intake of Vitamin D. a more complete picture of the Vitamin D status COULD have been supplied through Vitamin D levels in Blood; HOWEVER, NO biological samples are AVAILABLE.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('SUPERFICIAL_RELATIONSHIP', 28), ('IMPORTANT_CONSIDERATION', 55), ('IMPORTANT_CONSIDERATION', 63), ('PROBABLE_UNDERSTANDING', 74), ('INCOMPLETE_EVIDENCE', 77), ('PROBLEM_COMPLICATION', 84), ('INCOMPLETE_EVIDENCE', 93), ('INCOMPLETE_EVIDENCE', 187), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 247), ('FULL_UNKNOWN', 256)]	11	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('UBERON_0000178', 'blood', 240, 'blood')]
S0-PMC2963768	PMC2963768	10/2010	S0-PMC2963768	['Vitamin D status of infants in northeastern rural bangladesh: preliminary observations and a review of potential determinants\n\nabstract\nVitamin D deficiency is a GLOBAL PUBLIC-HEALTH CONCERN, EVEN in tropical regions where the risk of deficiency was PREVIOUSLY ASSUMED to be low due to cutaneous Vitamin D Synthesis stimulated by exposure to sun.']	[('IMPORTANT_CONSIDERATION', 162), ('ANOMALY_CURIOUS_FINDING', 192), ('INCOMPLETE_EVIDENCE', 250), ('PROBABLE_UNDERSTANDING', 261)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_28384', 'vitamin K', 136, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 296, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 296, 'vitamin D synthesis')]
S1-PMC2963768	PMC2963768	10/2010	S1-PMC2963768	['POOR Vitamin D status, INDICATED by low Serum concentrations of 25-Hydroxyvitamin D [25(Oh)D], HAS BEEN observed in south asian populations.']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 95)]	3	[('CHEBI_27300', 'vitamin D', 5, 'vitamin D'), ('UBERON_0001977', 'blood serum', 40, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 64, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D')]
S2-PMC2963768	PMC2963768	10/2010	S2-PMC2963768	['HOWEVER, LIMITED INFORMATION is available on the Vitamin D status of young infants in this region.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9)]	2	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
S3-PMC2963768	PMC2963768	10/2010	S3-PMC2963768	['THEREFORE, to gain PRELIMINARY INSIGHTS into the Vitamin D status of infants in rural bangladesh, 25(Oh)D was ASSESSED in a group of community-sampled control participants in a pneumonia case-control study in rural sylhet, bangladesh (25°n) during the winter dry season (january-february).']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 110)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 98, '25(OH)D')]
S10-PMC2963768	PMC2963768	10/2010	S10-PMC2963768	['in conclusion, the Vitamin D status in young infants in rural sylhet, bangladesh, was poorer than MIGHT be expected based on geographic CONSIDERATIONS.']	[('INCOMPLETE_EVIDENCE', 98), ('IMPORTANT_CONSIDERATION', 136)]	2	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D')]
S13-PMC2963768	PMC2963768	10/2010	S13-PMC2963768	['HOWEVER, SINCE Vitamin D status has become READILY estimable BASED on Serum/Plasma 25-Hydroxyvitamin D concentration [25(Oh)D] (2), epidemiologic RESEARCH aimed at identifying PREVIOUSLY-UNCHARACTERIZED AT-risk populations and characterizing NOVEL disease ASSOCIATIONS with Vitamin D status HAS BEEN greatly facilitated.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('PROBABLE_UNDERSTANDING', 43), ('QUESTION_ANSWERED_BY_THIS_WORK', 61), ('FUTURE_WORK', 146), ('INCOMPLETE_EVIDENCE', 176), ('INCOMPLETE_EVIDENCE', 187), ('IMPORTANT_CONSIDERATION', 203), ('FULL_UNKNOWN', 242), ('SUPERFICIAL_RELATIONSHIP', 256), ('INCOMPLETE_EVIDENCE', 291)]	11	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0001977', 'blood serum', 70, 'serum'), ('UBERON_0001969', 'blood plasma', 76, 'plasma'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 83, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D')]
S16-PMC2963768	PMC2963768	10/2010	S16-PMC2963768	['FEW STUDIES on Vitamin D status in infancy HAVE BEEN conducted in south asia (table 1).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 43)]	2	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D')]
S19-PMC2963768	PMC2963768	10/2010	S19-PMC2963768	"[""summary of studies of Vitamin D status of infants and children aged 1 month to <5 years in bangladesh, pakistan, and indiastudyparticipantslocationlatitudeseasonno.mean 25(Oh)d (nmol/l)categorical descriptions of Vitamin D statuscombs et al ., 2008 (9)aged 1-5 years; no clinical signs of ricketschakaria subdistrict, cox's bazar, bangladesh21°nunknown15868.3\n25(Oh)D <25 nmol/l in 6% (10/158)\n25(Oh)D <37.5 nmol/l in 21% (33/158)fischer et al ., 1999 (10)cases in case-control study of rickets; aged 10-120 monthschakaria subdistrict, bangladesh21°nunknown1450\nrange 17.5-162.5 nmol/l\n25(Oh)D <35 nmol/l in 2/14 (14%).controlschakaria subdistrict, bangladesh21°nunknown1362.5\nrange 55-87.5 nmol/l\nnone with 25(Oh)D <35 nmol/latiq et al ., 1998 (11)aged 6 weeks-11 months; immunization clinickarachi, pakistan25°nnovember-march2324.5\n25(Oh)D <25 nmol/l in 52% (throughout the year)april-october4840.7agarwal et al ., 2002 (12)aged 9-24 months; high-pollution areamorigate, delhi, india28°nmarch-april2631\n25(oh)d <30 nmol/l in 35%aged 9-24 months; low-pollution areagurgaon, delhi, india28°nmarch-april3168\n25(Oh)D <30 nmol/l in 0%bhalala et al ., 2007 (13)healthy breastfed infants aged 3 monthsmumbai, india18°nthroughout the year3545.5\n25(Oh)D <62.5 nmol/l in 80%tiwari and puliyel, 2004 (14)aged 9-30 months living in impoverished neighbourhoodssundernagari, delhi, india28°njanuary4796.3\n25(Oh)D <35 nmol/l in 2%rajiv colony, delhi, india28°nfebruary4923.8\n25(Oh)D <35nmol/l in 82.9%rajiv colony, delhi, india28°naugust4817.8\n25(Oh)D <35 nmol/l in 84.0%gurgaon, delhi, india28°naugust5219.2\n25(Oh)D <35 nmol/l in 82.0%wayse et al ., 2004 (15)healthy controls in case-control study; aged <5 yearsindapur, india17°nmay-june7038.4\n25(Oh)D <22.5 nmol/l in 31%\n25(Oh)D <50 nmol/l in 61%\nknowledge of the Vitamin D status of young children and infants IS NEEDED to DESIGN STUDIES targeting the aetiologic mechanisms and POTENTIAL health IMPLICATIONS of deficiency.""]"	[('FUTURE_WORK', 1851), ('FUTURE_WORK', 1864), ('INCOMPLETE_EVIDENCE', 1919), ('IMPORTANT_CONSIDERATION', 1936)]	4	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_37972', 'phosphorus-32 atom', 169, '25'), ('CHEBI_17792', 'organohalogen compound', 172, 'OH'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 360, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 394, '25(OH)D'), ('CHEBI_33010', 'chromide(1-)', 588, '(OH)D'), ('CHEBI_71657', 'versiconol acetate', 708, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 711, 'OH ... D'), ('CHEBI_71657', 'versiconol acetate', 834, '25(OH)D'), ('PR_000006880', 'extracellular matrix protein 2', 834, '25 ... OH)D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 1110, 'OH)D'), ('CHEBI_71657', 'versiconol acetate', 1239, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1393, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 1399, 'D'), ('CHEBI_71657', 'versiconol acetate', 1462, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1531, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1596, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1733, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 1761, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 1804, 'vitamin D')]
S20-PMC2963768	PMC2963768	10/2010	S20-PMC2963768	['a case-control study on the ASSOCIATION between acute Lower Respiratory Tract infection (alri) and Vitamin D status in infants and young children conducted in zakiganj subdistrict of sylhet district in bangladesh, during january-february 2008, provided an OPPORTUNITY to gain PRELIMINARY INSIGHTS into the Vitamin D status of infants in northeastern rural bangladesh (4).']	[('SUPERFICIAL_RELATIONSHIP', 28), ('FUTURE_WORK', 256), ('INCOMPLETE_EVIDENCE', 276), ('INCOMPLETE_EVIDENCE', 288)]	4	[('UBERON_0004905', 'articulation', 54, 'lower respiratory tract'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 306, 'vitamin D')]
S21-PMC2963768	PMC2963768	10/2010	S21-PMC2963768	['HERE, we AIMED to describe the Vitamin D status of the source population and briefly review the POTENTIAL DETERMINANTS of low infant 25(Oh)D in this setting.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 106)]	4	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 133, '25 ... OH ... D')]
S33-PMC2963768	PMC2963768	10/2010	S33-PMC2963768	['collection of data\ncaregivers (mothers) of participants were administered a questionnaire that addressed selected infant, maternal and household characteristics POTENTIALLY associated with Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 161)]	1	[('CHEBI_27300', 'vitamin D', 189, 'vitamin D')]
S45-PMC2963768	PMC2963768	10/2010	S45-PMC2963768	['as a secondary exploratory analysis, observations relating to infant, maternal or household FACTORS that POTENTIALLY INFLUENCED Vitamin D status were drawn from the complete sample of 74 participants (cases and controls) in whom 25(Oh)D was measured.']	[('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 105), ('SUPERFICIAL_RELATIONSHIP', 117)]	3	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 229, '25(OH)D')]
S51-PMC2963768	PMC2963768	10/2010	S51-PMC2963768	['given that the DETERMINANTS of Vitamin D status MAY DIFFER across age-groups, associational analyses were repeated among participants aged less than six months.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 52)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
S76-PMC2963768	PMC2963768	10/2010	S76-PMC2963768	['results of analyses of ASSOCIATIONS of Vitamin D status with POTENTIAL RISK FACTORS were SIMILAR when repeated in a group restricted to participants aged less than six months (data not shown).']	[('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 71), ('SUPERFICIAL_RELATIONSHIP', 89)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
S83-PMC2963768	PMC2963768	10/2010	S83-PMC2963768	"[""cement, brick, or tin)\xa0\xa0floor03 (6)0.221\xa0\xa0walls6 (25)16 (32)0.537\xa0\xa0roof20 (83)45 (90)0.411child is/was usually swaddled during the first 6 months of Life24 (100)46 (92)0.154child was deliberately exposed to sunlight before Learning to crawl/walk18 (75)36 (72)0.786mother's clothing practices when outdoors\xa0\xa0head usually covered23 (96)50 (100)0.146\xa0\xa0Face usually covered00-\xa0\xa0Arms usually covered24 (100)48 (96)0.321\xa0\xa0usually wears burka in public21 (91)47 (94)0.672number of meals at which mother reportedly Consumed Food items from Animal source during the past week (median±iqr)any type of fish13.0±514.5±120.158\xa0\xa0small fish with Bones6.0±76±80.561\xa0\xa0milk0±00±70.119\xa0\xa0meat0±0.50±20.415\xa0\xa0Eggs0±1.50±20.247\xa0\xa0Liver0±00±00.324\nfigures in parentheses indicate percentages;\niqr=interquartile range;\nsd=standard deviation\n\ndiscussion\nTHIS PRELIMINARY STUDY in sylhet during the winter dry season REVEALED that the Vitamin d status of young infants in rural bangladesh MIGHT be POOR enough to put many AT RISK of rickets and other POTENTIAL Vitamin D-RELATED health consequences.""]"	[('QUESTION_ANSWERED_BY_THIS_WORK', 827), ('QUESTION_ANSWERED_BY_THIS_WORK', 832), ('QUESTION_ANSWERED_BY_THIS_WORK', 832), ('INCOMPLETE_EVIDENCE', 889), ('INCOMPLETE_EVIDENCE', 961), ('IMPORTANT_CONSIDERATION', 970), ('IMPORTANT_CONSIDERATION', 994), ('INCOMPLETE_EVIDENCE', 1023), ('SUPERFICIAL_RELATIONSHIP', 1043)]	9	[('UBERON_0008878', 'palmar part of manus', 149, 'life24'), ('GO_0007612', 'learning', 223, 'learning'), ('UBERON_0001456', 'face', 349, 'Face'), ('UBERON_0001460', 'arm', 374, 'Arms'), ('GO_0007631', 'feeding behavior', 507, 'consumed'), ('CHEBI_33290', 'food', 516, 'food'), ('NCBITaxon_33208', 'Metazoa', 532, 'animal'), ('UBERON_0001474', 'bone element', 631, 'bones6'), ('CL_0000059', 'ameloblast', 687, 'Eggs0'), ('UBERON_0001773', 'sclera', 706, 'Liver0'), ('CHEBI_33229', 'vitamin (role)', 907, 'vitamin'), ('CHEBI_27300', 'vitamin D', 1033, 'vitamin D')]
S85-PMC2963768	PMC2963768	10/2010	S85-PMC2963768	['TO OUR KNOWLEDGE, THIS is the FIRST report of Vitamin D status in young infants in bangladesh.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 30)]	3	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
S87-PMC2963768	PMC2963768	10/2010	S87-PMC2963768	['to put these FINDINGS in a global context, it is first useful to draw a comparison with WHAT is PERHAPS the ONLY young infant ‘reference’ group studied at the equator where Vitamin D status would be expected to be optimal throughout the year in the absence of dietary supplementation or fortification.']	[('INCOMPLETE_EVIDENCE', 13), ('EXPLICIT_QUESTION', 88), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 108)]	4	[('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
S99-PMC2963768	PMC2963768	10/2010	S99-PMC2963768	['THEREFORE, these data from rural bangladesh, in combination with EARLIER FINDINGS from infants in urban pakistan, india, and uae, have DEMONSTRATED that the Vitamin D status of young infants in south asia and the middle east MAY BE no better than that of unsupplemented infants at much higher northern latitudes in north america, where GUIDELINES SUPPORT the provision of routine Vitamin D supplementation to all breastfed infants (21,22).']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 73), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 225), ('PROBABLE_UNDERSTANDING', 336), ('INCOMPLETE_EVIDENCE', 347)]	7	[('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 380, 'vitamin D')]
S102-PMC2963768	PMC2963768	10/2010	S102-PMC2963768	['IN FACT, a seasonal differential in Vitamin D status was OBSERVED among pakistani infants (11).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 57)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
S103-PMC2963768	PMC2963768	10/2010	S103-PMC2963768	['THEREFORE, the representativeness of our data is LIMITED because they REFLECT Vitamin D status during the winter, when ultraviolet radiation exposure is at its nadir, and when cutaneous Vitamin D Synthesis would be expected to be relatively minimal (24).']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 70)]	3	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 186, 'vitamin D synthesis')]
S111-PMC2963768	PMC2963768	10/2010	S111-PMC2963768	['RECENTLY STUDIED female workers in a garment factory in dhaka and SPECULATED that their long day-time hours in indoors, brief exposure to low-intensity sunlight in the early morning, outdoor air pollution, and widespread sunscreen use, in combination with darkly-Pigmented skin, MAY CONTRIBUTE to their POOR Vitamin D status (mean 25(Oh)D of 37 nmol/l, and 15% of the participants had 25(Oh)D <25 nmol/l) (28).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 279), ('SUPERFICIAL_RELATIONSHIP', 283), ('IMPORTANT_CONSIDERATION', 303)]	5	[('CHEBI_26130', 'biological pigment', 263, 'pigmented'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 331, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 385, '25(OH)D')]
S113-PMC2963768	PMC2963768	10/2010	S113-PMC2963768	['inferences regarding the DETERMINANTS of infant/toddlers’ Vitamin D status in THIS STUDY were LIMITED, largely BECAUSE of the SMALL sample-size and substantial uniformity with respect to selected maternal clothing and dietary practices.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('INCOMPLETE_EVIDENCE', 94), ('PROBLEM_COMPLICATION', 111), ('INCOMPLETE_EVIDENCE', 126)]	5	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
S117-PMC2963768	PMC2963768	10/2010	S117-PMC2963768	['SINCE the concentration of Vitamin D Metabolites in Breastmilk is determined by maternal Vitamin D status, maternal Vitamin D deficiency during Lactation MAY cause ongoing deficits in Postnatal infants’ Vitamin D intake (42); YET, maternal FACTORS CANNOT ENTIRELY ACCOUNT for the persistence of low 25(Oh)D among toddlers (table 1) who experience direct exposure to sun and should BE unaffected by the conservative clothing practices of their mothers.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 154), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 226), ('ANOMALY_CURIOUS_FINDING', 226), ('SUPERFICIAL_RELATIONSHIP', 240), ('INCOMPLETE_EVIDENCE', 248), ('IMPORTANT_CONSIDERATION', 264), ('ANOMALY_CURIOUS_FINDING', 381)]	9	[('CHEBI_26871', 'terpene alkaloid', 27, 'vitamin D metabolites'), ('UBERON_0001348', 'brown adipose tissue', 52, 'breastmilk'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007595', 'lactation', 144, 'lactation'), ('GO_0007567', 'parturition', 184, 'postnatal'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 299, '25(OH)D')]
S118-PMC2963768	PMC2963768	10/2010	S118-PMC2963768	['THEREFORE, much remains to be learnt about the DETERMINANTS of Vitamin D status throughout infancy and childhood, PARTICULARLY where 25(Oh)D APPEARS DISCREPANT from that which would be expected BASED ON latitude.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 47), ('IMPORTANT_CONSIDERATION', 114), ('ANOMALY_CURIOUS_FINDING', 141), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 149), ('SUPERFICIAL_RELATIONSHIP', 194)]	6	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D')]
S138-PMC2963768	PMC2963768	10/2010	S138-PMC2963768	['beyond rickets, SPECULATION abounds regarding the POTENTIAL Extra-Skeletal CONSEQUENCES of suboptimal Vitamin D status during Foetal Development and infancy.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 50), ('PROBLEM_COMPLICATION', 75)]	3	[('UBERON_0005614', 'lens anterior epithelium', 60, 'extra'), ('UBERON_0004288', 'skeleton', 66, 'skeletal'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0060324', 'face development', 126, 'foetal development')]
S141-PMC2963768	PMC2963768	10/2010	S141-PMC2963768	['if Vitamin D deficiency is CONFIRMED AS a RISK FACTOR for pneumonia, INTERVENTIONS to improve maternal-infant Vitamin D status COULD reduce THE GLOBAL BURDEN of alri, the single most IMPORTANT cause of early childhood death in the world (58).']	[('INCOMPLETE_EVIDENCE', 27), ('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 42), ('FUTURE_WORK', 69), ('INCOMPLETE_EVIDENCE', 127), ('QUESTION_ANSWERED_BY_THIS_WORK', 140), ('IMPORTANT_CONSIDERATION', 144), ('IMPORTANT_CONSIDERATION', 183)]	8	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
S143-PMC2963768	PMC2963768	10/2010	S143-PMC2963768	['HOWEVER, rigorous studies of the broad health benefits of interventions to improve the Antenatal or Postnatal Vitamin D status in south asian mothers and infants have YET to be REPORTED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 167), ('INCOMPLETE_EVIDENCE', 177)]	3	[('GO_0007567', 'parturition', 87, 'antenatal'), ('GO_0007567', 'parturition', 100, 'postnatal'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
S146-PMC2963768	PMC2963768	10/2010	S146-PMC2963768	['selection of control was necessarily non-random from the perspective of age and gender and, thus, UNFORTUNATELY led to an over-representation of boys; however, there is UNLIKELY to be a gender DIFFERENTIAL in Vitamin D status during early infancy (63).']	[('IMPORTANT_CONSIDERATION', 98), ('PROBABLE_UNDERSTANDING', 169), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 193)]	3	[('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
S148-PMC2963768	PMC2963768	10/2010	S148-PMC2963768	['aside from these caveats, the community-based sampling was LIKELY random with respect to most DETERMINANTS of Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 59), ('SUPERFICIAL_RELATIONSHIP', 94)]	2	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
S152-PMC2963768	PMC2963768	10/2010	S152-PMC2963768	['conclusions\nTHIS STUDY provides initial OBSERVATIONS on the Vitamin D status of young infants in northeastern rural bangladesh.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('INCOMPLETE_EVIDENCE', 40)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
S86-PMC3004407	PMC3004407	12/2010	S86-PMC3004407	['a small percentage (5.2%) of the women reported dietary restrictions that MAY have INFLUENCED their Vitamin D status; 3% reported such restrictions for health reasons such as type 2 diabetes, 0.9% for religious reasons (vegetarian), and 1.3% gave no reason.']	[('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 83)]	2	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
S87-PMC3004407	PMC3004407	12/2010	S87-PMC3004407	['the mean Vitamin D status of the cohort, AS measured by total circulating 25(Oh)D, was 21.7 ± 9.7\u2009ng/ml (range 3.8 to 73.8; unavailable for 7 participants).']	[('PROBABLE_UNDERSTANDING', 41)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 74, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 74, '25(OH)D')]
S101-PMC3004407	PMC3004407	12/2010	S101-PMC3004407	['multinomial logistic regression models for the three Vitamin D categories (deficient, insufficient, and sufficient) were constructed TO EVALUATE the ASSOCIATION between Vitamin D status and age, gravidity, race, and season of measurement.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 133), ('SUPERFICIAL_RELATIONSHIP', 149)]	2	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
S104-PMC3004407	PMC3004407	12/2010	S104-PMC3004407	['the association between RELEVANT prior and current medical conditions and present Vitamin D status is summarized intable 4.']	[('IMPORTANT_CONSIDERATION', 24)]	1	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
S130-PMC3004407	PMC3004407	12/2010	S130-PMC3004407	['women who reported taking a Prenatal Vitamin containing 400\u2009iu Vitamin D did not differ from those who did not in Vitamin D status as measured by 25(Oh)d.\nWHILE present in caucasian women, the greatest prevalence of deficiency was NOTED in those women of darker pigmentation, specifically, african-american and hispanic women.']	[('ANOMALY_CURIOUS_FINDING', 155), ('ANOMALY_CURIOUS_FINDING', 231)]	2	[('GO_0007565', 'female pregnancy', 28, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 37, 'vitamin'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 146, '25(OH')]
S143-PMC3004407	PMC3004407	12/2010	S143-PMC3004407	['after accounting for the EFFECT of Gestational age through multivariable regression, 25(Oh)D status retained a significant negative ASSOCIATION with pth, CONFIRMING that EVEN during Pregnancy, pth is a PREDICTOR of Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 25), ('SUPERFICIAL_RELATIONSHIP', 132), ('PROBABLE_UNDERSTANDING', 154), ('ANOMALY_CURIOUS_FINDING', 170), ('SUPERFICIAL_RELATIONSHIP', 202)]	5	[('GO_0007565', 'female pregnancy', 35, 'gestational'), ('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D'), ('PR_000011040', 'nuclear receptor coactivator 1', 87, '(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 91, 'D'), ('GO_0007565', 'female pregnancy', 182, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D')]
S150-PMC3004407	PMC3004407	12/2010	S150-PMC3004407	['what is MOST CONCERNING is that use of Prenatal Vitamins containing 400\u2009iu/tablet was IRRELEVANT in AFFECTING Vitamin D status: those who took their prescribed Prenatal vitamin containing Vitamin D did not differ from those who did not.']	[('PROBABLE_UNDERSTANDING', 8), ('IMPORTANT_CONSIDERATION', 13), ('IMPORTANT_CONSIDERATION', 86), ('SUPERFICIAL_RELATIONSHIP', 100)]	4	[('GO_0007565', 'female pregnancy', 39, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 48, 'vitamins'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('GO_0007565', 'female pregnancy', 160, 'prenatal'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D')]
S151-PMC3004407	PMC3004407	12/2010	S151-PMC3004407	['women taking their Prenatal Vitamins SHOULD BE counseled that the amount of Vitamin D contained in their Prenatal Vitamin will not affect their Vitamin D status [33,56,57].']	[('FUTURE_WORK', 37)]	1	[('GO_0007565', 'female pregnancy', 19, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 28, 'vitamins'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007565', 'female pregnancy', 105, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 114, 'vitamin'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
S152-PMC3004407	PMC3004407	12/2010	S152-PMC3004407	['the STRENGTHS of the study are that a large and diverse group of women at various stages of Pregnancy were studied to: (1) ascertain their Vitamin D status at the time of presentation to a community health center and (2) find WHAT FACTORS were most PREDICTIVE of that status in a sun-rich environment where THEORETICALLY there are no LIMITATIONS to achieving an adequate Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 4), ('EXPLICIT_QUESTION', 226), ('SUPERFICIAL_RELATIONSHIP', 231), ('SUPERFICIAL_RELATIONSHIP', 249), ('INCOMPLETE_EVIDENCE', 307), ('INCOMPLETE_EVIDENCE', 334)]	6	[('GO_0007565', 'female pregnancy', 92, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 371, 'vitamin D')]
S0-PMC3034879	PMC3034879	12/2010	S0-PMC3034879	['maternal Vitamin D status AFFECTS bone growth in early childhood—a prospective cohort study\n\nabstract\n\nsummary\nin this prospective study, 87 children were followed up from Birth to 14\xa0months with data on maternal Vitamin D status during the Pregnancy.']	[('SUPERFICIAL_RELATIONSHIP', 26)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007567', 'parturition', 172, 'birth'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('GO_0007565', 'female pregnancy', 241, 'pregnancy')]
S1-PMC3034879	PMC3034879	12/2010	S1-PMC3034879	['Postnatal Vitamin D supplementation improved Vitamin D status BUT ONLY PARTLY eliminated the differences in bone variables induced by maternal Vitamin D status during the fetal period.']	[('ANOMALY_CURIOUS_FINDING', 62), ('ANOMALY_CURIOUS_FINDING', 66), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 71)]	4	[('GO_0007567', 'parturition', 0, 'Postnatal'), ('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
S3-PMC3034879	PMC3034879	12/2010	S3-PMC3034879	['we EVALUATED the ROLE of Prenatal and Postnatal Vitamin D status on bone parameters in early infancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 17)]	2	[('GO_0007565', 'female pregnancy', 25, 'prenatal'), ('GO_0007567', 'parturition', 38, 'postnatal'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
S8-PMC3034879	PMC3034879	12/2010	S8-PMC3034879	['FINDINGS were compared with maternal Vitamin D status during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy')]
S14-PMC3034879	PMC3034879	12/2010	S14-PMC3034879	['conclusions\nPostnatal Vitamin D supplementation improved Vitamin D status BUT ONLY PARTLY eliminated the differences in bone variables induced by maternal Vitamin D status during the fetal period.']	[('ANOMALY_CURIOUS_FINDING', 74), ('ANOMALY_CURIOUS_FINDING', 78), ('INCOMPLETE_EVIDENCE', 83)]	3	[('GO_0007567', 'parturition', 12, 'Postnatal'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
S15-PMC3034879	PMC3034879	12/2010	S15-PMC3034879	['FURTHER ATTENTION SHOULD BE PAID to improving Vitamin D status during Pregnancy.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('FUTURE_WORK', 18), ('IMPORTANT_CONSIDERATION', 28)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy')]
S19-PMC3034879	PMC3034879	12/2010	S19-PMC3034879	['low maternal Vitamin D status or inadequate dietary Vitamin D intake during Pregnancy PREDISPOSES children to asthma and allergic rhinitis [6], diabetes [7], acute lower respiratory infection [8], and impaired bone mass accrual.']	[('SUPERFICIAL_RELATIONSHIP', 86)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy')]
S28-PMC3034879	PMC3034879	12/2010	S28-PMC3034879	['BASED ON these results, it was CONCLUDED that maternal Vitamin D status AFFECTS bone Mineral accrual and INFLUENCES bone size during the Intrauterine Period [10].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 72), ('SUPERFICIAL_RELATIONSHIP', 105)]	5	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_46662', 'mineral', 85, 'mineral'), ('UBERON_0006351', 'principal vein of forelimb', 137, 'intrauterine period')]
S30-PMC3034879	PMC3034879	12/2010	S30-PMC3034879	['the first was to follow WHETHER the Vitamin D-ASSOCIATED Skeletal EFFECTS observed at Birth persist during the first year of Life, and the second was TO EVALUATE the IMPACT of Postnatal Vitamin D status on bone growth and development in early infancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('SUPERFICIAL_RELATIONSHIP', 46), ('SUPERFICIAL_RELATIONSHIP', 66), ('QUESTION_ANSWERED_BY_THIS_WORK', 150), ('SUPERFICIAL_RELATIONSHIP', 166)]	5	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0004288', 'skeleton', 57, 'skeletal'), ('GO_0007567', 'parturition', 86, 'birth'), ('UBERON_0000104', 'life cycle', 125, 'life'), ('GO_0007567', 'parturition', 176, 'postnatal'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D')]
S104-PMC3034879	PMC3034879	12/2010	S104-PMC3034879	['higher dietary intake of Vitamin D and use of d3supplements were RELATED to improved Vitamin D status.']	[('SUPERFICIAL_RELATIONSHIP', 65)]	1	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
S145-PMC3034879	PMC3034879	12/2010	S145-PMC3034879	['we CONSIDER this as a random finding because it is UNLIKELY that higher maternal Vitamin D status would contribute to this and SEVERAL STUDIES have witnessed that Vitamin D deficiency is RELATED to delayed age of walking [24,25].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('PROBABLE_UNDERSTANDING', 51), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 187)]	4	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
S153-PMC3034879	PMC3034879	12/2010	S153-PMC3034879	['Tibia csa REMAINED SOMEWHAT larger in infants whose mothers had better Vitamin D status during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 19)]	2	[('UBERON_0000979', 'tibia', 0, 'Tibia'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007565', 'female pregnancy', 95, 'pregnancy')]
S166-PMC3034879	PMC3034879	12/2010	S166-PMC3034879	['the greater increase in bmc in low d group is LIKELY to be due to increased calcium accrual, AS reverted Vitamin D status enhances calcium absorption.']	[('PROBABLE_UNDERSTANDING', 46), ('PROBABLE_UNDERSTANDING', 93)]	2	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
S167-PMC3034879	PMC3034879	12/2010	S167-PMC3034879	['SOME STUDIES have witnessed that insufficient Vitamin D status during Pregnancy is RELATED to lower bone Mineral status in the newborn [9,10,28].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 83)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('CHEBI_46662', 'mineral', 105, 'mineral')]
S169-PMC3034879	PMC3034879	12/2010	S169-PMC3034879	['improved Postnatal Vitamin D status results in catch-up in bmc, BUT NOT in csa.']	[('ANOMALY_CURIOUS_FINDING', 64)]	1	[('GO_0007567', 'parturition', 9, 'postnatal'), ('CHEBI_27300', 'vitamin D', 19, 'vitamin D')]
S179-PMC3034879	PMC3034879	12/2010	S179-PMC3034879	['INTERESTINGLY, the use of d3supplements was ASSOCIATED with improved Vitamin D status to a greater extent than use of d2supplements, which is IN LINE WITH FINDINGS of houghton and vieth [38].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 142), ('INCOMPLETE_EVIDENCE', 155)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
S185-PMC3034879	PMC3034879	12/2010	S185-PMC3034879	['the study SHOWS that fetal Vitamin D status, RATHER than Postnatal Vitamin D status, AFFECTS bone growth during the first year.']	[('INCOMPLETE_EVIDENCE', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 45), ('SUPERFICIAL_RELATIONSHIP', 85)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007567', 'parturition', 57, 'postnatal'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
S189-PMC3034879	PMC3034879	12/2010	S189-PMC3034879	['there was a positive ASSOCIATION between total intake of Vitamin D and 25-Ohd in the entire group and in high d, but NOT among those infants in low D whose Vitamin D status during Pregnancy was worse.']	[('SUPERFICIAL_RELATIONSHIP', 21), ('ANOMALY_CURIOUS_FINDING', 117)]	2	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_72765', 'verruculogen', 71, '25-OHD'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 148, 'D'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0007565', 'female pregnancy', 180, 'pregnancy')]
S192-PMC3034879	PMC3034879	12/2010	S192-PMC3034879	['optimally, Vitamin D sufficiency SHOULD BE guaranteed during fetal Life AS the FINDINGS of the PRESENT STUDY SUGGEST that the CONSEQUENCES of POOR Vitamin D status during the fetal period cannot be totally reverted by Postnatal Vitamin D supplementation.']	[('FUTURE_WORK', 33), ('IMPORTANT_CONSIDERATION', 33), ('PROBABLE_UNDERSTANDING', 72), ('INCOMPLETE_EVIDENCE', 79), ('QUESTION_ANSWERED_BY_THIS_WORK', 95), ('INCOMPLETE_EVIDENCE', 109), ('PROBLEM_COMPLICATION', 126), ('IMPORTANT_CONSIDERATION', 142)]	8	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0000104', 'life cycle', 67, 'life'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007567', 'parturition', 218, 'postnatal'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D')]
S198-PMC3034879	PMC3034879	12/2010	S198-PMC3034879	['HOWEVER, the strength of THIS STUDY was a prospective study design with Antenatal Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 25)]	2	[('GO_0007567', 'parturition', 72, 'antenatal'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
S199-PMC3034879	PMC3034879	12/2010	S199-PMC3034879	['it CAN BE concluded that Postnatal Vitamin D supplementation improved Vitamin D status in infants and PARTLY eliminated the differences in bone variables that had resulted from maternal Vitamin D status during the fetal period.']	[('FUTURE_WORK', 3), ('INCOMPLETE_EVIDENCE', 102)]	2	[('GO_0007567', 'parturition', 25, 'postnatal'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D')]
S201-PMC3034879	PMC3034879	12/2010	S201-PMC3034879	['it SEEMS UNLIKELY, THEREFORE, that IMPROVING Vitamin D intake merely in infancy would revert the CONSEQUENCES of POOR Vitamin D status during the Fetal Period.']	[('ANOMALY_CURIOUS_FINDING', 3), ('PROBABLE_UNDERSTANDING', 9), ('PROBABLE_UNDERSTANDING', 19), ('FUTURE_WORK', 35), ('PROBLEM_COMPLICATION', 97), ('IMPORTANT_CONSIDERATION', 113)]	6	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('UBERON_0002375', 'cricoid cartilage', 146, 'fetal period')]
S202-PMC3034879	PMC3034879	12/2010	S202-PMC3034879	['based ON these OBSERVATIONS, ADDITIONAL EFFORTS SHOULD BE MADE to improve Vitamin D status during Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 6), ('ANOMALY_CURIOUS_FINDING', 6), ('INCOMPLETE_EVIDENCE', 15), ('FUTURE_WORK', 29), ('FUTURE_WORK', 40), ('FUTURE_WORK', 48)]	6	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy')]
S40-PMC3061267	PMC3061267	2/2011	S40-PMC3061267	['WHILE DEFICIENCIES of several Nutrients besides iron CAN cause anemia, and SOME Nutrients like Vitamin A are OFTEN LINKED to iron status, a RECENT review FOUND no greater IMPACT of a multimicronutrient supplement on iron status THAN supplementing with iron alone [17].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 6), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 75), ('PROBABLE_UNDERSTANDING', 109), ('SUPERFICIAL_RELATIONSHIP', 115), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 154), ('SUPERFICIAL_RELATIONSHIP', 171), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228)]	10	[('CHEBI_33284', 'nutrient', 30, 'nutrients'), ('CHEBI_33284', 'nutrient', 80, 'nutrients'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin A')]
S11-PMC3075531	PMC3075531	7/2010	S11-PMC3075531	['SHOWED that sun exposure in Childhood period PREVENTS from ms.16third, it SEEMS low risk of ms in white population is ASSOCIATED with high Serum level of vitamin d or high oral Intake via supplements or oily fish in SOME STUDIES.217–19fourth, it HAVE BEEN SHOWN that Vitamin D CAN be a PROTECTIVE agent against experimental Autoimmune encephalitis in Mice (like ms in Humans).48finally, some scientists administered 100-1700 iu/day Vitamin D supplements in ms patients and OBSERVED the reduction of relapses.20–22the CANDIDATE for estimating Serum level of Vitamin D is 25-Hydroxy Vitamin D, BECAUSE of its prolonged half-Life.823–25it is used to assess an Individual’s overall Vitamin D nutritional status, BECAUSE its formation, UNLIKE that of 1, 25-Dihydroxy Vitamin D, is not tightly Regulated and it has a relatively long half-life (20-60 days).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 45), ('ANOMALY_CURIOUS_FINDING', 74), ('SUPERFICIAL_RELATIONSHIP', 118), ('INCOMPLETE_EVIDENCE', 216), ('INCOMPLETE_EVIDENCE', 246), ('INCOMPLETE_EVIDENCE', 277), ('SUPERFICIAL_RELATIONSHIP', 286), ('INCOMPLETE_EVIDENCE', 473), ('INCOMPLETE_EVIDENCE', 517), ('PROBABLE_UNDERSTANDING', 592), ('PROBABLE_UNDERSTANDING', 708), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 731)]	13	[('UBERON_0013628', 'pollical pad', 28, 'childhood'), ('UBERON_0001977', 'blood serum', 139, 'serum'), ('GO_0007631', 'feeding behavior', 177, 'intake'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 324, 'autoimmune'), ('NCBITaxon_10088', 'Mus <genus>', 351, 'mice'), ('NCBITaxon_9606', 'Homo sapiens', 368, 'humans'), ('CHEBI_27300', 'vitamin D', 432, 'vitamin D'), ('UBERON_0001977', 'blood serum', 542, 'serum'), ('CHEBI_27300', 'vitamin D', 557, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 570, '25-hydroxy vitamin D'), ('UBERON_0000104', 'life cycle', 622, 'life'), ('NCBITaxon_1', 'root', 657, 'individual'), ('CHEBI_27300', 'vitamin D', 678, 'vitamin D'), ('CHEBI_43176', 'hydroxy group', 752, 'dihydroxy'), ('CHEBI_27300', 'vitamin D', 762, 'vitamin D'), ('GO_0065007', 'biological regulation', 788, 'regulated')]
S43-PMC3075531	PMC3075531	7/2010	S43-PMC3075531	['relative to sun exposure, diet is a POOR source of Colecalciferol, providing ONLY 40-400 iu per Food serving,12WHEREAS whole-body uvb exposure for 20 min for a light-skinned Person during the summer months will produce AT LEAST 10,000 iu.713HOWEVER, increased skin pigmentation, age, use of sunscreen, built environment, and environmental FACTORS that reduce the strength of uvb reaching the earth’s surface (e.g., winter season, high latitude, pollution, cloud cover, and Ozone levels) all CONTRIBUTE to reduce skin Colecalciferol production to the point at which diet MIGHT become the primary source.7–14BECAUSE Melanin Pigment in Human skin absorbs uvb,28black People have lower 25 Hydroxyvitamin D concentrations than white People, and are OFTEN Vitamin D deficient.21HOWEVER, the risk of ms in black People is lower than in white People (BECAUSE of Genetic differences).28analyses of the RELATION between Vitamin D status and ms risk are THEREFORE BETTER done separately within each race/ethnic group.']	[('IMPORTANT_CONSIDERATION', 36), ('ANOMALY_CURIOUS_FINDING', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('PROBABLE_UNDERSTANDING', 219), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 241), ('SUPERFICIAL_RELATIONSHIP', 339), ('SUPERFICIAL_RELATIONSHIP', 491), ('INCOMPLETE_EVIDENCE', 570), ('PROBABLE_UNDERSTANDING', 606), ('PROBABLE_UNDERSTANDING', 744), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 772), ('PROBABLE_UNDERSTANDING', 843), ('SUPERFICIAL_RELATIONSHIP', 893), ('PROBABLE_UNDERSTANDING', 943), ('IMPORTANT_CONSIDERATION', 953)]	15	[('CHEBI_50553', 'mancude carbobicyclic parent', 51, 'colecalciferol'), ('CHEBI_33290', 'food', 96, 'food'), ('NCBITaxon_10088', 'Mus <genus>', 174, 'person'), ('CHEBI_25812', 'ozone', 473, 'ozone'), ('CHEBI_50553', 'mancude carbobicyclic parent', 517, 'colecalciferol'), ('CHEBI_25179', 'melanins', 614, 'melanin'), ('CHEBI_26130', 'biological pigment', 622, 'pigment'), ('NCBITaxon_9606', 'Homo sapiens', 633, 'human'), ('NCBITaxon_10088', 'Mus <genus>', 664, 'people'), ('CHEBI_67828', 'rel-(3aR,4S,6aS,7R,9aR,10aS)-10a-Hydroxy-7-isopropyl-1,4,9a-trimethyl-4,5,6,6a,7,8,9,9a,10,10a-decahydro-3aH-dicyclopenta[a,d]cycloocten-3-one', 682, '25 hydroxyvitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 728, 'people'), ('CHEBI_27300', 'vitamin D', 750, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 805, 'people'), ('NCBITaxon_10088', 'Mus <genus>', 835, 'people'), ('SO_0000704', 'gene', 854, 'genetic'), ('CHEBI_27300', 'vitamin D', 910, 'vitamin D')]
S1-PMC3103150	PMC3103150	3/2011	S1-PMC3103150	['the data on Vitamin D status of healthy term breastfed indian infants and mothers are SCANT.']	[('INCOMPLETE_EVIDENCE', 86)]	1	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D')]
S2-PMC3103150	PMC3103150	3/2011	S2-PMC3103150	['THEREFORE, we undertook THIS STUDY TO DETERMINE the prevalence of Vitamin D deficiency and insufficiency [Serum 25 Hydroxyvitamin D (25Ohd) ≤ 15 ng/ml and 15-20 ng/ml, respectively] among healthy term Breastfed 3 month old infants and their mothers, evaluate for clinical and radiological rickets in those infants having 25Ohd < 10 ng/ml, and check for seasonal variation and PREDICTORS of infants’ Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('SUPERFICIAL_RELATIONSHIP', 376)]	4	"[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('UBERON_0001977', 'blood serum', 106, 'serum'), ('CHEBI_67828', 'rel-(3aR,4S,6aS,7R,9aR,10aS)-10a-Hydroxy-7-isopropyl-1,4,9a-trimethyl-4,5,6,6a,7,8,9,9a,10,10a-decahydro-3aH-dicyclopenta[a,d]cycloocten-3-one', 112, '25 hydroxyvitamin D'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 133, '25OHD'), ('GO_0007567', 'parturition', 201, 'breastfed'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 321, '25OHD'), ('CHEBI_27300', 'vitamin D', 399, 'vitamin D')]"
S13-PMC3103150	PMC3103150	3/2011	S13-PMC3103150	['during the first 6-8 wk of Life, the Vitamin D status of infants is determined by the Vitamin D levels at Birth, which depend ON the Vitamin D status of the mother1.']	[('ANOMALY_CURIOUS_FINDING', 126)]	1	[('UBERON_0000104', 'life cycle', 27, 'life'), ('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('GO_0007567', 'parturition', 106, 'birth'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
S41-PMC3103150	PMC3103150	3/2011	S41-PMC3103150	['these definitions are based ON recent RECOMMENDATIONS regarding classification of Vitamin D status in children, developed after consideration of BIOMARKERS such as changes in alp, bone density and calcium absorption at varying concentrations of 25Ohd16.']	[('ANOMALY_CURIOUS_FINDING', 28), ('ANOMALY_CURIOUS_FINDING', 28), ('FUTURE_WORK', 38), ('SUPERFICIAL_RELATIONSHIP', 145)]	4	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_63310', 'mycinamicin IV(1+)', 245, '25OHD16')]
S124-PMC3103150	PMC3103150	3/2011	S124-PMC3103150	['HOWEVER, for any given infant, it is DIFFICULT to determine reliably the amount of sunlight exposure sufficient to maintain normal Vitamin D status, as it is influenced by many factors such as clothing, skin pigmentation, sunscreen use, weather conditions, latitude, air pollution, time of the day and time of the year31.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('DIFFICULT_TASK', 37)]	2	[('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
S130-PMC3103150	PMC3103150	3/2011	S130-PMC3103150	['maternal Vitamin D status, intake of Vitamin supplement by infant and exposure to sunlight were positively CORRELATED with infants’ 25Ohd concentration.']	[('SUPERFICIAL_RELATIONSHIP', 107)]	1	"[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 37, 'vitamin'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 132, '25OHD')]"
S22-PMC3235789	PMC3235789	12/2011	S22-PMC3235789	['ONE us cohort STUDY has EXAMINED the ASSOCIATION between maternal Vitamin D status and bv in Pregnancy, FINDING a dose-response RELATIONSHIP between the mean unadjusted Serum 25-Oh-D concentration and the prevalence of Bv per gram stain of Vaginal smears obtained in early Pregnancy [29].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 104), ('SUPERFICIAL_RELATIONSHIP', 128)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007565', 'female pregnancy', 93, 'pregnancy'), ('UBERON_0001977', 'blood serum', 169, 'serum'), ('CHEBI_65350', 'lorcaserin hydrochloride', 177, '-OH-D'), ('PR_000004696', 'apoptosis facilitator Bcl-2-like protein 14', 219, 'BV'), ('UBERON_0001987', 'placenta', 240, 'vaginal'), ('GO_0007565', 'female pregnancy', 273, 'pregnancy')]
S32-PMC3235789	PMC3235789	12/2011	S32-PMC3235789	['THIS STUDY involved the biochemical assessment of Vitamin D, Folate, and polyunsaturated Fatty Acid status from stored edta Plasma samples collected during the Delivery admission and comparison of Vitamin D, Folate, and polyunsaturated Fatty Acid nutriture for women with and without a diagnosis of bv during the Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0)]	1	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 61, 'folate'), ('CHEBI_35366', 'fatty acid', 89, 'fatty acid'), ('UBERON_0001969', 'blood plasma', 124, 'plasma'), ('GO_0007567', 'parturition', 160, 'delivery'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 208, 'folate'), ('CHEBI_35366', 'fatty acid', 236, 'fatty acid'), ('GO_0007565', 'female pregnancy', 313, 'pregnancy')]
S105-PMC3235789	PMC3235789	12/2011	S105-PMC3235789	['adequate Vitamin D status MAY offer protection against bv by induction of Cathelicidin [41].']	[('INCOMPLETE_EVIDENCE', 26)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('PR_000006009', 'alpha-catulin', 74, 'cathelicidin')]
S108-PMC3235789	PMC3235789	12/2011	S108-PMC3235789	['circulating levels of 25-Oh-D are a direct REFLECTION of total body Vitamin D status, which DEPENDS upon access to Vitamin D EITHER through exposure to sunlight or dietary intake.']	[('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 92), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 125)]	3	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 22, '25-OH-D'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
S110-PMC3235789	PMC3235789	12/2011	S110-PMC3235789	['also, suboptimal Vitamin D status, defined as 25-Oh-D <75\u2009nmol/l (30\u2009ng/ml), is more PREVALENT among non-hispanic black compared with non-hispanic white women (74–95% versus 46–62%) [46].']	[('IMPORTANT_CONSIDERATION', 85)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 46, '25-OH-D')]
S115-PMC3235789	PMC3235789	12/2011	S115-PMC3235789	['THUS, in addition to the myriad OTHER health REASONS for addressing the POOR UNDERLYING Vitamin D and Folate status of us women [48,49], decreasing the susceptibility of women of Reproductive age to bv MAY provide further RATIONALE.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('PROBABLE_UNDERSTANDING', 45), ('IMPORTANT_CONSIDERATION', 72), ('SUPERFICIAL_RELATIONSHIP', 77), ('INCOMPLETE_EVIDENCE', 202), ('PROBABLE_UNDERSTANDING', 222)]	7	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 102, 'folate'), ('GO_0000003', 'reproduction', 179, 'reproductive')]
S0-PMC3257641	PMC3257641	3/2010	S0-PMC3257641	['Vitamin D status during Pregnancy and aspects of offspring health\n\nabstract\nlow maternal Vitamin D levels during Pregnancy HAVE BEEN LINKED to various health outcomes in the offspring, ranging from periconceptional EFFECTS to diseases of Adult onset.']	[('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 133), ('SUPERFICIAL_RELATIONSHIP', 215)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 24, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy'), ('UBERON_0007023', 'adult organism', 238, 'adult')]
S6-PMC3257641	PMC3257641	3/2010	S6-PMC3257641	['in THIS REVIEW, we OUTLINE the RESEARCH EVIDENCE TO DATE RELATING to Vitamin D status and Pregnancy, including a range of POSSIBLE health outcomes from pre-Conception to later Life (figure 1).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 57), ('INCOMPLETE_EVIDENCE', 122)]	7	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 90, 'pregnancy'), ('GO_0007620', 'copulation', 156, 'conception'), ('UBERON_0000104', 'life cycle', 176, 'life')]
S8-PMC3257641	PMC3257641	3/2010	S8-PMC3257641	['caption (fig): figure 1\n\nmanifestation of reviewed POSSIBLE major outcomes RELATED to Vitamin D status at different Life Stages.']	[('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 75)]	2	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0000104', 'life cycle', 116, 'life stages')]
S39-PMC3257641	PMC3257641	3/2010	S39-PMC3257641	['the prevalence of low Vitamin D status during Pregnancy\nas noted above, Vitamin D adequacy DEPENDS on both endogenous, uv-induced synthesis, and exogenous sources, i.e., diet and Supplements.']	[('SUPERFICIAL_RELATIONSHIP', 91)]	1	[('CHEBI_28384', 'vitamin K', 22, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 46, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 179, 'supplements')]
S43-PMC3257641	PMC3257641	3/2010	S43-PMC3257641	['furthermore, SINCE 25(Oh)D is stored in Adipose Tissue, there is SOME EVIDENCE that obesity is a FURTHER RISK FACTOR for Vitamin D insufficiency.nutrients-02-00389-t001_table 1\n\ncaption (table-wrap): table 1\n\nrisk factors for Vitamin D deficiency.low ambient uvr level high latitude locationwinter season inadequate sun exposure built or indoor environmentextensive clothing cover (e.g., veiled)excess sun avoidance – (shade, sunscreen) host factors dark skin pigmentationold ageobesitymalabsorptive syndromes (e.g., inflammatory Bowel disease)\nMANY STUDIES HAVE REPORTED on the Vitamin D status of Pregnant women, in a range of environments (summarized intable 2, including studies from 1997–2006).']	[('PROBLEM_COMPLICATION', 13), ('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 97), ('SUPERFICIAL_RELATIONSHIP', 105), ('INCOMPLETE_EVIDENCE', 545), ('INCOMPLETE_EVIDENCE', 558)]	6	[('CHEBI_71657', 'versiconol acetate', 19, '25(OH)D'), ('UBERON_0001013', 'adipose tissue', 40, 'adipose tissue'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('UBERON_0000160', 'intestine', 530, 'bowel'), ('CHEBI_27300', 'vitamin D', 579, 'vitamin D'), ('GO_0007565', 'female pregnancy', 599, 'pregnant')]
S45-PMC3257641	PMC3257641	3/2010	S45-PMC3257641	['NEVERTHELESS, low Vitamin D status is also PREVALENT in Pregnant caucasian populations, PARTICULARLY those not receiving supplementation (table 2).nutrients-02-00389-t002_table 2\n\ncaption (table-wrap): table 2\n\nthe prevalence of a low Vitamin D status in Pregnancy.referenceyearcountrypopulationstage Of Pregnancydefinition% n/n[127]1997iraniran women attending largest tehran hospitaldelivery<25 nmol/l80% (40/50)[128]1997-2001usaafrican american–90% receiving Prenatal Vitamins4-21 week Gestation<37.5 nmol/l44.9% (89/194)[128]1997-2001usawhite–90% receiving Prenatal Vitamins4-21 week Gestation<37.5 nmol/l2% (4/199)[128]1997-2001usaafrican–american37-42 weeks<37.5 nmol/l29.2% (54/185)[128]1997-2001usawhite37-42 weeks<37.5 nmol/l5% (10/199)[128]1997-2001usaturkish12 week Gestation<25 nmol/l83.5% (66/79)[128]1997-2001usamoroccan12 week Gestation<25 nmol/l81.2% (56/69)[128]1997-2001usaother non-western12 week Gestation<25 nmol/l59% (62/105)[129]1999irelandcaucasians in ulster–on supplements (54–55on)12 weeks<25 nmol/l4.5% (1/22)[129]1999irelandno supplements12 weeks<25 nmol/l44.2% (34/77)[129]1999irelandsupplements20 weeks<25 nmol/l22.7% (5/22)[129]1999irelandno supplements20 weeks<25 nmol/l50.6% (39/77)[129]1999irelandsupplements35 weeks<25 nmol/l0% (0/22)[129]1999irelandno supplements35 weeks<25 nmol/l20.8% (16/77)[32]1999-2000australiaveiled &/or dark skinned women attending Antenatal clinicduring Antenatal care, when a routine Blood test was ordered<22.5 nmol/l80.5% (66/82)[130]1999-2000united arab emirateskuwaitdelivery<25 nmol/l40% (86/214)[131]2002indiaattendees of queen mary’s hosptal, lucknow (26.8on) northern india – urbandelivery–full term, live<22.5 nmol/l84.3% (118/140)[131]2002indiaattendees of queen mary’s hosptal, lucknow (26.8on) northern india–urbanrural<56.3 nmol/l84%(56/67)[132]2005-2006indiaresidents of barabanki district, 26.8onsecond trimester<50 nmol/l74.1% (103/139)\n\n4.1.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 43), ('ANOMALY_CURIOUS_FINDING', 88), ('IMPORTANT_CONSIDERATION', 88)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 56, 'pregnant'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D'), ('GO_0007565', 'female pregnancy', 255, 'pregnancy'), ('GO_0007308', 'oocyte construction', 301, 'of PregnancyDefinition'), ('GO_0007565', 'female pregnancy', 462, 'prenatal'), ('CHEBI_38749', 'dihydroxyflavanone', 471, 'vitamins4'), ('GO_0007565', 'female pregnancy', 489, 'gestation'), ('GO_0007565', 'female pregnancy', 561, 'prenatal'), ('CHEBI_38749', 'dihydroxyflavanone', 570, 'vitamins4'), ('GO_0007565', 'female pregnancy', 588, 'gestation'), ('GO_0007565', 'female pregnancy', 777, 'gestation'), ('GO_0007565', 'female pregnancy', 842, 'gestation'), ('GO_0007565', 'female pregnancy', 916, 'gestation'), ('GO_0007567', 'parturition', 1394, 'antenatal'), ('GO_0007567', 'parturition', 1417, 'antenatal'), ('UBERON_0000178', 'blood', 1448, 'blood')]
S75-PMC3257641	PMC3257641	3/2010	S75-PMC3257641	['ONGOING RESEARCH is examining the ROLE of 1,25(Oh)2D in decreasing the risk of infections during Pregnancy and WHETHER Vitamin D status alters the risk of developing adverse outcomes following such infections.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111)]	3	[('CHEBI_82784', 'PVP38-Ag NP', 42, '1,25(OH)2D'), ('GO_0007565', 'female pregnancy', 97, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
S85-PMC3257641	PMC3257641	3/2010	S85-PMC3257641	['Immunomodulation\nearly Life Immunomodulation is LIKELY to also be AFFECTED by Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 48), ('SUPERFICIAL_RELATIONSHIP', 66)]	2	[('GO_0060819', 'inactivation of X chromosome by genetic imprinting', 0, 'Immunomodulation'), ('UBERON_0000104', 'life cycle', 23, 'life'), ('GO_0050900', 'leukocyte migration', 28, 'immunomodulation'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
S90-PMC3257641	PMC3257641	3/2010	S90-PMC3257641	['in a cross sectional study, caesarean section was almost four-times MORE COMMON in women with Vitamin D insufficiency (Serum 25(Oh)D < 37.5 nmol/l) compared to Vitamin D-sufficient women (Serum 25(Oh)D ≥ 37.5 nmol/l), after adjustment for race, age, education level, insurance status, and Alcohol use (adjusted or 3.84; 95% ci 1.71–8.62) [59].']	[('PROBABLE_UNDERSTANDING', 68)]	1	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0001977', 'blood serum', 119, 'serum'), ('CHEBI_71657', 'versiconol acetate', 125, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 125, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('UBERON_0001977', 'blood serum', 188, 'serum'), ('CHEBI_71657', 'versiconol acetate', 194, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 194, '25(OH)D'), ('CHEBI_30879', 'alcohol', 289, 'alcohol')]
S92-PMC3257641	PMC3257641	3/2010	S92-PMC3257641	['Birth weight\nOBSERVATIONAL STUDIES of Vitamin D status during Pregnancy and physical characteristics of the offspring are FEW and provide CONFLICTING results.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 138)]	3	[('GO_0007567', 'parturition', 0, 'Birth'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0007565', 'female pregnancy', 62, 'pregnancy')]
S93-PMC3257641	PMC3257641	3/2010	S93-PMC3257641	['ONE STUDY FOUND Pregnancies of mothers with low Vitamin D status were shorter (by 0.7 week; 95% ci −1.3, −0.1) [60], and the babies had poorer Intrauterine long bone growth [60], WHILE in OTHER studies, offspring had lower Birth weight [61,62,63].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 188)]	4	[('GO_0007565', 'female pregnancy', 16, 'pregnancies'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0022293', 'reproductive gland secretion', 143, 'intrauterine'), ('GO_0007567', 'parturition', 223, 'birth')]
S103-PMC3257641	PMC3257641	3/2010	S103-PMC3257641	['low maternal Vitamin D status MAY slow neonatal Cardiac Development [69] and alter Brain morphology [70,71], with changes in the latter persisting into Adulthood [72].']	[('INCOMPLETE_EVIDENCE', 30)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007507', 'heart development', 48, 'cardiac development'), ('UBERON_0000948', 'heart', 48, 'cardiac'), ('UBERON_0000955', 'brain', 83, 'brain'), ('UBERON_0000113', 'post-juvenile adult stage', 152, 'adulthood')]
S111-PMC3257641	PMC3257641	3/2010	S111-PMC3257641	['bone health\nmaternal Vitamin D status INFLUENCES bone health in the offspring [76].']	[('SUPERFICIAL_RELATIONSHIP', 38)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
S134-PMC3257641	PMC3257641	3/2010	S134-PMC3257641	['OBSERVATIONAL studies provide INDIRECT EVIDENCE that low Vitamin D status during early Life MAY increase the RISK of multiple sclerosis [107,108].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 92), ('IMPORTANT_CONSIDERATION', 109)]	4	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0000104', 'life cycle', 87, 'life')]
S139-PMC3257641	PMC3257641	3/2010	S139-PMC3257641	['OTHER CANDIDATE diseases that REQUIRE FURTHER RESEARCH with regard to the POTENTIAL ROLE of Prenatal Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 6), ('FUTURE_WORK', 30), ('IMPORTANT_CONSIDERATION', 30), ('FUTURE_WORK', 38), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 84)]	7	[('GO_0007565', 'female pregnancy', 92, 'prenatal'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
S140-PMC3257641	PMC3257641	3/2010	S140-PMC3257641	['seasonal PATTERNS of Birth in Adults [114] and children [115] with Brain tumors and epilepsy [116] HAVE BEEN NOTED and COULD BE evidence of an EFFECT of low Vitamin D status, BUT this is far from CONCLUSIVE.']	[('SUPERFICIAL_RELATIONSHIP', 9), ('INCOMPLETE_EVIDENCE', 99), ('ANOMALY_CURIOUS_FINDING', 109), ('INCOMPLETE_EVIDENCE', 119), ('SUPERFICIAL_RELATIONSHIP', 143), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 196)]	7	[('GO_0007567', 'parturition', 21, 'birth'), ('UBERON_0007023', 'adult organism', 30, 'adults'), ('UBERON_0000955', 'brain', 67, 'brain'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
S141-PMC3257641	PMC3257641	3/2010	S141-PMC3257641	['a TENTATIVE LINK between Vitamin D status and autism HAS BEEN POSTULATED, arising MAINLY from the FINDINGS of population level studies [117,118].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 2), ('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 62), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 98)]	7	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D')]
S143-PMC3257641	PMC3257641	3/2010	S143-PMC3257641	['in Adult ecological and observational studies there is considerable EVIDENCE that Vitamin D status MAY BE RELATED to risk or prognosis of a number of cancers, including of the Prostate [121] and Breast [122].']	[('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 106)]	3	[('UBERON_0007023', 'adult organism', 3, 'adult'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('UBERON_0002367', 'prostate gland', 176, 'prostate'), ('UBERON_0000310', 'breast', 195, 'breast')]
S147-PMC3257641	PMC3257641	3/2010	S147-PMC3257641	['overview\nIN SUMMARY, we have reviewed the EXISTING EVIDENCE for a range of POSSIBLE adverse offspring health outcomes resulting from low maternal Vitamin D status in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 75)]	3	[('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('GO_0007565', 'female pregnancy', 166, 'pregnancy')]
S152-PMC3257641	PMC3257641	3/2010	S152-PMC3257641	['the MERIT of achieving a relatively high Vitamin D status (>100 nmol/l) has NOT BEEN FULLY ESTABLISHED, particularly in RELATION to offspring Cardiovascular or atopic disease development.']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 120)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 142, 'cardiovascular')]
S153-PMC3257641	PMC3257641	3/2010	S153-PMC3257641	['HOWEVER, the MAJORITY of POTENTIAL adverse offspring health outcomes pertain to low Prenatal Vitamin D status and the EVOLVING EVIDENCE has provided greater IMPETUS for PUBLIC HEALTH EFFORTS to ensure mothers are not frankly Vitamin D deficient (<25 nmol/l) in Pregnancy, ALTHOUGH the value of treating relative Vitamin D insufficiency in Pregnancy is NOT clearly ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 13), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 118), ('IMPORTANT_CONSIDERATION', 157), ('IMPORTANT_CONSIDERATION', 169), ('FUTURE_WORK', 183), ('ANOMALY_CURIOUS_FINDING', 272), ('FULL_UNKNOWN', 352)]	9	[('GO_0007565', 'female pregnancy', 84, 'prenatal'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('GO_0007565', 'female pregnancy', 261, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 312, 'vitamin D'), ('GO_0007565', 'female pregnancy', 339, 'pregnancy')]
S161-PMC3257641	PMC3257641	3/2010	S161-PMC3257641	['for these studies, observational studies will NEED to include seasonal variation in Vitamin D status, POTENTIALLY CONFOUNDING by other seasonal factors such as infection, and also deseasonalized interpersonal variation in Ingested Vitamin D or uvr-derived Vitamin D. with regard to these deaseasonalized MARKERS of Vitamin D status, it is highly LIKELY that Vitamin d status in Pregnancy will be CORRELATED with Ingested or uvr-derived Vitamin D exposure for mothers preceding Pregnancy and offspring after Pregnancy.']	[('FUTURE_WORK', 46), ('INCOMPLETE_EVIDENCE', 102), ('PROBLEM_COMPLICATION', 114), ('SUPERFICIAL_RELATIONSHIP', 304), ('PROBABLE_UNDERSTANDING', 346), ('SUPERFICIAL_RELATIONSHIP', 396)]	6	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0007631', 'feeding behavior', 222, 'ingested'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 315, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 358, 'vitamin'), ('GO_0007565', 'female pregnancy', 378, 'pregnancy'), ('GO_0007631', 'feeding behavior', 412, 'ingested'), ('CHEBI_27300', 'vitamin D', 436, 'vitamin D'), ('GO_0007565', 'female pregnancy', 477, 'pregnancy'), ('GO_0007565', 'female pregnancy', 507, 'pregnancy')]
S162-PMC3257641	PMC3257641	3/2010	S162-PMC3257641	['in this situation, the timing of low Vitamin D’s EFFECT over the Life Course will HAVE TO BE carefully determined, using specific Life Course analytic techniques [125], TO ASSESS WHETHER any low Prenatal Vitamin D status is INDEPENDENTLY ASSOCIATED with health outcomes INDEPENDENTLY of the mother’s Vitamin D status before Pregnancy and the offspring’s Vitamin D status during Postnatal Life.']	[('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 82), ('QUESTION_ANSWERED_BY_THIS_WORK', 169), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179), ('SUPERFICIAL_RELATIONSHIP', 224), ('SUPERFICIAL_RELATIONSHIP', 238), ('SUPERFICIAL_RELATIONSHIP', 270)]	7	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('UBERON_0001281', 'hepatic sinusoid', 65, 'life course'), ('UBERON_0001281', 'hepatic sinusoid', 130, 'life course'), ('GO_0007565', 'female pregnancy', 195, 'prenatal'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 300, 'vitamin D'), ('GO_0007565', 'female pregnancy', 324, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 354, 'vitamin D'), ('GO_0007567', 'parturition', 378, 'postnatal'), ('UBERON_0000104', 'life cycle', 388, 'life')]
S0-PMC3271033	PMC3271033	1/2012	S0-PMC3271033	['EFFECTS of ethnicity and Vitamin D supplementation on Vitamin D status and changes in bone Mineral content in infants\n\nabstract\n\nabstract\n\nbackground\nTO EVALUATE the EFFECTS on Serum 25(Oh)D and Bone mineralization of supplementation of Breast-Fed hispanic and non-hispanic caucasian infants with Vitamin D in infants in houston, texas.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 150), ('SUPERFICIAL_RELATIONSHIP', 166)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_46662', 'mineral', 91, 'mineral'), ('UBERON_0001977', 'blood serum', 177, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 186, 'OH)D'), ('GO_0007567', 'parturition', 195, 'bone'), ('UBERON_0000310', 'breast', 237, 'breast'), ('GO_0007631', 'feeding behavior', 244, 'fed'), ('CHEBI_27300', 'vitamin D', 297, 'vitamin D')]
S13-PMC3271033	PMC3271033	1/2012	S13-PMC3271033	['REMARKABLY, FEW DATA have LOOKED AT modern techniques of assessing bone Mineral status and compared it to Vitamin D levels and supplementation in this population [5].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 26)]	3	[('CHEBI_46662', 'mineral', 72, 'mineral'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
S14-PMC3271033	PMC3271033	1/2012	S14-PMC3271033	['Serum 25-Hydroxyvitamin D (25(Oh)D) is ACCEPTED as the BEST MARKER of Vitamin D status ALTHOUGH it MAY serve PRIMARILY as a MARKER of exposure RATHER than clinical outcomes [2].there are FEW DATA that CORRELATE Serum 25(Oh)D levels with functional outcomes in newborns and small infants.']	[('INCOMPLETE_EVIDENCE', 39), ('IMPORTANT_CONSIDERATION', 55), ('SUPERFICIAL_RELATIONSHIP', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 87), ('INCOMPLETE_EVIDENCE', 99), ('PROBABLE_UNDERSTANDING', 109), ('SUPERFICIAL_RELATIONSHIP', 124), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143), ('INCOMPLETE_EVIDENCE', 187), ('SUPERFICIAL_RELATIONSHIP', 201)]	10	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 6, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 27, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('UBERON_0001977', 'blood serum', 211, 'serum'), ('CHEBI_71657', 'versiconol acetate', 217, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 217, '25(OH)D')]
S15-PMC3271033	PMC3271033	1/2012	S15-PMC3271033	['neonatal Serum 25(Oh)D levels REFLECT a range of in utero FACTORS, most significant of these being the maternal Vitamin D status [6].']	[('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 58)]	2	[('UBERON_0001977', 'blood serum', 9, 'serum'), ('CHEBI_71657', 'versiconol acetate', 15, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 15, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
S20-PMC3271033	PMC3271033	1/2012	S20-PMC3271033	['HOWEVER, the RELATIONSHIP between Vitamin D status and bone-related outcomes in supplemented infants provides INFORMATION about the EFFECTS of these Cord levels and Vitamin D supplementation in early Infancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 110), ('SUPERFICIAL_RELATIONSHIP', 132)]	4	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 149, 'cord'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('UBERON_0000023', 'wing', 200, 'infancy')]
S21-PMC3271033	PMC3271033	1/2012	S21-PMC3271033	['furthermore, FEW DATA have EVALUATED hispanic infants who MAY BE at high-risk for low Vitamin D status DUE TO POOR maternal Vitamin D intake [4].']	[('INCOMPLETE_EVIDENCE', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('INCOMPLETE_EVIDENCE', 58), ('PROBABLE_UNDERSTANDING', 103), ('PROBLEM_COMPLICATION', 110)]	5	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
S109-PMC3271033	PMC3271033	1/2012	S109-PMC3271033	['supplementation with 400 iu/day of Vitamin D to these infants LED TO a relatively greater increase in those who were Born with the lowest Vitamin D status and there was no suggestion of any bone Mineral outcome deficits at one week or three months of age in infants with low Cord 25(Oh)D levels.']	[('SUPERFICIAL_RELATIONSHIP', 62)]	1	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007567', 'parturition', 117, 'born'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('CHEBI_46662', 'mineral', 195, 'mineral'), ('UBERON_0002240', 'spinal cord', 275, 'cord'), ('CHEBI_71657', 'versiconol acetate', 280, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 280, '25(OH)D')]
S113-PMC3271033	PMC3271033	1/2012	S113-PMC3271033	['the close RELATIONSHIPS between weight and length and initial bmc IMPLY that calcium transfer across the Placenta is closely RELATED to overall Nutrient transfer and not to Vitamin D status (7).']	[('SUPERFICIAL_RELATIONSHIP', 10), ('PROBABLE_UNDERSTANDING', 66), ('SUPERFICIAL_RELATIONSHIP', 125)]	3	[('UBERON_0001987', 'placenta', 105, 'placenta'), ('CHEBI_33284', 'nutrient', 144, 'nutrient'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
S140-PMC3271033	PMC3271033	1/2012	S140-PMC3271033	['HOWEVER, it APPEARS that, AT LEAST in a southern us setting, 400 iu/day is adequate for infants REGARDLESS OF Vitamin D status at Birth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 12), ('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 96)]	4	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('GO_0007567', 'parturition', 130, 'birth')]
S147-PMC3271033	PMC3271033	1/2012	S147-PMC3271033	['the 30 ng/ml target is well above that LIKELY TO BE NEEDED for adequate Vitamin D status in the newborn BASED UPON the recent RECOMMENDATIONS of the institute of medicine [2].']	[('FUTURE_PREDICTION', 39), ('SUPERFICIAL_RELATIONSHIP', 104), ('IMPORTANT_CONSIDERATION', 126)]	3	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
S20-PMC3277098	PMC3277098	12/2011	S20-PMC3277098	['more RECENTLY variations in Vitamin D status and intake HAS BEEN IMPLICATED in Allergy Development and CONSIDERED AS one of a NUMBER OF EXPLANATIONS for epidemiological and immunological ASSOCIATIONS.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 65), ('IMPORTANT_CONSIDERATION', 103), ('INCOMPLETE_EVIDENCE', 103), ('PROBABLE_UNDERSTANDING', 114), ('INCOMPLETE_EVIDENCE', 126), ('PROBABLE_UNDERSTANDING', 136), ('SUPERFICIAL_RELATIONSHIP', 187)]	9	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0060021', 'roof of mouth development', 79, 'allergy development')]
S28-PMC3277098	PMC3277098	12/2011	S28-PMC3277098	['lifestyle patterns and environments that do not facilitate adequate sun exposure (indoor occupation, “screen time” and active sun avoidance) PREDISPOSE to inadequate Vitamin D synthesis and status.']	[('SUPERFICIAL_RELATIONSHIP', 141)]	1	[('CHEBI_27300', 'vitamin D', 166, 'vitamin D')]
S33-PMC3277098	PMC3277098	12/2011	S33-PMC3277098	['the developing foetus depends entirely on its mother for supply of 25(Oh)D and poor maternal Vitamin D status is REFLECTED in the infant at Birth [23].']	[('SUPERFICIAL_RELATIONSHIP', 113)]	1	[('CHEBI_71657', 'versiconol acetate', 67, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('GO_0007567', 'parturition', 140, 'birth')]
S34-PMC3277098	PMC3277098	12/2011	S34-PMC3277098	['in non-supplemented infants serum 25(Oh)D status TENDS to decrease over the first few months of Life until sun exposure is increased and Vitamin D-containing Foods introduced into the diet.']	[('SUPERFICIAL_RELATIONSHIP', 49)]	1	[('CHEBI_71657', 'versiconol acetate', 34, '25(OH)D'), ('UBERON_0000104', 'life cycle', 96, 'life'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('CHEBI_33290', 'food', 158, 'foods')]
S35-PMC3277098	PMC3277098	12/2011	S35-PMC3277098	['this RAISES the QUESTION of WHETHER Vitamin D status in utero and early Life has EFFECTS on Immune function and development of allergic disease.']	[('EXPLICIT_QUESTION', 5), ('EXPLICIT_QUESTION', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('SUPERFICIAL_RELATIONSHIP', 81)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0000104', 'life cycle', 72, 'life'), ('UBERON_0002405', 'immune system', 92, 'immune')]
S133-PMC3277098	PMC3277098	12/2011	S133-PMC3277098	['in this cohort 6.5% of women took a Vitamin D-containing Supplement, a FACTOR that was borderline significant for Vitamin D status, and only 3 women met the uk dietary RECOMMENDATION of 10 µg/day.']	[('SUPERFICIAL_RELATIONSHIP', 71), ('FUTURE_WORK', 168)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 57, 'supplement'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
S140-PMC3277098	PMC3277098	12/2011	S140-PMC3277098	['Cord Blood (Cb) HAS BEEN used as a measure of fetal Vitamin D status at Birth in the investigation of Immune function and allergic outcomes.']	[('INCOMPLETE_EVIDENCE', 16)]	1	[('UBERON_0000948', 'heart', 0, 'Cord'), ('UBERON_0000178', 'blood', 5, 'blood'), ('UBERON_2005013', 'concurrent branch afferent branchial artery', 12, 'CB'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007567', 'parturition', 72, 'birth'), ('UBERON_0002405', 'immune system', 102, 'immune')]
S179-PMC3277098	PMC3277098	12/2011	S179-PMC3277098	['FEWER STUDIES have investigated Vitamin D status and Food allergy outcomes.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_33290', 'food', 53, 'food')]
S185-PMC3277098	PMC3277098	12/2011	S185-PMC3277098	['SUPPORTING this observation are SEVERAL STUDIES which FOUND Vitamin D supplementation to be ASSOCIATED with an INCREASED RISK of atopic dermatitis [73], allergic rhinitis [35,74], asthma, sensitisation [69,74] and Food allergy [70], HOWEVER NONE of these papers are SUPPORTED by biological measures of Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 92), ('IMPORTANT_CONSIDERATION', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 233), ('INCOMPLETE_EVIDENCE', 241), ('INCOMPLETE_EVIDENCE', 266)]	8	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_33290', 'food', 214, 'food'), ('CHEBI_27300', 'vitamin D', 302, 'vitamin D')]
S198-PMC3277098	PMC3277098	12/2011	S198-PMC3277098	['IN SUMMARY, the CONTRARY epidemiological OBSERVATIONS between Serum status (GENERALLY PROTECTIVE) and Oral exposure (supplementation increasing allergy risk in MANY STUDIES) HIGHLIGHT the uncertainty surrounding Vitamin D in Allergy Development and precludes population RECOMMENDATIONS.']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 41), ('PROBABLE_UNDERSTANDING', 76), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 174), ('FUTURE_WORK', 270)]	8	[('UBERON_0001977', 'blood serum', 62, 'serum'), ('UBERON_0000165', 'mouth', 102, 'oral'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('GO_0060021', 'roof of mouth development', 225, 'allergy development')]
S199-PMC3277098	PMC3277098	12/2011	S199-PMC3277098	['most of these OBSERVATIONAL studies DID NOT have direct serological measures of 25(Oh)D levels to ACCURATELY CONFIRM Vitamin D status and cross sectional study designs involving older children and Adults fail TO provide EVIDENCE on aetiological FACTORS.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 98), ('INCOMPLETE_EVIDENCE', 109), ('QUESTION_ANSWERED_BY_THIS_WORK', 209), ('INCOMPLETE_EVIDENCE', 220), ('SUPERFICIAL_RELATIONSHIP', 245)]	7	[('CHEBI_71657', 'versiconol acetate', 80, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 80, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('UBERON_0007023', 'adult organism', 197, 'adults')]
S201-PMC3277098	PMC3277098	12/2011	S201-PMC3277098	['FUTURE RESEARCH MUST accurately account for the DIFFERENT sources of Vitamin D, stage of Immune Development and Genetic FACTORS in order to understand the immunological consequences of changing Vitamin d status through supplementation or lifestyle changes.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('SUPERFICIAL_RELATIONSHIP', 120)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0001822', 'kidney development', 89, 'immune development'), ('UBERON_0002405', 'immune system', 89, 'immune'), ('SO_0000704', 'gene', 112, 'genetic'), ('CHEBI_33229', 'vitamin (role)', 194, 'vitamin')]
S205-PMC3277098	PMC3277098	12/2011	S205-PMC3277098	['AS this early Life stage is RELEVANT TO programming of future Immune function it is CRUCIAL to understand the EFFECTS of Vitamin D and identify optimal status levels.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 28), ('IMPORTANT_CONSIDERATION', 84), ('SUPERFICIAL_RELATIONSHIP', 110)]	4	[('UBERON_0000104', 'life cycle', 14, 'life'), ('UBERON_0002405', 'immune system', 62, 'immune'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
S0-PMC3296991	PMC3296991	2/2012	S0-PMC3296991	['EVIDENCE of ASSOCIATIONS between feto-maternal Vitamin D status, Cord Parathyroid Hormone and bone-specific alkaline phosphatase, and newborn Whole body bone Mineral content\n\nabstract\nin SPITE of a high prevalence of Vitamin D inadequacy in Pregnant women and neonates, RELATIONSHIPS among Vitamin D status (25(Oh)D), Parathyroid hormone (pth), bone specific alkaline phosphatase (balp), and Whole body bone Mineral content (wbbmc) in the newborn are POORLY characterized.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 12), ('ANOMALY_CURIOUS_FINDING', 187), ('SUPERFICIAL_RELATIONSHIP', 270), ('PROBLEM_COMPLICATION', 451)]	5	[('CHEBI_28384', 'vitamin K', 47, 'Vitamin D'), ('UBERON_0000948', 'heart', 65, 'Cord'), ('UBERON_0001132', 'parathyroid gland', 70, 'Parathyroid'), ('CHEBI_5762', 'hordatine A', 82, 'Hormone'), ('UBERON_0004043', 'semicircular canal ampulla', 142, 'Whole'), ('CHEBI_46662', 'mineral', 158, 'Mineral'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('GO_0007565', 'female pregnancy', 241, 'pregnant'), ('CHEBI_27300', 'vitamin D', 290, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 308, '25(OH)D'), ('UBERON_0001132', 'parathyroid gland', 318, 'parathyroid'), ('UBERON_0007688', 'anlage', 392, 'whole'), ('CHEBI_46662', 'mineral', 408, 'mineral')]
S10-PMC3296991	PMC3296991	2/2012	S10-PMC3296991	['HOWEVER, the behavior of these BIOMARKERS in the fetus and their RELATIONSHIP with Vitamin D status and neonatal bone mineralization are POORLY characterized.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 31), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBLEM_COMPLICATION', 137)]	4	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
S17-PMC3296991	PMC3296991	2/2012	S17-PMC3296991	['bone BIOMARKERS including balp increase during Pregnancy REGARDLESS OF Vitamin D status and attain higher values in Umbilical Cord Blood than maternal Blood [14], POSSIBLY reflecting higher rates of bone turnover.']	[('SUPERFICIAL_RELATIONSHIP', 5), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 163)]	3	[('GO_0007565', 'female pregnancy', 47, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0002331', 'umbilical cord', 116, 'umbilical cord'), ('UBERON_0000178', 'blood', 131, 'blood'), ('UBERON_0000178', 'blood', 151, 'blood')]
S19-PMC3296991	PMC3296991	2/2012	S19-PMC3296991	['DEMONSTRATED that maternal Vitamin D status CAN INFLUENCE Fetal Femoral Development as early as 19 weeks Gestation [15].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 48)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007631', 'feeding behavior', 58, 'fetal'), ('GO_0009556', 'microsporogenesis', 64, 'femoral development'), ('UBERON_0000981', 'femur', 64, 'femoral'), ('GO_0007565', 'female pregnancy', 105, 'gestation')]
S22-PMC3296991	PMC3296991	2/2012	S22-PMC3296991	['the PURPOSE of the PRESENT STUDY was TO INVESTIGATE the RELATIONSHIPS among maternal and Cord Vitamin D status, pth, balp, and Whole Body bmc (wbbmc) in newborns in a multiethnic population in oakland, california and TO EVALUATE the predictive value of the biochemical indices as indicators of neonatal wbbmc.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 37), ('SUPERFICIAL_RELATIONSHIP', 56), ('QUESTION_ANSWERED_BY_THIS_WORK', 217)]	5	[('UBERON_0002240', 'spinal cord', 89, 'cord'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0000468', 'multicellular organism', 127, 'whole body')]
S48-PMC3296991	PMC3296991	2/2012	S48-PMC3296991	['statistical analysis\nmeasurement of infant wbbmc by dxa in the present study was conducted as a secondary outcome in a comprehensive study estimating prevalence, PREDICTORS, and consequences of Vitamin D status during Pregnancy [18].']	[('SUPERFICIAL_RELATIONSHIP', 162)]	1	[('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('GO_0007565', 'female pregnancy', 218, 'pregnancy')]
S76-PMC3296991	PMC3296991	2/2012	S76-PMC3296991	['season, maternal age, race, pre-Gestational bmi, Vitamin D intake, and Vitamin D status and infant age at the time of the scan, Gestational age at Birth, Feeding pattern (Breast Fed, Formula Fed, or mixed) and Vitamin D status did NOT remain in the final predictive models.']	[('ANOMALY_CURIOUS_FINDING', 231)]	1	[('GO_0007565', 'female pregnancy', 32, 'gestational'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007565', 'female pregnancy', 128, 'gestational'), ('GO_0007567', 'parturition', 147, 'birth'), ('GO_0007631', 'feeding behavior', 154, 'feeding'), ('GO_0007567', 'parturition', 171, 'breast fed'), ('UBERON_0000310', 'breast', 171, 'breast'), ('GO_0009407', 'toxin catabolic process', 183, 'formula fed'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D')]
S98-PMC3296991	PMC3296991	2/2012	S98-PMC3296991	['FURTHER RESEARCH is NECESSARY to CONSIDER the behavior of OTHER BIOMARKERS in RELATIONSHIP to Vitamin D status and their POTENTIAL CONTRIBUTION to PREDICTION of neonatal wbbmc.']	[('FUTURE_WORK', 0), ('IMPORTANT_CONSIDERATION', 20), ('FUTURE_WORK', 33), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 58), ('SUPERFICIAL_RELATIONSHIP', 64), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 121), ('SUPERFICIAL_RELATIONSHIP', 131), ('SUPERFICIAL_RELATIONSHIP', 147)]	9	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
S100-PMC3296991	PMC3296991	2/2012	S100-PMC3296991	['conclusion\nTHIS STUDY PROVIDES EVIDENCE of ASSOCIATIONS between feto-maternal Vitamin D status, cord pth and balp, and neonatal wbbmc, THOUGH neither Cord nor maternal 25(Oh)D were directly CORRELATED with wbbmc.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('PROBABLE_UNDERSTANDING', 22), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 43), ('ANOMALY_CURIOUS_FINDING', 135), ('SUPERFICIAL_RELATIONSHIP', 190)]	6	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 150, 'cord'), ('CHEBI_33010', 'chromide(1-)', 170, '(OH)D')]
S102-PMC3296991	PMC3296991	2/2012	S102-PMC3296991	['because Vitamin D inadequacy during Gestation and its IMPACTS on offspring bone integrity are of PUBLIC HEALTH CONCERN, FURTHER STUDIES ARE WARRANTED to investigate the COMPLEX mechanisms LINKING in utero Vitamin D status to fetal Bone Development.']	[('SUPERFICIAL_RELATIONSHIP', 54), ('IMPORTANT_CONSIDERATION', 97), ('FUTURE_WORK', 120), ('FUTURE_WORK', 128), ('DIFFICULT_TASK', 169), ('SUPERFICIAL_RELATIONSHIP', 188)]	6	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007565', 'female pregnancy', 36, 'gestation'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D'), ('GO_0048539', 'bone marrow development', 231, 'bone development')]
S161-PMC3338544	PMC3338544	4/2012	S161-PMC3338544	['there are AS YET no epidemiological studies DEMONSTRATING a direct ASSOCIATION between autistic spectrum disorders and developmental Vitamin D levels, YET there are EFFECTS of season of Birth, latitude of Birth, and migrant status that MAY INDICATE a POSSIBLE ASSOCIATION (for review,[39]).']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 67), ('ANOMALY_CURIOUS_FINDING', 151), ('SUPERFICIAL_RELATIONSHIP', 165), ('INCOMPLETE_EVIDENCE', 236), ('INCOMPLETE_EVIDENCE', 240), ('INCOMPLETE_EVIDENCE', 251), ('SUPERFICIAL_RELATIONSHIP', 260)]	9	[('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0007567', 'parturition', 186, 'birth'), ('GO_0007567', 'parturition', 205, 'birth')]
S12-PMC3347007	PMC3347007	4/2012	S12-PMC3347007	['during Pregnancy, Vitamin D is transported from mother to fetus through the Placenta in the form of 25(Oh)D which is also the established MARKER of Vitamin D status [1,3,4].']	[('SUPERFICIAL_RELATIONSHIP', 138)]	1	[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('UBERON_0001987', 'placenta', 76, 'placenta'), ('CHEBI_71657', 'versiconol acetate', 100, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
S16-PMC3347007	PMC3347007	4/2012	S16-PMC3347007	['studies have SUGGESTED that children Born to women with low Vitamin D status have lower scores in terms of Birth weight, Birth length, and bone Mineral content [4].']	[('INCOMPLETE_EVIDENCE', 13)]	1	[('GO_0007567', 'parturition', 37, 'born'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007567', 'parturition', 107, 'birth'), ('GO_0007567', 'parturition', 121, 'birth'), ('CHEBI_46662', 'mineral', 144, 'mineral')]
S19-PMC3347007	PMC3347007	4/2012	S19-PMC3347007	['Animal studies SHOW a POSSIBLE ASSOCIATION between maternal Vitamin D status and Brain Development in pups, which COULD POSSIBLY play a ROLE in Cognitive and Neurological Development [4].']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 120), ('SUPERFICIAL_RELATIONSHIP', 136)]	6	[('NCBITaxon_33208', 'Metazoa', 0, 'Animal'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007420', 'brain development', 81, 'brain development'), ('UBERON_0000955', 'brain', 81, 'brain'), ('GO_0050890', 'cognition', 144, 'cognitive ...'), ('GO_0007399', 'nervous system development', 158, 'neurological development'), ('UBERON_0001016', 'nervous system', 158, 'neurological')]
S21-PMC3347007	PMC3347007	4/2012	S21-PMC3347007	['the definition of optimal Vitamin D status and optimal intake level of Vitamin D HAVE BEEN subject to much DEBATE, and RECOMMENDATIONS VARY between countries.']	[('INCOMPLETE_EVIDENCE', 81), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107), ('FUTURE_WORK', 119), ('DIFFICULT_TASK', 135)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
S22-PMC3347007	PMC3347007	4/2012	S22-PMC3347007	['in scandinavia, all Pregnant women are RECOMMENDED 10 µg of Vitamin D per day to ensure sufficient Vitamin D status [14].']	[('FUTURE_WORK', 39)]	1	[('GO_0007565', 'female pregnancy', 20, 'pregnant'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
S63-PMC3347007	PMC3347007	4/2012	S63-PMC3347007	['the following FACTORS were regarded as POTENTIAL DETERMINANTS of Vitamin D intake and included in the analyses: maternal age (<20, 20–25, 25–30, 30–35, 35–40, ≥40), pre-Pregnancy bmi (≤18.5, 18.5–25, 25–30, 30–35, 35–40, >40), energy intake, parity (0, 1, 2, 3+), civil status (single, coupled/married), socio-occupational status (high, medium, skilled, student, unskilled, unemployed), physical activity level (inactive, light, moderate, high), smoking during Pregnancy (non-smoker, occasional smoker, <15 cigarettes per day, ≥15 cigarettes per day), Alcohol Consumption during Pregnancy (yes, no), season of filling out the ffq, and planned Pregnancy (planned, partly planned, not planned).']	[('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 49)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('GO_0007565', 'female pregnancy', 169, 'pregnancy'), ('GO_0007565', 'female pregnancy', 461, 'pregnancy'), ('CHEBI_30879', 'alcohol', 552, 'alcohol'), ('GO_0007631', 'feeding behavior', 560, 'consumption'), ('GO_0007565', 'female pregnancy', 579, 'pregnancy'), ('GO_0007565', 'female pregnancy', 643, 'pregnancy')]
S97-PMC3347007	PMC3347007	4/2012	S97-PMC3347007	['adjustment for pre-Pregnancy bmi, parity, civil status, socio-occupational status, physical activity level, season of filling out the ffq, smoking and alcohol use during Pregnancy, total energy intake, and Planning Of Pregnancy made the direct ASSOCIATION between maternal age and sufficient total Vitamin D intake stronger.']	[('SUPERFICIAL_RELATIONSHIP', 244)]	1	[('GO_0007565', 'female pregnancy', 19, 'pregnancy'), ('GO_0007565', 'female pregnancy', 170, 'pregnancy'), ('GO_0006915', 'apoptotic process', 206, 'planning of pregnancy'), ('CHEBI_27300', 'vitamin D', 298, 'vitamin D')]
S159-PMC3347007	PMC3347007	4/2012	S159-PMC3347007	['high socio-economic status and education was found TO BE directly ASSOCIATED with Vitamin D intake and supplement use in OTHER studies [17,18,27,28,29].']	[('ANOMALY_CURIOUS_FINDING', 51), ('SUPERFICIAL_RELATIONSHIP', 66), ('INCOMPLETE_EVIDENCE', 121)]	3	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
S163-PMC3347007	PMC3347007	4/2012	S163-PMC3347007	['we also FOUND civil status to be non-significantly ASSOCIATED with Vitamin D intake, with single women being less LIKELY to have sufficient total Vitamin D intake.']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 51), ('PROBABLE_UNDERSTANDING', 114)]	3	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D')]
S43-PMC3347028	PMC3347028	3/2012	S43-PMC3347028	['the half-life of 25(Oh)D is 2–3 weeks, making it a much better INDICATOR of the body’s Vitamin D status than Vitamin D. OF NOTE, 25(Oh)D can be expressed as ng/ml or nmol/l.']	[('SUPERFICIAL_RELATIONSHIP', 63), ('ANOMALY_CURIOUS_FINDING', 120)]	2	[('CHEBI_71657', 'versiconol acetate', 17, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 129, '25(OH)D')]
S83-PMC3347028	PMC3347028	3/2012	S83-PMC3347028	['THUS, pth levels are RELATED to Vitamin D status as well: pth upregulates 1-α-hydroxylase, the enzyme responsible for 1-α-hydroxylation of 25(Oh)D, converting 25(Oh)D to 1,25(Oh)2D.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 21)]	2	"[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 139, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 159, '25(OH)D'), ('CHEBI_66212', ""5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone"", 172, '25(OH)2D')]"
S87-PMC3347028	PMC3347028	3/2012	S87-PMC3347028	['it IS NOT SURPRISING, then that during Pregnancy pth as a MARKER of Vitamin D status is a LESS RELIABLE PREDICTOR than in nonpregnant Adults [60,61,62].']	[('PROBABLE_UNDERSTANDING', 3), ('PROBABLE_UNDERSTANDING', 6), ('ANOMALY_CURIOUS_FINDING', 10), ('SUPERFICIAL_RELATIONSHIP', 58), ('INCOMPLETE_EVIDENCE', 90), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 104)]	7	[('GO_0007565', 'female pregnancy', 39, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0007023', 'adult organism', 134, 'adults')]
S97-PMC3347028	PMC3347028	3/2012	S97-PMC3347028	['WHILE okonofua, et al, SUGGEST that normalization of maternal calcium and pth would be useful endpoints in determining the success of Vitamin D supplementation during Pregnancy, more RECENT STUDIES SUGGEST that BECAUSE pth threshold ESTIMATES cannot be precisely defined, total circulating 25(Oh)D ALONE is a BETTER measure of maternal Vitamin D status [60,64,65].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 183), ('INCOMPLETE_EVIDENCE', 198), ('PROBLEM_COMPLICATION', 211), ('INCOMPLETE_EVIDENCE', 233), ('ANOMALY_CURIOUS_FINDING', 298), ('INCOMPLETE_EVIDENCE', 298), ('INCOMPLETE_EVIDENCE', 309)]	9	[('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007565', 'female pregnancy', 167, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 290, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 336, 'vitamin D')]
S123-PMC3347028	PMC3347028	3/2012	S123-PMC3347028	['a GLOBAL PERSPECTIVE on Vitamin D status of women during Pregnancy\nwith improved laboratory techniques for the measurement of Vitamin D developed in the early 1980’s [73], investigators began to measure the Vitamin D status of Pregnant women.']	[('IMPORTANT_CONSIDERATION', 2), ('INCOMPLETE_EVIDENCE', 9)]	2	[('CHEBI_28384', 'vitamin K', 24, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 57, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D'), ('GO_0007565', 'female pregnancy', 227, 'pregnant')]
S156-PMC3347028	PMC3347028	3/2012	S156-PMC3347028	['BECAUSE Vitamin D status has not been a consistent CONCERN during Pregnancy, long-term DATA are SPARSE.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 51), ('INCOMPLETE_EVIDENCE', 87)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007565', 'female pregnancy', 66, 'pregnancy')]
S166-PMC3347028	PMC3347028	3/2012	S166-PMC3347028	['GIVES INVALUABLE INSIGHT into Vitamin D status of darker Pigmented Individuals living in a sun-rich environment in eastern africa [141].']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 6), ('IMPORTANT_CONSIDERATION', 6), ('INCOMPLETE_EVIDENCE', 17)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_26130', 'biological pigment', 57, 'pigmented'), ('NCBITaxon_1', 'root', 67, 'individuals')]
S177-PMC3347028	PMC3347028	3/2012	S177-PMC3347028	['in addition, WHAT amount of sunlight is sufficient to achieve optimal Vitamin D status varies DEPENDING ON a host of FACTORS such as the time of day, the time of year, the latitude, degree of skin pigmentation, type and extend of clothing, body surface area exposed and one’s body mass index (bmi) [146].']	[('EXPLICIT_QUESTION', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 94), ('SUPERFICIAL_RELATIONSHIP', 117)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
S196-PMC3347028	PMC3347028	3/2012	S196-PMC3347028	['secondary analysis INDICATED that Preterm Birth and labor were inversely RELATED to pre-Delivery Vitamin D status (Preterm Birth or = 0.50 per 10 ng/ml, p = 0.002; Preterm Labor or Birth or = 0.72 per 10 ng/ml, p = 0.012), an EFFECT that PERSISTED EVEN after controlling for race.']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 73), ('SUPERFICIAL_RELATIONSHIP', 226), ('INCOMPLETE_EVIDENCE', 238), ('ANOMALY_CURIOUS_FINDING', 248)]	5	[('GO_0007565', 'female pregnancy', 34, 'preterm'), ('GO_0007567', 'parturition', 42, 'birth'), ('GO_0007567', 'parturition', 88, 'delivery'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'preterm'), ('GO_0007567', 'parturition', 123, 'birth'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 164, 'preterm labor'), ('GO_0007567', 'parturition', 181, 'birth')]
S215-PMC3347028	PMC3347028	3/2012	S215-PMC3347028	['the SIGNIFICANCE of these trials is that Vitamin D status is improved with 4000 iu vitamin D3Taken daily to achieve: (1) optimization of 1,25(Oh)2D production, and (2) improved Cord Blood 25(Oh)D concentration.']	[('IMPORTANT_CONSIDERATION', 4)]	1	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_51469', 'butyllithium', 91, 'D3taken'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 142, 'OH)2D'), ('UBERON_0009472', 'axilla', 177, 'cord blood'), ('CHEBI_71657', 'versiconol acetate', 188, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 188, '25(OH ... D')]
S216-PMC3347028	PMC3347028	3/2012	S216-PMC3347028	['having a higher 25(Oh)D concentration was ASSOCIATED with improved health outcomes in both studies, BUT WHETHER improved Vitamin D status is a MARKER of some OTHER parameter or a direct EFFECT of Vitamin D supplementation REMAINS UNCLEAR at this time.']	[('SUPERFICIAL_RELATIONSHIP', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 104), ('SUPERFICIAL_RELATIONSHIP', 143), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('SUPERFICIAL_RELATIONSHIP', 186), ('FULL_UNKNOWN', 222)]	7	[('CHEBI_71657', 'versiconol acetate', 16, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D')]
S229-PMC3347028	PMC3347028	3/2012	S229-PMC3347028	['WHAT about the interplay between genetics, epigenetics and daily fluxes in Vitamin D status?']	[('EXPLICIT_QUESTION', 0), ('EXPLICIT_QUESTION', 91)]	2	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
S242-PMC3347028	PMC3347028	3/2012	S242-PMC3347028	['a RECENT randomized controlled TRIAL with 350 women of diverse racial and ethnic backgrounds SHOWED that 4000 iu Vitamin D/day is MOST EFFECTIVE in improving the Vitamin D status of Pregnant women, attaining circulating levels of at least 40 ng/ml (100 nmol/l) for 25(Oh)D, and was NECESSARY to achieve OPTIMAL 1,25(Oh)2D production.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 93), ('PROBABLE_UNDERSTANDING', 130), ('SUPERFICIAL_RELATIONSHIP', 135), ('IMPORTANT_CONSIDERATION', 282), ('IMPORTANT_CONSIDERATION', 303)]	6	"[('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('GO_0007565', 'female pregnancy', 182, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 265, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 267, '(OH ... D'), ('CHEBI_37983', 'sulfur-35 atom', 311, '1'), ('CHEBI_66212', ""5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone"", 313, '25(OH)2D')]"
S4-PMC3355895	PMC3355895	1/2011	S4-PMC3355895	['THUS factors such as maternal lifestyle, diet, body build, physical activity, and Vitamin D status in Pregnancy all APPEAR to INFLUENCE offspring bone Mineral accrual.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 116), ('SUPERFICIAL_RELATIONSHIP', 126)]	3	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('CHEBI_46662', 'mineral', 151, 'mineral')]
S52-PMC3355895	PMC3355895	1/2011	S52-PMC3355895	['these OBSERVATIONS MAY SUGGEST a POSSIBLE mechanism for the INFLUENCE of maternal Vitamin D status on Placental Calcium Transport and Intrauterine bone Mineral accrual.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 60)]	5	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'placental'), ('UBERON_0001987', 'placenta', 102, 'placental'), ('GO_0006816', 'calcium ion transport', 112, 'calcium transport'), ('UBERON_0022293', 'reproductive gland secretion', 134, 'intrauterine'), ('CHEBI_46662', 'mineral', 152, 'mineral')]
S86-PMC3355895	PMC3355895	1/2011	S86-PMC3355895	"[""adjunctive EVIDENCE SUPPORTING a ROLE for maternal Vitamin D status was obtained in the southampton women's survey, where maternal Vitamin D concentrations again CORRELATED with neonatal bone mass (harvey et al.,2008).""]"	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 33), ('SUPERFICIAL_RELATIONSHIP', 162)]	4	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
S88-PMC3355895	PMC3355895	1/2011	S88-PMC3355895	['in developing southern hemisphere populations where sunshine is in abundance, OFTEN calcium nutrition is a greater ISSUE than that of 25(oh)-Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 78), ('IMPORTANT_CONSIDERATION', 115)]	2	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
S91-PMC3355895	PMC3355895	1/2011	S91-PMC3355895	['THUS, in populations in nutritional transition, where maternal sunlight exposure is sufficient to maintain adequate Vitamin D status, the availability of calcium becomes a more CRITICAL DETERMINANT of fetal and childhood bone Mineral accrual.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 177), ('SUPERFICIAL_RELATIONSHIP', 186)]	3	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('CHEBI_46662', 'mineral', 226, 'mineral')]
S53-PMC3356951	PMC3356951	4/2012	S53-PMC3356951	['consumption of Vitamin D-fortified Foods and exposure to some sunlight are ESSENTIAL for maintaining a healthy Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 75)]	1	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CHEBI_33290', 'food', 35, 'foods'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
S56-PMC3356951	PMC3356951	4/2012	S56-PMC3356951	"[""[52] Vitamin D content of Human Milk is RELATED to the mother's Vitamin D status; THEREFORE mothers who supplement with high doses of Vitamin D MAY have high levels of Vitamin D in their milk.""]"	[('SUPERFICIAL_RELATIONSHIP', 40), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 144)]	3	[('CHEBI_28384', 'vitamin K', 5, 'Vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 26, 'human'), ('UBERON_0001913', 'milk', 32, 'milk'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
S88-PMC3356951	PMC3356951	4/2012	S88-PMC3356951	['[68] another example of Extrarenal Regulation of 1α-hydroxylase is that the increased Production Of 1,25(Oh)2D by Keratinocytes in wounds[69] THEREFORE provides a good ESTIMATE of Vitamin D status, BUT Regulation of 1α-hydroxylase activity SHOULD also BE CONSIDERED.']	[('SUPERFICIAL_RELATIONSHIP', 35), ('PROBABLE_UNDERSTANDING', 142), ('INCOMPLETE_EVIDENCE', 168), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 198), ('FUTURE_WORK', 240), ('ANOMALY_CURIOUS_FINDING', 252), ('FUTURE_WORK', 255)]	7	[('UBERON_0001691', 'external ear', 24, 'extrarenal'), ('GO_0065007', 'biological regulation', 35, 'regulation'), ('GO_0034205', 'amyloid-beta formation', 86, 'production of ... 2D'), ('CHEBI_82784', 'PVP38-Ag NP', 100, '1,25(OH)2D'), ('CL_0000312', 'keratinocyte', 114, 'keratinocytes'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('GO_0065007', 'biological regulation', 202, 'regulation')]
S144-PMC3356951	PMC3356951	4/2012	S144-PMC3356951	['Serum circulating 25-Hydroxyvitamin D [25(Oh) D] level SHOULD BE measured to evaluate Vitamin D status in patients who are AT RISK for vdd.']	[('FUTURE_WORK', 55), ('IMPORTANT_CONSIDERATION', 55), ('IMPORTANT_CONSIDERATION', 123)]	3	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 18, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 39, '25(OH) D'), ('PR_000006444', 'diacylglycerol kinase delta', 46, 'D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
S76-PMC3366289	PMC3366289	7/2011	S76-PMC3366289	['Serum Retinol <1.05\xa0μmol/l and Breast Milk Retinol ≤1.05\xa0μmol/l or ≤28\xa0μmol/kg Milk fat (≤8\xa0μg/g milk fat) were considered INDICATIVE of low Vitamin A status and low Breast Milk Vitamin A content [18].']	[('PROBABLE_UNDERSTANDING', 123)]	1	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_26536', 'retinoic acid', 6, 'retinol'), ('UBERON_0000310', 'breast', 31, 'breast'), ('UBERON_0001913', 'milk', 38, 'milk'), ('CHEBI_26536', 'retinoic acid', 43, 'retinol'), ('UBERON_0001913', 'milk', 79, 'milk'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin A'), ('UBERON_0000310', 'breast', 166, 'breast'), ('UBERON_0001913', 'milk', 173, 'milk'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin A')]
S1-PMC3395583	PMC3395583	7/2012	S1-PMC3395583	"[""we AIMED TO INVESTIGATE WHETHER season of Birth INFLUENCES the risk of rheumatoid arthritis, crohn's disease, ulcerative colitis and systemic lupus erythematosus in addition to multiple sclerosis, and TO EXPLORE the CORRELATION between the risk of id and predicted ultraviolet b (uvb) light exposure and Vitamin D status during Gestation.""]"	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('SUPERFICIAL_RELATIONSHIP', 48), ('QUESTION_ANSWERED_BY_THIS_WORK', 201), ('SUPERFICIAL_RELATIONSHIP', 216)]	6	[('GO_0007567', 'parturition', 42, 'birth'), ('CHEBI_27300', 'vitamin D', 304, 'vitamin D'), ('GO_0007565', 'female pregnancy', 328, 'gestation')]
S3-PMC3395583	PMC3395583	7/2012	S3-PMC3395583	"[""predicted uvb radiation and Vitamin D status in different time windows during Pregnancy were calculated for each month of Birth and CORRELATED with risk of id using the spearman's correlation coefficient.""]"	[('SUPERFICIAL_RELATIONSHIP', 132)]	1	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007565', 'female pregnancy', 78, 'pregnancy'), ('GO_0007567', 'parturition', 122, 'birth')]
S6-PMC3395583	PMC3395583	7/2012	S6-PMC3395583	"[""the risk of id was inversely CORRELATED with PREDICTED second Trimester uvb exposure (spearman's rho = -0.49, p = 0.00005) and third Trimester Vitamin D status (spearman's rho = -0.44, p = 0.0003).""]"	[('SUPERFICIAL_RELATIONSHIP', 29), ('SUPERFICIAL_RELATIONSHIP', 45)]	2	[('GO_0009294', 'DNA mediated transformation', 62, 'trimester'), ('GO_0009294', 'DNA mediated transformation', 133, 'trimester'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
S36-PMC3395583	PMC3395583	7/2012	S36-PMC3395583	['average monthly 25-Oh-D levels were collected from a large cohort of Adult scottish and english women (n = 3,787) as previously described [28] and used as a PROXY for the seasonal variation in Gestational Vitamin D status.']	[('SUPERFICIAL_RELATIONSHIP', 157)]	1	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 16, '25-OH-D'), ('UBERON_0007023', 'adult organism', 69, 'adult'), ('GO_0007565', 'female pregnancy', 193, 'gestational'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D')]
S56-PMC3395583	PMC3395583	7/2012	S56-PMC3395583	['we next INVESTIGATED WHETHER the monthly risk of id inversely CORRELATED with PREDICTED Gestational Uvb exposure and Vitamin D status during different Trimesters of Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('SUPERFICIAL_RELATIONSHIP', 62), ('SUPERFICIAL_RELATIONSHIP', 78)]	4	"[('GO_0007565', 'female pregnancy', 88, 'gestational'), ('CHEBI_37043', ""pyrimidine 2'-deoxyribonucleoside 5'-triphosphate"", 100, 'UVB'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('GO_0043033', 'isoamylase complex', 151, 'trimesters'), ('GO_0007565', 'female pregnancy', 165, 'pregnancy')]"
S59-PMC3395583	PMC3395583	7/2012	S59-PMC3395583	['figure3shows the direct RELATION between uvb radiation and Vitamin D status and the amount of time required for a change in uvb to IMPACT on Vitamin D Metabolism.']	[('SUPERFICIAL_RELATIONSHIP', 24), ('SUPERFICIAL_RELATIONSHIP', 131)]	2	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 141, 'vitamin D metabolism')]
S85-PMC3395583	PMC3395583	7/2012	S85-PMC3395583	['furthermore, the seasonal variation of 25-Oh-D levels WAS NOT INVESTIGATED AND NO other STUDIES have tried to answer the same QUESTION in id OTHER than ms. we FOUND that the risk of id was inversely ASSOCIATED with PREDICTED second trimester Uvb exposure and third trimester Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 54), ('FULL_UNKNOWN', 58), ('QUESTION_ANSWERED_BY_THIS_WORK', 62), ('EXPLICIT_QUESTION', 126), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('INCOMPLETE_EVIDENCE', 159), ('SUPERFICIAL_RELATIONSHIP', 199), ('SUPERFICIAL_RELATIONSHIP', 215)]	8	"[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 39, '25-OH-D'), ('CHEBI_37043', ""pyrimidine 2'-deoxyribonucleoside 5'-triphosphate"", 242, 'UVB'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D')]"
S88-PMC3395583	PMC3395583	7/2012	S88-PMC3395583	['this is also the case among Pregnant women, whose Vitamin D status largely DEPENDS on season and follows the same distribution as the levels of the general population [28,42,43].']	[('SUPERFICIAL_RELATIONSHIP', 75)]	1	[('GO_0007565', 'female pregnancy', 28, 'pregnant'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
S85-PMC3407995	PMC3407995	7/2012	S85-PMC3407995	['HOWEVER, a recent global review of Vitamin D status HAS SHOWN that its Intake is OFTEN TOO low TO sustain healthy circulating 25(Oh)D in countries without mandatory staple Food fortification and is EVEN too low in countries that do fortify due to low Milk Consumption, vegetarianism, non-supplement use and low fish Intake [46].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 52), ('PROBABLE_UNDERSTANDING', 81), ('DIFFICULT_TASK', 87), ('ANOMALY_CURIOUS_FINDING', 198)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007631', 'feeding behavior', 71, 'intake'), ('CHEBI_71657', 'versiconol acetate', 126, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 126, '25(OH ... D'), ('CHEBI_33290', 'food', 172, 'food'), ('UBERON_0001913', 'milk', 251, 'milk'), ('GO_0007631', 'feeding behavior', 256, 'consumption'), ('GO_0007631', 'feeding behavior', 316, 'intake')]
S91-PMC3407995	PMC3407995	7/2012	S91-PMC3407995	['in addition, Pregnant women with darker skin pigmentation are at EVEN greater RISK of low Vitamin D status as COMPARED to Pregnant women with lighter skin pigmentation [49].']	[('ANOMALY_CURIOUS_FINDING', 65), ('IMPORTANT_CONSIDERATION', 78), ('ANOMALY_CURIOUS_FINDING', 110)]	3	[('GO_0007565', 'female pregnancy', 13, 'pregnant'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnant')]
S258-PMC3407995	PMC3407995	7/2012	S258-PMC3407995	['a recent review of studies LINKING maternal Vitamin D status during Pregnancy with maternal, foetal and Postnatal outcomes SUPPORTS a ROLE of maternal Vitamin D status, PARTICULARLY early in Pregnancy, in Modulating the risk of Pregnancy complications and in sustaining foetal growth, body composition, Skeletal Development, Immune Maturation and Respiratory health [141].']	[('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 134), ('IMPORTANT_CONSIDERATION', 169)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy'), ('GO_0007567', 'parturition', 104, 'postnatal'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007565', 'female pregnancy', 191, 'pregnancy'), ('GO_0065007', 'biological regulation', 205, 'modulating'), ('GO_0007565', 'female pregnancy', 228, 'pregnancy'), ('GO_0001501', 'skeletal system development', 303, 'skeletal development'), ('UBERON_0004288', 'skeleton', 303, 'skeletal'), ('GO_0050900', 'leukocyte migration', 325, 'immune maturation'), ('UBERON_0002405', 'immune system', 325, 'immune'), ('UBERON_0001004', 'respiratory system', 347, 'respiratory')]
S259-PMC3407995	PMC3407995	7/2012	S259-PMC3407995	['SEVERAL STUDIES have DEMONSTRATED an ASSOCIATION between POOR maternal Vitamin D status and SEVERE Preeclampsia that CAN result in Miscarriage [141].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 37), ('IMPORTANT_CONSIDERATION', 57), ('IMPORTANT_CONSIDERATION', 92), ('INCOMPLETE_EVIDENCE', 117)]	6	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 99, 'preeclampsia'), ('GO_0046660', 'female sex differentiation', 131, 'miscarriage')]
S260-PMC3407995	PMC3407995	7/2012	S260-PMC3407995	['Miscarriages CAN also result from an increased rate of bacterial vaginosis in the 1st Trimester of Pregnancy that is ASSOCIATED with low Vitamin D status [49].']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 117)]	2	[('GO_0042700', 'luteinizing hormone signaling pathway', 0, 'Miscarriages'), ('GO_0009294', 'DNA mediated transformation', 86, 'trimester'), ('GO_0007565', 'female pregnancy', 99, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
S261-PMC3407995	PMC3407995	7/2012	S261-PMC3407995	['maternal Vitamin D status early in Pregnancy was ASSOCIATED with risk of low Birth weight and small-for-Gestational age infants in ONE STUDY, WHEREAS another study FOUND this RELATION ONLY among white women [141].']	[('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 131), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142), ('INCOMPLETE_EVIDENCE', 164), ('SUPERFICIAL_RELATIONSHIP', 175), ('ANOMALY_CURIOUS_FINDING', 184), ('INCOMPLETE_EVIDENCE', 184)]	7	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 35, 'pregnancy'), ('GO_0007567', 'parturition', 77, 'birth'), ('GO_0007565', 'female pregnancy', 104, 'gestational')]
S263-PMC3407995	PMC3407995	7/2012	S263-PMC3407995	['evidence from RECENT STUDIES SUGGESTS an early Prenatal INFLUENCE of maternal Vitamin D status on foetal Skeletal Development, with lasting Postnatal EFFECTS [141].']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 56), ('SUPERFICIAL_RELATIONSHIP', 150)]	4	[('GO_0007565', 'female pregnancy', 47, 'prenatal'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0001501', 'skeletal system development', 105, 'skeletal development'), ('UBERON_0004288', 'skeleton', 105, 'skeletal'), ('GO_0007567', 'parturition', 140, 'postnatal')]
S306-PMC3407995	PMC3407995	7/2012	S306-PMC3407995	['studies SHOWING CORRELATION between maternal and foetal Vitamin D status\nfive hundred and six Pregnant women were given 400 iu (10μg) of Vitamin D per day from about the 12th week of Pregnancy until Delivery [150].']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 16)]	2	[('CHEBI_28384', 'vitamin K', 56, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnant'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('GO_0007565', 'female pregnancy', 183, 'pregnancy'), ('GO_0007567', 'parturition', 199, 'delivery')]
S433-PMC3407995	PMC3407995	7/2012	S433-PMC3407995	['independent researchers have RECOMMENDED up to 100 μg (4000 iu) daily to increase maternal and neonatal Vitamin D status to OPTIMAL levels [171].']	[('FUTURE_WORK', 29), ('IMPORTANT_CONSIDERATION', 124)]	2	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D')]
S486-PMC3407995	PMC3407995	7/2012	S486-PMC3407995	['epidemiological studies have LINKED low maternal Vitamin D status to SEVERE Preeclampsia resulting in Miscarriage, risk of low Birth weight and small-for-Gestational age infants, neonatal hypocalcaemia with seizures and POSSIBLE INVOLVEMENT in the development of schizophrenia.']	[('SUPERFICIAL_RELATIONSHIP', 29), ('IMPORTANT_CONSIDERATION', 69), ('INCOMPLETE_EVIDENCE', 220), ('SUPERFICIAL_RELATIONSHIP', 229)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 76, 'preeclampsia'), ('GO_0046660', 'female sex differentiation', 102, 'miscarriage'), ('GO_0007567', 'parturition', 127, 'birth'), ('GO_0007565', 'female pregnancy', 154, 'gestational')]
S66-PMC3417531	PMC3417531	7/2012	S66-PMC3417531	"[""(91)childreninfectious diseasehigh rate of simkania negevensis among canadian inuit infants hospitalized with Lower Respiratory Tract infections (92)childrennutritioniron deficiency and anaemia prevalence and ASSOCIATED etiologic RISK FACTORS in first nations and inuit communities in northern ontario and nunavut (93)childrennutritionfood insecurity among inuit preschoolers: nunavut inuit child health survey, 2007–2008 (59)childrennutritionvitamin D status of inuit preschoolers reflects season and Vitamin D intake (56)childrenenvironment/environmental exposures; infectious diseaseeffect of Prenatal exposure to Polychlorinated Biphenyls on incidence of acute Respiratory infections in preschool inuit children (25)childrenchronic disease; interventions/programmingthe benefits of sound field amplification in classrooms of inuit students of nunavik: a pilot project (73)childrensocial DETERMINANTS of health; tobaccocultural, socioeconomic, and health indicators among inuit preschoolers: nunavut inuit child health survey, 2007–2008 (9)childreninfectious disease; tobaccoindoor air quality and the risk of Lower Respiratory Tract infections in young canadian inuit children (41)childreninfectious disease; interventions/programmingheat recovery ventilators prevent Respiratory disorders in inuit children (40)childrengenetics; nutritionadaptation of inuit children to a low-calcium diet (83)childreninfectious disease; health care, policy, Human resourcesbronchiolitis in inuit children from a canadian central arctic community, 1995–1996 (69)youthchronic diseasecauses and CONTRIBUTIONS to differences in Life expectancy for inuit nunangat and canada, 1994–2003 (82)youthinfectious diseaseotitis media and Hearing loss among 12–16 year-old inuit of inukjuak, quebec, canada (35)youthinjuryinjury mortality risk assessment and targeting the subpopulations for prevention in the northwest territories, canada (86)youthnutritionage differences in Vitamin A intake among canadian inuit (55)youthmental health and wellbeingcompleted suicides among the inuit of northern quebec, 1982–1996: a case-control study (77)youthmental health and wellbeing; social determinants of healthsuicidality in a sample of arctic households (76)youthinfectious disease; interventions/programminghiv testing experiences of aboriginal youth in canada: service IMPLICATIONS (74)youthinfections disease; social determinants of healthdeterminants of Sexually Transmitted infections among canadian inuit adolescent populations (30)youthinfections disease; mental health and wellbeingyouth sexual health in nunavut: a needs-based survey of knowledge, attitudes and behaviour (31)maternalbirth outcomesreclaiming Birth, health, and community: midwifery in the inuit villages of nunavik, canada (68)maternalenvironment/environmental exposuresorganochlorine levels in maternal and Umbilical Cord Blood Plasma in arctic canada (49)maternalenvironment/environmental exposuresexposure of the inuit population of nunavik (arctic quebec) to lead and mercury (48)maternalnutritiondietary assessment of indigenous canadian arctic women with a focus on Pregnancy and Lactation (54)maternalnutritioncontribution of selected traditional and market Foods to the diet of nunavik inuit women (57)maternalbirth outcomes; tobaccomaternal smoking at first Prenatal visit as a MARKER of risk for adverse Pregnancy outcomes in the qikiqtaaluk (baffin) region (8)maternalnutrition; environment/environmental exposuresfish Consumption and Blood Lipids in 3 ethnic groups of quebec (canada) (51)maternalhealth care, policy, Human resources; Birth outcomesconverging epistemologies: CRITICAL ISSUES in canadian inuit Childbirth and Pregnancy (65)maternalenvironment/environmental exposures; nutritiondeterminants of Polychlorinated Biphenyls and Methylmercury exposure in inuit women of Childbearing age (50)maternalhealth care, policy, Human resources; interventions/programmingthe outcome of Perinatal Care in inukjuak, nunavik, canada 1998–2002 (70)maternalhealth care, policy, Human resources; Birth outcomesthe inuulitsivik maternities: culturally appropriate midwifery and epistemological accommodation (66)maternalinfectious disease; interventions/programmingoncogenic human papillomavirus infection and Cervical lesions in aboriginal women in nunavut, canada (94)maternalchronic disease; social determinants of health; tobacco; mental health and Wellbeingthe health of cree, inuit and southern quebec women: similarities and differences (79)maternalnutrition; social DETERMINANTS of health; environment/environmental exposuresfood insecurity among inuit women exacerbated by socioeconomic stresses and climate change (60)children; youthchronic diseasethe RELATIONSHIP between socio-economic and geographic factors and asthma among canada's aboriginal populations (81)children; youthinfectious diseasehospitalization due to pneumonia among innu, inuit and non-aboriginal communities, newfoundland and labrador, canada (24)children; maternalbirth outcomesheart defects and other malformations in the inuit in canada: a baseline study (62)children; maternalbirth outcomesbirth outcomes in the inuit-inhabited areas of canada (95)children; maternalbirth outcomesdegree of rural isolation and Birth outcomes (63)children; maternalbirth outcomesrisks of adverse Pregnancy outcomes among inuit and north american indian women in quebec, 1985–97 (64)children; maternalenvironment/environmental exposuresprenatal exposure to Methylmercury and Pcbs AFFECTS distinct stages of information processing: an event-related POTENTIAL study with inuit children (44)children; maternalenvironment/environmental exposuresthe RELATION of lead neurotoxicity to the event-related potential p3b component in inuit children from arctic quebec (47)children; maternalenvironment/environmental exposuresthyroid hormone levels of Pregnant inuit women and their infants exposed to environmental contaminants (96)children; maternalenvironment/environmental exposuresneuromotor functions in inuit preschool children exposed to Pb, Pcbs, and hg (43)children; maternalenvironment/environmental exposuresbeneficial EFFECTS of a polyunsaturated Fatty Acid on infant development: EVIDENCE from the inuit of arctic quebec (52)children; maternalenvironment/environmental exposuresthe RELATION of environmental contaminants exposure to behavioural indicators in inuit preschoolers in arctic quebec (46)children; maternalinfectious diseaseneonatal Vitamin A deficiency and its IMPACT on acute Respiratory infections among preschool inuit children (33)children; maternalnutritionanaemia and iron status in inuit infants from northern quebec (97)children; maternalbirth outcomes; nutritioncongenital Heart defects in canadian inuit: is more Folic Acid making a difference?""]"	[('SUPERFICIAL_RELATIONSHIP', 209), ('SUPERFICIAL_RELATIONSHIP', 230), ('SUPERFICIAL_RELATIONSHIP', 891), ('SUPERFICIAL_RELATIONSHIP', 1581), ('IMPORTANT_CONSIDERATION', 2342), ('SUPERFICIAL_RELATIONSHIP', 3334), ('IMPORTANT_CONSIDERATION', 3635), ('IMPORTANT_CONSIDERATION', 3644), ('SUPERFICIAL_RELATIONSHIP', 4527), ('SUPERFICIAL_RELATIONSHIP', 4715), ('SUPERFICIAL_RELATIONSHIP', 5499), ('INCOMPLETE_EVIDENCE', 5567), ('SUPERFICIAL_RELATIONSHIP', 5664), ('SUPERFICIAL_RELATIONSHIP', 6139), ('INCOMPLETE_EVIDENCE', 6202), ('SUPERFICIAL_RELATIONSHIP', 6304), ('SUPERFICIAL_RELATIONSHIP', 6495), ('EXPLICIT_QUESTION', 6787)]	18	[('UBERON_0004905', 'articulation', 110, 'lower respiratory tract'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 451, 'D'), ('CHEBI_27300', 'vitamin D', 502, 'vitamin D'), ('GO_0007565', 'female pregnancy', 596, 'prenatal'), ('CHEBI_53421', 'poly(oxymethylene) macromolecule', 617, 'polychlorinated biphenyls'), ('UBERON_0001004', 'respiratory system', 665, 'respiratory'), ('UBERON_0004905', 'articulation', 1113, 'lower respiratory tract'), ('UBERON_0001004', 'respiratory system', 1272, 'respiratory'), ('NCBITaxon_9606', 'Homo sapiens', 1447, 'human'), ('UBERON_0000104', 'life cycle', 1613, 'life'), ('GO_0007605', 'sensory perception of sound', 1714, 'hearing'), ('CHEBI_27300', 'vitamin D', 1952, 'vitamin A'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 2429, 'sexually transmitted'), ('GO_0007567', 'parturition', 2689, 'birth'), ('UBERON_0002331', 'umbilical cord', 2855, 'umbilical cord'), ('UBERON_0000178', 'blood', 2870, 'blood'), ('UBERON_0001969', 'blood plasma', 2876, 'plasma'), ('GO_0007565', 'female pregnancy', 3119, 'pregnancy'), ('GO_0007595', 'lactation', 3133, 'lactation'), ('CHEBI_33290', 'food', 3212, 'foods'), ('GO_0007565', 'female pregnancy', 3314, 'prenatal'), ('GO_0007565', 'female pregnancy', 3361, 'pregnancy'), ('GO_0007631', 'feeding behavior', 3477, 'consumption'), ('UBERON_0000178', 'blood', 3493, 'blood'), ('CHEBI_18059', 'lipid', 3499, 'lipids'), ('NCBITaxon_9606', 'Homo sapiens', 3577, 'human'), ('GO_0007567', 'parturition', 3594, 'birth'), ('GO_0007623', 'circadian rhythm', 3669, 'childbirth'), ('GO_0007565', 'female pregnancy', 3684, 'pregnancy'), ('CHEBI_53421', 'poly(oxymethylene) macromolecule', 3768, 'polychlorinated biphenyls'), ('CHEBI_33963', 'metallocene', 3798, 'methylmercury'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 3839, 'childbearing'), ('NCBITaxon_9606', 'Homo sapiens', 3889, 'human'), ('GO_0036356', 'cyclic 2,3-diphosphoglycerate synthetase activity', 3946, 'perinatal care'), ('UBERON_0012101', 'perinatal stage', 3946, 'perinatal'), ('NCBITaxon_9606', 'Homo sapiens', 4033, 'human'), ('GO_0007567', 'parturition', 4050, 'birth'), ('UBERON_0005434', 'cervical region', 4263, 'cervical'), ('GO_0035706', 'T-helper 1 cell chemotaxis', 4406, 'wellbeingThe'), ('GO_0007567', 'parturition', 5248, 'birth'), ('GO_0007565', 'female pregnancy', 5316, 'pregnancy'), ('CHEBI_33963', 'metallocene', 5476, 'methylmercury'), ('CHEBI_26199', 'polyprenol', 5494, 'PCBs'), ('GO_0007565', 'female pregnancy', 5860, 'pregnant'), ('CHEBI_37983', 'sulfur-35 atom', 6054, 'Pb'), ('CHEBI_26199', 'polyprenol', 6058, 'PCBs'), ('CHEBI_35366', 'fatty acid', 6168, 'fatty acid'), ('CHEBI_27300', 'vitamin D', 6466, 'vitamin A'), ('UBERON_0001004', 'respiratory system', 6511, 'respiratory'), ('UBERON_0000948', 'heart', 6716, 'heart'), ('CHEBI_30751', 'formic acid', 6757, 'folic acid')]
S3-PMC3427192	PMC3427192	4/2012	S3-PMC3427192	['additionally, a GROWING body of LITERATURE SUGGESTS that there is a RELATIONSHIP between Vitamin D status and Respiratory symptoms, PRESUMABLY through immunomodulatory EFFECTS of Vitamin D. this review discusses Vitamin D as it RELATES to asthma across the age spectrum, with a FOCUS on Human studies.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 68), ('PROBABLE_UNDERSTANDING', 132), ('SUPERFICIAL_RELATIONSHIP', 168), ('SUPERFICIAL_RELATIONSHIP', 228), ('QUESTION_ANSWERED_BY_THIS_WORK', 278)]	8	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 110, 'respiratory'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 287, 'human')]
S9-PMC3427192	PMC3427192	4/2012	S9-PMC3427192	['indeed, numerous dietary hypotheses HAVE BEEN PROPOSED.13-15among the Nutrients and antioxidants included in this HYPOTHESIS, Vitamin D is of particular INTEREST SINCE Vitamin D concentrations decrease with increased time spent indoors, decreased exposure to sunlight, less exercise, obesity, and inadequate Calcium intake.16additionally, a GROWING BODY of literature SUGGESTS that there is a RELATIONSHIP between Vitamin D status and asthma-RELATED Respiratory symptoms,17-22PRESUMABLY through the immunomodulatory EFFECTS of Vitamin D.23,24this brief review discusses Vitamin D as it RELATES to asthma across the age spectrum, with a FOCUS on EMERGING Human STUDIES over the past decade.']	[('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 114), ('ANOMALY_CURIOUS_FINDING', 153), ('PROBABLE_UNDERSTANDING', 162), ('INCOMPLETE_EVIDENCE', 341), ('INCOMPLETE_EVIDENCE', 368), ('SUPERFICIAL_RELATIONSHIP', 393), ('SUPERFICIAL_RELATIONSHIP', 442), ('ANOMALY_CURIOUS_FINDING', 474), ('SUPERFICIAL_RELATIONSHIP', 516), ('SUPERFICIAL_RELATIONSHIP', 586), ('QUESTION_ANSWERED_BY_THIS_WORK', 636), ('INCOMPLETE_EVIDENCE', 645)]	14	[('CHEBI_33284', 'nutrient', 70, 'nutrients'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 308, 'calcium'), ('CHEBI_27300', 'vitamin D', 414, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 450, 'respiratory'), ('CHEBI_27300', 'vitamin D', 527, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 570, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 654, 'human')]
S19-PMC3427192	PMC3427192	4/2012	S19-PMC3427192	['Biosynthesis Of Vitamin D.\n\nVitamin D THRESHOLDS\nSerum concentrations of 25(Oh)D are CONSIDERED to be a BIOMARKER and INDICATOR of Vitamin D status.44,45ALTHOUGH Vitamin D insufficiency HAS TRADITIONALLY BEEN defined as a Serum 25(Oh)D concentration of 20 to 29 ng/ml,46a panel of experts from the institute of medicine RECENTLY SUGGESTED that Vitamin D INSUFFICIENCY be redefined AS a Serum 25(Oh)D concentration less than 20 ng/ml.47this RECOMMENDATION was based ON INCONCLUSIVE evidence for the threshold of 29 ng/ml and EVIDENCE for adverse Skeletal EFFECTS at thresholds less than 20 ng/ml.47HOWEVER, this revised definition of Vitamin D insufficiency has generated significant CONTROVERSY48,49AND THUS there is presently NO universally ACCEPTED definition for “optimal” 25(Oh)d concentrations INDEPENDENT of Musculoskeletal health.']	[('PROBABLE_UNDERSTANDING', 38), ('INCOMPLETE_EVIDENCE', 85), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 118), ('ANOMALY_CURIOUS_FINDING', 151), ('IMPORTANT_CONSIDERATION', 186), ('INCOMPLETE_EVIDENCE', 190), ('PROBABLE_UNDERSTANDING', 190), ('INCOMPLETE_EVIDENCE', 320), ('INCOMPLETE_EVIDENCE', 329), ('IMPORTANT_CONSIDERATION', 354), ('PROBABLE_UNDERSTANDING', 381), ('FUTURE_WORK', 440), ('ANOMALY_CURIOUS_FINDING', 465), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 468), ('INCOMPLETE_EVIDENCE', 524), ('SUPERFICIAL_RELATIONSHIP', 554), ('ANOMALY_CURIOUS_FINDING', 595), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 683), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 697), ('PROBABLE_UNDERSTANDING', 703), ('INCOMPLETE_EVIDENCE', 727), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 742), ('INCOMPLETE_EVIDENCE', 742), ('SUPERFICIAL_RELATIONSHIP', 799)]	25	[('GO_0033593', 'BRCA2-MAGE-D1 complex', 0, 'Biosynthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 28, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 49, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 73, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('UBERON_0001977', 'blood serum', 222, 'serum'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 228, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 344, 'vitamin D'), ('UBERON_0001977', 'blood serum', 386, 'serum'), ('CHEBI_71657', 'versiconol acetate', 392, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 392, '25(OH)D'), ('UBERON_0004288', 'skeleton', 545, 'skeletal'), ('CHEBI_27300', 'vitamin D', 633, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 776, '25(OH)'), ('UBERON_0002204', 'musculoskeletal system', 814, 'musculoskeletal')]
S28-PMC3427192	PMC3427192	4/2012	S28-PMC3427192	['studies of Vitamin D exposure in early Life and Respiratory outcomesauthoryearcountrystudy designsample sizeage of children at assessmentdetermination of Vitamin D statusassociation between Vitamin D and Respiratory outcomesbelderbos572011netherlandsprospective cohort156 neonatesbirth to 1 ymaternal Food-frequency questionnaire and Cord Blood 25(Oh)Dlower 25(Oh)D concentrations ASSOCIATED with an increased risk of Respiratory syncytial Virus infectioncamargo582007united statesprospective cohort1194 mother-child dyads3 ymaternal Food-frequency questionnairehighest quartile of Vitamin D intake during Pregnancy ASSOCIATED with a lower risk of recurrent wheezingcamargo592011new zealandprospective cohort922 newbornsbirth to 5 ycord Blood 25(Oh)Dhigher 25(Oh)D ASSOCIATED with a decreased risk of Respiratory infection and wheezing BUT NO associations with childhood asthma NOTEDCARROLL602011CANADACROSS-sectional340 mother-infant dyads5–29 weeksmaternal whole Blood 25(Oh)Dincreasing maternal 25(Oh)D ASSOCIATED with decreased odds of asthma in mothers BUT no associations with infantile wheezing noteddevereux612007scotlandprospective cohort2000 Pregnant women, 1212 children5 ymaternal Food-frequency questionnairehighest and lowest maternal Vitamin D intakes ASSOCIATED with lower risk of wheezingerkkola622009finlandprospective cohort1669 mother-child dyads5 ymaternal Food-frequency questionnairehigher maternal Vitamin D intake ASSOCIATED with lower risk of asthma and allergic rhinitisgale632008ukprospective cohort466 mothers and 178 children9 mo and 9 ymaternal Serum 25(Oh)Dmaternal Vitamin D levels > 75 nmol/l ASSOCIATED with increased risk of atopic dermatitis and asthmamiyake642010japanprospective cohort763 mother-child dyads16–24 momaternal Food-frequency questionnairehigher maternal Vitamin D intake ASSOCIATED with a decreased risk of wheeze and atopic dermatitismorales652012spainprospective cohort1724 children12 mo, 4–6 ymaternal plasma 25(Oh)Dincreased maternal 25(Oh)D ASSOCIATED with a decreased risk of lower Respiratory infections BUT NOT wheezing or asthmarothers662011united statesprospective cohort219 childrenbirth to 5 ycord Blood 25(Oh)Dboth low and high Cord Blood 25(Oh)D ASSOCIATED with increased Aeroallergen sensitization BUT NOT with allergic rhinitis or asthma\nin other Birth cohort studies where 25(Oh)D concentrations were measured in the Plasma and whole Blood of Pregnant women, median 25(Oh)D concentrations ranged from APPROXIMATELY 20 to 29.5 ng/ml.60,63,65a 50% decrease in the odds of maternal asthma was FURTHER OBSERVED with every 35 nmol/l increase in 25(Oh)D levels, SUGGESTING a POSSIBLE LINK between Vitamin D status and asthma during Pregnancy.60HOWEVER, similar to the studies of maternal Vitamin D intake, NO CONSISTENT RELATIONSHIPS between 25(Oh)D concentrations and Respiratory symptoms during childhood HAVE BEEN observed.']	[('SUPERFICIAL_RELATIONSHIP', 381), ('SUPERFICIAL_RELATIONSHIP', 616), ('SUPERFICIAL_RELATIONSHIP', 765), ('ANOMALY_CURIOUS_FINDING', 836), ('ANOMALY_CURIOUS_FINDING', 878), ('SUPERFICIAL_RELATIONSHIP', 1006), ('ANOMALY_CURIOUS_FINDING', 1058), ('SUPERFICIAL_RELATIONSHIP', 1267), ('SUPERFICIAL_RELATIONSHIP', 1439), ('SUPERFICIAL_RELATIONSHIP', 1627), ('SUPERFICIAL_RELATIONSHIP', 1824), ('SUPERFICIAL_RELATIONSHIP', 1999), ('ANOMALY_CURIOUS_FINDING', 2064), ('SUPERFICIAL_RELATIONSHIP', 2213), ('ANOMALY_CURIOUS_FINDING', 2266), ('INCOMPLETE_EVIDENCE', 2471), ('INCOMPLETE_EVIDENCE', 2560), ('INCOMPLETE_EVIDENCE', 2568), ('INCOMPLETE_EVIDENCE', 2626), ('INCOMPLETE_EVIDENCE', 2639), ('SUPERFICIAL_RELATIONSHIP', 2648), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2706), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2770), ('SUPERFICIAL_RELATIONSHIP', 2784), ('INCOMPLETE_EVIDENCE', 2871)]	25	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0000104', 'life cycle', 39, 'life'), ('UBERON_0001004', 'respiratory system', 48, 'respiratory'), ('CHEBI_28384', 'vitamin K', 154, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 204, 'respiratory'), ('CHEBI_33290', 'food', 301, 'food'), ('UBERON_0002240', 'spinal cord', 334, 'cord'), ('UBERON_0000178', 'blood', 339, 'blood'), ('CHEBI_78858', '(R)-2-methylpyrrolidine', 345, '25(OH)DLower'), ('CHEBI_71657', 'versiconol acetate', 358, '25(OH)D'), ('UBERON_0001004', 'respiratory system', 418, 'respiratory'), ('NCBITaxon_1', 'root', 440, 'virus'), ('CHEBI_33290', 'food', 534, 'food'), ('CHEBI_27300', 'vitamin D', 582, 'vitamin D'), ('GO_0007565', 'female pregnancy', 606, 'pregnancy'), ('UBERON_0000178', 'blood', 737, 'blood'), ('CHEBI_72842', '9-oxo-ODE', 743, '25(OH)DHigher'), ('CHEBI_71657', 'versiconol acetate', 757, '25(OH)D'), ('UBERON_0001004', 'respiratory system', 801, 'respiratory'), ('UBERON_0000178', 'blood', 965, 'blood'), ('CHEBI_74350', 'N-diazoacetylnorleucine methyl ester', 971, '25(OH)DIncreasing'), ('PR_000011614', 'opioid growth factor receptor', 974, 'OH'), ('PR_000006449', 'diacylglycerol kinase kappa', 977, 'DIncreasing'), ('CHEBI_71657', 'versiconol acetate', 998, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 998, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 1152, 'pregnant'), ('CHEBI_33290', 'food', 1193, 'food'), ('CHEBI_27300', 'vitamin D', 1249, 'vitamin D'), ('CHEBI_33290', 'food', 1378, 'food'), ('CHEBI_27300', 'vitamin D', 1422, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1576, 'serum'), ('CHEBI_51469', 'butyllithium', 1582, '25(OH)DMaternal'), ('CHEBI_27300', 'vitamin D', 1598, 'vitamin D'), ('CHEBI_33290', 'food', 1763, 'food'), ('CHEBI_27300', 'vitamin D', 1807, 'vitamin D'), ('CHEBI_86378', '(25R)-3beta-hydroxycholest-5-en-26-oic acid', 1965, '25(OH)DIncreased'), ('PR_000011040', 'nuclear receptor coactivator 1', 1967, '(OH'), ('CHEBI_71657', 'versiconol acetate', 1991, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 1991, '25(OH ... D'), ('UBERON_0001004', 'respiratory system', 2041, 'respiratory'), ('UBERON_0000178', 'blood', 2163, 'blood'), ('CHEBI_73803', 'Ala-Asp', 2169, '25(OH)DBoth'), ('UBERON_0002240', 'spinal cord', 2194, 'cord'), ('UBERON_0000178', 'blood', 2199, 'blood'), ('CHEBI_71657', 'versiconol acetate', 2205, '25(OH)D'), ('CHEBI_2500', 'Aescin', 2239, 'aeroallergen'), ('GO_0007567', 'parturition', 2316, 'birth'), ('CHEBI_71657', 'versiconol acetate', 2343, '25(OH)D'), ('UBERON_0001969', 'blood plasma', 2387, 'plasma'), ('UBERON_0000178', 'blood', 2404, 'blood'), ('GO_0007565', 'female pregnancy', 2413, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 2436, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 2610, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 2616, 'D'), ('CHEBI_27300', 'vitamin D', 2661, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2696, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 2752, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 2806, '25(OH)D'), ('UBERON_0001004', 'respiratory system', 2833, 'respiratory')]
S36-PMC3427192	PMC3427192	4/2012	S36-PMC3427192	['Vitamin D in school-aged children with asthma\nseveral RECENT STUDIES HAVE SHOWN ASSOCIATIONS between Vitamin D status and asthma outcomes in school-age children (table 2), ALTHOUGH there is considerable variation between the study populations.']	[('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 80), ('ANOMALY_CURIOUS_FINDING', 172)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
S37-PMC3427192	PMC3427192	4/2012	S37-PMC3427192	['OF PARTICULAR INTEREST is the FINDING of racial DISPARITIES in Vitamin D status.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('IMPORTANT_CONSIDERATION', 48)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
S38-PMC3427192	PMC3427192	4/2012	S38-PMC3427192	['due to higher levels of Melanin, african americans have the highest prevalence of Vitamin D deficiency, with the highest prevalence in those living in urban environments.43,76at the same time, asthma is also more PREVALENT in african american children.10,11only ONE STUDY TO DATE has FOCUSED on Vitamin D status in school-aged african american asthmatic children.']	[('IMPORTANT_CONSIDERATION', 213), ('INCOMPLETE_EVIDENCE', 262), ('INCOMPLETE_EVIDENCE', 272), ('QUESTION_ANSWERED_BY_THIS_WORK', 284)]	4	[('CHEBI_25179', 'melanins', 24, 'melanin'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D')]
S40-PMC3427192	PMC3427192	4/2012	S40-PMC3427192	['HOWEVER, 25(Oh)D concentrations in the non-asthmatic group were significantly higher than PREVIOUSLY-REPORTED average values in african american children.21the childhood asthma management program study, which consisted of a racially diverse population, also FOUND that 24% of Vitamin D deficient subjects were african american, compared with only 7% in the Vitamin D sufficient group.69the FACTORS responsible for the racial DISPARITY in Vitamin D status are UNCLEAR and WARRANT FURTHER STUDY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 90), ('INCOMPLETE_EVIDENCE', 101), ('INCOMPLETE_EVIDENCE', 258), ('SUPERFICIAL_RELATIONSHIP', 390), ('IMPORTANT_CONSIDERATION', 425), ('FULL_UNKNOWN', 459), ('FUTURE_WORK', 471), ('FUTURE_WORK', 479)]	10	[('CHEBI_71657', 'versiconol acetate', 9, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 357, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 438, 'vitamin D')]
S42-PMC3427192	PMC3427192	4/2012	S42-PMC3427192	['studies of Vitamin D status in school-age children with asthmaauthoryearn(% male)age (years)study designsampleoutcome measuresfindingsbrehm412009616 (60)8.7cross-sectionalmild-to-severe persistent asthmaasthma exacerbationsincreased 25(Oh)D ASSOCIATED with reduced hospitalization, reduced Anti-Inflammatory Medication use and reduced Airway hyperresponsivenessbrehm6920101024 (60)8.9prospective cohortmild-to-moderate persistent asthmahospitalization or emergency Department visitbaseline 25(Oh)D levels < 30 ng/ml ASSOCIATED with higher odds of hospitalization or emergency department over 4 ychinellato70201175 (60)9.6cross-sectionalwell-controlled and POORLY controlled asthmaspirometry, asthma controlpositive CORRELATIONS NOTED between 25(Oh)d and asthma controlchinellato71201145 (60)10cross-sectionalintermittent asthmalung function and Airway hyperresponsivenesslower Serum 25(Oh)D ASSOCIATED with decreased Lung function and increased Airway hyperresponsiveness with exercisefreishtat72201092 (63)11.1cross-sectionalafrican americans with and without asthmaphysician-diagnosed asthmadecreased 25(Oh)D in asthmatics vs. controlsmajak73201148 (67)11.5randomized, double-blind, parallel arm clinical trialnewly diagnosed asthmaasthma exacerbationsfewer exacerbations in children with Vitamin D3Supplementation added to inhaled Budesonidesearing742010100 (64)7cross-sectionalmoderate to severe persistent asthmacorticosteroid use and Airflow limitationdecreased 25(Oh)D ASSOCIATED with lower Lung function and higher Corticosteroid requirementsurashima752010217 (57)10.0randomized, double-blind clinical trialschoolchildren (allcomers), subgroup with physician-diagnosed asthmaasthma exacerbationsreduced risk of asthma exacerbations in the subgroup with asthma after Vitamin D3Supplementation\nother cross-sectional studies of Vitamin D status have also examined the ASSOCIATIONS between 25(Oh)D concentrations and asthma Control in school-age children.']	[('SUPERFICIAL_RELATIONSHIP', 241), ('SUPERFICIAL_RELATIONSHIP', 516), ('PROBLEM_COMPLICATION', 656), ('SUPERFICIAL_RELATIONSHIP', 715), ('ANOMALY_CURIOUS_FINDING', 728), ('SUPERFICIAL_RELATIONSHIP', 891), ('SUPERFICIAL_RELATIONSHIP', 1476), ('SUPERFICIAL_RELATIONSHIP', 1873)]	8	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 233, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 233, '25(OH)D'), ('CHEBI_60426', 'dioleoyl phosphatidylglycerol', 290, 'anti-inflammatory medication'), ('UBERON_0001005', 'respiratory airway', 335, 'airway'), ('UBERON_0008247', 'tube foot', 465, 'department'), ('CHEBI_71657', 'versiconol acetate', 490, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 490, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 742, '25(OH'), ('UBERON_0001005', 'respiratory airway', 845, 'airway'), ('UBERON_0001977', 'blood serum', 877, 'serum'), ('CHEBI_71657', 'versiconol acetate', 883, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 885, '(OH ... D'), ('UBERON_0002048', 'lung', 917, 'lung'), ('UBERON_0001005', 'respiratory airway', 945, 'airway'), ('CHEBI_71657', 'versiconol acetate', 1103, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1103, '25(OH)D'), ('CHEBI_52915', 'phosphatediyl group', 1291, 'vitamin D3supplementation'), ('CHEBI_72362', 'phosphatidylethanolamine 44:1-OH', 1334, 'budesonideSearing742010100'), ('UBERON_0001005', 'respiratory airway', 1440, 'airflow'), ('CHEBI_71657', 'versiconol acetate', 1468, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1468, '25(OH)D'), ('UBERON_0002048', 'lung', 1498, 'lung'), ('CHEBI_36916', 'cation', 1523, 'corticosteroid'), ('CHEBI_52915', 'phosphatediyl group', 1774, 'vitamin D3supplementation'), ('CHEBI_27300', 'vitamin D', 1833, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 1894, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 1900, 'D'), ('GO_0065007', 'biological regulation', 1928, 'control')]
S47-PMC3427192	PMC3427192	4/2012	S47-PMC3427192	['given the LIMITATIONS ASSOCIATED with these epidemiologic studies, randomized controlled TRIALS of Vitamin D ARE NEEDED in children to BETTER UNDERSTAND the causal RELATIONSHIP between Vitamin D status and Respiratory outcomes such as asthma Control in this population.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 22), ('FUTURE_WORK', 89), ('FUTURE_WORK', 109), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 164)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 206, 'respiratory'), ('GO_0065007', 'biological regulation', 242, 'control')]
S53-PMC3427192	PMC3427192	4/2012	S53-PMC3427192	['Vitamin D in Adults with asthma\nin Adults, the RECOMMENDED dietary intake for Vitamin D ranges from 600 to 800 iu daily.47HOWEVER, DESPITE the large variety of Foods supplemented with Vitamin D, a large proportion of the Adult population remains Vitamin D deficient,77,78perhaps DUE IN PART to INADEQUATE sun exposure and the rising PREVALENCE of obesity which CAN LEAD TO decreased Vitamin D bioavailability.79SIMILAR to the studies in school age children, a NUMBER OF cross-sectional studies in Adults have also DEMONSTRATED ASSOCIATIONS between Vitamin D status and asthma Control (table 3).']	[('FUTURE_WORK', 47), ('ANOMALY_CURIOUS_FINDING', 120), ('ANOMALY_CURIOUS_FINDING', 120), ('ANOMALY_CURIOUS_FINDING', 131), ('IMPORTANT_CONSIDERATION', 279), ('INCOMPLETE_EVIDENCE', 283), ('IMPORTANT_CONSIDERATION', 294), ('IMPORTANT_CONSIDERATION', 333), ('INCOMPLETE_EVIDENCE', 361), ('SUPERFICIAL_RELATIONSHIP', 365), ('INCOMPLETE_EVIDENCE', 409), ('INCOMPLETE_EVIDENCE', 460), ('INCOMPLETE_EVIDENCE', 514), ('SUPERFICIAL_RELATIONSHIP', 527)]	14	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0007023', 'adult organism', 13, 'Adults'), ('UBERON_0007023', 'adult organism', 35, 'adults'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_33290', 'food', 160, 'foods'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('UBERON_0007023', 'adult organism', 221, 'adult'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 383, 'vitamin D'), ('UBERON_0007023', 'adult organism', 497, 'adults'), ('CHEBI_27300', 'vitamin D', 548, 'vitamin D'), ('GO_0065007', 'biological regulation', 576, 'control')]
S55-PMC3427192	PMC3427192	4/2012	S55-PMC3427192	['furthermore, in those subjects with current asthma, lower 25(Oh)D concentrations were ASSOCIATED with increased odds of asthma exacerbations and healthcare utilization in the preceding year.81OTHER STUDIES have also NOTED ASSOCIATIONS between decreased Serum 25(Oh)D concentrations and decreased Lung function, increased Airway hyperresponsiveness to Methacholine, and blunted Glucocorticoid responsiveness.80,82,84HOWEVER, in a RECENT case-control STUDY of obese subjects with and without asthma, no associations between Vitamin D status and asthma prevalence were NOTED.83the cross-sectional nature of these studies SHOULD again BE EMPHASIZED SINCE causation CANNOT BE determined DUE TO potential CONFOUNDING of the study results.']	[('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 190), ('ANOMALY_CURIOUS_FINDING', 216), ('SUPERFICIAL_RELATIONSHIP', 222), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 413), ('INCOMPLETE_EVIDENCE', 429), ('ANOMALY_CURIOUS_FINDING', 566), ('FUTURE_WORK', 618), ('ANOMALY_CURIOUS_FINDING', 631), ('IMPORTANT_CONSIDERATION', 634), ('PROBLEM_COMPLICATION', 645), ('DIFFICULT_TASK', 661), ('PROBLEM_COMPLICATION', 682), ('PROBLEM_COMPLICATION', 699)]	14	[('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('UBERON_0001977', 'blood serum', 253, 'serum'), ('CHEBI_71657', 'versiconol acetate', 259, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 259, '25 ... OH ... D'), ('UBERON_0002048', 'lung', 296, 'lung'), ('UBERON_0001005', 'respiratory airway', 321, 'airway'), ('CHEBI_6805', 'methacycline', 351, 'methacholine'), ('CHEBI_24261', 'glucocorticoid', 377, 'glucocorticoid'), ('CHEBI_27300', 'vitamin D', 522, 'vitamin D')]
S60-PMC3427192	PMC3427192	4/2012	S60-PMC3427192	['studies of Vitamin D status in Adults with asthmaauthoryearn(% male)age (years)study designsampleoutcome measuresfindingsblack80200514,091 (55)> 20 ycross-sectionalgeneral us populationlung functionhigher Serum 25(Oh)D ASSOCIATED with increased Lung functionkeet8120116857 (49)23.6cross-sectionalgeneral us populationwheeze, history of asthma, and asthma exacerbationhigher serum 25(Oh)D ASSOCIATED with decreased odds of current wheezing and asthma as well as emergency visits for asthma and asthma exacerbationsli822011435 (38)48.57cross-sectionalnewly diagnosed asthmaticslung function, total Serum igehigher 25(Oh)D ASSOCIATED with greater Lung function with no associations NOTED for igeoren832008290 (26)43cross-sectionalobese patientsasthma and allergic rhinitis25(Oh)D deficiency (< 25 ng/ml) ASSOCIATED with increased odds of atopic dermatitis BUT no associations with asthmasutherland84201054 (43)38.3cross-sectionalpersistent asthmalung function, Airway hyper-responsiveness, Glucocorticoid responsivenessdecreased 25(Oh)D ASSOCIATED with decreased Lung function, increased Airway hyperresponsiveness, and reduced Glucocorticoid responses\n\ngenetics of Vitamin D and asthma\nSOME STUDIES have FOCUSED on Genetic ASSOCIATIONS between Vitamin D and asthma in larger populations.']	[('SUPERFICIAL_RELATIONSHIP', 219), ('SUPERFICIAL_RELATIONSHIP', 388), ('SUPERFICIAL_RELATIONSHIP', 620), ('ANOMALY_CURIOUS_FINDING', 679), ('SUPERFICIAL_RELATIONSHIP', 801), ('ANOMALY_CURIOUS_FINDING', 853), ('SUPERFICIAL_RELATIONSHIP', 1034), ('INCOMPLETE_EVIDENCE', 1184), ('QUESTION_ANSWERED_BY_THIS_WORK', 1202), ('SUPERFICIAL_RELATIONSHIP', 1221)]	10	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0007023', 'adult organism', 31, 'adults'), ('UBERON_0001977', 'blood serum', 205, 'serum'), ('CHEBI_71657', 'versiconol acetate', 211, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 211, '25(OH)D'), ('UBERON_0002048', 'lung', 245, 'lung'), ('CHEBI_71657', 'versiconol acetate', 380, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 380, '25(OH)D'), ('UBERON_0001977', 'blood serum', 596, 'serum'), ('CHEBI_71657', 'versiconol acetate', 612, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 612, '25(OH)D'), ('UBERON_0002048', 'lung', 644, 'lung'), ('CHEBI_33010', 'chromide(1-)', 771, '(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 775, 'D'), ('UBERON_0001005', 'respiratory airway', 958, 'airway'), ('CHEBI_24261', 'glucocorticoid', 987, 'glucocorticoid'), ('CHEBI_71657', 'versiconol acetate', 1026, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 1029, 'OH ... D'), ('UBERON_0002048', 'lung', 1060, 'lung'), ('UBERON_0001005', 'respiratory airway', 1085, 'airway'), ('CHEBI_24261', 'glucocorticoid', 1125, 'glucocorticoid'), ('CHEBI_28384', 'vitamin K', 1163, 'Vitamin D'), ('SO_0000704', 'gene', 1213, 'genetic'), ('CHEBI_27300', 'vitamin D', 1242, 'vitamin D')]
S66-PMC3427192	PMC3427192	4/2012	S66-PMC3427192	['in ONE STUDY, modest ASSOCIATIONS were NOTED between several Genes in the Vitamin D pathway and asthma and allergic sensitization in populations enriched for subjects with current asthma.86a separate study of asthmatics also FOUND Haplotype ASSOCIATIONS for Cyp24A1 , the primary enzyme ASSOCIATED with Calcidiol Metabolism, where a 5-point Haplotype was ASSOCIATED with asthma, allergic sensitization, and Vitamin D Metabolites in asthmatic subjects.92while these PRELIMINARY results SUGGEST that Genetic components MAY account for Vitamin D status in subjects with asthma, OTHER STUDIES ARE NEEDED to determine tease out the Genetic vs. environmental UNDERPINNINGS of Vitamin D status in this population.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 21), ('ANOMALY_CURIOUS_FINDING', 39), ('INCOMPLETE_EVIDENCE', 225), ('SUPERFICIAL_RELATIONSHIP', 241), ('SUPERFICIAL_RELATIONSHIP', 287), ('SUPERFICIAL_RELATIONSHIP', 355), ('INCOMPLETE_EVIDENCE', 465), ('INCOMPLETE_EVIDENCE', 485), ('INCOMPLETE_EVIDENCE', 517), ('FUTURE_WORK', 575), ('FUTURE_WORK', 581), ('SUPERFICIAL_RELATIONSHIP', 653)]	13	[('SO_0000704', 'gene', 61, 'genes'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('SO_0001024', 'haplotype', 231, 'haplotype'), ('PR_000006101', 'cytochrome P450 1A1', 258, 'CYP24A1'), ('CHEBI_17933', 'calcidiol', 303, 'calcidiol'), ('GO_0008152', 'metabolic process', 313, 'metabolism'), ('SO_0001024', 'haplotype', 341, 'haplotype'), ('CHEBI_27300', 'vitamin D', 407, 'vitamin D'), ('CHEBI_25212', 'metabolite', 417, 'metabolites'), ('SO_0000704', 'gene', 498, 'genetic'), ('CHEBI_27300', 'vitamin D', 533, 'vitamin D'), ('SO_0000704', 'gene', 627, 'genetic'), ('CHEBI_27300', 'vitamin D', 670, 'vitamin D')]
S71-PMC3427192	PMC3427192	4/2012	S71-PMC3427192	['ultimately, randomized, double-blind, Placebo-controlled STUDIES ARE NEEDED in asthma populations to sort out causal RELATIONSHIPS between Vitamin D status and outcomes and to develop RECOMMENDATIONS for treatment.']	[('FUTURE_WORK', 57), ('SUPERFICIAL_RELATIONSHIP', 117), ('FUTURE_WORK', 184)]	3	[('CHEBI_26130', 'biological pigment', 38, 'placebo'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D')]
S1-PMC3427250	PMC3427250	8/2012	S1-PMC3427250	['there are NO representative country data AVAILABLE on Vitamin D status of Pregnant women in europe.']	[('FULL_UNKNOWN', 10)]	1	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007565', 'female pregnancy', 74, 'pregnant')]
S2-PMC3427250	PMC3427250	8/2012	S2-PMC3427250	['the AIM of THIS STUDY was to estimate the prevalence of Vitamin D deficiency among belgian Pregnant women and TO ASSESS the determinants of Vitamin D status in the first and third Trimester of Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 110)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007565', 'female pregnancy', 91, 'pregnant'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 180, 'trimester'), ('GO_0007565', 'female pregnancy', 193, 'pregnancy')]
S22-PMC3427250	PMC3427250	8/2012	S22-PMC3427250	['due to its longer half-life, 25-(Oh)D IS CONSIDERED the best bio-marker of Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 38)]	1	[('CHEBI_72657', '19,20-DiHDPA', 29, '25-(OH)D'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
S32-PMC3427250	PMC3427250	8/2012	S32-PMC3427250	['the adequacy of the current Vitamin D dietary RECOMMENDATIONS to reach an optimal Vitamin D status during Pregnancy HAS BEEN QUESTIONED[24].']	[('FUTURE_WORK', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116)]	2	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy')]
S33-PMC3427250	PMC3427250	8/2012	S33-PMC3427250	['ALTHOUGH previous small surveys SUGGEST that Vitamin D deficiency among Pregnant women is common in europe[29],[30], there are NO RELIABLE country-wide estimates of Vitamin D status of Pregnant women in european countries.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 127)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'pregnant'), ('CHEBI_27300', 'vitamin D', 165, 'vitamin D'), ('GO_0007565', 'female pregnancy', 185, 'pregnant')]
S34-PMC3427250	PMC3427250	8/2012	S34-PMC3427250	['THEREFORE the AIM of THIS STUDY was to carry out the FIRST national representative random sample survey on Vitamin D status in Pregnant women in a european country and TO ASSESS the determinants of Vitamin D status in the first and third Trimester of Pregnancy.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('INCOMPLETE_EVIDENCE', 53), ('QUESTION_ANSWERED_BY_THIS_WORK', 168)]	5	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('GO_0007565', 'female pregnancy', 127, 'pregnant'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 238, 'trimester'), ('GO_0007565', 'female pregnancy', 251, 'pregnancy')]
S66-PMC3427250	PMC3427250	8/2012	S66-PMC3427250	['of all women included, 15% Smoked during Pregnancy and 12% reported having drunk Alcohol during Pregnancy (table 2).10.1371/journal.pone.0043868.t002\n\ncaption (table-wrap): table 2\ncharacteristics of the Pregnant women included in the study (n\u200a=\u200a1311) (belgian national survey on Vitamin D status in Pregnant women, 2010–2011).characteristicnmean age28.5±5.11305mean bmi*(kg/m2)24.4±5.11290% underweight5.6673% healthy weight59.20763% overweight22.09285% obese13.10169 ethnicity % white/caucasian73.61965% asiatic2.5233% african (black)4.8864% north african13.42176% hispanic0.9212% not known4.6561 education level % secondary education or lower54.54715% higher education27.23357% university or higher14.87195% other education0.233% no diploma0.699% not known2.4432 smoking % yes16.78220% of which during past 4 wks15.41202% no82.911087% not known0.314 Drinking Alcohol % yes20.37267% of which during past 4 wks11.51151% no78.491029% not known1.1415\nfirst trimester bmi used as a PROXY for Prepregnancy bmi.']	[('SUPERFICIAL_RELATIONSHIP', 980)]	1	[('GO_0007601', 'visual perception', 27, 'smoked'), ('GO_0007565', 'female pregnancy', 41, 'pregnancy'), ('CHEBI_30879', 'alcohol', 81, 'alcohol'), ('GO_0007565', 'female pregnancy', 96, 'pregnancy'), ('GO_0007565', 'female pregnancy', 204, 'pregnant'), ('CHEBI_27300', 'vitamin D', 280, 'vitamin D'), ('GO_0007565', 'female pregnancy', 300, 'pregnant'), ('GO_0006307', 'DNA dealkylation involved in DNA repair', 853, 'Drinking'), ('CHEBI_30879', 'alcohol', 862, 'alcohol'), ('GO_0007565', 'female pregnancy', 990, 'prepregnancy')]
S97-PMC3427250	PMC3427250	8/2012	S97-PMC3427250	['however, the PRESENT STUDY is the FIRST national survey on Vitamin D status among Pregnant women in belgium.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 34)]	2	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnant')]
S98-PMC3427250	PMC3427250	8/2012	S98-PMC3427250	['the high prevalence of Vitamin D deficiency in belgium stems from the fact that the contribution of dietary sources to the Vitamin D status is negligible as was shown by the flemish Food Consumption survey among preschoolers which ESTIMATED the mean Vitamin D intake at ONLY 2 µg/day[35].']	[('INCOMPLETE_EVIDENCE', 231), ('ANOMALY_CURIOUS_FINDING', 270)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('CHEBI_33290', 'food', 182, 'food'), ('GO_0007631', 'feeding behavior', 182, 'food consumption'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D')]
S101-PMC3427250	PMC3427250	8/2012	S101-PMC3427250	['the variations of 25-(Oh)D concentration with seasons REFLECT the changes in uvb exposure, one of the main DETERMINANTS of Vitamin D status in many european countries.']	[('SUPERFICIAL_RELATIONSHIP', 54), ('SUPERFICIAL_RELATIONSHIP', 107)]	2	[('CHEBI_72657', '19,20-DiHDPA', 18, '25-(OH)D'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
S102-PMC3427250	PMC3427250	8/2012	S102-PMC3427250	['the ASSOCIATION of Vitamin D status with bmi HAS BEEN ATTRIBUTED to an excessive Storage Of Vitamin D in fat Tissue decreasing thereby Serum concentrations[47].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 54)]	3	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0030730', 'sequestering of triglyceride', 81, 'storage of vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('UBERON_0000479', 'tissue', 109, 'tissue'), ('UBERON_0001977', 'blood serum', 135, 'serum')]
S103-PMC3427250	PMC3427250	8/2012	S103-PMC3427250	['ethnicity was also a major DETERMINANT of Vitamin D status in the PRESENT STUDY, as PREVIOUSLY reported in the Adult population[32]and in Pregnant women[29],[48],[49].']	[('SUPERFICIAL_RELATIONSHIP', 27), ('QUESTION_ANSWERED_BY_THIS_WORK', 66), ('INCOMPLETE_EVIDENCE', 84)]	3	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0007023', 'adult organism', 111, 'adult'), ('GO_0007565', 'female pregnancy', 138, 'pregnant')]
S105-PMC3427250	PMC3427250	8/2012	S105-PMC3427250	['in addition education level was ASSOCIATED with Vitamin D status in our Pregnant women population.']	[('SUPERFICIAL_RELATIONSHIP', 32)]	1	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'pregnant')]
S143-PMC3465343	PMC3465343	10/2012	S143-PMC3465343	['TO verify the reduction of Vitamin A in Mice receiving vad diet, we measured the Vitamin A level of mothers before Mating and their offspring at Postnatal day 1, and confirmed the vad status during Pregnancy in the vad group as previously described[33].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0)]	1	[('CHEBI_27300', 'vitamin D', 27, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 40, 'mice'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin A'), ('GO_0007618', 'mating', 115, 'mating'), ('GO_0007567', 'parturition', 145, 'postnatal'), ('GO_0007565', 'female pregnancy', 198, 'pregnancy')]
S1-PMC3470091	PMC3470091	9/2012	S1-PMC3470091	['THIS STUDY was carried out TO EVALUATE the efficacy of 300,000 iu Vitamin D given intramuscularly on body status in new cases of Gestational diabetes mellitus (gdm).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 27)]	2	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'gestational')]
S12-PMC3470091	PMC3470091	9/2012	S12-PMC3470091	['conclusions: the single 300,000 im dose of Vitamin D is REGARDED AS an EFFECTIVE and SAFE to promptly improve Vitamin D status in gdm.']	[('PROBABLE_UNDERSTANDING', 56), ('PROBABLE_UNDERSTANDING', 65), ('SUPERFICIAL_RELATIONSHIP', 71), ('IMPORTANT_CONSIDERATION', 85)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
S19-PMC3470091	PMC3470091	9/2012	S19-PMC3470091	['such a RELATION HAS BEEN ATTRIBUTED to special receptors for Vitamin D in Pancreatic Betacells.9moreover, Vitamin D WAS SHOWN to have positive EFFECTS on Insulin sensitivity, and its deficiency to have negative EFFECTS on the function of Betacells.11IN AGREEMENT with this, cohort studies REVEALED that Vitamin D had a PROTECTIVE EFFECT against diabetes type Ii.8,11also, Serum concentration of Vitamin D during 24-29thweek of Pregnancy in women suffering from Gestational diabetes mellitus (gdm) was lower than that in women without the disease.12\nthe study of Vitamin D status and improving it in the Lactating mothers with previous gdm is of CONSPICUOUS VALUE.4,13\ndue to the limited exposure to sunshine and inadequate Intake, the level of Vitamin D is reduced in the milk of Lactating mothers.']	[('SUPERFICIAL_RELATIONSHIP', 7), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 143), ('SUPERFICIAL_RELATIONSHIP', 211), ('INCOMPLETE_EVIDENCE', 250), ('INCOMPLETE_EVIDENCE', 289), ('SUPERFICIAL_RELATIONSHIP', 319), ('SUPERFICIAL_RELATIONSHIP', 330), ('IMPORTANT_CONSIDERATION', 645)]	11	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CL_0000169', 'type B pancreatic cell', 74, 'pancreatic betacells'), ('UBERON_0001264', 'pancreas', 74, 'pancreatic'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('PR_000045358', 'insulin family protein', 154, 'insulin'), ('CL_0000365', 'animal zygote', 238, 'betacells'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D'), ('CL_0002212', 'type II muscle cell', 359, 'II'), ('UBERON_0001977', 'blood serum', 372, 'serum'), ('CHEBI_27300', 'vitamin D', 395, 'vitamin D'), ('GO_0007565', 'female pregnancy', 427, 'pregnancy'), ('GO_0007565', 'female pregnancy', 461, 'gestational'), ('CHEBI_27300', 'vitamin D', 562, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 603, 'lactating'), ('GO_0007631', 'feeding behavior', 723, 'intake'), ('CHEBI_27300', 'vitamin D', 744, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 780, 'lactating')]
S20-PMC3470091	PMC3470091	9/2012	S20-PMC3470091	['THEREFORE, Vitamin D supplementation in high doses HAS BEEN RECOMMENDED, and oral doses of 20000 or 40000 iu were ASSOCIATED with positive outcomes.6,14moreover, higher oral dose of (6400 iu per day) to Lactating mothers significantly increased Vitamin D status in mothers as well as the Vitamin D content and antirachitic activity of their Milk.14THEREFORE, high doses of Vitamin D, EITHER orally OR through injection, HAS RECENTLY BEEN RECOMMENDED.15-24\na single dose of Vitamin D, administered parenterally, WOULD BE more EFFECTIVE, BECAUSE it is not associated with the NONCOMPLIANCE ASSOCIATED with an oral dose.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 51), ('FUTURE_WORK', 60), ('SUPERFICIAL_RELATIONSHIP', 114), ('PROBABLE_UNDERSTANDING', 348), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 384), ('INCOMPLETE_EVIDENCE', 420), ('FUTURE_WORK', 438), ('FUTURE_PREDICTION', 511), ('SUPERFICIAL_RELATIONSHIP', 525), ('PROBLEM_COMPLICATION', 536), ('PROBLEM_COMPLICATION', 574), ('SUPERFICIAL_RELATIONSHIP', 588)]	13	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 203, 'lactating'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 288, 'vitamin D'), ('UBERON_0001913', 'milk', 341, 'milk'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 473, 'vitamin D')]
S21-PMC3470091	PMC3470091	9/2012	S21-PMC3470091	['a dose of 600,000 iu Vitamin D resulted in hypercalcemia, THEREFORE, it can not be REGARDED a SAFE dose.17there is NO STUDY to evaluate Vitamin D status in mothers with previous gdm, and present oral Vitamin D products are not fully EFFECTIVE,16THEREFORE, THIS STUDY was DESIGNED TO EVALUATE the EFFECT of intramuscular injection of 300,000 iu during a three-month period.']	[('PROBABLE_UNDERSTANDING', 58), ('PROBABLE_UNDERSTANDING', 83), ('IMPORTANT_CONSIDERATION', 94), ('FULL_UNKNOWN', 115), ('SUPERFICIAL_RELATIONSHIP', 233), ('PROBABLE_UNDERSTANDING', 245), ('QUESTION_ANSWERED_BY_THIS_WORK', 256), ('QUESTION_ANSWERED_BY_THIS_WORK', 271), ('QUESTION_ANSWERED_BY_THIS_WORK', 280), ('SUPERFICIAL_RELATIONSHIP', 296)]	10	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
S67-PMC3470091	PMC3470091	9/2012	S67-PMC3470091	['caption (table-wrap): table 3:\n\nthe number and (percentage) frequency distribution of Vitamin D status in the intervention group (ig) and control group (cg) before and after interventiongroupsvitamin D status (nmol/l)igcgbeforeafterbeforeaftersevere deficient (<12.5)0000moderate deficient (12.5-24.9)15(62.5%)09(42.9%)10(47.6%)mild deficient (25-34.9)4(16.7%)1(4.2%)7(33.3%)3(14.3%)optimal (>35)5(20.8%)23(95.8%)4(19%)6(28.6%)\n\ndiscussion\nif Vitamin D deficiency is DEFINED as Serum concentration of 25(Oh) Vitamin D3 lower than 35 nmol/l,12ABOUT 80% of the mothers with gdm in the present study were suffering to some degrees from Vitamin D deficiency.']	[('PROBABLE_UNDERSTANDING', 467), ('INCOMPLETE_EVIDENCE', 542)]	2	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 200, 'D'), ('PR_000006444', 'diacylglycerol kinase delta', 200, 'D'), ('CHEBI_27300', 'vitamin D', 443, 'vitamin D'), ('UBERON_0001977', 'blood serum', 478, 'serum'), ('CHEBI_30778', 'gallic acid', 501, '25(OH)'), ('CHEBI_33279', 'vitamin D5', 508, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 508, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 633, 'vitamin D')]
S69-PMC3470091	PMC3470091	9/2012	S69-PMC3470091	['this INDICATES the efficacy of THIS procedure in dramatic improvement of Vitamin D status in the mothers, especially in the region with high Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 5), ('QUESTION_ANSWERED_BY_THIS_WORK', 31)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
S94-PMC3470091	PMC3470091	9/2012	S94-PMC3470091	['conclusion\nthe FINDINGS of the study INDICATE that intramuscular administration of a single dose of 300,000 iu of Vitamin D is EFFECTIVE and SAFE to improve Vitamin D status, and to ameliorate the FACTORS RELATED to the health of mothers and infants, PARTICULARLY in the regions with SEVERE Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 127), ('IMPORTANT_CONSIDERATION', 141), ('SUPERFICIAL_RELATIONSHIP', 197), ('SUPERFICIAL_RELATIONSHIP', 205), ('ANOMALY_CURIOUS_FINDING', 251), ('IMPORTANT_CONSIDERATION', 284)]	8	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin D')]
S105-PMC3471827	PMC3471827	10/2012	S105-PMC3471827	['the phenotype, especially impaired Brain Formation in ttp knockdown Zebrafish Embryos RAISES the INTRIGUING POSSIBILITY that low Vitamin E status has adverse events in early Central Nervous System development in other Animals, including Humans.']	[('EXPLICIT_QUESTION', 86), ('ANOMALY_CURIOUS_FINDING', 97), ('INCOMPLETE_EVIDENCE', 108)]	3	[('GO_0001503', 'ossification', 35, 'brain formation'), ('UBERON_0000955', 'brain', 35, 'brain'), ('NCBITaxon_7955', 'Danio rerio', 68, 'zebrafish'), ('UBERON_0000922', 'embryo', 78, 'embryos'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin E'), ('GO_0022412', 'cellular process involved in reproduction in multicellular organism', 174, 'central nervous system'), ('UBERON_0001017', 'central nervous system', 174, 'central nervous system'), ('NCBITaxon_33208', 'Metazoa', 218, 'animals'), ('NCBITaxon_9606', 'Homo sapiens', 237, 'humans')]
S111-PMC3471827	PMC3471827	10/2012	S111-PMC3471827	['in SUPPORT of this NOTION, PREVIOUS STUDIES HAVE SHOWN a clear ASSOCIATION between maternal Vitamin E status during Gestation and Cognitive function of the offspring[21]–[23].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 63)]	5	[('CHEBI_27300', 'vitamin D', 92, 'vitamin E'), ('GO_0007565', 'female pregnancy', 116, 'gestation'), ('GO_0050890', 'cognition', 130, 'cognitive')]
S5-PMC3472720	PMC3472720	8/2012	S5-PMC3472720	['using the refgensep database for ms trios (the patient and his/her parents), we collected the parents’ dates of Birth and assessed a potential season of Birth EFFECT that COULD POTENTIALLY be indicative of the Vitamin D status of the Pregnant grandmothers.']	[('SUPERFICIAL_RELATIONSHIP', 159), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 177)]	3	[('GO_0007567', 'parturition', 112, 'birth'), ('GO_0007567', 'parturition', 153, 'birth'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('GO_0007565', 'female pregnancy', 234, 'pregnant')]
S12-PMC3472720	PMC3472720	8/2012	S12-PMC3472720	['IN ORDER TO TEST the HYPOTHESIS that low Vitamin D status during Gestation is a RISK FACTOR for ms, we explored a well-DESCRIBED developmental Vitamin D (dvd) deficiency Rodent MODEL, [11,12].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 119), ('INCOMPLETE_EVIDENCE', 177)]	6	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'gestation'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 170, 'rodent')]
S22-PMC3472720	PMC3472720	8/2012	S22-PMC3472720	['we wondered IF the second generation (f2) had any persisting alterations in Immune function RELATED to the Vitamin D status of the Pregnant f0female Mice.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('SUPERFICIAL_RELATIONSHIP', 92)]	2	[('UBERON_0002405', 'immune system', 76, 'immune'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('GO_0007565', 'female pregnancy', 131, 'pregnant'), ('NCBITaxon_10088', 'Mus <genus>', 149, 'mice')]
S31-PMC3472720	PMC3472720	8/2012	S31-PMC3472720	['the QUESTION we have ADDRESSED was WHETHER one’s parents’ season of Birth (AS a PROXY-measure of developmental Vitamin D status) COULD BE an additional RISK FACTOR for ms patients?']	[('EXPLICIT_QUESTION', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('EXPLICIT_QUESTION', 35), ('PROBABLE_UNDERSTANDING', 75), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 152), ('EXPLICIT_QUESTION', 179)]	9	[('GO_0007567', 'parturition', 68, 'birth'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 119, 'D')]
S32-PMC3472720	PMC3472720	8/2012	S32-PMC3472720	['using the refgensep database for ms trios (the patient and his/her parents), we collected the parents’ dates of Birth and assessed a potential season of Birth EFFECT that COULD POTENTIALLY be indicative of the Vitamin D status of the Pregnant grandmothers.']	[('SUPERFICIAL_RELATIONSHIP', 159), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 177)]	3	[('GO_0007567', 'parturition', 112, 'birth'), ('GO_0007567', 'parturition', 153, 'birth'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('GO_0007565', 'female pregnancy', 234, 'pregnant')]
S72-PMC3476426	PMC3476426	8/2012	S72-PMC3476426	['the horizontal line inside the box represents the median and the whiskers represent the non-outlier (between 1.5 and 3 iqr) or extreme (more than 3 iqr) maximum and minimum values of Serum 25-Hydroxy Vitamin D.\n\ncaption (table-wrap): table 1\n\nbasic clinical data and Vitamin D status of the studied childrenclinical dataautistic children (\u2009 n \u2009= 50)control children (\u2009 n \u2009= 30) age ( years)8.24 ± 2.378.63 ± 2.65sex (male/female)39/1124/6the duration of sun exposure (hours/week)6.48 ± 1.296.23 ± 1.41vitamin D deficiency (<10 ng/ml)40% (20/50)0vitamin D insufficiency (10 to 30 ng/ml)48% (24/50)20% (6/30)Vitamin D sufficiency (>30 ng/ml)12% (6/50)80% (24/30)\nSerum 25-Hydroxy Vitamin D had significant negative CORRELATIONS with cars (r = −0.84, p< 0.001).']	[('SUPERFICIAL_RELATIONSHIP', 713)]	1	[('UBERON_0001977', 'blood serum', 183, 'serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 189, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 509, 'D'), ('PR_000006444', 'diacylglycerol kinase delta', 553, 'D'), ('CHEBI_28384', 'vitamin K', 606, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 661, 'Serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 667, '25-hydroxy vitamin D')]
S108-PMC3476426	PMC3476426	8/2012	S108-PMC3476426	['maternal Vitamin D deficiency MAY BE a risk factor for autism, POSSIBLY by AFFECTING fetal Brain Development as well as by AFFECTING maternal Immune System status during Pregnancy [37,38].']	[('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 75), ('SUPERFICIAL_RELATIONSHIP', 123)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007420', 'brain development', 91, 'brain development'), ('UBERON_0000955', 'brain', 91, 'brain'), ('UBERON_0002405', 'immune system', 142, 'immune system'), ('GO_0007565', 'female pregnancy', 170, 'pregnancy')]
S1-PMC3515553	PMC3515553	12/2012	S1-PMC3515553	['Brain Development occurs primarily in utero and early infancy, BUT the ROLE of maternal Vitamin B-12 status during Pregnancy on offspring Cognitive function is UNCLEAR.']	[('ANOMALY_CURIOUS_FINDING', 63), ('SUPERFICIAL_RELATIONSHIP', 71), ('FULL_UNKNOWN', 160)]	3	[('GO_0060132', 'prolactin secreting cell development', 0, 'Brain development'), ('UBERON_0000955', 'brain', 0, 'Brain'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 88, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy'), ('GO_0050890', 'cognition', 138, 'cognitive')]
S2-PMC3515553	PMC3515553	12/2012	S2-PMC3515553	['in THIS STUDY we ASSESSED the EFFECT of Vitamin B-12 status in well-nourished Pregnant women on the Cognitive ability of their offspring in a uk birth cohort (alspac).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('SUPERFICIAL_RELATIONSHIP', 30)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 40, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 78, 'pregnant'), ('GO_0050890', 'cognition', 100, 'cognitive')]
S13-PMC3515553	PMC3515553	12/2012	S13-PMC3515553	['Vitamin B-12 concentration in Breast Milk and Vitamin B-12 status of the infant are ASSOCIATED with Vitamin B-12 concentration in maternal Blood[4].']	[('SUPERFICIAL_RELATIONSHIP', 84)]	1	[('PR_000017269', 'ventral anterior homeobox 2', 0, 'Vitamin B-12'), ('UBERON_0001348', 'brown adipose tissue', 30, 'breast milk'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 46, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 100, 'vitamin B-12'), ('UBERON_0000178', 'blood', 139, 'blood')]
S15-PMC3515553	PMC3515553	12/2012	S15-PMC3515553	['DESPITE the IMPORTANCE of Vitamin B-12 to Neuronal Development and the dependency of the developing foetus and infant on maternal Vitamin B-12 status, it is UNKNOWN WHETHER variation in maternal Pregnancy Vitamin B-12, across the normal range, INFLUENCES offspring Neurodevelopment.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 12), ('FULL_UNKNOWN', 157), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 165), ('SUPERFICIAL_RELATIONSHIP', 244)]	5	[('CHEBI_27300', 'vitamin D', 26, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 26, 'vitamin B-12'), ('CL_0000540', 'neuron', 42, 'neuronal'), ('GO_0007399', 'nervous system development', 42, 'neuronal development'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 130, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 195, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 205, 'vitamin B-12'), ('GO_0007399', 'nervous system development', 265, 'neurodevelopment')]
S69-PMC3515553	PMC3515553	12/2012	S69-PMC3515553	['in these analyses, we log transformed Vitamin B-12 to base 2 so that results are INTERPRETED as a mean difference in iq per doubling of Vitamin B-12 intake or status.10.1371/journal.pone.0051084.t002\n\ncaption (table-wrap): table 2\nASSOCIATION of maternal dietary vitamin b-12 Intake during Pregnancy with offspring iq at age 8.']	[('PROBABLE_UNDERSTANDING', 81), ('SUPERFICIAL_RELATIONSHIP', 231)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 38, 'vitamin B-12'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin B'), ('GO_0007631', 'feeding behavior', 276, 'intake'), ('GO_0007565', 'female pregnancy', 290, 'pregnancy')]
S75-PMC3515553	PMC3515553	12/2012	S75-PMC3515553	['AS offspring genotype MAY INFLUENCE Cognitive ability per se , we adjusted for offspring genotype to estimate the EFFECT of maternal Vitamin B-12 status during Pregnancy on offspring iq.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 26), ('SUPERFICIAL_RELATIONSHIP', 114)]	4	[('GO_0050890', 'cognition', 36, 'cognitive'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 133, 'vitamin B-12'), ('CHEBI_37983', 'sulfur-35 atom', 143, '12'), ('GO_0007565', 'female pregnancy', 160, 'pregnancy')]
S93-PMC3515553	PMC3515553	12/2012	S93-PMC3515553	['Vitamin B-12 status RELATED Snps, maternal dietary intake of Vitamin B-12 and Cord Blood Vitamin B-12\nneither of the maternal Snps was associated with maternal dietary Intake of Vitamin B-12 during Pregnancy in a linear model, ALTHOUGH tcn2 rs1801198 heterozygotes showed higher Vitamin B-12 intake than either homozygote group (p\u200a=\u200a0.02).']	[('SUPERFICIAL_RELATIONSHIP', 20), ('ANOMALY_CURIOUS_FINDING', 227)]	2	[('PR_000017269', 'ventral anterior homeobox 2', 0, 'Vitamin B-12'), ('SO_0000694', 'SNP', 28, 'SNPs'), ('PR_000017269', 'ventral anterior homeobox 2', 61, 'Vitamin B-12'), ('UBERON_0000948', 'heart', 78, 'Cord'), ('UBERON_0000178', 'blood', 83, 'Blood'), ('PR_000017269', 'ventral anterior homeobox 2', 89, 'Vitamin B-12'), ('SO_0000694', 'SNP', 126, 'SNPs'), ('GO_0007631', 'feeding behavior', 168, 'intake'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 178, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 198, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 279, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 279, 'vitamin B-12')]
S134-PMC3515553	PMC3515553	12/2012	S134-PMC3515553	['conditioning on offspring genotype made this ASSOCIATION SOMEWHAT stronger, giving SUPPORT to the HYPOTHESIS that offspring iq score MAY BE INFLUENCED by maternal Vitamin B-12 status during the Intra-Uterine or Perinatal Period RATHER than REFLECT post-Natal offspring exposure to dietary Vitamin B-12.']	[('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 98), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 140), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228), ('SUPERFICIAL_RELATIONSHIP', 240)]	8	[('CHEBI_27300', 'vitamin D', 163, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 163, 'vitamin B-12'), ('UBERON_0001273', 'ilium', 194, 'intra'), ('UBERON_0000995', 'uterus', 200, 'uterine'), ('GO_0036268', 'swimming', 211, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 211, 'perinatal period'), ('GO_0007567', 'parturition', 253, 'natal'), ('CHEBI_27300', 'vitamin D', 289, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 289, 'vitamin B-12')]
S153-PMC3515553	PMC3515553	12/2012	S153-PMC3515553	['it HAS been PREVIOUSLY SHOWN that maternal cobalamin status is a strong PREDICTOR of Vitamin B-12 in breastfed infants up to AT LEAST 6 months of age[35].']	[('IMPORTANT_CONSIDERATION', 3), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 72), ('PROBABLE_UNDERSTANDING', 125)]	4	[('CHEBI_27300', 'vitamin D', 85, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 85, 'vitamin B-12')]
S32-PMC3521768	PMC3521768	12/2012	S32-PMC3521768	['DESPITE the existence of MANY rcts and OBSERVATIONAL studies which evaluated the EFFECT of Prenatal zinc and Vitamin A status on Birthweight, THE CURRENT STUDY is WORTH documentable as it HAS BEEN conducted in area with high prevalence of zinc and Vitamin A deficiencies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 25), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 81), ('QUESTION_ANSWERED_BY_THIS_WORK', 142), ('ANOMALY_CURIOUS_FINDING', 163), ('INCOMPLETE_EVIDENCE', 188)]	8	[('GO_0007565', 'female pregnancy', 91, 'prenatal'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin A'), ('GO_0007596', 'blood coagulation', 129, 'birthweight'), ('CHEBI_27300', 'vitamin D', 248, 'vitamin A')]
S66-PMC3521768	PMC3521768	12/2012	S66-PMC3521768	['apart from the main independent variables (Prenatal Vitamin A and zinc statuses), OTHER independent variables of interest were maternal Literacy (ability to Read and write), maternal employment, household wealth index, agro-ecological zone, antenatal care (anc) follow up, Blood pressure during Pregnancy, type of staple diet, distance from the nearby health facility, maternal thinness (maternal mid-upper Arm circumference (muac) less than 220 mm), maternal stunting (maternal height less than 145 cm), elevated crp (crp greater or equal to 5 mg/dl), newborn sex, maternal age and primiparity.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 82)]	1	[('GO_0007565', 'female pregnancy', 43, 'prenatal'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin A'), ('GO_0007612', 'learning', 136, 'literacy'), ('GO_0006281', 'DNA repair', 157, 'read'), ('UBERON_0000178', 'blood', 273, 'blood'), ('GO_0007565', 'female pregnancy', 295, 'pregnancy'), ('UBERON_0002362', 'arachnoid mater', 407, 'Arm')]
S143-PMC3521768	PMC3521768	12/2012	S143-PMC3521768	['IN ORDER TO INVESTIGATE the POSSIBILITY of synergetic INTERACTION of the two deficiencies in causing lbw, the study subjects were categorized into four groups based on Vitamin A and zinc deficiency statuses and analyzed accordingly (table 3).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 54)]	3	[('CHEBI_27300', 'vitamin D', 168, 'vitamin A')]
S0-PMC3552819	PMC3552819	12/2012	S0-PMC3552819	['pharmacokinetics of a single oral dose of Vitamin D3 (70,000 iu) in Pregnant and non-Pregnant women\n\nabstract\n\nbackground\nimprovements in Antenatal Vitamin D status MAY have maternal-infant health benefits.']	[('INCOMPLETE_EVIDENCE', 165)]	1	[('CHEBI_33279', 'vitamin D5', 42, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 42, 'vitamin D3'), ('GO_0007565', 'female pregnancy', 68, 'pregnant'), ('GO_0007565', 'female pregnancy', 85, 'pregnant'), ('GO_0007567', 'parturition', 138, 'antenatal'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
S12-PMC3552819	PMC3552819	12/2012	S12-PMC3552819	['there is considerable SPECULATION regarding the POTENTIAL EFFECTS of Vitamin D on both Skeletal and Extra-Skeletal aspects of Reproductive physiology and Fetal Development, YET it REMAINS UNKNOWN WHETHER there are benefits to improving maternal Antenatal Vitamin D status beyond the correction of SEVERE deficiency [2,3].']	[('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 58), ('ANOMALY_CURIOUS_FINDING', 173), ('FULL_UNKNOWN', 180), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 196), ('IMPORTANT_CONSIDERATION', 297)]	7	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('UBERON_0004288', 'skeleton', 87, 'skeletal'), ('UBERON_0001431', 'distal carpal bone 2', 100, 'extra-skeletal'), ('GO_0000003', 'reproduction', 126, 'reproductive'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 154, 'fetal development'), ('GO_0007567', 'parturition', 245, 'antenatal'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D')]
S13-PMC3552819	PMC3552819	12/2012	S13-PMC3552819	['clinical trials employing Vitamin D dose regimens that SAFELY optimize maternal-fetal Vitamin D status will enable testing of these HYPOTHESES [4].']	[('IMPORTANT_CONSIDERATION', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
S15-PMC3552819	PMC3552819	12/2012	S15-PMC3552819	['moreover, there is a near complete absence of Pharmacological data in south asia, where the Vitamin D status of Pregnant women [7] and young infants [8] is poor IN SPITE of the tropical climate.']	[('ANOMALY_CURIOUS_FINDING', 161)]	1	[('CHEBI_52217', 'pharmaceutical', 46, 'pharmacological'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'pregnant')]
S16-PMC3552819	PMC3552819	12/2012	S16-PMC3552819	['the pharmacokinetics of oral Vitamin D3 are CONVENTIONALLY described with respect to its EFFECT on the Serum concentration of the predominant circulating Metabolite, 25-Hydroxyvitamin D ([25(Oh)D]), which is a WELL-ESTABLISHED BIOMARKER of systemic Vitamin D status [9].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('SUPERFICIAL_RELATIONSHIP', 89), ('PROBABLE_UNDERSTANDING', 210), ('SUPERFICIAL_RELATIONSHIP', 227)]	4	[('CHEBI_33279', 'vitamin D5', 29, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 29, 'vitamin D3'), ('UBERON_0001977', 'blood serum', 103, 'serum'), ('CHEBI_39382', 'flufenoxuron', 154, 'metabolite'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 166, '25-hydroxyvitamin D'), ('CHEBI_33010', 'chromide(1-)', 190, '(OH)D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D')]
S222-PMC3552819	PMC3552819	12/2012	S222-PMC3552819	['HOWEVER, the unpredictability of the 25(Oh)D response at the individual level, PREVIOUS REPORTS of adverse EFFECTS of large single doses [23], and the THEORETICAL DISADVANTAGES of excessive fluctuations in Vitamin D status [29] SUGGEST that the use of large single or infrequent intermittent doses of Vitamin D3 MAY BE physiologically DISADVANTAGEOUS DESPITE its practical APPEAL.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 88), ('SUPERFICIAL_RELATIONSHIP', 107), ('INCOMPLETE_EVIDENCE', 151), ('IMPORTANT_CONSIDERATION', 163), ('INCOMPLETE_EVIDENCE', 228), ('INCOMPLETE_EVIDENCE', 312), ('IMPORTANT_CONSIDERATION', 335), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 351), ('ANOMALY_CURIOUS_FINDING', 351), ('IMPORTANT_CONSIDERATION', 373)]	12	[('CHEBI_71657', 'versiconol acetate', 37, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 301, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 301, 'vitamin D3')]
S2-PMC3613945	PMC3613945	2/2013	S2-PMC3613945	['they are common enough to generate population-wide constitutive DIFFERENCES in Vitamin D status, based on assay of the Serum Metabolite, 25-Hydroxyvitamin D (25Ohd).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 64)]	1	"[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('UBERON_0001977', 'blood serum', 119, 'serum'), ('CHEBI_39382', 'flufenoxuron', 125, 'metabolite'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 137, '25-hydroxyvitamin D'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 158, '25OHD')]"
S50-PMC3613945	PMC3613945	2/2013	S50-PMC3613945	['WHILE these common polymorphisms are ASSOCIATED with dbp status, others have DEMONSTRATED ASSOCIATION between genotype and Serum Vitamin D Metabolite levels.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 90)]	4	[('UBERON_0001977', 'blood serum', 123, 'serum'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CHEBI_39382', 'flufenoxuron', 139, 'metabolite')]
S60-PMC3613945	PMC3613945	2/2013	S60-PMC3613945	['Vitamin D, dbp and Innate Immunity – an EMERGING theme\nthe ROLE of dbp in the biology of Vitamin D as it RELATES to the Endocrine status of bone and Mineral Metabolism is well established and the reader is referred to reviews47,48, monographs49and authoritative web sites50.']	[('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 59), ('SUPERFICIAL_RELATIONSHIP', 105)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('GO_0045087', 'innate immune response', 19, 'innate immunity'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0006397', 'mRNA processing', 120, 'endocrine'), ('CHEBI_46662', 'mineral', 149, 'mineral'), ('GO_0008152', 'metabolic process', 157, 'metabolism')]
S207-PMC3613945	PMC3613945	2/2013	S207-PMC3613945	['cancer\nseveral OBSERVATIONAL STUDIES have DEMONSTRATED an inverse RELATIONSHIP between uvb irradiance (REQUIRED for the cutaneous Synthesis Of Vitamin D) or Vitamin D status [Serum 25(Oh)D concentrations] and the incidence of mortality from Endometrial126, Lung127,128, Breast127,129–133, Prostate134–137, Ovarian138,139and Colorectal cancer140–149.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 103)]	4	[('GO_0030474', 'spindle pole body duplication', 130, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D'), ('UBERON_0001977', 'blood serum', 175, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 184, 'OH)D'), ('UBERON_0004167', 'orbitofrontal cortex', 241, 'endometrial126'), ('UBERON_0002048', 'lung', 257, 'lung127'), ('UBERON_0013550', 'Brodmann (1909) area 19', 270, 'breast127'), ('UBERON_0003820', 'prostate bud', 289, 'prostate134'), ('UBERON_0008231', 'dorsal thoracic segment of trunk', 306, 'ovarian138'), ('UBERON_0012652', 'colorectum', 324, 'colorectal')]
S208-PMC3613945	PMC3613945	2/2013	S208-PMC3613945	['the UNDERLYING mechanism by which Vitamin D status AFFECTS cancer RISK is UNKNOWN, HOWEVER, 1,25(Oh)2D3Has BEEN SHOWN to Modulate Cell Proliferation and Differentiation Of both normal and malignant Cells.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 51), ('IMPORTANT_CONSIDERATION', 66), ('FULL_UNKNOWN', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('ANOMALY_CURIOUS_FINDING', 83), ('INCOMPLETE_EVIDENCE', 107)]	7	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_76957', 'N-2-hydroxytetracosenoylsphingosine', 92, '1,25(OH)2D3has'), ('GO_0065007', 'biological regulation', 121, 'modulate'), ('GO_0008283', 'cell proliferation', 130, 'cell proliferation'), ('GO_0030154', 'cell differentiation', 153, 'differentiation of ... cells')]
S210-PMC3613945	PMC3613945	2/2013	S210-PMC3613945	['Breast cancer\necological case-control studies INDICATE an inverse CORRELATION between Vitamin D status and Breast cancer RISK, HOWEVER, the RELATIONSHIP is LESS CLEAR in longitudinal studies150,151.']	[('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 121), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('ANOMALY_CURIOUS_FINDING', 127), ('SUPERFICIAL_RELATIONSHIP', 140), ('FULL_UNKNOWN', 156)]	7	[('UBERON_0000310', 'breast', 0, 'Breast'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0000310', 'breast', 107, 'breast')]
S238-PMC3613945	PMC3613945	2/2013	S238-PMC3613945	['moreover, SEVERAL STUDIES HAVE SHOWN an inverse CORRELATION between Serum levels of Vitamin D and ms173,174, SUGGESTING that polymorphisms INFLUENCING Vitamin D status MIGHT CONTRIBUTE to the initiation or progression of disease.']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 139), ('INCOMPLETE_EVIDENCE', 168), ('SUPERFICIAL_RELATIONSHIP', 174)]	7	[('UBERON_0001977', 'blood serum', 68, 'serum'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D')]
S73-PMC3629265	PMC3629265	4/2013	S73-PMC3629265	['adequate transfer of stores DEPENDS ON the Vitamin D status of the mother.']	[('SUPERFICIAL_RELATIONSHIP', 28)]	1	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D')]
S0-PMC3641012	PMC3641012	4/2013	S0-PMC3641012	['randomized placebo-controlled trial of high-dose Prenatal third-Trimester Vitamin D3 supplementation in bangladesh: the avidd trial\n\nabstract\n\nbackground\nantenatal Vitamin D status MAY be ASSOCIATED with the RISK of adverse Pregnancy and neonatal outcomes; HOWEVER, the benefits of Vitamin D supplementation during Pregnancy remain UNKNOWN.']	[('INCOMPLETE_EVIDENCE', 181), ('SUPERFICIAL_RELATIONSHIP', 188), ('IMPORTANT_CONSIDERATION', 208), ('ANOMALY_CURIOUS_FINDING', 257), ('FULL_UNKNOWN', 332)]	5	[('GO_0007565', 'female pregnancy', 49, 'prenatal'), ('GO_0009294', 'DNA mediated transformation', 64, 'trimester'), ('CHEBI_33279', 'vitamin D5', 74, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 74, 'vitamin D3'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007565', 'female pregnancy', 224, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 282, 'vitamin D'), ('GO_0007565', 'female pregnancy', 315, 'pregnancy')]
S13-PMC3641012	PMC3641012	4/2013	S13-PMC3641012	['HOWEVER, the EFFECTS of Vitamin D on maternal, Placental or Fetal Tissues are UNCERTAIN [2], and the extent to which health outcomes are responsive to changes in maternal-fetal Vitamin D status REMAINS UNKNOWN [2,6,7].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('FULL_UNKNOWN', 78), ('FULL_UNKNOWN', 194)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('UBERON_0001987', 'placenta', 47, 'placental'), ('UBERON_0000922', 'embryo', 60, 'fetal'), ('UBERON_0000479', 'tissue', 66, 'tissues'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D')]
S21-PMC3641012	PMC3641012	4/2013	S21-PMC3641012	['determination of the Vitamin D intake level (and corresponding Serum 25(Oh)D concentration) that SAFELY optimizes Vitamin D-responsive maternal-infant health outcomes would have GLOBAL IMPLICATIONS, but MAY be particularly RELEVANT to resource-poor communities in south asia, where a relatively low Prenatal Vitamin D status OVERLAPS with a HIGH BURDEN of morbidity and mortality ASSOCIATED with adverse Birth and early infant health outcomes [15].']	[('IMPORTANT_CONSIDERATION', 97), ('IMPORTANT_CONSIDERATION', 178), ('IMPORTANT_CONSIDERATION', 185), ('INCOMPLETE_EVIDENCE', 203), ('SUPERFICIAL_RELATIONSHIP', 223), ('SUPERFICIAL_RELATIONSHIP', 325), ('IMPORTANT_CONSIDERATION', 341), ('SUPERFICIAL_RELATIONSHIP', 380)]	8	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0001977', 'blood serum', 63, 'serum'), ('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 69, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('GO_0007565', 'female pregnancy', 299, 'prenatal'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D'), ('GO_0007567', 'parturition', 404, 'birth')]
S55-PMC3641012	PMC3641012	4/2013	S55-PMC3641012	['Serum aliquots were frozen at −20°c and shipped at ambient temperature from bangladesh to toronto for measurement of Serum 25(Oh)D concentration, a WELL-ESTABLISHED BIOMARKER of systemic Vitamin D status [17].']	[('PROBABLE_UNDERSTANDING', 148), ('SUPERFICIAL_RELATIONSHIP', 165)]	2	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('UBERON_0001977', 'blood serum', 117, 'serum'), ('CHEBI_71657', 'versiconol acetate', 123, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 123, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D')]
S128-PMC3641012	PMC3641012	4/2013	S128-PMC3641012	['Vitamin D supplementation had a substantial, statistically significant EFFECT on maternal and neonatal Vitamin D status at the time of Delivery, as reflected in the overall 25(Oh)D distributions (figure\xa02; table\xa04) as well as the proportion of participants considered to have low 25(Oh)D using cut-offs (table\xa02).']	[('SUPERFICIAL_RELATIONSHIP', 71)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007567', 'parturition', 135, 'delivery'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 176, 'OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 179, 'D'), ('CHEBI_71657', 'versiconol acetate', 280, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 280, '25(OH)D')]
S161-PMC3641012	PMC3641012	4/2013	S161-PMC3641012	['given the substantial inter-Individual VARIABILITY in the response to Vitamin D supplementation (figure\xa03), we EXPLORED the ROLE of the following POTENTIAL MODIFIERS of the magnitude of the change in 25(Oh)D (δ25(Oh)D) from baseline to Delivery (selected a priori ): maternal weight at baseline, maternal age, Gestational age, maternal body mass index at baseline (bmi), gravidity, parity, baseline Pth status, season and baseline Vitamin D status.']	[('DIFFICULT_TASK', 39), ('QUESTION_ANSWERED_BY_THIS_WORK', 111), ('SUPERFICIAL_RELATIONSHIP', 124), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 156)]	5	[('NCBITaxon_1', 'root', 28, 'individual'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 200, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 206, 'D'), ('CHEBI_33010', 'chromide(1-)', 212, '(OH)D'), ('GO_0007567', 'parturition', 236, 'delivery'), ('GO_0007565', 'female pregnancy', 310, 'gestational'), ('CHEBI_8102', 'phenylmethanesulfonyl fluoride', 399, 'PTH'), ('CHEBI_27300', 'vitamin D', 431, 'vitamin D')]
S163-PMC3641012	PMC3641012	4/2013	S163-PMC3641012	['ALTHOUGH δ25(Oh)D was inversely ASSOCIATED with baseline Vitamin D status, and ABOUT 24% of the variance in δ25(Oh)D in the Vitamin D group was EXPLAINED by baseline 25(Oh)D, this ASSOCIATION APPEARED TO BE due to regression to the mean, SINCE similar TRENDS were observed in both the Vitamin D and placebo groups.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 79), ('PROBABLE_UNDERSTANDING', 144), ('SUPERFICIAL_RELATIONSHIP', 180), ('ANOMALY_CURIOUS_FINDING', 192), ('PROBABLE_UNDERSTANDING', 238), ('SUPERFICIAL_RELATIONSHIP', 252)]	8	[('CHEBI_33010', 'chromide(1-)', 12, '(OH)D'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 111, '(OH)D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 166, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 166, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 285, 'vitamin D')]
S242-PMC3641012	PMC3641012	4/2013	S242-PMC3641012	['this SUGGESTED a Homeostatic Adjustment to the altered Vitamin D status, with no further increase in Serum calcium after a steady-state 25(Oh)D was reached.']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('GO_0044809', 'chemokine (C-C motif) ligand 17 production', 17, 'homeostatic adjustment'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0001977', 'blood serum', 101, 'serum'), ('CHEBI_71657', 'versiconol acetate', 136, '25(OH)D')]
S250-PMC3641012	PMC3641012	4/2013	S250-PMC3641012	['in addition, enrolment was not conducted throughout the entire season, but RATHER occurred during a period in which Vitamin D status was declining from its summer peak.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 75)]	1	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
S89-PMC3651971	PMC3651971	5/2013	S89-PMC3651971	['comparisons between participants of the randomised Supplement group\nthe Vitamin A and placebo groups of tested children were similar on measures of socioeconomic and nutritional status assessed during the original nnips-2 trial, the one IMPORTANT and expected difference being that a higher proportion of children whose mothers had been night blind during Pregnancy were in the placebo vs Vitamin A group (15.5% vs 8.2%, p=0.02).']	[('IMPORTANT_CONSIDERATION', 237)]	1	[('CHEBI_16158', 'steroid sulfate', 51, 'supplement'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin A'), ('GO_0007565', 'female pregnancy', 356, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 389, 'vitamin A')]
S19-PMC3659910	PMC3659910	1/2013	S19-PMC3659910	['[2] there are increasing STUDIES worldwide reporting POOR Vitamin D status, including those in tropical countries.']	[('INCOMPLETE_EVIDENCE', 25), ('IMPORTANT_CONSIDERATION', 53)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
S66-PMC3659910	PMC3659910	1/2013	S66-PMC3659910	"[""THUS, increasing Vitamin D intake from Vitamin D fortified foods, and Vitamin D supplements, in combination with SENSIBLE sun exposure, maximize a Person's vitamin d status to promote good health.""]"	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 113)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 147, 'person')]
S118-PMC3659910	PMC3659910	1/2013	S118-PMC3659910	['nutritional Vitamin D status has very RECENTLY been LINKED to the Human innate Immune System and its ability to contain mycobacterium tuberculosis.']	[('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 52)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 66, 'human'), ('GO_0007566', 'embryo implantation', 79, 'immune'), ('UBERON_0002405', 'immune system', 79, 'immune system')]
S144-PMC3659910	PMC3659910	1/2013	S144-PMC3659910	['lower maternal Vitamin D status was ASSOCIATED with lower bone Mineral concentration and impaired Glucose Homeostasis in newborn infants.']	[('SUPERFICIAL_RELATIONSHIP', 36)]	1	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CHEBI_46662', 'mineral', 63, 'mineral'), ('CHEBI_17234', 'glucose', 98, 'glucose'), ('GO_0042593', 'glucose homeostasis', 98, 'glucose homeostasis')]
S158-PMC3659910	PMC3659910	1/2013	S158-PMC3659910	['the BASIS for these RECOMMENDATIONS was made BEFORE IT WAS POSSIBLE to measure the circulating concentration of 25-Hydroxyvitamin D [25(Oh) D], the INDICATOR of nutritional Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 4), ('FUTURE_WORK', 20), ('DIFFICULT_TASK', 45), ('SUPERFICIAL_RELATIONSHIP', 148)]	4	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 112, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH) D'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
S160-PMC3659910	PMC3659910	1/2013	S160-PMC3659910	['[43] IF electing to test Vitamin D status, Serum 25-Hydroxyvitamin D is the ACCEPTED BIOMARKER to be offered early in Pregnancy.']	[('IMPORTANT_CONSIDERATION', 5), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 85)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0001977', 'blood serum', 43, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 49, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 118, 'pregnancy')]
S173-PMC3659910	PMC3659910	1/2013	S173-PMC3659910	['HOWEVER this RECOMMENDED level, which was LARGELY ARBITRARILY set, SEEMS TO BE LESS HELPFUL to improve the nutritional Vitamin D status of Pregnant women.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 13), ('INCOMPLETE_EVIDENCE', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 50), ('ANOMALY_CURIOUS_FINDING', 67), ('FUTURE_PREDICTION', 73), ('IMPORTANT_CONSIDERATION', 79)]	7	[('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('GO_0007565', 'female pregnancy', 139, 'pregnant')]
S175-PMC3659910	PMC3659910	1/2013	S175-PMC3659910	['a RECENT systematic review CONCLUDED that Antenatal Vitamin D supplementation is EFFECTIVE in improving the Vitamin D status of asian and white women, improves growth in the first year of Life in south asian babies and THEREFORE MAY CONTRIBUTE to reducing the incidence of rickets in this latter group, without evidence of harm.']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 81), ('PROBABLE_UNDERSTANDING', 219), ('FUTURE_PREDICTION', 229), ('SUPERFICIAL_RELATIONSHIP', 233)]	6	[('GO_0007567', 'parturition', 42, 'antenatal'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('UBERON_0000104', 'life cycle', 188, 'life')]
S9-PMC3668200	PMC3668200	5/2013	S9-PMC3668200	['MOST physicians consider 1,25-Oh2-D as a KEY substance to the assessment of Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 41)]	2	[('CHEBI_82627', '15(R)-HPETE', 25, '1,25-OH2-D'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
S10-PMC3668200	PMC3668200	5/2013	S10-PMC3668200	['HOWEVER, measuring 1,25-Oh2-D levels AS a PREDICTOR of Vitamin D status CAN LEAD TO ERRONEOUS CONCLUSIONS BECAUSE, compared with 25(Oh)D levels, 1,25-Oh2-D levels CAN be normal or EVEN elevated DESPITE Vitamin D deficiency due to secondary hyperparathyroidism.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 72), ('PROBABLE_UNDERSTANDING', 76), ('QUESTION_ANSWERED_BY_THIS_WORK', 81), ('PROBLEM_COMPLICATION', 84), ('PROBLEM_COMPLICATION', 84), ('PROBABLE_UNDERSTANDING', 94), ('PROBABLE_UNDERSTANDING', 106), ('PROBLEM_COMPLICATION', 106), ('INCOMPLETE_EVIDENCE', 163), ('ANOMALY_CURIOUS_FINDING', 180), ('ANOMALY_CURIOUS_FINDING', 194)]	14	[('CHEBI_78731', '9(R)-HPETE', 21, '25-OH2-D'), ('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 129, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 135, 'D'), ('CHEBI_78731', '9(R)-HPETE', 147, '25-OH2-D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D')]
S30-PMC3668200	PMC3668200	5/2013	S30-PMC3668200	['ALTHOUGH nursing mothers were supplemented with 1,000 to 2,000 iu of Vitamin D daily, the supplementation had little effect on the Vitamin D concentration status of breastfed infants14).']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D')]
S50-PMC3668200	PMC3668200	5/2013	S50-PMC3668200	['with respect to Prenatal supplementation, the GENERALLY prescribed daily intake of 400 iu of Vitamin D is NOT sufficient to achieve the OPTIMAL Vitamin D status in newborns18).']	[('PROBABLE_UNDERSTANDING', 46), ('ANOMALY_CURIOUS_FINDING', 106), ('IMPORTANT_CONSIDERATION', 136)]	3	[('GO_0007565', 'female pregnancy', 16, 'prenatal'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
S1-PMC3672018	PMC3672018	5/2013	S1-PMC3672018	['HOWEVER, the IMPORTANCE of maternal Vitamin D status on offspring health later in Life has not been widely studied.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 13)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0000104', 'life cycle', 82, 'life')]
S29-PMC3672018	PMC3672018	5/2013	S29-PMC3672018	['with the high general prevalence of Vitamin D deficiency, the status of Pregnant and Lactating women is of particular CONCERN.']	[('PROBLEM_COMPLICATION', 118)]	1	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'pregnant'), ('GO_0007594', 'puparial adhesion', 85, 'lactating')]
S36-PMC3672018	PMC3672018	5/2013	S36-PMC3672018	['to date, the RELATIONSHIP between Vitamin D status during fetal Life and long-term health has not been widely examined, and interventions are generally lacking.']	[('SUPERFICIAL_RELATIONSHIP', 13)]	1	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0000104', 'life cycle', 64, 'life')]
S107-PMC3672018	PMC3672018	5/2013	S107-PMC3672018	['25(Oh)D3 level from dbs cards\nBECAUSE the 25(Oh)D3 levels in the newborn Blood REFLECTS the Vitamin D status of the newborn as well as the mother at the end of Pregnancy [29], measurement of 25(Oh)D3 levels in dbs will serve as VALIDATION for the EFFECT of fortification for incident cases.']	[('PROBABLE_UNDERSTANDING', 30), ('SUPERFICIAL_RELATIONSHIP', 79), ('INCOMPLETE_EVIDENCE', 228), ('SUPERFICIAL_RELATIONSHIP', 247)]	4	[('CHEBI_62946', 'ammonium sulfate', 0, '25(OH)D3'), ('PR_000029655', '28S rRNA (cytosine-C(5))-methyltransferase', 0, '25(OH)D3'), ('CHEBI_62946', 'ammonium sulfate', 42, '25(OH)D3'), ('PR_000029655', '28S rRNA (cytosine-C(5))-methyltransferase', 42, '25(OH)D3'), ('UBERON_0000178', 'blood', 73, 'blood'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 160, 'pregnancy'), ('CHEBI_62946', 'ammonium sulfate', 191, '25(OH)D3'), ('PR_000029655', '28S rRNA (cytosine-C(5))-methyltransferase', 191, '25(OH)D3')]
S146-PMC3672018	PMC3672018	5/2013	S146-PMC3672018	['HOWEVER, Vitamin D fortification is especially beneficial when Vitamin D status is low [9], e.g.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
S162-PMC3672018	PMC3672018	5/2013	S162-PMC3672018	['AS diet is USUALLY different between families with higher socioeconomic status and those with lower status [31], maternal socioeconomic status MAY have AFFECTED Margarine/milk Intake and THUS exposure to Vitamin D. information on socioeconomic position, education and ethnicity is available from statistics denmark and can be controlled for.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 143), ('SUPERFICIAL_RELATIONSHIP', 152), ('PROBABLE_UNDERSTANDING', 187)]	5	[('CHEBI_6784', 'mestranol', 161, 'margarine'), ('GO_0007631', 'feeding behavior', 176, 'intake'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 212, 'D')]
S164-PMC3672018	PMC3672018	5/2013	S164-PMC3672018	['finally, the uncertainties RELATED to lack of knowledge about real Vitamin D status in mother and offspring MAY BE eliminated by assessing the measurement of infant Blood Vitamin D levels in those developing the three disease entities and comparing to time and gender-matched controls to examine actual exposure differences at Birth.']	[('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 108)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('UBERON_0000178', 'blood', 165, 'blood'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('GO_0007567', 'parturition', 327, 'birth')]
S165-PMC3672018	PMC3672018	5/2013	S165-PMC3672018	['implications\nUNLIKE many OTHER nutritional deficiencies, low Vitamin D status is PREVALENT among industrialized populations, and, ACCORDING TO danish health authorities, about half of all adults have Vitamin D insufficiency (below 50\u2009nmol/l) [32].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('IMPORTANT_CONSIDERATION', 81), ('INCOMPLETE_EVIDENCE', 130)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
S167-PMC3672018	PMC3672018	5/2013	S167-PMC3672018	['THUS, AS IT IS CLEAR that Vitamin D status of danes NEEDS to be improved, the danish health authorities currently DEBATE, WHETHER to resume Vitamin D fortification of Food [35].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 6), ('FUTURE_WORK', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('EXPLICIT_QUESTION', 122)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('CHEBI_33290', 'food', 167, 'food')]
S0-PMC3685533	PMC3685533	6/2013	S0-PMC3685533	['Vitamin D status in Cord Blood and newborns: ethnic differences\n\nabstract\n\nbackground\na deficiency in Vitamin D (25Ohd) is common throughout the world in both Adults and children, being RELATED to skin pigmentation, sun exposure, dietary intake and obesity.']	[('SUPERFICIAL_RELATIONSHIP', 186)]	1	"[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0002240', 'spinal cord', 20, 'cord'), ('UBERON_0000178', 'blood', 25, 'blood'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 113, '25OHD'), ('UBERON_0007023', 'adult organism', 159, 'adults')]"
S15-PMC3685533	PMC3685533	6/2013	S15-PMC3685533	['circulating 25Ohd is the MAJOR circulating form of Vitamin D and is CONSIDERED AS the primary INDICATOR of Vitamin D status [1].']	[('IMPORTANT_CONSIDERATION', 25), ('IMPORTANT_CONSIDERATION', 68), ('PROBABLE_UNDERSTANDING', 79), ('SUPERFICIAL_RELATIONSHIP', 94)]	4	"[('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 12, '25OHD'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]"
S30-PMC3685533	PMC3685533	6/2013	S30-PMC3685533	['currently, the literature SHOWS that neonatal Vitamin D status at Birth is highly CORRELATED with maternal Vitamin storage.']	[('INCOMPLETE_EVIDENCE', 26), ('SUPERFICIAL_RELATIONSHIP', 82)]	2	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0007567', 'parturition', 66, 'birth'), ('CHEBI_33229', 'vitamin (role)', 107, 'vitamin')]
S14-PMC3691177	PMC3691177	6/2013	S14-PMC3691177	['dietary intake of Vitamin D makes a relatively small CONTRIBUTION to overall Vitamin D status, and APPARENT EFFECTS of Vitamin D intake MAY BE CONFOUNDED by OTHER CORRELATED nutrients.']	[('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 108), ('INCOMPLETE_EVIDENCE', 136), ('DIFFICULT_TASK', 143), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 157), ('SUPERFICIAL_RELATIONSHIP', 163)]	7	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
S15-PMC3691177	PMC3691177	6/2013	S15-PMC3691177	['THESE STUDIES DID NOT REPORT outcomes in RELATION to maternal Serum 25-Hydroxyvitamin D (25(Oh)D) concentration, which takes account of skin synthesis, our primary source of Vitamin D, and is the gold STANDARD measure of Vitamin D status[5],[6].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 201)]	4	[('UBERON_0001977', 'blood serum', 62, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 68, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 89, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D')]
S129-PMC3691177	PMC3691177	6/2013	S129-PMC3691177	['two RECENT OBSERVATIONAL STUDIES that DOCUMENTED Prenatal Vitamin D status by measuring Cord Blood 25(Oh)D concentration, FOUND RELATIONSHIPS with allergic sensitisation and/or wheezing in early childhood[8],[31].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 128)]	5	[('GO_0007565', 'female pregnancy', 49, 'prenatal'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 88, 'cord'), ('UBERON_0000178', 'blood', 93, 'blood'), ('CHEBI_71657', 'versiconol acetate', 99, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 99, '25(OH ... D')]
S132-PMC3691177	PMC3691177	6/2013	S132-PMC3691177	['the results of our randomised controlled trial do not SUPPORT a strong causal RELATIONSHIP between low Prenatal Vitamin D status within the deficient/insufficient range and INCREASED RISK of Allergic sensitization or wheezing in early childhood.']	[('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 78), ('IMPORTANT_CONSIDERATION', 173)]	3	[('GO_0007565', 'female pregnancy', 103, 'prenatal'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0040011', 'locomotion', 191, 'allergic')]
S1-PMC3695234	PMC3695234	7/2013	S1-PMC3695234	['in THIS STUDY, we INVESTIGATED the ASSOCIATION between Serum Vitamin D status and the clinical manifestation of ad.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('SUPERFICIAL_RELATIONSHIP', 35)]	3	[('UBERON_0001977', 'blood serum', 55, 'serum'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
S22-PMC3695234	PMC3695234	7/2013	S22-PMC3695234	['in THIS STUDY, we INVESTIGATED the ASSOCIATION between Serum Vitamin D status and the clinical manifestation of ad.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('SUPERFICIAL_RELATIONSHIP', 35)]	3	[('UBERON_0001977', 'blood serum', 55, 'serum'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
S61-PMC3695234	PMC3695234	7/2013	S61-PMC3695234	['camargo et al.13found no decreased risk of ad in the children of mothers with higher intakes of Vitamin D. a northern finland Birth cohort INDICATED the ASSOCIATION between Vitamin D supplementation in the first year of Life and an increased risk of atopy at age 31 years.14a FURTHER prospective study REPORTED that an increased concentration of 25(Oh)D3In maternal Serum predisposed infants to ad at 9 months of age.15these variable results MAY BE secondary to the differences in the absolute amount of Vitamin D exposure, the baseline Vitamin D status, and the timing of exposure.']	[('INCOMPLETE_EVIDENCE', 139), ('SUPERFICIAL_RELATIONSHIP', 153), ('INCOMPLETE_EVIDENCE', 276), ('INCOMPLETE_EVIDENCE', 302), ('INCOMPLETE_EVIDENCE', 442)]	5	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('GO_0007567', 'parturition', 126, 'birth'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('UBERON_0000104', 'life cycle', 220, 'life'), ('PR_000001883', 'lysosome-associated membrane protein', 346, '25(OH)D3in'), ('UBERON_0001977', 'blood serum', 366, 'serum'), ('CHEBI_27300', 'vitamin D', 504, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 537, 'vitamin D')]
S64-PMC3695234	PMC3695234	7/2013	S64-PMC3695234	['chi et al.16ASSESSED the INFLUENCE of Prenatal Vitamin D status on Immune function at Birth.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 25)]	2	[('GO_0007565', 'female pregnancy', 38, 'prenatal'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('UBERON_0002405', 'immune system', 67, 'immune'), ('GO_0007567', 'parturition', 86, 'birth')]
S0-PMC3702245	PMC3702245	6/2013	S0-PMC3702245	['Vitamin D nutrition in Pregnancy: current opinion\n\nabstract\nthere is INCREASING INTEREST in Vitamin D nutrition during Pregnancy because of widespread REPORTS of a high prevalence of low vitamin d status in Pregnant women.']	[('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 151)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 23, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy'), ('GO_0007565', 'female pregnancy', 207, 'pregnant')]
S2-PMC3702245	PMC3702245	6/2013	S2-PMC3702245	['CONSISTENT with the expanded ROLE of Vitamin D, RECENT OBSERVATIONAL STUDIES have DEMONSTRATED that low Vitamin D status in Pregnancy is ASSOCIATED with multiple POTENTIAL adverse maternal, fetal, and infant outcomes and CONTRIBUTES to low Vitamin D status in infants at Birth.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 55), ('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 137), ('INCOMPLETE_EVIDENCE', 162), ('SUPERFICIAL_RELATIONSHIP', 221)]	8	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007565', 'female pregnancy', 124, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D'), ('GO_0007567', 'parturition', 271, 'birth')]
S3-PMC3702245	PMC3702245	6/2013	S3-PMC3702245	['THEREFORE, an overview of the CURRENT understanding of Vitamin D nutrition in Pregnancy and a review of the results of studies to optimize Vitamin D status during Pregnancy and in the offspring is of PUBLIC HEALTH IMPORTANCE and timely.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 30), ('IMPORTANT_CONSIDERATION', 200), ('IMPORTANT_CONSIDERATION', 214)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 78, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('GO_0007565', 'female pregnancy', 163, 'pregnancy')]
S4-PMC3702245	PMC3702245	6/2013	S4-PMC3702245	['introduction\nVitamin D deficiency in Pregnancy is widespread in many parts of the world,1and there is an ASSOCIATION between low Vitamin D status and multiple POTENTIAL adverse outcomes of Pregnancy.2–5therefore, Vitamin D nutrition in Pregnancy SHOULD BE of GLOBAL HEALTH INTEREST.']	[('SUPERFICIAL_RELATIONSHIP', 105), ('INCOMPLETE_EVIDENCE', 159), ('FUTURE_WORK', 246), ('IMPORTANT_CONSIDERATION', 259)]	4	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 37, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('GO_0007565', 'female pregnancy', 189, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('GO_0007565', 'female pregnancy', 236, 'pregnancy')]
S6-PMC3702245	PMC3702245	6/2013	S6-PMC3702245	['in addition, it is now known to be INVOLVED in Immunomodulation, Cell Proliferation, and Cell Differentiation, and in other physiologic functions in diverse Tissues and Organs, including the Brain, Pancreas, and Heart.6despite the REPORTED high prevalence of Vitamin D deficiency and its POSSIBLE consequences, the criteria for defining an optimal level in the body, and HENCE the amount of Vitamin D intake REQUIRED to maintain adequate levels, is CONTROVERSIAL.3,7,8this overview addresses the CURRENT INFORMATION about Vitamin D function, the GLOBAL BURDEN and POTENTIAL consequences of low Vitamin D status in Pregnancy, and current STRATEGIES to optimize Vitamin D status in Pregnant mothers and their offspring.']	[('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 231), ('INCOMPLETE_EVIDENCE', 288), ('PROBABLE_UNDERSTANDING', 371), ('IMPORTANT_CONSIDERATION', 408), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 449), ('INCOMPLETE_EVIDENCE', 496), ('IMPORTANT_CONSIDERATION', 546), ('INCOMPLETE_EVIDENCE', 564), ('FUTURE_WORK', 637)]	10	[('GO_0050900', 'leukocyte migration', 47, 'immunomodulation'), ('GO_0008283', 'cell proliferation', 65, 'cell proliferation'), ('GO_0030154', 'cell differentiation', 89, 'cell differentiation'), ('UBERON_0000479', 'tissue', 157, 'tissues'), ('UBERON_0000062', 'organ', 169, 'organs'), ('UBERON_0000955', 'brain', 191, 'brain'), ('UBERON_0001264', 'pancreas', 198, 'pancreas'), ('UBERON_0000948', 'heart', 212, 'heart'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 391, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 522, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 594, 'vitamin D'), ('GO_0007565', 'female pregnancy', 614, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 660, 'vitamin D'), ('GO_0007565', 'female pregnancy', 680, 'pregnant')]
S9-PMC3702245	PMC3702245	6/2013	S9-PMC3702245	['SEVERAL REPORTS in the literature HAVE SHOWN that INADEQUATE or lack of sunlight exposure without appropriate corrective Vitamin D intake or supplements accounts FOR the high prevalence of Vitamin D deficiency in women.11–18\nafter synthesis in the skin, Vitamin D attaches to Vitamin D-binding protein and is transported to the Liver, where it undergoes a process of hydroxylation to form 25-Hydroxyvitamin D [25(Oh)D].9the Serum concentration of 25(Oh)D is the MOST reliable MARKER of Vitamin D nutritional status.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 34), ('IMPORTANT_CONSIDERATION', 50), ('QUESTION_ANSWERED_BY_THIS_WORK', 162), ('PROBABLE_UNDERSTANDING', 462), ('SUPERFICIAL_RELATIONSHIP', 476)]	7	[('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 284, 'D'), ('UBERON_0002107', 'liver', 328, 'liver'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 389, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 410, '25(OH)D'), ('UBERON_0001977', 'blood serum', 424, 'serum'), ('CHEBI_71657', 'versiconol acetate', 447, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 486, 'vitamin D')]
S13-PMC3702245	PMC3702245	6/2013	S13-PMC3702245	['HOWEVER, sustained Vitamin D deficiency results in rickets in children and osteomalacia in Adults.28the COMMONLY evaluated BIOMARKERS of Vitamin D nutrition include Serum 25(Oh)D concentrations, the inverse RELATIONSHIP between 25(Oh)D and Parathyroid hormone, Intestinal calcium absorption, and assessment of Skeletal integrity.29WHILE there is an inverse RELATIONSHIP between Serum Parathyroid hormone and 25(Oh)D in nonpregnant states, this RELATIONSHIP HAS BEEN SHOWN in RECENT STUDIES to be weak during Pregnancy,6,18,30,31INDICATING that Serum Parathyroid hormone MAY BE a LESS RELIABLE BIOMARKER of maternal Vitamin D status during Pregnancy than Serum 25(Oh)d.32the maternal 25(Oh)D level does not vary significantly during Pregnancy unless there is a change in Vitamin D intake or Endogenous Synthesis.2,33,34HOWEVER, Serum 1,25(Oh)2D levels increase by 100%–200% starting in the first trimester in both the mother and the fetus.35–37the increase in maternal 1,25(Oh)2D, which originates mostly from the Kidneys, accounts for increased Intestinal calcium absorption during Pregnancy.38,39the increase in fetal 1,25(Oh)2D level SEEMS to BE RELATED to synthesis in Placental and Fetal Tissues.39,40\nan IMPORTANT aspect of Vitamin D nutrition in Pregnancy is that the Vitamin D status of the infant at Birth and in early infancy DEPENDS ON the vitamin d status of the mother during Pregnancy.41vitamin D stores in the infant start with transplacental Transfer of 25(Oh)D in early Pregnancy from mother to fetus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 104), ('SUPERFICIAL_RELATIONSHIP', 123), ('SUPERFICIAL_RELATIONSHIP', 207), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 329), ('SUPERFICIAL_RELATIONSHIP', 357), ('SUPERFICIAL_RELATIONSHIP', 444), ('INCOMPLETE_EVIDENCE', 457), ('INCOMPLETE_EVIDENCE', 475), ('INCOMPLETE_EVIDENCE', 526), ('INCOMPLETE_EVIDENCE', 570), ('INCOMPLETE_EVIDENCE', 579), ('IMPORTANT_CONSIDERATION', 584), ('SUPERFICIAL_RELATIONSHIP', 593), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 816), ('ANOMALY_CURIOUS_FINDING', 1136), ('ANOMALY_CURIOUS_FINDING', 1145), ('SUPERFICIAL_RELATIONSHIP', 1148), ('IMPORTANT_CONSIDERATION', 1209), ('SUPERFICIAL_RELATIONSHIP', 1335)]	20	"[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0007023', 'adult organism', 91, 'adults'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('UBERON_0001977', 'blood serum', 165, 'serum'), ('CHEBI_30778', 'gallic acid', 171, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 177, 'D'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('UBERON_0001132', 'parathyroid gland', 240, 'parathyroid'), ('UBERON_0000160', 'intestine', 261, 'intestinal'), ('UBERON_0004288', 'skeleton', 310, 'skeletal'), ('UBERON_0001977', 'blood serum', 378, 'serum'), ('UBERON_0001132', 'parathyroid gland', 384, 'parathyroid'), ('CHEBI_71657', 'versiconol acetate', 408, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 411, 'OH ... D'), ('GO_0007565', 'female pregnancy', 508, 'pregnancy'), ('UBERON_0001977', 'blood serum', 544, 'serum'), ('UBERON_0001132', 'parathyroid gland', 550, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 615, 'vitamin D'), ('GO_0007565', 'female pregnancy', 639, 'pregnancy'), ('UBERON_0001977', 'blood serum', 654, 'serum'), ('CHEBI_30778', 'gallic acid', 660, '25(OH)'), ('CHEBI_71657', 'versiconol acetate', 683, '25(OH)D'), ('GO_0007565', 'female pregnancy', 732, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 770, 'vitamin D'), ('GO_0042400', 'ectoine catabolic process', 790, 'endogenous synthesis'), ('UBERON_0001977', 'blood serum', 827, 'serum'), ('CHEBI_37958', 'dye', 833, '1,'), ('CHEBI_66212', ""5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone"", 835, '25(OH)2D'), ('CHEBI_37958', 'dye', 968, '1,'), ('CHEBI_66212', ""5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone"", 970, '25(OH)2D'), ('UBERON_0002113', 'kidney', 1013, 'kidneys'), ('UBERON_0000160', 'intestine', 1045, 'intestinal'), ('GO_0007565', 'female pregnancy', 1082, 'pregnancy'), ('CHEBI_37958', 'dye', 1119, '1,'), ('CHEBI_66212', ""5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone"", 1121, '25(OH)2D'), ('UBERON_0001987', 'placenta', 1172, 'placental'), ('UBERON_0005291', 'embryonic tissue', 1186, 'fetal tissues'), ('CHEBI_27300', 'vitamin D', 1229, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1252, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1274, 'vitamin D'), ('GO_0007567', 'parturition', 1308, 'birth'), ('GO_0007565', 'female pregnancy', 1388, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1408, 'D'), ('GO_0006412', 'translation', 1457, 'transfer'), ('CHEBI_71657', 'versiconol acetate', 1469, '25(OH)D'), ('GO_0007565', 'female pregnancy', 1486, 'pregnancy')]"
S14-PMC3702245	PMC3702245	6/2013	S14-PMC3702245	['physiologically active 1,25(Oh)2D does not readily cross the Placenta.41MANY STUDIES HAVE SHOWN that the Vitamin D status of infants at Birth as measured by Cord Blood 25(Oh)D CORRELATES positively with maternal Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 70), ('INCOMPLETE_EVIDENCE', 85), ('SUPERFICIAL_RELATIONSHIP', 176)]	3	[('CHEBI_82784', 'PVP38-Ag NP', 23, '1,25(OH)2D'), ('UBERON_0001987', 'placenta', 61, 'placenta'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007567', 'parturition', 136, 'birth'), ('UBERON_0002240', 'spinal cord', 157, 'cord'), ('UBERON_0000178', 'blood', 162, 'blood'), ('CHEBI_71657', 'versiconol acetate', 168, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 171, 'OH ... D'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
S16-PMC3702245	PMC3702245	6/2013	S16-PMC3702245	['high prevalence of low Vitamin D intake in Pregnancy\nthe Vitamin D status in Adults, including Pregnant women, is based currently on measurement of Serum 25(Oh)D concentrations, BUT WHAT constitutes the “normal” OR “optimal” level is CONTROVERSIAL.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 178), ('EXPLICIT_QUESTION', 182), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 212), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 234)]	4	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007565', 'female pregnancy', 43, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0007023', 'adult organism', 77, 'adults'), ('GO_0007565', 'female pregnancy', 95, 'pregnant'), ('UBERON_0001977', 'blood serum', 148, 'serum'), ('CHEBI_63056', 'zinc cation', 154, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 160, 'D')]
S17-PMC3702245	PMC3702245	6/2013	S17-PMC3702245	['the institute of medicine in the us in its RECENT report RECOMMENDS that a Serum 25(Oh)D concentration of 50 nmol/l (20 ng/ml) is adequate for calcium absorption and bone health in Adults, including Pregnant women, in the us and canada.7HOWEVER, new clinical guidelines from the endocrine society RECOMMEND maintaining a Serum 25(Oh)D concentration >75 nmol/l (30 ng/ml) in order to maximize calcium absorption and bone health, and for POTENTIAL Extraskeletal benefits noted in observational studies.8many RECENT STUDIES13,15–17,48–57that evaluated Vitamin D nutrition during Pregnancy in different geographic locations REPORTED wide VARIATION in Vitamin D status depending on latitude, season, sunlight exposure behavior, and Vitamin D intake (table 1).']	[('INCOMPLETE_EVIDENCE', 43), ('FUTURE_WORK', 57), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 236), ('FUTURE_WORK', 297), ('INCOMPLETE_EVIDENCE', 436), ('INCOMPLETE_EVIDENCE', 506), ('INCOMPLETE_EVIDENCE', 620), ('DIFFICULT_TASK', 634)]	8	[('UBERON_0001977', 'blood serum', 75, 'serum'), ('CHEBI_71657', 'versiconol acetate', 81, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 81, '25(OH)D'), ('UBERON_0007023', 'adult organism', 181, 'adults'), ('GO_0007565', 'female pregnancy', 199, 'pregnant'), ('UBERON_0001977', 'blood serum', 321, 'serum'), ('CHEBI_71657', 'versiconol acetate', 327, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 327, '25(OH)D'), ('UBERON_0001431', 'distal carpal bone 2', 446, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 549, 'vitamin D'), ('GO_0007565', 'female pregnancy', 576, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 647, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 727, 'vitamin D')]
S19-PMC3702245	PMC3702245	6/2013	S19-PMC3702245	['there is a high prevalence of Vitamin D deficiency [Serum 25(Oh) D <50 nmol/l], and as shown intable 1, most women studied (>80%) have Serum 25(Oh)D concentrations <75 nmol/l, which are CONSIDERED “INSUFFICIENT”.8mean Serum 25(Oh)D concentrations are highest and the prevalence of Vitamin D deficiency is lowest in sun-enriched populations,51,57WHILE the lowest mean Serum 25(Oh)d and the highest prevalence of Vitamin D deficiency are REPORTED in sunshine-deprived populations.16,17,50,55,56the high prevalence of low Vitamin D ASSOCIATED with sunshine deprivation and INADEQUATE corrective Vitamin D intake SHOULD RAISE PUBLIC HEALTH CONCERN about the INCREASED RISK of adverse health EFFECTS of low Vitamin D status for the mother and fetus and poor Vitamin D nutrition in the infant at Birth.']	[('INCOMPLETE_EVIDENCE', 186), ('PROBLEM_COMPLICATION', 198), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 343), ('INCOMPLETE_EVIDENCE', 436), ('SUPERFICIAL_RELATIONSHIP', 529), ('IMPORTANT_CONSIDERATION', 570), ('FUTURE_WORK', 609), ('IMPORTANT_CONSIDERATION', 616), ('IMPORTANT_CONSIDERATION', 622), ('IMPORTANT_CONSIDERATION', 654), ('SUPERFICIAL_RELATIONSHIP', 687)]	11	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0001977', 'blood serum', 52, 'serum'), ('CHEBI_71657', 'versiconol acetate', 58, '25(OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 58, '25(OH) D'), ('UBERON_0001977', 'blood serum', 135, 'serum'), ('CHEBI_71657', 'versiconol acetate', 141, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 141, '25(OH)D'), ('UBERON_0001977', 'blood serum', 218, 'serum'), ('CHEBI_30778', 'gallic acid', 224, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 230, 'D'), ('CHEBI_27300', 'vitamin D', 281, 'vitamin D'), ('UBERON_0001977', 'blood serum', 367, 'serum'), ('CHEBI_30778', 'gallic acid', 373, '25(OH)'), ('CHEBI_27300', 'vitamin D', 411, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 519, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 592, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 702, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 753, 'vitamin D'), ('GO_0007567', 'parturition', 790, 'birth')]
S20-PMC3702245	PMC3702245	6/2013	S20-PMC3702245	['implications of low Vitamin D status during Pregnancy\n\nSkeletal and calcemic COMPLICATIONS\nit is GENERALLY ACCEPTED that maternal Vitamin D deficiency CAN result in osteomalacia.']	[('PROBLEM_COMPLICATION', 77), ('PROBABLE_UNDERSTANDING', 97), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 151)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0007565', 'female pregnancy', 44, 'pregnancy'), ('UBERON_0004288', 'skeleton', 55, 'Skeletal'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D')]
S21-PMC3702245	PMC3702245	6/2013	S21-PMC3702245	['a Serum 25(Oh)D concentration <25 nmol/l (10 ng/ml), which is ASSOCIATED with INCREASED RISK of osteomalacia in Adults,7is common during Pregnancy, AS INDICATED by RECENT REPORTS from many parts of the world.1for example, Serum 25(Oh)D < 25 nmol/l during Pregnancy HAS BEEN REPORTED in 17%–18% of the caucasian population in the uk,48,4961% of a mixed population in new zealand,5432%–42% in the indian population,15,4559%–84% of a nonwestern population in the netherlands,1441% of the kuwaiti population,1680% of the iranian population,17and 75% of the arab population in the united arab emirates.1HOWEVER, there are LIMITED STUDIES on the ASSOCIATION between such low levels of Vitamin D status and Skeletal integrity in Pregnant women.']	[('SUPERFICIAL_RELATIONSHIP', 62), ('IMPORTANT_CONSIDERATION', 78), ('PROBABLE_UNDERSTANDING', 148), ('INCOMPLETE_EVIDENCE', 151), ('INCOMPLETE_EVIDENCE', 164), ('INCOMPLETE_EVIDENCE', 171), ('INCOMPLETE_EVIDENCE', 265), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 597), ('INCOMPLETE_EVIDENCE', 617), ('SUPERFICIAL_RELATIONSHIP', 640)]	10	[('UBERON_0001977', 'blood serum', 2, 'serum'), ('CHEBI_71657', 'versiconol acetate', 8, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 8, '25(OH)D'), ('UBERON_0007023', 'adult organism', 112, 'adults'), ('GO_0007565', 'female pregnancy', 137, 'pregnancy'), ('UBERON_0001977', 'blood serum', 222, 'serum'), ('CHEBI_71657', 'versiconol acetate', 228, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 228, '25(OH)D'), ('GO_0007565', 'female pregnancy', 255, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 679, 'vitamin D'), ('UBERON_0004288', 'skeleton', 700, 'skeletal'), ('GO_0007565', 'female pregnancy', 722, 'pregnant')]
S24-PMC3702245	PMC3702245	6/2013	S24-PMC3702245	['further, a RECENT STUDY of the RELATIONSHIP between Serum 25(Oh)D and bone turnover in Pregnant women in istanbul, turkey, FOUND a negative CORRELATION between the second and third trimester and Postpartum 25(Oh)D concentrations and Serum cross-linked c-terminal telopeptide of Type 1 Collagen, which is a MARKER of Bone Resorption.58THESE studies SEEM to INDICATE a LINK between very low Vitamin D status and subclinical osteomalacia in the mothers.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 31), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 140), ('SUPERFICIAL_RELATIONSHIP', 306), ('INCOMPLETE_EVIDENCE', 332), ('ANOMALY_CURIOUS_FINDING', 348), ('INCOMPLETE_EVIDENCE', 356), ('SUPERFICIAL_RELATIONSHIP', 367)]	9	[('UBERON_0001977', 'blood serum', 52, 'serum'), ('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 58, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 87, 'pregnant'), ('GO_0007565', 'female pregnancy', 195, 'postpartum'), ('CHEBI_71657', 'versiconol acetate', 206, '25(OH)D'), ('UBERON_0001977', 'blood serum', 233, 'serum'), ('PR_000002123', 'C-C motif chemokine 3', 278, 'type 1 collagen'), ('GO_0045453', 'bone resorption', 316, 'bone resorption'), ('CHEBI_27300', 'vitamin D', 389, 'vitamin D')]
S34-PMC3702245	PMC3702245	6/2013	S34-PMC3702245	['Fetal growth\nthe ASSOCIATION between Birth weight and maternal Vitamin D status or intake REMAINS INCONCLUSIVE.5while SOME OBSERVATIONAL68–71and interventional53,72,73studies FOUND improvement in Birth weight with maternal Vitamin D supplementation or improved Vitamin D status, several other observational studies31,74–76and SOME interventional studies18,33,77,78showed no improvement with higher Vitamin D status or supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('INCOMPLETE_EVIDENCE', 90), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 98), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 123), ('INCOMPLETE_EVIDENCE', 175), ('INCOMPLETE_EVIDENCE', 326)]	7	[('GO_0008618', '7-methylguanosine metabolic process', 0, 'Fetal'), ('GO_0007567', 'parturition', 37, 'birth'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('GO_0007567', 'parturition', 196, 'birth'), ('CHEBI_27300', 'vitamin D', 223, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 261, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 398, 'vitamin D')]
S38-PMC3702245	PMC3702245	6/2013	S38-PMC3702245	['the RELATIONSHIP between maternal Vitamin D status and small-for-Gestational age infants was found to be u-shaped in a study from pittsburgh in the us,81BUT this WAS NOT CONFIRMED in the above studies.68,80the REASONS for this DIFFERENCE are UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 151), ('INCOMPLETE_EVIDENCE', 162), ('PROBABLE_UNDERSTANDING', 210), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 227), ('FULL_UNKNOWN', 242)]	6	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'gestational')]
S40-PMC3702245	PMC3702245	6/2013	S40-PMC3702245	['randomized controlled STUDIES including larger sample sizes and repeated Vitamin D measurements during Pregnancy WILL BE NEEDED to CONFIRM the RELATIONSHIP between Vitamin D supplementation and fetal growth.82\n\nmaternal COMPLICATIONS\nOBSERVATIONAL studies REPORTED an ASSOCIATION between maternal Vitamin D status during Pregnancy and development of pre-eclampsia, which has both a Genetic and an immunologic pathogenesis.']	[('FUTURE_WORK', 22), ('FUTURE_WORK', 113), ('INCOMPLETE_EVIDENCE', 131), ('SUPERFICIAL_RELATIONSHIP', 143), ('PROBLEM_COMPLICATION', 220), ('INCOMPLETE_EVIDENCE', 234), ('INCOMPLETE_EVIDENCE', 256), ('SUPERFICIAL_RELATIONSHIP', 268)]	8	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 297, 'vitamin D'), ('GO_0007565', 'female pregnancy', 321, 'pregnancy'), ('SO_0000704', 'gene', 382, 'genetic')]
S41-PMC3702245	PMC3702245	6/2013	S41-PMC3702245	['a study from pittsburgh SHOWED an inverse RELATIONSHIP between Vitamin D status and the risk of pre-eclampsia.83the authors FOUND that the risk of pre-eclampsia was more than doubled (odds ratio 2.4; ci 1.1–5.4) for a 50 nmol/l decrease in maternal Serum 25(Oh)D concentration.']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 124)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001977', 'blood serum', 249, 'serum'), ('CHEBI_71657', 'versiconol acetate', 255, '25(OH)D')]
S45-PMC3702245	PMC3702245	6/2013	S45-PMC3702245	['CONSISTENT with THIS report, a systematic review and meta-analysis of seven observational studies performed between 2008 and 2011 FOUND Serum 25(Oh)D < 50 nmol/l to be ASSOCIATED with Gestational diabetes BUT with an overall lower odds ratio of 1.61 (ci 1.19–2.17).86another meta-analysis of maternal Vitamin D status and Pregnancy outcomes,87which included 24 studies up to 2012, FOUND an overall INCREASED RISK of Preeclampsia (odds ratio 2.09; ci 1.50–2.90) and Gestational diabetes (odds ratio 1.38; ci 1.12–1.70).']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 168), ('ANOMALY_CURIOUS_FINDING', 205), ('INCOMPLETE_EVIDENCE', 381), ('IMPORTANT_CONSIDERATION', 398)]	7	[('UBERON_0001977', 'blood serum', 136, 'serum'), ('CHEBI_71657', 'versiconol acetate', 142, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 142, '25(OH)D'), ('GO_0007565', 'female pregnancy', 184, 'gestational'), ('CHEBI_27300', 'vitamin D', 301, 'vitamin D'), ('GO_0007565', 'female pregnancy', 322, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 416, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 465, 'gestational')]
S51-PMC3702245	PMC3702245	6/2013	S51-PMC3702245	['further, there is a SUGGESTION of an ASSOCIATION between Vitamin D and Periodontal disease,90and maternal Serum 25(Oh)D < 75 nmol/l during Early Pregnancy HAS BEEN ASSOCIATED with a two-fold INCREASED risk of Periodontal disease.91in a RECENT randomized controlled TRIAL of Vitamin D supplementation from south carolina, Vitamin D supplementation of 4000 iu/day during Pregnancy was ASSOCIATED with a reduction in the risk of combined morbidities, such as Maternal infection, Preterm labor, and Preterm Birth.92\nIN VIEW of the POSSIBLE ASSOCIATION between maternal Vitamin D status and the pattern of fetal growth, pre-eclampsia, Gestational diabetes mellitus, and maternal infection, and the significant POTENTIAL for Perinatal morbidities ASSOCIATED with these conditions, evaluation of Vitamin D nutrition in early Pregnancy and the EFFECT of appropriate supplementation SEEMS WARRANTED.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 164), ('IMPORTANT_CONSIDERATION', 191), ('INCOMPLETE_EVIDENCE', 236), ('SUPERFICIAL_RELATIONSHIP', 383), ('QUESTION_ANSWERED_BY_THIS_WORK', 512), ('INCOMPLETE_EVIDENCE', 515), ('INCOMPLETE_EVIDENCE', 527), ('SUPERFICIAL_RELATIONSHIP', 536), ('INCOMPLETE_EVIDENCE', 705), ('SUPERFICIAL_RELATIONSHIP', 741), ('SUPERFICIAL_RELATIONSHIP', 836), ('ANOMALY_CURIOUS_FINDING', 874), ('FUTURE_WORK', 874)]	16	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('UBERON_0001758', 'periodontium', 71, 'periodontal'), ('UBERON_0001977', 'blood serum', 106, 'serum'), ('CHEBI_71657', 'versiconol acetate', 112, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 112, '25(OH ... D'), ('GO_0051318', 'G1 phase', 139, 'early'), ('GO_0007565', 'female pregnancy', 145, 'pregnancy'), ('UBERON_0001758', 'periodontium', 209, 'periodontal'), ('CHEBI_27300', 'vitamin D', 274, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 321, 'vitamin D'), ('GO_0007565', 'female pregnancy', 369, 'pregnancy'), ('GO_0007618', 'mating', 456, 'maternal'), ('GO_0007565', 'female pregnancy', 476, 'preterm'), ('GO_0007565', 'female pregnancy', 495, 'preterm'), ('GO_0007567', 'parturition', 503, 'birth'), ('CHEBI_27300', 'vitamin D', 565, 'vitamin D'), ('GO_0007565', 'female pregnancy', 630, 'gestational'), ('GO_0036268', 'swimming', 719, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 719, 'perinatal'), ('CHEBI_27300', 'vitamin D', 789, 'vitamin D'), ('GO_0007565', 'female pregnancy', 818, 'pregnancy')]
S52-PMC3702245	PMC3702245	6/2013	S52-PMC3702245	['IMPACT on neonate and infant\nboth in vitro and observational studies have DEMONSTRATED that Vitamin D status during Pregnancy IMPACTS the Immune Response of the offspring.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 126)]	3	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 116, 'pregnancy'), ('GO_0006955', 'immune response', 138, 'immune response'), ('UBERON_0002405', 'immune system', 138, 'immune')]
S54-PMC3702245	PMC3702245	6/2013	S54-PMC3702245	['Monocytes cultured in Vitamin D-deficient Plasma (Serum 25(Oh)D < 30 nmol/l) SHOWED significantly decreased Tolllike Receptor-mediated Expression of Cathelicidin (p < 0.05) compared with those conditioned in Vitamin D-sufficient Plasma (Serum 25(Oh)D > 75 nmol/l).93CONSISTENT with these in vitro FINDINGS, OBSERVATIONAL clinical DATA FOUND an ASSOCIATION between Vitamin D status in Cord Blood and the RISK of Lower Respiratory Tract infection in the first year of Life.94the risk of Respiratory syncytial Virus bronchiolitis in the first year of Life is increased by six-fold (ci 1.6–24.9) in infants with Cord Blood 25(Oh)D < 50 nmol/l compared with infants with 25(Oh)D > 75 nmol/l.']	[('INCOMPLETE_EVIDENCE', 77), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('INCOMPLETE_EVIDENCE', 297), ('INCOMPLETE_EVIDENCE', 307), ('FUTURE_WORK', 330), ('INCOMPLETE_EVIDENCE', 335), ('SUPERFICIAL_RELATIONSHIP', 344), ('IMPORTANT_CONSIDERATION', 403)]	9	[('CL_0000576', 'monocyte', 0, 'Monocytes'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 42, 'plasma'), ('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_71657', 'versiconol acetate', 56, '25(OH)D'), ('PR_000001660', 'prostaglandin F2-alpha receptor', 108, 'tolllike receptor'), ('GO_0010467', 'gene expression', 135, 'expression'), ('PR_000006009', 'alpha-catulin', 149, 'cathelicidin'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 229, 'plasma'), ('UBERON_0001977', 'blood serum', 237, 'serum'), ('CHEBI_71657', 'versiconol acetate', 243, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 243, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 364, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 384, 'cord'), ('UBERON_0000178', 'blood', 389, 'blood'), ('UBERON_0004905', 'articulation', 411, 'lower respiratory tract'), ('UBERON_0000104', 'life cycle', 466, 'life'), ('UBERON_0001004', 'respiratory system', 485, 'respiratory'), ('NCBITaxon_1', 'root', 507, 'virus'), ('UBERON_0000104', 'life cycle', 548, 'life'), ('UBERON_0002240', 'spinal cord', 608, 'cord'), ('UBERON_0000178', 'blood', 613, 'blood'), ('CHEBI_71657', 'versiconol acetate', 619, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 619, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 666, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 666, '25(OH)D')]
S56-PMC3702245	PMC3702245	6/2013	S56-PMC3702245	['IN CONTRAST, an OBSERVATIONAL study REPORTED an increased RISK of infantile eczema and pneumonia in ASSOCIATION with maternal Serum 25(Oh)D > 75 nmol/l in the last trimester.76HOWEVER, another RECENT STUDY with a larger sample size from the same institution DID NOT FIND an ASSOCIATION between maternal 25(Oh)d > 75 nmol/l in late Pregnancy and eczema or asthma at 12 months and three and six years of age.97there was no report on the ASSOCIATION between maternal Vitamin D status and Respiratory infections in the latter study.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 36), ('IMPORTANT_CONSIDERATION', 58), ('SUPERFICIAL_RELATIONSHIP', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174), ('INCOMPLETE_EVIDENCE', 193), ('INCOMPLETE_EVIDENCE', 258), ('SUPERFICIAL_RELATIONSHIP', 274), ('SUPERFICIAL_RELATIONSHIP', 435)]	10	[('UBERON_0001977', 'blood serum', 126, 'serum'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 132, '25(OH)D'), ('CHEBI_30778', 'gallic acid', 303, '25(OH)'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 303, '25(OH'), ('GO_0007565', 'female pregnancy', 331, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 464, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 485, 'respiratory')]
S57-PMC3702245	PMC3702245	6/2013	S57-PMC3702245	['regarding Neurocognitive Development, WHILE ONE STUDY FOUND no association between maternal Vitamin D status during Pregnancy and Neurocognitive function,76a RECENT larger-sized STUDY LINKED maternal Serum 25(Oh)D levels during Pregnancy with Language Development in the offspring.98the results of the above studies SUGGEST that childhood infections, atopy, and Neurocognitive development NEED TO BE included as outcomes of interest following Vitamin D supplementation in Pregnancy, and that clinical trials SHOULD include a RELEVANT group of subjects CONSIDERED to be replete for Vitamin D.\ntaken TOGETHER, the high prevalence of Vitamin D deficiency in Pregnancy and the POSSIBLE multiple POTENTIAL adverse EFFECTS on mother and offspring IDENTIFIED in SEVERAL epidemiologic STUDIES UNDERSCORE the URGENT NEED FOR large randomized controlled TRIALS to identify the amount of Vitamin D supplementation that optimizes Vitamin D status during Pregnancy, and to DETERMINE the EFFECT of supplementation on POTENTIAL adverse conditions ASSOCIATED with Vitamin D deficiency and any POSSIBLE Vitamin D excess.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 38), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 54), ('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 184), ('INCOMPLETE_EVIDENCE', 316), ('FUTURE_WORK', 389), ('FUTURE_WORK', 508), ('IMPORTANT_CONSIDERATION', 525), ('IMPORTANT_CONSIDERATION', 552), ('INCOMPLETE_EVIDENCE', 598), ('INCOMPLETE_EVIDENCE', 673), ('INCOMPLETE_EVIDENCE', 691), ('SUPERFICIAL_RELATIONSHIP', 709), ('INCOMPLETE_EVIDENCE', 741), ('INCOMPLETE_EVIDENCE', 755), ('IMPORTANT_CONSIDERATION', 785), ('IMPORTANT_CONSIDERATION', 800), ('FUTURE_WORK', 807), ('INCOMPLETE_EVIDENCE', 807), ('FUTURE_WORK', 844), ('QUESTION_ANSWERED_BY_THIS_WORK', 960), ('SUPERFICIAL_RELATIONSHIP', 974), ('INCOMPLETE_EVIDENCE', 1003), ('SUPERFICIAL_RELATIONSHIP', 1032), ('INCOMPLETE_EVIDENCE', 1077)]	26	[('GO_0007399', 'nervous system development', 10, 'neurocognitive development'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 116, 'pregnancy'), ('GO_0050905', 'neuromuscular process', 130, 'neurocognitive'), ('UBERON_0001977', 'blood serum', 200, 'serum'), ('CHEBI_71657', 'versiconol acetate', 206, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 206, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 228, 'pregnancy'), ('GO_0060132', 'prolactin secreting cell development', 243, 'language development'), ('GO_0050905', 'neuromuscular process', 362, 'neurocognitive'), ('CHEBI_27300', 'vitamin D', 443, 'vitamin D'), ('GO_0007565', 'female pregnancy', 472, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 581, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 631, 'vitamin D'), ('GO_0007565', 'female pregnancy', 655, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 877, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 918, 'vitamin D'), ('GO_0007565', 'female pregnancy', 942, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1048, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1086, 'vitamin D')]
S62-PMC3702245	PMC3702245	6/2013	S62-PMC3702245	['these RECOMMENDATIONS are based MOSTLY ON STUDIES from the us and MAY not be applicable worldwide DUE TO DIFFERENCES in baseline Vitamin D status,100particularly in populations where severe Vitamin D deficiency is PREVALENT.']	[('FUTURE_WORK', 6), ('INCOMPLETE_EVIDENCE', 32), ('PROBABLE_UNDERSTANDING', 32), ('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 66), ('PROBLEM_COMPLICATION', 98), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105), ('IMPORTANT_CONSIDERATION', 214)]	8	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D')]
S70-PMC3702245	PMC3702245	6/2013	S70-PMC3702245	['OF NOTE, in two of the five studies, the mean concentration of 25(Oh)D after supplementation was <50 nmol/l,33,78and Serum 25(Oh)D WAS NOT MEASURED in ONE STUDY.73all these STUDIES underscore the uncertainty about the amount of Vitamin D supplementation REQUIRED to optimize Vitamin D status in Pregnancy and which would be generalizable worldwide.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 131), ('INCOMPLETE_EVIDENCE', 151), ('INCOMPLETE_EVIDENCE', 173), ('IMPORTANT_CONSIDERATION', 254)]	5	[('CHEBI_71657', 'versiconol acetate', 63, '25(OH)D'), ('UBERON_0001977', 'blood serum', 117, 'serum'), ('CHEBI_71657', 'versiconol acetate', 123, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 123, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D'), ('GO_0007565', 'female pregnancy', 295, 'pregnancy')]
S71-PMC3702245	PMC3702245	6/2013	S71-PMC3702245	['as mentioned earlier, the criteria for defining WHAT constitutes “normal” Vitamin D status are CONTROVERSIAL.']	[('EXPLICIT_QUESTION', 48), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95)]	2	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
S73-PMC3702245	PMC3702245	6/2013	S73-PMC3702245	['WHILE the DEBATE and studies to identify OPTIMAL Serum 25(Oh)D concentration CONTINUE, it is PRUDENT to monitor Vitamin D status and develop STRATEGIES to ensure AT LEAST a minimum Serum 25(Oh)D concentration of 50 nmol/l in Pregnant women, especially in an environment where Vitamin D deficiency is endemic.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('IMPORTANT_CONSIDERATION', 41), ('FUTURE_WORK', 77), ('FUTURE_WORK', 93), ('IMPORTANT_CONSIDERATION', 93), ('FUTURE_WORK', 141), ('PROBABLE_UNDERSTANDING', 162)]	8	[('UBERON_0001977', 'blood serum', 49, 'serum'), ('CHEBI_71657', 'versiconol acetate', 55, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 55, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('UBERON_0001977', 'blood serum', 181, 'serum'), ('CHEBI_71657', 'versiconol acetate', 187, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 187, '25(OH)D'), ('GO_0007565', 'female pregnancy', 225, 'pregnant'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D')]
S75-PMC3702245	PMC3702245	6/2013	S75-PMC3702245	['because of CONTROVERSY surrounding Vitamin D REQUIREMENTS during Pregnancy, investigators from south carolina performed a comprehensive, large, randomized controlled study of Vitamin D supplementation in Pregnancy to achieve optimal Vitamin D status, DEFINED as a Serum 25(Oh)D concentration ≥80 nmol/l at Delivery.18BASED on the pharmacokinetics of Vitamin d, the authors INVESTIGATED the SAFETY and EFFECTIVENESS of high-dose Vitamin D supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('IMPORTANT_CONSIDERATION', 45), ('PROBABLE_UNDERSTANDING', 251), ('PROBABLE_UNDERSTANDING', 315), ('QUESTION_ANSWERED_BY_THIS_WORK', 373), ('IMPORTANT_CONSIDERATION', 390), ('SUPERFICIAL_RELATIONSHIP', 401)]	7	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 65, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('GO_0007565', 'female pregnancy', 204, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D'), ('UBERON_0001977', 'blood serum', 264, 'serum'), ('CHEBI_71657', 'versiconol acetate', 270, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 270, '25(OH)D'), ('GO_0007567', 'parturition', 306, 'delivery'), ('CHEBI_33229', 'vitamin (role)', 350, 'vitamin'), ('CHEBI_27300', 'vitamin D', 428, 'vitamin D')]
S79-PMC3702245	PMC3702245	6/2013	S79-PMC3702245	['Vitamin D status was monitored in the mother during Pregnancy and in Cord Blood AS a SURROGATE marker of infant Vitamin D status at Birth.']	[('PROBABLE_UNDERSTANDING', 80), ('SUPERFICIAL_RELATIONSHIP', 85)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 69, 'cord'), ('UBERON_0000178', 'blood', 74, 'blood'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0007567', 'parturition', 132, 'birth')]
S89-PMC3702245	PMC3702245	6/2013	S89-PMC3702245	['IF the institute of medicine’s target of a Serum 25(Oh)D concentration ≥50 nmol/l7was adopted for neonatal Vitamin D status, 79%, 58%, and 40%, respectively, of the infants of mothers on 4000, 2000, and 400 iu per day achieved adequate Vitamin D status ( p = 0.0001).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('UBERON_0001977', 'blood serum', 43, 'serum'), ('CHEBI_71657', 'versiconol acetate', 49, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 49, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D')]
S91-PMC3702245	PMC3702245	6/2013	S91-PMC3702245	['based on this protocol, the authors CONCLUDED that 4000 iu/day of Vitamin D3Supplementation is SAFE and MOST EFFECTIVE in achieving Vitamin D sufficiency in mothers and adequate Vitamin D status in their offspring, irrespective of ethnicity.']	[('INCOMPLETE_EVIDENCE', 36), ('IMPORTANT_CONSIDERATION', 95), ('PROBABLE_UNDERSTANDING', 104), ('SUPERFICIAL_RELATIONSHIP', 109)]	4	[('CHEBI_52915', 'phosphatediyl group', 66, 'vitamin D3supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 66, 'vitamin D3supplementation'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
S93-PMC3702245	PMC3702245	6/2013	S93-PMC3702245	['another RECENT STUDY from the united arab emirates among Pregnant arab women with a high prevalence of Vitamin D deficiency also CONFIRMED that 4000 iu/day of Vitamin D supplementation was SAFE and more EFFECTIVE than 2000 iu/day and 400 iu/day in optimizing Vitamin D status during Pregnancy and in achieving Vitamin D sufficiency at Birth in mothers and offspring.106in the united arab emirates study, the increment from baseline to Delivery was about four-fold higher than expected BASED ON previous pharmacokinetic STUDIES, POSSIBLY RELATED to low baseline Vitamin D status.100this INDICATES that baseline Vitamin D status SHOULD BE taken INTO CONSIDERATION when evaluating Vitamin D supplementation.100,107\nthe FINDINGS of these RECENT intervention STUDIES INDICATE an URGENT NEED for more randomized controlled trials in diverse geographic locations with large sample sizes to identify the Vitamin D intake REQUIRED to optimize Vitamin D status, and TO ASSESS the EFFECT on Pregnancy-related and infant-related COMPLICATIONS.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 129), ('IMPORTANT_CONSIDERATION', 189), ('SUPERFICIAL_RELATIONSHIP', 203), ('PROBABLE_UNDERSTANDING', 485), ('INCOMPLETE_EVIDENCE', 519), ('INCOMPLETE_EVIDENCE', 528), ('SUPERFICIAL_RELATIONSHIP', 537), ('INCOMPLETE_EVIDENCE', 586), ('FUTURE_WORK', 627), ('IMPORTANT_CONSIDERATION', 643), ('FUTURE_WORK', 648), ('INCOMPLETE_EVIDENCE', 716), ('INCOMPLETE_EVIDENCE', 734), ('INCOMPLETE_EVIDENCE', 762), ('IMPORTANT_CONSIDERATION', 774), ('FUTURE_WORK', 781), ('IMPORTANT_CONSIDERATION', 913), ('QUESTION_ANSWERED_BY_THIS_WORK', 956), ('SUPERFICIAL_RELATIONSHIP', 970), ('PROBLEM_COMPLICATION', 1017)]	21	[('GO_0007565', 'female pregnancy', 57, 'pregnant'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D'), ('GO_0007565', 'female pregnancy', 283, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 310, 'vitamin D'), ('GO_0007567', 'parturition', 335, 'birth'), ('GO_0007567', 'parturition', 435, 'delivery'), ('CHEBI_27300', 'vitamin D', 561, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 610, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 678, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 896, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 934, 'vitamin D'), ('GO_0007565', 'female pregnancy', 980, 'pregnancy')]
S94-PMC3702245	PMC3702245	6/2013	S94-PMC3702245	['BASED ON BIOMARKERS AFFECTED by Vitamin D status, and FINDINGS from observational studies and recent randomized trials, FUTURE STUDIES SHOULD include trial arms to achieve Serum 25(Oh)D concentrations that HAVE BEEN ASSOCIATED with POTENTIAL Extraskeletal benefits8,82,84,94–96of Vitamin D to understand BETTER both the benefits and risks of Vitamin D supplementation to mother and offspring.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 9), ('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 54), ('FUTURE_WORK', 120), ('FUTURE_WORK', 135), ('INCOMPLETE_EVIDENCE', 206), ('SUPERFICIAL_RELATIONSHIP', 216), ('INCOMPLETE_EVIDENCE', 232), ('INCOMPLETE_EVIDENCE', 304)]	11	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('UBERON_0001977', 'blood serum', 172, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 181, 'OH)D'), ('UBERON_0001431', 'distal carpal bone 2', 242, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 280, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 342, 'vitamin D')]
S96-PMC3702245	PMC3702245	6/2013	S96-PMC3702245	['in VIEW of the high prevalence of low Vitamin D status in Pregnancy worldwide, INTERVENTION trials to identify optimal Vitamin D status and the REQUIRED SAFE Vitamin D intake COULD BE an IMPORTANT part of PUBLIC HEALTH STRATEGY to improve the health of mothers, and the short-term and long-term outcomes for their offspring.']	[('INCOMPLETE_EVIDENCE', 3), ('FUTURE_WORK', 79), ('IMPORTANT_CONSIDERATION', 144), ('IMPORTANT_CONSIDERATION', 153), ('INCOMPLETE_EVIDENCE', 175), ('IMPORTANT_CONSIDERATION', 187), ('IMPORTANT_CONSIDERATION', 205), ('FUTURE_WORK', 219)]	8	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]
S152-PMC3702339	PMC3702339	6/2013	S152-PMC3702339	['association between Vitamin A status and various POTENTIAL risk factors among Pregnant women in rural sidama, southern ethiopia, february 2011variableserum Retinol µmol/l (mean ±sd)vad+vad-crude or (95% ci)adjusted or (95% ci)**staple diet\xa0\xa0enset-based0.81±0.411802711.28 (0.93-1.77)-\xa0\xa0Cereal-based0.88±0.42851641r-dietary diversity in the previous day\xa0\xa0low (dds ≤3)0.75±0.411191242.55 (1.63-4.00)*1.94 (1.17-3.19)*\xa0\xa0optimal (dds of 4 or 5)0.87±0.411082101.37 (0.88-2.12)1.10 (0.70-1.72)\xa0\xa0high (dds ≥6)0.91±0.43381011r1rconsumed Foods from Animal source in the previous day\xa0\xa0no0.81±0.422163031.92 (1.33-2.78)*1.51 (1.04-2.13)*\xa0\xa0yes0.91±0.39491321r1rsevere acute malnutrition\xa0\xa0no (muac ≥220 mm)0.87±0.421783301r1r\xa0\xa0yes (muac <220 mm)0.75±0.39871051.54 (1.10-2.15)*1.26 (0.88-1.81)zinc deficiency status\xa0\xa0non-deficient0.92±0.41912381r1r\xa0\xa0deficient0.76±0.401741972.31 (1.68-3.17)*1.80 (1.28-2.53)*parity\xa0\xa000.89±0.4034821r1r\xa0\xa01-20.85±0.411021741.41 (0.86-2.26)1.14 (0.69-1.87)\xa0\xa03-40.84±0.42911401.57 (0.97-2.53)1.35 (0.81-2.26)\xa0\xa0≥50.72±0.4038392.35 (1.29-4.28)*1.92 (1.02-3.64)*walking distance from nearby Health facility\xa0\xa00-30 minutes0.83±0.412293691r-\xa0\xa0longer than 30 minutes0.89±0.4436660.88 (0.57-1.36)-number of anc follow-ups\xa0\xa000.87±0.411212431r1r\xa0\xa01-20.80±0.431341731.56 (1.14-2.13)*1.42 (0.97-2.02)\xa0\xa0≥30.86±0.4110191.06 (0.48-2.34)0.70 (0.30-1.64)received Nutrition education during Pregnancy\xa0\xa0yes0.80±0.41701051r-\xa0\xa0no0.85±0.421953300.89 (0.62-1.26)-\n*statistically significant association at 0.05 level of significance;\n**adjusted for all significant variables in the table plus Gestational age and crp level; ci=confidence interval; r=reference value; sd=standard deviation\n\nlinear regression modelling\nin the linear regression model, ABOUT 26.2% of the VARIABILITY in Serum Retinol level (μmol/l) was explained by 8 independent variables (table 2).']	[('INCOMPLETE_EVIDENCE', 49), ('INCOMPLETE_EVIDENCE', 1742), ('DIFFICULT_TASK', 1761)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin A'), ('GO_0007565', 'female pregnancy', 78, 'pregnant'), ('CHEBI_26536', 'retinoic acid', 156, 'retinol'), ('CHEBI_27989', 'cis-dodec-3-enoyl-CoA', 286, 'Cereal'), ('CHEBI_33290', 'food', 529, 'foods'), ('NCBITaxon_33208', 'Metazoa', 540, 'animal'), ('UBERON_0000025', 'tube', 1103, 'health'), ('CHEBI_35222', 'inhibitor', 1361, 'nutrition'), ('GO_0007565', 'female pregnancy', 1388, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1585, 'gestational'), ('UBERON_0001977', 'blood serum', 1776, 'serum'), ('CHEBI_26536', 'retinoic acid', 1782, 'retinol')]
S14-PMC3705320	PMC3705320	3/2013	S14-PMC3705320	['HOWEVER, observational studies have SUGGESTED ASSOCIATIONS between Vitamin D status during Pregnancy and Postnatal infant health outcomes [3,4,5].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 46)]	3	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy'), ('GO_0007567', 'parturition', 105, 'postnatal')]
S15-PMC3705320	PMC3705320	3/2013	S15-PMC3705320	['Serum 25-Hydroxyvitamin D concentration ([25(Oh)D]) ≥ 50 nmol/l is ASSOCIATED with Skeletal health benefits [1], BUT SOME data SUGGEST that IMPROVING Vitamin D status to attain Serum [25(Oh)D] ≥ 80 nmol/l MAY enhance a range of Vitamin D-related functions [6,7,8].']	[('SUPERFICIAL_RELATIONSHIP', 67), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 127), ('FUTURE_WORK', 140), ('INCOMPLETE_EVIDENCE', 205)]	6	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 6, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 42, '25(OH)D'), ('UBERON_0004288', 'skeleton', 83, 'skeletal'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('UBERON_0001977', 'blood serum', 177, 'serum'), ('CHEBI_71657', 'versiconol acetate', 184, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D')]
S17-PMC3705320	PMC3705320	3/2013	S17-PMC3705320	['the POSSIBLE ASSOCIATION between maternal-fetal Vitamin D status and infant health outcomes MAY be particularly relevant to south asian countries such as bangladesh, where adverse Perinatal outcomes and infant mortality are PUBLIC HEALTH PRIORITIES [10], and where Vitamin D deficiency HAS BEEN observed among women of Reproductive age [11] and young infants [12].']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 92), ('IMPORTANT_CONSIDERATION', 224), ('IMPORTANT_CONSIDERATION', 238), ('INCOMPLETE_EVIDENCE', 286)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0036268', 'swimming', 180, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 180, 'perinatal'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D'), ('GO_0000003', 'reproduction', 319, 'reproductive')]
S180-PMC3705320	PMC3705320	3/2013	S180-PMC3705320	['HOWEVER, SINCE the ROLE of pth as a Vitamin D status BIOMARKER during Pregnancy is UNCLEAR [26], the clinical significance of the APPARENT dose-response EFFECT of Vitamin D on pth REQUIRES FURTHER STUDY.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('SUPERFICIAL_RELATIONSHIP', 19), ('SUPERFICIAL_RELATIONSHIP', 53), ('FULL_UNKNOWN', 83), ('ANOMALY_CURIOUS_FINDING', 130), ('SUPERFICIAL_RELATIONSHIP', 153), ('IMPORTANT_CONSIDERATION', 180), ('FUTURE_WORK', 189)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007565', 'female pregnancy', 70, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
S68-PMC3717170	PMC3717170	5/2013	S68-PMC3717170	['Vitamin D during Pregnancy and Lactation\nVitamin D as a preprohormone has EFFECTS that extend beyond Calcium Metabolism and Homeostasis throughout Life but which are most vivid during Pregnancy when Vitamin D Metabolism is disengaged from its usual constraints.12at no other time during the Lifecycle is 25(Oh)D3Linked directly to 1,25(Oh)2d3production, the latter rising more than 2.5 times above nonpregnant levels.12this elevation of 1,25(oh)2d3likely serves the purpose of Immune Regulation, THOUGH there HAVE BEEN ONLY a FEW STUDIES that have evaluated the EFFECT of Vitamin D status on Immune function during Pregnancy to SUPPORT THIS HYPOTHESIS.']	[('SUPERFICIAL_RELATIONSHIP', 74), ('SUPERFICIAL_RELATIONSHIP', 484), ('ANOMALY_CURIOUS_FINDING', 496), ('INCOMPLETE_EVIDENCE', 509), ('INCOMPLETE_EVIDENCE', 519), ('INCOMPLETE_EVIDENCE', 526), ('SUPERFICIAL_RELATIONSHIP', 562), ('INCOMPLETE_EVIDENCE', 628), ('QUESTION_ANSWERED_BY_THIS_WORK', 636), ('INCOMPLETE_EVIDENCE', 641)]	10	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 17, 'pregnancy'), ('GO_0007595', 'lactation', 31, 'lactation'), ('CHEBI_28384', 'vitamin K', 41, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 41, 'Vitamin D'), ('GO_0018884', 'carbazole metabolic process', 101, 'calcium metabolism'), ('GO_0042592', 'homeostatic process', 124, 'homeostasis'), ('UBERON_0000104', 'life cycle', 147, 'life'), ('GO_0007565', 'female pregnancy', 184, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 199, 'vitamin D metabolism'), ('UBERON_0000104', 'life cycle', 291, 'lifecycle'), ('CHEBI_77914', '3-methylbut-1-ene', 304, '25(OH)D3linked'), ('CHEBI_63056', 'zinc cation', 333, '25(OH'), ('CHEBI_17996', 'chloride', 438, ','), ('GO_0002521', 'leukocyte differentiation', 477, 'immune regulation'), ('UBERON_0002405', 'immune system', 477, 'immune'), ('CHEBI_27300', 'vitamin D', 572, 'vitamin D'), ('UBERON_0002405', 'immune system', 592, 'immune'), ('GO_0007565', 'female pregnancy', 615, 'pregnancy')]
S69-PMC3717170	PMC3717170	5/2013	S69-PMC3717170	"[""in addition, FEW randomized controlled trials HAVE BEEN conducted in Pregnant women to determine optimal Vitamin D status.13–15\ncarol l. wagner (medical university of south carolina) DISCUSSED two RECENT STUDIES performed by her group in collaboration with bruce hollis's group—the national institute of child health and Human development (nichd) Vitamin D Pregnancy trial12and the thrasher research fund Vitamin D community-based supplementation trial16—that INDICATE that 400 iu Vitamin D, the amount found in MOST Prenatal Vitamins, is INADEQUATE and that 4000 iu/day is NECESSARY to optimize 1,25(Oh)2D3Production, achieved when total circulating 25(Oh)d3is at least 40 ng/ml (fig.""]"	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 46), ('INCOMPLETE_EVIDENCE', 183), ('INCOMPLETE_EVIDENCE', 197), ('INCOMPLETE_EVIDENCE', 460), ('PROBABLE_UNDERSTANDING', 512), ('IMPORTANT_CONSIDERATION', 539), ('PROBLEM_COMPLICATION', 539), ('IMPORTANT_CONSIDERATION', 574)]	9	[('GO_0007565', 'female pregnancy', 69, 'pregnant'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 321, 'Human'), ('CHEBI_28384', 'vitamin K', 347, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 357, 'Pregnancy'), ('CHEBI_28384', 'vitamin K', 405, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 405, 'Vitamin'), ('CHEBI_27300', 'vitamin D', 481, 'vitamin D'), ('GO_0007565', 'female pregnancy', 517, 'prenatal'), ('CHEBI_33277', 'gamma-tocotrienol', 526, 'vitamins'), ('CHEBI_37983', 'sulfur-35 atom', 596, '1'), ('CHEBI_74151', 'S-palmitoyl-L-cysteine residue', 597, ',25(OH)2D3production'), ('PR_000029121', 'leucine-rich repeat and guanylate kinase domain-containing protein', 604, '2D3production'), ('CHEBI_33310', 'neon atom', 653, '(OH)')]
S76-PMC3717170	PMC3717170	5/2013	S76-PMC3717170	['it WAS THOUGHT for decades that Human Milk was minimally sufficient in Vitamin D;17yet, PRELIMINARY results of the RECENTLY COMPLETED nichd Vitamin D supplementation trial during Lactation SHOW that when a mother is Vitamin D replete, with an Intake of 6400 iu Vitamin D3/day, Breast Milk is replete and a breastfeeding infant has excellent Vitamin D status without infant supplementation that is COMPARABLE to combined maternal and infant supplementation of 400 iu Vitamin D3/day.18the IMPLICATIONS of SAFELY achieving vitamin d SUFFICIENCY for both mother and breastfeeding infant solely through maternal supplementation is just BEGINNING TO BE UNDERSTOOD and will LIKELY CHALLENGE researchers for decades to come.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 115), ('INCOMPLETE_EVIDENCE', 189), ('INCOMPLETE_EVIDENCE', 397), ('IMPORTANT_CONSIDERATION', 487), ('IMPORTANT_CONSIDERATION', 503), ('IMPORTANT_CONSIDERATION', 530), ('INCOMPLETE_EVIDENCE', 631), ('PROBABLE_UNDERSTANDING', 667), ('DIFFICULT_TASK', 674)]	12	[('NCBITaxon_9606', 'Homo sapiens', 32, 'human'), ('UBERON_0001913', 'milk', 38, 'milk'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D'), ('GO_0007595', 'lactation', 179, 'lactation'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D'), ('GO_0007631', 'feeding behavior', 243, 'intake'), ('CHEBI_33279', 'vitamin D5', 261, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 261, 'vitamin D3'), ('UBERON_0000310', 'breast', 277, 'breast'), ('UBERON_0001913', 'milk', 284, 'milk'), ('CHEBI_27300', 'vitamin D', 341, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 466, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 466, 'vitamin D3')]
S87-PMC3717170	PMC3717170	5/2013	S87-PMC3717170	['2; unpublished data) and improved MARKERS of adiposity and Vitamin D status (Plasma concentrations of Glucose, Insulin, adiponectin, 25(Oh)D3, 1,25(Oh)2D3, and pth), BUT an increased Plasma Ca2+.']	[('SUPERFICIAL_RELATIONSHIP', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 166)]	2	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 77, 'plasma'), ('CHEBI_17234', 'glucose', 102, 'glucose'), ('PR_000045358', 'insulin family protein', 111, 'insulin'), ('CHEBI_62946', 'ammonium sulfate', 133, '25(OH)D3'), ('CHEBI_73394', 'Ala-Ser', 145, '25(OH)2D3'), ('UBERON_0001969', 'blood plasma', 183, 'plasma'), ('CHEBI_29108', 'calcium(2+)', 190, 'Ca2+.')]
S136-PMC3717170	PMC3717170	5/2013	S136-PMC3717170	['in Humans, the ROLE of Vitamin D in type 2 diabetes is SUGGESTED by a large NUMBER OF cross-sectional STUDIES that have CONSISTENTLY FOUND an inverse ASSOCIATION between Vitamin D status and prevalent hyperglycemia, including a REPORTED seasonal variation in the Control Of Glycemia in patients with diabetes, being worse in the winter when hypovitaminosis d is more prevalent.35in the MAJORITY of longitudinal OBSERVATIONAL studies, lower Vitamin D status is also ASSOCIATED with INCREASED RISK of incident type 2 diabetes.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 55), ('INCOMPLETE_EVIDENCE', 76), ('PROBABLE_UNDERSTANDING', 120), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 150), ('INCOMPLETE_EVIDENCE', 228), ('PROBABLE_UNDERSTANDING', 386), ('INCOMPLETE_EVIDENCE', 411), ('SUPERFICIAL_RELATIONSHIP', 465), ('IMPORTANT_CONSIDERATION', 481)]	11	[('NCBITaxon_9606', 'Homo sapiens', 3, 'humans'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('GO_0006936', 'muscle contraction', 263, 'control of glycemia'), ('CHEBI_27300', 'vitamin D', 440, 'vitamin D')]
S139-PMC3717170	PMC3717170	5/2013	S139-PMC3717170	['HOWEVER, pittas CAUTIONED that one SHOULD RESIST making inferences on the basis of OBSERVATIONAL studies BECAUSE of the POSSIBILITY of CONFOUNDING ISSUES, which MAY BE especially TRUE when assessing Vitamin D status, BECAUSE WHILE 25(Oh)D3Concentration is an excellent MARKER of good health many of the VARIABLES that CONTRIBUTE to 25(Oh)d3concentration (e.g., skin pigmentation, physical inactivity, Aging, unhealthy dietary patterns) are also RISK FACTORS for the development of diabetes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 16), ('INCOMPLETE_EVIDENCE', 16), ('FUTURE_WORK', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('INCOMPLETE_EVIDENCE', 83), ('PROBLEM_COMPLICATION', 105), ('INCOMPLETE_EVIDENCE', 120), ('PROBLEM_COMPLICATION', 135), ('PROBLEM_COMPLICATION', 147), ('INCOMPLETE_EVIDENCE', 161), ('PROBABLE_UNDERSTANDING', 179), ('PROBABLE_UNDERSTANDING', 217), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 225), ('SUPERFICIAL_RELATIONSHIP', 269), ('SUPERFICIAL_RELATIONSHIP', 303), ('SUPERFICIAL_RELATIONSHIP', 318), ('SUPERFICIAL_RELATIONSHIP', 445)]	18	[('CHEBI_27300', 'vitamin D', 199, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 231, '25(OH)D3concentration'), ('CHEBI_30778', 'gallic acid', 332, '25(OH)'), ('GO_0007568', 'aging', 401, 'aging')]
S144-PMC3717170	PMC3717170	5/2013	S144-PMC3717170	['THEREFORE, CONFIRMATION of a POTENTIAL beneficial EFFECT of Vitamin D in type 2 diabetes IS NEEDED in trials conducted in well-defined populations (e.g., pre-diabetes and early diabetes) SPECIFICALLY DESIGNED TO TEST the COMPELLING BUT YET UNPROVEN HYPOTHESIS that Vitamin D status is a direct CONTRIBUTOR to the pathogenesis of type 2 diabetes.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 50), ('FUTURE_WORK', 89), ('QUESTION_ANSWERED_BY_THIS_WORK', 187), ('QUESTION_ANSWERED_BY_THIS_WORK', 200), ('QUESTION_ANSWERED_BY_THIS_WORK', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 232), ('ANOMALY_CURIOUS_FINDING', 236), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 240), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 294)]	14	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D')]
S171-PMC3717170	PMC3717170	5/2013	S171-PMC3717170	['there is STRONG EVIDENCE that obesity is ASSOCIATED with POOR Vitamin D status due to fat sequestration.48in fact, compared with the non-obese, higher doses of Vitamin D are REQUIRED in obese Individuals.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 41), ('IMPORTANT_CONSIDERATION', 57), ('IMPORTANT_CONSIDERATION', 174)]	4	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('NCBITaxon_1', 'root', 192, 'individuals')]
S179-PMC3717170	PMC3717170	5/2013	S179-PMC3717170	['Vitamin D AFFECTS several pathways RELATED to inflammation and Cell Proliferation, including inhibition of aromatase (conversion from Testosterone to Estrogens), Cox2, prostaglandin receptor, Nf-κb, Hif-1 and Vegf, and stimulation of Igfbp-3 and E-Cadherin.52in addition, poor Vitamin D status is a RISK factor for several Autoimmune diseases, CONFIRMING the ROLE of this Vitamin in Immune function.']	[('SUPERFICIAL_RELATIONSHIP', 10), ('SUPERFICIAL_RELATIONSHIP', 35), ('SUPERFICIAL_RELATIONSHIP', 299), ('PROBABLE_UNDERSTANDING', 344), ('SUPERFICIAL_RELATIONSHIP', 359)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0008283', 'cell proliferation', 63, 'cell proliferation'), ('CHEBI_17347', 'testosterone', 134, 'testosterone'), ('CHEBI_50114', 'estrogen', 150, 'estrogens'), ('PR_000005773', 'cytochrome c oxidase copper chaperone', 162, 'COX2'), ('GO_0005883', 'neurofilament', 192, 'NF'), ('PR_000008539', 'protein-cysteine N-palmitoyltransferase HHAT-like protein', 199, 'HIF-1'), ('PR_000017279', 'testis-specific basic protein Y 1', 209, 'VEGF'), ('PR_000008940', 'intraflagellar transport protein 88', 234, 'IGFBP-3'), ('PR_000001447', 'cadherin-1', 246, 'E-cadherin'), ('CHEBI_27300', 'vitamin D', 277, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 323, 'autoimmune'), ('CHEBI_33229', 'vitamin (role)', 372, 'vitamin'), ('UBERON_0002405', 'immune system', 383, 'immune')]
S18-PMC3717763	PMC3717763	8/2013	S18-PMC3717763	"[""in RECENT YEARS, there HAS BEEN particular CONCERN about Vitamin D levels among children in the uk, and the rise in Vitamin D deficiency disease, presenting as rickets, symptomatic hypocalcaemia and motor delay.5–12vitamin d is hard to source through diet alone; 90% comes from exposure to sunlight.13if the mother's Vitamin D status is low during Pregnancy, the infant will also have low levels.14estimates CONSISTENTLY SHOW that the MAJORITY of uk children aged between 1.5 and 3\u2005years do not get their daily reference Nutrient intake of Vitamin D.15–18one RECENT STUDY REPORTS that supplying hs Vitamins to all Pregnant women and young children resulted in a substantial reduction in symptomatic Vitamin D deficiency in children in one primary care trust (pct), where 75% of the population were from ethnic minority groups PARTICULARLY AT RISK of Vitamin D deficiency.19\nTHIS PAPER reports on research with parents and professionals with the AIM of understanding WHY the provision of free hs Vitamins has not resulted in higher levels of use among low income families in england.""]"	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 43), ('PROBABLE_UNDERSTANDING', 408), ('INCOMPLETE_EVIDENCE', 421), ('PROBABLE_UNDERSTANDING', 435), ('INCOMPLETE_EVIDENCE', 559), ('INCOMPLETE_EVIDENCE', 572), ('IMPORTANT_CONSIDERATION', 826), ('IMPORTANT_CONSIDERATION', 839), ('QUESTION_ANSWERED_BY_THIS_WORK', 874), ('QUESTION_ANSWERED_BY_THIS_WORK', 945), ('EXPLICIT_QUESTION', 966)]	13	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 317, 'vitamin D'), ('GO_0007565', 'female pregnancy', 348, 'pregnancy'), ('CHEBI_33284', 'nutrient', 521, 'nutrient'), ('CHEBI_27300', 'vitamin D', 540, 'vitamin D'), ('CHEBI_33277', 'gamma-tocotrienol', 598, 'vitamins'), ('GO_0007565', 'female pregnancy', 614, 'pregnant'), ('CHEBI_27300', 'vitamin D', 699, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 850, 'vitamin D'), ('CHEBI_33277', 'gamma-tocotrienol', 995, 'vitamins')]
S172-PMC3739737	PMC3739737	8/2013	S172-PMC3739737	['the results STRONGLY SUGGEST that low Vitamin D status exacerbates disease progression[41].']	[('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 21)]	2	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D')]
S27-PMC3742894	PMC3742894	7/2013	S27-PMC3742894	['to improve the nutritional status (the MAJOR cause of anemia in Pregnancy) of ethiopian women, there HAVE BEEN several interventions by the ministry of health through its essential nutrition action plan (ena), consisting of supplementation of three major Nutrients (Vitamin A, Iron, and Iodine) and other promotive activities to improve maternal and child nutrition (18).']	[('IMPORTANT_CONSIDERATION', 39), ('INCOMPLETE_EVIDENCE', 101)]	2	[('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('CHEBI_33284', 'nutrient', 255, 'nutrients'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin A'), ('CHEBI_24870', 'ion', 277, 'iron'), ('CHEBI_24859', 'iodine atom', 287, 'iodine')]
S1-PMC3760821	PMC3760821	9/2013	S1-PMC3760821	['the second AIM of the study was TO INVESTIGATE POTENTIAL INTERACTIONS between maternal body mass index (bmi) and foetal Vitamin D status.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 57)]	4	[('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
S21-PMC3760821	PMC3760821	9/2013	S21-PMC3760821	['hypovitaminosis D is commonly SEEN in both Pregnant and non-Pregnant women worldwide[5]; with many FACTORS IMPACTING on Vitamin D status, including; exposure to sunlight, skin colour, season, latitude and obesity, among others[6].']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 99), ('SUPERFICIAL_RELATIONSHIP', 107)]	3	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 16, 'D'), ('GO_0007565', 'female pregnancy', 43, 'pregnant'), ('GO_0007565', 'female pregnancy', 60, 'pregnant'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
S34-PMC3760821	PMC3760821	9/2013	S34-PMC3760821	['the results of a large RECENTLY published prospective study has, HOWEVER, FOUND NO EVIDENCE of an association between the maternal Vitamin D status in Pregnancy and late childhood bone Mineral content (average age 10 yrs)[14].']	[('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 65), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 80)]	4	[('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'pregnancy'), ('CHEBI_46662', 'mineral', 185, 'mineral')]
S46-PMC3760821	PMC3760821	9/2013	S46-PMC3760821	['the second AIM of the study was TO INVESTIGATE POTENTIAL INTERACTIONS between maternal bmi and foetal Vitamin D status.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 57)]	4	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
S125-PMC3760821	PMC3760821	9/2013	S125-PMC3760821	['furthermore, within spring, winter and autumn, post-Delivery 25Ohd levels were significantly greater than Cord Blood levels.10.1371/journal.pone.0074068.g001\n\ncaption (fig): figure 1\nIMPACT of maternal Vitamin D status and bmi on neonatal Vitamin D levels.']	[('SUPERFICIAL_RELATIONSHIP', 183)]	1	"[('GO_0007567', 'parturition', 52, 'delivery'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 61, '25OHD'), ('UBERON_0002240', 'spinal cord', 106, 'cord'), ('UBERON_0000178', 'blood', 111, 'blood'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin D')]"
S155-PMC3760821	PMC3760821	9/2013	S155-PMC3760821	['the FINDINGS of THE CURRENT STUDY that, in women with t1dm, low Vitamin D levels are EVIDENCED throughout Gestation are IN AGREEMENT with PREVIOUS GROUPS who HAVE reported compromised Vitamin D status in Pregnancy[5].']	[('INCOMPLETE_EVIDENCE', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 120), ('INCOMPLETE_EVIDENCE', 138), ('IMPORTANT_CONSIDERATION', 158)]	6	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 106, 'gestation'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('GO_0007565', 'female pregnancy', 204, 'pregnancy')]
S181-PMC3760821	PMC3760821	9/2013	S181-PMC3760821	['clearly, prospective clinical randomised controlled trials of Vitamin D supplementation ARE REQUIRED TO evaluate and CLARIFY the ASSOCIATION between Vitamin D status and Glycaemic Control in t1dm Pregnancy.']	[('FUTURE_WORK', 88), ('IMPORTANT_CONSIDERATION', 92), ('QUESTION_ANSWERED_BY_THIS_WORK', 101), ('FUTURE_WORK', 117), ('SUPERFICIAL_RELATIONSHIP', 129)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('GO_0051162', 'L-arabitol metabolic process', 170, 'glycaemic control'), ('GO_0007565', 'female pregnancy', 196, 'pregnancy')]
S184-PMC3760821	PMC3760821	9/2013	S184-PMC3760821	['in conclusion, the FINDING that Vitamin D DEPENDENT processes MAY BE negatively IMPACTED by maternal nutritional status and obesity in a t1dm cohort is a significant one and provides FURTHER EVIDENCE that population-based INTERVENTIONS aimed at reducing obesity and improving pre-Pregnancy and Gestational Vitamin D status ARE NEEDED.']	[('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 80), ('FUTURE_WORK', 183), ('INCOMPLETE_EVIDENCE', 183), ('FUTURE_WORK', 222), ('FUTURE_WORK', 323)]	8	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 280, 'pregnancy'), ('GO_0007565', 'female pregnancy', 294, 'gestational'), ('CHEBI_27300', 'vitamin D', 306, 'vitamin D')]
S185-PMC3760821	PMC3760821	9/2013	S185-PMC3760821	['GIVEN the SAFETY of Vitamin D, the low cost of supplementation and its REQUIREMENT for OPTIMAL bone health (and POTENTIALLY other health outcomes) in both the mother and off-spring, the FINDINGS of THE CURRENT STUDY SUPPORT the case for determining Vitamin D status and, IF NECESSARY, administering Vitamin D in t1dm pregnancy.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 10), ('IMPORTANT_CONSIDERATION', 71), ('IMPORTANT_CONSIDERATION', 87), ('INCOMPLETE_EVIDENCE', 112), ('INCOMPLETE_EVIDENCE', 186), ('QUESTION_ANSWERED_BY_THIS_WORK', 198), ('INCOMPLETE_EVIDENCE', 216), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 271), ('IMPORTANT_CONSIDERATION', 274)]	10	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D')]
S0-PMC3773018	PMC3773018	4/2013	S0-PMC3773018	['the longitudinal trajectory of Vitamin D status from Birth to early childhood on the development of Food sensitization\n\nabstract\n\nbackground\nINCREASING EVIDENCE SUPPORTS the immunomodulatory EFFECT of Vitamin D on Allergic diseases.']	[('INCOMPLETE_EVIDENCE', 141), ('INCOMPLETE_EVIDENCE', 161), ('SUPERFICIAL_RELATIONSHIP', 191)]	3	[('CHEBI_28384', 'vitamin K', 31, 'Vitamin D'), ('GO_0007567', 'parturition', 53, 'Birth'), ('CHEBI_33290', 'food', 100, 'Food'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D'), ('GO_0040011', 'locomotion', 214, 'allergic')]
S1-PMC3773018	PMC3773018	4/2013	S1-PMC3773018	['the combined ROLE of Prenatal and Postnatal Vitamin D status in the development of Food Sensitization (fs) and Food Allergy REMAINS under-STUDIED.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 137)]	3	[('GO_0007565', 'female pregnancy', 21, 'prenatal'), ('GO_0007567', 'parturition', 34, 'postnatal'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_33290', 'food', 83, 'food'), ('GO_0031318', 'detection of folic acid', 83, 'food sensitization'), ('CHEBI_33290', 'food', 111, 'food'), ('GO_0007631', 'feeding behavior', 111, 'food allergy')]
S6-PMC3773018	PMC3773018	4/2013	S6-PMC3773018	['HOWEVER, in combination, persistence of low Vitamin D status at Birth and early childhood increased the risk of fs (or=2.03, 95%ci:1.02–4.04), PARTICULARLY among children carrying the c Allele of rs2243250 (or=3.23, 95%ci:1.37–7.60).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 143)]	3	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007567', 'parturition', 64, 'birth'), ('SO_0001023', 'allele', 186, 'allele')]
S13-PMC3773018	PMC3773018	4/2013	S13-PMC3773018	['to date, ONLY three birth cohort studies have examined the EFFECT of Prenatal Vitamin D exposure on allergic phenotypes using Cord Blood 25(Oh)D concentrations, an objective measure of Vitamin D status reflecting both dietary intake and sun exposure.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 59)]	2	[('GO_0007565', 'female pregnancy', 69, 'prenatal'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 126, 'cord'), ('UBERON_0000178', 'blood', 131, 'blood'), ('CHEBI_71657', 'versiconol acetate', 137, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 137, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
S19-PMC3773018	PMC3773018	4/2013	S19-PMC3773018	['HOWEVER, FINDINGS regarding the combined EFFECTS of Prenatal and Postnatal Vitamin D status on fs, two of the most CRITICAL periods for Immune System Development (19,20), are UNCLEAR.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 41), ('IMPORTANT_CONSIDERATION', 115), ('FULL_UNKNOWN', 175)]	5	[('GO_0007565', 'female pregnancy', 52, 'prenatal'), ('GO_0007567', 'parturition', 65, 'postnatal'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('GO_0002520', 'immune system development', 136, 'immune system development'), ('UBERON_0002405', 'immune system', 136, 'immune system')]
S21-PMC3773018	PMC3773018	4/2013	S21-PMC3773018	['THIS STUDY FURTHER extends and strengthens our PREVIOUS work by EXAMINING the risk of fs in RELATION to the longitudinal trajectory of Vitamin D status from Birth to early childhood in the same Birth cohort.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 47), ('QUESTION_ANSWERED_BY_THIS_WORK', 64), ('SUPERFICIAL_RELATIONSHIP', 92)]	5	[('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('GO_0007567', 'parturition', 157, 'birth'), ('GO_0007567', 'parturition', 194, 'birth')]
S22-PMC3773018	PMC3773018	4/2013	S22-PMC3773018	['HEREIN, we EXAMINED the INTERACTION of a Promoter polymorphism (rs2243250: c-590t) in the Il4 Gene and the longitudinal trajectory of Vitamin D status from Birth to early childhood on the risk of fs.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('SUPERFICIAL_RELATIONSHIP', 24)]	3	[('SO_0000167', 'promoter', 41, 'promoter'), ('PR_000008989', 'interleukin-1 family member 7', 90, 'IL4'), ('SO_0000704', 'gene', 94, 'gene'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007567', 'parturition', 156, 'birth')]
S35-PMC3773018	PMC3773018	4/2013	S35-PMC3773018	['we grouped the children according to longitudinal trajectory of 25(Oh)D based on if a child had: 1) low Vitamin D status at Birth (< 11ng/ml) AS SUGGESTED by the institute of medicine (26) or 2) low Postnatal Vitamin D status (< 30ng/ml) ACCORDING TO the Endocrine society clinical practice guidelines on Vitamin D insufficiency (27,28).']	[('PROBABLE_UNDERSTANDING', 142), ('INCOMPLETE_EVIDENCE', 145), ('INCOMPLETE_EVIDENCE', 238)]	3	[('CHEBI_71657', 'versiconol acetate', 64, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 64, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007567', 'parturition', 124, 'birth'), ('GO_0007567', 'parturition', 199, 'postnatal'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 255, 'Endocrine'), ('CHEBI_28384', 'vitamin K', 305, 'Vitamin D')]
S38-PMC3773018	PMC3773018	4/2013	S38-PMC3773018	['we also conducted the above regression analyses stratified by the genotypes of rs2243250, and then EXAMINED the statistical significance for the multiplicative INTERACTION between low Vitamin D status and rs2243250.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 99), ('SUPERFICIAL_RELATIONSHIP', 160)]	2	[('CHEBI_27300', 'vitamin D', 184, 'vitamin D')]
S53-PMC3773018	PMC3773018	4/2013	S53-PMC3773018	['HOWEVER, children with persistently low Vitamin D status had the highest risk of fs (or= 2.04, 95%ci: 1.02–4.04), AS compared to those with sufficient Vitamin D status at Birth and follow-up.']	[('ANOMALY_CURIOUS_FINDING', 0), ('PROBABLE_UNDERSTANDING', 114)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007567', 'parturition', 171, 'birth')]
S57-PMC3773018	PMC3773018	4/2013	S57-PMC3773018	['finally, we OBSERVED an INTERACTION EFFECT between rs2243250 and persistently low Vitamin D status on the risk of fs (pinteraction= 0.02).']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 24), ('SUPERFICIAL_RELATIONSHIP', 36)]	3	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
S58-PMC3773018	PMC3773018	4/2013	S58-PMC3773018	['among children carrying the c Allele of rs2243250 (~65% of the study subjects), persistently low Vitamin D status was ASSOCIATED with an over 3-fold increased risk of fs (or = 3.23, 95%ci: 1.37–7.60) compared to those with sufficient Vitamin D at both time points.']	[('SUPERFICIAL_RELATIONSHIP', 118)]	1	[('SO_0001023', 'allele', 30, 'allele'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 234, 'vitamin D')]
S61-PMC3773018	PMC3773018	4/2013	S61-PMC3773018	['discussion\nTHIS is the FIRST STUDY TO EXAMINE the EFFECTS of longitudinal trajectory Vitamin D status, by measurement of Plasma 25(Oh)D concentrations from Birth to early childhood, on the development of fs.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('QUESTION_ANSWERED_BY_THIS_WORK', 38), ('SUPERFICIAL_RELATIONSHIP', 50)]	6	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 121, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 128, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 128, '25(OH ... D'), ('GO_0007567', 'parturition', 156, 'birth')]
S62-PMC3773018	PMC3773018	4/2013	S62-PMC3773018	['we FOUND that persistently low Vitamin D status from Birth to early childhood was ASSOCIATED with fs in the bbc.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 82)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007567', 'parturition', 53, 'birth')]
S67-PMC3773018	PMC3773018	4/2013	S67-PMC3773018	['we also FOUND high proportions of children with low Vitamin D status (i.e., <30ng.ml) during the first year of Life, 1–2 years, and 2–3 years (i.e., 29%, 36%, and 40%).']	[('INCOMPLETE_EVIDENCE', 8)]	1	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('UBERON_0000104', 'life cycle', 111, 'life')]
S71-PMC3773018	PMC3773018	4/2013	S71-PMC3773018	['insufficient Vitamin D status is UNDESIRABLE from many viewpoints, ESPECIALLY BECAUSE of its IMPACT on bone health and Immune function.']	[('IMPORTANT_CONSIDERATION', 33), ('IMPORTANT_CONSIDERATION', 67), ('PROBLEM_COMPLICATION', 78), ('SUPERFICIAL_RELATIONSHIP', 93)]	4	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('UBERON_0002405', 'immune system', 119, 'immune')]
S74-PMC3773018	PMC3773018	4/2013	S74-PMC3773018	['the FINDINGS from THIS extended STUDY EMPHASIZE the IMPORTANT ROLE of Postnatal Vitamin D status in the development of fs.']	[('INCOMPLETE_EVIDENCE', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('IMPORTANT_CONSIDERATION', 38), ('IMPORTANT_CONSIDERATION', 52), ('SUPERFICIAL_RELATIONSHIP', 62)]	6	[('GO_0007567', 'parturition', 70, 'postnatal'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
S75-PMC3773018	PMC3773018	4/2013	S75-PMC3773018	['children who had very low Vitamin D status at Birth but had sufficient Vitamin D during their early Life had no risk or a lower RISK of fs; WHILE children who were exposed to persistently low Vitamin D both pre- and post-Natally had the highest risk of fa (table 3).']	[('IMPORTANT_CONSIDERATION', 128), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 140)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007567', 'parturition', 46, 'birth'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0000104', 'life cycle', 100, 'life'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D'), ('GO_0007567', 'parturition', 221, 'natally')]
S82-PMC3773018	PMC3773018	4/2013	S82-PMC3773018	['OF NOTE, OUR FINDINGS from the stratified analyses SUGGESTED stronger ASSOCIATIONS between low Vitamin D status and high RISK of fs among children Born Preterm, which NEEDS to be FURTHER explored in a larger sample.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 70), ('IMPORTANT_CONSIDERATION', 121), ('IMPORTANT_CONSIDERATION', 167), ('FUTURE_WORK', 179), ('INCOMPLETE_EVIDENCE', 179)]	8	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('GO_0007567', 'parturition', 147, 'born'), ('GO_0007565', 'female pregnancy', 152, 'preterm')]
S83-PMC3773018	PMC3773018	4/2013	S83-PMC3773018	['furthermore, we OBSERVED significant INTERACTION EFFECTS between the Il4 Gene polymorphism and persistently low Vitamin D status on fs in this SMALLER sized study sample.']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 143)]	4	[('PR_000008989', 'interleukin-1 family member 7', 69, 'IL4'), ('SO_0000704', 'gene', 73, 'gene'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
S84-PMC3773018	PMC3773018	4/2013	S84-PMC3773018	['among subjects carrying the c Allele of rs2243250, persistently low Vitamin D status dramatically increased the RISK of fs, WHILE sufficient Vitamin D status during early childhood attenuated the risk of Perinatal Vitamin D deficiency on fs to null.']	[('IMPORTANT_CONSIDERATION', 112), ('ANOMALY_CURIOUS_FINDING', 124)]	2	[('SO_0001023', 'allele', 30, 'allele'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('GO_0036268', 'swimming', 204, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 204, 'perinatal'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D')]
S85-PMC3773018	PMC3773018	4/2013	S85-PMC3773018	['among those carrying the tt genotype, post-Natal sufficient Vitamin D status EVEN SHOWED a decreased risk of fs.']	[('ANOMALY_CURIOUS_FINDING', 77), ('INCOMPLETE_EVIDENCE', 82)]	2	[('GO_0007567', 'parturition', 43, 'natal'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
S92-PMC3773018	PMC3773018	4/2013	S92-PMC3773018	['there is no gold standard for HOW to define low Vitamin D status at Birth and in early childhood.']	[('EXPLICIT_QUESTION', 30)]	1	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007567', 'parturition', 68, 'birth')]
S54-PMC3809191	PMC3809191	1/2013	S54-PMC3809191	['data RELATING Vitamin D status to gdm RISK are INCONSISTENT and LIMITED.']	[('SUPERFICIAL_RELATIONSHIP', 5), ('IMPORTANT_CONSIDERATION', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('INCOMPLETE_EVIDENCE', 64)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D')]
S60-PMC3809191	PMC3809191	1/2013	S60-PMC3809191	['first, Serum 25 (Oh) D concentrations determined in late trimester MAY not show the status of maternal Vitamin D during the whole Pregnancy Period and HENCE to IDENTIFY the ASSOCIATION of Gdm Development and Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 67), ('PROBABLE_UNDERSTANDING', 151), ('QUESTION_ANSWERED_BY_THIS_WORK', 160), ('SUPERFICIAL_RELATIONSHIP', 173)]	4	[('UBERON_0001977', 'blood serum', 7, 'serum'), ('CHEBI_71657', 'versiconol acetate', 13, '25 (OH) D'), ('PR_000006444', 'diacylglycerol kinase delta', 21, 'D'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('UBERON_0018298', 'stylocone', 130, 'pregnancy period'), ('GO_0072147', 'glomerular parietal epithelial cell fate commitment', 188, 'GDM development'), ('CHEBI_27300', 'vitamin D', 208, 'vitamin D')]
S0-PMC3814422	PMC3814422	10/2013	S0-PMC3814422	['maternal 25-Hydroxyvitamin D and its ASSOCIATION with childhood atopic outcomes and Lung function\n\nabstract\n\nbackground\nit HAS BEEN SUGGESTED that maternal Vitamin D status in Pregnancy INFLUENCES the risk of asthma and atopy in the offspring.']	[('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 186)]	3	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 9, '25-hydroxyvitamin D'), ('UBERON_0002048', 'lung', 84, 'lung'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0007565', 'female pregnancy', 176, 'pregnancy')]
S10-PMC3814422	PMC3814422	10/2013	S10-PMC3814422	['introduction\nVitamin D MAY play an IMPORTANT ROLE in normal fetal Lung and Immune System Development1And there is increasing SPECULATION that maternal Vitamin D status in Pregnancy MIGHT be causally LINKED to the development of asthma and atopy in the offspring.']	[('INCOMPLETE_EVIDENCE', 23), ('IMPORTANT_CONSIDERATION', 35), ('SUPERFICIAL_RELATIONSHIP', 45), ('INCOMPLETE_EVIDENCE', 125), ('INCOMPLETE_EVIDENCE', 181), ('SUPERFICIAL_RELATIONSHIP', 199)]	6	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('GO_0006266', 'DNA ligation', 66, 'lung ...'), ('UBERON_0002048', 'lung', 66, 'lung'), ('GO_0002415', 'immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor', 75, 'immune system development1and'), ('UBERON_0002405', 'immune system', 75, 'immune system'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007565', 'female pregnancy', 171, 'pregnancy')]
S12-PMC3814422	PMC3814422	10/2013	S12-PMC3814422	['HOWEVER, an OPPOSING argument holds that the increasing PREVALENCE of asthma and atopy MAY BE PARTLY a consequence of the fortification of childhood Foods with Vitamin D and HENCE high Vitamin D status in early childhood3–7.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('IMPORTANT_CONSIDERATION', 56), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 94), ('PROBABLE_UNDERSTANDING', 174)]	6	[('CHEBI_33290', 'food', 149, 'foods'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
S14-PMC3814422	PMC3814422	10/2013	S14-PMC3814422	['HOWEVER, a MAJOR LIMITATION of these studies is that diet makes a relatively minor CONTRIBUTION to total Vitamin D status, which is derived largely from Photosynthesis in the skin.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 11), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 83)]	4	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0006654', 'phosphatidic acid biosynthetic process', 153, 'photosynthesis')]
S16-PMC3814422	PMC3814422	10/2013	S16-PMC3814422	['the gold STANDARD measure of Vitamin D status is the Blood concentration of 25-Hydroxyvitamin D (25(Oh)D)11.']	[('INCOMPLETE_EVIDENCE', 9)]	1	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('UBERON_0000178', 'blood', 53, 'blood'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 76, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 97, '25(OH)D')]
S133-PMC3814422	PMC3814422	10/2013	S133-PMC3814422	['HOWEVER, given that Vitamin D intake is a POOR PROXY for total Vitamin D status11, APPARENT ASSOCIATIONS with dietary Vitamin D MAY HAVE BEEN CONFOUNDED by OTHER dietary or non-dietary factors which had not been controlled for in those Birth cohort studies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 42), ('PROBLEM_COMPLICATION', 42), ('SUPERFICIAL_RELATIONSHIP', 47), ('ANOMALY_CURIOUS_FINDING', 83), ('INCOMPLETE_EVIDENCE', 83), ('SUPERFICIAL_RELATIONSHIP', 92), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 132), ('DIFFICULT_TASK', 142), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 156)]	11	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007567', 'parturition', 236, 'birth')]
S139-PMC3814422	PMC3814422	10/2013	S139-PMC3814422	['in particular, we have not FOUND EVIDENCE to SUGGEST that higher Prenatal Vitamin D status in Pregnancy PROTECTS against the development of early childhood wheezing or later asthma.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 104)]	3	[('GO_0007565', 'female pregnancy', 65, 'prenatal'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy')]
S142-PMC3814422	PMC3814422	10/2013	S142-PMC3814422	['reassuringly, our data also SUGGEST that higher maternal Vitamin D status in Pregnancy is UNLIKELY to increase the risk of atopy in the offspring.']	[('INCOMPLETE_EVIDENCE', 28), ('PROBABLE_UNDERSTANDING', 90)]	2	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy')]
S4-PMC3827489	PMC3827489	10/2013	S4-PMC3827489	['the RISK FACTORS for Vitamin D insufficiency or deficiency in the pediatric population are season (winter), insufficient time spent outdoors, ethnicity (non-white), older age, more advanced stage of puberty, obesity, low milk Consumption, low socioeconomic status, and female gender.']	[('SUPERFICIAL_RELATIONSHIP', 4)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007631', 'feeding behavior', 226, 'consumption')]
S5-PMC3827489	PMC3827489	10/2013	S5-PMC3827489	['it is RECOMMENDED that all infants, children, and adolescents have a minimum daily intake of 400 iu (10 µg) of Vitamin D. SINCE the vitamin d status of the newborn is highly RELATED to maternal Vitamin D levels, optimal Vitamin D levels in the mother during Pregnancy SHOULD BE maintained.']	[('FUTURE_WORK', 6), ('PROBABLE_UNDERSTANDING', 122), ('SUPERFICIAL_RELATIONSHIP', 174), ('FUTURE_WORK', 268)]	4	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('GO_0007565', 'female pregnancy', 258, 'pregnancy')]
S13-PMC3827489	PMC3827489	10/2013	S13-PMC3827489	['in the Liver, vitamin d3is converted to 25-Hydroxyvitamin D (25[Oh]D), the MAJOR circulating form and BEST INDICATOR of Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 75), ('IMPORTANT_CONSIDERATION', 102), ('SUPERFICIAL_RELATIONSHIP', 107)]	3	[('UBERON_0002107', 'liver', 7, 'liver'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 40, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 61, '25[OH]D'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D')]
S34-PMC3827489	PMC3827489	10/2013	S34-PMC3827489	['a RECENT STUDY in hangzhou, china investigated the Vitamin D status of 6,008 chinese children aged 1 month to 16 years18).']	[('INCOMPLETE_EVIDENCE', 2)]	1	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
S39-PMC3827489	PMC3827489	10/2013	S39-PMC3827489	['seasonal variability has an IMPORTANT IMPACT on Vitamin D status24); the Vitamin D levels are lowest in winter, compared with spring, summer, and autumn20)BECAUSE MOST Vitamin D is produced following exposure to sunlight.']	[('IMPORTANT_CONSIDERATION', 28), ('SUPERFICIAL_RELATIONSHIP', 38), ('PROBABLE_UNDERSTANDING', 155), ('PROBABLE_UNDERSTANDING', 163)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 168, 'vitamin D')]
S40-PMC3827489	PMC3827489	10/2013	S40-PMC3827489	['a RECENT STUDY based on the knhanes iv 2008-2009 examining a total of 1,510 healthy adolescents aged 12-18 years (806 male subjects and 704 female subjects; mean age, 14.7 years) ASSESSED that the prevalence of Vitamin D deficiency (25[Oh]D<20.0 ng/ml) was 89.1% in spring, 53.7% in summer, 63.9% in autumn, and 90.5% in winter, and that independent PREDICTORS for low Vitamin D status were season (winter), higher education level, and a lack of Vitamin D supplementation22).']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 179), ('SUPERFICIAL_RELATIONSHIP', 350)]	3	[('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 233, '25[OH]D'), ('CHEBI_27300', 'vitamin D', 369, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 446, 'vitamin D')]
S44-PMC3827489	PMC3827489	10/2013	S44-PMC3827489	['girls are at particular RISK for low Vitamin D status, which HAS BEEN ASCRIBED to lifestyle factors such as frequent use of sunscreen or coverage of skin by clothing that COULD AFFECT cutaneous Synthesis Of Vitamin D6).']	[('IMPORTANT_CONSIDERATION', 24), ('INCOMPLETE_EVIDENCE', 61), ('PROBABLE_UNDERSTANDING', 70), ('INCOMPLETE_EVIDENCE', 171), ('SUPERFICIAL_RELATIONSHIP', 177)]	5	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0034205', 'amyloid-beta formation', 194, 'synthesis of ... D6'), ('CHEBI_33237', 'vitamin D4', 207, 'vitamin D6'), ('PR_000017299', 'VIP peptides', 207, 'vitamin D6')]
S47-PMC3827489	PMC3827489	10/2013	S47-PMC3827489	['low Vitamin D status in black Individuals MAY BE ATTRIBUTED MAINLY to decreased skin Synthesis Of Vitamin D due to greater skin pigmentation32)OR to the high prevalence of obesity in black populations25,33,34).']	[('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 49), ('PROBABLE_UNDERSTANDING', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143)]	4	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('NCBITaxon_1', 'root', 30, 'individuals'), ('GO_0030474', 'spindle pole body duplication', 85, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
S65-PMC3827489	PMC3827489	10/2013	S65-PMC3827489	['THUS, the QUESTION has BEEN RAISED as to WHETHER Vitamin D status INFLUENCES the RISK of Respiratory Tract infections such as common Viral infections or Pulmonary tuberculosis in children.']	[('PROBABLE_UNDERSTANDING', 0), ('EXPLICIT_QUESTION', 10), ('ANOMALY_CURIOUS_FINDING', 23), ('EXPLICIT_QUESTION', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('EXPLICIT_QUESTION', 41), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 81)]	8	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 89, 'respiratory tract'), ('NCBITaxon_1', 'root', 133, 'viral'), ('UBERON_0002048', 'lung', 153, 'pulmonary')]
S87-PMC3827489	PMC3827489	10/2013	S87-PMC3827489	['taken TOGETHER, THESE FINDINGS SUGGEST that PUBLIC HEALTH INTERVENTIONS such as outdoor activity and Vitamin D supplementation, which enhance Vitamin D status, MAY improve the health of adolescents with Metabolic PROBLEMS.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 31), ('IMPORTANT_CONSIDERATION', 44), ('FUTURE_WORK', 58), ('INCOMPLETE_EVIDENCE', 160), ('IMPORTANT_CONSIDERATION', 213)]	7	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('GO_0008152', 'metabolic process', 203, 'metabolic')]
S93-PMC3827489	PMC3827489	10/2013	S93-PMC3827489	['IN CONTRAST, OTHER OBSERVATIONAL studies SHOWED no correlation between maternal Vitamin D status and infant Birth weight68,69).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 41)]	4	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007567', 'parturition', 108, 'birth')]
S94-PMC3827489	PMC3827489	10/2013	S94-PMC3827489	['there are prospective studies SUGGESTING that higher maternal Vitamin D status during Pregnancy MAY lower the development of wheezing episodes in infancy70,71)or Lower Respiratory Tract infections72).']	[('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 96)]	2	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy'), ('UBERON_0009567', 'nail of pedal digit', 162, 'lower'), ('UBERON_0000065', 'respiratory tract', 168, 'respiratory tract')]
S95-PMC3827489	PMC3827489	10/2013	S95-PMC3827489	['ONE STUDY FOUND that higher maternal Vitamin D status during Pregnancy increased the development of atopic dermatitis or asthma in the offspring69), and another FOUND no significant associations between maternal late-Pregnancy Vitamin D status and either asthma or wheezing at the age of 6 years73).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 161)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy'), ('GO_0007565', 'female pregnancy', 217, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D')]
S96-PMC3827489	PMC3827489	10/2013	S96-PMC3827489	['IN GENERAL, the OBSERVATIONAL EVIDENCE LINKING low maternal Vitamin D status during Pregnancy to an increase in the risk of allergic diseases in the offspring SEEMS more convincing.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 39), ('ANOMALY_CURIOUS_FINDING', 159)]	5	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy')]
S1-PMC3873449	PMC3873449	12/2013	S1-PMC3873449	['LITTLE IS KNOWN about Vitamin D status in chinese Pregnant women.']	[('FULL_UNKNOWN', 0)]	1	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('GO_0007565', 'female pregnancy', 50, 'pregnant')]
S2-PMC3873449	PMC3873449	12/2013	S2-PMC3873449	['the PURPOSE of THIS STUDY was TO ASSESS the Vitamin D status of Pregnant women residing in beijing in winter AND EVALUATE the IMPACT of maternal factors on Serum 25-hydroxyvitamin d [25(Oh)D] levels.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 109), ('SUPERFICIAL_RELATIONSHIP', 126)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnant'), ('UBERON_0001977', 'blood serum', 156, 'serum'), ('CHEBI_71657', 'versiconol acetate', 183, '25(OH)D')]
S12-PMC3873449	PMC3873449	12/2013	S12-PMC3873449	['duration of sun exposure and the use of multivitamin were the most IMPORTANT DETERMINANTS for Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 67), ('SUPERFICIAL_RELATIONSHIP', 77)]	2	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
S14-PMC3873449	PMC3873449	12/2013	S14-PMC3873449	['OTHER measures MIGHT have to be taken for Pregnant women to improve their Vitamin D status in winter.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 15)]	2	[('GO_0007565', 'female pregnancy', 42, 'pregnant'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
S22-PMC3873449	PMC3873449	12/2013	S22-PMC3873449	['a RECENT STUDY systematically reviews randomized controlled trials and observational studies of maternal Vitamin D status in Pregnancy on the Extraskeletal health of the offspring [7].']	[('INCOMPLETE_EVIDENCE', 2)]	1	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007565', 'female pregnancy', 125, 'pregnancy'), ('UBERON_0001431', 'distal carpal bone 2', 142, 'extraskeletal')]
S29-PMC3873449	PMC3873449	12/2013	S29-PMC3873449	['FEW STUDIES have examined Vitamin D status in chinese Pregnant women.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007565', 'female pregnancy', 54, 'pregnant')]
S36-PMC3873449	PMC3873449	12/2013	S36-PMC3873449	['also, LITTLE IS KNOWN about maternal FACTORS INFLUENCING Vitamin D status in chinese Pregnant women.']	[('FULL_UNKNOWN', 6), ('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 45)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007565', 'female pregnancy', 85, 'pregnant')]
S39-PMC3873449	PMC3873449	12/2013	S39-PMC3873449	['there is considerable INTEREST in FACTORS that MAY INFLUENCE Vitamin D status in chinese Pregnant women.']	[('ANOMALY_CURIOUS_FINDING', 22), ('SUPERFICIAL_RELATIONSHIP', 34), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 51)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnant')]
S42-PMC3873449	PMC3873449	12/2013	S42-PMC3873449	['the PURPOSE of THIS STUDY was TO ASSESS the Vitamin D status in Pregnant women residing in beijing in winter.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 30)]	3	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnant')]
S44-PMC3873449	PMC3873449	12/2013	S44-PMC3873449	['the results SHOULD provide a BETTER UNDERSTANDING of the maternal FACTORS that INFLUENCE Vitamin D status during Pregnancy and help in raising AWARENESS as well as SUGGESTING STRATEGIES to prevent Vitamin D deficiency in china.']	[('FUTURE_WORK', 12), ('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 66), ('SUPERFICIAL_RELATIONSHIP', 79), ('IMPORTANT_CONSIDERATION', 143), ('FUTURE_WORK', 164), ('INCOMPLETE_EVIDENCE', 164), ('FUTURE_WORK', 175)]	8	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D')]
S62-PMC3873449	PMC3873449	12/2013	S62-PMC3873449	['ALTHOUGH there HAS BEEN DEBATE over WHICH level of Serum 25(Oh)D REFLECTS optimum Vitamin D status, it is GENERALLY ACCEPTED that Serum 25(Oh)d level of < 30ng/ml(75nmol/l) is the cut-off value for insufficiency [15-17], which is ASSOCIATED with maximal suppression of Parathyroid hormone [18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('EXPLICIT_QUESTION', 36), ('SUPERFICIAL_RELATIONSHIP', 65), ('PROBABLE_UNDERSTANDING', 106), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 230)]	9	[('UBERON_0001977', 'blood serum', 51, 'serum'), ('CHEBI_71657', 'versiconol acetate', 57, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('UBERON_0001977', 'blood serum', 130, 'serum'), ('CHEBI_63056', 'zinc cation', 136, '25(OH'), ('UBERON_0001132', 'parathyroid gland', 269, 'parathyroid')]
S65-PMC3873449	PMC3873449	12/2013	S65-PMC3873449	['for the analysis, in OUR STUDY we classified women into groups that defined Vitamin D status: severe Vitamin D deficiency: 25(Oh)D < 25 nmol/l; mild Vitamin D deficiency: 25 nmol/l ≤ 25(Oh)D < 50 nmol/l; Vitamin D insufficiency: 50 nmol/l ≤ 25(Oh)D < 75 nmol/l; and sufficiency: 25(Oh)D≥75 nmol/l.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 21)]	1	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 123, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 183, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 241, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 279, '25(OH)D')]
S92-PMC3873449	PMC3873449	12/2013	S92-PMC3873449	['the prevalence of Vitamin D deficiency (25(Oh)D < 50 nmol/l ) was 96.8% and no women had Serum 25(Oh)D concentrations ≥ 75 nmol/l which is CONSIDERED AS an OPTIMAL level.10.1371/journal.pone.0085081.t001\n\ncaption (table-wrap): table 1\nprevalence of Vitamin D deficiency and insufficiency in Pregnant women.25(Oh)D levelsnumber%severe deficiency5644.8(< 25 nmol/l )mild deficiency6552.0(25- < 50 nmol/l)insufficiency43.2(50 - < 75 nmol/l)sufficiency00.0(≥75 nmol/l)total125100.0\n\nmaternal characteristics and Vitamin D status\nmaternal characteristics, stratified by Vitamin D status, are shown intable 2.']	[('IMPORTANT_CONSIDERATION', 139), ('PROBABLE_UNDERSTANDING', 150), ('IMPORTANT_CONSIDERATION', 156)]	3	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 40, '25(OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 40, '25('), ('PR_000006444', 'diacylglycerol kinase delta', 46, 'D'), ('UBERON_0001977', 'blood serum', 89, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 98, 'OH)D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('GO_0007565', 'female pregnancy', 291, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 306, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 508, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 565, 'vitamin D')]
S96-PMC3873449	PMC3873449	12/2013	S96-PMC3873449	['degree or higher (n, %)38 (67.9)59 (85.5)p = 0.019income (rmb thousand yuan/month/Person, sd)5.10 (2.69)4.62 (2.28)p = 0.289multivitamin users (n, %)13 (23.2)45 (65.2)p < 0.001sun exposure (h/day, sd)0.76 (0.71)1.08 (0.68)p = 0.014computer usage ((h/day, sd)3.96 (2.56)3.64 (2.46)p = 0.494walking (min/day, sd)137.5 (94.47)133.3 (83.18)p = 0.796\n\nthe INFLUENCE of maternal factors on Vitamin D status\nforty eight women (38.4%) had sun exposure time ≤ 0.5 h/day.']	[('SUPERFICIAL_RELATIONSHIP', 351)]	1	[('NCBITaxon_10088', 'Mus <genus>', 82, 'person'), ('CHEBI_27300', 'vitamin D', 384, 'vitamin D')]
S108-PMC3873449	PMC3873449	12/2013	S108-PMC3873449	['TO DETERMINE WHETHER education levels IMPACT Vitamin D status, women were grouped by better educated women (with associate degree or higher) and less educated women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('SUPERFICIAL_RELATIONSHIP', 38)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D')]
S120-PMC3873449	PMC3873449	12/2013	S120-PMC3873449	['ONE STUDY OBSERVED the Vitamin D status in Pregnant women of several ethnic backgrounds who reside in the hague in the netherlands (52° n).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 10)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007565', 'female pregnancy', 43, 'pregnant')]
S166-PMC3873449	PMC3873449	12/2013	S166-PMC3873449	['OTHER STUDIES have ALSO SHOWN that the air pollution has a significant INFLUENCE on Vitamin D status [34,35].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 71)]	3	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
S168-PMC3873449	PMC3873449	12/2013	S168-PMC3873449	['THEREFORE OTHER EFFECTIVE measures MAY NEED to be taken to improve Vitamin D status in chinese Pregnant women.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 10), ('SUPERFICIAL_RELATIONSHIP', 16), ('INCOMPLETE_EVIDENCE', 35), ('FUTURE_WORK', 39)]	5	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007565', 'female pregnancy', 95, 'pregnant')]
S169-PMC3873449	PMC3873449	12/2013	S169-PMC3873449	['it HAS BEEN REPORTED that Vitamin D supplementation CAN EFFECTIVELY improve Vitamin D status [36].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 52), ('IMPORTANT_CONSIDERATION', 56)]	4	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
S182-PMC3873449	PMC3873449	12/2013	S182-PMC3873449	['HOWEVER, in Pregnant women, a study evaluating Plasma Vitamin D status HAS SHOWN that Vitamin D supplementation of <2000 iu/day is not EFFECTIVE in achieving sufficiency [42].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 135)]	3	[('GO_0007565', 'female pregnancy', 12, 'pregnant'), ('UBERON_0001969', 'blood plasma', 47, 'plasma'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
S197-PMC3873449	PMC3873449	12/2013	S197-PMC3873449	['this SUGGESTS that education levels are MOST LIKELY to INFLUENCE women’s health awareness RATHER than directly AFFECT Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 5), ('PROBABLE_UNDERSTANDING', 40), ('PROBABLE_UNDERSTANDING', 45), ('SUPERFICIAL_RELATIONSHIP', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('SUPERFICIAL_RELATIONSHIP', 111)]	6	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
S199-PMC3873449	PMC3873449	12/2013	S199-PMC3873449	['it HAS BEEN REPORTED that pre-gravid obese women had significantly lower Serum 25(Oh)D concentrations and dose-DEPENDENT RELATIONS between pre-Pregnancy bmi and maternal Vitamin D status [48].']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 111), ('SUPERFICIAL_RELATIONSHIP', 121)]	3	[('UBERON_0001977', 'blood serum', 73, 'serum'), ('CHEBI_71657', 'versiconol acetate', 79, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 79, '25(OH)D'), ('GO_0007565', 'female pregnancy', 143, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]
S203-PMC3873449	PMC3873449	12/2013	S203-PMC3873449	['THEREFORE, there were no enough subjects who were over weight or obese for analysis of the IMPACT of this factor on Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 91)]	2	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
S210-PMC3873449	PMC3873449	12/2013	S210-PMC3873449	['TO OUR KNOWLEDGE, THIS STUDY is the FIRST to report the INFLUENCE of maternal FACTORS on Vitamin D status in chinese Pregnant women.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 56), ('SUPERFICIAL_RELATIONSHIP', 78)]	5	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 117, 'pregnant')]
S211-PMC3873449	PMC3873449	12/2013	S211-PMC3873449	['this design allowed us TO ASSESS the IMPACT of these factors on Vitamin D status in chinese Pregnant women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('SUPERFICIAL_RELATIONSHIP', 37)]	2	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 92, 'pregnant')]
S213-PMC3873449	PMC3873449	12/2013	S213-PMC3873449	['IMPORTANTLY, we did have the INFORMATION on multivitamin supplement usage, which allowed us to SHOW that WHILE Pregnancy-specific multivitamin supplements improve the status in women at low risk of severe Vitamin D deficiency, it does not prevent women from Vitamin D deficiency in winter.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 105)]	4	[('GO_0007565', 'female pregnancy', 111, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 205, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
S214-PMC3873449	PMC3873449	12/2013	S214-PMC3873449	['measures MAY HAVE TO BE taken to improve Vitamin D status in Pregnant women in china.']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 13)]	2	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 61, 'pregnant')]
S66-PMC3882256	PMC3882256	1/2014	S66-PMC3882256	['maternal Vitamin C intake (which we CONSIDERED a POTENTIAL effect modifier of maternal iron status on offspring outcomes) was calculated from the Food frequency questionnaire as described above for iron intake.']	[('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 49)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin C'), ('PR_000004900', 'complement C3', 17, 'C'), ('CHEBI_33290', 'food', 146, 'food')]
S108-PMC3882256	PMC3882256	1/2014	S108-PMC3882256	['there was also no association between cord ferritin and either maternal dietary iron intake or hemoglobin.10.1371/journal.pone.0084684.t005\n\ncaption (table-wrap): table 5\nmultivariable linear regression estimates from stratified analyses for associations between Maternal Iron intake and hemoglobin in Pregnancy with offspring vascular indicators and body mass index with testing for EFFECT modification by maternal Vitamin C intake during Pregnancy and child sex (n\u200a=\u200a2958).offspring pulse wavevelocity (m/s)offspring Flow mediateddilatation (%)offspring systolic bloodpressure (mmhg)offspring diastolic bloodpressure (mmhg)offspring body massindex (kg/m2)b#99% ci®p*b#99% ci®p*b#99% ci®p*b#99% ci®p*b#99% ci®p* Maternal Pregnancy dietary iron intake (continuous) (per 10 mg/d) in participants with Vitamin Cintake >50 mg/day0−0.3, 0.30.50.6−0.2, 1.50.5−0.3−2.4, 1.90.70.8−1.1, 2.70.80−.0.7, 0.60.3in participants with Vitamin Cintake ≤50 mg/day0.2−0.7, 1.1−0.3−2.7, 2.1−1.8−7.3, 3.71.2−4.0, 6.41.2−1.1, 3.5males0.2−0.2, 0.60.40.6−0.4, 1.60.20.4−2.3, 3.10.90.9−1.5, 3.20.70.2−0.7, 1.00.4females0−0.4, 0.40.5−0.7, 1.6−0.9−3.8, 2.00.7−1.9, 3.30.1−0.9, 1.0 maternal Pregnancy Iron supplement use in participants with Vitamin cintake >50 mg/day0−0.1, 0.20.20.30, 0.70.1−0.8−1.7, 0.10.9−0.4−1.2, 0.50.90.1−0.2, 0.30.9in participants with Vitamin Cintake ≤50 mg/day0.2−0.1, 0.5−0.3−1.1, 0.6−0.8−2.7, 1.2−0.1−2.0, 1.80−0.8, 0.8males0.1−0.1, 0.20.80.2−0.2, 0.60.9−0.9−2.1, 0.30.7−0.9−1.9, 0.10.06−0.1−0.4, 0.30.5females0.1−0.1, 0.20.3−0.3, 0.7−0.7−1.9, 0.50.2−0.8, 1.30.1−0.3, 0.5 maternal early Pregnancy anemia (<11 g/dl) males0−0.4, 0.40.90.2−0.9, 1.20.3−1.3−4.1, 1.40.80.3−2.1, 2.60.40.4−0.5, 1.20.2females−0.1−0.5, 0.4−0.5−1.7, 0.7−1.0−4.1, 2.1−0.9−3.7, 1.8−0.2−1.2, 0.8\n#adjusting for potential CONFOUNDING characteristics: maternal age, pre-Pregnancy bmi, smoking in Pregnancy, educational qualification (AS a PROXY for socioeconomic status), parity, and maternal total energy intake in the models with dietary iron intake as exposure).']	[('SUPERFICIAL_RELATIONSHIP', 384), ('PROBLEM_COMPLICATION', 1794), ('PROBABLE_UNDERSTANDING', 1905), ('SUPERFICIAL_RELATIONSHIP', 1910)]	4	[('GO_0007618', 'mating', 263, 'maternal'), ('CHEBI_24870', 'ion', 272, 'iron'), ('GO_0007565', 'female pregnancy', 302, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 416, 'vitamin C'), ('GO_0007565', 'female pregnancy', 440, 'pregnancy'), ('GO_0007601', 'visual perception', 519, 'flow'), ('GO_0007618', 'mating', 713, 'Maternal'), ('GO_0007565', 'female pregnancy', 722, 'pregnancy'), ('CHEBI_64167', 'alpha-D-Manp-(1->3)-alpha-D-Manp-(1->2)-alpha-D-Manp', 800, 'vitamin Cintake'), ('CHEBI_64167', 'alpha-D-Manp-(1->3)-alpha-D-Manp-(1->2)-alpha-D-Manp', 920, 'vitamin Cintake'), ('GO_0007565', 'female pregnancy', 1164, 'pregnancy'), ('CHEBI_24870', 'ion', 1174, 'iron'), ('CHEBI_33229', 'vitamin (role)', 1215, 'vitamin'), ('CHEBI_64167', 'alpha-D-Manp-(1->3)-alpha-D-Manp-(1->2)-alpha-D-Manp', 1334, 'vitamin Cintake'), ('GO_0007565', 'female pregnancy', 1589, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1841, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1867, 'pregnancy')]
S95-PMC3901983	PMC3901983	1/2013	S95-PMC3901983	['SEVERAL STUDIES have presented an INCREASED RISK of bronchopulmonary dysplasia (bpd) in preterm infants with insufficient Vitamin A status [17].']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 34)]	2	[('CHEBI_27300', 'vitamin D', 122, 'vitamin A')]
S97-PMC3901983	PMC3901983	1/2013	S97-PMC3901983	['it HAS BEEN SUGGESTED that the Vitamin A status of Pregnant women CAN INFLUENCE Vitamin A stores in the fetus Liver [20].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 66), ('SUPERFICIAL_RELATIONSHIP', 70)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin A'), ('GO_0007565', 'female pregnancy', 51, 'pregnant'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin A'), ('UBERON_0002107', 'liver', 110, 'liver')]
S1-PMC3926113	PMC3926113	1/2014	S1-PMC3926113	['the Brain is one of the Organs containing the highest concentration of Vitamin C (Vitc) and Vitc deficiency during Foetal Development MAY place the Brain AT RISK of redox status imbalance.']	[('INCOMPLETE_EVIDENCE', 134), ('IMPORTANT_CONSIDERATION', 154)]	2	[('UBERON_0000955', 'brain', 4, 'brain'), ('UBERON_0000062', 'organ', 24, 'organs'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin C'), ('PR_000017299', 'VIP peptides', 82, 'VitC'), ('PR_000017299', 'VIP peptides', 92, 'VitC'), ('GO_0060324', 'face development', 115, 'foetal development'), ('UBERON_0000955', 'brain', 148, 'brain')]
S0-PMC3933171	PMC3933171	3/2014	S0-PMC3933171	['Vitamin D status of early preterm infants and the EFFECTS of Vitamin D intake during hospital stay\n\nabstract\n\nobjectives\nTO EVALUATE Vitamin D (vitd) status in early preterm infants (eptis) at Birth and during Birth hospitalisation on current vitd intake.']	[('SUPERFICIAL_RELATIONSHIP', 50), ('QUESTION_ANSWERED_BY_THIS_WORK', 121)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D'), ('GO_0007567', 'parturition', 193, 'birth'), ('GO_0007567', 'parturition', 210, 'birth')]
S12-PMC3933171	PMC3933171	3/2014	S12-PMC3933171	['introduction\nlow Vitamin D (vitd) status is a risk FACTOR for rickets and HAS BEEN ASSOCIATED with INCREASED prevalence of Respiratory infections and other adverse health outcomes in infants and children.12in response to the CONCERN about widespread childhood vitd deficiency, professional bodies have RECOMMENDED vitd intake of 400\u2005iu/ day for all infants.13the european society for paediatrics gastroenterology, hepatology and nutrition RECOMMENDS 800–1000\u2005iu/day for preterm infants.4based on BIOMARKERS of vitd status MOSTLY in adults, Serum 25-Hydroxyvitamin-D [25(Oh)D] concentration ≥50\u2005nmol/l was also RECOMMENDED.13HOWEVER, the functional benefit of this level is CONTROVERSIAL.']	[('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 74), ('SUPERFICIAL_RELATIONSHIP', 83), ('IMPORTANT_CONSIDERATION', 99), ('IMPORTANT_CONSIDERATION', 225), ('FUTURE_WORK', 302), ('FUTURE_WORK', 439), ('SUPERFICIAL_RELATIONSHIP', 496), ('PROBABLE_UNDERSTANDING', 522), ('FUTURE_WORK', 610), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 622), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 673)]	12	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 123, 'respiratory'), ('UBERON_0001977', 'blood serum', 540, 'serum'), ('CHEBI_67320', 'majusculamide A', 546, '25-hydroxyvitamin-D'), ('CHEBI_71657', 'versiconol acetate', 567, '25(OH)D')]
S20-PMC3991049	PMC3991049	11/2013	S20-PMC3991049	['BECAUSE 25-Hydroxyvitamin D crosses the Placenta,1and Fetal and Cord Blood levels of the new born Vitamin D status CORRELATE with the mother levels of Vitamin D,2,3a higher level of Vitamin D in the fetus MAY raise the concern of POSSIBLE POTENTIAL fetal harm.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 115), ('INCOMPLETE_EVIDENCE', 205), ('INCOMPLETE_EVIDENCE', 230), ('INCOMPLETE_EVIDENCE', 239)]	5	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 8, '25-hydroxyvitamin D'), ('UBERON_0001987', 'placenta', 40, 'placenta'), ('UBERON_0000922', 'embryo', 54, 'fetal'), ('UBERON_0002240', 'spinal cord', 64, 'cord'), ('UBERON_0000178', 'blood', 69, 'blood'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D')]
S68-PMC3991049	PMC3991049	11/2013	S68-PMC3991049	['SEVERAL STUDIES have REPORTED ASSOCIATION between infant size and Vitamin D status.13,14reduced concentration of 25-Hydroxyvitamin D in mothers during late Pregnancy is ASSOCIATED with reduced Whole Body and Lumbar-Spine bone Mineral content in their children at the age of 9 years.15several studies HYPOTHESIZED that low Prenatal and Perinatal Vitamin D concentrations AFFECT the functional characteristics of various Tissues of the body, which leads to greater risk in later Life of multiple sclerosis, cancer, Insulin-dependent diabetes mellitus and schizophrenia.16,17\nthe current RECOMMENDED dose of Vitamin D during Pregnancy DIFFERS in DIFFERENT parts of the world.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 169), ('INCOMPLETE_EVIDENCE', 300), ('SUPERFICIAL_RELATIONSHIP', 370), ('FUTURE_WORK', 585), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 632), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 643)]	9	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 113, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 156, 'pregnancy'), ('UBERON_0000468', 'multicellular organism', 193, 'whole body'), ('UBERON_0006074', 'lumbar region of vertebral column', 208, 'lumbar-spine'), ('CHEBI_46662', 'mineral', 226, 'mineral'), ('GO_0007565', 'female pregnancy', 322, 'prenatal'), ('GO_0036268', 'swimming', 335, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 335, 'perinatal'), ('CHEBI_27300', 'vitamin D', 345, 'vitamin D'), ('UBERON_0000479', 'tissue', 419, 'tissues'), ('UBERON_0000104', 'life cycle', 477, 'life'), ('PR_000045358', 'insulin family protein', 513, 'insulin'), ('CHEBI_27300', 'vitamin D', 605, 'vitamin D'), ('GO_0007565', 'female pregnancy', 622, 'pregnancy')]
S80-PMC3991049	PMC3991049	11/2013	S80-PMC3991049	['we NEED rct of Vitamin D supplementation with measurement of 25-Hydroxyvitamin D to determine the baseline status, the level achieved on supplementation with appropriate design to avoid any CONFOUNDER, and TO ASSESS WHAT is the appropriate level of Vitamin D during Pregnancy and in newborns with no complications or toxicity through out.']	[('FUTURE_WORK', 3), ('PROBLEM_COMPLICATION', 190), ('QUESTION_ANSWERED_BY_THIS_WORK', 206), ('EXPLICIT_QUESTION', 216)]	4	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 61, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('GO_0007565', 'female pregnancy', 266, 'pregnancy')]
S22-PMC4018592	PMC4018592	4/2014	S22-PMC4018592	['[17] in a study in nepal, multiple Micronutrient supplementations during Pregnancy did NOT reduce early infant mortality;[18] HOWEVER, it led TO improved folate status and reduced the prevalence of riboflavin, Vitamin B6, Vitamin B12, Folate and Vitamin D deficiencies.']	[('ANOMALY_CURIOUS_FINDING', 87), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 126), ('QUESTION_ANSWERED_BY_THIS_WORK', 142)]	3	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 35, 'micronutrient'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('CHEBI_33237', 'vitamin D4', 210, 'vitamin B6'), ('CHEBI_33279', 'vitamin D5', 222, 'vitamin B12'), ('CHEBI_30863', '5-azaorotic acid', 235, 'folate'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D')]
S4-PMC4045304	PMC4045304	2/2014	S4-PMC4045304	['there is also a GROWING body of RESEARCH that SUGGESTS that Vitamin D status EITHER in utero OR early in Life MAY BE a RISK for autism.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('INCOMPLETE_EVIDENCE', 110), ('IMPORTANT_CONSIDERATION', 119)]	6	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0000104', 'life cycle', 105, 'life')]
S184-PMC4045304	PMC4045304	2/2014	S184-PMC4045304	['there is a GROWING body of RESEARCH that SUGGESTS that Vitamin D status EITHER in utero OR early in Life MAY BE a RISK of autism.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72), ('INCOMPLETE_EVIDENCE', 105), ('IMPORTANT_CONSIDERATION', 114)]	6	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0000104', 'life cycle', 100, 'life')]
S190-PMC4045304	PMC4045304	2/2014	S190-PMC4045304	['Vitamin D and autism hypotheses\nseveral HYPOTHESES HAVE BEEN PROPOSED and tested to EXPLAIN the ASSOCIATION between Vitamin D status of mother and/or autistic child.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 40), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 61), ('PROBABLE_UNDERSTANDING', 84), ('SUPERFICIAL_RELATIONSHIP', 96)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
S191-PMC4045304	PMC4045304	2/2014	S191-PMC4045304	['investigators have ADVANCED the HYPOTHESIS that ASSOCIATION between Vitamin D and autism COULD BE EXPLAINED by the RELATIONSHIP between seasonality and low maternal Serum 25-Hydroxyvitamin D concentration (a valid INDICATOR of Vitamin D status) [73].']	[('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 48), ('INCOMPLETE_EVIDENCE', 89), ('PROBABLE_UNDERSTANDING', 98), ('SUPERFICIAL_RELATIONSHIP', 115), ('SUPERFICIAL_RELATIONSHIP', 214)]	7	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0001977', 'blood serum', 165, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 171, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D')]
S272-PMC4045304	PMC4045304	2/2014	S272-PMC4045304	['POOR maternal Vitamin D status or early childhood Vitamin deficiency or low activity of various Vitamin D RELATED enzymes MAY result in deficient activity in the Vitamin D system crucial for Brain Development.']	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 106), ('INCOMPLETE_EVIDENCE', 122)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 50, 'vitamin'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('GO_0007420', 'brain development', 191, 'brain development'), ('UBERON_0000955', 'brain', 191, 'brain')]
S15-PMC4072587	PMC4072587	6/2014	S15-PMC4072587	['dietary intake makes ONLY a small CONTRIBUTION to Vitamin D status[3],[7].']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 34)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
S127-PMC4072587	PMC4072587	6/2014	S127-PMC4072587	['SEVERAL STUDIES have FOUND an ASSOCIATION between maternal Vitamin D status and post-Natal growth, BUT results are INCONSISTENT and the majority are OBSERVATIONAL studies that HAVE been carried out in developed countries.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115), ('INCOMPLETE_EVIDENCE', 149), ('IMPORTANT_CONSIDERATION', 176)]	7	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('GO_0007567', 'parturition', 85, 'natal')]
S129-PMC4072587	PMC4072587	6/2014	S129-PMC4072587	['OTHER STUDIES HAVE SHOWN no differences in weight or height across quartiles of Vitamin D status during infancy[40].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14)]	2	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
S149-PMC4072587	PMC4072587	6/2014	S149-PMC4072587	['TO OUR KNOWLEDGE, OUR STUDY is the largest and MOST COMPREHENSIVE study on maternal Vitamin D status to be conducted in vietnam.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('PROBABLE_UNDERSTANDING', 47)]	3	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D')]
S42-PMC4106226	PMC4106226	7/2014	S42-PMC4106226	['[5] assessed Vitamin D status in egyptian children and adolescents with t1dm in order to clarify the prevalence of Vitamin D deficiency and its ROLE in the pathogenesis of t1dm.']	[('SUPERFICIAL_RELATIONSHIP', 144)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
S45-PMC4106226	PMC4106226	7/2014	S45-PMC4106226	['the authors conclude that PUBLIC HEALTH MESSAGE on the IMPORTANCE of Vitamin D status especially in diabetic children and adolescents, SHOULD BE disseminated to the public.']	[('IMPORTANT_CONSIDERATION', 26), ('IMPORTANT_CONSIDERATION', 40), ('IMPORTANT_CONSIDERATION', 55), ('FUTURE_WORK', 135)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
S4-PMC4113768	PMC4113768	7/2014	S4-PMC4113768	['commencing with a session of talks providing overviews of randomised trials of supplementation and global Vitamin D status, the meeting proceeded with a session on pre-Birth related Vitamin D RESEARCH—evolution, genetics & fertility—which led into several talks in the area of child health.']	[('INCOMPLETE_EVIDENCE', 192)]	1	[('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('GO_0007567', 'parturition', 168, 'birth'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D')]
S11-PMC4113768	PMC4113768	7/2014	S11-PMC4113768	['the existence of a u-shaped RELATIONSHIP between Vitamin D status and RISK of certain health outcomes was ANOTHER area of discussion.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('IMPORTANT_CONSIDERATION', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 106)]	3	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
S27-PMC4113768	PMC4113768	7/2014	S27-PMC4113768	['conclusions: sex-specific ASSOCIATIONS of 25(Oh)D3With Serum Lipids MAY exist in elderly subjects, and an adequate Vitamin D status MAY have a beneficial IMPACT on dyslipidaemia in elderly women.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 132), ('SUPERFICIAL_RELATIONSHIP', 154)]	4	[('CHEBI_86970', 'N-[(15Z)-tetracosenoyl]-tetradecasphing-4-enine-1-phosphoethanolamine', 42, '25(OH)D3with'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 42, '25(OH'), ('PR_000006480', 'type I iodothyronine deiodinase', 48, 'D3with'), ('UBERON_0001977', 'blood serum', 55, 'serum'), ('CHEBI_18059', 'lipid', 61, 'lipids'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
S55-PMC4113768	PMC4113768	7/2014	S55-PMC4113768	['conclusions: the PRESENT INVESTIGATION INDICATES that the Vitamin D status MAY function AS an INDEPENDENT positive PREDICTOR of sod, especially in non-obese, non-smoking elderly women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 75), ('PROBABLE_UNDERSTANDING', 88), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 115)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D')]
S84-PMC4113768	PMC4113768	7/2014	S84-PMC4113768	['background: Serum 25-Hydroxy Vitamin D (25(Oh)D) is the ESTABLISHED BIOMARKER of Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 68)]	2	[('UBERON_0001977', 'blood serum', 12, 'Serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 18, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 40, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
S101-PMC4113768	PMC4113768	7/2014	S101-PMC4113768	['Cyp2R1 and Cyp24A1 are capable of the 25-hydroxylation and 24-Hydroxylation, respectively, of Vitamin D. IT IS REPORTED that different Single Nucleotide Polymorphisms of Cyp2R1 and Cyp24A1 are ASSOCIATED with the 25(Oh)D status (wang, t.j., et al.']	[('PROBABLE_UNDERSTANDING', 105), ('INCOMPLETE_EVIDENCE', 111), ('SUPERFICIAL_RELATIONSHIP', 193)]	3	[('PR_000006110', 'cytochrome P450 27, mitochondrial', 0, 'CYP2R1'), ('PR_000006101', 'cytochrome P450 1A1', 11, 'CYP24A1'), ('GO_0006298', 'mismatch repair', 59, '24-hydroxylation'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('SO_0000694', 'SNP', 135, 'single nucleotide polymorphisms'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 170, 'CYP2R1'), ('PR_000006101', 'cytochrome P450 1A1', 181, 'CYP24A1'), ('CHEBI_71657', 'versiconol acetate', 213, '25(OH)D')]
S118-PMC4113768	PMC4113768	7/2014	S118-PMC4113768	['background: PREVIOUS RESEARCH has FOUND an ASSOCIATION between Vitamin D status (25-Hydroxy Vitamin D, 25(Oh)D) and volumetric bone Mineral density (vbmd) in caucasians (pedone, c., et al.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 43)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 81, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 103, '25(OH)D'), ('CHEBI_46662', 'mineral', 132, 'Mineral')]
S133-PMC4113768	PMC4113768	7/2014	S133-PMC4113768	['discussion: overall, in caucasians Vitamin D status APPEARS TO BE positively CORRELATED with radial and Tibial bone mass and size.']	[('ANOMALY_CURIOUS_FINDING', 52), ('SUPERFICIAL_RELATIONSHIP', 77)]	2	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('UBERON_0002101', 'limb', 104, 'tibial')]
S134-PMC4113768	PMC4113768	7/2014	S134-PMC4113768	['in south asians, Vitamin D status APPEARS TO BE positively CORRELATED with distal radial Trabecular density.']	[('ANOMALY_CURIOUS_FINDING', 34), ('SUPERFICIAL_RELATIONSHIP', 59)]	2	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('UBERON_0002363', 'dura mater', 89, 'trabecular')]
S136-PMC4113768	PMC4113768	7/2014	S136-PMC4113768	['FURTHER ANALYSIS is underway to assess POSSIBLE EXPLANATIONS for these varying RELATIONSHIPS between Vitamin D status and bone geometry by ethnicity and bone site.']	[('FUTURE_WORK', 0), ('INCOMPLETE_EVIDENCE', 39), ('PROBABLE_UNDERSTANDING', 48), ('SUPERFICIAL_RELATIONSHIP', 79)]	4	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
S149-PMC4113768	PMC4113768	7/2014	S149-PMC4113768	['THEREFORE, in THIS STUDY, ASSOCIATIONS between sleep quality and Vitamin D status in uk dwelling south asian (a) and caucasian (c) women were INVESTIGATED.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('SUPERFICIAL_RELATIONSHIP', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 142)]	4	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D')]
S162-PMC4113768	PMC4113768	7/2014	S162-PMC4113768	['ALTHOUGH there is SOME SUGGESTION that SELF-REPORTED sleep quality and sleep latency MIGHT be ASSOCIATED with Vitamin D status, results APPEAR TO vary by ethnicity.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 85), ('SUPERFICIAL_RELATIONSHIP', 94), ('ANOMALY_CURIOUS_FINDING', 136)]	7	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
S174-PMC4113768	PMC4113768	7/2014	S174-PMC4113768	['higher Vitamin D status (per 25 nmol/l increase in Serum/Plasma 25(Oh)D) was ASSOCIATED with IMPROVED Colorectal cancer specific survival (adjusted hr = 0.92 (95% ci: 0.86–0.98, p< 0.001) and overall survival (pooled adjusted hr = 0.87 (95% ci: 0.79–0.95, p< 0.001) in pooled estimates of 5 prospective studies.']	[('SUPERFICIAL_RELATIONSHIP', 77), ('IMPORTANT_CONSIDERATION', 93)]	2	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('UBERON_0001977', 'blood serum', 51, 'serum'), ('UBERON_0001969', 'blood plasma', 57, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 64, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 64, '25(OH ... D'), ('UBERON_0012652', 'colorectum', 102, 'colorectal')]
S178-PMC4113768	PMC4113768	7/2014	S178-PMC4113768	['conclusions: epidemiological EVIDENCE SUPPORTS an ASSOCIATION between increased Vitamin D status and improved survival amongst Colorectal cancer patients.']	[('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 50)]	3	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('UBERON_0012652', 'colorectum', 127, 'colorectal')]
S246-PMC4113768	PMC4113768	7/2014	S246-PMC4113768	['strategies aimed at improving maternal Vitamin D status during Pregnancy, especially in the winter months, ARE NEEDED and MIGHT decrease the RISK of lrti in early childhood.']	[('FUTURE_WORK', 107), ('INCOMPLETE_EVIDENCE', 122), ('IMPORTANT_CONSIDERATION', 141)]	3	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy')]
S286-PMC4113768	PMC4113768	7/2014	S286-PMC4113768	['BASED ON the Skeletal and non Skeletal EFFECTS of Vitamin D (vd), it SEEMS REASONABLE to optimize their vd status.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 39), ('ANOMALY_CURIOUS_FINDING', 69), ('PROBABLE_UNDERSTANDING', 75)]	5	[('UBERON_0004288', 'skeleton', 13, 'skeletal'), ('UBERON_0004288', 'skeleton', 30, 'skeletal'), ('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
S287-PMC4113768	PMC4113768	7/2014	S287-PMC4113768	['circulating vd is predominantly bound to Vitamin D Binding Protein (Vdbp) and Albumin (alb) and HENCE assessment of vd status during acute phase of critical illness MAY BE hazardous.']	[('PROBABLE_UNDERSTANDING', 96), ('INCOMPLETE_EVIDENCE', 165)]	2	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 41, 'vitamin D binding protein'), ('PR_000017279', 'testis-specific basic protein Y 1', 68, 'VDBP'), ('PR_000005908', 'alpha-crystallin B chain', 78, 'albumin')]
S389-PMC4113768	PMC4113768	7/2014	S389-PMC4113768	['background: RECENT STUDIES SUGGEST an ASSOCIATION between higher latitude, a PROXY of Vitamin D (vd) status, and allergic diseases.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 77)]	4	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
S407-PMC4113768	PMC4113768	7/2014	S407-PMC4113768	['jr.\nbackground: low Vitamin D (vd) status is common among patients with atopic dermatitis (ad) and SOME STUDIES SUGGEST an ASSOCIATION between vd deficiency and increased ad severity.']	[('INCOMPLETE_EVIDENCE', 99), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 123)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D')]
S443-PMC4113768	PMC4113768	7/2014	S443-PMC4113768	['IF Vitamin D status does indeed IMPACT on Neurodevelopment, seasonal variation in Lateral Ventricular diameter MIGHT be expected.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 111)]	3	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('GO_0007399', 'nervous system development', 42, 'neurodevelopment'), ('UBERON_0004086', 'brain ventricle', 82, 'lateral ventricular')]
S456-PMC4113768	PMC4113768	7/2014	S456-PMC4113768	['THEREFORE, the larger mean foetal Lateral Ventricle size SEEN in october–december is LIKELY to RELATE to adverse exposure in june–september, when maternal Vitamin D status is highest.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 57), ('PROBABLE_UNDERSTANDING', 85), ('SUPERFICIAL_RELATIONSHIP', 95)]	4	[('UBERON_0002285', 'telencephalic ventricle', 34, 'lateral ventricle'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D')]
S479-PMC4113768	PMC4113768	7/2014	S479-PMC4113768	['conclusions: (1) SINCE the use of supplements containing Vitamin A as well as Vitamin D is common, WHETHER in Cod Liver oil OR multi-vitamins, especially in developed countries, Vitamin A status is LIKELY to CONFOUND rcts of Vitamin D in westernized populations; (2) in particular, high Vitamin A Intakes COULD ACCOUNT for j or inverse u shaped curves for outcomes in rcts, AS COULD Gene polymorphisms increasing circulating Retinol/Retinoids; (3) CONVERSELY, poor Vitamin D status MAY BE expected to CONFOUND rcts of Vitamin A in developing countries; (4) as well as Vitamin A intakes, other lifestyle factors that are POTENTIAL CONFOUNDERS of the EFFECTS of Vitamin D SHOULD BE CONSIDERED in the PLANNING of FUTURE rcts of supplemental Vitamin D, including intakes of other Nutrients, tobacco usage, and also betel-chewing which MAY increase Catabolism Of Vitamin D and is a habit used by 10% of the world population.']	[('PROBABLE_UNDERSTANDING', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99), ('PROBABLE_UNDERSTANDING', 198), ('PROBLEM_COMPLICATION', 208), ('INCOMPLETE_EVIDENCE', 305), ('IMPORTANT_CONSIDERATION', 311), ('PROBABLE_UNDERSTANDING', 374), ('INCOMPLETE_EVIDENCE', 377), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 448), ('INCOMPLETE_EVIDENCE', 482), ('PROBLEM_COMPLICATION', 501), ('INCOMPLETE_EVIDENCE', 620), ('PROBLEM_COMPLICATION', 630), ('SUPERFICIAL_RELATIONSHIP', 649), ('FUTURE_WORK', 670), ('FUTURE_WORK', 680), ('FUTURE_WORK', 698), ('FUTURE_WORK', 710), ('INCOMPLETE_EVIDENCE', 831)]	19	[('CHEBI_27300', 'vitamin D', 57, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 110, 'cod'), ('UBERON_0002107', 'liver', 114, 'liver'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 225, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin A'), ('GO_0007631', 'feeding behavior', 297, 'intakes'), ('SO_0000704', 'gene', 383, 'gene'), ('CHEBI_26536', 'retinoic acid', 425, 'retinol'), ('CHEBI_26537', 'retinoid', 433, 'retinoids'), ('CHEBI_27300', 'vitamin D', 465, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 518, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 568, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 660, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 738, 'vitamin D'), ('CHEBI_33284', 'nutrient', 776, 'nutrients'), ('GO_0044851', 'hair cycle phase', 844, 'catabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 858, 'vitamin D')]
S599-PMC4113768	PMC4113768	7/2014	S599-PMC4113768	['this NOVEL FINDING SUPPORTED an A priori HYPOTHESIS that low uvb exposure and low Vitamin D status have an etiologic ROLE in Food allergy.']	[('FULL_UNKNOWN', 5), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 19), ('FUTURE_WORK', 32), ('INCOMPLETE_EVIDENCE', 41), ('SUPERFICIAL_RELATIONSHIP', 117)]	6	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_33290', 'food', 125, 'food')]
S602-PMC4113768	PMC4113768	7/2014	S602-PMC4113768	['the current analysis, based on two large cohort studies, EXAMINED the ASSOCIATION between peri-Pregnancy Vitamin D status in mothers, season of Birth of their offspring, and the risk of incident Peanut/Tree Nut (p/tn) allergy during childhood.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 57), ('SUPERFICIAL_RELATIONSHIP', 70)]	2	[('GO_0007565', 'female pregnancy', 95, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007567', 'parturition', 144, 'birth'), ('NCBITaxon_10088', 'Mus <genus>', 195, 'peanut'), ('NCBITaxon_33208', 'Metazoa', 202, 'tree nut')]
S622-PMC4113768	PMC4113768	7/2014	S622-PMC4113768	['conclusions: peri-Pregnancy Vitamin D status of mothers had a u-shaped ASSOCIATION with risk of p/tn allergy in offspring, with lowest risk for mothers with predicted 25Ohd between 80–85 nmol/l.']	[('SUPERFICIAL_RELATIONSHIP', 71)]	1	"[('GO_0007565', 'female pregnancy', 18, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 167, '25OHD')]"
S625-PMC4113768	PMC4113768	7/2014	S625-PMC4113768	['these prospective data SUPPORT the HYPOTHESIS that maternal Vitamin D status and child season of Birth CONTRIBUTE to RISK of childhood p/tn allergy.']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 103), ('IMPORTANT_CONSIDERATION', 117)]	4	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007567', 'parturition', 97, 'birth')]
S631-PMC4113768	PMC4113768	7/2014	S631-PMC4113768	['; kiely, m.\nbackground: obesity is a RISK FACTOR for low circulating 25-Hydroxy Vitamin D (25(Oh)D), which is the BIOMARKER of Vitamin D status, and there are CONSISTENT negative ASSOCIATIONS between 25(Oh)D and measures of adiposity in Adults and children.']	[('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 114), ('INCOMPLETE_EVIDENCE', 159), ('SUPERFICIAL_RELATIONSHIP', 179)]	4	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 69, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 91, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 200, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 206, 'D'), ('UBERON_0007023', 'adult organism', 237, 'adults')]
S633-PMC4113768	PMC4113768	7/2014	S633-PMC4113768	"[""maternal Vitamin D status in Pregnancy is ASSOCIATED with adiposity in the offspring: findings from the southampton women's survey.""]"	[('SUPERFICIAL_RELATIONSHIP', 42)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 29, 'pregnancy')]
S635-PMC4113768	PMC4113768	7/2014	S635-PMC4113768	['to date, LITTLE IS KNOWN about the EFFECT of low Vitamin D status at Birth on body composition during the Neonatal Period.']	[('FULL_UNKNOWN', 9), ('SUPERFICIAL_RELATIONSHIP', 35)]	2	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007567', 'parturition', 69, 'birth'), ('UBERON_0007221', 'neonate stage', 106, 'neonatal period')]
S664-PMC4113768	PMC4113768	7/2014	S664-PMC4113768	['we will continue to examine LINKS between Vitamin D status throughout early childhood and body composition.']	[('SUPERFICIAL_RELATIONSHIP', 28)]	1	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
S668-PMC4113768	PMC4113768	7/2014	S668-PMC4113768	['; dyall, l.; kepa, m.\nbackground: POSSIBLE CONSEQUENCES of low Vitamin D status include osteoporosis, falls, Cardiovascular disease, cancer, and diabetes, all of which are LIKELY to be more SERIOUS for men and women of advanced age (>80 years) compared to younger Adults.']	[('INCOMPLETE_EVIDENCE', 34), ('PROBLEM_COMPLICATION', 43), ('PROBABLE_UNDERSTANDING', 172), ('IMPORTANT_CONSIDERATION', 190)]	4	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 109, 'cardiovascular'), ('UBERON_0007023', 'adult organism', 264, 'adults')]
S669-PMC4113768	PMC4113768	7/2014	S669-PMC4113768	['the PURPOSE of THIS STUDY was TO ASSESS Vitamin D status and its cross-sectional DETERMINANTS in this vulnerable population.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 30), ('SUPERFICIAL_RELATIONSHIP', 81)]	4	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
S682-PMC4113768	PMC4113768	7/2014	S682-PMC4113768	['conclusions: frequent use of high-dose oral Vitamin D APPEARS TO HAVE resulted in a high overall Vitamin D status in older new zealanders, which is in STARK CONTRAST TO the relatively low status REPORTED PREVIOUSLY.']	[('ANOMALY_CURIOUS_FINDING', 54), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 151), ('INCOMPLETE_EVIDENCE', 195), ('INCOMPLETE_EVIDENCE', 204)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
S683-PMC4113768	PMC4113768	7/2014	S683-PMC4113768	['poorer Vitamin D status in māori MAY REFLECT darker skin tone or inequitable supply of oral Vitamin D. primary care practitioners SHOULD BE aware of the availability and common use of high-dose Vitamin D preparations, and SHOULD ask about over-the-counter Supplement use before prescribing Pharmaceutical Vitamin D in those of advanced aged.']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 37), ('FUTURE_WORK', 130), ('FUTURE_WORK', 222)]	4	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 256, 'supplement'), ('CHEBI_52217', 'pharmaceutical', 290, 'pharmaceutical'), ('CHEBI_27300', 'vitamin D', 305, 'vitamin D')]
S690-PMC4113768	PMC4113768	7/2014	S690-PMC4113768	['methods: as part of a study examining the IMPACT of the introduction of the london low emission zone on children’s Respiratory health, we ASSESSED the feasibility and acceptability of a Finger prick dried Blood spot method for assessing Vitamin D status (pro-diagnostics, london, uk).']	[('SUPERFICIAL_RELATIONSHIP', 42), ('QUESTION_ANSWERED_BY_THIS_WORK', 138)]	2	[('UBERON_0001004', 'respiratory system', 115, 'respiratory'), ('UBERON_0002389', 'manual digit', 186, 'finger'), ('UBERON_0000178', 'blood', 205, 'blood'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
S700-PMC4113768	PMC4113768	7/2014	S700-PMC4113768	['conclusions: a finger-prick dried Blood spot method is FEASIBLE and acceptable way of assessing the Vitamin D status of primary schoolchildren.']	[('PROBABLE_UNDERSTANDING', 55)]	1	[('UBERON_0000178', 'blood', 34, 'blood'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
S706-PMC4113768	PMC4113768	7/2014	S706-PMC4113768	['due to Renal dysfunction and altered Vitamin D Metabolism, the Serum Matrix and Metabolite composition of this patient cohort differ from the healthy, which represents a CHALLENGE in the accurate determination of their Vitamin D status.']	[('DIFFICULT_TASK', 170)]	1	[('UBERON_0002113', 'kidney', 7, 'renal'), ('CHEBI_28384', 'vitamin K', 37, 'Vitamin D'), ('GO_0046443', 'FAD metabolic process', 37, 'Vitamin D metabolism'), ('UBERON_0001977', 'blood serum', 63, 'serum'), ('GO_0031012', 'extracellular matrix', 69, 'matrix'), ('CHEBI_39382', 'flufenoxuron', 80, 'metabolite'), ('CHEBI_27300', 'vitamin D', 219, 'vitamin D')]
S712-PMC4113768	PMC4113768	7/2014	S712-PMC4113768	['subjects in each cohort were classified as having optimal or suboptimal Vitamin D status BASED on a cut-off of 30 ng/ml AS recommended by many EXPERTS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 89), ('PROBABLE_UNDERSTANDING', 120), ('PROBABLE_UNDERSTANDING', 143)]	3	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
S807-PMC4113768	PMC4113768	7/2014	S807-PMC4113768	['these transporters contain putative Vitamin D receptor response elements within their Promoters, SUGGESTING that amino acid transporters MAY BE Modulated by maternal Vitamin D status, a measure previously shown to RELATE to adiposity and bone health of the offspring.']	[('INCOMPLETE_EVIDENCE', 97), ('INCOMPLETE_EVIDENCE', 137), ('SUPERFICIAL_RELATIONSHIP', 214)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('SO_0000167', 'promoter', 86, 'promoters'), ('GO_0065007', 'biological regulation', 144, 'modulated'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D')]
S830-PMC4113768	PMC4113768	7/2014	S830-PMC4113768	['the patients were asked similar questions to ascertain their knowledge of Vitamin D and the level of information they had been given, whether they were taking or plan to take Supplements, whether any other young children in their family take Supplements and their AT-RISK status.']	[('IMPORTANT_CONSIDERATION', 264), ('IMPORTANT_CONSIDERATION', 267)]	2	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 175, 'supplements'), ('CHEBI_33341', 'titanium atom', 242, 'supplements')]
S877-PMC4113768	PMC4113768	7/2014	S877-PMC4113768	['the results of this review are at ODDS with findings from SOME observational studies, which have SUGGESTED that Vitamin D status AFFECTS Hand-grip strength.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 97), ('SUPERFICIAL_RELATIONSHIP', 129)]	4	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('UBERON_0002398', 'manus', 137, 'hand')]
S960-PMC4113768	PMC4113768	7/2014	S960-PMC4113768	['participants completed a questionnaire detailing potential demographic and lifestyle DETERMINANTS of Vitamin D status, and gave a Blood sample for analysis of Serum 25-Hydroxy Vitamin D (25(Oh)D) concentration and dna extraction.']	[('SUPERFICIAL_RELATIONSHIP', 85)]	1	[('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0000178', 'blood', 130, 'blood'), ('UBERON_0001977', 'blood serum', 159, 'serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 165, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 176, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 187, '25(OH)D')]
S978-PMC4113768	PMC4113768	7/2014	S978-PMC4113768	['; kiely, m.\nbackground: persistence of the INFLUENCE of Vitamin D status at Birth into Infancy HAS RECENTLY BEEN SHOWN (við streym, s., et al .']	[('SUPERFICIAL_RELATIONSHIP', 43), ('INCOMPLETE_EVIDENCE', 95)]	2	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007567', 'parturition', 76, 'birth'), ('UBERON_0000023', 'wing', 87, 'infancy')]
S986-PMC4113768	PMC4113768	7/2014	S986-PMC4113768	['ASSOCIATIONS between low circulating 25-Hydroxy Vitamin D (25(Oh)D), the BIOMARKER of Vitamin D status, and muscle weakness in older Adults (bischoff-ferrari, h.a., et al .']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 73)]	2	[('CHEBI_62218', '23,24-dihydrocucurbitacin D', 37, '25-hydroxy vitamin D'), ('CHEBI_71657', 'versiconol acetate', 59, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0007023', 'adult organism', 133, 'adults')]
S1050-PMC4113768	PMC4113768	7/2014	S1050-PMC4113768	['results: a 10 nmol/l increase in season-adjusted 25(Oh) Vitamin D was significantly ASSOCIATED with a 0.14 nmol/l increase ( p = 0.01) in Osteocalcin after adjustment for study, city, fasting status, daytime of Blood draw, personal characteristics (age, sex, bmi, detectable sex hormones, total physical activity level) and socioeconomic factors (parental education, single parent status and income).']	[('SUPERFICIAL_RELATIONSHIP', 84)]	1	[('CHEBI_30778', 'gallic acid', 49, '25(OH)'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 64, 'D'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 138, 'osteocalcin'), ('UBERON_0000178', 'blood', 211, 'blood')]
S1057-PMC4113768	PMC4113768	7/2014	S1057-PMC4113768	['; van schoor, n.; de jongh, r.t.; visser, m.; lips, p.\nbackground: physical activity (pa) MAY have an IMPACT on Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 90), ('SUPERFICIAL_RELATIONSHIP', 102)]	2	[('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
S1172-PMC4113768	PMC4113768	7/2014	S1172-PMC4113768	['studies FOUND INCONSISTENT results regarding the RELATIONSHIP of Vitamin D status and bone Mineral density (bmd) and quantitative ultrasound measurements (qus).']	[('INCOMPLETE_EVIDENCE', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('SUPERFICIAL_RELATIONSHIP', 49)]	3	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_46662', 'mineral', 91, 'mineral')]
S1173-PMC4113768	PMC4113768	7/2014	S1173-PMC4113768	['THIS STUDY has two AIMS: (1) TO EXAMINE the ASSOCIATION between Vitamin D status and qus and bmd; and (2) TO EXAMINE WHETHER gender, age, physical activity or body mass index (bmi) MODIFY these ASSOCIATIONS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('SUPERFICIAL_RELATIONSHIP', 44), ('QUESTION_ANSWERED_BY_THIS_WORK', 106), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 117), ('SUPERFICIAL_RELATIONSHIP', 181), ('SUPERFICIAL_RELATIONSHIP', 194)]	8	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D')]
S1176-PMC4113768	PMC4113768	7/2014	S1176-PMC4113768	['multiple linear regression was used TO ASSESS WHETHER Vitamin D status was RELATED to qus and bmd and WHETHER age (below vs. above the median age), gender, bmi (≤26.5 vs.>26.5 kg/m2) or physical activity (low vs. high) MODIFIED these RELATIONSHIPS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 36), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('SUPERFICIAL_RELATIONSHIP', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102), ('SUPERFICIAL_RELATIONSHIP', 219), ('SUPERFICIAL_RELATIONSHIP', 234)]	6	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
S1178-PMC4113768	PMC4113768	7/2014	S1178-PMC4113768	['low Vitamin D status (<25 nmol/l) was significantly ASSOCIATED with lower bua as COMPARED TO the reference group (≥50 nmol/l); this ASSOCIATION was modified by bmi ( p< 0.1).']	[('SUPERFICIAL_RELATIONSHIP', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('SUPERFICIAL_RELATIONSHIP', 132)]	3	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D')]
S1181-PMC4113768	PMC4113768	7/2014	S1181-PMC4113768	['in lasa-ii no associations of Vitamin D status with bua were FOUND.']	[('INCOMPLETE_EVIDENCE', 61)]	1	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D')]
S1183-PMC4113768	PMC4113768	7/2014	S1183-PMC4113768	['conclusion: the ASSOCIATION between Vitamin D status and bua was modified by bmi in the older cohorts, with the strongest EFFECT in Person with low-to-normal bmi (<26.5 kg/m2).']	[('SUPERFICIAL_RELATIONSHIP', 16), ('SUPERFICIAL_RELATIONSHIP', 122)]	2	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 132, 'person')]
S1184-PMC4113768	PMC4113768	7/2014	S1184-PMC4113768	['no significant associations of Vitamin D status and sos and bmd were FOUND.']	[('INCOMPLETE_EVIDENCE', 69)]	1	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
S1283-PMC4113768	PMC4113768	7/2014	S1283-PMC4113768	['; filteau, s.; trilok, kumar, g.\nbackground: Vitamin D status or parent-selected Vitamin D supplementation in infancy HAVE BEEN ASSOCIATED with better bone growth and mineralization in later childhood.']	[('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 128)]	2	[('CHEBI_28384', 'vitamin K', 45, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
S1288-PMC4113768	PMC4113768	7/2014	S1288-PMC4113768	['for the present divids-2 study we followed up the children, now aged 3–6 years, to measure bone structure and strength by quantitative ultrasound (qus).the PURPOSE of THE STUDY was (1) TO DETERMINE the EFFECT of Vitamin D supplementation in infancy on bone structure and strength of children aged 3–6 years; (2) TO EVALUATE the ASSOCIATION of current Vitamin D status with bone structure and strength.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 156), ('QUESTION_ANSWERED_BY_THIS_WORK', 167), ('QUESTION_ANSWERED_BY_THIS_WORK', 185), ('SUPERFICIAL_RELATIONSHIP', 202), ('QUESTION_ANSWERED_BY_THIS_WORK', 312), ('SUPERFICIAL_RELATIONSHIP', 328)]	6	[('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 351, 'vitamin D')]
S1386-PMC4113768	PMC4113768	7/2014	S1386-PMC4113768	['robust randomised controlled TRIALS ARE NEEDED to determine WHETHER improving Vitamin D status has a positive EFFECT on Insulin resistance OR OTHER pathophysiological indicators of dm including Beta-Cell function.']	[('FUTURE_WORK', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 60), ('SUPERFICIAL_RELATIONSHIP', 110), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('PR_000045358', 'insulin family protein', 120, 'insulin'), ('CL_0000349', 'extraembryonic cell', 194, 'beta-cell')]
S1444-PMC4113768	PMC4113768	7/2014	S1444-PMC4113768	['background: epidemiological studies SUGGEST an ASSOCIATION between Vitamin D status and Cardiovascular disease (cvd) RISK.']	[('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 47), ('IMPORTANT_CONSIDERATION', 117)]	3	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 88, 'cardiovascular')]
S1445-PMC4113768	PMC4113768	7/2014	S1445-PMC4113768	['suboptimal Vitamin D status APPEARS TO increase an Individual’s RISK of developing cvd, ALTHOUGH the OPTIMAL level REQUIRED is UNCLEAR and the results of intervention studies REMAIN HETEROGENEOUS and INCONCLUSIVE.']	[('ANOMALY_CURIOUS_FINDING', 28), ('IMPORTANT_CONSIDERATION', 64), ('ANOMALY_CURIOUS_FINDING', 88), ('IMPORTANT_CONSIDERATION', 101), ('IMPORTANT_CONSIDERATION', 115), ('FULL_UNKNOWN', 127), ('INCOMPLETE_EVIDENCE', 175), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('DIFFICULT_TASK', 182), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 200)]	10	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('NCBITaxon_1', 'root', 51, 'individual')]
S1448-PMC4113768	PMC4113768	7/2014	S1448-PMC4113768	['THIS STUDY INVESTIGATED WHETHER Vitamin D status PREDICTS ed and OTHER cvd MARKERS in Ageing men.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('SUPERFICIAL_RELATIONSHIP', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 65), ('SUPERFICIAL_RELATIONSHIP', 75)]	6	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007568', 'aging', 86, 'ageing')]
S1461-PMC4113768	PMC4113768	7/2014	S1461-PMC4113768	['there is a NEED for randomised controlled Human intervention trials to investigate WHETHER improving Vitamin D status in men ameliorates vasculogenic ed and reduces the RISK of cvd.']	[('FUTURE_WORK', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('IMPORTANT_CONSIDERATION', 169)]	3	[('NCBITaxon_9606', 'Homo sapiens', 42, 'human'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D')]
S1519-PMC4113768	PMC4113768	7/2014	S1519-PMC4113768	['THUS, Genetic FACTORS MAY help to identify who is MOST AT RISK of developing low Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 22), ('PROBABLE_UNDERSTANDING', 50), ('IMPORTANT_CONSIDERATION', 55)]	5	[('SO_0000704', 'gene', 6, 'genetic'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D')]
S1578-PMC4113768	PMC4113768	7/2014	S1578-PMC4113768	['AS MOST studies examining Vitamin D status and disease progression to date have included Individuals receiving art, the AIMS of THIS STUDY are TO EVALUATE the EFFECT of vitamin d status over time on immunological outcomes, such as cd4+ cell count and cd4+ percentage in hiv-infected Individuals with hiv viraemia.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 120), ('QUESTION_ANSWERED_BY_THIS_WORK', 128), ('QUESTION_ANSWERED_BY_THIS_WORK', 143), ('SUPERFICIAL_RELATIONSHIP', 159)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('NCBITaxon_1', 'root', 89, 'individuals'), ('NCBITaxon_1', 'root', 283, 'individuals')]
S1584-PMC4113768	PMC4113768	7/2014	S1584-PMC4113768	['generalised estimating equations will be used to examine the RELATIONSHIP between Vitamin D status and changes in absolute cd4+ cell count and cd4% over time.']	[('SUPERFICIAL_RELATIONSHIP', 61)]	1	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
S1597-PMC4113768	PMC4113768	7/2014	S1597-PMC4113768	['SEVERAL STUDIES have FOUND an INTERACTION between Vitamin D status and Antiretroviral therapy on calcaemic outcomes such as 1,25(Oh)2D and pth levels.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 30)]	3	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_65417', '(+)-aplysinillin', 71, 'antiretroviral'), ('CHEBI_82784', 'PVP38-Ag NP', 124, '1,25(OH)2D')]
S1613-PMC4113768	PMC4113768	7/2014	S1613-PMC4113768	['conclusions: tdf has the PREDOMINANT EFFECT on bmd irrespective of Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 25), ('SUPERFICIAL_RELATIONSHIP', 37)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
S1651-PMC4113768	PMC4113768	7/2014	S1651-PMC4113768	['conclusions: addition of intermittent bolus-dose Vitamin D supplementation to a daily low-dose regimen improved Vitamin D status in older Adults and their carers, BUT it did not influence risk of ari, and was less effective at preventing uri.']	[('ANOMALY_CURIOUS_FINDING', 163)]	1	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('UBERON_0007023', 'adult organism', 138, 'adults')]
S1710-PMC4113768	PMC4113768	7/2014	S1710-PMC4113768	['we THEREFORE CONDUCTED a study TO DETERMINE the prevalence of Vitamin D deficiency in a cohort of Adults with asthma who were screened for participation in a clinical trial in london, uk, and TO IDENTIFY CORRELATES of poor asthma Control and low Vitamin D status in this population.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 192), ('SUPERFICIAL_RELATIONSHIP', 204)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0007023', 'adult organism', 98, 'adults'), ('GO_0065007', 'biological regulation', 230, 'control'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D')]
S1713-PMC4113768	PMC4113768	7/2014	S1713-PMC4113768	['multivariate logistic regression was performed TO IDENTIFY POTENTIAL DETERMINANTS of Vitamin D status and of six clinical MARKERS of asthma Control (asthma Control test score, british Thoracic society treatment step, number of exacerbations in preceding 12 months, % predicted fev1, exhaled Nitric Oxide concentration and degree of reversibility of Airway obstruction following administration of inhaled Salbutamol).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 47), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 69), ('SUPERFICIAL_RELATIONSHIP', 122)]	4	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0065007', 'biological regulation', 140, 'control'), ('GO_0065007', 'biological regulation', 156, 'Control'), ('UBERON_0000915', 'thoracic segment of trunk', 184, 'Thoracic'), ('CHEBI_16480', 'nitric oxide', 291, 'nitric oxide'), ('UBERON_0001005', 'respiratory airway', 349, 'airway'), ('CHEBI_66163', 'samaderine Y', 404, 'salbutamol')]
S1718-PMC4113768	PMC4113768	7/2014	S1718-PMC4113768	['the MAJOR DETERMINANTS of Vitamin D status were season of sampling, sun-seeking behaviour, use of Vitamin D supplements and bmi.']	[('IMPORTANT_CONSIDERATION', 4), ('SUPERFICIAL_RELATIONSHIP', 10)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
S1793-PMC4113768	PMC4113768	7/2014	S1793-PMC4113768	['the AIM of the PRESENT STUDY was to follow up the study participants INVESTIGATING WHETHER the EFFECT of Vitamin D is restricted to the Prenatal period OR can also be SEEN in one or two year old infants INDEPENDENTLY from the maternal status during Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('SUPERFICIAL_RELATIONSHIP', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 152), ('INCOMPLETE_EVIDENCE', 167), ('SUPERFICIAL_RELATIONSHIP', 203)]	8	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007565', 'female pregnancy', 136, 'prenatal'), ('GO_0007565', 'female pregnancy', 249, 'pregnancy')]
S1805-PMC4113768	PMC4113768	7/2014	S1805-PMC4113768	['conclusions: OUR STUDY DEMONSTRATES that in east germany region (latitude: 51.3667) the Vitamin D status of one year old children is sufficient DUE to a general rickets prophylaxis, WHEREAS levels of two years old infants drop back to levels similar SEEN for Pregnant mothers.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('IMPORTANT_CONSIDERATION', 144), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('INCOMPLETE_EVIDENCE', 250)]	6	[('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('GO_0007565', 'female pregnancy', 259, 'pregnant')]
S1810-PMC4113768	PMC4113768	7/2014	S1810-PMC4113768	['DUE to pleiotropic Vitamin D EFFECTS it INFLUENCES NOT ONLY physical and mental health status BUT ALSO the quality of Life.']	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 29), ('SUPERFICIAL_RELATIONSHIP', 40), ('ANOMALY_CURIOUS_FINDING', 51), ('ANOMALY_CURIOUS_FINDING', 94)]	5	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('UBERON_0000104', 'life cycle', 118, 'life')]
S1866-PMC4113768	PMC4113768	7/2014	S1866-PMC4113768	['; lanham-new, s.\nbackground: maintaining a healthy Vitamin D status is PROBLEMATIC within the uk, largely DUE TO a combination of two FACTORS: required uv exposure for dermal Production Of Vitamin D is limited by seasonality and there are few Vitamin D-rich foods readily available within the diet.']	[('IMPORTANT_CONSIDERATION', 71), ('PROBLEM_COMPLICATION', 71), ('PROBABLE_UNDERSTANDING', 106), ('PROBLEM_COMPLICATION', 106), ('SUPERFICIAL_RELATIONSHIP', 134)]	5	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0018240', 'protein S-linked glycosylation via cysteine', 175, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D')]
S1867-PMC4113768	PMC4113768	7/2014	S1867-PMC4113768	['with the IMPLICATIONS of a low Vitamin D status KNOWN to include POOR bone and muscle function, establishing STRATEGIES to improve the availability of Vitamin D sources to the population is VITAL.']	[('IMPORTANT_CONSIDERATION', 9), ('INCOMPLETE_EVIDENCE', 48), ('IMPORTANT_CONSIDERATION', 65), ('FUTURE_WORK', 109), ('IMPORTANT_CONSIDERATION', 190)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D')]
S1879-PMC4113768	PMC4113768	7/2014	S1879-PMC4113768	['conclusions: THIS STUDY has IMPORTANT IMPLICATIONS for the FUTURE of Food fortification in helping to raise the Vitamin D status of the population.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('IMPORTANT_CONSIDERATION', 28), ('IMPORTANT_CONSIDERATION', 38), ('FUTURE_WORK', 59)]	4	[('CHEBI_33290', 'food', 69, 'food'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D')]
S1898-PMC4113768	PMC4113768	7/2014	S1898-PMC4113768	['maguire and colleagues SHOWED that most canadian children could maintain their Vitamin D status by Consuming Vitamin D fortified milk (maguire, j.l., et al.']	[('INCOMPLETE_EVIDENCE', 23)]	1	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D'), ('GO_0007631', 'feeding behavior', 99, 'consuming'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
S1899-PMC4113768	PMC4113768	7/2014	S1899-PMC4113768	[', pediatrics 2013, 131 , 739-753), SUGGESTING this COULD BE a more EFFECTIVE way of increasing and maintaining children’s Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 35), ('INCOMPLETE_EVIDENCE', 51), ('SUPERFICIAL_RELATIONSHIP', 67)]	3	[('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
S2024-PMC4113768	PMC4113768	7/2014	S2024-PMC4113768	['HOWEVER, a causal RELATIONSHIP between Vitamin D status and cardiovascular disease (cvd) risk factors, such as hypertension or an atherogenic Lipid profile, has NOT BEEN ESTABLISHED.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 18), ('FULL_UNKNOWN', 161)]	3	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_18059', 'lipid', 142, 'lipid')]
S2039-PMC4113768	PMC4113768	7/2014	S2039-PMC4113768	['; o’keane, m.; morrin, m.; molloy, e.; mccarthy, r.; onwuneme, c.; mcauliffe, f.; mcgowan, j.; toher, c.; murphy, n.; carroll, a.; flynn, m.\nbackground: we HAVE BEEN conducting clinical studies on Vitamin D status since the 1970s.']	[('INCOMPLETE_EVIDENCE', 156)]	1	[('CHEBI_27300', 'vitamin D', 197, 'vitamin D')]
S2040-PMC4113768	PMC4113768	7/2014	S2040-PMC4113768	['one of our early OBSERVATIONS was to note the primacy of Oral Intake over sunlight exposure in both the prevention and correction of hypovitaminosis d. we have DEMONSTRATED immense improvement in Vitamin D status since that time, DUE TO ready availability of low dose Vitamin D supplements and DUE TO the increasing fortification of foodstuffs with Vitamin D, starting with the fortification of milk in the mid-1980s.']	[('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 160), ('PROBABLE_UNDERSTANDING', 230), ('PROBABLE_UNDERSTANDING', 294)]	4	[('UBERON_0000165', 'mouth', 57, 'oral'), ('GO_0007631', 'feeding behavior', 62, 'intake'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 268, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 349, 'vitamin D')]
S2041-PMC4113768	PMC4113768	7/2014	S2041-PMC4113768	['despite these INTERVENTIONS, a substantial portion of our population is AT-RISK of suboptimal Vitamin D status.']	[('SUPERFICIAL_RELATIONSHIP', 14), ('IMPORTANT_CONSIDERATION', 72)]	2	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
S2043-PMC4113768	PMC4113768	7/2014	S2043-PMC4113768	['the RECENT iom 2011 report on dietary reference intakes for Calcium and Vitamin D for north america is apt for the irish population by providing the most COMPREHENSIVE EVIDENCE-BASED REPORT on Vitamin D.\nmethods: since 2007, we have conducted studies of Vitamin D status by measuring Serum 25-Hydroxy Vitamin D (25Ohd) in: preterm infants shortly after Birth ( n = 274) and after 15 weeks ( n = 148); paired term infants and mothers at Birth ( n = 39); children and adolescents from age 1 to 18 years ( n = 252); mothers during Pregnancy and infants at Birth divided according to winter Birth ( n = 30) and summer Birth ( n = 30); Pregnant mothers and ethnicity ( n = 116); patients attending an osteoporosis clinic ( n = 100); patients with cystic fibrosis ( n = 114); patients with multiple sclerosis ( n = 331) compared with healthy relatives ( n = 229) during winter months in 3 different regions in ireland; and patients with psoriasis undergoing phototherapy during the winter months ( n = 29) compared with controls ( n = 29).']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 154), ('INCOMPLETE_EVIDENCE', 168), ('QUESTION_ANSWERED_BY_THIS_WORK', 177), ('QUESTION_ANSWERED_BY_THIS_WORK', 177), ('INCOMPLETE_EVIDENCE', 183)]	6	"[('CHEBI_31341', 'calcium dihydroxide', 60, 'Calcium'), ('CHEBI_28384', 'vitamin K', 72, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 201, 'D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('UBERON_0001977', 'blood serum', 284, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 290, '25-hydroxy vitamin D'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 312, '25OHD'), ('GO_0007567', 'parturition', 353, 'birth'), ('GO_0007567', 'parturition', 436, 'birth'), ('GO_0007565', 'female pregnancy', 528, 'pregnancy'), ('GO_0007567', 'parturition', 553, 'birth'), ('GO_0007567', 'parturition', 587, 'birth'), ('GO_0007567', 'parturition', 614, 'birth'), ('GO_0007565', 'female pregnancy', 631, 'pregnant')]"
S2045-PMC4113768	PMC4113768	7/2014	S2045-PMC4113768	['results: prevalence for Vitamin D status (25Ohd nmol/l < 30, 30–50, > 50–125, > 125) was NOTED for the following groups: preterm at 3 weeks (14%, 65%, 21%, 0%); preterm at 15 weeks on 400 iu/day (3%, 11%, 86%, 8%); Pregnant women at term (21%, 34%, 45%, 0%) with Cord Blood at term (59%, 28%, 13%, 0%); children ranging from 1–18 years (22%, 33%, 45%, 0%); osteoporosis on 400–800 iu/day (1%, 8%, 91%, 2%); and cystic fibrosis on 400–1600 iu/d (23%, 28%, 49%, 3%); healthy Adults in winter (21%, 46%, 33%, 0%); and multiple sclerosis in winter (40%, 32%, 28%, 1%).']	[('ANOMALY_CURIOUS_FINDING', 89)]	1	"[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 42, '25OHD'), ('GO_0007565', 'female pregnancy', 215, 'pregnant'), ('UBERON_0002240', 'spinal cord', 263, 'cord'), ('UBERON_0000178', 'blood', 268, 'blood'), ('UBERON_0007023', 'adult organism', 473, 'adults')]"
S2046-PMC4113768	PMC4113768	7/2014	S2046-PMC4113768	['season had a distinct EFFECT on Vitamin D status during Pregnancy but not on Cord Blood.']	[('SUPERFICIAL_RELATIONSHIP', 22)]	1	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 56, 'pregnancy'), ('UBERON_0009472', 'axilla', 77, 'cord blood')]
S2049-PMC4113768	PMC4113768	7/2014	S2049-PMC4113768	['conclusions: Vitamin D status in ireland has improved immensely in ireland over the past 40 years, but TARGETED PUBLIC HEALTH policies of low-dose supplementation ARE NEEDED TO address AT-RISK groups, and mandated fortification to SAFE levels SHOULD maintain Vitamin D adequacy in the population.']	[('FUTURE_WORK', 103), ('IMPORTANT_CONSIDERATION', 112), ('FUTURE_WORK', 163), ('QUESTION_ANSWERED_BY_THIS_WORK', 174), ('IMPORTANT_CONSIDERATION', 185), ('IMPORTANT_CONSIDERATION', 231), ('FUTURE_WORK', 243)]	7	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D')]
S2051-PMC4113768	PMC4113768	7/2014	S2051-PMC4113768	['evaluation of Vitamin D status in RELATION to Immune Response in children with Lower Respiratory Tract infections\n\ngori, m.; vierucci, f.; fanos, m.; del pistoia, m.; erba, p.; saggese, g.\nbackground: in addition to its KNOWN Skeletal EFFECTS, Vitamin D plays a ROLE in the Regulation of Immune Response.']	[('SUPERFICIAL_RELATIONSHIP', 34), ('INCOMPLETE_EVIDENCE', 220), ('SUPERFICIAL_RELATIONSHIP', 235), ('SUPERFICIAL_RELATIONSHIP', 262)]	4	[('CHEBI_28384', 'vitamin K', 14, 'Vitamin D'), ('GO_0006955', 'immune response', 46, 'Immune Response'), ('UBERON_0009567', 'nail of pedal digit', 79, 'Lower'), ('UBERON_0000061', 'anatomical structure', 85, 'Respiratory Tract'), ('UBERON_0004288', 'skeleton', 226, 'skeletal'), ('CHEBI_27300', 'vitamin D', 244, 'vitamin D'), ('GO_0065007', 'biological regulation', 274, 'regulation'), ('GO_0006955', 'immune response', 288, 'immune response'), ('UBERON_0002405', 'immune system', 288, 'immune')]
S2052-PMC4113768	PMC4113768	7/2014	S2052-PMC4113768	['ONLY a LIMITED NUMBER OF studies EXAMINED the RELATIONSHIP between Vitamin D status and the prevalence and severity of Respiratory infections in children.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 7), ('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('SUPERFICIAL_RELATIONSHIP', 46)]	4	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 119, 'respiratory')]
S2053-PMC4113768	PMC4113768	7/2014	S2053-PMC4113768	['the AIM of THIS STUDY was TO ASSESS Vitamin D status in a group of children and adolescents with Lower Respiratory Tract infections and TO EVALUATE the RELATIONSHIP between 25-hydroxy vitamin d (25-Oh-D) levels and the severity of infection.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 136), ('SUPERFICIAL_RELATIONSHIP', 152)]	5	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0004905', 'articulation', 97, 'lower respiratory tract'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 195, '25-OH-D')]
S2115-PMC4113768	PMC4113768	7/2014	S2115-PMC4113768	['2008, 62 , 1079-1089) provides representative data TO ASSESS the current Vitamin D status of Adults in germany according to latitude of residence and to identify additional DETERMINANTS of Vitamin D status.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 51), ('SUPERFICIAL_RELATIONSHIP', 173)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0007023', 'adult organism', 93, 'adults'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D')]
S2132-PMC4113768	PMC4113768	7/2014	S2132-PMC4113768	['in multivariate analyses, sunnier season, lower latitude, higher Vitamin D intake index, Vitamin D supplement use, higher physical activity, lower bmi, and marital status were significantly ASSOCIATED with higher Serum 25(Oh)D levels in both sexes.']	[('SUPERFICIAL_RELATIONSHIP', 190)]	1	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('UBERON_0001977', 'blood serum', 213, 'serum'), ('CHEBI_71657', 'versiconol acetate', 219, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 219, '25 ... OH ... D')]
S2135-PMC4113768	PMC4113768	7/2014	S2135-PMC4113768	['the IDENTIFIED DETERMINANTS of Serum 25(Oh)D MAY CONTRIBUTE to tailor EVIDENCE-BASED RECOMMENDATIONS for optimizing Vitamin D status to specific target groups.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 15), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 70), ('FUTURE_WORK', 85)]	6	[('UBERON_0001977', 'blood serum', 31, 'serum'), ('CHEBI_71657', 'versiconol acetate', 37, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 37, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
S2146-PMC4113768	PMC4113768	7/2014	S2146-PMC4113768	['Vitamin D deficiency was CONFIRMED by measuring the Serum Calcium and 25(Oh)D3, an indicator for Vitamin D status.vitamin D deficient Rats had undetectable Serum 25(Oh)D3And hypocalcaemia.']	[('INCOMPLETE_EVIDENCE', 25)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 52, 'serum'), ('CHEBI_22313', 'alkaline earth metal atom', 58, 'calcium'), ('CHEBI_62946', 'ammonium sulfate', 70, '25(OH)D3'), ('PR_000029655', '28S rRNA (cytosine-C(5))-methyltransferase', 70, '25(OH)D3'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 122, 'D'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 134, 'rats'), ('UBERON_0001977', 'blood serum', 156, 'serum'), ('CHEBI_76945', 'manool', 162, '25(OH)D3and')]
S2292-PMC4113768	PMC4113768	7/2014	S2292-PMC4113768	['age and milk Consumption were the significant PREDICTORS of Vitamin D status, with 33.9% of variance perceived ( p< 0.001).']	[('SUPERFICIAL_RELATIONSHIP', 46)]	1	[('GO_0007631', 'feeding behavior', 13, 'consumption'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D')]
S2303-PMC4113768	PMC4113768	7/2014	S2303-PMC4113768	['in THIS cross-SECTIONAL case-CONTROL STUDY, we DESCRIBED the differences and ASSOCIATIONS in the Metabolic patterns of Adult saudis with and without hypothyroid dysfunction in RELATION to their Vitamin D status, pth, calcium and Lipid profile.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('INCOMPLETE_EVIDENCE', 47), ('SUPERFICIAL_RELATIONSHIP', 77), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('GO_0008152', 'metabolic process', 97, 'metabolic'), ('UBERON_0007023', 'adult organism', 119, 'adult'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_18059', 'lipid', 229, 'lipid')]
S2311-PMC4113768	PMC4113768	7/2014	S2311-PMC4113768	['the ASSOCIATION between pth and Cholesterol levels as well as the inverse ASSOCIATION between Vitamin D status and Ft3 NEEDS TO BE reassessed prospectively on a larger scale to confirm THESE FINDINGS.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 74), ('IMPORTANT_CONSIDERATION', 119), ('INCOMPLETE_EVIDENCE', 185)]	4	[('CHEBI_16113', 'cholesterol', 32, 'cholesterol'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('PR_000007702', 'galactoside alpha-(1,2)-fucosyltransferase 1', 115, 'FT3')]
S2346-PMC4113768	PMC4113768	7/2014	S2346-PMC4113768	['in THIS INTERVENTIONAL STUDY we measured the EFFECTS of improving Vitamin D status on bone biochemical MARKERS in overweight and obese Adult saudis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 45), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('UBERON_0007023', 'adult organism', 135, 'adult')]
S2398-PMC4113768	PMC4113768	7/2014	S2398-PMC4113768	['eligible studies included Pregnant women and their offspring, and one or more RELEVANT exposures (either assessment of Vitamin D status (dietary intake, sunlight exposure, circulating 25(Oh)D) or supplementation of participants with Vitamin D or Vitamin D containing Food e.g., oily fish) and outcomes (offspring birth weight, Birth length, Head circumference, bone mass, anthropometry and body composition, risk of asthma and atopy, small for Gestational dates, Preterm Birth, type 1 diabetes, low Birth weight, Serum calcium concentration, Blood pressure and rickets).']	[('IMPORTANT_CONSIDERATION', 78)]	1	[('GO_0007565', 'female pregnancy', 26, 'pregnant'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 184, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 184, '25(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 190, 'D'), ('CHEBI_27300', 'vitamin D', 233, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D'), ('CHEBI_33290', 'food', 267, 'food'), ('GO_0007567', 'parturition', 327, 'birth'), ('UBERON_0000033', 'head', 341, 'head'), ('GO_0007565', 'female pregnancy', 444, 'gestational'), ('GO_0007565', 'female pregnancy', 463, 'preterm birth'), ('GO_0007567', 'parturition', 499, 'birth'), ('UBERON_0001977', 'blood serum', 513, 'serum'), ('UBERON_0000178', 'blood', 542, 'blood')]
S2402-PMC4113768	PMC4113768	7/2014	S2402-PMC4113768	['indeed, no convincing evidence was FOUND for any association between maternal Vitamin D status and offspring asthma, atopy, type 1 diabetes or Blood pressure.']	[('INCOMPLETE_EVIDENCE', 35)]	1	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('UBERON_0000178', 'blood', 143, 'blood')]
S2404-PMC4113768	PMC4113768	7/2014	S2404-PMC4113768	['conclusions: there was MODEST EVIDENCE TO SUPPORT ASSOCIATIONS between maternal 25(oh)-Vitamin D status and offspring Serum Calcium concentrations, Birth weight and bone mass.']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 50)]	2	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0001977', 'blood serum', 118, 'serum'), ('CHEBI_22313', 'alkaline earth metal atom', 124, 'calcium'), ('GO_0007567', 'parturition', 148, 'birth')]
S2414-PMC4113768	PMC4113768	7/2014	S2414-PMC4113768	['we have PREVIOUSLY DEMONSTRATED that maternal lifestyle, body build, physical activity and Vitamin D status during Pregnancy are ASSOCIATED with offspring bone mass.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 129)]	3	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy')]
S2498-PMC4113768	PMC4113768	7/2014	S2498-PMC4113768	['KEY modifiable DETERMINANTS of achievement of peak bone mass are calcium intake, physical activity and Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 15)]	2	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
S2499-PMC4113768	PMC4113768	7/2014	S2499-PMC4113768	['female ballet dancers and gymnasts are known to have POOR Vitamin D status POSSIBLY DUE TO heavy indoor training schedules limiting sun exposure, however it is LIKELY that their high levels of physical activity ameliorate the DETRIMENTAL EFFECTS of low Vitamin D and dietary Calcium.']	[('IMPORTANT_CONSIDERATION', 53), ('INCOMPLETE_EVIDENCE', 75), ('PROBABLE_UNDERSTANDING', 84), ('PROBLEM_COMPLICATION', 84), ('PROBABLE_UNDERSTANDING', 160), ('IMPORTANT_CONSIDERATION', 226), ('SUPERFICIAL_RELATIONSHIP', 238)]	7	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 253, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 275, 'calcium')]
S2521-PMC4113768	PMC4113768	7/2014	S2521-PMC4113768	['background: understanding of the EFFECT of Vitamin D supplementation on Plasma 25(Oh)D levels is ESSENTIAL to optimizing nutritional status and health.']	[('SUPERFICIAL_RELATIONSHIP', 33), ('IMPORTANT_CONSIDERATION', 97)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 72, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 79, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 79, '25 ... OH ... D')]
S2547-PMC4113768	PMC4113768	7/2014	S2547-PMC4113768	['we applied gee regression methods to quantify the ASSOCIATIONS of Vitamin D supplementation and 25(Oh)D with Serum Calcium, while considering the CONFOUNDING POTENTIAL of age, gender, and body weight status.']	[('SUPERFICIAL_RELATIONSHIP', 50), ('PROBLEM_COMPLICATION', 146), ('INCOMPLETE_EVIDENCE', 158)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 96, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 102, 'D'), ('UBERON_0001977', 'blood serum', 109, 'serum'), ('CHEBI_22313', 'alkaline earth metal atom', 115, 'calcium')]
S2560-PMC4113768	PMC4113768	7/2014	S2560-PMC4113768	['background: SUBOPTIMAL Vitamin D status MAY BE ASSOCIATED with a variety of adverse health outcomes.']	[('IMPORTANT_CONSIDERATION', 12), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 47)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D')]
S2566-PMC4113768	PMC4113768	7/2014	S2566-PMC4113768	['eighty-eight Single Nucleotide Polymorphisms (Snps) in 41 candidate Genes RELATED to Vitamin D status were genotyped using sequenom massarray technology.']	[('SUPERFICIAL_RELATIONSHIP', 74)]	1	[('SO_0000694', 'SNP', 13, 'single nucleotide polymorphisms'), ('SO_0000694', 'SNP', 46, 'SNPs'), ('SO_0000704', 'gene', 68, 'genes'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
S2582-PMC4113768	PMC4113768	7/2014	S2582-PMC4113768	['low Vitamin D status is PREVALENT among industrialized populations.']	[('IMPORTANT_CONSIDERATION', 24)]	1	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D')]
S2584-PMC4113768	PMC4113768	7/2014	S2584-PMC4113768	['to date, the INFLUENCE of Vitamin D status during Gestation on long-term risk of t1d has not been widely studied.']	[('SUPERFICIAL_RELATIONSHIP', 13)]	1	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007565', 'female pregnancy', 50, 'gestation')]
S2616-PMC4113768	PMC4113768	7/2014	S2616-PMC4113768	['we INVESTIGATED the EFFECT of Vitamin D supplementation on the Metabolic status of Individuals at increased risk of developing t2d.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 20)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0008152', 'metabolic process', 63, 'metabolic'), ('NCBITaxon_1', 'root', 83, 'individuals')]
S2637-PMC4113768	PMC4113768	7/2014	S2637-PMC4113768	['; inskip, h.m.; cooper, c.; harvey, n.c.\nbackground: maternal 25-Hydroxy-Vitamin D (25(Oh)d) status in Pregnancy HAS BEEN ASSOCIATED with offspring Bone Development and adiposity.']	[('INCOMPLETE_EVIDENCE', 113), ('SUPERFICIAL_RELATIONSHIP', 122)]	2	[('CHEBI_70487', '(-)-sanguinolignan C', 62, '25-hydroxy-'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 84, '25(OH'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy'), ('GO_0048539', 'bone marrow development', 148, 'bone development')]
S2663-PMC4113768	PMC4113768	7/2014	S2663-PMC4113768	['HOWEVER, there is uncertainty as to WHETHER low Vitamin D status is a TRUE cause of these outcomes, OR simply a MARKER of OTHER lifestyle VARIABLES.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('PROBABLE_UNDERSTANDING', 70), ('SUPERFICIAL_RELATIONSHIP', 112), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('SUPERFICIAL_RELATIONSHIP', 138)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
S2681-PMC4113768	PMC4113768	7/2014	S2681-PMC4113768	['we were interested to see HOW this group of non-typical “patients” Vitamin D status compared with our local inner city birmingham gp population.']	[('EXPLICIT_QUESTION', 26)]	1	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
S2692-PMC4113768	PMC4113768	7/2014	S2692-PMC4113768	['there was a RELATIONSHIP between Vitamin D status and ethnicity for Serum and dbs samples ( p< 0.001 and p< 0.001 respectively) with caucasians more LIKELY to have an adequate status and asians more LIKELY to be severely deficient.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('PROBABLE_UNDERSTANDING', 149), ('PROBABLE_UNDERSTANDING', 199)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0001977', 'blood serum', 68, 'serum')]
S2773-PMC4113768	PMC4113768	7/2014	S2773-PMC4113768	['conclusions: the free and bio-available forms of 25(Oh)D MAY BE a more INFORMATIVE measure of Vitamin D status than total 25(Oh)d. adjustment for dbp phenotype MAY improve this FURTHER.']	[('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 160), ('FUTURE_WORK', 177), ('INCOMPLETE_EVIDENCE', 177)]	5	[('CHEBI_71657', 'versiconol acetate', 49, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 122, '25(OH')]
S2813-PMC4113768	PMC4113768	7/2014	S2813-PMC4113768	['as OTHER FACTORS in today’s modern lifestyles (e.g., sunscreen/Cosmetic use, indoor occupations, lack of outdoor activities) further limit such synthesis during the summer months, the general population is becoming increasingly reliant on dietary sources of Vitamin D to maintain adequate Vitamin D status (gillie, o. mol.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('SUPERFICIAL_RELATIONSHIP', 9)]	2	[('GO_0007620', 'copulation', 63, 'cosmetic'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 289, 'vitamin D')]
S2820-PMC4113768	PMC4113768	7/2014	S2820-PMC4113768	['methods: a total of 49 apparently healthy Adults ( n = 23 males; n = 26 female) aged 18–65 years consented to take part in the current study, conducted between february and march 2013 to remove the CONFOUNDING EFFECT of sun exposure on circulating MARKERS of Vitamin D status.']	[('PROBLEM_COMPLICATION', 198), ('SUPERFICIAL_RELATIONSHIP', 210), ('SUPERFICIAL_RELATIONSHIP', 248)]	3	[('UBERON_0007023', 'adult organism', 42, 'adults'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D')]
S2878-PMC4113768	PMC4113768	7/2014	S2878-PMC4113768	['RECENTLY, Vitamin D status during icu admission HAS BEEN shown to be ASSOCIATED with the RISK of short-term (30-, 60-, and 90-day) and long-term (1-year) mortality in critically ill patients.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 48), ('SUPERFICIAL_RELATIONSHIP', 69), ('IMPORTANT_CONSIDERATION', 89)]	4	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D')]
S2936-PMC4113768	PMC4113768	7/2014	S2936-PMC4113768	['background: adequate Vitamin D status is an IMPORTANT modulator of Immunity against mycobacterium tb.']	[('IMPORTANT_CONSIDERATION', 44)]	1	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007566', 'embryo implantation', 67, 'immunity')]
S2992-PMC4113768	PMC4113768	7/2014	S2992-PMC4113768	['assessment and correction of Vitamin D status SHOULD BE CONSIDERED in addition to the current routine treatment of secondary hyperparathyroidism.']	[('FUTURE_WORK', 46), ('FUTURE_WORK', 56)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D')]
S3112-PMC4113768	PMC4113768	7/2014	S3112-PMC4113768	['adjusting for hiv status, season, site, sex, weight-for age z score, breastfeeding, type of house, mother with previous tb diagnosis, age at Vitamin D determination, and inh/placebo treatment arm, vdid was INDEPENDENTLY ASSOCIATED with any tb (ahr 1.75, 95% ci 1.01–3.05; p = 0.046) as well as any tb or death (ahr 1.76, 95% ci 1.03–3.00; p = 0.038).']	[('SUPERFICIAL_RELATIONSHIP', 206), ('SUPERFICIAL_RELATIONSHIP', 220)]	2	[('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
S3122-PMC4113768	PMC4113768	7/2014	S3122-PMC4113768	['the OBJECTIVE of THIS RETROSPECTIVE case-CONTROL STUDY was TO FURTHER INVESTIGATE the POSSIBLE LINK between type i hypersensitivity and Vitamin D status in an inner-city population KNOWN to have a high prevalence of Vitamin D deficiency.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('QUESTION_ANSWERED_BY_THIS_WORK', 41), ('QUESTION_ANSWERED_BY_THIS_WORK', 59), ('INCOMPLETE_EVIDENCE', 86), ('SUPERFICIAL_RELATIONSHIP', 95), ('INCOMPLETE_EVIDENCE', 181)]	7	[('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D')]
S3130-PMC4113768	PMC4113768	7/2014	S3130-PMC4113768	['conclusions: THESE FINDINGS CONTRAST WITH OTHER RECENT STUDIES which SHOWED clear ASSOCIATIONS between Ige levels and Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 82)]	6	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 103, 'IgE'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
S3136-PMC4113768	PMC4113768	7/2014	S3136-PMC4113768	['DEPENDING ON the cutoff chosen, dietary intakes of Vitamin D MAY OR MAY NOT provide sufficient IMPACT upon Vitamin D status, in improving levels of 25(Oh)d. purpose: we SOUGHT TO EXAMINE WHETHER a supplemental dose of 10 mcg (400 iu) as found in fortified foods OR as a supplement, has a measurable IMPACT on Vitamin D status, as defined by improving status from below to above 50 nmol/l, or from less than 30 nmol/l to above 30 nmol/l.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 61), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 65), ('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 95), ('QUESTION_ANSWERED_BY_THIS_WORK', 169), ('QUESTION_ANSWERED_BY_THIS_WORK', 176), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 187), ('SUPERFICIAL_RELATIONSHIP', 299)]	9	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 148, '25(OH'), ('CHEBI_27300', 'vitamin D', 309, 'vitamin D')]
S3147-PMC4113768	PMC4113768	7/2014	S3147-PMC4113768	['Serum Vitamin D concentrations are ASSOCIATED with markers of Intestinal BUT NOT systemic inflammation in crohn’s disease in remission\n\nraftery, t.; smith, s.; o’morain, c.; mahmud, n.; healy, m.; cox, g.; mcnamara, d.; o’sullivan, m.\nbackground: there are ESTABLISHED ASSOCIATIONS between Vitamin D (vitd) status and crohn’s disease (cd).']	[('SUPERFICIAL_RELATIONSHIP', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 73), ('INCOMPLETE_EVIDENCE', 257), ('SUPERFICIAL_RELATIONSHIP', 269)]	4	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_28384', 'vitamin K', 6, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 6, 'Vitamin D'), ('UBERON_0000160', 'intestine', 62, 'Intestinal'), ('CHEBI_27300', 'vitamin D', 290, 'vitamin D')]
S3180-PMC4113768	PMC4113768	7/2014	S3180-PMC4113768	['background: there are FEW STUDIES that look AT Vitamin D status in children living in sunny climates AS it is ASSUMED that they receive adequate Vitamin D from sun exposure.']	[('INCOMPLETE_EVIDENCE', 22), ('IMPORTANT_CONSIDERATION', 44), ('PROBABLE_UNDERSTANDING', 101), ('PROBABLE_UNDERSTANDING', 110)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
S3181-PMC4113768	PMC4113768	7/2014	S3181-PMC4113768	['purpose: TO DETERMINE Vitamin D status and its PREDICTORS among school children aged 11–18 years in ethiopia.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('SUPERFICIAL_RELATIONSHIP', 47)]	2	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D')]
S3194-PMC4113768	PMC4113768	7/2014	S3194-PMC4113768	['; pearce, s.; rasvi, s.; jagger, c.\nbackground: DESPITE RECENT concerns about the high prevalence of low Vitamin D status in much of the british Adult and pediatric population, there is a dearth of data on Vitamin D status and its PREDICTORS in very old Adults, a sub-group of the population which is at INCREASED RISK of POOR Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 48), ('ANOMALY_CURIOUS_FINDING', 48), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 231), ('IMPORTANT_CONSIDERATION', 304), ('IMPORTANT_CONSIDERATION', 322)]	6	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('UBERON_0007023', 'adult organism', 145, 'adult'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D'), ('UBERON_0007023', 'adult organism', 254, 'adults'), ('CHEBI_27300', 'vitamin D', 327, 'vitamin D')]
S3336-PMC4113768	PMC4113768	7/2014	S3336-PMC4113768	['; xiao, j.p.; zang, j.; fei, x.; zhu, y.; pei, j.j.\nbackground: thereare LITTLE DATA about the status of Vitamin D in Pregnant women and their newborns in china, and we EVALUATED the Vitamin D status in Pregnant women and their newborns all the year around in wuxi city (north latitude 32°), jiangsu province, china.']	[('FULL_UNKNOWN', 73), ('INCOMPLETE_EVIDENCE', 73), ('QUESTION_ANSWERED_BY_THIS_WORK', 169)]	3	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('GO_0007565', 'female pregnancy', 118, 'pregnant'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('GO_0007565', 'female pregnancy', 203, 'pregnant')]
S3345-PMC4113768	PMC4113768	7/2014	S3345-PMC4113768	['(4) the Vitamin D status of Pregnant women SHOWED the same TREND as the air temperature fluctuations, BUT its phase lagged behind about two months, reaching its highest value in september.']	[('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 59), ('ANOMALY_CURIOUS_FINDING', 102)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007565', 'female pregnancy', 28, 'pregnant')]
S3349-PMC4113768	PMC4113768	7/2014	S3349-PMC4113768	['and the Vitamin D status in Pregnant women is significantly INFLUENCED by air temperature which is RELATED to the exposure of ultraviolet rays.']	[('SUPERFICIAL_RELATIONSHIP', 60), ('SUPERFICIAL_RELATIONSHIP', 99)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0007565', 'female pregnancy', 28, 'pregnant')]
S3363-PMC4113768	PMC4113768	7/2014	S3363-PMC4113768	['conclusion: the results SUGGESTED that quantitative ultrasound bmd COULD BE an INDICATOR for Vitamin D status in young children, and also provided FURTHER EVIDENCE to define Vitamin D deficiency for infants and children.']	[('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 79), ('INCOMPLETE_EVIDENCE', 147)]	4	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D')]
S231-PMC4161944	PMC4161944	9/2014	S231-PMC4161944	['independent of nutrition or pathogen exposure, seasonality CAN also change diurnal exposure to sunlight and levels of circulating Vitamin D. in the united kingdom, Vitamin D status during Gestation and Birth month HAS BEEN ASSOCIATED with diseases with Immune involvement, including rheumatoid arthritis, irritable Bowel diseases, and multiple sclerosis (174).']	[('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 214), ('SUPERFICIAL_RELATIONSHIP', 223)]	3	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007565', 'female pregnancy', 188, 'gestation'), ('GO_0007567', 'parturition', 202, 'birth'), ('UBERON_0002405', 'immune system', 253, 'immune'), ('UBERON_0000160', 'intestine', 315, 'bowel')]
S2-PMC4169453	PMC4169453	9/2014	S2-PMC4169453	['THIS STUDY EVALUATED WHETHER Vitamin D supplementation during Lactation enhances the maternal and infant’s Vitamin D status, bone mass and body composition.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21)]	3	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('GO_0007595', 'lactation', 62, 'lactation'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
S11-PMC4169453	PMC4169453	9/2014	S11-PMC4169453	['conclusions\nVitamin D supplementation at a dose of 400 iu/d was not sufficient to maintain 25(Oh)D >20 ng/ml in nursing women, WHILE 1200 iu/d APPEARED more EFFECTIVE, but had no effect on Breastfed offspring Vitamin D status, or changes in the bone mass and the body composition OBSERVED in both during breastfeeding.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('ANOMALY_CURIOUS_FINDING', 127), ('ANOMALY_CURIOUS_FINDING', 143), ('SUPERFICIAL_RELATIONSHIP', 157), ('INCOMPLETE_EVIDENCE', 280)]	5	[('CHEBI_28384', 'vitamin K', 12, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 91, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 91, '25(OH)D'), ('GO_0007567', 'parturition', 189, 'breastfed'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
S15-PMC4169453	PMC4169453	9/2014	S15-PMC4169453	['Postpartum deterioration of Vitamin D status MIGHT be EXPLAINED, AT LEAST IN PART, by less frequent multivitamin intake during Lactation compared to Pregnancy[5],[6]and decreasing multivitamin Intake in the course of Lactation[2].']	[('INCOMPLETE_EVIDENCE', 45), ('PROBABLE_UNDERSTANDING', 54), ('PROBABLE_UNDERSTANDING', 65), ('INCOMPLETE_EVIDENCE', 74)]	4	[('GO_0007567', 'parturition', 0, 'Postpartum'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007595', 'lactation', 127, 'lactation'), ('GO_0007565', 'female pregnancy', 149, 'pregnancy'), ('GO_0007631', 'feeding behavior', 193, 'intake'), ('GO_0007595', 'lactation', 217, 'lactation')]
S16-PMC4169453	PMC4169453	9/2014	S16-PMC4169453	['Vitamin D supplementation in Lactating women MAY ensure APPROPRIATE maternal Vitamin D status in cases of low Vitamin D dietary consumption and restricted synthesis in the skin[7].']	[('INCOMPLETE_EVIDENCE', 45), ('IMPORTANT_CONSIDERATION', 56)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007594', 'puparial adhesion', 29, 'lactating'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
S17-PMC4169453	PMC4169453	9/2014	S17-PMC4169453	['most of the RECENTLY PUBLISHED rct in Lactating women HAVE BEEN focused on maternal supplementation as a method of achieving APPROPRIATE Vitamin D status in both, mothers and their Breastfed offspring[8]–[11].']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 54), ('IMPORTANT_CONSIDERATION', 125)]	3	[('GO_0007594', 'puparial adhesion', 38, 'lactating'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D'), ('GO_0007567', 'parturition', 181, 'breastfed')]
S25-PMC4169453	PMC4169453	9/2014	S25-PMC4169453	['further, in addition to the body composition indices (fat and lean mass) Vitamin D status SEEMS an INDEPENDENT CONTRIBUTOR to bone Mineral density in girls and women[24],[25].']	[('ANOMALY_CURIOUS_FINDING', 90), ('SUPERFICIAL_RELATIONSHIP', 99), ('SUPERFICIAL_RELATIONSHIP', 111)]	3	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_46662', 'mineral', 131, 'mineral')]
S28-PMC4169453	PMC4169453	9/2014	S28-PMC4169453	['we HYPOTHESIZED that maternal Vitamin D supplementation during Lactation at a dose of 1200 iu/d, BUT NOT 400 iu/d, is more beneficial for both breastfeeding mothers and Breastfed infants, when Vitamin D status, bone mass and body composition are controlled for.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 97)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007595', 'lactation', 63, 'lactation'), ('GO_0007567', 'parturition', 169, 'breastfed'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D')]
S103-PMC4169453	PMC4169453	9/2014	S103-PMC4169453	['the itt approach ASSESSES the EFFECTIVENESS of improving Vitamin D status via different oral Vitamin D supplementation, regardless of whether the subject adhered to the dosing regimen.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 17), ('SUPERFICIAL_RELATIONSHIP', 30)]	2	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
S114-PMC4169453	PMC4169453	9/2014	S114-PMC4169453	['the participants who exited the study had similar baseline characteristics as those in the analyzed population with the EXCEPTION of a 2-fold higher rate of additional formula-Feeding (table 2).10.1371/journal.pone.0107708.g002\n\ncaption (fig): figure 2\nmaternal (a) and infants’ (b) Vitamin D status.']	[('ANOMALY_CURIOUS_FINDING', 120)]	1	[('GO_0007631', 'feeding behavior', 176, 'feeding'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D')]
S124-PMC4169453	PMC4169453	9/2014	S124-PMC4169453	['Vitamin D status\nmaternal 25(Oh)D level was SIMILAR in both groups at baseline and after 3 months of Vitamin D supplementation, HOWEVER, at v6 significantly higher 25(Oh)D levels were NOTED in the 1200 iu/d group (fig.']	[('SUPERFICIAL_RELATIONSHIP', 44), ('ANOMALY_CURIOUS_FINDING', 128), ('ANOMALY_CURIOUS_FINDING', 184)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 26, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 164, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 170, 'D')]
S184-PMC4169453	PMC4169453	9/2014	S184-PMC4169453	['there is GROWING EVIDENCE SHOWING Serum 25(Oh)D levels higher than 30 ng/ml, or EVEN higher than 40 ng/ml as EFFECTIVE for expression of Extra-Skeletal EFFECTS RELATED to proper Vitamin D status[1],[34],[35].']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 26), ('ANOMALY_CURIOUS_FINDING', 80), ('SUPERFICIAL_RELATIONSHIP', 109), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 160)]	6	[('UBERON_0001977', 'blood serum', 34, 'serum'), ('CHEBI_71657', 'versiconol acetate', 40, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 40, '25(OH)D'), ('UBERON_0001431', 'distal carpal bone 2', 137, 'extra-skeletal'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
S189-PMC4169453	PMC4169453	9/2014	S189-PMC4169453	['DESPITE the AFOREMENTIONED CONTROVERSIES, the improvement in Vitamin D status in studied groups was achieved without any evidence of hypervitaminosis D, such as elevated 25(Oh)d, hypercalcemia, or increased hypercalciuria.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 27)]	4	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 150, 'D'), ('CHEBI_30778', 'gallic acid', 170, '25(OH)')]
S204-PMC4169453	PMC4169453	9/2014	S204-PMC4169453	['our results REVEALED that maternal Vitamin D supplementation at a dose up to 1200 iu/d had no influence on the breastfed offspring’s Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 12)]	1	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 133, 'vitamin D')]
S212-PMC4169453	PMC4169453	9/2014	S212-PMC4169453	['ANOTHER INTERESTING OBSERVATION RELATES to pth as a functional MARKER of Vitamin D status in Adults, children and infants but not necessarily in neonates[44]–[47].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 8), ('ANOMALY_CURIOUS_FINDING', 20), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 63)]	5	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('UBERON_0007023', 'adult organism', 93, 'adults')]
S218-PMC4169453	PMC4169453	9/2014	S218-PMC4169453	['our results INDICATE that the pth concentration SHOULD NOT BE considered a reliable functional MARKER of Vitamin D status in newborn infants.']	[('INCOMPLETE_EVIDENCE', 12), ('FUTURE_WORK', 48), ('SUPERFICIAL_RELATIONSHIP', 95)]	3	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
S221-PMC4169453	PMC4169453	9/2014	S221-PMC4169453	['keeping IN MIND the diminutive DIFFERENCES in 25(Oh)D levels among the study groups, we ASSUMED that the Vitamin D status in nursing women had no IMPACT on bone mass and body composition.']	[('IMPORTANT_CONSIDERATION', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('PROBABLE_UNDERSTANDING', 88), ('SUPERFICIAL_RELATIONSHIP', 146)]	4	[('CHEBI_71657', 'versiconol acetate', 46, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 52, 'D'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
S223-PMC4169453	PMC4169453	9/2014	S223-PMC4169453	['the INFLUENCE of Vitamin D status and bone mass in nursing women MIGHT BE evaluated FURTHER BUT higher Vitamin D doses are NECESSARY.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 65), ('ANOMALY_CURIOUS_FINDING', 71), ('FUTURE_WORK', 84), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 92), ('IMPORTANT_CONSIDERATION', 123)]	6	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
S241-PMC4169453	PMC4169453	9/2014	S241-PMC4169453	['Vitamin D3 supplementation at a dose of 1200 iu/d is more EFFECTIVE at improving Vitamin D status of nursing women, but STILL SEEMS TOO low TO fully replenish Vitamin D deficiency/insufficiency.']	[('SUPERFICIAL_RELATIONSHIP', 58), ('ANOMALY_CURIOUS_FINDING', 120), ('IMPORTANT_CONSIDERATION', 120), ('ANOMALY_CURIOUS_FINDING', 126), ('DIFFICULT_TASK', 132)]	5	[('CHEBI_33237', 'vitamin D4', 0, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D3'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
S2-PMC4188019	PMC4188019	1/2010	S2-PMC4188019	['OBJECTIVES : THIS was a PRELIMINARY EXPLORATION of the Vitamin D status in Pregnant women visiting the Antenatal clinic in the antwerp university hospital.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('INCOMPLETE_EVIDENCE', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 36)]	4	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnant'), ('GO_0007567', 'parturition', 103, 'antenatal'), ('UBERON_0001760', 'frontal sinus', 103, 'antenatal')]
S23-PMC4192458	PMC4192458	9/2014	S23-PMC4192458	['Nutrient status HAS also BEEN directly LINKED with increased risk of pre-eclampsia, including increased Serum Triglyceride and Fatty Acids, and reduced levels of Serum calcium, Vitamin D, magnesium, and zinc [9].']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 39)]	2	[('CHEBI_33284', 'nutrient', 0, 'Nutrient'), ('UBERON_0001977', 'blood serum', 104, 'serum'), ('CHEBI_17855', 'triglyceride', 110, 'triglyceride'), ('CHEBI_35366', 'fatty acid', 127, 'fatty acids'), ('UBERON_0001977', 'blood serum', 162, 'serum'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D')]
S91-PMC4210909	PMC4210909	10/2014	S91-PMC4210909	['iron status CAN also be AFFECTED by the intake of OTHER Nutrients that MAY inhibit (e.g., calcium, phytates) OR promote (e.g., Vitamin C) iron absorption [43].']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 50), ('INCOMPLETE_EVIDENCE', 71), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 109)]	5	[('CHEBI_33284', 'nutrient', 56, 'nutrients'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin C')]
S12-PMC4231606	PMC4231606	10/2013	S12-PMC4231606	['children with s-ecc were significantly more LIKELY to have Vitamin D levels below RECOGNIZED THRESHOLDS for optimal and adequate status (i.e.']	[('PROBABLE_UNDERSTANDING', 44), ('PROBABLE_UNDERSTANDING', 82), ('PROBABLE_UNDERSTANDING', 93)]	3	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
S108-PMC4231606	PMC4231606	10/2013	S108-PMC4231606	['logistic regression for caries status was also performed, REVEALING that lower household income, poorer ratings of children’s general health, and lower Vitamin D levels were significantly ASSOCIATED with s-ecc (table\xa04).']	[('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 188)]	2	[('CHEBI_27300', 'vitamin D', 152, 'vitamin D')]
S112-PMC4231606	PMC4231606	10/2013	S112-PMC4231606	['discussion\nthe PURPOSE of THIS STUDY was TO DETERMINE WHETHER children with s-ecc have different nutritional profiles THAN their caries-free peers, specifically Vitamin D, calcium and albumin status.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('QUESTION_ANSWERED_BY_THIS_WORK', 41), ('EXPLICIT_QUESTION', 54), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 118)]	5	[('CHEBI_27300', 'vitamin D', 161, 'vitamin D')]
S122-PMC4231606	PMC4231606	10/2013	S122-PMC4231606	['regression techniques were employed to determine WHETHER the ASSOCIATION between caries and Vitamin D status REMAINED after controlling for CONFOUNDERS.']	[('EXPLICIT_QUESTION', 49), ('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 109), ('PROBLEM_COMPLICATION', 140)]	4	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
S155-PMC4231606	PMC4231606	10/2013	S155-PMC4231606	['THIS STUDY SUGGESTS a CLEAR RELATIONSHIP between Vitamin D levels and the caries status of preschool children.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 22), ('SUPERFICIAL_RELATIONSHIP', 28)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D')]
S12-PMC4251419	PMC4251419	12/2014	S12-PMC4251419	['THUS, higher latitude is OFTEN taken AS a PROXY for both lower levels of ultraviolet radiation (uvr) and lower Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 25), ('PROBABLE_UNDERSTANDING', 37), ('SUPERFICIAL_RELATIONSHIP', 42)]	4	[('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
S22-PMC4251419	PMC4251419	12/2014	S22-PMC4251419	['in case-control studies, participants with one of these Autoimmune diseases TEND to report lower past sun exposure, and/or have lower Vitamin D status (measured as the Blood concentration of the intermediary Metabolite, 25(Oh)D, seefigure 1), than healthy controls (see for example recent reviews [12,13]).']	[('SUPERFICIAL_RELATIONSHIP', 76)]	1	[('UBERON_0001442', 'skeleton of manus', 56, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('UBERON_0000178', 'blood', 168, 'blood'), ('CHEBI_39382', 'flufenoxuron', 208, 'metabolite'), ('CHEBI_71657', 'versiconol acetate', 220, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 220, '25(OH)D')]
S25-PMC4251419	PMC4251419	12/2014	S25-PMC4251419	['this is a stronger study design because the direction of causality is established, that is, the low Vitamin D status PRECEDES the onset of the health outcome.']	[('SUPERFICIAL_RELATIONSHIP', 117)]	1	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D')]
S26-PMC4251419	PMC4251419	12/2014	S26-PMC4251419	['lower Vitamin D status HAS BEEN LINKED to increased risk of multiple sclerosis (see case study [14]) and to type 1 diabetes [15], although not all studies SHOW a PROTECTIVE ASSOCIATION [16].']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 155), ('SUPERFICIAL_RELATIONSHIP', 162), ('SUPERFICIAL_RELATIONSHIP', 173)]	5	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D')]
S130-PMC4251419	PMC4251419	12/2014	S130-PMC4251419	['in addition, with respect to an ability of supplemental Vitamin D to alter the course of Autoimmune diseases, there is DEBATE about the VALIDITY of biochemical OR cellular markers from Blood AS TRULY representative of disease status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 119), ('IMPORTANT_CONSIDERATION', 136), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 160), ('PROBABLE_UNDERSTANDING', 191), ('PROBABLE_UNDERSTANDING', 194)]	5	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 89, 'autoimmune'), ('UBERON_0000178', 'blood', 185, 'blood')]
S137-PMC4251419	PMC4251419	12/2014	S137-PMC4251419	['HOWEVER, SEVERAL STUDIES SUGGEST that low Vitamin D status or low levels of ambient uvr during the in utero period [49], or during childhood [40], are ASSOCIATED with increased risk of Immune-related disorders.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 25), ('SUPERFICIAL_RELATIONSHIP', 151)]	4	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0002405', 'immune system', 185, 'immune')]
S145-PMC4251419	PMC4251419	12/2014	S145-PMC4251419	['TRADITIONALLY the level of total 25(Oh)D HAS BEEN CONSIDERED the best ESTIMATE of Vitamin D status, BUT RECENT STUDIES have SUGGESTED that the “bioavailable” (albumin-bound and free) 25(Oh)D concentration MAY BE more RELEVANT to health and disease [83].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 41), ('INCOMPLETE_EVIDENCE', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 100), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 205), ('SUPERFICIAL_RELATIONSHIP', 217)]	8	[('CHEBI_71657', 'versiconol acetate', 33, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 39, 'D'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 183, '25(OH)D')]
S0-PMC4256222	PMC4256222	12/2014	S0-PMC4256222	['maternal Vitamin D status and offspring bone fractures: prospective study over two decades in aarhus city, denmark\n\nabstract\n\nbackground\nstudies investigating the ASSOCIATION between maternal Vitamin D status and offspring bone mass measured by dual-energy x-ray absorptiometry (dxa) during childhood HAVE SHOWN CONFLICTING results.']	[('SUPERFICIAL_RELATIONSHIP', 163), ('INCOMPLETE_EVIDENCE', 301), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 312)]	3	[('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D')]
S1-PMC4256222	PMC4256222	12/2014	S1-PMC4256222	['purpose\nwe used occurrence of bone fractures up to the age of 18 as a measure reflecting offspring bone mass and RELATED that to maternal Vitamin D status.']	[('SUPERFICIAL_RELATIONSHIP', 113)]	1	[('CHEBI_27300', 'vitamin D', 138, 'vitamin D')]
S8-PMC4256222	PMC4256222	12/2014	S8-PMC4256222	['multivariable cox regression models using age as the underlying time scale INDICATED no overall association between maternal Vitamin D status and first time bone fractures.']	[('INCOMPLETE_EVIDENCE', 75)]	1	[('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
S10-PMC4256222	PMC4256222	12/2014	S10-PMC4256222	['adjustment for Vitamin D status strengthened this ASSOCIATION (1.82, 1.12–2.97), which INDICATED a POTENTIAL seasonal IMPACT on offspring fractures INDEPENDENT of maternal Vitamin D status.']	[('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 118), ('SUPERFICIAL_RELATIONSHIP', 148)]	5	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D')]
S12-PMC4256222	PMC4256222	12/2014	S12-PMC4256222	['conclusion\noverall, our results DID NOT substantiate an association between maternal Vitamin D status and offspring bone fractures.']	[('INCOMPLETE_EVIDENCE', 32)]	1	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
S14-PMC4256222	PMC4256222	12/2014	S14-PMC4256222	['introduction\nAdult bone mass MAY BE INFLUENCED by FACTORS operating as early as in fetal Life[1], and there has in particular been interest on the ROLE of maternal Vitamin D status in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 36), ('SUPERFICIAL_RELATIONSHIP', 50), ('SUPERFICIAL_RELATIONSHIP', 147)]	4	[('UBERON_0007023', 'adult organism', 13, 'Adult'), ('UBERON_0000104', 'life cycle', 89, 'life'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007565', 'female pregnancy', 184, 'pregnancy')]
S16-PMC4256222	PMC4256222	12/2014	S16-PMC4256222	['CONSEQUENTLY, offspring of mothers with low status of Vitamin D MAY BE in a deficient state already from the first days of Life.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 64)]	2	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('UBERON_0000104', 'life cycle', 123, 'life')]
S17-PMC4256222	PMC4256222	12/2014	S17-PMC4256222	['Vitamin D plays a MAJOR ROLE in the REGULATION of calcium homeostasis[3],[4], and studies have FOUND that children Born to women with low Vitamin D status had lower Birth weight, Birth length, and lower bone Mineral content (bmc) at Birth[2].']	[('IMPORTANT_CONSIDERATION', 18), ('SUPERFICIAL_RELATIONSHIP', 24), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 95)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007567', 'parturition', 115, 'born'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('GO_0007567', 'parturition', 165, 'birth'), ('GO_0007567', 'parturition', 179, 'birth'), ('CHEBI_46662', 'mineral', 208, 'mineral'), ('GO_0007567', 'parturition', 233, 'birth')]
S18-PMC4256222	PMC4256222	12/2014	S18-PMC4256222	['DIFFERENT LINES of EVIDENCE also SUGGEST that maternal Vitamin D status MAY IMPACT offspring bone health in the short as well as the long term, BUT the studies have shown CONFLICTING results[5]–[9].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 33), ('INCOMPLETE_EVIDENCE', 72), ('SUPERFICIAL_RELATIONSHIP', 76), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 144), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 171)]	8	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
S21-PMC4256222	PMC4256222	12/2014	S21-PMC4256222	['TO OUR KNOWLEDGE, NO earlier STUDIES have focused on the INFLUENCE of Vitamin D status during Pregnancy on incident occurrences of offspring bone fractures during childhood.']	[('PROBABLE_UNDERSTANDING', 0), ('FULL_UNKNOWN', 18), ('SUPERFICIAL_RELATIONSHIP', 57)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy')]
S25-PMC4256222	PMC4256222	12/2014	S25-PMC4256222	['in a prospective cohort with follow up over two decades, we therefore EXAMINED WHETHER the risk of bone fractures during the first 18 years of Life was ASSOCIATED with the maternal status of Vitamin D in Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 70), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('SUPERFICIAL_RELATIONSHIP', 152)]	3	[('UBERON_0000104', 'life cycle', 143, 'life'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('GO_0007565', 'female pregnancy', 204, 'pregnancy')]
S33-PMC4256222	PMC4256222	12/2014	S33-PMC4256222	['approximately 20 years later, the Serum samples were analyzed for concentrations of Vitamin D by the liquid chromatography coupled with a tandem mass spectrometric (lc-ms/ms) method (“ms/ms Vitamin D” kit from perkin elmer, waltham ma), which is CONSIDERED to be the most accurate measure of Vitamin D status[14].']	[('INCOMPLETE_EVIDENCE', 246)]	1	[('UBERON_0001977', 'blood serum', 34, 'serum'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 292, 'vitamin D')]
S42-PMC4256222	PMC4256222	12/2014	S42-PMC4256222	['we DEFINED the total maternal Vitamin D status as the sum of measured 25(Oh)D2 and 25(Oh)D3 concentrations.']	[('PROBABLE_UNDERSTANDING', 3)]	1	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_77765', '2,4,6-trihydroxybenzophenone(1-)', 70, '25(OH)D2'), ('CHEBI_62946', 'ammonium sulfate', 83, '25(OH)D3')]
S64-PMC4256222	PMC4256222	12/2014	S64-PMC4256222	['furthermore, we analyzed the ASSOCIATION between maternal Vitamin D status and offspring Forearm fractures and performed sensitivity analyses where we excluded all fractures related to traffic accidents.']	[('SUPERFICIAL_RELATIONSHIP', 29)]	1	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('UBERON_0002386', 'forelimb zeugopod', 89, 'forearm')]
S73-PMC4256222	PMC4256222	12/2014	S73-PMC4256222	['no statistical differences in the characteristics were FOUND between women with available measured Vitamin D status and women without measured Vitamin D status, except for season at Blood draw (p\u200a=\u200a0.004).']	[('INCOMPLETE_EVIDENCE', 55)]	1	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('UBERON_0000178', 'blood', 182, 'blood')]
S74-PMC4256222	PMC4256222	12/2014	S74-PMC4256222	['women without a measured Vitamin D status were more OFTEN in the 30thweek of Gestation during the winter months (dec/jan/feb).']	[('PROBABLE_UNDERSTANDING', 52)]	1	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'gestation')]
S76-PMC4256222	PMC4256222	12/2014	S76-PMC4256222	['total Vitamin D status was significantly ASSOCIATED with parity (p\u200a=\u200a0.004), with parous women being more LIKELY to be in deficient or insufficient state.']	[('SUPERFICIAL_RELATIONSHIP', 41), ('PROBABLE_UNDERSTANDING', 106)]	2	[('CHEBI_27300', 'vitamin D', 6, 'vitamin D')]
S78-PMC4256222	PMC4256222	12/2014	S78-PMC4256222	['maternal Vitamin D status was INDEPENDENT of maternal age, occupational status and sex of the child.']	[('SUPERFICIAL_RELATIONSHIP', 30)]	1	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D')]
S79-PMC4256222	PMC4256222	12/2014	S79-PMC4256222	['season for Blood sampling was highly RELATED to the status of Vitamin D (p<0.001).10.1371/journal.pone.0114334.t001\n\ncaption (table-wrap): table 1\nbackground characteristics of participants in the dafo88 cohort according to offspring bone fracture (yes/no) and maternal vitamin d status (nmol/l) around Gestational week 30 (n\u200a=\u200a850) in aarhus city, denmark.fracturevitamin d status (%)missing %yes n\u200a=\u200a294no n\u200a=\u200a556 p value<50 n\u200a=\u200a21750–74.9 n\u200a=\u200a19975–125 n\u200a=\u200a321>125 n\u200a=\u200a113 p valuematernalage (mean)29.129.00.72a28.829.329.128.90.62abmi (mean)3.621.321.50.26a21.921.221.421.10.10aeducationstatus (%)unskilled14.012.70.85b17.110.712.313.00.59bskilled25.426.424.627.324.929.6university39.036.435.835.337.941.7higheracademic14.316.914.419.816.710.2other7.37.58.06.98.25.6smokingnever (%)5.357.461.20.30b55.856.062.567.00.12bparity (%)nulliparous58.857.00.26b46.157.864.261.10.004b1 child28.933.440.533.225.930.12+children12.29.513.49.010.08.8sex, boy (%)57.149.80.04b48.455.851.755.70.41bseason of blood draw (%)mar/apr/may14.011.90.26b12.414.616.24.4<0.001bjun/jul/aug30.825.88.818.134.372.6sep/oct/nov34.237.452.135.729.917.7dec/jan/feb21.024.826.731.719.65.3\ntwo-sided anova for measure of association.']	[('SUPERFICIAL_RELATIONSHIP', 37)]	1	[('UBERON_0000178', 'blood', 11, 'blood'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 303, 'gestational')]
S97-PMC4256222	PMC4256222	12/2014	S97-PMC4256222	['HOWEVER, in sensitivity analyses we FOUND a borderline significant inverse ASSOCIATION (p\u200a=\u200a0.054) between Vitamin D status in Pregnancy and offspring Forearm fractures.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 75)]	3	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('GO_0007565', 'female pregnancy', 127, 'pregnancy'), ('UBERON_0002386', 'forelimb zeugopod', 151, 'forearm')]
S99-PMC4256222	PMC4256222	12/2014	S99-PMC4256222	['adjustment for Vitamin D status did not attenuate this ASSOCIATION as would be expected if the ASSOCIATION were DUE TO seasonal variation in Vitamin D status, RATHER it was strengthened upon adjustment.']	[('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 95), ('PROBLEM_COMPLICATION', 112), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 159)]	4	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]
S102-PMC4256222	PMC4256222	12/2014	S102-PMC4256222	['in that study, the authors SUGGESTED their findings to be caused by seasonal variation in Vitamin D status during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 27)]	1	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0007565', 'female pregnancy', 114, 'pregnancy')]
S103-PMC4256222	PMC4256222	12/2014	S103-PMC4256222	['HOWEVER, IF our results are reliable, there MIGHT be OTHER aspects UNDERLYING a seasonal variation during Pregnancy on bone fracture risk later in Life INDEPENDENTLY of Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 44), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 53), ('SUPERFICIAL_RELATIONSHIP', 67), ('SUPERFICIAL_RELATIONSHIP', 152)]	6	[('GO_0007565', 'female pregnancy', 106, 'pregnancy'), ('UBERON_0000104', 'life cycle', 147, 'life'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin D')]
S106-PMC4256222	PMC4256222	12/2014	S106-PMC4256222	['the PRESENT STUDY is TO OUR KNOWLEDGE the FIRST to INVESTIGATE WHETHER maternal Vitamin D status PREDICTS offspring bone fractures.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('PROBABLE_UNDERSTANDING', 21), ('INCOMPLETE_EVIDENCE', 42), ('QUESTION_ANSWERED_BY_THIS_WORK', 51), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('EXPLICIT_QUESTION', 63), ('SUPERFICIAL_RELATIONSHIP', 97)]	7	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D')]
S108-PMC4256222	PMC4256222	12/2014	S108-PMC4256222	['[5]SHOWED a direct ASSOCIATION between maternal Vitamin D status during Pregnancy and bmc and bmd in 160 offspring at 9 years of age.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 19)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy')]
S110-PMC4256222	PMC4256222	12/2014	S110-PMC4256222	['[6]were UNABLE TO detect any RELEVANT ASSOCIATION between maternal Vitamin D status and bmc and bmd shortly after Birth, ALTHOUGH they did indeed find a positive CORRELATION between maternal Vitamin D status and fetal Femur volume measured by three-dimensional ultrasound.']	[('DIFFICULT_TASK', 8), ('IMPORTANT_CONSIDERATION', 29), ('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 121), ('ANOMALY_CURIOUS_FINDING', 121), ('SUPERFICIAL_RELATIONSHIP', 162)]	6	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007567', 'parturition', 114, 'birth'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('UBERON_0000981', 'femur', 218, 'femur')]
S113-PMC4256222	PMC4256222	12/2014	S113-PMC4256222	['[8]in the same cohort FOUND no RELEVANT association between maternal Vitamin D status in Pregnancy and bmc in 3960 offspring at 9–10 years of age.']	[('INCOMPLETE_EVIDENCE', 22), ('IMPORTANT_CONSIDERATION', 31)]	2	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy')]
S116-PMC4256222	PMC4256222	12/2014	S116-PMC4256222	['[9], in the australian raine study FOUND a lower peak bone mass in 341 offspring at 20 years of age, when the maternal Vitamin D status was below 50 nmol/l.']	[('INCOMPLETE_EVIDENCE', 35)]	1	[('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
S120-PMC4256222	PMC4256222	12/2014	S120-PMC4256222	['one POTENTIAL EXPLANATION for the null ASSOCIATION between maternal Vitamin D status and offspring bone fractures MAY BE the low prevalence of Vitamin D deficiency in our study population.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 14), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 114)]	4	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
S121-PMC4256222	PMC4256222	12/2014	S121-PMC4256222	['IF a TRUE UNDERLYING beneficial EFFECT of maternal Vitamin D status on offspring bone health exists and is LIMITED to very low levels, we MAY not be able to detect such a RELATIONSHIP in our data, where ONLY 6.3% of the study population had a Vitamin D status below 25 nmol/l and 25.5% had a status below 50 nmol/l.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 5), ('SUPERFICIAL_RELATIONSHIP', 10), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 138), ('SUPERFICIAL_RELATIONSHIP', 171), ('ANOMALY_CURIOUS_FINDING', 203), ('INCOMPLETE_EVIDENCE', 203)]	9	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D')]
S126-PMC4256222	PMC4256222	12/2014	S126-PMC4256222	['we FOUND a borderline significant inverse ASSOCIATION between Vitamin D status in Pregnancy and offspring Forearm fractures.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 42)]	2	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('UBERON_0002386', 'forelimb zeugopod', 106, 'forearm')]
S129-PMC4256222	PMC4256222	12/2014	S129-PMC4256222	['it would be OF great INTEREST to conduct similar analysis to investigate the ASSOCIATION between maternal status of Vitamin D and offspring Forearm fractures in a study population large enough to allow such subdivision of fractures and further stratification by Vitamin D status.']	[('ANOMALY_CURIOUS_FINDING', 12), ('FUTURE_WORK', 21), ('SUPERFICIAL_RELATIONSHIP', 77)]	3	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('UBERON_0002386', 'forelimb zeugopod', 140, 'forearm'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin D')]
S133-PMC4256222	PMC4256222	12/2014	S133-PMC4256222	['until 1995, we ONLY have access to diagnoses recorded during hospitalization, which MAY EXPLAIN WHY maternal Vitamin D status in our data is unassociated with offspring bone fractures.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 84), ('PROBABLE_UNDERSTANDING', 88), ('EXPLICIT_QUESTION', 96)]	4	[('CHEBI_27300', 'vitamin D', 109, 'vitamin D')]
S135-PMC4256222	PMC4256222	12/2014	S135-PMC4256222	['weight and height MAY BE RELATED both to maternal Vitamin D status and offspring bone mass, and our results MAY BE CONFOUNDED when those data are missing.']	[('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 25), ('INCOMPLETE_EVIDENCE', 108), ('DIFFICULT_TASK', 115)]	4	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
S138-PMC4256222	PMC4256222	12/2014	S138-PMC4256222	['THUS, we cannot preclude that early Vitamin D supplementation IMPACTED offspring bone fracture RISK in our data and has blurred an ASSOCIATION with maternal Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 62), ('IMPORTANT_CONSIDERATION', 95), ('SUPERFICIAL_RELATIONSHIP', 131)]	4	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
S141-PMC4256222	PMC4256222	12/2014	S141-PMC4256222	['ON THE OTHER HAND, in the RECENT alspac STUDY[8]it WAS SHOWN that offspring level of physical activity and dietary Vitamin D intake were not associated with maternal Vitamin D status[10].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 51)]	4	[('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D')]
S144-PMC4256222	PMC4256222	12/2014	S144-PMC4256222	['in conclusion, our data INDICATED no overall association between maternal Vitamin D status during Pregnancy and offspring bone fractures in a prospective cohort with 18 years of follow-up through high-quality registries.']	[('INCOMPLETE_EVIDENCE', 24)]	1	[('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy')]
S145-PMC4256222	PMC4256222	12/2014	S145-PMC4256222	['FURTHER STUDIES on this subject ARE NEEDED, BUT such STUDIES MUST BE conducted in study populations large enough to allow for INVESTIGATION of seasonal variation, subdivision of fractures and further stratification of study participants by Vitamin D status.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('FUTURE_WORK', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('FUTURE_WORK', 53), ('IMPORTANT_CONSIDERATION', 61), ('ANOMALY_CURIOUS_FINDING', 66), ('FUTURE_WORK', 126)]	8	[('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
S29-PMC4268639	PMC4268639	11/2014	S29-PMC4268639	['caption (table-wrap): table 1\n\nEMPHASIS of nutrition education classesnutrientspreconception1st trimester2nd trimester3rd trimesterpostnatal protein adequatecomplete, Carnitine, methionine, cysteine, 0.8 g/kgcomplete, adequate 1.1 g/kgcomplete, adequate 1.1 g/kgcomplete, adequate fat essential Fatty Acidsomega 3omega 3omega 3omega 3 Carbohydrate complexcomplexcomplex,fiber complexcomplex Minerals Iodine, iron, magnesium, zinc, calcium, Seleniumiodine, Seleniumiron, magnesium, calciumiron, zinc, magnesiumiron, calcium Vitamins methylation factorsvitamins d, b6, b12, folatevitamins e, D, cvitamins C, ab Vitamins, Vitamin D Phytonutrients full range of colors of fruits and vegetablescolors: oxidative reservecolors: Organ growthcolors: newborn preferencecolors: oxidant balance Probiotics immune balanceimmune balanceimmune balance\n\ncaption (table-wrap): table 2\n\nPrenatal supplements adjusted to levels of Hemoglobin, hematocrit, mean corpuscular volume, Vitamin D, Zinc, Carnitine, and mthfr statusvitamin a Mixed Carotenoids5000 iumethylcobalamin800 µgchromium (Chromium Niacinate)200 µgvitamin c250 mgbiotin100 µgmolybdenum (Molybdenum Glycinate)25 µgvitamin d32000 iupantothenic Acid (D-Calcium Pantothenate)25 mgomega-3 Fatty Acids620 mgvitamin E (Mixed)110 iuiron (iron Bisglycinate)25 mgepa400 mgthiamine (Mononitrate)5 mgiodine (Potassium Iodide)150 µgdha200 mgriboflavin (5 phosphate)5 mgzinc (Zinc Citrate)25 mgother omega-320 mgniacinamide25 mgselenium (l Selenomethionine)100 µgl-Carnitine as 1492 mg l-Carnitine tartrate1000 mgb6(Pyridoxal 5 Phosphate)15 mgcopper (Copper Gluconate)1.5 mgprobiotic blend: lactobacillus acidophilus 60 b cful-5-Methylfolate1000 µgmanganese (manganese gluconate)5 mg bifidobacterium lectis, lactobacillus plantarum, lactobacillus salivarius, streptococcus thermophilus\nabbreviations: cfu, colony-forming unit; Dha, Docosahexaenoic Acid; Epa, Eicosapentaenoic Acid; mthfr, Methylenetetrahydrofolate reductase.']	[('IMPORTANT_CONSIDERATION', 31)]	1	"[('CHEBI_17126', 'carnitine', 167, 'carnitine'), ('CHEBI_39327', '(1S)-cis-(alphaR)-cyhalothrin', 295, 'fatty acidsOmega'), ('CHEBI_16646', 'carbohydrate', 335, 'Carbohydrate'), ('CHEBI_25468', 'naphthaldehydes', 391, 'Minerals'), ('CHEBI_31719', 'ipriflavone', 400, 'Iodine'), ('CHEBI_9107', 'senecionine', 440, 'seleniumIodine'), ('CHEBI_30483', 'trihydridotellurate(1-)', 456, 'seleniumIron'), ('CHEBI_28371', 'vitamin K epoxide', 523, 'Vitamins'), ('PR_000006444', 'diacylglycerol kinase delta', 590, 'D'), ('PR_000004900', 'complement C3', 603, 'C'), ('CHEBI_33277', 'gamma-tocotrienol', 609, 'vitamins'), ('CHEBI_27300', 'vitamin D', 619, 'vitamin D'), ('CHEBI_36961', 'chalcocarbonic acid', 629, 'Phytonutrients'), ('UBERON_0000062', 'organ', 722, 'organ'), ('CHEBI_8474', 'propane-2-thiol', 784, 'Probiotics'), ('GO_0007565', 'female pregnancy', 870, 'Prenatal'), ('CHEBI_5679', 'herniarin', 913, 'Hemoglobin'), ('CHEBI_28384', 'vitamin K', 962, 'Vitamin D'), ('CHEBI_27377', ""Unsym-bis(4'-chlorophenyl)ethylene"", 973, 'Zinc'), ('CHEBI_17126', 'carnitine', 979, 'Carnitine'), ('CHEBI_60004', 'mixture', 1016, 'mixed'), ('CHEBI_77957', 'm-fluoro-L-phenylalanine', 1022, 'carotenoids5000'), ('CHEBI_53471', 'chromium(III) sulfate', 1071, 'chromium niacinate'), ('UBERON_0002365', 'exocrine gland', 1135, 'molybdenum'), ('CHEBI_32508', 'glycinate', 1146, 'glycinate'), ('CHEBI_37527', 'acid', 1190, 'acid'), ('CHEBI_38294', 'dicarba-nido-undecaborane(11)', 1196, 'd-calcium pantothenate'), ('CHEBI_78128', 'fatty acid anion 24:0', 1232, 'fatty acids620'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1257, 'E'), ('CHEBI_60004', 'mixture', 1260, 'mixed'), ('CHEBI_32499', 'amineptine', 1283, 'bisglycinate'), ('CHEBI_29440', 'methanuidyl', 1320, 'mononitrate'), ('CHEBI_8346', 'potassium iodide', 1344, 'potassium iodide'), ('CHEBI_46916', 'vinyl acetate', 1410, 'zinc citrate'), ('CHEBI_26630', 'selenocystathionine', 1474, 'selenomethionine'), ('CHEBI_17126', 'carnitine', 1499, 'carnitine'), ('CHEBI_17126', 'carnitine', 1522, 'carnitine'), ('CHEBI_16462', 'glycylpeptide', 1550, 'Pyridoxal 5 phosphate'), ('CHEBI_23401', 'coumaric acid', 1585, 'copper gluconate'), ('CHEBI_82350', '5-Nitroacenaphthene', 1661, '5-Methylfolate1000'), ('CHEBI_17874', 'dihydrozeatin', 1861, 'DHA'), ('CHEBI_36003', 'decenoic acid', 1866, 'docosahexaenoic acid'), ('CHEBI_34733', 'EPN', 1888, 'EPA'), ('CHEBI_36003', 'decenoic acid', 1893, 'eicosapentaenoic acid'), ('CHEBI_38725', 'mevinphos', 1923, 'methylenetetrahydrofolate')]"
S141-PMC4289552	PMC4289552	12/2014	S141-PMC4289552	['Vitamin D is ESSENTIAL for calcium homeostatis and now recognized as an IMPORTANT Nutrient for bone health including modest SUPPORT for maternal Vitamin D status and increased offspring bone mass among [50].']	[('IMPORTANT_CONSIDERATION', 13), ('IMPORTANT_CONSIDERATION', 72), ('INCOMPLETE_EVIDENCE', 124)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_33284', 'nutrient', 82, 'nutrient'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D')]
S13-PMC4303849	PMC4303849	1/2015	S13-PMC4303849	['Calcidiol is the major Vitamin D Metabolite present in the circulation and the BEST INDICATOR of vd nutritional status.']	[('IMPORTANT_CONSIDERATION', 79), ('SUPERFICIAL_RELATIONSHIP', 84)]	2	[('CHEBI_17933', 'calcidiol', 0, 'Calcidiol'), ('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('CHEBI_39382', 'flufenoxuron', 33, 'metabolite')]
S133-PMC4303849	PMC4303849	1/2015	S133-PMC4303849	['25Ohd values lesser than 50 nmol/l MAY sustain long-term adverse health consequences and are classified as “deficiency.” the 75 nmol/l cut-off is the point above which there is no upper stimulation of pth [102] and was thereafter designated as “sufficient.” HOWEVER, heaney POINTED out that 25Ohd concentrations < 80 nmol/l are ASSOCIATED with reduced calcium absorption and osteoporosis risk [103]; therefore, values lesser than 75 nmol/l are considered AS “insufficient.” the conversion factor between 25Ohd nmol/l and ng/ml is 2.5 (table 2).nutrients-07-00443-t001_table 1\n\ncaption (table-wrap): table 1\n\ntargets Modulated by Calcitriol in the Human Placenta (+ = stimulation; − = inhibition).targetbiological networkregulationbioeffectcell typereferenceplacental Lactogencell Life and death+growth controltrophoblast[97]Tnf-Αimmune function−restraining inflammationtrophoblast[91,92]−immunosupressiondecidual cells[89]Il-6Immune function−restraining inflammationtrophoblast[91,92]−immunosupressiondecidual cells[89]Csf2 (Colony Stimulating Factor 2)immune function−immunosupressiondecidual Cells[89]hctdimmune function+restraining infectiontrophoblast[90]Decidual Cells[89]Cyp24A1Bone and Mineral Metabolism+Calcitriol Catabolismtrophoblast[12]Decidual Cells[104]Cyp27B1Bone and Mineral Metabolism−Calcitriol synthesistrophoblast[12]Il-10 (Interleukin 10)immune function−reducing risk of infectiontrophoblast[105]Kcnh1 (potassium voltage-Gated channel)Cell Life and Death−unknowntrophoblast[106]Calbindin-D 28 kdabone and Mineral Metabolism+Calcium transfertrophoblast[61,62]Calbindin-D 9 kdabone and Mineral Metabolism+Calcium transfertrophoblast[61]hcg (Human Chorionic Gonadotrophin)Cell Life and Death+, −maintenance of Pregnancytrophoblast[96]3β-hsd (3Β-Hydroxysteroid dehydrogenase) *Cell Life and Death+Progesterone Synthesistrophoblast[95]Cyp19 (aromatase) *Cell Life and Death+Estradiol Synthesistrophoblast[95]Prolactincell Life and Death+Establishment Of Pregnancydecidual Cells[107]Vdrbone and Mineral Metabolism+allowing Calcitriol actionstrophoblast[62]Platelet-Activating factor acetylhydrolasecell life and Death−inactivation of Platelet-Activating factordecidual Macrophages[108]Hoxa10 (Homeobox A10)Cell Life and Death+Embryo Implantationdecidual cells[109]Osteopontinbone and Mineral Metabolism+Embryo Implantationdecidual Cells[104]Hbd2Immune function+restraining infectiontrophoblast[93]Hbd3Immune function+restraining infectiontrophoblast[93]\n* only observed at the enzyme activity level.nutrients-07-00443-t002_table 2\n\ncaption (table-wrap): table 2\n\ncut-offs in Vitamin D status according to the Endocrine society [110].Vitamin D status25ohd (nmol/l)25Ohd (ng/ml)severe deficiency<25<10deficiency<50<20insufficiency<75<30sufficiency75–11030–44toxicity>250>100\ntable 2shows the criteria for vd status as PROPOSED by the Endocrine society.']	[('INCOMPLETE_EVIDENCE', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 258), ('INCOMPLETE_EVIDENCE', 274), ('SUPERFICIAL_RELATIONSHIP', 328), ('PROBABLE_UNDERSTANDING', 455), ('INCOMPLETE_EVIDENCE', 2831)]	6	"[('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 0, '25OHD'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 291, '25OHD'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 504, '25OHD'), ('GO_0065007', 'biological regulation', 616, 'modulated'), ('CHEBI_17823', 'calcitriol', 629, 'calcitriol'), ('NCBITaxon_9606', 'Homo sapiens', 647, 'human'), ('UBERON_0001987', 'placenta', 653, 'placenta'), ('CHEBI_35417', 'alpha-amino-acid residue radical', 767, 'lactogenCell'), ('PR_000009797', 'LIM/homeobox protein Lhx9', 767, 'lactogenCell'), ('UBERON_0000104', 'life cycle', 780, 'life'), ('PR_000000045', 'S-phase kinase-associated protein 1A', 824, 'TNF-αImmune'), ('PR_000008988', 'interleukin-1 family member 5', 922, 'IL-6Immune'), ('PR_000005890', 'crooked neck-like protein 1', 1019, 'CSF2'), ('PR_000005528', 'chloride channel protein, skeletal muscle', 1025, 'colony stimulating factor 2'), ('CL_0000573', 'retinal cone cell', 1094, 'cells'), ('CL_0000635', ""Deiter's cell"", 1159, 'Decidual cells'), ('PR_000006081', 'NADH-cytochrome b5 reductase 2', 1177, 'CYP24A1Bone'), ('CHEBI_46662', 'mineral', 1193, 'mineral'), ('GO_0008152', 'metabolic process', 1201, 'metabolism'), ('CHEBI_17823', 'calcitriol', 1212, 'Calcitriol'), ('GO_0019065', 'receptor-mediated endocytosis of virus by host cell', 1212, 'Calcitriol catabolismTrophoblast'), ('CL_0000635', ""Deiter's cell"", 1248, 'Decidual cells'), ('PR_000006081', 'NADH-cytochrome b5 reductase 2', 1267, 'CYP27B1Bone'), ('CHEBI_46662', 'mineral', 1283, 'mineral'), ('GO_0008152', 'metabolic process', 1291, 'metabolism'), ('CHEBI_17823', 'calcitriol', 1302, 'Calcitriol'), ('PR_000001470', 'interleukin-28B', 1337, 'IL-10'), ('PR_000001470', 'interleukin-28B', 1344, 'Interleukin 10'), ('PR_000000793', 'voltage-gated potassium channel KCNH4', 1417, 'KCNH1'), ('PR_000004587', 'beta-1,3-galactosyltransferase 6', 1441, '-gated'), ('GO_0008219', 'cell death', 1456, 'Cell life ... death'), ('PR_000004968', 'calretinin', 1499, 'Calbindin-D 28'), ('CHEBI_46662', 'mineral', 1526, 'mineral'), ('GO_0008152', 'metabolic process', 1534, 'metabolism'), ('CHEBI_31341', 'calcium dihydroxide', 1545, 'Calcium'), ('PR_000004998', 'calmodulin-regulated spectrin-associated protein 1', 1579, 'Calbindin-D'), ('CHEBI_46662', 'mineral', 1605, 'mineral'), ('GO_0008152', 'metabolic process', 1613, 'metabolism'), ('CHEBI_31341', 'calcium dihydroxide', 1624, 'Calcium'), ('NCBITaxon_9606', 'Homo sapiens', 1660, 'human'), ('PR_000005170', 'CD37 molecule', 1666, 'chorionic gonadotrophin'), ('UBERON_0003124', 'chorion', 1666, 'chorionic'), ('GO_0008219', 'cell death', 1690, 'Cell life ... death'), ('GO_0006412', 'translation', 1728, 'pregnancyTrophoblast'), ('CHEBI_36864', '25-hydroxy steroid', 1760, '3β-hydroxysteroid'), ('GO_0008219', 'cell death', 1794, 'Cell life ... death'), ('UBERON_0000104', 'life cycle', 1799, 'life'), ('CHEBI_17026', 'progesterone', 1814, 'Progesterone'), ('GO_0072598', 'protein localization to chloroplast', 1814, 'Progesterone synthesisTrophoblast'), ('PR_000006100', 'aromatase', 1851, 'CYP19'), ('GO_0008219', 'cell death', 1870, 'Cell life ... death'), ('UBERON_0000104', 'life cycle', 1875, 'life'), ('CHEBI_4856', 'esmolol', 1890, 'Estradiol'), ('GO_0072596', 'establishment of protein localization to chloroplast', 1890, 'Estradiol synthesisTrophoblast'), ('PR_000013039', 'POU domain, class 3, transcription factor 2', 1924, 'ProlactinCell'), ('GO_0006266', 'DNA ligation', 1938, 'life ... death'), ('GO_0006884', 'cell volume homeostasis', 1953, 'Establishment of pregnancyDecidual cells'), ('CL_0000573', 'retinal cone cell', 1988, 'cells'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1998, 'VDRBone'), ('CHEBI_46662', 'mineral', 2010, 'mineral'), ('GO_0008152', 'metabolic process', 2018, 'metabolism'), ('CHEBI_17823', 'calcitriol', 2038, 'calcitriol'), ('CL_0000233', 'platelet', 2071, 'Platelet'), ('GO_0030168', 'platelet activation', 2071, 'Platelet-activating'), ('GO_0007608', 'sensory perception of smell', 2127, '... death'), ('CL_0000233', 'platelet', 2149, 'platelet'), ('GO_0030168', 'platelet activation', 2149, 'platelet-activating'), ('CL_0000235', 'macrophage', 2184, 'macrophages'), ('PR_000008689', 'homeobox protein Hox-A13', 2200, 'HOXA10'), ('PR_000008469', 'holocytochrome c-type synthase', 2208, 'Homeobox A10'), ('GO_0008219', 'cell death', 2221, 'Cell life ... death'), ('UBERON_0000104', 'life cycle', 2226, 'life'), ('GO_0007601', 'visual perception', 2241, 'Embryo'), ('UBERON_0000922', 'embryo', 2241, 'Embryo'), ('GO_0007446', 'imaginal disc growth', 2248, 'implantationDecidual'), ('PR_000021995', 'dual specificity mitogen-activated protein kinase kinase 4 phosphorylated form', 2279, 'OsteopontinBone'), ('CHEBI_46662', 'mineral', 2299, 'mineral'), ('GO_0008152', 'metabolic process', 2307, 'metabolism'), ('UBERON_0000922', 'embryo', 2318, 'Embryo'), ('GO_0007446', 'imaginal disc growth', 2325, 'implantationDecidual'), ('CL_0000573', 'retinal cone cell', 2346, 'cells'), ('PR_000000035', 'BMP receptor type-1A', 2356, 'HBD2Immune'), ('PR_000000035', 'BMP receptor type-1A', 2412, 'HBD3Immune'), ('CHEBI_27300', 'vitamin D', 2590, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 2624, 'Endocrine'), ('CHEBI_28384', 'vitamin K', 2648, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 2648, 'Vitamin'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 2678, '25OHD'), ('UBERON_0005063', 'left ventricular compact myocardium', 2847, 'Endocrine')]"
S0-PMC4329404	PMC4329404	10/2014	S0-PMC4329404	['Vitamin D deficiency induces th2 skewing and Eosinophilia in neonatal allergic Airways disease\n\nabstract\n\nbackground\nASSOCIATIONS between Vitamin D status and childhood asthma are increasingly REPORTED, but direct causation and mechanisms UNDERLYING an EFFECT remain UNKNOWN.']	[('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 239), ('SUPERFICIAL_RELATIONSHIP', 253), ('FULL_UNKNOWN', 267)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CL_0000771', 'eosinophil', 45, 'eosinophilia'), ('UBERON_0001005', 'respiratory airway', 79, 'airways'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D')]
S21-PMC4329404	PMC4329404	10/2014	S21-PMC4329404	"[""maternal Vitamin D status during Pregnancy MAY also determine risk of asthma Development RATHER than the child's own Vitamin D levels.""]"	[('INCOMPLETE_EVIDENCE', 43), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 89)]	2	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('GO_0008289', 'lipid binding', 77, 'development'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
S24-PMC4329404	PMC4329404	10/2014	S24-PMC4329404	['CONVERSELY, maternal Vitamin D status HAS BEEN REPORTED to have no associations with asthma or wheeze (19,20).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 38)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
S115-PMC4329404	PMC4329404	10/2014	S115-PMC4329404	['additionally, Pulmonary Il-10 remained the same in all hdm challenged pups and was not influenced by Vitamin D status EVEN THOUGH numbers of Cd4+il-10+cells were reduced with Vitamin D insufficiency (figs3d and4b).']	[('ANOMALY_CURIOUS_FINDING', 118), ('ANOMALY_CURIOUS_FINDING', 123)]	2	[('UBERON_0002048', 'lung', 14, 'pulmonary'), ('PR_000001470', 'interleukin-28B', 24, 'IL-10'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('PR_000001204', 'C-C chemokine receptor type 8', 141, 'CD4'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D')]
S119-PMC4329404	PMC4329404	10/2014	S119-PMC4329404	['Vitamin D supplementation reduces Airway collagen in hdm-exposed pups\nGoblet Cell hyperplasia was evident in hdm-exposed pups; HOWEVER, Vitamin D status did not alter this (fig.5a).']	[('ANOMALY_CURIOUS_FINDING', 127)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0001005', 'respiratory airway', 34, 'airway'), ('CL_0000160', 'goblet cell', 70, 'Goblet cell'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
S140-PMC4329404	PMC4329404	10/2014	S140-PMC4329404	['ours is the FIRST STUDY TO INVESTIGATE the IMPACT of maternal Vitamin D status on early-Life allergic inflammation.']	[('INCOMPLETE_EVIDENCE', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('SUPERFICIAL_RELATIONSHIP', 43)]	3	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0000104', 'life cycle', 88, 'life')]
S147-PMC4329404	PMC4329404	10/2014	S147-PMC4329404	['this highlights the IMPORTANCE of age and Vitamin D status on Lung function in Adults COMPARED TO in utero and early-Life deficiency.']	[('IMPORTANT_CONSIDERATION', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0002048', 'lung', 62, 'lung'), ('UBERON_0007023', 'adult organism', 79, 'adults'), ('UBERON_0000104', 'life cycle', 117, 'life')]
S150-PMC4329404	PMC4329404	10/2014	S150-PMC4329404	['studies in asthmatic children HAVE SHOWN ASSOCIATIONS between low Vitamin D status and increased use of inhaled Steroids (34), SUGGESTING the immunomodulatory EFFECTS of Vitamin D MAY impact on efficacy of Steroids.']	[('INCOMPLETE_EVIDENCE', 30), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 159), ('INCOMPLETE_EVIDENCE', 180)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_35341', 'steroid', 112, 'steroids'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('CHEBI_35341', 'steroid', 206, 'steroids')]
S151-PMC4329404	PMC4329404	10/2014	S151-PMC4329404	['data from Adult studies SHOW an ASSOCIATION between Vitamin D status and Steroid response (23).']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 32)]	2	[('UBERON_0007023', 'adult organism', 10, 'adult'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_35341', 'steroid', 73, 'steroid')]
S12-PMC4329745	PMC4329745	10/2014	S12-PMC4329745	['IN ORDER to obtain a better estimation of the Vitamin D status in iran, STUDIES encompassing different populations in various age and sex groups ARE REQUIRED.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('FUTURE_WORK', 72), ('FUTURE_WORK', 145), ('IMPORTANT_CONSIDERATION', 149)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D')]
S13-PMC4329745	PMC4329745	10/2014	S13-PMC4329745	['FEW STUDIES HAVE BEEN performed on Vitamin D status in this country, focused mainly on Pregnant or elderly women (5,6).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 12)]	2	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 87, 'pregnant')]
S65-PMC4329745	PMC4329745	10/2014	S65-PMC4329745	['Serum 25-Ohd level is the BEST INDICATOR of Vitamin D status in Individuals (7).']	[('IMPORTANT_CONSIDERATION', 26), ('SUPERFICIAL_RELATIONSHIP', 31)]	2	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_72765', 'verruculogen', 6, '25-OHD'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('NCBITaxon_1', 'root', 64, 'individuals')]
S69-PMC4329745	PMC4329745	10/2014	S69-PMC4329745	['DEMONSTRATED that low early-Pregnancy Vitamin D status was ASSOCIATED with more depressive symptoms in Pregnancy (11).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 59)]	2	[('GO_0007565', 'female pregnancy', 28, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0007565', 'female pregnancy', 103, 'pregnancy')]
S92-PMC4329745	PMC4329745	10/2014	S92-PMC4329745	['at first glance, it SEEMS that the MAJOR cause for these very low levels of Vitamin D in iranian women is the highly covered type of dressing in iran, BUT this would not rationalize the low vitamin status in iranian men (8,9).']	[('ANOMALY_CURIOUS_FINDING', 20), ('IMPORTANT_CONSIDERATION', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 151)]	3	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
S95-PMC4329745	PMC4329745	10/2014	S95-PMC4329745	['THIS STUDY was performed on Vitamin D status specially on women .we did have some LIMITATIONS in our work; detailed diet habits of the participants as well as rates of sun exposure were NOT CONSIDERED in the method BECAUSE of practical DIFFICULTIES.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 82), ('INCOMPLETE_EVIDENCE', 186), ('PROBLEM_COMPLICATION', 215), ('DIFFICULT_TASK', 236)]	5	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
S93-PMC4340999	PMC4340999	3/2015	S93-PMC4340999	['INCONSISTENT findings and MIXED explanations of underlying mechanism HAVE BEEN REPORTED, including SPECULATION that early temperature exposure is ASSOCIATED with physiological Regulation Of Birth Weight or that extremely low ambient temperature INFLUENCES the Conceived Embryo or the selection of the Sperm that fuses with the Ovum.19–21HOWEVER, the findings from the current study APPEARED to more strongly SUGGEST the POSSIBLE etiological ROLE of Prenatal maternal exposure to ultraviolet b radiation (uvb) and Vitamin D status in Adult chronic diseases.29–31\nsun exposure provides one of the MAJOR ways to meet Vitamin D REQUIREMENTS during Pregnancy, ESPECIALLY for those of older generations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 26), ('INCOMPLETE_EVIDENCE', 69), ('INCOMPLETE_EVIDENCE', 99), ('SUPERFICIAL_RELATIONSHIP', 146), ('SUPERFICIAL_RELATIONSHIP', 176), ('SUPERFICIAL_RELATIONSHIP', 245), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 334), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 335), ('ANOMALY_CURIOUS_FINDING', 382), ('INCOMPLETE_EVIDENCE', 408), ('INCOMPLETE_EVIDENCE', 420), ('SUPERFICIAL_RELATIONSHIP', 441), ('IMPORTANT_CONSIDERATION', 595), ('IMPORTANT_CONSIDERATION', 624), ('IMPORTANT_CONSIDERATION', 655)]	16	[('GO_0009937', 'regulation of gibberellic acid mediated signaling pathway', 176, 'regulation of birth weight'), ('GO_0070268', 'cornification', 260, 'conceived'), ('UBERON_0000922', 'embryo', 270, 'embryo'), ('CL_0000019', 'sperm', 301, 'sperm'), ('UBERON_0000978', 'leg', 327, 'ovum'), ('GO_0007565', 'female pregnancy', 449, 'prenatal'), ('CHEBI_27300', 'vitamin D', 513, 'vitamin D'), ('UBERON_0007023', 'adult organism', 533, 'adult'), ('CHEBI_27300', 'vitamin D', 614, 'vitamin D'), ('GO_0007565', 'female pregnancy', 644, 'pregnancy')]
S94-PMC4340999	PMC4340999	3/2015	S94-PMC4340999	['for latitudes with distinct seasonal changes in availability of uvb, there is a WELL-DOCUMENTED seasonal cycle in Vitamin D status, with a maximum in late summer and a minimum in late winter.32low Vitamin D during Gestation MAY STRONGLY INFLUENCE susceptibility to obesity later in Life.33\nhowever, relatively LITTLE IS KNOWN about the critical period of fetal growth at which low Vitamin D is of particular IMPORTANCE.']	[('PROBABLE_UNDERSTANDING', 80), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 224), ('PROBABLE_UNDERSTANDING', 228), ('SUPERFICIAL_RELATIONSHIP', 237), ('FULL_UNKNOWN', 310), ('IMPORTANT_CONSIDERATION', 408)]	7	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D'), ('GO_0007565', 'female pregnancy', 214, 'gestation'), ('UBERON_0000104', 'life cycle', 282, 'life'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D')]
S99-PMC4340999	PMC4340999	3/2015	S99-PMC4340999	['FURTHER STUDIES ARE WARRANTED to test the ASSOCIATION between Prenatal Vitamin D status and Adult adiposity in an Adult population older than 35 years.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 42)]	3	[('GO_0007565', 'female pregnancy', 62, 'prenatal'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0007023', 'adult organism', 92, 'adult'), ('UBERON_0007023', 'adult organism', 114, 'adult')]
S101-PMC4340999	PMC4340999	3/2015	S101-PMC4340999	['month of Birth and three trimesters in relation to the calendar month of year, season, and the level of uvb radiation\nto OUR KNOWLEDGE, NO PREVIOUS STUDY has examined the RELATIONSHIP between Prenatal Vitamin D status and ll.']	[('PROBABLE_UNDERSTANDING', 121), ('FULL_UNKNOWN', 136), ('SUPERFICIAL_RELATIONSHIP', 171)]	3	[('GO_0007567', 'parturition', 9, 'birth'), ('GO_0007565', 'female pregnancy', 192, 'prenatal'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D')]
S102-PMC4340999	PMC4340999	3/2015	S102-PMC4340999	['ll in the PRESENT STUDY followed an opposite seasonal TREND to that of Adult adiposity measures, for which maternal uvb exposure (and HENCE Vitamin D status) is STILL a reasonable EXPLANATION.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('INCOMPLETE_EVIDENCE', 54), ('PROBABLE_UNDERSTANDING', 134), ('IMPORTANT_CONSIDERATION', 161), ('PROBABLE_UNDERSTANDING', 180)]	5	[('UBERON_0007023', 'adult organism', 71, 'adult'), ('CHEBI_27300', 'vitamin D', 140, 'vitamin D')]
S106-PMC4340999	PMC4340999	3/2015	S106-PMC4340999	['lucas et al FOUND that seasonal variation in Vitamin D status in australian Adults (living in an area spanning 27°–43° south) had greater amplitude compared to australian Adults living in a different region, and Vitamin D deficiency increased with increasing latitude, REFLECTING stronger seasonal variation in ambient uvb and less skin exposure due to colder temperatures.38hunan, being another site presenting seasonal variation in ll, has lower latitude than seven other study sites but the greatest yearly sunshine variation of all the study sites (seeetable 1).']	[('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 269)]	2	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0007023', 'adult organism', 76, 'adults'), ('UBERON_0007023', 'adult organism', 171, 'adults'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D')]
S107-PMC4340999	PMC4340999	3/2015	S107-PMC4340999	['besides significant seasonal variation in sunshine, peak and trough windows are also SUPPOSED to last long enough to INFLUENCE Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('SUPERFICIAL_RELATIONSHIP', 117)]	2	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
S109-PMC4340999	PMC4340999	3/2015	S109-PMC4340999	['results in the PRESENT STUDY IMPLY that Prenatal Vitamin D status MIGHT be a POTENTIAL pathway LINKING ll with Adult risks of obesity39,40and a range of chronic diseases.8–10HOWEVER, seasonal variation in ll DEPENDING ON region SUGGESTS that ll CAN ONLY be used as anthropometric BIOMARKER of Prenatal Vitamin D status in SOME geographic regions.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('PROBABLE_UNDERSTANDING', 29), ('INCOMPLETE_EVIDENCE', 66), ('INCOMPLETE_EVIDENCE', 77), ('SUPERFICIAL_RELATIONSHIP', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 172), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 208), ('INCOMPLETE_EVIDENCE', 228), ('INCOMPLETE_EVIDENCE', 245), ('INCOMPLETE_EVIDENCE', 249), ('SUPERFICIAL_RELATIONSHIP', 280), ('INCOMPLETE_EVIDENCE', 322)]	12	[('GO_0007565', 'female pregnancy', 40, 'prenatal'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0007023', 'adult organism', 111, 'adult'), ('GO_0007565', 'female pregnancy', 293, 'prenatal'), ('CHEBI_27300', 'vitamin D', 302, 'vitamin D')]
S89-PMC4346113	PMC4346113	3/2015	S89-PMC4346113	['low maternal Protein Consumption or poor Vitamin B and methionine status are ASSOCIATED with behavioral and Cardiovascular abnormalities, and sex-specific changes in Hepatic Gene Expression in Rat fetuses and changes in Imprinted Gene Expression in the Rat Embryo-fetal axis [40,74-76].']	[('SUPERFICIAL_RELATIONSHIP', 77)]	1	[('GO_0006412', 'translation', 13, 'protein consumption'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin B'), ('UBERON_0004535', 'cardiovascular system', 108, 'cardiovascular'), ('UBERON_0002107', 'liver', 166, 'hepatic'), ('GO_0010467', 'gene expression', 174, 'gene expression'), ('SO_0000704', 'gene', 174, 'gene'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 193, 'rat'), ('GO_0071514', 'genetic imprinting', 220, 'imprinted'), ('GO_0010467', 'gene expression', 230, 'gene expression'), ('SO_0000704', 'gene', 230, 'gene'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 253, 'rat'), ('UBERON_0000922', 'embryo', 257, 'embryo')]
S162-PMC4377870	PMC4377870	3/2015	S162-PMC4377870	['copd progression MAY also be AFFECTED by Vitamin D status through absence of the Vitamin D receptor and Parenchyma degradation [128].']	[('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 29)]	2	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('UBERON_0000353', 'parenchyma', 104, 'parenchyma')]
S178-PMC4377870	PMC4377870	3/2015	S178-PMC4377870	['a SMALL STUDY in sweden FOUND that in older subjects with SEVERE copd, Intakes of Folic Acid and Selenium were below recommended levels, and although intake of calcium was adequate, Serum calcium levels were low, LIKELY RELATED to their Vitamin D status AS Intake was lower than recommended [141].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 24), ('IMPORTANT_CONSIDERATION', 58), ('PROBABLE_UNDERSTANDING', 213), ('SUPERFICIAL_RELATIONSHIP', 220), ('PROBABLE_UNDERSTANDING', 254)]	6	[('GO_0007631', 'feeding behavior', 71, 'intakes'), ('CHEBI_30751', 'formic acid', 82, 'folic acid'), ('CHEBI_27568', 'selenium atom', 97, 'selenium'), ('UBERON_0001977', 'blood serum', 182, 'serum'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D'), ('GO_0007631', 'feeding behavior', 257, 'intake')]
S128-PMC4377879	PMC4377879	3/2015	S128-PMC4377879	['christian and stewart [52] have SUGGESTED a conceptual FRAMEWORK for HOW Maternal diet and Micronutrient status MAY EFFECT the development of chronic disease; the MOST LIKELY, GIVEN PRESENT KNOWLEDGE, SEEM to be Vitamin A, Folate, iron and zinc and PERHAPS calcium and magnesium AS SHOWN in their conceptual framework (figure 1).']	[('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 55), ('EXPLICIT_QUESTION', 69), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 116), ('PROBABLE_UNDERSTANDING', 163), ('PROBABLE_UNDERSTANDING', 168), ('INCOMPLETE_EVIDENCE', 176), ('PROBABLE_UNDERSTANDING', 176), ('INCOMPLETE_EVIDENCE', 182), ('ANOMALY_CURIOUS_FINDING', 201), ('INCOMPLETE_EVIDENCE', 249), ('INCOMPLETE_EVIDENCE', 279)]	13	[('GO_0007618', 'mating', 73, 'maternal'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 91, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin A'), ('CHEBI_30863', '5-azaorotic acid', 223, 'folate')]
S181-PMC4377879	PMC4377879	3/2015	S181-PMC4377879	['oral supplementation of urban indian women with Vitamin B-12 throughout Pregnancy and early Lactation significantly increased Vitamin B-12 status of both mothers and infants [9] and so WORTH CONSIDERING where Vitamin B12 intakes are marginal.']	[('IMPORTANT_CONSIDERATION', 185), ('FUTURE_WORK', 191)]	2	[('CHEBI_27300', 'vitamin D', 48, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 48, 'vitamin B-12'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('GO_0007595', 'lactation', 92, 'lactation'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 126, 'vitamin B-12'), ('CHEBI_33279', 'vitamin D5', 209, 'vitamin B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 217, 'B12')]
S0-PMC4380518	PMC4380518	9/2014	S0-PMC4380518	['Prenatal Vitamin use and Vitamin D status during Pregnancy, differences by race and overweight status\n\nabstract\n\nobjective\nwe AIMED TO STUDY WHETHER Prenatal Vitamin (pnv) use PROTECTS against low 25(Oh)D levels in all women and PARTICULARLY in obese and black women who are both AT RISK of Vitamin D deficiency and poor pregnancy outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 126), ('QUESTION_ANSWERED_BY_THIS_WORK', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 141), ('SUPERFICIAL_RELATIONSHIP', 176), ('IMPORTANT_CONSIDERATION', 229), ('IMPORTANT_CONSIDERATION', 280)]	6	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_33229', 'vitamin (role)', 9, 'Vitamin'), ('CHEBI_28384', 'vitamin K', 25, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 49, 'Pregnancy'), ('GO_0007565', 'female pregnancy', 149, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 158, 'vitamin'), ('CHEBI_71657', 'versiconol acetate', 197, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 203, 'D'), ('CHEBI_27300', 'vitamin D', 291, 'vitamin D')]
S7-PMC4380518	PMC4380518	9/2014	S7-PMC4380518	['introduction\nPerinatal health outcomes VARY dramatically by race in the united states.1african american women develop Preeclampsia more OFTEN than their white counterparts2and are more LIKELY to develop preterm labor.3the result is that black infants are 60% more LIKELY BE preterm and four times more LIKELY to die due to prematurity than white infants.1BECAUSE of less efficient Vitamin D Synthesis in the skin of darker Pigmented Individuals, african americans are at higher RISK than white americans of Vitamin D deficiency.4,5black women are also more LIKELY than white women to be overweight or obese6which is of CONCERN BECAUSE obesity is another RISK FACTOR for Vitamin D deficiency5,7and poor Perinatal outcomes.8in OBSERVATIONAL studies, 25-Hydroxyvitamin D (25[Oh]D) levels HAVE BEEN SHOWN to be ASSOCIATED with higher risk of several adverse Perinatal outcomes including Gestational diabetes9,10, preeclampsia,11preterm Birth12And small-for-Gestational age status.13,14,15,16,17BECAUSE of the PAUCITY of Vitamin D trial data with respect to Perinatal outcomes, WHETHER DIFFERENCES in Vitamin D status during Pregnancy explains or partially explains Perinatal DISPARITIES is PLAUSIBLE18but REMAINS UNKNOWN.']	[('DIFFICULT_TASK', 39), ('PROBABLE_UNDERSTANDING', 136), ('PROBABLE_UNDERSTANDING', 185), ('PROBABLE_UNDERSTANDING', 264), ('PROBABLE_UNDERSTANDING', 302), ('PROBABLE_UNDERSTANDING', 355), ('IMPORTANT_CONSIDERATION', 478), ('PROBABLE_UNDERSTANDING', 557), ('PROBLEM_COMPLICATION', 619), ('PROBABLE_UNDERSTANDING', 627), ('SUPERFICIAL_RELATIONSHIP', 654), ('INCOMPLETE_EVIDENCE', 725), ('INCOMPLETE_EVIDENCE', 785), ('SUPERFICIAL_RELATIONSHIP', 807), ('PROBABLE_UNDERSTANDING', 990), ('INCOMPLETE_EVIDENCE', 1005), ('EXPLICIT_QUESTION', 1073), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1081), ('IMPORTANT_CONSIDERATION', 1171), ('INCOMPLETE_EVIDENCE', 1186), ('FULL_UNKNOWN', 1201)]	21	[('GO_0036268', 'swimming', 13, 'Perinatal'), ('UBERON_0012101', 'perinatal stage', 13, 'Perinatal'), ('GO_0007128', 'meiotic prophase I', 118, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 381, 'vitamin D synthesis'), ('CHEBI_26130', 'biological pigment', 423, 'pigmented'), ('NCBITaxon_1', 'root', 433, 'individuals'), ('CHEBI_27300', 'vitamin D', 507, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 670, 'vitamin D'), ('GO_0036268', 'swimming', 702, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 702, 'perinatal'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 748, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 769, '25[OH]D'), ('GO_0036268', 'swimming', 854, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 854, 'perinatal'), ('GO_0007565', 'female pregnancy', 883, 'gestational'), ('GO_0007594', 'puparial adhesion', 932, 'birth12and'), ('GO_0007565', 'female pregnancy', 953, 'gestational'), ('CHEBI_27300', 'vitamin D', 1016, 'vitamin D'), ('GO_0036268', 'swimming', 1053, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1053, 'perinatal'), ('CHEBI_27300', 'vitamin D', 1096, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1120, 'pregnancy'), ('GO_0036268', 'swimming', 1161, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 1161, 'perinatal')]
S8-PMC4380518	PMC4380518	9/2014	S8-PMC4380518	['furthermore, WHILE multivitamin intake HAS BEEN SHOWN to VARY by race,19it REMAINS UNKNOWN WHETHER multivitamin intake improves Vitamin D status among the HIGHEST RISK groups (african americans and overweight/obese) during Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('INCOMPLETE_EVIDENCE', 39), ('DIFFICULT_TASK', 57), ('FULL_UNKNOWN', 75), ('EXPLICIT_QUESTION', 91), ('IMPORTANT_CONSIDERATION', 155)]	6	[('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('GO_0007565', 'female pregnancy', 223, 'pregnancy')]
S51-PMC4380518	PMC4380518	9/2014	S51-PMC4380518	['in ANOTHER STUDY of massachusetts women, black women REPORTED taking periconceptional multivitamins half as often as white women.19additionally, our prevalence of Vitamin D deficiency is SIMILAR TO that REPORTED in nhanes24and in another boston cohort, project viva.13,25others have ANALYZED the ASSOCIATION between pnv use and Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 187), ('INCOMPLETE_EVIDENCE', 203), ('INCOMPLETE_EVIDENCE', 283), ('SUPERFICIAL_RELATIONSHIP', 296)]	6	[('CHEBI_27300', 'vitamin D', 163, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 328, 'vitamin D')]
S66-PMC4380518	PMC4380518	9/2014	S66-PMC4380518	['FUTURE ANALYSES of health EFFECTS of Vitamin D status in this population are PLANNED but beyond the scope of THIS analysis.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 26), ('FUTURE_WORK', 77), ('QUESTION_ANSWERED_BY_THIS_WORK', 109)]	4	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
S68-PMC4380518	PMC4380518	9/2014	S68-PMC4380518	['IN LIGHT OF two RECENT meta-analyses/systematic reviews CONCLUDING that low 25(Oh)D levels during Pregnancy are ASSOCIATED with SEVERAL morbidities in Pregnancy15,16, optimizing Vitamin D status during Pregnancy MAY BE IMPORTANT.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 16), ('PROBABLE_UNDERSTANDING', 56), ('SUPERFICIAL_RELATIONSHIP', 112), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 212), ('IMPORTANT_CONSIDERATION', 219)]	7	[('CHEBI_71657', 'versiconol acetate', 76, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 76, '25 ... OH ... D'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy'), ('GO_0007565', 'female pregnancy', 151, 'pregnancy15'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('GO_0007565', 'female pregnancy', 202, 'pregnancy')]
S31-PMC4396835	PMC4396835	1/2015	S31-PMC4396835	['a NUMBER OF STUDIES in sweden, denmark, uk and north-east usa on season of Birth HAVE SHOWN that more children with asd are Born in winter and spring [42,43], with highest relative rates in march [44,45] SUGGESTING that lower Vitamin D status in the mother during Pregnancy may constitute a risk FACTOR [46].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 81), ('INCOMPLETE_EVIDENCE', 204), ('SUPERFICIAL_RELATIONSHIP', 296)]	4	[('GO_0007567', 'parturition', 75, 'birth'), ('GO_0007567', 'parturition', 124, 'born'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('GO_0007565', 'female pregnancy', 264, 'pregnancy')]
S71-PMC4396835	PMC4396835	1/2015	S71-PMC4396835	['DUE TO the WELL-KNOWN ethnic disparity of Vitamin D status, we chose to categorise the participants into three ethnic origin groups: swedish, miscellaneous (non-scandinavian europe, south america and east asia) and african/middle east.']	[('PROBLEM_COMPLICATION', 0), ('PROBABLE_UNDERSTANDING', 11)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
S89-PMC4396835	PMC4396835	1/2015	S89-PMC4396835	['GIVEN our main HYPOTHESIS of lower Vitamin D status in asd compared to controls, a case COULD BE made for one-tailed tests, HOWEVER, our results are conservatively reported as two-tailed with probabilities <0.05 accepted as significant.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 124)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
S128-PMC4396835	PMC4396835	1/2015	S128-PMC4396835	['ACCORDINGLY, the swedish somali women and women from the middle east SEEM PARTICULARLY vulnerable to low Vitamin D levels, AFFECTING the Vitamin D status of the offspring, PRESUMABLY due to both dark skin [32] and covered clothing.']	[('INCOMPLETE_EVIDENCE', 0), ('ANOMALY_CURIOUS_FINDING', 69), ('ANOMALY_CURIOUS_FINDING', 74), ('SUPERFICIAL_RELATIONSHIP', 123), ('PROBABLE_UNDERSTANDING', 172)]	5	[('CHEBI_27300', 'vitamin D', 105, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
S130-PMC4396835	PMC4396835	1/2015	S130-PMC4396835	['HOWEVER, the LACK OF effect of season of sampling (= season of Birth in OUR STUDY) on 25(Oh)D levels in our african/middle east group, all having low Vitamin D status throughout the year, HAS also BEEN REPORTED in women with african/middle east origin living in norway [59].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 72), ('INCOMPLETE_EVIDENCE', 188), ('INCOMPLETE_EVIDENCE', 202)]	5	[('GO_0007567', 'parturition', 63, 'birth'), ('CHEBI_71657', 'versiconol acetate', 86, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 86, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D')]
S22-PMC4405493	PMC4405493	4/2015	S22-PMC4405493	['HOWEVER, OTHER STUDIES have DEMONSTRATED no association between Vitamin D status and adverse Pregnancy outcomes [11–12].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 28)]	3	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007565', 'female pregnancy', 93, 'pregnancy')]
S62-PMC4405493	PMC4405493	4/2015	S62-PMC4405493	['categorization of Vitamin D status\nRECENTLY published criteria from the institute of medicine were used to categorize Vitamin D status by Plasma 25-Oh Vitamin D concentrations: severe deficiency (<10 ng/ml [25nmol/l]); deficiency (< 20 ng/ml [50nmol/l]); insufficiency (21–29 ng/ml [51–74 nmol/l]); and sufficiency (≥ 30 ng/ml [75nmol/l] [18].']	[('INCOMPLETE_EVIDENCE', 35)]	1	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 138, 'plasma'), ('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 145, '25-OH'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D')]
S117-PMC4405493	PMC4405493	4/2015	S117-PMC4405493	['this study was NOT POWERED to detect ASSOCIATIONS between Vitamin D status and these individual Pregnancy complications.fig 1compares our study population with RECENTLY PUBLISHED cohort studies and randomized controlled trials (reviewed in christesen [2012] and wei [2013]) [13,39].10.1371/journal.pone.0123763.g001\n\ncaption (fig): fig 1\ncomparison of study parameters in recent Vitamin D OBSERVATIONAL and intervention studies.']	[('DIFFICULT_TASK', 15), ('SUPERFICIAL_RELATIONSHIP', 37), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 389)]	4	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 379, 'vitamin D')]
S120-PMC4405493	PMC4405493	4/2015	S120-PMC4405493	['the etiology of the decline of Vitamin D status in women is LIKELY MULTIFACTORIAL, but is due IN PART to increasing bmi and increased sun protection, coupled with decreased dietary intake of Vitamin D, such as milk and other dairy products.']	[('PROBABLE_UNDERSTANDING', 60), ('DIFFICULT_TASK', 67), ('INCOMPLETE_EVIDENCE', 94)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
S133-PMC4405493	PMC4405493	4/2015	S133-PMC4405493	['these levels are CONSIDERED to be an accurate representation of the Vitamin D status of an Individual [1,45].']	[('INCOMPLETE_EVIDENCE', 17)]	1	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('NCBITaxon_1', 'root', 91, 'individual')]
S175-PMC4405493	PMC4405493	4/2015	S175-PMC4405493	['this study was NOT POWERED to detect ASSOCIATIONS between Vitamin D status and these individual complications of Pregnancy.']	[('DIFFICULT_TASK', 15), ('SUPERFICIAL_RELATIONSHIP', 37)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy')]
S0-PMC4427001	PMC4427001	4/2015	S0-PMC4427001	['Vitamin D status in women with Gestational diabetes mellitus during Pregnancy and Postpartum\n\nabstract\nof many Vitamin D Extraskeletal functions, its modulatory ROLE in Insulin secretion and action is ESPECIALLY RELEVANT for Gestational diabetes mellitus (gdm).']	[('SUPERFICIAL_RELATIONSHIP', 161), ('IMPORTANT_CONSIDERATION', 201), ('SUPERFICIAL_RELATIONSHIP', 212)]	3	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 31, 'Gestational'), ('GO_0007565', 'female pregnancy', 68, 'Pregnancy'), ('GO_0007567', 'parturition', 82, 'Postpartum'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 121, 'extraskeletal'), ('PR_000045358', 'insulin family protein', 169, 'insulin'), ('GO_0007565', 'female pregnancy', 225, 'gestational')]
S1-PMC4427001	PMC4427001	4/2015	S1-PMC4427001	['the AIMS of the PRESENT STUDY were TO DETERMINE Midgestational and early Postpartum Vitamin D status in Pregnant women with and without gdm and to describe the RELATIONSHIP between Midgestational and Postpartum Vitamin D status and parallel changes of Glucose tolerance.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('SUPERFICIAL_RELATIONSHIP', 160)]	4	[('GO_0007507', 'heart development', 48, 'midgestational'), ('GO_0007565', 'female pregnancy', 73, 'postpartum'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0007565', 'female pregnancy', 104, 'pregnant'), ('GO_0007507', 'heart development', 181, 'midgestational'), ('GO_0007565', 'female pregnancy', 200, 'postpartum'), ('CHEBI_27300', 'vitamin D', 211, 'vitamin D'), ('CHEBI_17234', 'glucose', 252, 'glucose')]
S29-PMC4427001	PMC4427001	4/2015	S29-PMC4427001	"[""circulating Plasma concentration of 25(Oh)D IS CONSIDERED the MOST RELIABLE INDICATOR of Individual's Vitamin D status.""]"	[('INCOMPLETE_EVIDENCE', 44), ('PROBABLE_UNDERSTANDING', 62), ('IMPORTANT_CONSIDERATION', 67), ('SUPERFICIAL_RELATIONSHIP', 76)]	4	[('UBERON_0001969', 'blood plasma', 12, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 36, '25(OH)D'), ('NCBITaxon_1', 'root', 89, 'individual'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
S38-PMC4427001	PMC4427001	4/2015	S38-PMC4427001	['currently, LITTLE IS KNOWN about Postpartum Vitamin D status in women with history of gdm and POSSIBLE RELATIONSHIP between 25(Oh)D Plasma levels measured at the time of gdm diagnosis and the degree of Glucose (in)tolerance Postpartum.']	[('FULL_UNKNOWN', 11), ('INCOMPLETE_EVIDENCE', 94), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('GO_0007565', 'female pregnancy', 33, 'postpartum'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 124, '25(OH)D'), ('UBERON_0001969', 'blood plasma', 132, 'plasma'), ('CHEBI_17234', 'glucose', 202, 'glucose'), ('GO_0007565', 'female pregnancy', 224, 'postpartum')]
S40-PMC4427001	PMC4427001	4/2015	S40-PMC4427001	['THEREFORE, the AIMS of the PRESENT STUDY were (1) TO DETERMINE Midgestational and early Postpartum Vitamin D status by measuring 25(Oh)D Plasma levels in Pregnant women with and without gdm to CONFIRM the hypothetical deficiency in gdm in central european population and (2) to describe the RELATIONSHIP between Midgestational and Postpartum Vitamin D status and parallel changes of parameters characterising Glucose tolerance.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('QUESTION_ANSWERED_BY_THIS_WORK', 50), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 291)]	6	[('GO_0007507', 'heart development', 63, 'midgestational'), ('GO_0007565', 'female pregnancy', 88, 'postpartum'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 129, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 132, 'OH ... D'), ('UBERON_0001969', 'blood plasma', 137, 'plasma'), ('GO_0007565', 'female pregnancy', 154, 'pregnant'), ('GO_0007507', 'heart development', 312, 'midgestational'), ('GO_0007565', 'female pregnancy', 331, 'postpartum'), ('CHEBI_27300', 'vitamin D', 342, 'vitamin D'), ('CHEBI_17234', 'glucose', 409, 'glucose')]
S113-PMC4427001	PMC4427001	4/2015	S113-PMC4427001	['NEVERTHELESS, Vitamin D levels in asian population are in general lower than in caucasian population and criteria used in her study would classify most european women as having optimal Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]
S126-PMC4427001	PMC4427001	4/2015	S126-PMC4427001	['[43] DID NOT FIND association between maternal Vitamin D status in 559 nondiabetic Pregnant women from south india and the RISK of gdm.']	[('INCOMPLETE_EVIDENCE', 5), ('IMPORTANT_CONSIDERATION', 123)]	2	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnant')]
S556-PMC4448820	PMC4448820	5/2015	S556-PMC4448820	['○ Conjunctival impression cytology HAS BEEN used as a marker for Vitamin A status but has not been widely adopted (324).']	[('INCOMPLETE_EVIDENCE', 35)]	1	[('UBERON_0001811', 'conjunctiva', 2, 'Conjunctival'), ('CHEBI_27300', 'vitamin D', 65, 'vitamin A')]
S584-PMC4448820	PMC4448820	5/2015	S584-PMC4448820	['for instance, neonatal Vitamin A supplementation had a DIFFERENT EFFECT on in vitro whole-Blood cytokine responses DEPENDING ON the sex and the vaccination status of the children (301).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 55), ('SUPERFICIAL_RELATIONSHIP', 65), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 115)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin A'), ('UBERON_0000178', 'blood', 90, 'blood')]
S596-PMC4448820	PMC4448820	5/2015	S596-PMC4448820	['important EFFECT modifiers MAY BE population Vitamin A status, age, sex, vaccination status, season, pathogen prevalence, disease type, and disease BURDEN.']	[('SUPERFICIAL_RELATIONSHIP', 10), ('INCOMPLETE_EVIDENCE', 27), ('IMPORTANT_CONSIDERATION', 148)]	3	[('CHEBI_27300', 'vitamin D', 45, 'vitamin A')]
S782-PMC4448820	PMC4448820	5/2015	S782-PMC4448820	['caption (boxed-text): text box 27\u2003\nresearch priorities\n\n● accurate and stable biomarkers of vad\n● EFFECT of Vitamin A supplementation on inflammation and inflammatory markers\n● mechanisms behind the variable clinical outcomes SEEN as a result of the IMPACT of Vitamin A on the different Immune Responses\n● EFFECT of Vitamin A supplementation on neonates and infants <6 mo\n● INFLUENCE of zinc status on vaccine response\n● other CONFOUNDERS in the zinc–vaccine response ASSOCIATION (age, sex, degree of zinc deficiency, etc.)']	[('SUPERFICIAL_RELATIONSHIP', 98), ('INCOMPLETE_EVIDENCE', 226), ('SUPERFICIAL_RELATIONSHIP', 250), ('SUPERFICIAL_RELATIONSHIP', 306), ('SUPERFICIAL_RELATIONSHIP', 374), ('PROBLEM_COMPLICATION', 427), ('SUPERFICIAL_RELATIONSHIP', 468)]	7	[('CHEBI_27300', 'vitamin D', 108, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 260, 'vitamin A'), ('GO_0006955', 'immune response', 287, 'immune responses'), ('UBERON_0002405', 'immune system', 287, 'immune'), ('CHEBI_27300', 'vitamin D', 316, 'vitamin A')]
S1037-PMC4448820	PMC4448820	5/2015	S1037-PMC4448820	['● observational studies IDENTIFIED an inverse ASSOCIATION between asthma risk and Vitamin A status, which MAY BE EXPLAINED by reduction in Serum Retinol due to inflammation.']	[('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 106), ('PROBABLE_UNDERSTANDING', 113)]	4	[('CHEBI_27300', 'vitamin D', 82, 'vitamin A'), ('UBERON_0001977', 'blood serum', 139, 'serum'), ('CHEBI_26536', 'retinoic acid', 145, 'retinol')]
S1039-PMC4448820	PMC4448820	5/2015	S1039-PMC4448820	['Vitamin D\n\n● POOR Prenatal Vitamin D status HAS BEEN IMPLICATED in increased asthma risk and severity in the offspring, ALTHOUGH EVIDENCE TO SUPPORT an IMPORTANT RELATION remains CONTROVERSIAL (577).']	[('IMPORTANT_CONSIDERATION', 13), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 53), ('ANOMALY_CURIOUS_FINDING', 120), ('INCOMPLETE_EVIDENCE', 129), ('IMPORTANT_CONSIDERATION', 152), ('SUPERFICIAL_RELATIONSHIP', 162), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 179)]	8	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 18, 'prenatal'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin D')]
S1243-PMC4448820	PMC4448820	5/2015	S1243-PMC4448820	['● the wg explored aspects of these INTERACTIONS on BIOMARKERS of specific Nutrients including iron, Vitamin A, hemoglobin, zinc, Iodine, Folate, and Vitamins b-6, b-12, c, and d.\n\nwg RECOMMENDATIONS:\n\none or more biomarkers of inflammation SHOULD BE measured in assessments of Micronutrient status in populations with a known or suspected moderate-to-high prevalence of inflammation.']	[('SUPERFICIAL_RELATIONSHIP', 35), ('SUPERFICIAL_RELATIONSHIP', 51), ('FUTURE_WORK', 183), ('FUTURE_WORK', 240)]	4	[('CHEBI_33284', 'nutrient', 74, 'nutrients'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 129, 'iodine'), ('CHEBI_30863', '5-azaorotic acid', 137, 'folate'), ('CHEBI_33277', 'gamma-tocotrienol', 149, 'vitamins'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 277, 'micronutrient')]
S1447-PMC4448820	PMC4448820	5/2015	S1447-PMC4448820	['text box 47 provides a summary of currently available BIOMARKERS of Vitamin A.\n\ncaption (boxed-text): text box 47\u2003\nCURRENTLY available indicators of Vitamin A\n\n● night blindness: primary functional BIOMARKER\n● Serum Retinol:\n○ Retinol in Serum measured by hplc is the most widely used and ACCEPTED INDICATOR for Vitamin A status.']	[('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 198), ('INCOMPLETE_EVIDENCE', 289), ('SUPERFICIAL_RELATIONSHIP', 298)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin A'), ('UBERON_0001977', 'blood serum', 210, 'Serum'), ('CHEBI_26536', 'retinoic acid', 216, 'retinol'), ('CHEBI_27810', 'resorcinol', 227, 'Retinol'), ('UBERON_0001977', 'blood serum', 238, 'serum'), ('CHEBI_27300', 'vitamin D', 312, 'vitamin A')]
S1453-PMC4448820	PMC4448820	5/2015	S1453-PMC4448820	['○ BECAUSE it CORRELATES well with Retinol, rbp measurements CAN be used to ESTIMATE Vitamin A status.']	[('PROBABLE_UNDERSTANDING', 2), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 60), ('INCOMPLETE_EVIDENCE', 75)]	4	[('CHEBI_26536', 'retinoic acid', 34, 'retinol'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin A')]
S1457-PMC4448820	PMC4448820	5/2015	S1457-PMC4448820	['● Retinol isotope dilution: ALTHOUGH not widely used clinically or programmatically, this is the most sensitive BIOMARKER of Vitamin A status to Liver reserves of Vitamin A.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 28), ('SUPERFICIAL_RELATIONSHIP', 112)]	2	[('CHEBI_27810', 'resorcinol', 2, 'Retinol'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin A'), ('UBERON_0002107', 'liver', 145, 'liver'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin A')]
S1471-PMC4448820	PMC4448820	5/2015	S1471-PMC4448820	['BECAUSE Human Milk HAS BEEN SUGGESTED as a POTENTIALLY useful BIOMARKER of Vitamin A status of women and, by extrapolation, of their children and POTENTIALLY OTHER groups within the population (324), it is useful to explore the POTENTIAL IMPACT of inflammation on the use of Breast-Milk Vitamin A concentrations and interpretation.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 62), ('INCOMPLETE_EVIDENCE', 146), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 158), ('INCOMPLETE_EVIDENCE', 228), ('SUPERFICIAL_RELATIONSHIP', 238)]	8	[('NCBITaxon_9606', 'Homo sapiens', 8, 'human'), ('UBERON_0001913', 'milk', 14, 'milk'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin A'), ('UBERON_0000310', 'breast', 275, 'breast'), ('UBERON_0001913', 'milk', 282, 'milk'), ('CHEBI_27300', 'vitamin D', 287, 'vitamin A')]
S1520-PMC4448820	PMC4448820	5/2015	S1520-PMC4448820	['data on the INFLUENCE of inflammation on BIOMARKERS of Vitamin D status are LIMITED.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 76)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D')]
S77-PMC4452099	PMC4452099	6/2015	S77-PMC4452099	['when assessing the benefits of Food fortification, MOSTLY medium SCALE clinical TRIALS are conducted, SO FAR SHOWING that Vitamin D-fortified Foods improve Vitamin D status in Adults [22].']	[('INCOMPLETE_EVIDENCE', 51), ('PROBABLE_UNDERSTANDING', 51), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 109)]	4	[('CHEBI_33290', 'food', 31, 'food'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_33290', 'food', 142, 'foods'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('UBERON_0007023', 'adult organism', 176, 'adults')]
S79-PMC4452099	PMC4452099	6/2015	S79-PMC4452099	['additionally, in finland, where Vitamin D since february 2003 has been added to all liquid Milk products, Margarine and butter, before-after comparisons in various cohorts SHOWED that fortification has improved the Vitamin D status in both children and Adults [23,24].']	[('INCOMPLETE_EVIDENCE', 172)]	1	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('UBERON_0001913', 'milk', 91, 'milk'), ('CHEBI_6784', 'mestranol', 106, 'margarine'), ('CHEBI_27300', 'vitamin D', 215, 'vitamin D'), ('UBERON_0007023', 'adult organism', 253, 'adults')]
S0-PMC4466139	PMC4466139	6/2015	S0-PMC4466139	['high prevalence of Vitamin D deficiency in native versus migrant mothers and newborns in the north of italy: a CALL TO act with a stronger prevention program\n\nabstract\n\nbackground\nVitamin D status during Pregnancy is RELATED to neonatal Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 111), ('SUPERFICIAL_RELATIONSHIP', 217)]	2	[('CHEBI_28384', 'vitamin K', 19, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 19, 'Vitamin D'), ('CHEBI_28384', 'vitamin K', 180, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 204, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
S16-PMC4466139	PMC4466139	6/2015	S16-PMC4466139	['Vitamin D levels during fetal Life and the Neonatal Period MAY play a ROLE in the development of these conditions through epigenetic changes [11], THEREFORE, Vitamin D status during Pregnancy and in the newborn COULD provide IMPORTANT information.']	[('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 70), ('PROBABLE_UNDERSTANDING', 147), ('INCOMPLETE_EVIDENCE', 211), ('IMPORTANT_CONSIDERATION', 225)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0000104', 'life cycle', 30, 'life'), ('UBERON_0007221', 'neonate stage', 43, 'neonatal period'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('GO_0007565', 'female pregnancy', 182, 'pregnancy')]
S17-PMC4466139	PMC4466139	6/2015	S17-PMC4466139	['the AIM of THIS STUDY was TO ASSESS the Vitamin D status in a population of mothers, living in novara (piedmont, north italy, 45° parallel of latitude), at the time of Delivery and in their newborns two days after Birth.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007567', 'parturition', 168, 'delivery'), ('GO_0007567', 'parturition', 214, 'birth')]
S88-PMC4466139	PMC4466139	6/2015	S88-PMC4466139	['these two classifications of Vitamin D status are significantly DIVERGENT and the issue of DESIRABLE Vitamin D levels for a given age is a matter of great DEBATE, especially in the light of the Skeletal and Extraskeletal EFFECTS of Vitamin D (these were NOT BEEN INVESTIGATED in this study).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 64), ('IMPORTANT_CONSIDERATION', 91), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 155), ('SUPERFICIAL_RELATIONSHIP', 221), ('FULL_UNKNOWN', 254)]	5	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0004288', 'skeleton', 194, 'skeletal'), ('UBERON_0001431', 'distal carpal bone 2', 207, 'extraskeletal'), ('CHEBI_27300', 'vitamin D', 232, 'vitamin D')]
S106-PMC4466139	PMC4466139	6/2015	S106-PMC4466139	['these results SHOW a strong ROLE for supplementation in increasing 25Ohd levels and also that supplementation at 400 iu/die is INSUFFICIENT to provide an appropriate Vitamin D status in Pregnant women and their offsprings.']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 28), ('PROBLEM_COMPLICATION', 127)]	3	"[('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 67, '25OHD'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('GO_0007565', 'female pregnancy', 186, 'pregnant')]"
S116-PMC4466139	PMC4466139	6/2015	S116-PMC4466139	['the RELATIONSHIP between 25Ohd levels, ethnicity and supplementation in Pregnancy SUGGESTS a ROLE for Genetic DETERMINANTS for Vitamin D status and STRESSES the IMPORTANCE of Vitamin D integration in preventative STRATEGIES.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 82), ('SUPERFICIAL_RELATIONSHIP', 93), ('SUPERFICIAL_RELATIONSHIP', 110), ('IMPORTANT_CONSIDERATION', 148), ('IMPORTANT_CONSIDERATION', 161), ('FUTURE_WORK', 213)]	7	"[('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 25, '25OHD'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('SO_0000704', 'gene', 102, 'genetic'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D')]"
S118-PMC4466139	PMC4466139	6/2015	S118-PMC4466139	['furthermore, AS maternal Vitamin D deficiency status AFFECTS the newborn, it MAY BE CONSIDERED as a risk FACTOR for other Vitamin D-related disorders in these newborns.']	[('PROBABLE_UNDERSTANDING', 13), ('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 77), ('IMPORTANT_CONSIDERATION', 84), ('SUPERFICIAL_RELATIONSHIP', 105)]	5	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D')]
S120-PMC4466139	PMC4466139	6/2015	S120-PMC4466139	['we DID NOT investigate lifestyle variable such as clothing, outdoor sports activities and socio-economic status of the population and used two different assays re Vitamin D levels in newborns and mothers.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
S121-PMC4466139	PMC4466139	6/2015	S121-PMC4466139	['in conclusion, Vitamin D insufficiency in Pregnancy is widely present in piedmont and it is RELATED to Vitamin D status in newborns.']	[('SUPERFICIAL_RELATIONSHIP', 92)]	1	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0007565', 'female pregnancy', 42, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
S137-PMC4490503	PMC4490503	6/2015	S137-PMC4490503	['gdm develops when beta cell dysfunction coexists, and MAY BE characterised by further abnormalities in adipokine and cytokine profiles, increased Free Fatty Acids (ffa), Triglycerides (tg), low Vitamin D and Endothelial dysfunction.ijms-16-13442-t001_table 1\n\ncaption (table-wrap): table 1\n\nlongitudinal studies of inflammatory markers in prediction of gdm.inflammatory markerfirst author (year)study designgdm statusgdm diagnostic criteriagestational age at testing (weeks)EFFECT in gdmmatching or adjustment for confounderstnf-αkirwan (2002) [63]prospective5 gdm 10 ngt24–28 weeks carpenter and coustan criteria [64]pre-gravid 12–14 weeks 34–36 weekstnf-Α ↑ 34–36 weeks in gdm inversely CORRELATED with Insulin sensitivityfat massgao (2008) [65]nested case-control22 gdm 10 igt 20 ngtunknown12–20 weeks 24–32 weekstnf-Α ↑ in gdm positively CORRELATED with bmi 14–20 weeksn/ageorgiou (2008) [56]nested case-control14 gdm 14 ngt28 weeks adips criteria 1998 [66]11 weeks 24–28 weeksno differenceage ethnicity gravidity parity bmisaucedo (2011) [67]prospective60 gdm 60 ngt24–28 weeks ada criteria 2010 [68]30 weeks 6 weeks 6 months Postpartumtnf-Α ↑ in both groups at 6 weeks Tnf-Α ↑ 6months Postpartum in gdmage weightlopez-tinoco (2012) [69]case-control63 gdm 63 ngt24–28 weeks nddg criteria [70]mean ~29 weekstnf-Α ↑ in gdmbmiguillemette (2014) [71]prospective61 gdm 695 ngt24–28 weeks iadpsg criteria [44]5–16 weeks 24–28 weekstnf-Α ↑ in both groups and ASSOCIATED with Insulin resistanceage bmi tg adiponectin.il-6morrisett (2011) [72]case-control20 gdm 27 ngt26.1 ± 3.7 weeks cda criteria [73]26.1 ± 3.7 weeks 8 weeks post-partumil-6 ↑ in gdm and post-Partum, CORRELATED with Insulin sensitivity and bmibmihassiakos (2015) [74]case-control40 gdm 94 ngt24–28 weeks iadpsg criteria [44]11–14 weekil-6 ↑ in gdm and inversely RELATED to Birth weightmaternal weightleptinkirwan (2002) [63]prospective5 gdm 10 ngt24–28 weeks carpenter and coustan criteria [64]pre-gravid 12–14 weeks 34–36 weeksleptin ↑ across Pregnancy inverse CORRELATION with Insulin sensitivity, BUT non-significant when adjusted for fat massfat massgeorgiou (2008) [56]nested case-control14 gdm 14 ngt28 weeks adips criteria 1998 [66]11 weeks 24–28 weeksno differenceage ethnicity gravidity parity bmiqiu (2004) [75]prospective47 gdm 776 ngt26–28 weeks carpenter and coustan criteria [64]13 weeks10-ng/ml ↑ in leptin ASSOCIATED with 20% ↑ gdmparity bmi family history of non-Insulin dependent diabetesadiponectingeorgiou (2008) [56]nested case-control14 gdm 14 ngt28 weeks adips criteria 1998 [66]11 weeks 24–28 weeksage ethnicity gravidity parity bmimcmanus (2014) [76]case-control36 gdm 37 ngt24–28 weeks cda criteria [73]31 weekadiponectin ↓ gdm and offspringage maternal weightwilliams (2004) [77]nested case-control41 gdm 70 ngt26–28 weeks carpenter and coustan criteria [64]13 week4.6-fold ↑ risk of gdm if adiponectin < 6.4 mcg/ml, overweight women 11-fold ↑ risk of gdmbmilain (2008) [78]nested case-control30 gdm 29 ngt24–28 weeks carpenter and coustan criteria [64]9.3 ± 2.6 weeksadiponectin < 25th 11-fold ↑ risk gdmbmilowe (2010) [57]prospective1481 Pregnant women24–32 weeks 2 h 75 g ogtt unblinded if fpg > 5.8 mmol/l 2 h > 11.1 mmol/l or random Glucose ≥ 8.9 mmol/l24–32 weeks↓ adiponectin ASSOCIATED with ↑ Glucose and bmibmi c-peptide Gestation genderlacroix (2013) [79]prospective38 gdm 407 ngt24–28 weeks iadpsg criteria [44]6–13 week↓ adiponectin ASSOCIATED with ↑ risk gdm (or1.12 per 1 µg/ml ↓ of adiponectin) and ASSOCIATED with Insulin sensitivitybmi hba1cianniello (2013) [39]prospective16 gdm 32 ngt24–28 weeks carpenter and coustan criteria [64]all trimesters↓ adiponectin PREDICTIVE of gdm in overweight/obesen/aweerakiet (2006) [80]prospective60 gdm 299 ngt24–28 weeks carpenter and coustan criteria [64]21–27 weekadiponectin 10 µg/ml has sensitivity of 91% and specificity of 31% for gdmbmirbp-4krzyzanovska (2008) [81]nested case-control20 gdm 22 ngt24–28 weeks carpenter and coustan criteria [64]30 weekrbp-4 ↓ in gdmn/ananda (2013) [82]nested case-control60 gdm 240 ngt24–28 weeks who criteria 2006 [83]11–13 weeksno differencen/aabetew (2013) [84]nested case-control173 gdm 187 ngt24–28 weeks carpenter and coustan criteria [64]16 weeksrbp-4 ↑ in gdm BUT NOT significant after adjustmentmaternal age ethnicityresistinlain (2008) [78]nested case-control30 gdm 29 ngt24–28 weeks carpenter and coustan criteria [64]9.3 ± 2.6 weeksno differencebmigeorgiou (2008) [56]nested case-control14 gdm 14 ngt28 weeks adips criteria 1998 [66]11 weeks 24–28 weeksno differenceage ethnicity gravidity parity bmilowe (2010) [57]prospective1481 Pregnant women24–32 weeks 2 h 75 g ogtt unblinded if fpg > 5.8 mmol/l 2 h > 11.1 mmol/l or Random Glucose ≥ 8.9 mmol/l24–32 weeksnot ASSOCIATED with Glucose or Birth weightbmi c-peptide Gestation gendernanda (2012) [85]nested case-control60 gdm 240 ngt24–28 weeks who criteria 2006 [83]11–13 weeksno differencen/amcmanus (2014) [76]case-control36 gdm 37 ngt24–28 weeks cda criteria [73]31 weeksresistin ↓ in gdm and offspringage maternal weightvisfatinkrzyzanovska (2006) [86]nested case-control64 gdm 30 ngt24–28 weeks carpenter and coustan criteria [64]28–30 weeks 38–40 weeks 2 weeks post-Partumvisfatin ↑ in gdmbmiferreira (2011) [87]case-control100 gdm 300 ngt24–28 weeks who criteria 2006 [83]11–13 weekvisfatin ↑ in gdmn/a\nngt = normal Glucose tolerance; igt = impaired Glucose tolerance; fpg = fasting plasma Glucose; homa-ir = homeostasis model assessment for Insulin resistance; matsuda index = measure of Insulin sensitivity; bmi = body mass index; tg = Triglycerides; n/a = not available; ↓ = decreased levels; ↑ = increased levels; adips = australasian diabetes in Pregnancy society; ada = american diabetes association; nddg = national diabetes data group; iadpsg = international association of diabetes and Pregnancy study group; cda = canadian diabetes association; who = world health organisation.']	[('INCOMPLETE_EVIDENCE', 54), ('SUPERFICIAL_RELATIONSHIP', 474), ('SUPERFICIAL_RELATIONSHIP', 689), ('SUPERFICIAL_RELATIONSHIP', 842), ('SUPERFICIAL_RELATIONSHIP', 1457), ('SUPERFICIAL_RELATIONSHIP', 1665), ('SUPERFICIAL_RELATIONSHIP', 1827), ('SUPERFICIAL_RELATIONSHIP', 2027), ('ANOMALY_CURIOUS_FINDING', 2065), ('SUPERFICIAL_RELATIONSHIP', 2387), ('SUPERFICIAL_RELATIONSHIP', 3275), ('SUPERFICIAL_RELATIONSHIP', 3437), ('SUPERFICIAL_RELATIONSHIP', 3506), ('SUPERFICIAL_RELATIONSHIP', 3670), ('ANOMALY_CURIOUS_FINDING', 4255), ('SUPERFICIAL_RELATIONSHIP', 4764)]	16	[('CHEBI_37958', 'dye', 146, 'free'), ('CHEBI_35366', 'fatty acid', 151, 'fatty acids'), ('CHEBI_17855', 'triglyceride', 170, 'triglycerides'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('UBERON_0001986', 'endothelium', 208, 'endothelial'), ('PR_000000034', 'BMP', 655, '-α'), ('PR_000045358', 'insulin family protein', 705, 'insulin'), ('PR_000000034', 'BMP', 819, '-α'), ('GO_0030254', 'protein secretion by the type III secretion system', 1131, 'postpartumTNF'), ('PR_000000034', 'BMP', 1144, '-α'), ('PR_000000134', 'tumor necrosis factor alpha', 1175, 'TNF-α'), ('GO_0007565', 'female pregnancy', 1191, 'postpartum'), ('PR_000000034', 'BMP', 1314, '-α'), ('PR_000000034', 'BMP', 1433, '-α'), ('PR_000045358', 'insulin family protein', 1473, 'insulin'), ('PR_000000035', 'BMP receptor type-1A', 1636, '-6'), ('GO_0007567', 'parturition', 1657, 'partum'), ('PR_000045358', 'insulin family protein', 1681, 'insulin'), ('PR_000000035', 'BMP receptor type-1A', 1801, '-6'), ('GO_0007567', 'parturition', 1838, 'birth'), ('GO_0007565', 'female pregnancy', 2009, 'pregnancy'), ('PR_000045358', 'insulin family protein', 2044, 'insulin'), ('PR_000045358', 'insulin family protein', 2445, 'insulin'), ('GO_0007565', 'female pregnancy', 3132, 'pregnant'), ('CHEBI_17234', 'glucose', 3230, 'glucose'), ('CHEBI_17234', 'glucose', 3293, 'glucose'), ('GO_0007565', 'female pregnancy', 3322, 'gestation'), ('PR_000045358', 'insulin family protein', 3522, 'insulin'), ('GO_0007565', 'female pregnancy', 4631, 'pregnant'), ('CHEBI_45267', 'praziquantel', 4722, 'random'), ('CHEBI_17234', 'glucose', 4729, 'glucose'), ('CHEBI_17234', 'glucose', 4780, 'glucose'), ('GO_0007567', 'parturition', 4791, 'birth'), ('GO_0007565', 'female pregnancy', 4817, 'gestation'), ('GO_0030164', 'protein denaturation', 5223, 'partumVisfatin'), ('CHEBI_17234', 'glucose', 5374, 'glucose'), ('CHEBI_17234', 'glucose', 5408, 'glucose'), ('CHEBI_17234', 'glucose', 5448, 'glucose'), ('PR_000045358', 'insulin family protein', 5500, 'insulin'), ('PR_000045358', 'insulin family protein', 5547, 'insulin'), ('CHEBI_17855', 'triglyceride', 5596, 'triglycerides'), ('GO_0007565', 'female pregnancy', 5709, 'Pregnancy'), ('GO_0007565', 'female pregnancy', 5853, 'Pregnancy')]
S296-PMC4490503	PMC4490503	6/2015	S296-PMC4490503	['early Pregnancy Vitamin D status HAS BEEN inversely ASSOCIATED with gdm risk [123].']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 52)]	2	[('GO_0007565', 'female pregnancy', 6, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D')]
S2-PMC4499946	PMC4499946	7/2015	S2-PMC4499946	['IMPORTANTLY, LITTLE IS KNOWN about the EFFECT of maternal Vitamin D status on infant linear growth in communities in south asia where stunting is highly prevalent and maternal-infant Vitamin D status is commonly SUBOPTIMAL.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 13), ('SUPERFICIAL_RELATIONSHIP', 39), ('IMPORTANT_CONSIDERATION', 212)]	4	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]
S10-PMC4499946	PMC4499946	7/2015	S10-PMC4499946	['THIS TRIAL is expected to contribute unique INSIGHTS into the EFFECTS of improving maternal-infant Vitamin D status in a low-income setting where stunting and adverse Perinatal outcomes represent SIGNIFICANT PUBLIC HEALTH BURDENS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 5), ('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 62), ('IMPORTANT_CONSIDERATION', 196), ('IMPORTANT_CONSIDERATION', 208)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0036268', 'swimming', 167, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 167, 'perinatal')]
S22-PMC4499946	PMC4499946	7/2015	S22-PMC4499946	['EFFECTS of improvements in Vitamin D status on linear growth in infants and children without rickets have not been widely studied; HOWEVER, in one TRIAL in india, weekly Vitamin D supplementation of low Birth weight infants reduced the risk of stunting in adjusted analyses [14].']	[('SUPERFICIAL_RELATIONSHIP', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('INCOMPLETE_EVIDENCE', 147)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D'), ('GO_0007567', 'parturition', 203, 'birth')]
S23-PMC4499946	PMC4499946	7/2015	S23-PMC4499946	['Vitamin D status is THEREFORE a logical CANDIDATE AS a modifiable nutritional DETERMINANT of linear growth in communities where stunting is prevalent and Vitamin D status is commonly SUBOPTIMAL.']	[('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 40), ('PROBABLE_UNDERSTANDING', 50), ('SUPERFICIAL_RELATIONSHIP', 78), ('IMPORTANT_CONSIDERATION', 183)]	5	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
S27-PMC4499946	PMC4499946	7/2015	S27-PMC4499946	['because maternal Vitamin D status is the PREDOMINANT DETERMINANT of fetal and neonatal Vitamin D stores [18], Prenatal Vitamin D supplementation represents the OPTIMAL approach to testing the EFFECT of improving maternal-infant Vitamin D status on fetal-infant growth and other health outcomes.']	[('PROBABLE_UNDERSTANDING', 41), ('SUPERFICIAL_RELATIONSHIP', 53), ('IMPORTANT_CONSIDERATION', 160), ('SUPERFICIAL_RELATIONSHIP', 192)]	4	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007565', 'female pregnancy', 110, 'prenatal'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D')]
S28-PMC4499946	PMC4499946	7/2015	S28-PMC4499946	['OBSERVATIONAL studies of the ASSOCIATION between maternal Prenatal Vitamin D status and infant anthropometry have yielded CONFLICTING findings [19–23].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122)]	3	[('GO_0007565', 'female pregnancy', 58, 'prenatal'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
S37-PMC4499946	PMC4499946	7/2015	S37-PMC4499946	['HOWEVER, SOME Animal [27] and observational [21,28] studies have SUGGESTED an EFFECT of maternal Prenatal Vitamin D status on growth of the fetus.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 65), ('SUPERFICIAL_RELATIONSHIP', 78)]	4	[('NCBITaxon_33208', 'Metazoa', 14, 'animal'), ('GO_0007565', 'female pregnancy', 97, 'prenatal'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
S94-PMC4499946	PMC4499946	7/2015	S94-PMC4499946	['interventions and control\n\nVitamin D doses\nthe primary OBJECTIVE of the mdig trial is to establish evidence of a causal RELATIONSHIP between maternal-infant Vitamin D status and infant stature.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 55), ('SUPERFICIAL_RELATIONSHIP', 120)]	2	[('CHEBI_28384', 'vitamin K', 27, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
S295-PMC4499946	PMC4499946	7/2015	S295-PMC4499946	['the mdig trial will THEREFORE offer unique INSIGHTS into the EFFECT of improving maternal-infant Vitamin D status in a low-income setting where Vitamin D insufficiency is common and there is a high prevalence of infant linear growth faltering.']	[('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 61)]	3	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
S13-PMC4516377	PMC4516377	6/2015	S13-PMC4516377	['the deficiency of Micronutrients, such as Calcium and Vitamin D, is common in many countries, REGARDLESS OF the nutritional status; HOWEVER, its magnitude is greater in children with excess weight.2,5-7in this context, CONCERNS about the ASSOCIATION between Calcium intake and Serum Vitamin D and Metabolic diseases in children has gained prominence in the scientific world for at least 30 years,8and SEVERAL STUDIES HAVE ATTEMPTED to clarify the several QUESTIONS about the subject,6,9,10as the combination of low Serum 25-Hydroxyvitamin D (25 [Oh] D) and INADEQUATE Calcium Intake HAS BEEN ASSOCIATED with Cardiovascular risk factors such as hypertension, obesity, Metabolic syndrome (ms) and type 2 diabetes mellitus.2,4,5,8that is, the combined deficiency of both Nutrients DESERVE special CONSIDERATION in children.4\nHOWEVER, the RECOMMENDATIONS of Calcium and Vitamin D intake have NOT been PROPOSED for the PREVENTION of noncommunicable chronic diseases, AS the STUDIES are STILL SCARCE, INCONSISTENT and SOMETIMES of poor quality.11ALTHOUGH Vitamin D insufficiency and low Calcium intake are commonly REPORTED, LITTLE IS KNOWN about the EFFECT of these Micronutrients in the prevention and treatment of diseases such as obesity.']	[('INCOMPLETE_EVIDENCE', 94), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 132), ('PROBLEM_COMPLICATION', 219), ('SUPERFICIAL_RELATIONSHIP', 238), ('INCOMPLETE_EVIDENCE', 401), ('IMPORTANT_CONSIDERATION', 417), ('DIFFICULT_TASK', 422), ('INCOMPLETE_EVIDENCE', 422), ('EXPLICIT_QUESTION', 455), ('IMPORTANT_CONSIDERATION', 557), ('INCOMPLETE_EVIDENCE', 583), ('SUPERFICIAL_RELATIONSHIP', 592), ('IMPORTANT_CONSIDERATION', 778), ('FUTURE_WORK', 794), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 822), ('FUTURE_WORK', 835), ('ANOMALY_CURIOUS_FINDING', 888), ('INCOMPLETE_EVIDENCE', 897), ('SUPERFICIAL_RELATIONSHIP', 914), ('PROBABLE_UNDERSTANDING', 962), ('INCOMPLETE_EVIDENCE', 969), ('IMPORTANT_CONSIDERATION', 981), ('INCOMPLETE_EVIDENCE', 987), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 995), ('INCOMPLETE_EVIDENCE', 1012), ('ANOMALY_CURIOUS_FINDING', 1038), ('INCOMPLETE_EVIDENCE', 1109), ('FULL_UNKNOWN', 1119), ('SUPERFICIAL_RELATIONSHIP', 1145)]	29	[('CHEBI_33839', 'macromolecule', 18, 'micronutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 42, 'calcium'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 258, 'calcium'), ('UBERON_0001977', 'blood serum', 277, 'serum'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D'), ('GO_0008152', 'metabolic process', 297, 'metabolic'), ('UBERON_0001977', 'blood serum', 515, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 521, '25-hydroxyvitamin D'), ('CHEBI_15643', '(6R)-6-(L-erythro-1,2-dihydroxypropyl)-7,8-dihydro-6H-pterin', 542, '25 [OH] D'), ('CHEBI_22313', 'alkaline earth metal atom', 568, 'calcium'), ('GO_0007631', 'feeding behavior', 576, 'intake'), ('UBERON_0004535', 'cardiovascular system', 608, 'cardiovascular'), ('GO_0008152', 'metabolic process', 667, 'metabolic'), ('CHEBI_33284', 'nutrient', 768, 'nutrients'), ('CHEBI_22313', 'alkaline earth metal atom', 854, 'calcium'), ('CHEBI_27300', 'vitamin D', 866, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1049, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 1081, 'calcium'), ('CHEBI_33839', 'macromolecule', 1161, 'micronutrients')]
S43-PMC4516377	PMC4516377	6/2015	S43-PMC4516377	['Serum levels of Vitamin D were significantly ASSOCIATED with higher bmi, waist circumference and Serum Triacylglycerols, as well as lower hdl levels.20the authors of this study used the same categorization of Vitamin D levels of the iom, BUT cited another reference.22finally, a longitudinal study in the brazilian amazon region, followed children from 2007 to 2012 with the OBJECTIVE of evaluating the EFFECT of the Fto Gene on bmi modifications during childhood, as well as verifying WHETHER the Vitamin D status COULD modify this EFFECT.']	[('SUPERFICIAL_RELATIONSHIP', 45), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 238), ('QUESTION_ANSWERED_BY_THIS_WORK', 375), ('SUPERFICIAL_RELATIONSHIP', 403), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 486), ('INCOMPLETE_EVIDENCE', 515), ('SUPERFICIAL_RELATIONSHIP', 533)]	7	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('UBERON_0001977', 'blood serum', 97, 'serum'), ('CHEBI_17075', '6-hydroxyhexano-6-lactone', 103, 'triacylglycerols'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D'), ('PR_000007702', 'galactoside alpha-(1,2)-fucosyltransferase 1', 417, 'FTO'), ('SO_0000704', 'gene', 421, 'gene'), ('CHEBI_27300', 'vitamin D', 498, 'vitamin D')]
S442-PMC4586450	PMC4586450	10/2015	S442-PMC4586450	['diet and growth in relation to biochemical outcomes\n\niron status\niron status was INVESTIGATED in RELATION to Food and Nutrient intakes at 1.5 years in the cif subsample (n = 796).60ferritin concentration (a measure of stored iron) was more sensitive to Nutrient intakes (energy-adjusted) than hemoglobin; calcium intake was negatively RELATED to ferritin ( r = −0.22; p< 0.001), and iron, Vitamin C, and fiber intakes were positively RELATED (all p< 0.05).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 81), ('SUPERFICIAL_RELATIONSHIP', 97), ('SUPERFICIAL_RELATIONSHIP', 335), ('SUPERFICIAL_RELATIONSHIP', 434)]	4	[('CHEBI_33290', 'food', 109, 'food'), ('CHEBI_33284', 'nutrient', 118, 'nutrient'), ('CHEBI_33284', 'nutrient', 253, 'nutrient'), ('CHEBI_27300', 'vitamin D', 389, 'vitamin C')]
S566-PMC4586450	PMC4586450	10/2015	S566-PMC4586450	['in the children at preschool ages, the RELATIONSHIP between diet and iron status was explored.60ferritin was negatively ASSOCIATED with calcium and Cows’ milk Intake and positively ASSOCIATED with iron intake, and hemoglobin was positively ASSOCIATED with Vitamin C and fruit and vegetable intake.']	[('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 120), ('SUPERFICIAL_RELATIONSHIP', 181), ('SUPERFICIAL_RELATIONSHIP', 240)]	4	[('NCBITaxon_33208', 'Metazoa', 148, 'cows'), ('GO_0007631', 'feeding behavior', 159, 'intake'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin C')]
S190-PMC4586451	PMC4586451	10/2015	S190-PMC4586451	['a weak ASSOCIATION was FOUND between maternal dietary iron and magnesium Intake and height, particularly sitting height; it was greatly attenuated on full adjustment.19\n\ncaption (table-wrap): table 3\n\nassociations of maternal dietary intakes, iron supplement use, anemia, and Vitamin D status during Pregnancy with measures of offspring growth, Blood pressure, and Bone developmentmeasure in childdietary factoradjustments appliedminimally adjusted resultsfully adjusted resultscommentsheight at 7.5 y, n = 6663 singletons19\niron\nmagnesium\nvitamin c\nminimal: child sex, age at measurement, Pregnancy energy Intake\nfull: plus maternal age, bmi, height, smoking, seb, parity, breastfeeding\nβ = 0.08 (95% ci, 0.05–0.12), p< 0.001\nβ = 0.10 (95% ci, 0.07–0.14), p< 0.001\nβ = 0.05 (95% ci, 0.03–0.08), p< 0.001\nβ = 0.04 (95% ci, 0.01–0.08), p = 0.02\nβ = 0.05 (95% ci, 0.01–0.08), p = 0.04\nβ = 0.02 (95% ci, −0.01 to 0.04), p = 0.2\nregression analysis using standard deviation scores.']	[('SUPERFICIAL_RELATIONSHIP', 7), ('INCOMPLETE_EVIDENCE', 23)]	2	[('GO_0007631', 'feeding behavior', 73, 'intake'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin D'), ('GO_0007565', 'female pregnancy', 300, 'pregnancy'), ('UBERON_0000178', 'blood', 345, 'blood'), ('GO_0007567', 'parturition', 365, 'bone'), ('GO_0007565', 'female pregnancy', 590, 'pregnancy'), ('GO_0007631', 'feeding behavior', 607, 'intake')]
S212-PMC4586451	PMC4586451	10/2015	S212-PMC4586451	['there was also no evidence of an association between maternal Vitamin D status during Pregnancy and offspring bone Mineral content (table 3).24the SUGGESTION that maternal body fat stores are IMPORTANT for fetal bone Mineral deposition was investigated in a further study.25there was NO evidence of an independent association between maternal Prepregnancy bmi and offspring bone mass at age 9 years once adjustments were made for Birth weight and the current height and weight of the child.25\nthese data SUGGEST it is UNLIKELY that Pregnancy diet has an IMPORTANT EFFECT on any of the outcomes investigated in this section, ALTHOUGH the ASSOCIATIONS that were FOUND were with Nutrients that are most LIKELY to be inadequate in the diet of this population.8\n\nNeurocognitive and behavioral development Of the offspring\nBrain Cell Membranes have a high content of n-3 lc-pufas, and the predominant sources of these Nutrients in the diets of uk residents are fish and seafood.']	[('INCOMPLETE_EVIDENCE', 147), ('IMPORTANT_CONSIDERATION', 192), ('INCOMPLETE_EVIDENCE', 284), ('INCOMPLETE_EVIDENCE', 504), ('PROBABLE_UNDERSTANDING', 518), ('IMPORTANT_CONSIDERATION', 554), ('SUPERFICIAL_RELATIONSHIP', 564), ('ANOMALY_CURIOUS_FINDING', 624), ('SUPERFICIAL_RELATIONSHIP', 637), ('INCOMPLETE_EVIDENCE', 660), ('PROBABLE_UNDERSTANDING', 700)]	11	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy'), ('CHEBI_46662', 'mineral', 115, 'mineral'), ('CHEBI_46662', 'mineral', 217, 'mineral'), ('GO_0007565', 'female pregnancy', 343, 'prepregnancy'), ('GO_0007567', 'parturition', 430, 'birth'), ('GO_0007565', 'female pregnancy', 532, 'pregnancy'), ('CHEBI_33284', 'nutrient', 676, 'nutrients'), ('GO_0043102', 'amino acid salvage', 758, 'Neurocognitive ... of ...'), ('UBERON_0000955', 'brain', 817, 'Brain'), ('GO_0005886', 'plasma membrane', 823, 'cell membranes'), ('CHEBI_33284', 'nutrient', 912, 'nutrients')]
S6-PMC4598849	PMC4598849	10/2015	S6-PMC4598849	['THIS STUDY PROVIDES the FIRST epidemiological EVIDENCE that there was an inverted u shaped RELATIONSHIP between neonatal Vitamin D status and fetal growth, and the risk of sga reduced at moderate concentration.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 91)]	5	[('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
S11-PMC4598849	PMC4598849	10/2015	S11-PMC4598849	['the LINK between maternal Vitamin D status and fetal growth, AS measured most frequently by infant Birth weight and small for Gestational age (sga), HAS BEEN explored by a NUMBER OF observational STUDIES9101112131415AND randomized supplementation trials1617181920worldwide with MIXED results.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('PROBABLE_UNDERSTANDING', 61), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 172), ('INCOMPLETE_EVIDENCE', 196), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 278)]	6	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007567', 'parturition', 99, 'birth'), ('GO_0007565', 'female pregnancy', 126, 'gestational')]
S13-PMC4598849	PMC4598849	10/2015	S13-PMC4598849	['EVIDENCES from SOME STUDIES SUPPORT the HYPOTHESIS that lower Vitamin D status causes adverse fetal growth in a linear way, more SEVERE deficiency would be expected to have a stronger EFFECT than less severe deficiency or sufficiency91012131416.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 40), ('IMPORTANT_CONSIDERATION', 129), ('SUPERFICIAL_RELATIONSHIP', 184)]	6	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
S51-PMC4598849	PMC4598849	10/2015	S51-PMC4598849	['currently, there is LIMITED INFORMATION on the ASSOCIATION between fetal Vitamin D status and fetal growth.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 47)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
S55-PMC4598849	PMC4598849	10/2015	S55-PMC4598849	['PREVIOUS STUDIES have several LIMITATIONS including SMALL sample sizes, INCONSISTENT definitions for fetal Vitamin D status, FEW adjustment for confounders and ONLY linear models performed.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72), ('INCOMPLETE_EVIDENCE', 125), ('INCOMPLETE_EVIDENCE', 160)]	6	[('CHEBI_27300', 'vitamin D', 107, 'vitamin D')]
S59-PMC4598849	PMC4598849	10/2015	S59-PMC4598849	['the FINDING that Vitamin D levels in the upper range increased the health RISK in THIS STUDY was CONSISTENT with PREVIOUS STUDIES examining the risk of fetal growth restriction11, Allergic Response3031, lower-extremity function32, frailty status33, as well as Cardiovascular disease3435.']	[('INCOMPLETE_EVIDENCE', 4), ('IMPORTANT_CONSIDERATION', 74), ('QUESTION_ANSWERED_BY_THIS_WORK', 82), ('INCOMPLETE_EVIDENCE', 97), ('INCOMPLETE_EVIDENCE', 113)]	5	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0019267', 'asparagine biosynthetic process from cysteine', 180, 'allergic response3031'), ('UBERON_0004535', 'cardiovascular system', 260, 'cardiovascular')]
S60-PMC4598849	PMC4598849	10/2015	S60-PMC4598849	['ALTHOUGH the neonatal 25(Oh)D levels at Birth cannot fully represent the Vitamin D status during CRITICAL times of Gestation DUE TO a half-life of several weeks of 25(Oh)D34, IT was quite POSSIBLE that the neonates with lower or higher Cord Blood 25(Oh)D levels MAY also have lower or higher average levels of 25(Oh)D during the whole Pregnancy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 97), ('PROBLEM_COMPLICATION', 125), ('ANOMALY_CURIOUS_FINDING', 175), ('INCOMPLETE_EVIDENCE', 188), ('INCOMPLETE_EVIDENCE', 262)]	7	[('CHEBI_71657', 'versiconol acetate', 22, '25(OH)D'), ('GO_0007567', 'parturition', 40, 'birth'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'gestation'), ('CHEBI_79189', 'D-ribofuranose-2,5-bisphosphate', 164, '25(OH)D34'), ('PR_000001177', 'D(2) dopamine receptor', 170, 'D34'), ('UBERON_0002240', 'spinal cord', 236, 'cord'), ('UBERON_0000178', 'blood', 241, 'blood'), ('CHEBI_71657', 'versiconol acetate', 247, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 253, 'D'), ('CHEBI_71657', 'versiconol acetate', 310, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 316, 'D'), ('GO_0007565', 'female pregnancy', 335, 'pregnancy')]
S79-PMC4598849	PMC4598849	10/2015	S79-PMC4598849	['in CONCLUSION, THIS STUDY PROVIDES the FIRST epidemiological EVIDENCE that there was an inverted u shaped RELATIONSHIP between neonatal Vitamin D status and fetal growth.']	[('INCOMPLETE_EVIDENCE', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('PROBABLE_UNDERSTANDING', 26), ('INCOMPLETE_EVIDENCE', 39), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 106)]	6	[('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
S5-PMC4600246	PMC4600246	10/2015	S5-PMC4600246	['Plasma Phylloquinone concentrations fluctuate BASED on recent dietary intakes.213DESPITE the fact that a high percentage of undercarboxylated osteocalcin INDICATES poor Vitamin K status, this value can also vary based on recent Vitamin K intake and supplementation214and MAY not INDICATE chronic Vitamin K status.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 46), ('ANOMALY_CURIOUS_FINDING', 78), ('INCOMPLETE_EVIDENCE', 154), ('INCOMPLETE_EVIDENCE', 271), ('INCOMPLETE_EVIDENCE', 279)]	5	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('CHEBI_26124', 'phytosteroid', 7, 'phylloquinone'), ('CHEBI_27300', 'vitamin D', 169, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 296, 'vitamin K')]
S6-PMC4600246	PMC4600246	10/2015	S6-PMC4600246	['moreover, a normal carboxylated mgp protein in the Serum MAY NOT NECESSARILY INDICATE a normal Vitamin K status, AS carboxylated mgp in the Serum COULD BE normal, BUT suboptimal in the Arteries (where Vitamin K2Is needed to prevent vascular calcification.)']	[('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 77), ('PROBABLE_UNDERSTANDING', 113), ('INCOMPLETE_EVIDENCE', 146), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 163)]	6	[('UBERON_0001977', 'blood serum', 51, 'serum'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin K'), ('UBERON_0001977', 'blood serum', 140, 'serum'), ('UBERON_0001637', 'artery', 185, 'arteries'), ('CHEBI_35684', 'antiplatyhelmintic drug', 201, 'vitamin K2is')]
S24-PMC4600246	PMC4600246	10/2015	S24-PMC4600246	['Coronary Heart disease (chd)\nMAY reduce the RISK of chd, chd mortality and all-cause mortality52676\nInsulin sensitivity\nMAY help improve Insulin sensitivity40\nwarfarin international normalised ratio (inr)\nMAY help to stabilise inr in patients on warfarin41\nlow Vitamin K status (indicated by undercarboxylated mgp) is ASSOCIATED with increased vascular calcifications, and these levels CAN be improved by effective Vitamin K supplementation28–32it was long BELIEVED that Vitamin K was ONLY INVOLVED in forming Coagulation factors (ie, maintaining Haemostasis).']	[('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 44), ('INCOMPLETE_EVIDENCE', 120), ('INCOMPLETE_EVIDENCE', 205), ('SUPERFICIAL_RELATIONSHIP', 318), ('INCOMPLETE_EVIDENCE', 386), ('INCOMPLETE_EVIDENCE', 457), ('INCOMPLETE_EVIDENCE', 485), ('SUPERFICIAL_RELATIONSHIP', 490)]	9	[('UBERON_0002949', 'tectospinal tract', 0, 'Coronary heart'), ('PR_000045358', 'insulin family protein', 100, 'Insulin'), ('PR_000045358', 'insulin family protein', 137, 'insulin'), ('CHEBI_27300', 'vitamin D', 261, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 415, 'vitamin K'), ('CHEBI_27300', 'vitamin D', 471, 'vitamin K'), ('GO_0050817', 'coagulation', 510, 'coagulation'), ('GO_0007599', 'hemostasis', 547, 'haemostasis')]
S76-PMC4600246	PMC4600246	10/2015	S76-PMC4600246	['later, cranenburg et al ,71while evaluating Vitamin K status and Intake in such patients, REPORTED subnormal levels in 45% of study participants.']	[('INCOMPLETE_EVIDENCE', 90)]	1	[('CHEBI_27300', 'vitamin D', 44, 'vitamin K'), ('GO_0007631', 'feeding behavior', 65, 'intake')]
S13-PMC4624803	PMC4624803	10/2015	S13-PMC4624803	['results from two RECENT STUDIES on the ASSOCIATION between Vitamin D status and adhd diagnosis SHOWED an ASSOCIATION between low levels of D vitamin and an adhd diagnosis [5,6].']	[('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 95), ('SUPERFICIAL_RELATIONSHIP', 105)]	4	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 139, 'D')]
S99-PMC4624803	PMC4624803	10/2015	S99-PMC4624803	['[11] SHOWED that the mother’s Vitamin D status during Pregnancy had no association with behavioural problems in the offspring, including symptoms of adhd, several years later.']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 54, 'pregnancy')]
S101-PMC4624803	PMC4624803	10/2015	S101-PMC4624803	['WHILE strøm et al have analysed the levels of D Vitamin in the Serum from the mothers at Pregnancy, we have analysed D Vitamin levels in the Serum collected from the child at Birth, which should REFLECT the Prenatal Vitamin D status of the child.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 195)]	2	[('CHEBI_28748', 'doxorubicin', 46, 'D vitamin'), ('UBERON_0001977', 'blood serum', 63, 'serum'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_28748', 'doxorubicin', 117, 'D vitamin'), ('UBERON_0001977', 'blood serum', 141, 'serum'), ('GO_0007567', 'parturition', 175, 'birth'), ('GO_0007565', 'female pregnancy', 207, 'prenatal'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D')]
S61-PMC4627942	PMC4627942	10/2015	S61-PMC4627942	['a study in west kiang hdss, gambia, SHOWED that nutritional rickets, a disease caused largely by Vitamin D deficiency, the EFFECTS of which CAN include Cardiac failure and hypoglycaemic seizures, was more PREVALENT in infants whose mothers had poor Vitamin D status during Pregnancy (21).']	[('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 123), ('INCOMPLETE_EVIDENCE', 140), ('IMPORTANT_CONSIDERATION', 205)]	4	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('UBERON_0000948', 'heart', 152, 'cardiac'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('GO_0007565', 'female pregnancy', 273, 'pregnancy')]
S103-PMC4627942	PMC4627942	10/2015	S103-PMC4627942	['caption (table-wrap): table 2\n\nbiological causes of malnutrition: findings from indepth studieshdss siteyearauthorsmain findingsagincourt hdss, south africa2011kimani-murage et al.children infected with hiv had significantly worse nutritional outcomes than their uninfected peers.west kiang hdss, gambia2008nwenekahiv-positive children had significantly worse scores in terms of weight-for-age, height-for-age, and bmi than hiv-negative children.africa centre, south africa2007papathakis et al.breastfeeding mothers in south africa who were hiv-positive had poorer protein and Micronutrient status than hiv-negative women.africa centre, south africa2001filteau et al.providing Pregnant women who are hiv-positive with Vitamin A supplementation MAY improve Gut function of their hiv-infected infants.']	[('INCOMPLETE_EVIDENCE', 744)]	1	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 577, 'micronutrient'), ('GO_0007565', 'female pregnancy', 677, 'pregnant'), ('CHEBI_27300', 'vitamin D', 718, 'vitamin A'), ('UBERON_0001555', 'digestive tract', 756, 'gut')]
S14-PMC4632418	PMC4632418	10/2015	S14-PMC4632418	['HOWEVER, it is NOT CLEAR WHETHER a POOR Vitamin D status is ASSOCIATED with the RISK of gdm.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FULL_UNKNOWN', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('IMPORTANT_CONSIDERATION', 35), ('SUPERFICIAL_RELATIONSHIP', 60), ('IMPORTANT_CONSIDERATION', 80)]	6	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
S24-PMC4632418	PMC4632418	10/2015	S24-PMC4632418	['CONTRADICTORILY, SOME STUDIES SUGGESTED that no significant differences in Vitamin D status were FOUND between women with gdm and normal Glucose tolerance [15,16].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 97)]	5	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_17234', 'glucose', 137, 'glucose')]
S34-PMC4632418	PMC4632418	10/2015	S34-PMC4632418	['study selection\noriginal research evaluating the ASSOCIATIONS between Vitamin D status and Pregnancy outcomes were scrutinized and subsequently selected if they fulfilled the following inclusion criteria: a. study population was Pregnant women without pre-existing chronic disease; b. gdm as outcome and the control were women with normal Glucose tolerance (ngt); c. contained RELEVANT data to calculate the effect size and corresponding 95% confidence intervals (ci); d. met the predefined methodological quality assessment criteria for observational studies (supplementary data box 1) [18]; e. only studies published in english were considered.']	[('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 377)]	2	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy'), ('GO_0007565', 'female pregnancy', 229, 'pregnant'), ('CHEBI_17234', 'glucose', 339, 'glucose')]
S107-PMC4632418	PMC4632418	10/2015	S107-PMC4632418	['for ONE STUDY, the majority of study participants were reported Consuming Prenatal multivitamins or taking Nutritional supplements, as well as living in a geographical location which MAY AFFECT the Vitamin D status [15].']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 183), ('SUPERFICIAL_RELATIONSHIP', 187)]	3	[('GO_0007631', 'feeding behavior', 64, 'consuming'), ('GO_0007565', 'female pregnancy', 74, 'prenatal'), ('CHEBI_7495', 'nefazodone hydrochloride', 107, 'nutritional'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D')]
S126-PMC4632418	PMC4632418	10/2015	S126-PMC4632418	['thirdly, there is one more POINT that the OBSERVED ASSOCIATIONS between maternal Vitamin D status and the risk of adverse Pregnancy outcomes COULD BE AFFECTED by CONFOUNDING FACTORS, such as bmi and skin tone.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 141), ('SUPERFICIAL_RELATIONSHIP', 150), ('PROBLEM_COMPLICATION', 162)]	6	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnancy')]
S101-PMC4632423	PMC4632423	10/2015	S101-PMC4632423	['low Vitamin D status is also ASSOCIATED with physical anomalies including osteomalacia and Skeletal malformations [27].']	[('SUPERFICIAL_RELATIONSHIP', 29)]	1	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('UBERON_0004288', 'skeleton', 91, 'skeletal')]
S106-PMC4632423	PMC4632423	10/2015	S106-PMC4632423	['increased adiposity itself is ASSOCIATED with lower Serum levels of some fat-soluble Nutrients, such as Vitamin D, and this PREDICTS poor status of this Nutrient during Pregnancy [27].']	[('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 124)]	2	[('UBERON_0001977', 'blood serum', 52, 'serum'), ('CHEBI_33284', 'nutrient', 85, 'nutrients'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_33284', 'nutrient', 153, 'nutrient'), ('GO_0007565', 'female pregnancy', 169, 'pregnancy')]
S175-PMC4663595	PMC4663595	11/2015	S175-PMC4663595	['our group also REPORTED that Dha supplementation with 400 mg/day during Pregnancy induced Dna Methylation changes in inflammatory Genes and Line-1 , especially in infants born to mothers who smoked during Pregnancy [99].nutrients-07-05467-t002_table 2\n\ncaption (table-wrap): table 2\n\nintervention studies for maternal nutritional status and epigenetic profile in offspring.Nutrientsmechanismoutcomesamplemethodref.Folate and Multivitamins(1)Dna Methylation↓ methylation of Igf2 2r in girls, ↓ methylation of Gtl2-2 in boyscord Blood27K illumina[93]folatedna methylation↓ methylation of Line1 Cord Bloodpyrosequencing[94]Dna Methylation↑ methylation of Igf2 dmrcord Bloodepi-typer[95]Dna Methylation↓ methylation of h19 dmr (4 cpgs)Cord Bloodpyrosequencing[96]Dna Methylation↓ methylation of peg3 and Line1 ; ↑ methylation of Igf2 Cord Bloodpyrosequencing[97]cholinedna methylationhistone modification↑ methylation of crh , Nr3C1 in Placenta; ↓ methylation of crh , Nr3C1 in Cord Blood Leukocyte; ↑ H3K9Me2Placenta, Cord Bloodlc-ms/ms[98]Dhadna Methylation↑ Line1 methylation ↑ Infγ/Il13 methylation ratiocord Bloodpyrosequencing[99]\n(1)Zinc and Vitamins A, b, c and d; Peg3, Paternally-Expressed Gene 3; Crh, Corticotropin-Releasing Hormone; Nr3C1, Nuclear receptor subfamily 3, Group C, Member 1.']	[('INCOMPLETE_EVIDENCE', 15)]	1	"[('CHEBI_17874', 'dihydrozeatin', 29, 'DHA'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('GO_0006306', 'DNA methylation', 90, 'DNA methylation'), ('SO_0000704', 'gene', 130, 'genes'), ('PR_000009877', 'loss of heterozygosity 11 chromosomal region 2 gene A protein', 140, 'LINE-1'), ('GO_0007565', 'female pregnancy', 205, 'pregnancy'), ('CHEBI_8329', 'Pomiferin', 373, 'NutrientsMechanismOutcomeSampleMethodRef'), ('CHEBI_81245', 'Vulpecholate', 414, 'Folate'), ('CHEBI_7036', 'Musennin', 425, 'Multivitamins'), ('GO_0006323', 'DNA packaging', 441, 'DNA methylation↓'), ('PR_000008989', 'interleukin-1 family member 7', 473, 'IGF2'), ('PR_000008305', 'glutathione S-transferase theta-1', 508, 'GTL2'), ('UBERON_0001977', 'blood serum', 527, 'blood27k'), ('PR_000009877', 'loss of heterozygosity 11 chromosomal region 2 gene A protein', 586, 'LINE1'), ('UBERON_0000948', 'heart', 592, 'Cord'), ('UBERON_0011919', 'yolk sac blood island', 597, 'bloodPyrosequencing'), ('GO_0006306', 'DNA methylation', 620, 'DNA methylation'), ('PR_000008989', 'interleukin-1 family member 7', 652, 'IGF2'), ('UBERON_0001970', 'bile', 665, 'bloodEpi'), ('GO_0006323', 'DNA packaging', 683, 'DNA methylation↓'), ('UBERON_0000948', 'heart', 731, 'Cord'), ('UBERON_0011919', 'yolk sac blood island', 736, 'bloodPyrosequencing'), ('GO_0006323', 'DNA packaging', 759, 'DNA methylation↓'), ('PR_000009877', 'loss of heterozygosity 11 chromosomal region 2 gene A protein', 800, 'LINE1'), ('PR_000008989', 'interleukin-1 family member 7', 825, 'IGF2'), ('UBERON_0000948', 'heart', 830, 'Cord'), ('UBERON_0011919', 'yolk sac blood island', 835, 'bloodPyrosequencing'), ('PR_000011403', 'photoreceptor-specific nuclear receptor', 923, 'NR3C1'), ('UBERON_0001987', 'placenta', 932, 'placenta'), ('PR_000011403', 'photoreceptor-specific nuclear receptor', 965, 'NR3C1'), ('CL_0000107', 'autonomic neuron', 974, 'cord blood'), ('UBERON_0002240', 'spinal cord', 974, 'cord'), ('UBERON_0000178', 'blood', 979, 'blood'), ('CL_0000738', 'leukocyte', 985, 'leukocyte'), ('SO_0001736', 'H3K9_methylation_site', 998, 'H3K9me2Placenta'), ('UBERON_0002240', 'spinal cord', 1015, 'cord'), ('UBERON_0000178', 'blood', 1020, 'bloodLC'), ('GO_0010424', 'DNA methylation on cytosine within a CG sequence', 1037, 'DHADNA methylation'), ('PR_000009877', 'loss of heterozygosity 11 chromosomal region 2 gene A protein', 1057, 'LINE1'), ('PR_000009020', ""Golgi-resident adenosine 3',5'-bisphosphate 3'-phosphatase"", 1077, 'INFγ'), ('PR_000001470', 'interleukin-28B', 1082, 'IL13'), ('UBERON_0011919', 'yolk sac blood island', 1109, 'bloodPyrosequencing'), ('CHEBI_27377', ""Unsym-bis(4'-chlorophenyl)ethylene"", 1136, 'Zinc'), ('CHEBI_27300', 'vitamin D', 1145, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 1154, 'A'), ('PR_000012529', 'PDZK1-interacting protein 1', 1169, 'PEG3'), ('PR_000012270', 'pappalysin-1', 1175, 'paternally-expressed gene 3'), ('GO_0010467', 'gene expression', 1186, 'expressed'), ('SO_0000704', 'gene', 1196, 'gene'), ('PR_000005864', 'protein CREG2', 1204, 'CRH'), ('CHEBI_3918', 'crocetin', 1209, 'corticotropin'), ('PR_000005968', 'cystatin-M', 1209, 'corticotropin-releasing hormone'), ('CHEBI_33280', 'molecular messenger', 1233, 'hormone'), ('PR_000011403', 'photoreceptor-specific nuclear receptor', 1242, 'NR3C1'), ('GO_0005634', 'nucleus', 1249, 'nuclear'), ('PR_000008294', 'glutathione S-transferase A1', 1279, 'group C, member 1')]"
S19-PMC4670104	PMC4670104	12/2015	S19-PMC4670104	['also, apps are OFTEN RECOMMENDED for use in population studies as correction factors for assessing status with respect to Micronutrients, whose indicator concentrations MAY decrease (e.g., Serum Retinol for Vitamin A) or rise (e.g, Serum ferritin for iron) with inflammation [13–15].']	[('PROBABLE_UNDERSTANDING', 15), ('FUTURE_WORK', 21), ('INCOMPLETE_EVIDENCE', 169)]	3	[('CHEBI_33839', 'macromolecule', 122, 'micronutrients'), ('UBERON_0001977', 'blood serum', 189, 'serum'), ('CHEBI_26536', 'retinoic acid', 195, 'retinol'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin A'), ('UBERON_0001977', 'blood serum', 232, 'serum')]
S61-PMC4684854	PMC4684854	12/2015	S61-PMC4684854	['the APPARENT DISPARITY between findings in VARIOUS STUDIES has caused SOME to reflexively CONCLUDE that Vitamin D status in Pregnancy is IRRELEVANT to maternal-fetal outcomes.']	[('ANOMALY_CURIOUS_FINDING', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 13), ('ANOMALY_CURIOUS_FINDING', 13), ('IMPORTANT_CONSIDERATION', 13), ('INCOMPLETE_EVIDENCE', 43), ('INCOMPLETE_EVIDENCE', 70), ('PROBABLE_UNDERSTANDING', 90), ('IMPORTANT_CONSIDERATION', 137)]	8	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007565', 'female pregnancy', 124, 'pregnancy')]
S63-PMC4684854	PMC4684854	12/2015	S63-PMC4684854	['it is IMPORTANT TO REALIZE that Vitamin D status is very different from WHETHER OR not someone is consuming Vitamin D supplementation.']	[('IMPORTANT_CONSIDERATION', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 72)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D')]
S64-PMC4684854	PMC4684854	12/2015	S64-PMC4684854	['many FACTORS MAY AFFECT the resultant status of Vitamin D in the body (AS reflected by measurement of 25(Oh)D levels) after Ingested supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 5), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 17), ('PROBABLE_UNDERSTANDING', 71)]	4	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 102, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 108, 'D'), ('GO_0007631', 'feeding behavior', 124, 'ingested')]
S76-PMC4684854	PMC4684854	12/2015	S76-PMC4684854	['Gestational Vitamin D status and obstetrical outcomes\nthe list of adverse Gestational outcomes in Pregnancy ASSOCIATED with Vitamin D insufficiency continues to mount.']	[('SUPERFICIAL_RELATIONSHIP', 108)]	1	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_28384', 'vitamin K', 12, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 74, 'gestational'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
S101-PMC4684854	PMC4684854	12/2015	S101-PMC4684854	['Gestational Vitamin D status also APPEARS to INFLUENCE outcomes beyond the Pregnancy and Delivery.']	[('ANOMALY_CURIOUS_FINDING', 34), ('SUPERFICIAL_RELATIONSHIP', 45)]	2	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('GO_0007567', 'parturition', 89, 'delivery')]
S113-PMC4684854	PMC4684854	12/2015	S113-PMC4684854	['maternal Vitamin D status during Gestation also APPEARS TO have INFLUENCE on many OTHER health indices in the future of the offspring.']	[('ANOMALY_CURIOUS_FINDING', 48), ('SUPERFICIAL_RELATIONSHIP', 64), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'gestation')]
S114-PMC4684854	PMC4684854	12/2015	S114-PMC4684854	['for example, Gestational Vitamin D status DIRECTLY CORRELATES with subsequent Whole-Body and Lumbar Spine bone Mineral content in progeny at 9 years of age [92].']	[('SUPERFICIAL_RELATIONSHIP', 42), ('SUPERFICIAL_RELATIONSHIP', 51)]	2	[('GO_0007565', 'female pregnancy', 13, 'gestational'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0000468', 'multicellular organism', 78, 'whole-body'), ('UBERON_0006074', 'lumbar region of vertebral column', 93, 'lumbar spine'), ('CHEBI_46662', 'mineral', 111, 'mineral')]
S15-PMC4689556	PMC4689556	12/2015	S15-PMC4689556	['there is MIXED OBSERVATIONAL evidence with regards to the EFFECT of pre-Natal 25(Oh) Vitamin D status on child health outcomes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 58)]	3	[('GO_0007567', 'parturition', 72, 'natal'), ('CHEBI_30778', 'gallic acid', 78, '25(OH)'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
S16-PMC4689556	PMC4689556	12/2015	S16-PMC4689556	['SEVERAL STUDIES have LINKED low Vitamin D status to a number of resource intensive childhood health PROBLEMS including allergy and infection [2–7], in addition to the WELL-ESTABLISHED EFFECTS on bone Metabolism.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 21), ('IMPORTANT_CONSIDERATION', 100), ('PROBABLE_UNDERSTANDING', 167), ('SUPERFICIAL_RELATIONSHIP', 184)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0008152', 'metabolic process', 200, 'metabolism')]
S26-PMC4689556	PMC4689556	12/2015	S26-PMC4689556	['we HYPOTHESIZED that Prenatal Vitamin D supplementation during Pregnancy would reduce a child’s healthcare utilisation during the first three years of Life through improved health status, by using the e-hr to quantify our outcome total healthcare utilisation.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('GO_0007565', 'female pregnancy', 21, 'prenatal'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 63, 'pregnancy'), ('UBERON_0000104', 'life cycle', 151, 'life')]
S143-PMC4689556	PMC4689556	12/2015	S143-PMC4689556	['we FOUND NO EVIDENCE that Prenatal Vitamin D status is RELATED to healthcare utilisation, HOWEVER one MIGHT argue that the very SMALL number of subjects with adequate Vitamin D status LIMITED the power of this analysis.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 55), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 90), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 184)]	7	[('GO_0007565', 'female pregnancy', 26, 'prenatal'), ('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
S149-PMC4689556	PMC4689556	12/2015	S149-PMC4689556	['[39]\nstudies in OTHER populations, USUALLY with higher Prenatal Vitamin D status THAN ours, have FOUND an inverse RELATIONSHIP between Cord Blood 25(Oh) Vitamin D level and child health outcomes [4].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 16), ('INCOMPLETE_EVIDENCE', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 81), ('INCOMPLETE_EVIDENCE', 97), ('SUPERFICIAL_RELATIONSHIP', 114)]	5	[('GO_0007565', 'female pregnancy', 55, 'prenatal'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 135, 'cord'), ('UBERON_0000178', 'blood', 140, 'blood'), ('CHEBI_30778', 'gallic acid', 146, '25(OH)'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D')]
S166-PMC4689556	PMC4689556	12/2015	S166-PMC4689556	['the RELATIONSHIP between Prenatal Vitamin D status and child health outcomes MAY not be linear.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 77)]	2	[('GO_0007565', 'female pregnancy', 25, 'prenatal'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D')]
S0-PMC4690051	PMC4690051	12/2015	S0-PMC4690051	['Gestational vitamin 25(oh)d status as a risk factor for Receptive Language Development: a 24-month, longitudinal, observational study\n\nabstract\nemerging data suggest that Vitamin D status during childhood and Adolescence CAN AFFECT Neurocognitive Development.']	[('INCOMPLETE_EVIDENCE', 221), ('SUPERFICIAL_RELATIONSHIP', 225)]	2	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('GO_0000003', 'reproduction', 56, 'Receptive'), ('GO_0008584', 'male gonad development', 66, 'Language Development'), ('UBERON_0003215', 'alveolus', 66, 'Language'), ('CHEBI_27300', 'vitamin D', 171, 'vitamin D'), ('GO_0048848', 'neurohypophysis morphogenesis', 209, 'adolescence'), ('GO_0007399', 'nervous system development', 232, 'neurocognitive development')]
S76-PMC4690051	PMC4690051	12/2015	S76-PMC4690051	['using stepwise selection (0.20 for entry, 0.05 to stay) to remove the insignificant variables, we retained 25(Oh)D status in the model while assessing the following POSSIBLE CONFOUNDERS: race (aa or ea), maternal iq, use of tobacco products or Alcohol during Pregnancy, maternal dietary Intake of Vitamin D, age, pre-Pregnancy bmi, total number of completed Pregnancies, Gestational hypertension or Gestational diabetes, insurance status, level of maternal education, marital status, child’s age at cv2, and Gestational age at Birth.']	[('INCOMPLETE_EVIDENCE', 165), ('PROBLEM_COMPLICATION', 174)]	2	[('CHEBI_71657', 'versiconol acetate', 107, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 107, '25(OH)D'), ('CHEBI_30879', 'alcohol', 244, 'alcohol'), ('GO_0007565', 'female pregnancy', 259, 'pregnancy'), ('GO_0007631', 'feeding behavior', 287, 'intake'), ('CHEBI_27300', 'vitamin D', 297, 'vitamin D'), ('GO_0007565', 'female pregnancy', 317, 'pregnancy'), ('GO_0007565', 'female pregnancy', 358, 'pregnancies'), ('GO_0007565', 'female pregnancy', 371, 'gestational'), ('GO_0007565', 'female pregnancy', 399, 'gestational'), ('GO_0007565', 'female pregnancy', 508, 'gestational'), ('GO_0007567', 'parturition', 527, 'birth')]
S170-PMC4690051	PMC4690051	12/2015	S170-PMC4690051	['DUE TO phlebotomy limits in infants and THE BURDEN of other candle procedures, this candle sub-study lacks repeated measures of 25(Oh)D status for participants and lacks individual assessments of Parathyroid hormone status or Vitamin D receptor ( vdr ) genotype.']	[('PROBLEM_COMPLICATION', 0), ('IMPORTANT_CONSIDERATION', 40)]	2	[('CHEBI_71657', 'versiconol acetate', 128, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 128, '25(OH)D'), ('UBERON_0001132', 'parathyroid gland', 196, 'parathyroid'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D')]
S69-PMC4691762	PMC4691762	12/2015	S69-PMC4691762	"[""participant's Vitamin D status will be defined by their Blood 25Ohd3 level, AS: severely deficient <12.5\u2005nmol/l; moderately deficient 12.5–25\u2005nmol/l; mild deficiency 26–49\u2005nmol/l; sufficient ≥50\u2005nmol/l; and elevated >220\u2005nmol/l.23\nparent baseline questionnaire : to check that potential environmental and OTHER CONFOUNDING factors are balanced between the two randomisation groups, baseline parent questionnaires will collect data on: parental smoking, medication use, parental ancestry, ethnicity, education, employment, occupation, family history of allergy, use of supplements including Vitamin A, d and cod Liver oil, number of siblings; and pet ownership.""]"	[('PROBABLE_UNDERSTANDING', 76), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 305), ('PROBLEM_COMPLICATION', 311)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0000178', 'blood', 56, 'blood'), ('CHEBI_63058', '(2R,3S)-EHNA', 62, '25OHD3'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 62, '25OHD3'), ('CHEBI_27300', 'vitamin D', 590, 'vitamin A'), ('UBERON_0002107', 'liver', 611, 'liver')]
S73-PMC4691762	PMC4691762	12/2015	S73-PMC4691762	['we have established that composite maternal uvr dose (or 0.50 (95% ci 0.37 to 0.69) p<0.001) and maternal skin exposure index (or 0.81 (95% ci 0.66 to 0.98) p=0.03) were ASSOCIATED with breastfed infant Vitamin D status BUT infant time in the sun during the first year was NOT.15infant Feeding (amount of breastfeeding, Formula Feeding and type of formula, introduction of solid Foods) will also be recorded.']	[('SUPERFICIAL_RELATIONSHIP', 170), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 220), ('ANOMALY_CURIOUS_FINDING', 220), ('ANOMALY_CURIOUS_FINDING', 273)]	4	[('CHEBI_27300', 'vitamin D', 203, 'vitamin D'), ('GO_0007631', 'feeding behavior', 286, 'feeding'), ('GO_0009057', 'macromolecule catabolic process', 320, 'formula'), ('GO_0007631', 'feeding behavior', 328, 'feeding'), ('CHEBI_33290', 'food', 379, 'foods')]
S15-PMC4719746	PMC4719746	1/2016	S15-PMC4719746	['there are FEW population-based STUDIES exploring Vitamin D deficiency in Pregnancy in today’s multiethnic europe, and LITTLE IS KNOWN about the IMPACT of socioeconomic status or the EFFECT of Vitamin D supplements [9,10].']	[('INCOMPLETE_EVIDENCE', 10), ('FULL_UNKNOWN', 118), ('SUPERFICIAL_RELATIONSHIP', 144), ('SUPERFICIAL_RELATIONSHIP', 182)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D')]
S95-PMC4719746	PMC4719746	1/2016	S95-PMC4719746	"['=\u20090.24independent variabler2adj.b95\xa0% cib95\xa0% cir2adj.b95\xa0% cib95\xa0% cilowerupperlowerupperlowerupperloweruppergestational week at inclusion (<15 ref)−0.0010.01ᅟ≥15−0.56−4.43.3 −6.4−10−2.3**−4.6−8.3−0.92* age at inclusion0.03 0.940.551.3** 0.14−0.210.490.03 1.10.641.5**0.700.261.1** parity (para 0 ref)0.020.01ᅟpara1−1.2−5.43.10.24−3.13.6−2.8−7.41.8 −4.4−8.7−0.22* ᅟpara ≥2 −11−17−6.3** −3.2−7.61.3 −9.3−15−3.8** −5.4−110.25geographic region (western europe ref)0.380.16ᅟsouth asia −37−40−33**−28−33−23**−26−31−21**−17−23−11** ᅟmiddle east −34−39−30**−24−29−18**−21−26−15**−9.5−16−2.9** ᅟsub-saharan africa −31−37−25**−20−27−13**−26−34−19**−12−20−3.1** ᅟeast asia −17−24−10**−11−18−3.9**−19−28−11**−11−20−1.6* ᅟother −13−19−6.4**−7.6−14−0.90*−9.0−17−1.3* −1.4−9.66.9season (summer ref)0.030.01ᅟwinter −9.9−14−6.1**−5.2−8.9−1.4**−5.7−9.8−1.6** −1.3−6.13.4geographic region*seasona−11−16−4.8**−15−22−7.4** education level (>12 y ref)0.110.08ᅟ10-12 year −14−18−10**−3.7−7.1−0.30*−11−15−6.8** −1.8−6.12.5ᅟ<10\xa0year −23−28−17**−5.2−10−0.31*−23−29−17**−8.6−15−2.5** Vitamin D supplements (≥10μgbref)0.080.02ᅟno or <10\xa0μg −15−19−11**−11−14−7.7**−8.2−13−3.8**−9.8−14−5.8** pre-Pregnancy bmi (<25\xa0kg/m2ref)−0.001−0.001ᅟ≥25\xa0kg/m2−0.76−4.73.2−0.11−4.44.2\nathe EFFECT of season on 25(Oh)d differed by ethnicity: the interaction term is ""1"" for records with both non-western and winter and ""0"" for western and summer (ref)\nbintake of ≥10\xa0μg Vitamin D daily past two weeks\nbold numbers indicate p \u2009<\u20090.05 (* p \u2009<\u20090.05, ** p \u2009<\u20090.01)\n\nVitamin D status at Gestational week 28\nat the beginning of the third trimester, the prevalence of 25(Oh)D <50\xa0nmol/l among the largest ethnic minority groups was lower than at study inclusion: south asia: 62\xa0%, the middle east: 58\xa0% and sub-saharan africa: 63\xa0%.']"	[('SUPERFICIAL_RELATIONSHIP', 1248)]	1	[('CHEBI_28384', 'vitamin K', 1059, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1168, 'pregnancy'), ('CHEBI_30778', 'gallic acid', 1268, '25(OH)'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1268, '25(OH'), ('CHEBI_27300', 'vitamin D', 1427, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 1435, 'D'), ('CHEBI_28384', 'vitamin K', 1519, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1539, 'gestational'), ('CHEBI_71657', 'versiconol acetate', 1618, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 1618, '25 ... OH ... D')]
S161-PMC4719746	PMC4719746	1/2016	S161-PMC4719746	['this cost-effective, and easy-to-administer RECOMMENDATION LIKELY CONTRIBUTED the most to the improved Vitamin D status later in Pregnancy for these women.']	[('FUTURE_WORK', 44), ('PROBABLE_UNDERSTANDING', 59), ('SUPERFICIAL_RELATIONSHIP', 66)]	3	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('GO_0007565', 'female pregnancy', 129, 'pregnancy')]
S24-PMC4729160	PMC4729160	1/2016	S24-PMC4729160	['vitamin a status is assessed by the Serum concentration of Retinol, but there was little about its value as a MARKER of Vitamin A status during Pregnancy in china.']	[('SUPERFICIAL_RELATIONSHIP', 110)]	1	[('UBERON_0001977', 'blood serum', 36, 'serum'), ('CHEBI_26536', 'retinoic acid', 59, 'retinol'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin A'), ('GO_0007565', 'female pregnancy', 144, 'pregnancy')]
S87-PMC4729160	PMC4729160	1/2016	S87-PMC4729160	['62(0.24–1.62)–\u2003general rural areas72840.94(0.42–2.13)–\u2003poor rural areas332383.48(1.72–7.03)a4.73(2.67–8.41)acollege or university\u2003no527802.03(1.07–3.85)a3.17 (1.51–6.67)a\u2003yes1236511income\u2003\u2009<\u200910,000141854.60(1.30–16.24)a4.91 (1.31–18.46)a\u200310,000–20,000223174.21(1.24–14.26)a4.33 (1.18–15.90)a\u200320,000–30,000254613.29(0.98–11.03)a3.64 (1.01–13.16)a\u2003\u2009>\u2009=30,000318211drinking\u2003yes201184.00(2.26–6.94)a3.10 (1.65–5.81)a\u2003no44102711smoking\u2003non-smoker without passive smoking2452911\u2003non-smoker with passive smoking315941.15(0.67–1.99)–\u2003smokers9229.02(3.75–21.67)a5.68 (2.23–14.49)agestational age\u2003first trimester1046111\u2003second trimester182743.03(1.38–6.66)a2.40(1.05–5.46)a\u2003third trimester364104.05(1.98–8.26)a2.82(1.34–5.93)a\nastatistically significant at 0.05 level of significance\n\ndiscussion\nOUR STUDY FIRST REPORTED about the Vitamin A nutritional status in a large group of chinese Pregnant women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 786), ('INCOMPLETE_EVIDENCE', 796), ('INCOMPLETE_EVIDENCE', 802)]	3	[('CHEBI_27300', 'vitamin D', 821, 'vitamin A'), ('GO_0007565', 'female pregnancy', 878, 'pregnant')]
S94-PMC4729160	PMC4729160	1/2016	S94-PMC4729160	['in THE CURRENT STUDY, Pregnant women age and va status were negatively ASSOCIATED and the level of Vitamin A decreased with age.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 71)]	2	[('GO_0007565', 'female pregnancy', 22, 'pregnant'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin A')]
S127-PMC4729160	PMC4729160	1/2016	S127-PMC4729160	['it is also LACK OF assessment of the participants’ physical behavior condition which INFLUENCES Vitamin A status of chinese Pregnant women.']	[('FULL_UNKNOWN', 11), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 85)]	3	[('CHEBI_27300', 'vitamin D', 96, 'vitamin A'), ('GO_0007565', 'female pregnancy', 124, 'pregnant')]
S128-PMC4729160	PMC4729160	1/2016	S128-PMC4729160	['MORE STUDIES ARE NEEDED to understand the INFLUENCE FACTORS of Vitamin A status of chinese Pregnant women.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 5), ('SUPERFICIAL_RELATIONSHIP', 42)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin A'), ('GO_0007565', 'female pregnancy', 91, 'pregnant')]
S132-PMC4729160	PMC4729160	1/2016	S132-PMC4729160	['so in the FUTURE health public policy on Vitamin A SHOULD BE paid more ATTENTION on Pregnant women with pertinent INFLUENCE FACTORS of vad, accordingly, eliminate vad improve the nutritional status of chinese Pregnant women.']	[('FUTURE_WORK', 10), ('FUTURE_WORK', 51), ('IMPORTANT_CONSIDERATION', 71), ('SUPERFICIAL_RELATIONSHIP', 114), ('SUPERFICIAL_RELATIONSHIP', 124)]	5	[('CHEBI_27300', 'vitamin D', 41, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 49, 'A'), ('GO_0007565', 'female pregnancy', 84, 'pregnant'), ('GO_0007565', 'female pregnancy', 209, 'pregnant')]
S7-PMC4764019	PMC4764019	1/2016	S7-PMC4764019	['the barker HYPOTHESIS HAS BEEN ELABORATED and evaluated in several reviews,2–4BUT TO THE BEST OF MY KNOWLEDGE, there HAS BEEN NO ATTEMPT to evaluate the HYPOTHESIS specifically for Vitamin D. THUS, what i PROPOSE TO explore in THIS very brief REVIEW is the EVIDENCE RELATING UNRECOGNIZED, Perinatal Vitamin D inadequacy to increased risk of certain chronic diseases later in Life, that is, to ascertain WHETHER any such EFFECTS MIGHT be an instance of the “barker HYPOTHESIS.”\ni deliberately avoid use of labels such as “deficient” or “insufficient” in characterizing Vitamin D status, AS these terms are OFTEN LINKED to specific values for serum 25-Hydroxyvitamin D [25(Oh)D], about which there is considerable CONTROVERSY.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 31), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 126), ('INCOMPLETE_EVIDENCE', 153), ('PROBABLE_UNDERSTANDING', 192), ('INCOMPLETE_EVIDENCE', 205), ('QUESTION_ANSWERED_BY_THIS_WORK', 205), ('QUESTION_ANSWERED_BY_THIS_WORK', 213), ('QUESTION_ANSWERED_BY_THIS_WORK', 227), ('QUESTION_ANSWERED_BY_THIS_WORK', 243), ('INCOMPLETE_EVIDENCE', 257), ('SUPERFICIAL_RELATIONSHIP', 266), ('INCOMPLETE_EVIDENCE', 275), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 403), ('SUPERFICIAL_RELATIONSHIP', 420), ('INCOMPLETE_EVIDENCE', 428), ('INCOMPLETE_EVIDENCE', 464), ('PROBABLE_UNDERSTANDING', 586), ('PROBABLE_UNDERSTANDING', 605), ('SUPERFICIAL_RELATIONSHIP', 611), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 712)]	25	[('CHEBI_27300', 'vitamin D', 181, 'vitamin D'), ('GO_0036268', 'swimming', 289, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 289, 'perinatal'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D'), ('UBERON_0000104', 'life cycle', 375, 'life'), ('CHEBI_27300', 'vitamin D', 568, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 647, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 668, '25(OH)D')]
S8-PMC4764019	PMC4764019	1/2016	S8-PMC4764019	['INSTEAD, i use terms such as “low” or “inadequate,” referencing in each such use prevailing values for Vitamin D status or input relative to values FOUND in those Individuals who do not manifest the disorders concerned.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 148)]	2	[('CHEBI_27300', 'vitamin D', 103, 'vitamin D'), ('NCBITaxon_1', 'root', 163, 'individuals')]
S9-PMC4764019	PMC4764019	1/2016	S9-PMC4764019	['i defer until the end of this review consideration of the actual, numerical range of Vitamin D status values that APPEARS to permit avoidance of the barker EFFECT if it is present.']	[('ANOMALY_CURIOUS_FINDING', 114), ('SUPERFICIAL_RELATIONSHIP', 156)]	2	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
S17-PMC4764019	PMC4764019	1/2016	S17-PMC4764019	['autoimmune disorders\ntwo SERIOUS Autoimmune diseases HAVE BEEN LINKED to low Vitamin D status in early Life, type 1 diabetes mellitus (dm1) and multiple sclerosis (ms).']	[('IMPORTANT_CONSIDERATION', 25), ('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 63)]	3	[('UBERON_0001442', 'skeleton of manus', 33, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('UBERON_0000104', 'life cycle', 103, 'life')]
S31-PMC4764019	PMC4764019	1/2016	S31-PMC4764019	['once again, may Births would have followed a winter-long, Vitamin D–deprived Pregnancy, WHEREAS november Births would have followed a summer-long pregnancy with PRESUMABLY higher Vitamin D status values.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('PROBABLE_UNDERSTANDING', 161)]	2	[('GO_0007567', 'parturition', 16, 'births'), ('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('GO_0007567', 'parturition', 105, 'births'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
S37-PMC4764019	PMC4764019	1/2016	S37-PMC4764019	['schizophrenia\nmcgrath et al9have EVALUATED the ASSOCIATION between Vitamin D status at Birth and the development of schizophrenia later in Life.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 33), ('SUPERFICIAL_RELATIONSHIP', 47)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007567', 'parturition', 87, 'birth'), ('UBERON_0000104', 'life cycle', 139, 'life')]
S38-PMC4764019	PMC4764019	1/2016	S38-PMC4764019	['denmark has a long-standing practice of storing Cord Blood samples on all newborns, making it possible to explore ASSOCIATIONS between late-Life–onset diseases and Vitamin D status at Birth.']	[('SUPERFICIAL_RELATIONSHIP', 114)]	1	[('UBERON_0002240', 'spinal cord', 48, 'cord'), ('UBERON_0000178', 'blood', 53, 'blood'), ('UBERON_0000104', 'life cycle', 140, 'life'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007567', 'parturition', 184, 'birth')]
S39-PMC4764019	PMC4764019	1/2016	S39-PMC4764019	['the OBSERVED ASSOCIATION is so strong that mcgrath et al ESTIMATED that 50% of the BURDEN of schizophrenia in the entire country of denmark COULD PERHAPS be ATTRIBUTED to PROBLEMS produced by low Perinatal Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 57), ('IMPORTANT_CONSIDERATION', 83), ('INCOMPLETE_EVIDENCE', 140), ('INCOMPLETE_EVIDENCE', 146), ('SUPERFICIAL_RELATIONSHIP', 157), ('IMPORTANT_CONSIDERATION', 171)]	8	[('GO_0036268', 'swimming', 196, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 196, 'perinatal'), ('CHEBI_27300', 'vitamin D', 206, 'vitamin D')]
S40-PMC4764019	PMC4764019	1/2016	S40-PMC4764019	['WHILE this ASSOCIATION MIGHT initially SEEM far-fetched, it is IMPORTANT TO NOTE that the great famine in china in 1958 to 1961 was ASSOCIATED with a subsequent rise in the incidence of schizophrenia in famine victims.2measured Vitamin D status values in these Individuals are NOT AVAILABLE, but it HAS long BEEN KNOWN that rickets was endemic in china and certainly was so at the time of the famine.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 23), ('ANOMALY_CURIOUS_FINDING', 39), ('IMPORTANT_CONSIDERATION', 63), ('SUPERFICIAL_RELATIONSHIP', 132), ('INCOMPLETE_EVIDENCE', 277), ('INCOMPLETE_EVIDENCE', 299)]	8	[('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('NCBITaxon_1', 'root', 261, 'individuals')]
S43-PMC4764019	PMC4764019	1/2016	S43-PMC4764019	['cognitive function and Learning disabilities\nwhitehouse et al12report on the prevalence of Learning disabilities in school-age children as a function of maternal Vitamin D status at the time when the children CONCERNED were Born.']	[('IMPORTANT_CONSIDERATION', 209)]	1	[('GO_0090232', 'positive regulation of spindle checkpoint', 23, 'LEARNING'), ('GO_0007612', 'learning', 91, 'learning'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D'), ('GO_0007567', 'parturition', 224, 'born')]
S44-PMC4764019	PMC4764019	1/2016	S44-PMC4764019	['briefly, at age 5 years, 13% of children Born of mothers in the lowest quartile of Vitamin D status [25(Oh)D <18 ng/ml] exhibited Learning disability, as contrasted with ONLY 4% of children Born of mothers in the highest 25(Oh)D quartile (>29 ng/ml), that is, a better than 3-fold increase in risk of the lowest quartile.']	[('ANOMALY_CURIOUS_FINDING', 170)]	1	[('GO_0007567', 'parturition', 41, 'born'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 101, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 101, '25 ... OH ... D'), ('GO_0007612', 'learning', 130, 'learning'), ('GO_0007567', 'parturition', 190, 'born'), ('CHEBI_71657', 'versiconol acetate', 221, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 221, '25(OH)D')]
S45-PMC4764019	PMC4764019	1/2016	S45-PMC4764019	['BECAUSE OTHER FACTORS, such as socioeconomic status and ethnic background, COULD EXPLAIN both the low Vitamin D status and the poor performance in school in this group of children, this ASSOCIATION CANNOT BE CONSIDERED causal.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 8), ('SUPERFICIAL_RELATIONSHIP', 14), ('INCOMPLETE_EVIDENCE', 75), ('PROBABLE_UNDERSTANDING', 81), ('SUPERFICIAL_RELATIONSHIP', 186), ('INCOMPLETE_EVIDENCE', 198)]	7	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D')]
S49-PMC4764019	PMC4764019	1/2016	S49-PMC4764019	['this is BECAUSE, EVEN IF there were no connection between the Vitamin D status and the observed Learning difficulty, the group of Pregnant women to be studied would HAVE TO BE placed and maintained on a Vitamin D status, which is recognized to be INADEQUATE on OTHER grounds (ie, <18 ng/ml) and THEREFORE productive of harmful outcomes.']	[('PROBLEM_COMPLICATION', 8), ('ANOMALY_CURIOUS_FINDING', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 22), ('IMPORTANT_CONSIDERATION', 165), ('IMPORTANT_CONSIDERATION', 247), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 261), ('PROBABLE_UNDERSTANDING', 295)]	7	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0007612', 'learning', 96, 'learning'), ('GO_0007565', 'female pregnancy', 130, 'pregnant'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D')]
S67-PMC4764019	PMC4764019	1/2016	S67-PMC4764019	['ARE there RECOGNIZED mechanisms whereby Vitamin D status MAY INFLUENCE late-Life outcomes?']	[('EXPLICIT_QUESTION', 0), ('PROBABLE_UNDERSTANDING', 10), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 61), ('EXPLICIT_QUESTION', 89)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0000104', 'life cycle', 76, 'life')]
S72-PMC4764019	PMC4764019	1/2016	S72-PMC4764019	['THAT MEANS that Vitamin D status CAN INFLUENCE not so much the content of our Genetic heritage as WHEN and to WHAT extent it gets Expressed.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 37), ('EXPLICIT_QUESTION', 98), ('EXPLICIT_QUESTION', 110)]	5	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('SO_0000704', 'gene', 78, 'genetic'), ('GO_0010467', 'gene expression', 130, 'expressed')]
S75-PMC4764019	PMC4764019	1/2016	S75-PMC4764019	['BUT the fact is that HOW we function after Birth does APPEAR TO BE SUSCEPTIBLE to INFLUENCE by Perinatal Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('EXPLICIT_QUESTION', 21), ('ANOMALY_CURIOUS_FINDING', 54), ('SUPERFICIAL_RELATIONSHIP', 67), ('SUPERFICIAL_RELATIONSHIP', 82)]	5	[('GO_0007567', 'parturition', 43, 'birth'), ('GO_0036268', 'swimming', 95, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 95, 'perinatal'), ('CHEBI_27300', 'vitamin D', 105, 'vitamin D')]
S82-PMC4764019	PMC4764019	1/2016	S82-PMC4764019	['in closing, it would SEEM IMPORTANT TO EMPHASIZE that the LIKELY Vitamin D status values (and the corresponding daily intakes) ASSOCIATED with protection from the delayed outcomes DISCUSSED HERE are entirely physiological, not Pharmacological (ie, in the range of 40–60 ng/ml).']	[('ANOMALY_CURIOUS_FINDING', 21), ('IMPORTANT_CONSIDERATION', 26), ('PROBABLE_UNDERSTANDING', 58), ('SUPERFICIAL_RELATIONSHIP', 127), ('INCOMPLETE_EVIDENCE', 180), ('QUESTION_ANSWERED_BY_THIS_WORK', 190)]	6	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_52217', 'pharmaceutical', 227, 'pharmacological')]
S83-PMC4764019	PMC4764019	1/2016	S83-PMC4764019	['african nationals living under ancestral conditions exhibit Vitamin D status values in the middle of this range (ie, approximately 46 ng/ml).16\nin conclusion, WHILE one cannot say that the barker HYPOTHESIS HAS BEEN definitively ESTABLISHED for each of the delayed Vitamin D inadequacy outcomes DESCRIBED HERE, it would SEEM that the PRUDENT course, both for oneself as an Individual and for one’s patients and clients, is to assume the applicability of the HYPOTHESIS and, accordingly, to ensure a Vitamin D status approximating that of ancestral Humans.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 159), ('INCOMPLETE_EVIDENCE', 196), ('INCOMPLETE_EVIDENCE', 207), ('INCOMPLETE_EVIDENCE', 229), ('INCOMPLETE_EVIDENCE', 295), ('QUESTION_ANSWERED_BY_THIS_WORK', 305), ('ANOMALY_CURIOUS_FINDING', 320), ('FUTURE_WORK', 334), ('INCOMPLETE_EVIDENCE', 458)]	9	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 265, 'vitamin D'), ('NCBITaxon_1', 'root', 373, 'individual'), ('CHEBI_27300', 'vitamin D', 499, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 548, 'humans')]
S117-PMC4765528	PMC4765528	12/2015	S117-PMC4765528	['one of the MODELS that HAS BEEN POSTULATED is the ROLE of maternal Vitamin D status and Postnatal calcium transfer.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 50)]	5	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007567', 'parturition', 88, 'postnatal')]
S123-PMC4765528	PMC4765528	12/2015	S123-PMC4765528	['studies using the alspac cohort SHOW that Bone Development of the child is clearly RELATED to the in utero environment, BUT that SOME of the ASSOCIATIONS CAN be explained IN PART by the shared ASSOCIATIONS with bone and body size, ALTHOUGH maternal Vitamin D status exerts persisting EFFECTS on bone mass development [19].']	[('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 83), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 120), ('INCOMPLETE_EVIDENCE', 129), ('SUPERFICIAL_RELATIONSHIP', 141), ('INCOMPLETE_EVIDENCE', 154), ('INCOMPLETE_EVIDENCE', 171), ('SUPERFICIAL_RELATIONSHIP', 193), ('ANOMALY_CURIOUS_FINDING', 231), ('SUPERFICIAL_RELATIONSHIP', 284)]	10	[('GO_0048539', 'bone marrow development', 42, 'bone development'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D')]
S55-PMC4772030	PMC4772030	1/2016	S55-PMC4772030	['Retinol <1.05 µmol/l was considered INDICATIVE of low Vitamin A and tdp <65 nmol/l of deficient Thiamine status [21,22].']	[('PROBABLE_UNDERSTANDING', 36)]	1	[('CHEBI_27810', 'resorcinol', 0, 'Retinol'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin A'), ('CHEBI_26948', 'vitamin B1', 96, 'thiamine')]
S20-PMC4785305	PMC4785305	3/2016	S20-PMC4785305	['results derived from Nutrient rct, specifically Vitamin D supplementation, SUFFER from several CONFOUNDING FACTORS RELATED to the baseline status, intake of OTHER Nutrients, such as calcium and proteins, and sun exposure, which are DIFFICULT to quantify accurately.']	[('IMPORTANT_CONSIDERATION', 75), ('PROBLEM_COMPLICATION', 95), ('SUPERFICIAL_RELATIONSHIP', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 157), ('DIFFICULT_TASK', 232)]	5	[('CHEBI_33284', 'nutrient', 21, 'nutrient'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_33284', 'nutrient', 163, 'nutrients')]
S22-PMC4785305	PMC4785305	3/2016	S22-PMC4785305	['WHILE the total Calcitriol levels double in the first trimester, free Calcitriol levels do not increase until the third trimester and remain so until Lactation.24conversely, Parathyroid hormone (pth) levels decrease early on and increase back to mid-normal range by term.2the total calcium level decreases during Pregnancy, due to haemodilution, WHILE the ionised calcium level remains stable.2vitamin D binding proteins also increase during Pregnancy secondary to high Oestrogen levels,45but the 25-Hydroxyvitamin D (25(Oh)D) level, the single best nutritional INDICATOR of Vitamin D status,6remains stable.7the changes in Calcitriol levels led to the description of Pregnancy as a state of ‘absorptive hypercalciuria’.12the above Adaptive physiology is KEY to SAFETY CONSIDERATIONS when using Vitamin D supplementation during Pregnancy, as well as to determining key biochemical and hormonal parameters to be monitored.']	[('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 346), ('SUPERFICIAL_RELATIONSHIP', 562), ('IMPORTANT_CONSIDERATION', 755), ('IMPORTANT_CONSIDERATION', 762), ('IMPORTANT_CONSIDERATION', 769)]	6	[('CHEBI_17823', 'calcitriol', 16, 'calcitriol'), ('CHEBI_17823', 'calcitriol', 70, 'calcitriol'), ('GO_0007595', 'lactation', 150, 'lactation'), ('UBERON_0001132', 'parathyroid gland', 174, 'parathyroid'), ('GO_0007565', 'female pregnancy', 313, 'pregnancy'), ('PR_000006444', 'diacylglycerol kinase delta', 402, 'D'), ('GO_0007565', 'female pregnancy', 442, 'pregnancy'), ('CHEBI_50114', 'estrogen', 470, 'oestrogen'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 497, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 518, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 575, 'vitamin D'), ('CHEBI_17823', 'calcitriol', 624, 'calcitriol'), ('GO_0007565', 'female pregnancy', 668, 'pregnancy'), ('GO_0018888', '3-chloroacrylic acid metabolic process', 732, 'adaptive'), ('CHEBI_27300', 'vitamin D', 795, 'vitamin D'), ('GO_0007565', 'female pregnancy', 828, 'pregnancy')]
S23-PMC4785305	PMC4785305	3/2016	S23-PMC4785305	['maternal Vitamin D status during Pregnancy\nvitamin D deficiency during Pregnancy is PREVALENT worldwide, ESPECIALLY in developing countries.8in a systematic review of 18 studies conducted in western countries during the first Trimester, white caucasian Pregnant women were found to have a mean 25(Oh)D level between 29 and 73\u2005nmol/l.9mean 25(Oh)D levels were lower in non-caucasian Pregnant women, ranging between 15.2 and 43\u2005nmol/l.9in addition to ethnicity, higher latitude was a significant predisposing FACTOR for hypovitaminosis d.9similarly, in non-western countries, more than half of the Pregnant women who were beyond their first trimester had 25(Oh)D levels below 75\u2005nmol/l; these include countries such as india,10kuwait,11pakistan12and turkey.13even lower levels (<25\u2005nmol/l) HAVE BEEN REPORTED at Delivery in saudi arabia, iran and the united arab emirates.14furthermore, immigrant women were at PARTICULAR RISK.1516an OBSERVATIONAL study from the netherlands SHOWED significantly lower 25(Oh)D levels during the first Trimester in immigrant Pregnant women (turkish, moroccan and others), compared to western participants.17\n\nASSOCIATION between maternal Vitamin D status and maternal adverse outcomes\nVitamin D insufficiency during Pregnancy is ASSOCIATED with adverse maternal outcomes such as increased risk of Gestational diabetes mellitus (gdm), preeclampsia, caesarean-section Delivery and bacterial vaginosis.18in a recent meta-analysis of observational studies, the risk of gdm was FOUND TO BE increased by 40–84% in Pregnant women with low 25(Oh)D levels, defined as <50\u2005nmol/l or <75\u2005nmol/l, DEPENDING ON the studies.19–21while Preeclampsia risk was significantly increased in Vitamin D insufficient women,22c-section rates were INCONSISTENTLY AFFECTED by Vitamin D status.23HOWEVER, THESE FINDINGS REMAIN LIMITED by the inherent BIASES of OBSERVATIONAL studies, INCONSISTENT adjustment for CONFOUNDERS, in addition to the wide HETEROGENEITY in Vitamin D assays and Vitamin D cut-offs definition.']	[('IMPORTANT_CONSIDERATION', 84), ('IMPORTANT_CONSIDERATION', 105), ('SUPERFICIAL_RELATIONSHIP', 507), ('INCOMPLETE_EVIDENCE', 788), ('IMPORTANT_CONSIDERATION', 909), ('INCOMPLETE_EVIDENCE', 932), ('INCOMPLETE_EVIDENCE', 973), ('SUPERFICIAL_RELATIONSHIP', 1139), ('SUPERFICIAL_RELATIONSHIP', 1259), ('ANOMALY_CURIOUS_FINDING', 1503), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1615), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1752), ('SUPERFICIAL_RELATIONSHIP', 1767), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1796), ('INCOMPLETE_EVIDENCE', 1807), ('INCOMPLETE_EVIDENCE', 1822), ('INCOMPLETE_EVIDENCE', 1829), ('PROBLEM_COMPLICATION', 1853), ('INCOMPLETE_EVIDENCE', 1863), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1886), ('PROBLEM_COMPLICATION', 1914), ('DIFFICULT_TASK', 1951)]	22	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 51, 'D'), ('GO_0007565', 'female pregnancy', 71, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 226, 'trimester'), ('GO_0007565', 'female pregnancy', 253, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 294, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 294, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 339, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 345, 'D'), ('GO_0007565', 'female pregnancy', 382, 'pregnant'), ('GO_0007565', 'female pregnancy', 596, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 653, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 653, '25(OH)D'), ('GO_0007567', 'parturition', 810, 'delivery'), ('CHEBI_71657', 'versiconol acetate', 1000, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1000, '25(OH)D'), ('GO_0009294', 'DNA mediated transformation', 1032, 'trimester'), ('GO_0007565', 'female pregnancy', 1055, 'pregnant'), ('CHEBI_27300', 'vitamin D', 1168, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 1215, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 1246, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1327, 'gestational'), ('GO_0007567', 'parturition', 1396, 'delivery'), ('GO_0007565', 'female pregnancy', 1538, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 1562, '25(OH)D'), ('GO_0007128', 'meiotic prophase I', 1651, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 1700, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1779, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1968, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1989, 'vitamin D')]
S35-PMC4785305	PMC4785305	3/2016	S35-PMC4785305	['these latter studies AIM at assessing the EFFECT of Vitamin D supplementation on offspring calcium status, maternal and infant Vitamin D status and bone status (by quantitative ultrasound) at 1\u2005year.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('SUPERFICIAL_RELATIONSHIP', 42)]	2	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
S25-PMC4800340	PMC4800340	5/2016	S25-PMC4800340	"[""THIS STUDY SUGGESTS that low sunlight and PRESUMABLY suboptimal Vitamin D status at Birth is ASSOCIATED with Food Allergy Development in childhood.30a large scale population-based study in australia SHOWED that infants with low Serum 25-Hydroxyvitamin (Oh) D3Levels (≤50 nmol/l) had almost 12 times and 4 times higher risk of developing Peanut and egg allergies, respectively, in the first year of Life THAN infants with adequate Serum Vitamin D level.31HOWEVER, ANOTHER STUDY conducted in germany DEMONSTRATED that 25(Oh)D3Concentration in Pregnant women's Serum and in Cord Blood were positively ASSOCIATED with increased risk of Food Allergy Development among children in the first 2 years.32a RECENT randomized double-blind controlled TRIAL SHOWED that maternal Vitamin D3Supplementation for 6 weeks during Lactation increased the risk of Food allergy diagnosis by 3.42 times [95% confidence interval (ci)=1.02–11.77] among children of supplementation group compared to control group by 2 years of age.33due to lack OF robustly designed studies, a causal ASSOCIATION between Vitamin D status during Prenatal and Neonatal Period and Food allergy Development In Children remains INCONCLUSIVE.""]"	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('PROBABLE_UNDERSTANDING', 42), ('SUPERFICIAL_RELATIONSHIP', 93), ('INCOMPLETE_EVIDENCE', 199), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 403), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 452), ('INCOMPLETE_EVIDENCE', 463), ('INCOMPLETE_EVIDENCE', 498), ('SUPERFICIAL_RELATIONSHIP', 598), ('INCOMPLETE_EVIDENCE', 697), ('INCOMPLETE_EVIDENCE', 739), ('INCOMPLETE_EVIDENCE', 745), ('ANOMALY_CURIOUS_FINDING', 1020), ('SUPERFICIAL_RELATIONSHIP', 1059), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1181)]	16	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0007567', 'parturition', 84, 'birth'), ('CHEBI_33290', 'food', 109, 'food'), ('GO_0048467', 'gynoecium development', 109, 'food allergy development'), ('UBERON_0001977', 'blood serum', 228, 'serum'), ('CHEBI_60346', 'alpha-Kdo-(2->8)-alpha-Kdo-OAll', 234, '25-hydroxyvitamin (OH) D3levels'), ('NCBITaxon_10088', 'Mus <genus>', 337, 'peanut'), ('UBERON_0000104', 'life cycle', 398, 'life'), ('UBERON_0001977', 'blood serum', 430, 'serum'), ('CHEBI_27300', 'vitamin D', 436, 'vitamin D'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 516, '25(OH)D3concentration'), ('GO_0007565', 'female pregnancy', 541, 'pregnant'), ('UBERON_0001977', 'blood serum', 558, 'serum'), ('UBERON_0009472', 'axilla', 571, 'cord blood'), ('CHEBI_33290', 'food', 632, 'food'), ('GO_0048467', 'gynoecium development', 632, 'food allergy development'), ('CHEBI_52915', 'phosphatediyl group', 766, 'vitamin D3supplementation'), ('GO_0007595', 'lactation', 811, 'lactation'), ('CHEBI_33290', 'food', 843, 'food'), ('CHEBI_27300', 'vitamin D', 1079, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1103, 'prenatal'), ('UBERON_0007221', 'neonate stage', 1116, 'neonatal period'), ('CHEBI_33290', 'food', 1136, 'food'), ('GO_0030163', 'protein catabolic process', 1149, 'development in children')]
S55-PMC4811107	PMC4811107	3/2016	S55-PMC4811107	['maternal atopic status was included because the primary goal of the cohort was to study allergic outcomes in the children and Prenatal and early Life Vitamin D levels have been investigated for their ROLE in allergic disease development [22,24–27].']	[('SUPERFICIAL_RELATIONSHIP', 200)]	1	[('GO_0007565', 'female pregnancy', 126, 'prenatal'), ('UBERON_0000104', 'life cycle', 145, 'life'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D')]
S97-PMC4811107	PMC4811107	3/2016	S97-PMC4811107	['EXAMINED WHETHER Prepregnancy obesity PREDICTED POOR Vitamin D status in neonates in their study of 400 women in pittsburgh, pennsylvania [7].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('SUPERFICIAL_RELATIONSHIP', 38), ('IMPORTANT_CONSIDERATION', 48)]	4	[('GO_0007565', 'female pregnancy', 17, 'prepregnancy'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D')]
S2-PMC4811441	PMC4811441	3/2016	S2-PMC4811441	['the pathophysiology of the Development Of Hypertension In Pregnancy is UNKNOWN, but studies SUGGEST an ASSOCIATION with Vitamin D status, measured as 25-Hydroxyvitamin D (25(Oh)D).']	[('FULL_UNKNOWN', 71), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('GO_0002234', 'detection of endoplasmic reticulum overloading', 27, 'development of hypertension in'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 150, '25-hydroxyvitamin D'), ('CHEBI_33010', 'chromide(1-)', 173, '(OH)D')]
S12-PMC4811441	PMC4811441	3/2016	S12-PMC4811441	['in conclusion, an increase in 25(Oh)D concentration during Pregnancy of at LEAST 30 nmol/l, REGARDLESS OF Vitamin D status in t1, was ASSOCIATED with a lower odds ratio for Preeclampsia.']	[('PROBABLE_UNDERSTANDING', 75), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 134)]	3	[('CHEBI_71657', 'versiconol acetate', 30, '25(OH)D'), ('GO_0007565', 'female pregnancy', 59, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 173, 'preeclampsia')]
S26-PMC4811441	PMC4811441	3/2016	S26-PMC4811441	['during the past decade, Vitamin D status has been ATTRIBUTED health BENEFITS beyond its RECOGNIZED EFFECTS on bone health.']	[('SUPERFICIAL_RELATIONSHIP', 50), ('IMPORTANT_CONSIDERATION', 68), ('PROBABLE_UNDERSTANDING', 88), ('SUPERFICIAL_RELATIONSHIP', 99)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
S29-PMC4811441	PMC4811441	3/2016	S29-PMC4811441	['poorer Vitamin D status (measured as 25-Hydroxyvitamin D (25(Oh)D) during Pregnancy HAS BEEN ASSOCIATED with INCREASED RISKS of pe and Gestational hypertension in SOME [11,12] BUT NOT ALL observational studies [13,14].']	[('INCOMPLETE_EVIDENCE', 84), ('SUPERFICIAL_RELATIONSHIP', 93), ('IMPORTANT_CONSIDERATION', 109), ('INCOMPLETE_EVIDENCE', 163), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 176), ('ANOMALY_CURIOUS_FINDING', 180)]	6	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 37, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 58, '25(OH)D'), ('GO_0007565', 'female pregnancy', 74, 'pregnancy'), ('GO_0007565', 'female pregnancy', 135, 'gestational')]
S30-PMC4811441	PMC4811441	3/2016	S30-PMC4811441	['cross sectional and cohort studies investigating the ASSOCIATION between Vitamin D status and pe show CONFLICTING results [11–14].']	[('SUPERFICIAL_RELATIONSHIP', 53), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 102)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
S31-PMC4811441	PMC4811441	3/2016	S31-PMC4811441	['case-control STUDIES OFTEN have INSUFFICIENT or no matching, GENERATING CONCERNS about CONFOUNDING AS VARIATIONS in Vitamin D status ASSOCIATED with season, skin pigmentation and lifestyle factors are known [15].']	[('INCOMPLETE_EVIDENCE', 13), ('PROBABLE_UNDERSTANDING', 21), ('PROBLEM_COMPLICATION', 32), ('PROBABLE_UNDERSTANDING', 61), ('PROBLEM_COMPLICATION', 72), ('PROBLEM_COMPLICATION', 87), ('PROBABLE_UNDERSTANDING', 99), ('DIFFICULT_TASK', 102), ('SUPERFICIAL_RELATIONSHIP', 133)]	9	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
S34-PMC4811441	PMC4811441	3/2016	S34-PMC4811441	['this LIMITS the evaluation of the POTENTIAL ROLE of Vitamin D status during early Pregnancy in the development and progression Of Pe.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 44)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007565', 'female pregnancy', 82, 'pregnancy'), ('GO_0001554', 'luteolysis', 127, 'of PE')]
S39-PMC4811441	PMC4811441	3/2016	S39-PMC4811441	['the primary outcome of the study was TO INVESTIGATE the ASSOCIATION between Vitamin D status and hypertensive disorders in Pregnancy and pe.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 37), ('SUPERFICIAL_RELATIONSHIP', 56)]	2	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007565', 'female pregnancy', 123, 'pregnancy')]
S87-PMC4811441	PMC4811441	3/2016	S87-PMC4811441	['Vitamin D status was used as time-varying in model 1, where the mean of the 25(Oh)D concentration in t1 and t3 was used as a PROXY for Vitamin D status at Gestational week 25 and the concentration at week 32 (t3) was duplicated for week 37.']	[('SUPERFICIAL_RELATIONSHIP', 125)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 76, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 135, 'vitamin D'), ('GO_0007565', 'female pregnancy', 155, 'gestational')]
S136-PMC4811441	PMC4811441	3/2016	S136-PMC4811441	['also, an increase in 25(Oh)D ≥30 nmol/l was not associated with Pregnancy-induced hypertension.10.1371/journal.pone.0152198.t004\n\ncaption (table-wrap): table 4\nbivariable and multivariable logistic regression analysis of the DETERMINANTS of Pregnancy-induced hypertension.bivariablemultivariableabor95% cipbor95% ciplowerupperlowerupper25(Oh)D t10.0081.0081.0011.0140.0240.0021.0020.9931.0100.709obesity t10.3661.4430.8972.3210.131-0.1690.8440.4641.5380.844nulliparity0.3611.4351.0391.9830.0290.2051.2280.8541.7650.269excessive gwg0.4731.6041.1462.2460.0060.3631.4380.9952.0780.054preexisting medical condition t10.6321.8810.8764.0400.1050.0891.0930.4542.6290.842assisted reproduction0.1821.2000.7881.8280.3950.0841.0880.6561.8030.745tobacco use t1-0.6330.5310.2161.3080.169-0.4470.6400.2621.5630.327height0.0541.0551.0291.083<0.0010.0351.0351.0051.0660.021age ≥40 years t1-0.1410.8680.3732.0240.744-0.1920.8250.3122.1840.699dbp t10.0871.0911.0691.114<0.0010.0881.0921.0671.117<0.001\n25(Oh)d = 25-Hydroxyvitamin D, t1 = first trimester, gwg = Gestational weight gain, dbp = diastolic Blood pressure,\ndichotomous: age ≥40 years, obesity, nulliparity, excessive gwg, preexisting medical condition and assisted reproduction\na.adjusted for multifetal Pregnancy, baseline employment status, Gestational age at t1, month of Conception and northern european country of Birth\n\ndiscussion\nthese results are the primary outcome of the gravid study–TO OUR KNOWLEDGE the FIRST STUDY reporting on the RELATIONSHIP between longitudinal Vitamin D status and its RELATION to pe and Gestational bp trajectory.']	[('SUPERFICIAL_RELATIONSHIP', 225), ('PROBABLE_UNDERSTANDING', 1438), ('INCOMPLETE_EVIDENCE', 1459), ('SUPERFICIAL_RELATIONSHIP', 1488), ('SUPERFICIAL_RELATIONSHIP', 1547)]	5	[('CHEBI_71657', 'versiconol acetate', 21, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 21, '25(OH)D'), ('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('GO_0007565', 'female pregnancy', 241, 'pregnancy'), ('CHEBI_33010', 'chromide(1-)', 338, '(OH)D'), ('CHEBI_63056', 'zinc cation', 984, '25(OH'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 994, '25-hydroxyvitamin D'), ('GO_0007565', 'female pregnancy', 1043, 'gestational'), ('UBERON_0000178', 'blood', 1084, 'blood'), ('GO_0007565', 'female pregnancy', 1247, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1286, 'gestational'), ('GO_0007620', 'copulation', 1318, 'conception'), ('GO_0007567', 'parturition', 1362, 'birth'), ('CHEBI_27300', 'vitamin D', 1522, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1566, 'gestational')]
S137-PMC4811441	PMC4811441	3/2016	S137-PMC4811441	['our results SUGGEST that an increase of AT LEAST 30 nmol/l in 25(Oh)D concentration during Pregnancy is RELATED to lower odds of pe, REGARDLESS OF Vitamin D status in early Pregnancy.']	[('INCOMPLETE_EVIDENCE', 12), ('PROBABLE_UNDERSTANDING', 40), ('SUPERFICIAL_RELATIONSHIP', 104), ('INCOMPLETE_EVIDENCE', 133)]	4	[('CHEBI_71657', 'versiconol acetate', 62, '25(OH)D'), ('GO_0007565', 'female pregnancy', 91, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy')]
S141-PMC4811441	PMC4811441	3/2016	S141-PMC4811441	['THEREFORE, IT IS POSSIBLE that Vitamin D status in early Pregnancy MIGHT not play a MAJOR ROLE in Placental Development, but that an increment during Gestation MAY prevent the Development Of Pe.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 67), ('IMPORTANT_CONSIDERATION', 84), ('SUPERFICIAL_RELATIONSHIP', 90), ('INCOMPLETE_EVIDENCE', 160)]	6	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007565', 'female pregnancy', 57, 'pregnancy'), ('GO_0001890', 'placenta development', 98, 'placental development'), ('UBERON_0001987', 'placenta', 98, 'placental'), ('GO_0007565', 'female pregnancy', 150, 'gestation'), ('GO_0042494', 'detection of bacterial lipoprotein', 176, 'development of PE')]
S149-PMC4811441	PMC4811441	3/2016	S149-PMC4811441	['we FOUND a positive ASSOCIATION between Vitamin D status and bp trajectory, BUT non-significant for dbp after adjustment for baseline bp.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 20), ('ANOMALY_CURIOUS_FINDING', 76)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
S167-PMC4811441	PMC4811441	3/2016	S167-PMC4811441	['another STRENGTH is that Blood samples were taken in both early and late Pregnancy, enabling INVESTIGATION of changes in Vitamin D status in RELATION to pe and bp.']	[('IMPORTANT_CONSIDERATION', 8), ('FUTURE_WORK', 93), ('SUPERFICIAL_RELATIONSHIP', 141)]	3	[('UBERON_0000178', 'blood', 25, 'blood'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
S169-PMC4811441	PMC4811441	3/2016	S169-PMC4811441	['our results SHOW that an increment in 25(Oh)D concentration during Pregnancy is ASSOCIATED with lower odds of pe, REGARDLESS OF early Pregnancy Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 114)]	3	[('CHEBI_71657', 'versiconol acetate', 38, '25(OH)D'), ('GO_0007565', 'female pregnancy', 67, 'pregnancy'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
S171-PMC4811441	PMC4811441	3/2016	S171-PMC4811441	['in conclusion, an increase in 25(Oh)D concentration during Pregnancy of at LEAST 30 nmol/l, REGARDLESS OF Vitamin D status at t1, was ASSOCIATED with a lower odds ratio for pe.']	[('PROBABLE_UNDERSTANDING', 75), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 134)]	3	[('CHEBI_71657', 'versiconol acetate', 30, '25(OH)D'), ('GO_0007565', 'female pregnancy', 59, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D')]
S106-PMC4825101	PMC4825101	10/2015	S106-PMC4825101	['Vitamins A and c, zinc and protein-energy status) have SO FAR NOT yielded positive findings.']	[('INCOMPLETE_EVIDENCE', 55)]	1	[('CHEBI_27300', 'vitamin D', 0, 'vitamins A')]
S8-PMC4829940	PMC4829940	5/2016	S8-PMC4829940	['in this large Genome wide assessment of the POTENTIAL INFLUENCE of maternal Vitamin D status on Dna Methylation, we DID NOT FIND any convincing ASSOCIATIONS in 1416 newborns.']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 144)]	4	[('SO_0001026', 'genome', 14, 'genome'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0006306', 'DNA methylation', 96, 'DNA methylation')]
S12-PMC4829940	PMC4829940	5/2016	S12-PMC4829940	['the MAJOR circulating form and indicator of Vitamin D status, 25-Hydroxyvitamin D (25(Oh)D), is supplied by 25-hydroxylation of Vitamin D produced in the skin upon uvb radiation or Vitamin D from the diet[1].']	[('IMPORTANT_CONSIDERATION', 4)]	1	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 62, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 83, '25(OH)D'), ('CHEBI_33229', 'vitamin (role)', 128, 'vitamin'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 136, 'D'), ('CHEBI_27300', 'vitamin D', 181, 'vitamin D')]
S19-PMC4829940	PMC4829940	5/2016	S19-PMC4829940	['ALTHOUGH a NUMBER OF STUDIES have REPORTED inverse ASSOCIATIONS between maternal Vitamin D status and Postnatal health outcomes, systematic reviews SHOW that there is STILL substantial heterogeneity between studies in terms of methodology and results, and FEW or NO randomized TRIALS HAVE BEEN performed[6],[8],[10],[11].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 51), ('INCOMPLETE_EVIDENCE', 148), ('IMPORTANT_CONSIDERATION', 167), ('INCOMPLETE_EVIDENCE', 256), ('FULL_UNKNOWN', 263), ('INCOMPLETE_EVIDENCE', 284)]	10	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007567', 'parturition', 102, 'postnatal')]
S115-PMC4829940	PMC4829940	5/2016	S115-PMC4829940	['DESPITE the EXISTING HYPOTHESIS that maternal Vitamin D status MAY INFLUENCE offspring health[41], we FOUND NO EVIDENCE for any Dna Methylation based EFFECT in Cord Blood, EITHER Genome-wide or in four candidate Genes.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 67), ('INCOMPLETE_EVIDENCE', 102), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 150), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 172)]	10	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0006306', 'DNA methylation', 128, 'DNA methylation'), ('UBERON_0002240', 'spinal cord', 160, 'cord'), ('UBERON_0000178', 'blood', 165, 'blood'), ('SO_0001026', 'genome', 179, 'genome'), ('SO_0000704', 'gene', 212, 'genes')]
S128-PMC4829940	PMC4829940	5/2016	S128-PMC4829940	['given that Vitamin D status fluctuates throughout Pregnancy, IT IS POSSIBLE that the fetus is more sensitive to Vitamin D levels at certain Gestational periods[6].']	[('INCOMPLETE_EVIDENCE', 61)]	1	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007565', 'female pregnancy', 50, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0007565', 'female pregnancy', 140, 'gestational')]
S22-PMC4832516	PMC4832516	10/2015	S22-PMC4832516	['Age At Menarche is a well-recalled measure of Pubertal timing in girls and HAS BEEN LINKED to Vitamin D status in prospective[13]and Genetic[14]studies.']	[('INCOMPLETE_EVIDENCE', 75), ('SUPERFICIAL_RELATIONSHIP', 84)]	2	[('GO_0007568', 'aging', 0, 'Age at'), ('GO_0042696', 'menarche', 7, 'menarche'), ('GO_0007567', 'parturition', 46, 'pubertal'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('SO_0000704', 'gene', 133, 'genetic')]
S132-PMC4832516	PMC4832516	10/2015	S132-PMC4832516	['LIMITATIONS of the study include no direct measurement of maternal/fetal Vitamin D status to fully establish a causal mechanism.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
S0-PMC4859539	PMC4859539	5/2016	S0-PMC4859539	['circulating Cathelicidin concentrations in a cohort of healthy children: INFLUENCE of age, body composition, gender and Vitamin D status\n\nabstract\nCathelicidin is an Antimicrobial peptide whose circulating levels are RELATED to Vitamin D status in Adults.']	[('SUPERFICIAL_RELATIONSHIP', 73), ('SUPERFICIAL_RELATIONSHIP', 217)]	2	[('CHEBI_3461', 'Casuarictin', 12, 'Cathelicidin'), ('PR_000004907', 'complement component C7', 12, 'Cathelicidin'), ('CHEBI_28384', 'vitamin K', 120, 'Vitamin D'), ('PR_000004907', 'complement component C7', 147, 'Cathelicidin'), ('CHEBI_65381', 'albizoside C', 166, 'antimicrobial'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('UBERON_0007023', 'adult organism', 248, 'adults')]
S1-PMC4859539	PMC4859539	5/2016	S1-PMC4859539	['THIS STUDY SOUGHT TO DETERMINE IF circulating Cathelicidin concentrations in healthy children are RELATED to the age of the child, body composition and Vitamin D status at Birth and at the time of the study visit.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('SUPERFICIAL_RELATIONSHIP', 98)]	5	[('PR_000006009', 'alpha-catulin', 46, 'cathelicidin'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('GO_0007567', 'parturition', 172, 'birth')]
S10-PMC4859539	PMC4859539	5/2016	S10-PMC4859539	['the LACK OF association between Vitamin D status and Cathelicidin in THIS STUDY MAY BE DUE TO the NARROW RANGE in OBSERVED 25(Oh)D values and WARRANTS ADDITIONAL STUDIES for further observation.']	[('INCOMPLETE_EVIDENCE', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 69), ('INCOMPLETE_EVIDENCE', 80), ('PROBLEM_COMPLICATION', 87), ('PROBLEM_COMPLICATION', 98), ('INCOMPLETE_EVIDENCE', 114), ('FUTURE_WORK', 142), ('FUTURE_WORK', 151)]	8	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('PR_000006009', 'alpha-catulin', 53, 'cathelicidin'), ('CHEBI_71657', 'versiconol acetate', 123, '25(OH)D')]
S14-PMC4859539	PMC4859539	5/2016	S14-PMC4859539	['additionally, WHILE ONE STUDY examined the levels of maternal and neonatal Vitamin D and Cathelicidin concentrations in healthy children at Delivery, there is a LACK OF research TO DETERMINE CORRELATIONS between Vitamin D status and cathelicidin among healthy children over time [20], as well as WHICH FACTORS such as age of the child, gender, and body composition MAY INDEPENDENTLY IMPACT Cathelicidin concentrations.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 161), ('QUESTION_ANSWERED_BY_THIS_WORK', 178), ('SUPERFICIAL_RELATIONSHIP', 191), ('EXPLICIT_QUESTION', 296), ('SUPERFICIAL_RELATIONSHIP', 302), ('INCOMPLETE_EVIDENCE', 365), ('SUPERFICIAL_RELATIONSHIP', 369), ('SUPERFICIAL_RELATIONSHIP', 383)]	10	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D'), ('CHEBI_3364', 'Canthiumine', 89, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 89, 'cathelicidin'), ('GO_0007567', 'parturition', 140, 'delivery'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('CHEBI_3364', 'Canthiumine', 390, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 390, 'cathelicidin')]
S15-PMC4859539	PMC4859539	5/2016	S15-PMC4859539	['to address this GAP in the literature, the AIM of THIS follow-up STUDY was TO DETERMINE IF maternal Vitamin D status during Pregnancy and/or a child’s current Vitamin D status AFFECT the circulating concentration of Cathelicidin in healthy children years after Delivery.']	[('FULL_UNKNOWN', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('QUESTION_ANSWERED_BY_THIS_WORK', 50), ('QUESTION_ANSWERED_BY_THIS_WORK', 75), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('GO_0007565', 'female pregnancy', 124, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('PR_000006009', 'alpha-catulin', 216, 'cathelicidin'), ('GO_0007567', 'parturition', 261, 'delivery')]
S69-PMC4859539	PMC4859539	5/2016	S69-PMC4859539	['DESPITE DIFFERENCES in Vitamin D status, there were no significant associations between Cathelicidin, race/ethnicity and Vitamin D status (see table 2 ).']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 8)]	2	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('PR_000006009', 'alpha-catulin', 88, 'cathelicidin'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D')]
S97-PMC4859539	PMC4859539	5/2016	S97-PMC4859539	"[""in MODELS 1 and 4, there was also a TREND NOTED with the child’s percent fat being positively ASSOCIATED with Cathelicidin (beta = 0.028, p = 0.052 and beta = 0.025, p = 0.087).10.1371/journal.pone.0152711.t003\n\ncaption (table-wrap): table 3\nmultivariable linear regression models assessing factors associated with natural logarithm for Cathelicidin.model 1 \xa0\xa0independent variablesbetase1p valuerace/ethnicity\xa0\xa0black-0.0390.230.864white---------hispanic-0.1490.2000.459genderfemale---------male0.3180.16 0.047 age0.1450.065 0.028 percent fat0.0280.0140.052child's current 25(Oh)D-0.0050.010.598 model 2 \xa0\xa0\xa0independent variablesbetasep valuerace/ethnicityblack0.0350.210.868white---------hispanic-0.1490.210.470genderfemale---------male0.2750.170.104age0.2120.07 0.004 percent fat0.0250.020.087child's 25(Oh)D at Birth-0.0030.010.748 model 3 \xa0\xa0\xa0independent variablesbetasep valuerace/ethnicity\xa0\xa0black0.0410.180.821white---------hispanic-0.1220.160.458genderfemale---------male0.0910.140.507age0.1550.07 0.023 percent fat0.0120.010.359maternal 25(Oh)D throughout Pregnancy<-0.000100.999 model 4 \xa0\xa0\xa0independent variablesbetasep valuerace/ethnicity\xa0\xa0black0.0460.1990.816white---------hispanic-0.0800.1850.669genderfemale---------male0.3180.158 0.047 age0.1510.064 0.021 percent fat0.0260.010.069maternal 25(Oh)D 1-month before Delivery0.0030.010.606\n1se represents standard error\n\ndiscussion\nin THIS STUDY of healthy children whose mothers had participated in a Vitamin D supplementation trial during Pregnancy, DESPITE DIFFERENCES in both maternal and childhood Vitamin D status, there were no significant differences in Cathelicidin concentration between the three racial/ethnic groups studied.""]"	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('INCOMPLETE_EVIDENCE', 36), ('ANOMALY_CURIOUS_FINDING', 42), ('SUPERFICIAL_RELATIONSHIP', 94), ('QUESTION_ANSWERED_BY_THIS_WORK', 1391), ('ANOMALY_CURIOUS_FINDING', 1508), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1516)]	7	[('CHEBI_3364', 'Canthiumine', 110, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 110, 'cathelicidin'), ('CHEBI_3461', 'Casuarictin', 337, 'Cathelicidin'), ('CHEBI_71657', 'versiconol acetate', 572, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 572, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 801, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 807, 'D'), ('GO_0007567', 'parturition', 812, 'birth'), ('CHEBI_71657', 'versiconol acetate', 1042, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 1048, 'D'), ('GO_0007565', 'female pregnancy', 1061, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 1300, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1300, '25(OH)D'), ('GO_0007567', 'parturition', 1323, 'delivery0'), ('CHEBI_27300', 'vitamin D', 1458, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1497, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1559, 'vitamin D'), ('CHEBI_3364', 'Canthiumine', 1618, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 1618, 'cathelicidin')]
S99-PMC4859539	PMC4859539	5/2016	S99-PMC4859539	['REGARDLESS OF Vitamin D status, there was no statistically significant difference in Cathelicidin concentrations between subjects, CONSISTENT with the FINDINGS of other RECENT STUDIES [6,7,12,14,17,20].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 131), ('INCOMPLETE_EVIDENCE', 151), ('INCOMPLETE_EVIDENCE', 169)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_3364', 'Canthiumine', 85, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 85, 'cathelicidin')]
S102-PMC4859539	PMC4859539	5/2016	S102-PMC4859539	['DIFFERENCES in age, health and initial Vitamin D status between cohorts, as well as study design, MAY EXPLAIN the CONFLICTING data.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 98), ('PROBABLE_UNDERSTANDING', 102), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D')]
S124-PMC4859539	PMC4859539	5/2016	S124-PMC4859539	['lastly, total circulating Cathelicidin was measured RATHER than cell-specific mrna Expression of Cathelicidin or 1,25(Oh)2D3Concentration [17], which MAY BE more closely LINKED with Vitamin D status during Fetal and childhood Development.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 52), ('INCOMPLETE_EVIDENCE', 150), ('SUPERFICIAL_RELATIONSHIP', 170)]	3	[('PR_000006009', 'alpha-catulin', 26, 'cathelicidin'), ('GO_0010467', 'gene expression', 83, 'expression'), ('PR_000006009', 'alpha-catulin', 97, 'cathelicidin'), ('CHEBI_52815', 'cresyl violet', 113, '1,25(OH)2D3concentration'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D'), ('GO_0030540', 'female genitalia development', 206, 'fetal ... development')]
S0-PMC4889866	PMC4889866	5/2016	S0-PMC4889866	['maternal Vitamin D level is ASSOCIATED with Viral toll-like receptor triggered Il-10 response but not the risk of infectious diseases in infancy\n\nabstract\nreports on the EFFECT of Prenatal Vitamin D status on fetal Immune Development and infectious diseases in childhood are LIMITED.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('SUPERFICIAL_RELATIONSHIP', 170), ('INCOMPLETE_EVIDENCE', 275)]	3	[('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 44, 'Viral'), ('PR_000001470', 'interleukin-28B', 79, 'IL-10'), ('GO_0007565', 'female pregnancy', 180, 'prenatal'), ('CHEBI_27300', 'vitamin D', 189, 'vitamin D'), ('GO_0001822', 'kidney development', 215, 'immune development'), ('UBERON_0002405', 'immune system', 215, 'immune')]
S20-PMC4889866	PMC4889866	5/2016	S20-PMC4889866	['furthermore, VERY FEW STUDIES address the IMPACT of Prenatal Vitamin D status on tlr-RELATED Innate Immune Response in neonatal infants.']	[('IMPORTANT_CONSIDERATION', 13), ('INCOMPLETE_EVIDENCE', 18), ('SUPERFICIAL_RELATIONSHIP', 42), ('SUPERFICIAL_RELATIONSHIP', 85)]	4	[('GO_0007565', 'female pregnancy', 52, 'prenatal'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('GO_0045087', 'innate immune response', 93, 'innate immune response'), ('UBERON_0002405', 'immune system', 100, 'immune')]
S81-PMC4889866	PMC4889866	5/2016	S81-PMC4889866	['PRELIMINARY analysis was also performed on maternal innate Immune function; the result SHOWED no correlation between maternal Vitamin D status and cytokine response to tlr ligands in maternal Mononuclear cells (supplement 1) (see supplementary material available online athttp://dx.doi.org/10.1155/2016/8175898).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 87)]	2	[('UBERON_0002405', 'immune system', 59, 'immune'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('CL_0000100', 'motor neuron', 192, 'mononuclear'), ('GO_0031097', 'medial cortex', 192, 'mononuclear')]
S84-PMC4889866	PMC4889866	5/2016	S84-PMC4889866	['analysis was made to INVESTIGATE WHETHER maternal or Cord Blood Vitamin D status was ASSOCIATED with Lower Respiratory Tract infection (bronchiolitis, pneumonia, and croup), infectious enteritis, and Urinary Tract infection at 1 year of age.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 33), ('SUPERFICIAL_RELATIONSHIP', 85)]	3	[('UBERON_0002240', 'spinal cord', 53, 'cord'), ('UBERON_0000178', 'blood', 58, 'blood'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('UBERON_0004905', 'articulation', 101, 'lower respiratory tract'), ('UBERON_0001553', 'medial tarsal artery', 200, 'urinary tract')]
S85-PMC4889866	PMC4889866	5/2016	S85-PMC4889866	['the results, summarized intable 3, SHOWED no significant association between maternal Vitamin D status and the incidence of infection during the first year of Life.']	[('INCOMPLETE_EVIDENCE', 35)]	1	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0000104', 'life cycle', 159, 'life')]
S89-PMC4889866	PMC4889866	5/2016	S89-PMC4889866	['TO OUR KNOWLEDGE, THIS is the FIRST cohort STUDY TO simultaneously ASSESS the EFFECT of both maternal and Cord Blood Vitamin D status on tlr-RELATED immune response and various infectious diseases during Infancy.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('QUESTION_ANSWERED_BY_THIS_WORK', 49), ('QUESTION_ANSWERED_BY_THIS_WORK', 67), ('SUPERFICIAL_RELATIONSHIP', 78), ('SUPERFICIAL_RELATIONSHIP', 141)]	8	[('UBERON_0002240', 'spinal cord', 106, 'cord'), ('UBERON_0000178', 'blood', 111, 'blood'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('GO_0007631', 'feeding behavior', 204, 'infancy')]
S92-PMC4889866	PMC4889866	5/2016	S92-PMC4889866	['our result SUGGESTED that the latter MIGHT be an IMPORTANT ISSUE to CONSIDER, BECAUSE DESPITE a strong CORRELATION between maternal and Cord Vitamin D level, OUR study had OBSERVED a distinction between maternal and cord Vitamin D status in their ASSOCIATION with tlr-triggered cytokine response.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 37), ('IMPORTANT_CONSIDERATION', 49), ('PROBLEM_COMPLICATION', 59), ('FUTURE_WORK', 68), ('IMPORTANT_CONSIDERATION', 68), ('PROBLEM_COMPLICATION', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('ANOMALY_CURIOUS_FINDING', 86), ('SUPERFICIAL_RELATIONSHIP', 103), ('QUESTION_ANSWERED_BY_THIS_WORK', 158), ('INCOMPLETE_EVIDENCE', 172), ('SUPERFICIAL_RELATIONSHIP', 247)]	13	[('UBERON_0002240', 'spinal cord', 136, 'cord'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin D')]
S93-PMC4889866	PMC4889866	5/2016	S93-PMC4889866	['THUS, when addressing the IMPACT of Prenatal Vitamin D status on various outcomes, it MIGHT be IMPORTANT to CONSIDER that Vitamin D levels in the Pregnant mothers and Cord Blood MIGHT not always correspond uniformly.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 86), ('IMPORTANT_CONSIDERATION', 95), ('FUTURE_WORK', 108), ('IMPORTANT_CONSIDERATION', 108), ('INCOMPLETE_EVIDENCE', 178)]	7	[('GO_0007565', 'female pregnancy', 36, 'prenatal'), ('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('GO_0007565', 'female pregnancy', 146, 'pregnant'), ('UBERON_0002240', 'spinal cord', 167, 'cord'), ('UBERON_0000178', 'blood', 172, 'blood')]
S109-PMC4889866	PMC4889866	5/2016	S109-PMC4889866	['FURTHER RESEARCH IS WARRANTED to investigate the mechanism in which maternal Vitamin D status AFFECTS neonatal tlr-RELATED Il-10 response.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('FUTURE_WORK', 17), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 115)]	5	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 123, 'IL-10')]
S112-PMC4889866	PMC4889866	5/2016	S112-PMC4889866	['our OBSERVATIONS are AT ODDS with SEVERAL STUDIES that SHOWED lower Vitamin D status to be ASSOCIATED with increased incidence or severity of infection during early childhood.']	[('INCOMPLETE_EVIDENCE', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 21), ('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 91)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
S127-PMC4889866	PMC4889866	5/2016	S127-PMC4889866	['finally, ALTHOUGH PRESENT STUDY had OBSERVED an ASSOCIATION between Prenatal Vitamin D status and Viral tlrs-triggered response (Tlr3 and Tlr7/8, both of which recognize Viral rna), the EFFECT of Vitamin D on cpg Double Stranded dna motif (Tlr9) of the Viral Genome also DEMANDS FURTHER EXPLORATION.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 186), ('IMPORTANT_CONSIDERATION', 271), ('FUTURE_WORK', 279)]	7	[('GO_0007565', 'female pregnancy', 68, 'prenatal'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('NCBITaxon_1', 'root', 98, 'viral'), ('PR_000001155', 'Toll-like receptor 4', 129, 'TLR3'), ('PR_000001155', 'Toll-like receptor 4', 138, 'TLR7'), ('NCBITaxon_1', 'root', 170, 'viral'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D'), ('SO_0000985', 'double', 213, 'double stranded'), ('PR_000001155', 'Toll-like receptor 4', 240, 'TLR9'), ('NCBITaxon_1', 'root', 253, 'viral'), ('SO_0001026', 'genome', 259, 'genome')]
S129-PMC4889866	PMC4889866	5/2016	S129-PMC4889866	['the result SHOWED no correlation between maternal Vitamin D status and neonatal Tlr9 triggered cytokine response (supplement 2), THOUGH such conclusion NEEDED to be INTERPRETED with CAUTION for the null CORRELATION MIGHT be DUE TO LACK OF POWER OWING TO SMALL number of test samples.']	[('INCOMPLETE_EVIDENCE', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 129), ('ANOMALY_CURIOUS_FINDING', 129), ('FUTURE_WORK', 152), ('FULL_UNKNOWN', 165), ('INCOMPLETE_EVIDENCE', 182), ('SUPERFICIAL_RELATIONSHIP', 203), ('INCOMPLETE_EVIDENCE', 215), ('PROBLEM_COMPLICATION', 224), ('INCOMPLETE_EVIDENCE', 231), ('PROBLEM_COMPLICATION', 231), ('PROBLEM_COMPLICATION', 245), ('INCOMPLETE_EVIDENCE', 254)]	13	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('PR_000001155', 'Toll-like receptor 4', 80, 'TLR9')]
S131-PMC4889866	PMC4889866	5/2016	S131-PMC4889866	['THIS STUDY EMPHASIZED that EVEN THOUGH Cord Vitamin D level was STRONGLY CORRELATED with maternal Vitamin D status, the extent of IMPACT on fetal Immune Cytokine Response MIGHT be distinctive.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('IMPORTANT_CONSIDERATION', 11), ('IMPORTANT_CONSIDERATION', 11), ('ANOMALY_CURIOUS_FINDING', 27), ('ANOMALY_CURIOUS_FINDING', 32), ('PROBABLE_UNDERSTANDING', 64), ('SUPERFICIAL_RELATIONSHIP', 73), ('SUPERFICIAL_RELATIONSHIP', 130), ('INCOMPLETE_EVIDENCE', 171)]	9	[('UBERON_0002240', 'spinal cord', 39, 'cord'), ('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0002250', 'adaptive immune response', 146, 'immune cytokine response'), ('UBERON_0002405', 'immune system', 146, 'immune')]
S132-PMC4889866	PMC4889866	5/2016	S132-PMC4889866	['ALTHOUGH OUR study DID NOT SHOW maternal Vitamin D concentration to have a significant IMPACT on the magnitude or functional capacity of the young infant to defend against infection, we BELIEVE OUR STUDY MAY contribute to a BETTER understanding of the EFFECT of Prenatal Vitamin D status on neonatal Innate Immunity and infectious disease during early Life.']	[('ANOMALY_CURIOUS_FINDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 87), ('INCOMPLETE_EVIDENCE', 186), ('QUESTION_ANSWERED_BY_THIS_WORK', 194), ('INCOMPLETE_EVIDENCE', 204), ('INCOMPLETE_EVIDENCE', 224), ('SUPERFICIAL_RELATIONSHIP', 252)]	9	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 262, 'prenatal'), ('CHEBI_27300', 'vitamin D', 271, 'vitamin D'), ('GO_0045087', 'innate immune response', 300, 'innate immunity'), ('UBERON_0000104', 'life cycle', 352, 'life')]
S136-PMC4889866	PMC4889866	5/2016	S136-PMC4889866	['PRELIMINARY result SHOWED no correlation between maternal Vitamin D status and cytokine response to tlr ligands in maternal Mononuclear Cells.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19)]	2	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CL_0000226', 'single nucleate cell', 124, 'mononuclear cells'), ('GO_0031097', 'medial cortex', 124, 'mononuclear')]
S140-PMC4889866	PMC4889866	5/2016	S140-PMC4889866	['PRELIMINARY result SHOWED no correlation between cord Vitamin D status and neonatal Tlr9-triggered cytokine response.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19)]	2	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('PR_000001155', 'Toll-like receptor 4', 84, 'TLR9')]
S147-PMC4891833	PMC4891833	6/2016	S147-PMC4891833	['a household survey will be administered with the following questionnaires:\n\ncaption (table-wrap): table 3\n\noutcomes of interestoutcomeinstrumentnotestiming of data collectionnutritional outcomes: \u2002height/lengthstadiometer (children and caregivers) (locally made, with 1\xa0mm gradations)length/height will be measured to the nearest 0.1\xa0cmbaseline, midline, endline\xa0(mothers/caregivers at endline only)\u2002weightelectronic mother-baby weighing scale with reading increments of 10\xa0g (seca model 874)weight will be measured to the nearest 100\xa0g. duplicate measures will be repeated if the difference between the measurements is >0.1\xa0kg.baseline, midline, endline\u2002anemia/hemoglobinhemocue hb 301 portable photometermeasurements will be obtained to the nearest 0.1\xa0g/dlbaseline, midline, endline\xa0(subsample)\u2002iron and Vitamin A statusenzyme-linked immunoassay (elisa) methodcapillary Blood samples in children 18-24 monthsendline (subsample) Child Development outcomes: \u2002Language and Cognitive and socio-Emotional Developmentages and stages questionnaire: inventory [51]combination of primary caregivers report and direct observation of children 0–36 mo [52]baseline, midline, endlinebayley scale [53]direct assessment\xa0(children 28-34 months)endline (subsample) intermediate indicators \u2002household Food securityhousehold Food security questionnaire (fanta)questions adapted and modified to reflect the cultural context, as NEEDED.']	[('FUTURE_WORK', 1411)]	1	[('CHEBI_27300', 'vitamin D', 807, 'vitamin A'), ('UBERON_0000178', 'blood', 873, 'blood'), ('GO_0007417', 'central nervous system development', 931, 'Child development'), ('GO_0040011', 'locomotion', 960, 'Language ...'), ('GO_0002553', 'histamine secretion by mast cell', 973, 'cognitive ... emotional developmentAges'), ('CHEBI_33290', 'food', 1286, 'food'), ('GO_0007631', 'feeding behavior', 1286, 'food'), ('CHEBI_33290', 'food', 1309, 'Food')]
S1046-PMC4896250	PMC4896250	4/2016	S1046-PMC4896250	['data on the RELATION of Vitamin D status and allergy are CONTROVERSIAL.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 57)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
S6120-PMC4896250	PMC4896250	4/2016	S6120-PMC4896250	['SOME STUDIES had SUGGESTED a RELATIONSHIP between Vitamin D status and allergic rhinitis, and others DID NOT.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 101)]	4	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D')]
S87-PMC4897157	PMC4897157	5/2016	S87-PMC4897157	['discussion\nwe HYPOTHESIZED that there MAY BE an ASSOCIATION between the Perinatal Vitamin D status and the development of Allergic Diseases.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 38), ('SUPERFICIAL_RELATIONSHIP', 48)]	3	[('GO_0036268', 'swimming', 72, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 72, 'perinatal'), ('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('GO_0000381', 'regulation of alternative mRNA splicing, via spliceosome', 122, 'allergic diseases')]
S123-PMC4897157	PMC4897157	5/2016	S123-PMC4897157	['THEREFORE, we SUGGEST that sun exposure and Vitamin D status during infancy MAY have an IMPACT on the LIKELIHOOD of developing allergic diseases.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 88), ('PROBABLE_UNDERSTANDING', 102)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
S135-PMC4897157	PMC4897157	5/2016	S135-PMC4897157	['HOWEVER, OTHER reports SUGGEST that the recent Vitamin D status is ASSOCIATED with Allergen sensitization32526).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 67)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_50904', 'allergen', 83, 'allergen')]
S148-PMC4897157	PMC4897157	5/2016	S148-PMC4897157	['third, we COULD NOT directly examine the RELATIONSHIP between Vitamin D status and allergic disease prevalence BECAUSE Serum Vitamin D levels were NOT RECORDED.']	[('DIFFICULT_TASK', 10), ('SUPERFICIAL_RELATIONSHIP', 41), ('PROBLEM_COMPLICATION', 111), ('ANOMALY_CURIOUS_FINDING', 147), ('FULL_UNKNOWN', 147)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0001977', 'blood serum', 119, 'serum'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
S149-PMC4897157	PMC4897157	5/2016	S149-PMC4897157	['finally, there is a LACK OF research on the EFFECT FACTOR for amount of sun exposure and Vitamin D status such as clothes and Vitamin D supplements.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 51)]	3	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
S87-PMC4903143	PMC4903143	5/2016	S87-PMC4903143	['Vitamin D\nthere is general CONSENSUS in the medical literature that the Vitamin D status of many Individuals and population groups throughout much of the world (as reflected by population measurements of Serum 25(Oh)D levels) is INSUFFICIENT for OPTIMAL health [74].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 27), ('PROBABLE_UNDERSTANDING', 27), ('PROBLEM_COMPLICATION', 229), ('IMPORTANT_CONSIDERATION', 246)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('NCBITaxon_1', 'root', 97, 'individuals'), ('UBERON_0001977', 'blood serum', 204, 'serum'), ('CHEBI_71657', 'versiconol acetate', 210, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 210, '25(OH ... D')]
S133-PMC4910734	PMC4910734	6/2015	S133-PMC4910734	['autistic children are NOTORIOUS picky eaters, leading to SOME DOCUMENTED DEFICIENCIES in individual case STUDIES, such as Vitamin A deficiencies.53nutritional status based on dietary record keeping, not surprisingly, gives CONFLICTING results,118in PART BECAUSE autistic children OFTEN SUFFER from Gastrointestinal mal-absorption PROBLEMS77OR BECAUSE Genetic factors MAY play a ROLE in nutritional deficiency.']	[('IMPORTANT_CONSIDERATION', 22), ('IMPORTANT_CONSIDERATION', 22), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 62), ('IMPORTANT_CONSIDERATION', 73), ('INCOMPLETE_EVIDENCE', 105), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 223), ('SUPERFICIAL_RELATIONSHIP', 249), ('PROBABLE_UNDERSTANDING', 254), ('PROBABLE_UNDERSTANDING', 280), ('IMPORTANT_CONSIDERATION', 286), ('IMPORTANT_CONSIDERATION', 330), ('PROBABLE_UNDERSTANDING', 343), ('INCOMPLETE_EVIDENCE', 367), ('SUPERFICIAL_RELATIONSHIP', 378)]	15	[('CHEBI_27300', 'vitamin D', 122, 'vitamin A'), ('UBERON_0005409', 'alimentary part of gastrointestinal system', 298, 'gastrointestinal'), ('SO_0000704', 'gene', 351, 'genetic')]
S89-PMC4923982	PMC4923982	5/2016	S89-PMC4923982	['neither the associations between gdm and either Heme iron nor non-heme iron APPEARED TO differ according to smoking status or Consumption of dietary Calcium or Vitamin C (data not shown).']	[('ANOMALY_CURIOUS_FINDING', 76)]	1	[('CHEBI_30413', 'heme', 48, 'heme'), ('GO_0007631', 'feeding behavior', 126, 'consumption'), ('CHEBI_22313', 'alkaline earth metal atom', 149, 'calcium'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin C')]
S0-PMC4930210	PMC4930210	7/2016	S0-PMC4930210	['the current recommended Vitamin D intake guideline for diet and supplements during Pregnancy is not adequate to achieve Vitamin D sufficiency for most Pregnant women\n\nabstract\n\nbackground\nthe aims of THIS STUDY were TO DETERMINE IF Pregnant women consumed the RECOMMENDED Vitamin D through diet alone or through diet and supplements, and if they achieved the current reference range Vitamin D status when their reported dietary intake met the current RECOMMENDATIONS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 200), ('QUESTION_ANSWERED_BY_THIS_WORK', 216), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 229), ('FUTURE_WORK', 260), ('FUTURE_WORK', 451)]	5	[('CHEBI_28384', 'vitamin K', 24, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'Pregnancy'), ('CHEBI_28384', 'vitamin K', 120, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 151, 'Pregnant'), ('GO_0007565', 'female pregnancy', 232, 'pregnant'), ('CHEBI_27300', 'vitamin D', 272, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 383, 'vitamin D')]
S8-PMC4930210	PMC4930210	7/2016	S8-PMC4930210	['conclusions\nwe DEMONSTRATED the current rda (600 iu/ day) MAY not be adequate to achieve Vitamin D status >75 nmol/l in SOME Pregnant women who are residing in higher latitudes (calgary, 51°n) in alberta, canada and the current Vitamin D RECOMMENDATIONS for canadian Pregnant women NEED TO be re-evaluated.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 58), ('INCOMPLETE_EVIDENCE', 120), ('FUTURE_WORK', 238), ('IMPORTANT_CONSIDERATION', 282)]	5	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D'), ('GO_0007565', 'female pregnancy', 125, 'pregnant'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('GO_0007565', 'female pregnancy', 267, 'pregnant')]
S9-PMC4930210	PMC4930210	7/2016	S9-PMC4930210	['introduction\nVitamin D plays an IMPORTANT ROLE in promoting healthy Pregnancy and Fetal Development, and POOR Vitamin D status HAS BEEN ASSOCIATED with adverse maternal and infant health [1].']	[('IMPORTANT_CONSIDERATION', 32), ('SUPERFICIAL_RELATIONSHIP', 42), ('IMPORTANT_CONSIDERATION', 105), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 136)]	5	[('CHEBI_28384', 'vitamin K', 13, 'Vitamin D'), ('GO_0007608', 'sensory perception of smell', 68, 'pregnancy ...'), ('GO_0002065', 'columnar/cuboidal epithelial cell differentiation', 82, 'fetal development'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
S18-PMC4930210	PMC4930210	7/2016	S18-PMC4930210	['HOWEVER, the daily use of Vitamin D supplements CONTRIBUTED to a better 25-Hydroxycholecalciferol (25(Oh)D) status [8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 48)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_50545', 'trans-isoeugenol', 72, '25-hydroxycholecalciferol'), ('CHEBI_71657', 'versiconol acetate', 99, '25(OH)D')]
S23-PMC4930210	PMC4930210	7/2016	S23-PMC4930210	['the BEST clinical laboratory INDICATOR of Vitamin D status is the Blood concentration of 25(Oh)D [4].']	[('IMPORTANT_CONSIDERATION', 4), ('SUPERFICIAL_RELATIONSHIP', 29)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0000178', 'blood', 66, 'blood'), ('CHEBI_71657', 'versiconol acetate', 89, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 95, 'D')]
S26-PMC4930210	PMC4930210	7/2016	S26-PMC4930210	['we RECENTLY SHOWED that not separating out Plasma 3-epi-25-hydroxycholecalciferol (3-Epi-25(Oh)D3) from Vitamin D status calculation UNDERESTIMATES the classification of Pregnant women and their newborns at risk for Vitamin D insufficiency (>75 nmol/l) [13].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('PROBLEM_COMPLICATION', 133)]	3	[('UBERON_0001969', 'blood plasma', 43, 'plasma'), ('CHEBI_76629', '2-lysophosphatidic acid', 83, '3-epi-25(OH)D3'), ('PR_000001177', 'D(2) dopamine receptor', 95, 'D3'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007565', 'female pregnancy', 170, 'pregnant'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D')]
S27-PMC4930210	PMC4930210	7/2016	S27-PMC4930210	['ALTHOUGH the literature regarding Vitamin D in Pregnancy is growing rapidly, several gaps in our knowledge REMAIN, including the prevalence of Vitamin D deficiency/ insufficiency during Pregnancy and the intake of Vitamin D during Pregnancy NEEDED to ensure optimal status.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 107), ('FUTURE_WORK', 241)]	3	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007565', 'female pregnancy', 47, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('GO_0007565', 'female pregnancy', 186, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 214, 'vitamin D'), ('GO_0007565', 'female pregnancy', 231, 'pregnancy')]
S28-PMC4930210	PMC4930210	7/2016	S28-PMC4930210	['our AIMS in the CURRENT STUDY were TO DETERMINE: a) if Pregnant women were Consuming the RECOMMENDED Vitamin D through diet alone or through diet and supplements, and b) IF Pregnant women can achieve the current reference range Vitamin D status when their reported dietary intake of Vitamin D met the current RECOMMENDATIONS.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 35), ('FUTURE_WORK', 89), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('FUTURE_WORK', 309)]	6	[('GO_0007565', 'female pregnancy', 55, 'pregnant'), ('GO_0007631', 'feeding behavior', 75, 'consuming'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 173, 'pregnant'), ('CHEBI_27300', 'vitamin D', 228, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 283, 'vitamin D')]
S68-PMC4930210	PMC4930210	7/2016	S68-PMC4930210	['Plasma concentrations of 25(Oh)D at <25 nmol/l [3,4], <50 nmol/l [3,4], and <75 nmol/l [5,6] were used to REFLECT several laboratory definitions of Vitamin D status CURRENTLY used.']	[('PROBABLE_UNDERSTANDING', 106), ('INCOMPLETE_EVIDENCE', 165)]	2	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('CHEBI_71657', 'versiconol acetate', 25, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 31, 'D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
S126-PMC4930210	PMC4930210	7/2016	S126-PMC4930210	['discussion\nTO OUR KNOWLEDGE, THIS is the largest STUDY TO date to SHOW 44% of Pregnant women with a higher socioeconomic status reported Vitamin D intake (diet and supplements) not meeting the dietary reference intakes (dri) recomendations.']	[('PROBABLE_UNDERSTANDING', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('QUESTION_ANSWERED_BY_THIS_WORK', 49), ('QUESTION_ANSWERED_BY_THIS_WORK', 55), ('INCOMPLETE_EVIDENCE', 66)]	5	[('GO_0007565', 'female pregnancy', 78, 'pregnant'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
S127-PMC4930210	PMC4930210	7/2016	S127-PMC4930210	['using lc-ms/ms, we separated epimer from estimation of Vitamin D status and were able to ACCURATELY ESTIMATE the prevalence of Vitamin D insufficiency in our Pregnant women.']	[('SUPERFICIAL_RELATIONSHIP', 89), ('INCOMPLETE_EVIDENCE', 100)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('GO_0007565', 'female pregnancy', 158, 'pregnant')]
S136-PMC4930210	PMC4930210	7/2016	S136-PMC4930210	['a RECENT STUDY of maternal Vitamin D status at third Trimester of Pregnancy and Postpartum periods of 467 Pregnant women in toronto SHOWED persistent Vitamin D deficiency/ insufficiency in two-thirds of participants DESPITE taking 400 iu/day of Vitamin D through their Prenatal Vitamin D [27].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 132), ('ANOMALY_CURIOUS_FINDING', 216)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 53, 'trimester'), ('GO_0007565', 'female pregnancy', 66, 'pregnancy'), ('GO_0007565', 'female pregnancy', 80, 'postpartum'), ('GO_0007565', 'female pregnancy', 106, 'pregnant'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 245, 'vitamin D'), ('GO_0007565', 'female pregnancy', 269, 'prenatal'), ('CHEBI_27300', 'vitamin D', 278, 'vitamin D')]
S140-PMC4930210	PMC4930210	7/2016	S140-PMC4930210	['in addition, we DEMONSTRATED the presence of 3-Epi-25(Oh)D3In all our Pregnant women’s Plasma samples across Pregnancy (second trimester), and that including this epimer in the measurement of Vitamin D status significantly INFLUENCED the classification of prevalence of Vitamin D sufficiency in Pregnancy.']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 223)]	2	[('CHEBI_15616', '(3S,5S)-3,5-diaminohexanoic acid', 45, '3-epi-25(OH)D3in'), ('PR_000011622', 'S-acyl fatty acid synthase thioesterase, medium chain', 54, 'OH ... D3in'), ('GO_0007565', 'female pregnancy', 70, 'pregnant'), ('UBERON_0001969', 'blood plasma', 87, 'plasma'), ('GO_0007565', 'female pregnancy', 109, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 270, 'vitamin D'), ('GO_0007565', 'female pregnancy', 295, 'pregnancy')]
S141-PMC4930210	PMC4930210	7/2016	S141-PMC4930210	['this FINDING is CONSISTENT with our PREVIOUS STUDY SHOWING epimer CAN alter Vitamin D status estimation of Pregnant women at the time of Delivery and in their Cord Blood [13].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 66)]	5	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007565', 'female pregnancy', 107, 'pregnant'), ('GO_0007567', 'parturition', 137, 'delivery'), ('UBERON_0002240', 'spinal cord', 159, 'cord'), ('UBERON_0000178', 'blood', 164, 'blood')]
S147-PMC4930210	PMC4930210	7/2016	S147-PMC4930210	['THESE FINDINGS EMPHASIZE THE NEED for FURTHER identification of the functional ROLE and clinical SIGNIFICANCE of 3-Epi-25(Oh)D3In the assessment of Vitamin D status in Pregnant women, given the fact that the cut-off for Vitamin D sufficiency in Pregnancy is UNCLEAR.']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 15), ('INCOMPLETE_EVIDENCE', 25), ('FUTURE_WORK', 29), ('FUTURE_WORK', 38), ('SUPERFICIAL_RELATIONSHIP', 79), ('IMPORTANT_CONSIDERATION', 97), ('FULL_UNKNOWN', 258)]	8	[('CHEBI_15616', '(3S,5S)-3,5-diaminohexanoic acid', 113, '3-epi-25(OH)D3in'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 125, 'D3in'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('GO_0007565', 'female pregnancy', 168, 'pregnant'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D'), ('GO_0007565', 'female pregnancy', 245, 'pregnancy')]
S154-PMC4930210	PMC4930210	7/2016	S154-PMC4930210	['the lower rate of Vitamin D insufficiency in OUR STUDY COULD BE RELATED to the cohort characteristics involving very educated, high socio-economic status Pregnant women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 64)]	3	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 154, 'pregnant')]
S155-PMC4930210	PMC4930210	7/2016	S155-PMC4930210	['still, we FOUND a wide distribution of Vitamin D intake and status, which allowed us to study the ASSOCIATION between maternal reported Vitamin D intake and maternal Vitamin d concentrations.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 98)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 166, 'vitamin')]
S170-PMC4930210	PMC4930210	7/2016	S170-PMC4930210	['this FINDING EXTENDS the literature SUGGESTING that 600 iu/day MAY not be enough to achieve Vitamin D status >75 nmol/l in Pregnant women residing in higher latitudes with limited sun exposure.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 36), ('INCOMPLETE_EVIDENCE', 63)]	5	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 123, 'pregnant')]
S4-PMC4934634	PMC4934634	11/2015	S4-PMC4934634	['Vitamin D is found naturally in only a few foods THUS supplementation CAN provide an accessible and effective way to raise Vitamin D status when dietary intakes and sunlight exposure are low.']	[('PROBABLE_UNDERSTANDING', 49), ('INCOMPLETE_EVIDENCE', 70)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
S10-PMC4934634	PMC4934634	11/2015	S10-PMC4934634	['over the past two decades, it HAS BEEN WELL ACCEPTED that Vitamin D is a pro-hormone, and suboptimal Vitamin D status HAS been increasingly LINKED to a broad range of diseases including, cancer, diabetes, Cardiovascular disease, and Autoimmune disorders.']	[('INCOMPLETE_EVIDENCE', 30), ('FUTURE_WORK', 39), ('INCOMPLETE_EVIDENCE', 44), ('PROBABLE_UNDERSTANDING', 44), ('IMPORTANT_CONSIDERATION', 118), ('SUPERFICIAL_RELATIONSHIP', 140)]	6	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 205, 'cardiovascular'), ('UBERON_0001442', 'skeleton of manus', 233, 'autoimmune')]
S19-PMC4934634	PMC4934634	11/2015	S19-PMC4934634	['rickets will not be discussed in this review (readers are referred to a review on this topic by elder and bishop, 2014 [5]) as this paper is FOCUSED on RECENT LITERATURE regarding the IMPORTANCE of maternal Vitamin D status on Pregnancy and infant outcomes, with an EMPHASIS on supplementation trials.healthcare-03-01097-t001_table 1\n\ncaption (table-wrap): table 1\n\ndesignation of Vitamin D status based on circulating Vitamin D levels by the u.s. institute of medicine (iom) and the Endocrine society.Vitamin D statusiomendocrine societydeficiency<12 ng/ml (30 nmol/l)<20 ng/ml (50 nmol/l)insufficiency12–20 ng/ml (30–50 nmol/l)21–29 ng/ml (52.5–72.5 nmol/l)sufficiency>20 ng/ml (50 nmol/l)>30 ng/ml (75 nmol/l)toxicity>50 ng/ml (125 nmol/l)>150 ng/ml (375 nmol/l)\n\n2.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 141), ('INCOMPLETE_EVIDENCE', 152), ('IMPORTANT_CONSIDERATION', 184), ('IMPORTANT_CONSIDERATION', 266)]	4	[('CHEBI_27300', 'vitamin D', 207, 'vitamin D'), ('GO_0007565', 'female pregnancy', 227, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 381, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 419, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 484, 'Endocrine'), ('CHEBI_28384', 'vitamin K', 502, 'Vitamin D')]
S20-PMC4934634	PMC4934634	11/2015	S20-PMC4934634	['factors INFLUENCING Vitamin D status\nnumerous and diverse lifestyle choices, and environmental and Genetic FACTORS CAN alter Vitamin D status [6];figure 1.']	[('SUPERFICIAL_RELATIONSHIP', 8), ('SUPERFICIAL_RELATIONSHIP', 107), ('INCOMPLETE_EVIDENCE', 115)]	3	[('CHEBI_28384', 'vitamin K', 20, 'Vitamin D'), ('SO_0000704', 'gene', 99, 'genetic'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
S25-PMC4934634	PMC4934634	11/2015	S25-PMC4934634	['caption (fig): figure 1\n\nmodifying factors that can AFFECT Vitamin D status throughout the Life Cycle.']	[('SUPERFICIAL_RELATIONSHIP', 52)]	1	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('UBERON_0000104', 'life cycle', 91, 'life cycle'), ('GO_0007049', 'cell cycle', 96, 'cycle')]
S28-PMC4934634	PMC4934634	11/2015	S28-PMC4934634	['Genetic variations in Cyp2R1 and Vitamin D binding protein CAN reduce the subsequent increases of Serum Vitamin D after uvb exposure and Consumption of Vitamin D fortified foods, respectively, SUGGESTING genetics play a ROLE in determining Vitamin D status [7].']	[('INCOMPLETE_EVIDENCE', 59), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 220)]	3	[('SO_0000704', 'gene', 0, 'Genetic'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 22, 'CYP2R1'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0001977', 'blood serum', 98, 'serum'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007631', 'feeding behavior', 137, 'consumption'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
S66-PMC4934634	PMC4934634	11/2015	S66-PMC4934634	[', REPORTED that 47.4% of women with recurrent Pregnancy losses (rpl), defined as three or more consecutive spontaneous Abortions before 20 weeks Gestation, had low Serum 25(Oh)D levels e.g., below 30 ng/ml, the Endocrine society cut-off for Vitamin D sufficiency status (table 1) [25].']	[('INCOMPLETE_EVIDENCE', 2)]	1	[('GO_0007565', 'female pregnancy', 46, 'pregnancy'), ('GO_0006915', 'apoptotic process', 119, 'abortions'), ('GO_0007565', 'female pregnancy', 145, 'gestation'), ('UBERON_0001977', 'blood serum', 164, 'serum'), ('CHEBI_71657', 'versiconol acetate', 170, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 170, '25(OH ... D'), ('UBERON_0005063', 'left ventricular compact myocardium', 211, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 241, 'vitamin D')]
S67-PMC4934634	PMC4934634	11/2015	S67-PMC4934634	['compared to women with Serum levels ≥30 ng/ml, women with low Vitamin D status had higher circulating Antiphospholipid Antibodies ASSOCIATED with poor Reproductive outcomes.']	[('SUPERFICIAL_RELATIONSHIP', 130)]	1	[('UBERON_0001977', 'blood serum', 23, 'serum'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_16240', 'hydrogen peroxide', 102, 'antiphospholipid'), ('GO_0042571', 'immunoglobulin complex, circulating', 119, 'antibodies'), ('GO_0000003', 'reproduction', 151, 'reproductive')]
S72-PMC4934634	PMC4934634	11/2015	S72-PMC4934634	[', DETECTED no difference in Pre-Pregnancy Vitamin D status among healthy danish women who were able to Conceive COMPARED TO those who could not Conceive in a ~6 month time period [28].']	[('INCOMPLETE_EVIDENCE', 2), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 112)]	2	[('GO_0007568', 'aging', 28, 'pre'), ('GO_0007565', 'female pregnancy', 32, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('GO_0007631', 'feeding behavior', 103, 'conceive'), ('GO_0007631', 'feeding behavior', 144, 'conceive')]
S75-PMC4934634	PMC4934634	11/2015	S75-PMC4934634	['MANY observational STUDIES have LINKED higher maternal Vitamin D status to an increase in rates of both clinical Pregnancy (sonographic presence of a heartbeat following ivf) and live Birth [29,30,31].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 32)]	2	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy'), ('GO_0007567', 'parturition', 184, 'birth')]
S80-PMC4934634	PMC4934634	11/2015	S80-PMC4934634	['the positive RELATIONSHIP between maternal Vitamin D status and post-Ivf Pregnancy in non-hispanic white, BUT NOT in asian women, SUGGESTS that genetics play a ROLE in the RELATIONSHIP between Vitamin D and fertility.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 106), ('ANOMALY_CURIOUS_FINDING', 106), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 160), ('SUPERFICIAL_RELATIONSHIP', 172)]	6	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0002006', 'vasoconstriction by vasopressin involved in systemic arterial blood pressure control', 69, 'IVF'), ('GO_0007565', 'female pregnancy', 73, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D')]
S85-PMC4934634	PMC4934634	11/2015	S85-PMC4934634	['ADDITIONAL clinical TRIALS in ethnically diverse populations with differing baseline Vitamin D levels ARE NEEDED to BETTER DELINEATE the EFFECT of Vitamin D status on Assisted Reproductive technology outcomes.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 102), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 137)]	4	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('GO_0000380', 'alternative mRNA splicing, via spliceosome', 167, 'assisted reproductive')]
S94-PMC4934634	PMC4934634	11/2015	S94-PMC4934634	['these data FURTHER ILLUSTRATE HOW DIFFERENT cut-offs used by the iom vs. endocrine society for defining Vitamin D status (table 1) INFLUENCES the reporting of Vitamin D deficiency PREVALENCE in the population.']	[('INCOMPLETE_EVIDENCE', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('EXPLICIT_QUESTION', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('SUPERFICIAL_RELATIONSHIP', 131), ('IMPORTANT_CONSIDERATION', 180)]	6	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
S142-PMC4934634	PMC4934634	11/2015	S142-PMC4934634	['it SHOULD BE NOTED that OTHER STUDIES have FAILED TO CONFIRM OBSERVATIONS that lower 25(Oh)D status is ASSOCIATED with the occurrence of Preeclampsia, and it is STILL UNCLEAR WHETHER suboptimal Vitamin D status is a cause, OR an EFFECT, of preeclampsia [55,56].']	[('IMPORTANT_CONSIDERATION', 3), ('ANOMALY_CURIOUS_FINDING', 10), ('ANOMALY_CURIOUS_FINDING', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('INCOMPLETE_EVIDENCE', 24), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 43), ('ANOMALY_CURIOUS_FINDING', 43), ('DIFFICULT_TASK', 43), ('INCOMPLETE_EVIDENCE', 53), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 103), ('FULL_UNKNOWN', 161), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 175), ('SUPERFICIAL_RELATIONSHIP', 229)]	14	[('CHEBI_71657', 'versiconol acetate', 85, '25(OH)D'), ('GO_0007128', 'meiotic prophase I', 137, 'preeclampsia'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D')]
S164-PMC4934634	PMC4934634	11/2015	S164-PMC4934634	['THUS, it is NOT SURPRISING that this study FOUND no effect of the Vitamin D supplementation on incidences of Preterm Birth, Preeclampsia, or small for Gestation age SINCE 23% of participants had persistent Serum 25(Oh)D below 10 ng/ml which IS CONSIDERED Vitamin D deficiency status by both the iom and endocrine society (table 1).']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 43), ('PROBABLE_UNDERSTANDING', 165), ('INCOMPLETE_EVIDENCE', 241)]	5	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007565', 'female pregnancy', 109, 'preterm birth'), ('GO_0007128', 'meiotic prophase I', 124, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 151, 'gestation'), ('UBERON_0001977', 'blood serum', 206, 'serum'), ('CHEBI_71657', 'versiconol acetate', 212, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 212, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D')]
S168-PMC4934634	PMC4934634	11/2015	S168-PMC4934634	['infants of mothers receiving Vitamin D supplementation were more LIKELY to reach Vitamin D sufficiency at Birth compare to infants of non-supplemented mothers (46.2% vs. 14%, respectively), HOWEVER, over half of the infants in the Supplement group still had suboptimal Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 65), ('ANOMALY_CURIOUS_FINDING', 190)]	2	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007567', 'parturition', 106, 'birth'), ('CHEBI_16158', 'steroid sulfate', 231, 'supplement'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D')]
S180-PMC4934634	PMC4934634	11/2015	S180-PMC4934634	['if women PLAN to exclusively Breast Feed their baby, it is IMPORTANT for mothers to have adequate Vitamin D status.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 9), ('IMPORTANT_CONSIDERATION', 59)]	2	[('GO_0007596', 'blood coagulation', 29, 'breast feed'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
S184-PMC4934634	PMC4934634	11/2015	S184-PMC4934634	['using dietary Intake data ALONE CAN be PROBLEMATIC SINCE uvb-induced skin Formation of Vitamin D CAN significantly alter Serum 25(Oh)D, THUS, dietary Intakes MIGHT not be a reliable INDICATOR of overall Vitamin D status.']	[('ANOMALY_CURIOUS_FINDING', 26), ('INCOMPLETE_EVIDENCE', 32), ('PROBLEM_COMPLICATION', 39), ('PROBABLE_UNDERSTANDING', 51), ('PROBLEM_COMPLICATION', 51), ('INCOMPLETE_EVIDENCE', 97), ('PROBABLE_UNDERSTANDING', 136), ('INCOMPLETE_EVIDENCE', 158), ('SUPERFICIAL_RELATIONSHIP', 182)]	9	[('GO_0007631', 'feeding behavior', 14, 'intake'), ('GO_0009057', 'macromolecule catabolic process', 74, 'formation'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('UBERON_0001977', 'blood serum', 121, 'serum'), ('CHEBI_71657', 'versiconol acetate', 127, '25(OH)D'), ('GO_0007631', 'feeding behavior', 150, 'intakes'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin D')]
S207-PMC4934634	PMC4934634	11/2015	S207-PMC4934634	['it is anticipated that THIS STUDY will provide valuable NEW information on the EFFECTS of maternal Vitamin D status and offspring allergy/asthma outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('FULL_UNKNOWN', 56), ('SUPERFICIAL_RELATIONSHIP', 79)]	3	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D')]
S237-PMC4934634	PMC4934634	11/2015	S237-PMC4934634	['as mentioned earlier, genetics CAN play a ROLE in determining an Individual’s Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 42)]	2	[('NCBITaxon_1', 'root', 65, 'individual'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
S261-PMC4934634	PMC4934634	11/2015	S261-PMC4934634	['ALTHOUGH both single and daily doses of Vitamin D3Seem to be SAFE, CAUTION SHOULD BE CONSIDERED when supplementing at these high doses in Pregnant women, PARTICULARLY if baseline Vitamin D status is sufficient.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 61), ('FUTURE_WORK', 67), ('INCOMPLETE_EVIDENCE', 67), ('FUTURE_WORK', 75), ('FUTURE_WORK', 85), ('ANOMALY_CURIOUS_FINDING', 154), ('IMPORTANT_CONSIDERATION', 154)]	8	[('CHEBI_64387', 'thiosultap(1-)', 40, 'vitamin D3seem'), ('GO_0007565', 'female pregnancy', 138, 'pregnant'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D')]
S306-PMC4934634	PMC4934634	11/2015	S306-PMC4934634	['WHILE the ESSENTIALITY of adequate Vitamin D during Pregnancy is not DISPUTED, CONTROVERSY exists over the RECOMMENDED dietary intake levels, the mathematical approaches to calculating that level, and the endpoints used to determine REQUIREMENTS; the concentrations of circulating 25(Oh)D that denote deficiency, insufficiency and adequacy status; and WHETHER race, body weight or OTHER factors SHOULD BE TAKEN into account when making dietary RECOMMENDATIONS, similarly, it is NOT CLEAR WHAT Vitamin D supplementation regimens are most EFFECTIVE during Pregnancy; WHETHER mother, child OR both SHOULD BE supplemented; and WHETHER there are long-term CONSEQUENCES of supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 10), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 69), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 79), ('FUTURE_WORK', 107), ('IMPORTANT_CONSIDERATION', 233), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 352), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 381), ('FUTURE_WORK', 395), ('IMPORTANT_CONSIDERATION', 405), ('FUTURE_WORK', 444), ('FULL_UNKNOWN', 478), ('EXPLICIT_QUESTION', 488), ('SUPERFICIAL_RELATIONSHIP', 537), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 565), ('FUTURE_WORK', 595), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 623), ('PROBLEM_COMPLICATION', 651)]	18	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 281, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 281, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 493, 'vitamin D'), ('GO_0007565', 'female pregnancy', 554, 'pregnancy')]
S18-PMC4944244	PMC4944244	7/2016	S18-PMC4944244	['[10] reported that Vitamin D status among Pregnant and non-Pregnant women (Reproductive age) living in vietnam SHOWED that the mean Serum 25(Oh)d differed between those living in urban and rural areas (78\xa0nmol/l versus 85\xa0nmol/l) with p \u2009=\u20090.02.']	[('INCOMPLETE_EVIDENCE', 111)]	1	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0007565', 'female pregnancy', 42, 'pregnant'), ('GO_0007565', 'female pregnancy', 59, 'pregnant'), ('GO_0000003', 'reproduction', 75, 'reproductive'), ('UBERON_0001977', 'blood serum', 132, 'serum'), ('CHEBI_37972', 'phosphorus-32 atom', 138, '25'), ('CHEBI_17792', 'organohalogen compound', 141, 'OH')]
S75-PMC4944244	PMC4944244	7/2016	S75-PMC4944244	['caption (table-wrap): table 1\n\nsocio-demographic, Antenatal, skin characteristics and Vitamin D intake of first trimester Pregnant women ( n \u2009=\u2009396)independent variablesnpercentmean\u2009±\u2009sd /\xa0median (iqr 25\xa0%, 75\xa0%)a) socio-demographic factors\u2003age (year)28.06\u2009±\u20094.09 (min\u2009=\u200918, max\u2009=\u200940)\u2003ethnic groups\u2003\u2003malay30777.5\u2003\u2003chinese4411.2\u2003\u2003indian358.8\u2003\u2003others102.5\u2003educational status\u2003\u2003primary school164.0\u2003\u2003secondary school14937.6\u2003\u2003tertiary school23158.4\u2003working status\u2003\u2003working30176.0\u2003\u2003not working9524.0\u2003household members3 (2,4) (min\u2009=\u20092, max\u2009=\u200912)\u2003household income per monthrm3500 (2800,5000) (min\u2009=\u2009rm900, max\u2009=\u2009rm20 000)b) factors related to Antenatal\u2003Week Of Pregnancy10 (8,12) (min\u2009=\u20094, max\u2009=\u200912)\u2003gravidity2 (1,3) (min\u2009=\u20091, max\u2009=\u20099)\u2003parity0 (0,1) (min\u2009=\u20090, max\u2009=\u20096)\u2003smoking status\u2003\u2003yes30.8\u2003\u2003no39399.2\u2003last child Birth\u2003\u2003≤ 2\xa0years12461.1\u2003\u2003>2\xa0years7938.9\u2003\u2003not applicable (first Pregnancy)193\u2003still breastfeeding\u2003\u2003yes4122.9\u2003\u2003no13879.1\u2003\u2003not applicable (no child)217\u2003body mass index (bmi) before Pregnancy(kg/m2)22.69 (19.95, 26.36) (min\u2009=\u200914.29, max\u2009=\u200953.90)\u2003weight at first Antenatal visit (kg)57.70 (49.60,68.00) (min\u2009=\u200933.00, max\u2009=\u2009148.70)c) factors related to skin\u2003fitzpatrick skin classification\u2003\u2003skin type i -ii10326.0\u2003\u2003skin type iii17343.7\u2003\u2003skin type iv-vi12030.3\u2003Melanin indices (using mexameter 18) (0-999.000)302.17 (245.00, 302.17) (min\u2009=\u2009133.33, max\u2009=\u2009949.33)\u2003sun protection score (0-8)5 (4,5) (min\u2009=\u20090, max\u2009=\u20097)\u2003the length of time exposed to sunlight (minutes per week)37.50 (0,150) (min\u2009=\u20090, max\u2009=\u20091680)d) factors related to Vitamin D intake\u2003intake of Vitamin D in Food (iu/day)202.16 (124.94, 334.62) (min\u2009=\u200913.50, max\u2009=\u20091523.12)\u2003the number of respondents taking Antenatal Supplements\u2003\u2003taking Supplements containing Vitamin D4411.1\u2003\u2003taking supplements without Vitamin D intake61.5\u2003\u2003not taking supplement34687.4\u2003Calcium and Vitamin D supplement\u2003\u2003no38697.5\u2003\u2003yes102.5\u2003intake of Vitamin D from Food and supplements (iu/day)220.04 (137.88, 376.45) (min\u2009=\u200915.10, max\u2009=\u20091523.12)\u2003the level of Vitamin D taken from Food and supplements (iu/day)\u2003\u2003<200\xa0iu/day17844.90\u2003\u2003≥200\xa0iu/day21855.10\n\ncaption (table-wrap): table 2\n\nSerum Vitamin D (25(Oh)D) concentrations among first Trimester Pregnant women ( n \u2009=\u2009396)Serum Vitamin dnpercentmedian (iqr 25\xa0%, 75\xa0%)Serum concentration of 25 (Oh)D nmol/l27.11 (19.87,36.99) (min\u2009=\u20097.50, max\u2009=\u2009121.43)Serum concentration of 25 (Oh) D nmol/l (categorized)\u2003<25.00\xa0nmol/l17443.9\u200325-49.99\xa0nmol/l18446.5\u200350-74.99\xa0nmol/l338.3\u2003≥75\xa0nmol/l51.3serum concentration of 25 (Oh) D nmol/l (categorized)\u2003<50\xa0nmol/l35890.4\u2003≥50\xa0nmol/l389.6\ntable\xa03shows the association between each independent variable with hypovitaminosis d. age, ethnicity, education level, fitzpatrick classification, Melanin indices, sun protection score and Intake of Vitamin D from Food have ASSOCIATION with hypovitaminosis D ( p \u2009<\u20090.05).']	[('SUPERFICIAL_RELATIONSHIP', 2779)]	1	[('GO_0007567', 'parturition', 50, 'antenatal'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('GO_0007565', 'female pregnancy', 122, 'pregnant'), ('GO_0003410', 'anterior rotation of the optic cup', 634, 'antenatal Week of pregnancy10'), ('GO_0007567', 'parturition', 806, 'Birth'), ('GO_0007565', 'female pregnancy', 869, 'pregnancy'), ('GO_0007565', 'female pregnancy', 984, 'pregnancy'), ('GO_0007567', 'parturition', 1064, 'antenatal'), ('CHEBI_25179', 'melanins', 1260, 'Melanin'), ('CHEBI_27300', 'vitamin D', 1528, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1555, 'vitamin D'), ('CHEBI_33290', 'food', 1568, 'food'), ('GO_0007567', 'parturition', 1667, 'antenatal'), ('CHEBI_33341', 'titanium atom', 1677, 'supplements'), ('CHEBI_33341', 'titanium atom', 1697, 'supplements'), ('CHEBI_72741', '2-arachidonyl-sn-glycero-3-phosphoethanolamine', 1720, 'vitamin D4411'), ('CHEBI_27300', 'vitamin D', 1764, 'vitamin D'), ('CHEBI_31341', 'calcium dihydroxide', 1815, 'Calcium'), ('CHEBI_27300', 'vitamin D', 1827, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1879, 'vitamin D'), ('CHEBI_33290', 'food', 1894, 'food'), ('CHEBI_27300', 'vitamin D', 1989, 'vitamin D'), ('CHEBI_33290', 'food', 2010, 'food'), ('UBERON_0001977', 'blood serum', 2114, 'Serum'), ('CHEBI_27300', 'vitamin D', 2120, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 2131, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 2131, '25 ... OH ... D'), ('GO_0009294', 'DNA mediated transformation', 2167, 'trimester'), ('GO_0007565', 'female pregnancy', 2177, 'pregnant'), ('UBERON_0001977', 'blood serum', 2203, 'Serum'), ('CHEBI_33229', 'vitamin (role)', 2209, 'vitamin'), ('UBERON_0001977', 'blood serum', 2249, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 2272, '25 (OH)D'), ('PR_000005506', 'Cbp/p300-interacting transactivator 2', 2272, '25'), ('PR_000006444', 'diacylglycerol kinase delta', 2279, 'D'), ('UBERON_0001977', 'blood serum', 2333, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 2356, '25 (OH) D'), ('CHEBI_71657', 'versiconol acetate', 2489, '25 (OH) D'), ('CHEBI_25179', 'melanins', 2702, 'melanin'), ('GO_0007631', 'feeding behavior', 2744, 'intake'), ('CHEBI_27300', 'vitamin D', 2754, 'vitamin D'), ('CHEBI_33290', 'food', 2769, 'food'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 2812, 'D')]
S100-PMC4944244	PMC4944244	7/2016	S100-PMC4944244	['this is IN LINE WITH OUR STUDY, where the PREVALENCE of hypovitaminosis D (25 (Oh) D Serum <50\xa0nmol/l) in the first trimester was high (90.4\xa0%) and only 11.1\xa0% took supplements containing Vitamin D. moreover, most of them had just started the Supplements and the results MAY not have AFFECTED their Vitamin D status yet.']	[('INCOMPLETE_EVIDENCE', 8), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('IMPORTANT_CONSIDERATION', 42), ('INCOMPLETE_EVIDENCE', 271), ('SUPERFICIAL_RELATIONSHIP', 284)]	5	[('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 72, 'D'), ('CHEBI_71657', 'versiconol acetate', 75, '25 (OH) D'), ('PR_000003010', 'moesin isoform 1', 78, '(OH ... D'), ('UBERON_0001977', 'blood serum', 85, 'serum'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('CHEBI_33341', 'titanium atom', 243, 'supplements'), ('CHEBI_27300', 'vitamin D', 299, 'vitamin D')]
S107-PMC4944244	PMC4944244	7/2016	S107-PMC4944244	['the low Vitamin D status in tehran was PROBABLY DUE TO wearing of full dress and veil among all women, regardless of race and religion.']	[('PROBABLE_UNDERSTANDING', 39), ('PROBLEM_COMPLICATION', 48)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D')]
S142-PMC4944244	PMC4944244	7/2016	S142-PMC4944244	['the significant predictive factors after multivariable analysis in OUR STUDY were ethnic group, educational status and dietary intake of Vitamin D. HOWEVER, the study by chailurkit et al.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 67), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 148)]	2	[('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
S173-PMC4944244	PMC4944244	7/2016	S173-PMC4944244	['[10] CLAIMED that work status (farmer versus non farmer) have significant IMPACT on Vitamin D levels, where farmers had higher levels of Serum 25(Oh)D COMPARED TO non-farmers.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 151)]	3	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('UBERON_0001977', 'blood serum', 137, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 146, 'OH)D')]
S177-PMC4944244	PMC4944244	7/2016	S177-PMC4944244	['most of the studies CLAIMED that there was no association between household income per month and Vitamin D status [34].']	[('INCOMPLETE_EVIDENCE', 20)]	1	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
S203-PMC4944244	PMC4944244	7/2016	S203-PMC4944244	['OUR STUDY SHOWED SIMILAR results where fair skin such as chinese had a higher level of Serum 25(Oh) D. initially, by using simple logistic regression analysis, the skin color type, Melanin index measurement and sun protection score SHOWED CORRELATION with Vitamin D status ( p \u2009<\u20090.05).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 232), ('SUPERFICIAL_RELATIONSHIP', 239)]	5	[('UBERON_0001977', 'blood serum', 87, 'serum'), ('CHEBI_71657', 'versiconol acetate', 93, '25(OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 93, '25(OH) D'), ('CHEBI_25179', 'melanins', 181, 'melanin'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D')]
S225-PMC4944244	PMC4944244	7/2016	S225-PMC4944244	['finally, AWARENESS of high PREVALENCE and DANGERS of hypovitaminosis d during Pregnancy NEEDS TO be highlighted to health care workers so that they are better informed of FACTORS INFLUENCING Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 9), ('IMPORTANT_CONSIDERATION', 27), ('IMPORTANT_CONSIDERATION', 42), ('FUTURE_WORK', 88), ('SUPERFICIAL_RELATIONSHIP', 171), ('SUPERFICIAL_RELATIONSHIP', 179)]	6	[('GO_0007565', 'female pregnancy', 78, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D')]
S138-PMC4949006	PMC4949006	7/2016	S138-PMC4949006	['Vitamin D\nadequate Vitamin D status during Pregnancy is NECESSARY to ensure appropriate maternal responses to the calcium demands of the fetus for bone Mineral accretion.']	[('IMPORTANT_CONSIDERATION', 56)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('GO_0007565', 'female pregnancy', 43, 'pregnancy'), ('CHEBI_46662', 'mineral', 152, 'mineral')]
S48-PMC4969253	PMC4969253	8/2016	S48-PMC4969253	['vitamin a-ra and Postnatal Airway disease\na NUMBER OF epidemiological STUDIES in children and Adult subjects have LINKED Vitamin A status with chronic Airway diseases.']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 114)]	2	[('GO_0007567', 'parturition', 17, 'postnatal'), ('UBERON_0001005', 'respiratory airway', 27, 'airway'), ('UBERON_0007023', 'adult organism', 94, 'adult'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin A'), ('UBERON_0001005', 'respiratory airway', 151, 'airway')]
S74-PMC4969253	PMC4969253	8/2016	S74-PMC4969253	['the IDEA that changes in Vitamin A-ra status during fetal Life CAN alter structural and mechanical properties of the Lung in Adult Life HAS BEEN SUGGESTED in few studies.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 63), ('INCOMPLETE_EVIDENCE', 136), ('INCOMPLETE_EVIDENCE', 145)]	4	[('CHEBI_27300', 'vitamin D', 25, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 33, 'A'), ('UBERON_0000104', 'life cycle', 58, 'life'), ('UBERON_0002048', 'lung', 117, 'lung'), ('UBERON_0000113', 'post-juvenile adult stage', 125, 'adult life')]
S90-PMC4969253	PMC4969253	8/2016	S90-PMC4969253	['circulating levels of Vitamin A (Retinol), Retinyl Esters, or ra do NOT NECESSARILY REFLECT the Retinoid status of target cells, SINCE activation of ra signaling depends on a COMPLEX interplay of the components of this pathway, including the presence of ra-synthesizing enzymes, ra receptors (rar, rxr), co-activators/co-repressors, and ra-Metabolizing enzymes.']	[('INCOMPLETE_EVIDENCE', 68), ('SUPERFICIAL_RELATIONSHIP', 84), ('PROBABLE_UNDERSTANDING', 129), ('PROBLEM_COMPLICATION', 129), ('DIFFICULT_TASK', 175)]	5	[('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('CHEBI_26536', 'retinoic acid', 33, 'retinol'), ('CHEBI_26523', 'reactive oxygen species', 43, 'retinyl esters'), ('CHEBI_26537', 'retinoid', 96, 'retinoid'), ('GO_0008152', 'metabolic process', 340, 'metabolizing')]
S82-PMC4971719	PMC4971719	8/2016	S82-PMC4971719	['THUS, MOST of the current literature uses 25-Oh-D as the assessment of overall Vitamin D status [28,42,43].']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 6)]	2	[('CHEBI_46744', 'DDT-2,3-dihydrodiol', 42, '25-OH-D'), ('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
S93-PMC4971719	PMC4971719	8/2016	S93-PMC4971719	['NO threshold has been ESTABLISHED for prevention of other diseases HYPOTHESIZED to be RELATED to Vitamin D status [43,45–47].']	[('FULL_UNKNOWN', 0), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 86)]	3	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
S0-PMC4973215	PMC4973215	8/2016	S0-PMC4973215	['racial DISPARITIES in Cord Blood Vitamin D levels and its ASSOCIATION with small-for-Gestational-age infants\n\nabstract\n\nobjective:\nTO EXAMINE the RELATIONSHIP of race and maternal characteristics and their ASSOCIATION with Cord Blood Vitamin D levels and small-for-Gestational-age (sga) status.']	[('IMPORTANT_CONSIDERATION', 7), ('SUPERFICIAL_RELATIONSHIP', 58), ('QUESTION_ANSWERED_BY_THIS_WORK', 131), ('SUPERFICIAL_RELATIONSHIP', 146), ('SUPERFICIAL_RELATIONSHIP', 206)]	5	[('UBERON_0002240', 'spinal cord', 22, 'cord'), ('UBERON_0000178', 'blood', 27, 'blood'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007565', 'female pregnancy', 85, 'gestational'), ('UBERON_0002240', 'spinal cord', 223, 'cord'), ('UBERON_0000178', 'blood', 228, 'blood'), ('CHEBI_27300', 'vitamin D', 234, 'vitamin D'), ('GO_0007565', 'female pregnancy', 265, 'gestational')]
S3-PMC4973215	PMC4973215	8/2016	S3-PMC4973215	['results:\nblack race, medicaid status, mean body mass index at Delivery and lack of Prenatal vitamin use were ASSOCIATED with Vitamin D deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 109)]	1	[('GO_0007567', 'parturition', 62, 'delivery'), ('GO_0007565', 'female pregnancy', 83, 'prenatal'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
S7-PMC4973215	PMC4973215	8/2016	S7-PMC4973215	['conclusion:\nidentification of RISK FACTORS (black race, medicaid status, obesity and lack of Prenatal Vitamin use) CAN LEAD TO OPPORTUNITIES for targeted Prenatal Vitamin supplementation to reduce the risk of neonatal Vitamin D deficiency and sga status.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 115), ('PROBABLE_UNDERSTANDING', 119), ('FUTURE_WORK', 127)]	4	[('GO_0007565', 'female pregnancy', 93, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 102, 'vitamin'), ('GO_0007565', 'female pregnancy', 154, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 163, 'vitamin'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D')]
S11-PMC4973215	PMC4973215	8/2016	S11-PMC4973215	['several large OBSERVATIONAL studies and meta-analyses have DESCRIBED the ASSOCIATION of maternal Vitamin D deficiency with Pregnancy COMPLICATIONS such as pre-eclampsia, Gestational diabetes and premature Birth.10,11,12,13racial DISPARITIES in maternal and neonatal Vitamin D deficiency HAVE BEEN DESCRIBED.1,14,15vitamin D deficiency is MORE COMMON and more SEVERE in black mothers.10,15,16,17,18,19racial DISPARITIES are also SEEN with Pregnancy COMPLICATIONS such as Preterm birth, pre-eclampsia and Gestational diabetes, as well as adverse neonatal outcomes including low Birth weight and small-for-Gestational-age (sga) status.15,17,20,21HOWEVER, the MAJORITY of studies EXAMINED maternal Vitamin D levels during the first and second Trimesters of Pregnancy7,8,22,23and CORRELATED these levels to neonatal outcomes.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 73), ('PROBLEM_COMPLICATION', 133), ('IMPORTANT_CONSIDERATION', 229), ('INCOMPLETE_EVIDENCE', 287), ('INCOMPLETE_EVIDENCE', 297), ('PROBABLE_UNDERSTANDING', 338), ('IMPORTANT_CONSIDERATION', 359), ('IMPORTANT_CONSIDERATION', 407), ('INCOMPLETE_EVIDENCE', 428), ('PROBLEM_COMPLICATION', 448), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 643), ('PROBABLE_UNDERSTANDING', 656), ('INCOMPLETE_EVIDENCE', 676), ('SUPERFICIAL_RELATIONSHIP', 775)]	16	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('GO_0007565', 'female pregnancy', 123, 'pregnancy'), ('GO_0007565', 'female pregnancy', 170, 'gestational'), ('GO_0007567', 'parturition', 205, 'birth'), ('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 322, 'D'), ('GO_0007565', 'female pregnancy', 438, 'pregnancy'), ('GO_0007565', 'female pregnancy', 470, 'preterm'), ('GO_0007565', 'female pregnancy', 503, 'gestational'), ('GO_0007567', 'parturition', 576, 'birth'), ('GO_0007565', 'female pregnancy', 603, 'gestational'), ('CHEBI_27300', 'vitamin D', 694, 'vitamin D'), ('GO_0043033', 'isoamylase complex', 739, 'trimesters'), ('GO_0007565', 'female pregnancy', 753, 'pregnancy7')]
S15-PMC4973215	PMC4973215	8/2016	S15-PMC4973215	['THUS, the primary PURPOSE of THIS STUDY was to EXAMINE the RELATIONSHIP between race, maternal characteristics, Cord Blood Vitamin D levels and sga status among infants during one winter season in a midwestern us population.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('QUESTION_ANSWERED_BY_THIS_WORK', 47), ('SUPERFICIAL_RELATIONSHIP', 59)]	5	[('UBERON_0002240', 'spinal cord', 112, 'cord'), ('UBERON_0000178', 'blood', 117, 'blood'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
S29-PMC4973215	PMC4973215	8/2016	S29-PMC4973215	['to explore RELATIONSHIPS between race, Vitamin D levels and sga, we first EVALUATED race as a PREDICTOR of Vitamin D levels (sufficient or deficient) in cord Blood and ASSESSED for POTENTIAL CONFOUNDERS: medicaid status, bmi at Delivery, hypertension, maternal age and Prenatal Vitamin use.']	[('SUPERFICIAL_RELATIONSHIP', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 74), ('SUPERFICIAL_RELATIONSHIP', 94), ('QUESTION_ANSWERED_BY_THIS_WORK', 168), ('INCOMPLETE_EVIDENCE', 181), ('PROBLEM_COMPLICATION', 191)]	6	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 107, 'vitamin D'), ('UBERON_0000178', 'blood', 158, 'blood'), ('GO_0007567', 'parturition', 228, 'delivery'), ('GO_0007565', 'female pregnancy', 269, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 278, 'vitamin')]
S30-PMC4973215	PMC4973215	8/2016	S30-PMC4973215	['these results informed the next stage of analyses that examined race and Vitamin D levels with the outcome of sga by assessing POTENTIAL CONFOUNDERS: race, smoking, pre-eclampsia, maternal age, medicaid status and bmi at Delivery.']	[('INCOMPLETE_EVIDENCE', 127), ('PROBLEM_COMPLICATION', 137)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007567', 'parturition', 221, 'delivery')]
S43-PMC4973215	PMC4973215	8/2016	S43-PMC4973215	['race, medicaid status, higher bmi at Delivery and lack of Prenatal vitamin use were all ASSOCIATED with Vitamin D deficiency (25(Oh)D <50\u2009nmol\u2009l−1; p<0.01).']	[('SUPERFICIAL_RELATIONSHIP', 88)]	1	[('GO_0007567', 'parturition', 37, 'delivery'), ('GO_0007565', 'female pregnancy', 58, 'prenatal'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 126, '25(OH)D')]
S45-PMC4973215	PMC4973215	8/2016	S45-PMC4973215	['SIMILARLY, infants on medicaid, a MARKER of socioeconomic status, had higher odds of Vitamin D deficiency (odds ratio (or) 2.3, 95% ci: 1.4, 3.8), WHEREAS Prenatal Vitamin use SHOWED a PROTECTIVE EFFECT (or 0.24, 95% ci: 0.09, 0.62).']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 147), ('INCOMPLETE_EVIDENCE', 176), ('SUPERFICIAL_RELATIONSHIP', 185), ('SUPERFICIAL_RELATIONSHIP', 196)]	6	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007565', 'female pregnancy', 155, 'prenatal'), ('CHEBI_33229', 'vitamin (role)', 164, 'vitamin')]
S50-PMC4973215	PMC4973215	8/2016	S50-PMC4973215	['AS Vitamin D levels also DIFFERED by race, we stratified the models predicting sga by race and EXAMINED Vitamin D deficiency, smoking, pre-eclampsia, maternal age, medicaid status and bmi at Delivery as covariates (table 3).']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 25), ('QUESTION_ANSWERED_BY_THIS_WORK', 95)]	3	[('CHEBI_27300', 'vitamin D', 3, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('GO_0007567', 'parturition', 191, 'delivery')]
S67-PMC4973215	PMC4973215	8/2016	S67-PMC4973215	['Vitamin D MAY AFFECT fetal growth through its EFFECT on Calcium Metabolism, bone growth and Placental Development.32ALTHOUGH INITIAL STUDIES SHOWED CONFLICTING results, more RECENT STUDIES SUGGEST that Vitamin D deficiency MAY adversely AFFECT growth and LEAD TO low Birth weight or sga infants.7,9,11,12,18,22,23,33BECAUSE of a KNOWN RELATIONSHIP between race and Vitamin D status, ATTENTION then turned to investigation of the RELATIONSHIP between race, Vitamin D deficiency and sga.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 116), ('INCOMPLETE_EVIDENCE', 125), ('INCOMPLETE_EVIDENCE', 141), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 148), ('INCOMPLETE_EVIDENCE', 174), ('INCOMPLETE_EVIDENCE', 189), ('INCOMPLETE_EVIDENCE', 223), ('SUPERFICIAL_RELATIONSHIP', 237), ('SUPERFICIAL_RELATIONSHIP', 255), ('PROBABLE_UNDERSTANDING', 316), ('INCOMPLETE_EVIDENCE', 329), ('SUPERFICIAL_RELATIONSHIP', 335), ('IMPORTANT_CONSIDERATION', 383), ('SUPERFICIAL_RELATIONSHIP', 429)]	17	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0018884', 'carbazole metabolic process', 56, 'calcium metabolism'), ('GO_0001890', 'placenta development', 92, 'placental development'), ('UBERON_0001987', 'placenta', 92, 'placental'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('GO_0007567', 'parturition', 267, 'birth'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 456, 'vitamin D')]
S70-PMC4973215	PMC4973215	8/2016	S70-PMC4973215	"[""for white mothers, measurement of maternal Serum 25(Oh)D at <22 weeks' Gestation SHOWED a u-shaped RELATIONSHIP between Vitamin D status and risk of sga, where the highest risk for sga was SEEN with both low and high Vitamin D levels.""]"	[('INCOMPLETE_EVIDENCE', 81), ('SUPERFICIAL_RELATIONSHIP', 99), ('INCOMPLETE_EVIDENCE', 189)]	3	[('UBERON_0001977', 'blood serum', 43, 'serum'), ('CHEBI_71657', 'versiconol acetate', 49, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 49, '25(OH)D'), ('GO_0007565', 'female pregnancy', 71, 'gestation'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D')]
S71-PMC4973215	PMC4973215	8/2016	S71-PMC4973215	['HOWEVER, no relationship was seen between Vitamin D status and sga among black mothers.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D')]
S74-PMC4973215	PMC4973215	8/2016	S74-PMC4973215	['they FOUND that Vitamin D status was ASSOCIATED with risk of sga in white and nonobese women, BUT that there was no association between Vitamin D and sga in black or obese mothers.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 94)]	3	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
S83-PMC4973215	PMC4973215	8/2016	S83-PMC4973215	['obesity is WELL KNOWN to be a RISK FACTOR for Vitamin D deficiency BECAUSE of a Sequestering Of Vitamin D in Adipose Tissue.35maternal obesity during Pregnancy HAS also BEEN ASSOCIATED with lower Vitamin D levels in neonates at Delivery.24,36,37,38our data are CONSISTENT and illustrate the inverse RELATIONSHIP between maternal bmi at Delivery and Vitamin D status after adjusting for confounding variables.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 30), ('PROBABLE_UNDERSTANDING', 67), ('INCOMPLETE_EVIDENCE', 160), ('SUPERFICIAL_RELATIONSHIP', 174), ('INCOMPLETE_EVIDENCE', 261), ('SUPERFICIAL_RELATIONSHIP', 299)]	7	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('GO_0051208', 'sequestering of calcium ion', 80, 'sequestering of vitamin D'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('UBERON_0001013', 'adipose tissue', 109, 'adipose tissue'), ('GO_0007565', 'female pregnancy', 150, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 196, 'vitamin D'), ('GO_0007567', 'parturition', 228, 'delivery'), ('GO_0007567', 'parturition', 336, 'delivery'), ('CHEBI_27300', 'vitamin D', 349, 'vitamin D')]
S99-PMC4973215	PMC4973215	8/2016	S99-PMC4973215	['corresponding maternal Vitamin D status at different Gestations during Pregnancy was UNKNOWN.']	[('FULL_UNKNOWN', 85)]	1	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0007565', 'female pregnancy', 53, 'gestations'), ('GO_0007565', 'female pregnancy', 71, 'pregnancy')]
S100-PMC4973215	PMC4973215	8/2016	S100-PMC4973215	['this WOULD have allowed for a more expansive definition of the RELATIONSHIP between maternal Vitamin D status and Perinatal outcomes.']	[('FUTURE_PREDICTION', 5), ('SUPERFICIAL_RELATIONSHIP', 63)]	2	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('GO_0036268', 'swimming', 114, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 114, 'perinatal')]
S105-PMC4973215	PMC4973215	8/2016	S105-PMC4973215	['a GREATER UNDERSTANDING of the variables that INFLUENCE Vitamin D status during Pregnancy CAN have an immense PUBLIC HEALTH IMPACT in the reduction of adverse Perinatal outcomes such as sga.']	[('IMPORTANT_CONSIDERATION', 2), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 90), ('IMPORTANT_CONSIDERATION', 110), ('SUPERFICIAL_RELATIONSHIP', 124)]	5	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('GO_0036268', 'swimming', 159, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 159, 'perinatal')]
S0-PMC4979151	PMC4979151	8/2016	S0-PMC4979151	['Prenatal high-dose Vitamin D3Supplementation has balanced EFFECTS on Cord Blood th1 and th2 Responses\n\nabstract\n\nbackground\nantenatal Vitamin D3(vitd3) supplementation significantly increases maternal and neonatal 25-Hydroxyvitamin D3(25(Oh)D3) concentration, YET the EFFECT of an improvement in maternal-fetal Vitamin D status on the neonatal immune response is UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 58), ('ANOMALY_CURIOUS_FINDING', 260), ('SUPERFICIAL_RELATIONSHIP', 268), ('FULL_UNKNOWN', 363)]	4	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('CHEBI_52915', 'phosphatediyl group', 19, 'vitamin D3supplementation'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 19, 'vitamin D3supplementation'), ('UBERON_0002240', 'spinal cord', 69, 'cord'), ('UBERON_0000178', 'blood', 74, 'blood'), ('GO_0060033', 'anatomical structure regression', 92, 'responses'), ('CHEBI_33279', 'vitamin D5', 134, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 134, 'vitamin D3'), ('CHEBI_63991', '15-epi-lipoxin B4', 214, '25-hydroxyvitamin D3'), ('PR_000001177', 'D(2) dopamine receptor', 232, 'D3'), ('CHEBI_62946', 'ammonium sulfate', 235, '25(OH)D3'), ('PR_000001177', 'D(2) dopamine receptor', 241, 'D3'), ('CHEBI_27300', 'vitamin D', 311, 'vitamin D')]
S10-PMC4979151	PMC4979151	8/2016	S10-PMC4979151	['introduction\nthe IMPORTANCE of adequate Vitamin D status during Pregnancy HAS BEEN SUGGESTED by OBSERVATIONAL studies DEMONSTRATING ASSOCIATIONS between low 25(Oh)D3And adverse Birth outcomes, childhood infections, and atopy [1,2].']	[('IMPORTANT_CONSIDERATION', 17), ('INCOMPLETE_EVIDENCE', 74), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 96), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 132)]	6	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('CHEBI_76945', 'manool', 157, '25(OH)D3and'), ('PR_000036846', 'class II olfactory receptor', 157, '25(OH)D3and'), ('GO_0007567', 'parturition', 177, 'birth')]
S15-PMC4979151	PMC4979151	8/2016	S15-PMC4979151	['maternal Vitamin D status during Pregnancy MAY AFFECT the fetal Immune System and CONTRIBUTE to the risk of development of Immune-mediated diseases and infection in the offspring.']	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 47), ('SUPERFICIAL_RELATIONSHIP', 82)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy'), ('UBERON_0002405', 'immune system', 64, 'immune system'), ('UBERON_0002405', 'immune system', 123, 'immune')]
S21-PMC4979151	PMC4979151	8/2016	S21-PMC4979151	['in a sub-set in the same trial cohort, we studied the IMPACT of Vitamin D status on the Expression profile of cytokines by Stimulated T Lymphocytes and on T Cell Activation pathway as a key component of Adaptive Immunity.']	[('SUPERFICIAL_RELATIONSHIP', 54)]	1	[('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('GO_0010467', 'gene expression', 88, 'expression'), ('CL_0002651', 'endothelial cell of venous sinus of spleen', 123, 'stimulated'), ('CL_0000084', 'T cell', 134, 'T lymphocytes'), ('CL_0000084', 'T cell', 155, 'T cell'), ('GO_0042110', 'T cell activation', 155, 'T cell activation'), ('GO_0051866', 'general adaptation syndrome', 203, 'adaptive immunity')]
S35-PMC4979151	PMC4979151	8/2016	S35-PMC4979151	['there is NO standard classification of Vitamin D status based on 25(Oh)D3Concentrations in Cord Blood; THUS, for the PURPOSE of the PRESENT STUDY we stratified the participants into four groups based on Serum 25(Oh)D concentrations as done earlier [20] :(1) ≥76\xa0nmol/l (high); (2) 50–75\xa0nmol/l (moderate); (3) 30–49\xa0nmol/l (low); (4) <30\xa0nmol/l (very low).']	[('FULL_UNKNOWN', 9), ('PROBABLE_UNDERSTANDING', 103), ('QUESTION_ANSWERED_BY_THIS_WORK', 117), ('QUESTION_ANSWERED_BY_THIS_WORK', 132)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_73735', 'gadoterate', 65, '25(OH)D3concentrations'), ('PR_000029608', 'DISP complex protein LRCH3', 65, '25 ... OH ... D3concentrations'), ('UBERON_0002240', 'spinal cord', 91, 'cord'), ('UBERON_0000178', 'blood', 96, 'blood'), ('UBERON_0001977', 'blood serum', 203, 'serum'), ('CHEBI_71657', 'versiconol acetate', 209, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 209, '25(OH)D')]
S114-PMC4979151	PMC4979151	8/2016	S114-PMC4979151	['discussion\nwe PREVIOUSLY SHOWED that supplementation with vitd3during the 3rd trimester of Pregnancy improved maternal and Cord Blood Vitamin D status [18] and reduction of antibacterial peptide ll-37 in Monocytes [20].']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 25)]	2	[('GO_0007565', 'female pregnancy', 91, 'pregnancy'), ('UBERON_0002240', 'spinal cord', 123, 'cord'), ('UBERON_0000178', 'blood', 128, 'blood'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('CL_0000576', 'monocyte', 204, 'monocytes')]
S14-PMC4982007	PMC4982007	8/2016	S14-PMC4982007	['among three studies of maternal Vitamin D status, two SHOWED lower Cognitive function in children of deficient mothers.']	[('INCOMPLETE_EVIDENCE', 54)]	1	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0050890', 'cognition', 67, 'cognitive')]
S39-PMC4982007	PMC4982007	8/2016	S39-PMC4982007	['THIS SYSTEMATIC REVIEW FOCUSSES on studies LINKING Cognitive function in children to the following indices of maternal nutritional status: a) anthropometry (body mass index (bmi), height and weight); b) status or Intake of selected single Micronutrients (Vitamins D, b1, b6, b12 and Folate) and iron and c) dietary Intake of Macronutrients (Carbohydrate, protein and fat).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('SUPERFICIAL_RELATIONSHIP', 43)]	3	[('GO_0050890', 'cognition', 51, 'cognitive'), ('GO_0007631', 'feeding behavior', 213, 'intake'), ('CHEBI_33839', 'macromolecule', 239, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 255, 'vitamins D'), ('CHEBI_30863', '5-azaorotic acid', 283, 'folate'), ('GO_0007631', 'feeding behavior', 315, 'intake'), ('CHEBI_33839', 'macromolecule', 325, 'macronutrients'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 341, 'carbohydrate')]
S69-PMC4982007	PMC4982007	8/2016	S69-PMC4982007	['n \u2009=\u20095832: age 4\xa0years \u2003n \u2009=\u20095191; age 8\xa0years \u2003n \u2009=\u20097339; age 16\xa0yearsmaternal Gestational weight gain (kg)3 categories of weight gain1: less than recommended2: as recommended3: more than recommendedpre-Pregnancy weight (kg)school entry assessment score-4\xa0yearsiq- wechsler intelligence scale for children -iii-8\xa0yearsadequate final exam results-16\xa0yearschildren of women gained weight\u2009<\u2009expected-↓ school entry assessment score (-0.075 sd) and adequate final-exam results (or\u2009=\u20090.88); ↑weight gain - early and mid Pregnancy -↑school entry assessment score (0.072 and 0.077 sd)↑ weight gain in all three periods of Pregnancy-↑ iq at 8\xa0years (0.070 to 0.078 sd) and ↑pre-Pregnancy weight-↓ school entry assessment score (-0.004 sd/kg), iq (-0.004 sd) and the odds (or\u2009=\u20090.99) of achieving adequate final exam resultsconfounders adjusted for: the child’s sex, current age, ma; me, parity, pre-Pregnancy bmi, smoking and mode of Delivery16 medium\nbmi body mass index, qs quality score, rb risk of bias, ga Gestational age, ma maternal age, bwt Birthweight, ses socio-economic status, me maternal education, pe paternal education, miq maternal intelligence, he home environment, ms maternal smoking, bf breast-feeding, dm maternal diabetes, pih Pregnancy induced hypertension\n\ncaption (table-wrap): table 3\n\nsummary of the studies examining ASSOCIATIONS of maternal Vitamin D status with offspring Cognitive functionauthor, year, sample size, age, country, study designnutrientcognitive functionresults after adjustment for confoundersqs and rb20gale c; 2008 \u2003n \u2009=\u2009178\u2003age 9\xa0years\u2003uk\u2003prospective longitudinalserum Vitamin D concentrations assessed at 28-42 weeks Gestation21.2\xa0% had <27.5\xa0nmol/l28.3\xa0% had 27.5-50\xa0nmol/lwechsler abbreviated scale of intelligencefull-scale, verbal or performance iqno association between Vitamin D concentrations and offspring iq (full-scale, verbal or performance)confounders adjusted for: unadjusted16 medium21whitehouse ajo; 2012\u2003age 5\xa0years ( n \u2009=\u2009534)\u2003age 10\xa0years ( n \u2009=\u2009474)\u2003australia\u2003prospective longitudinalserum Vitamin D concentrations assessed at 18\xa0weeks Gestation25.2\xa0% mothers had insufficiency (≤46\xa0nmol/l)(lowest quartile)peabody picture vocabulary test Receptive Languagechildren of mothers with Vitamin D insufficiency (lowest quartile (≤46\xa0nmol/l) were at INCREASED RISK (or\u2009=\u20091.97) of Language impairment compared to children of mothers without insufficiency (highest quartile (≥72\xa0nmol/l; or\u2009=\u20091.00)confounders adjusted for: ma, ms, parity, family income, season of maternal Blood sampling13 medium22morales\xa0e; 2012 \u2003n \u2009=\u20091820\u2003age 11-23 months\u2003spain\u2003prospective population based\u2003cohort studyplasma Vitamin D concentrations assessed during 12-23 weeks Gestation19.5\xa0% mothers had deficiency (<20\xa0ng/ml)31.5\xa0% had insufficiency (20-30\xa0ng/ml)bayley scales of infant development (mental (mdi) and psychomotor (pdi) developmental score)a positive linear ASSOCIATION between Vitamin D concentrations and mdi and pdiper 10\xa0ng/ml increase in Vitamin D concentrations mdi and pdi score increased by β\u2009=\u20090.79 and β\u2009=\u20090.88 points respectivelycompared to infants of deficient mothers, infants of mothers with normal level scored higher mdi (β\u2009=\u20092.60) and pdi (β\u2009=\u20092.32) points respectivelyconfounders adjusted for: the child’s sex, bwt, area of study, maternal country of origin, ma, parity, Pre-Pregnancy bmi, ses, me, ms, Alcohol and season15 medium\nqs quality score, rb risk of bias, ma maternal age, bwt Birthweight, me Maternal education, ms maternal smoking, bmi body mass index, ses socio-economic status\n\ncaption (table-wrap): table 4\n\nsummary of the studies examining ASSOCIATIONS of maternal Folate status with offspring Cognitive functionauthor, year, sample size, age, country, study designnutrientcognitive functionresults after adjustment for confoundersqs and rb23wu btf; 2012 \u2003n \u2009=\u2009154\u2003age 18 months\u2003canada\u2003prospectiveplasma Folate and thcy concentrations assessed at 16 and 36\xa0weeks Gestationno Folate deficiency (plasma Folate <6.8\xa0nmol/l)high thcy not reportedbayley scales of infant developmentreceptive language, expressive language, Cognitive skills, fine motor and gross motorno ASSOCIATION of Folate and thcy with Cognitive functionconfounders adjusted for: the child’s sex, bf, ethnicity, ma, miq, maternal Fatty Acid level13 medium24tamura t; 2005 \u2003n \u2009=\u2009355\u2003age 5\xa0years\u2003usa\u2003prospective\u2003mothers participated in zinc supplementation trial during Pregnancyred cell and Plasma Folate concentrations – 19, 26 and 37\xa0weeks Gestation and thcy concentrations-26 and 37\xa0weekslow Folate-(Plasma Folate <11\xa0nmol/l)19\xa0weeks- 7.4\xa0%; 26\xa0weeks- 8.2\xa0%; 37\xa0weeks- 14.0\xa0%Red Cell Folate <430\xa0nmol/l)19\xa0weeks- 7.2\xa0%; 26\xa0weeks- 3.8\xa0%; 37\xa0weeks- 3.3\xa0%high thcy (thcy\u2009>\u20097\xa0μmol/l)26\xa0weeks- 8.4\xa0%; 37\xa0weeks- 22.1\xa0%differential ability scale (verbal, nonverbal and general iq), Visual and Auditory sequential Memory (Visual and Auditory Memory span)knox cube (attention span and Short-Term Memory)gross motor scale (gross Motor Development and grooved pegboard (manipulative dexterity)no difference in the mental and psychomotor developmental scores between children of mothers with normal and deficient Folate and thcy groups.']	[('SUPERFICIAL_RELATIONSHIP', 1338), ('IMPORTANT_CONSIDERATION', 2306), ('SUPERFICIAL_RELATIONSHIP', 2901), ('SUPERFICIAL_RELATIONSHIP', 3617), ('SUPERFICIAL_RELATIONSHIP', 4142)]	5	[('GO_0007565', 'female pregnancy', 80, 'gestational'), ('GO_0007565', 'female pregnancy', 204, 'pregnancy'), ('GO_0007565', 'female pregnancy', 516, 'pregnancy'), ('GO_0007565', 'female pregnancy', 616, 'pregnancy'), ('GO_0007565', 'female pregnancy', 671, 'pregnancy'), ('GO_0007565', 'female pregnancy', 892, 'pregnancy'), ('GO_0007567', 'parturition', 927, 'delivery16'), ('GO_0007565', 'female pregnancy', 1004, 'gestational'), ('GO_0007596', 'blood coagulation', 1042, 'birthweight'), ('GO_0007565', 'female pregnancy', 1242, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1363, 'vitamin D'), ('GO_0050890', 'cognition', 1395, 'cognitive'), ('CHEBI_27300', 'vitamin D', 1611, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1660, 'gestation21'), ('CHEBI_27300', 'vitamin D', 1818, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2052, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2098, 'gestation25'), ('GO_0000724', 'double-strand break repair via homologous recombination', 2201, 'Receptive languageChildren'), ('CHEBI_27300', 'vitamin D', 2244, 'vitamin D'), ('GO_0006266', 'DNA ligation', 2336, 'language'), ('UBERON_0000178', 'blood', 2527, 'blood'), ('CHEBI_27300', 'vitamin D', 2650, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2703, 'gestation19'), ('CHEBI_27300', 'vitamin D', 2921, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2986, 'vitamin D'), ('GO_0007568', 'aging', 3332, 'pre'), ('GO_0007565', 'female pregnancy', 3336, 'pregnancy'), ('CHEBI_30879', 'alcohol', 3364, 'alcohol'), ('GO_0007596', 'blood coagulation', 3448, 'birthweight'), ('GO_0007618', 'mating', 3464, 'maternal'), ('CHEBI_30863', '5-azaorotic acid', 3642, 'folate'), ('GO_0050890', 'cognition', 3671, 'cognitive'), ('CHEBI_30863', '5-azaorotic acid', 3881, 'folate'), ('GO_0007565', 'female pregnancy', 3940, 'gestationNo'), ('CHEBI_30863', '5-azaorotic acid', 3952, 'folate'), ('CHEBI_30863', '5-azaorotic acid', 3978, 'folate'), ('GO_0050890', 'cognition', 4095, 'cognitive'), ('CHEBI_30863', '5-azaorotic acid', 4157, 'folate'), ('GO_0050890', 'cognition', 4178, 'cognitive'), ('CHEBI_35366', 'fatty acid', 4272, 'fatty acid'), ('GO_0007605', 'sensory perception of sound', 4410, 'pregnancyRed'), ('UBERON_0001969', 'blood plasma', 4432, 'plasma'), ('CHEBI_30863', '5-azaorotic acid', 4439, 'folate'), ('GO_0007565', 'female pregnancy', 4483, 'gestation'), ('CHEBI_30863', '5-azaorotic acid', 4536, 'folate'), ('UBERON_0001969', 'blood plasma', 4544, 'plasma'), ('CHEBI_30863', '5-azaorotic acid', 4551, 'folate'), ('CL_0000232', 'erythrocyte', 4619, 'Red cell'), ('CHEBI_30863', '5-azaorotic acid', 4628, 'folate'), ('GO_0007601', 'visual perception', 4819, 'Visual'), ('GO_0006754', 'ATP biosynthetic process', 4830, 'Auditory ...'), ('GO_0007613', 'memory', 4850, 'Memory'), ('GO_0007601', 'visual perception', 4858, 'visual'), ('GO_0007605', 'sensory perception of sound', 4869, 'auditory'), ('GO_0007613', 'memory', 4878, 'memory'), ('GO_0007608', 'sensory perception of smell', 4920, 'short-term memory'), ('GO_0009653', 'anatomical structure morphogenesis', 4963, 'motor development'), ('CHEBI_30863', '5-azaorotic acid', 5145, 'folate')]
S75-PMC4982007	PMC4982007	8/2016	S75-PMC4982007	['m; 2010 \u2003n \u2009=\u20099983 14\xa0years \u2003n \u2009=\u200910474 16\xa0years\u2003finland\u2003prospective Birth cohort studyhb concentrations at 3rd 7th and 9th Gestational monthsanaemiaschool performance14\xa0years- self report16\xa0years- school report↑maternal hb at 9\xa0months-↑ total school performance score (β\u2009=\u20090.03) and theory score at 14\xa0years and total score at 16\xa0years offspring of mothers with anaemia –low school scores (or\u2009=\u2009-0.05 at 14\xa0years and (or\u2009=\u2009-0.06) at 16\xa0yearsconfounders adjusted for: the child’s sex, bwt, Pregnancy wanted or not, me, social class, parity, marital status, ms, maternal mental health status18 low40davidson pw; 2008 \u2003n \u2009=\u2009229\u2003age 5, 9, 25and 30\xa0months\u2003republic of seychelles\u2003longitudinal cohort studyiron- total body stores at 14-24 weeks of Gestation assessed before the start of iron supplementationbayley scales of infant development: mental development index (mdi) and psychomotor development index (pdi) (9 and 30\xa0months)infant Cognition (fagan infantest-novelty preference) and Visual expectation paradigm –Visual recognition Memory (9 and 25\xa0months)a-not-b and delayed spatial alternation: inhibition, Working Memory, Planning and attention (25\xa0months)no association between maternal iron stores and Cognitive function at any age.confounders adjusted for: the child’s sex, bwt, ma, ses, he, miq and both parents living with the child (yes/no)19 low41lewis sj; 2013 \u2003n \u2009=\u2009~3,500\u2003age 8\xa0years\u2003uk\u2003population based prospective birth cohorthb concentrationsbefore 18\xa0weekshb <11.0\xa0g/dl -8\xa0%after 28\xa0weekshb <11.0\xa0g/dl -30\xa0%wechsler intelligence scale for children-iii- full- scale iqno ASSOCIATION between maternal hb and child’s iqconfounders adjusted for: ga, me, the child’s genotype, Iron supplementation, population stratification15 medium42tran td; 2013 \u2003n \u2009=\u2009378\u2003age 6\xa0months\u2003vietnam\u2003population based prospective cohort studyiron deficiency anaemia (hb <11.0\xa0g/dl and Serum ferritin <15\xa0ng/ml) during 12-28 weeks of Gestation-16\xa0%bayley scales of infant and toddler development-iii edition-Cognitive scoreinfants of anaemic mothers scored 11.6 points (0.77sd) lower in bsid Cognitive scores compared to infants of non-anaemic mothers.confounders adjusted for: parity, ma, me, wealth index, the child’s Birth and current weight, family support, bf.18 low43zhou sj; 2006 \u2003n \u2009=\u2009302\u2003age 4\xa0years; australia\u2003double blind randomized controlled trialiron Supplements (20\xa0mg/day) or placebo from 20\xa0weeks Gestation until deliverycompliance-86\xa0%stanford binet intelligence scale – iq (Verbal Reasoning, Visual Reasoning, Quantitative Reasoning and Short-Term Memory)no difference between the children of supplement group and placebo group in the mean score of composite iq or any subscales iq or in the proportion of children whose iq fell 1 or 2 sd below the mean.confounders adjusted for: sex, Birth order, Gestational age, ma, me, pe, he, bf20 low44li q; 2009 \u2003n \u2009=\u20091305\u2003age 3, 6 and 12\xa0months\u2003double blind cluster randomized controlled trial\u2003china3 intervention groups (all received Folic Acid)Folic Acid alone400\xa0μg ( n \u2009=\u2009471)-controliron 60\xa0mg\u2009+\u2009Folic Acid400\xa0μg ( n \u2009=\u2009438)multiple Micronutrients ((b Vitamins (1,2,3 6 and 12), Vitamin A, d, c, e and minerals (zinc, Iodine, copper, Selenium)\u2009+\u2009iron 30\xa0mg\u2009+\u2009400\xa0μg Folic Acid)) ( n \u2009=\u2009396)daily supplementation from enrolment until Delivery; inadequate information about compliancebayley scales of Infant Development :mental (md) and Psychomotor Development (pd)no significant difference in infants md and pd score at 3 and 6\xa0months and pd score at 12\xa0months between Supplement groupsmean md score among children of multiple Micronutrient group increased by 1 to 1.22 points COMPARED to children of Folic Acid alone, or Folic Acid\u2009+\u2009Iron group at 12\xa0monthsconfounders adjusted for: infants age, sex, Gestational age, apgar score, bwt, infant health, maternal age and bmi, parental education, occupation, ses, number of tablets consumed19 low\nqs quality score , rb risk of bias , hb haemoglobin , ga Gestational age , ma maternal age , bwt birthweight , ses socio-economic status , me maternal education , pe paternal education , miq maternal intelligence , he home environment , ms maternal smoking , bf breast-feeding , bmi body mass index\n\ncaption (table-wrap): table 7\n\nsummary of the studies examining ASSOCIATIONS of maternal Carbohydrate/protein with offspring Cognitive functionauthor, year, sample size, age, country, study designnutrientcognitive functionresults after adjustment for confoundersqs and rb45alderman h; 2014 \u2003n \u2009=\u20096774\u2003age 16-22 years\u2003double blind cluster randomized controlled trial\u2003gambiacarbohydrate/protein supplementsintervention group:2 biscuits daily (1015\xa0kcal Carbohydrate and 22\xa0g protein) from 20\xa0weeks of Gestation to Deliverycontrol group: same Supplements for 20\xa0weeks during Postpartum but not during Pregnancyno information about complianceraven’s progressive matrices- nonverbal reasoning abilitythe mill hill vocabulary testthe backward and forward digit-span testschooling achievement (questionnaire)no difference in any of the Cognitive test scores or schooling achievement between children whose mothers received thesupplements during Pregnancy and children whose mothers received Supplements during Postpartum.confounders adjusted for: the child’s sex, age, ga, me, pe, maternal height, parity, season of Birth, language and village allocation19 low\nqs quality score, rb risk of bias, ga Gestational age, me Maternal education, pe paternal education\n\nmaternal anthropometry (table\xa02)\nall were observational studies and from developed countries [8–19].']	[('SUPERFICIAL_RELATIONSHIP', 1587), ('ANOMALY_CURIOUS_FINDING', 3631), ('SUPERFICIAL_RELATIONSHIP', 4262)]	3	[('GO_0007567', 'parturition', 69, 'Birth'), ('GO_0007565', 'female pregnancy', 124, 'gestational'), ('GO_0007565', 'female pregnancy', 490, 'pregnancy'), ('GO_0007565', 'female pregnancy', 742, 'gestation'), ('GO_0050890', 'cognition', 933, 'cognition'), ('GO_0007601', 'visual perception', 984, 'Visual'), ('GO_0007601', 'visual perception', 1013, 'visual ...'), ('GO_0007613', 'memory', 1032, 'memory'), ('GO_0007631', 'feeding behavior', 1109, 'working memory'), ('GO_0006260', 'DNA replication', 1125, 'planning'), ('GO_0050890', 'cognition', 1207, 'cognitive'), ('CHEBI_24870', 'ion', 1689, 'iron'), ('UBERON_0001977', 'blood serum', 1876, 'serum'), ('GO_0007565', 'female pregnancy', 1924, 'gestation'), ('GO_0050890', 'cognition', 1998, 'cognitive'), ('GO_0050890', 'cognition', 2082, 'cognitive'), ('GO_0007567', 'parturition', 2210, 'birth'), ('CHEBI_33341', 'titanium atom', 2355, 'supplements'), ('GO_0007565', 'female pregnancy', 2404, 'gestation'), ('GO_0016055', 'Wnt signaling pathway', 2483, 'verbal reasoning'), ('GO_0007602', 'phototransduction', 2501, 'visual reasoning'), ('GO_0031028', 'septation initiation signaling', 2519, 'quantitative reasoning'), ('GO_0007608', 'sensory perception of smell', 2546, 'short-term memory'), ('GO_0007567', 'parturition', 2794, 'birth'), ('GO_0007565', 'female pregnancy', 2807, 'gestational'), ('CHEBI_30751', 'formic acid', 2985, 'folic acid'), ('CHEBI_30751', 'formic acid', 2996, 'Folic acid'), ('CHEBI_52727', 'ethyl nile blue A', 3051, 'folic acid400'), ('CHEBI_33839', 'macromolecule', 3088, 'micronutrients'), ('CHEBI_33277', 'gamma-tocotrienol', 3107, 'vitamins'), ('CHEBI_27300', 'vitamin D', 3134, 'vitamin A'), ('CHEBI_24859', 'iodine atom', 3173, 'iodine'), ('CHEBI_27568', 'selenium atom', 3189, 'selenium'), ('CHEBI_30751', 'formic acid', 3221, 'folic acid'), ('GO_0007567', 'parturition', 3288, 'delivery'), ('GO_0060119', 'inner ear receptor cell development', 3354, 'Infant Development'), ('GO_0035210', 'prepupal development', 3390, 'Psychomotor development'), ('CHEBI_16158', 'steroid sulfate', 3523, 'supplement'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 3581, 'micronutrient'), ('CHEBI_30751', 'formic acid', 3655, 'folic acid'), ('CHEBI_30751', 'formic acid', 3676, 'folic acid'), ('CHEBI_24870', 'ion', 3689, 'iron'), ('GO_0007565', 'female pregnancy', 3756, 'gestational'), ('GO_0007565', 'female pregnancy', 3955, 'gestational'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 4287, 'carbohydrate'), ('GO_0050890', 'cognition', 4323, 'cognitive'), ('CHEBI_16730', 'chloramphenicol 3-acetate', 4649, 'carbohydrate'), ('GO_0007565', 'female pregnancy', 4697, 'gestation'), ('GO_0051607', 'defense response to virus', 4710, 'deliveryControl'), ('CHEBI_33341', 'titanium atom', 4738, 'supplements'), ('GO_0007565', 'female pregnancy', 4770, 'postpartum'), ('GO_0007605', 'sensory perception of sound', 4796, 'pregnancyNo'), ('GO_0050890', 'cognition', 5027, 'cognitive'), ('GO_0007565', 'female pregnancy', 5136, 'pregnancy'), ('CHEBI_33341', 'titanium atom', 5182, 'supplements'), ('GO_0007565', 'female pregnancy', 5201, 'postpartum'), ('GO_0007567', 'parturition', 5307, 'birth'), ('GO_0007565', 'female pregnancy', 5390, 'gestational'), ('GO_0007618', 'mating', 5410, 'maternal')]
S127-PMC4982007	PMC4982007	8/2016	S127-PMC4982007	['ANOTHER STUDY FOUND higher Mental and Psychomotor Development scores (2-3 score points (0.1-0.2 sd)) in children of mothers with normal Vitamin D status (>75\xa0nmol/l) compared to those with deficiency (<50\xa0nmol/l) [22].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14)]	2	[('GO_0007613', 'memory', 27, 'mental ...'), ('GO_0030324', 'lung development', 38, 'psychomotor development'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D')]
S228-PMC4982007	PMC4982007	8/2016	S228-PMC4982007	['two out of three studies of maternal Vitamin D status SHOWED lower Cognitive function in children of deficient mothers.']	[('INCOMPLETE_EVIDENCE', 54)]	1	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0050890', 'cognition', 67, 'cognitive')]
S278-PMC4982007	PMC4982007	8/2016	S278-PMC4982007	['another LIMITATION was that maternal Vitamin D status was available ONLY during the second trimester; SINCE Vitamin D IS KNOWN to fluctuate with sunlight exposure, the timing of deficiency MAY BE CRUCIAL in determining Cognitive function.']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 68), ('PROBABLE_UNDERSTANDING', 102), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 189), ('IMPORTANT_CONSIDERATION', 196)]	6	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 108, 'vitamin D'), ('GO_0050890', 'cognition', 219, 'cognitive')]
S359-PMC4982007	PMC4982007	8/2016	S359-PMC4982007	['we FOUND SOME EVIDENCE LINKING maternal obesity and low Micronutrient status, in particular, that of Vitamin D, Folate and B12 during Pregnancy with poorer offspring Cognitive function, SUGGESTING that maternal nutrition is IMPORTANT for optimal offspring Neurodevelopment and Long-Term Cognition.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 186), ('IMPORTANT_CONSIDERATION', 224)]	5	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 56, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('CHEBI_30863', '5-azaorotic acid', 112, 'folate'), ('CHEBI_27778', 'abequose', 123, 'B12'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy'), ('GO_0050890', 'cognition', 166, 'cognitive'), ('GO_0007399', 'nervous system development', 256, 'neurodevelopment'), ('GO_0007040', 'lysosome organization', 277, 'long-term cognition')]
S345-PMC4989298	PMC4989298	8/2016	S345-PMC4989298	['HOWEVER, SEVERAL STUDIES report SUBOPTIMAL Vitamin D status in large parts of the population of children and Adults.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 32)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0007023', 'adult organism', 109, 'adults')]
S348-PMC4989298	PMC4989298	8/2016	S348-PMC4989298	['state of knowledge\na recent meta-analysis INVESTIGATED the RELATIONSHIP between alterations of Vitamin D status and a number OF pathological conditions [121].']	[('QUESTION_ANSWERED_BY_THIS_WORK', 42), ('SUPERFICIAL_RELATIONSHIP', 59), ('ANOMALY_CURIOUS_FINDING', 125)]	3	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
S351-PMC4989298	PMC4989298	8/2016	S351-PMC4989298	['the results of this meta-analysis SUPPORTS a CORRELATION between low Vitamin D status and diseases such as hypertension, rachitism in children, vaginosis in Pregnancy, the level of activity of rheumatoid arthritis, Colorectal cancer and falls in the elderly.']	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 45)]	2	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 157, 'pregnancy'), ('UBERON_0012652', 'colorectum', 215, 'colorectal')]
S295-PMC4990268	PMC4990268	8/2016	S295-PMC4990268	['as with all supplementation STRATEGIES to prevent the COMPLICATIONS ASSOCIATED with Micronutrient deficiencies, the IMPACT of supplementation in the Antenatal Period will DEPEND ON the overall Vitamin A status of the population and the special demands that Pregnancy makes on Vitamin A reserves.']	[('FUTURE_WORK', 28), ('IMPORTANT_CONSIDERATION', 54), ('PROBLEM_COMPLICATION', 54), ('SUPERFICIAL_RELATIONSHIP', 68), ('SUPERFICIAL_RELATIONSHIP', 116), ('SUPERFICIAL_RELATIONSHIP', 171)]	6	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 84, 'micronutrient'), ('GO_0007567', 'parturition', 149, 'antenatal'), ('UBERON_0006721', 'alisphenoid bone', 149, 'antenatal period'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin A'), ('GO_0007565', 'female pregnancy', 257, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 276, 'vitamin A')]
S161-PMC4990280	PMC4990280	8/2016	S161-PMC4990280	['iron status IMPACTS Plasma and Liver levels of Vitamin A [42].']	[('SUPERFICIAL_RELATIONSHIP', 12)]	1	[('UBERON_0001969', 'blood plasma', 20, 'plasma'), ('UBERON_0002107', 'liver', 31, 'liver'), ('CHEBI_27300', 'vitamin D', 47, 'vitamin A')]
S37-PMC4992225	PMC4992225	8/2016	S37-PMC4992225	['Serum levels of 25-Hydroxyvitamin D REFLECTS the body’s Vitamin D reserves and this is a WELL-KNOWN INDICATOR for examining Vitamin D status [15].']	[('SUPERFICIAL_RELATIONSHIP', 36), ('PROBABLE_UNDERSTANDING', 89), ('SUPERFICIAL_RELATIONSHIP', 100)]	3	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 16, '25-hydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
S8-PMC4997421	PMC4997421	8/2016	S8-PMC4997421	['results: the poverty score and race were significantly ASSOCIATED with Vitamin A status after adjustment for confounders.']	[('SUPERFICIAL_RELATIONSHIP', 55)]	1	[('CHEBI_27300', 'vitamin D', 71, 'vitamin A')]
S13-PMC4997421	PMC4997421	8/2016	S13-PMC4997421	['introduction\nvitamin a is an ESSENTIAL Nutrient throughout the Lifecycle; HOWEVER, its INFLUENCE is PARTICULARLY CRITICAL during periods when cells Proliferate rapidly and differentiate, such as during Pregnancy.adequate Vitamin A status in the mother is CRITICAL for fetal growth, Morphogenesis, and maturation of multiple Organ Systems, including the Immune System, Lungs, and Eyes [1,2].']	[('IMPORTANT_CONSIDERATION', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 74), ('SUPERFICIAL_RELATIONSHIP', 87), ('IMPORTANT_CONSIDERATION', 100), ('IMPORTANT_CONSIDERATION', 113), ('IMPORTANT_CONSIDERATION', 255)]	6	[('CHEBI_33284', 'nutrient', 39, 'nutrient'), ('UBERON_0000104', 'life cycle', 63, 'lifecycle'), ('GO_0008283', 'cell proliferation', 148, 'proliferate'), ('GO_0007565', 'female pregnancy', 202, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 221, 'vitamin A'), ('GO_0009653', 'anatomical structure morphogenesis', 282, 'morphogenesis'), ('UBERON_0000467', 'anatomical system', 324, 'organ systems'), ('UBERON_0002405', 'immune system', 353, 'immune system'), ('UBERON_0002048', 'lung', 368, 'lungs'), ('UBERON_0000970', 'eye', 379, 'eyes')]
S18-PMC4997421	PMC4997421	8/2016	S18-PMC4997421	['the united states has BEEN assumed to be free of Vitamin A deficiency BASED ON a high gross domestic product [12] and Vitamin A status has ONLY rarely BEEN investigated in the us population, especially in women of Childbearing age.']	[('ANOMALY_CURIOUS_FINDING', 22), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 139), ('ANOMALY_CURIOUS_FINDING', 151)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin A'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 214, 'childbearing')]
S23-PMC4997421	PMC4997421	8/2016	S23-PMC4997421	['THEREFORE, the OBJECTIVE of THIS STUDY was to use nhanes data to EXAMINE the Retinol status of women of Childbearing age in the united states, and TO ASSESS the IMPACT of poverty and race, as well as OTHER INDICATORS that have NOT previously BEEN EXAMINED in this population, including Food security and use of supplemental nutrition assistance programs (snap), on Vitamin A status.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 28), ('QUESTION_ANSWERED_BY_THIS_WORK', 65), ('QUESTION_ANSWERED_BY_THIS_WORK', 147), ('SUPERFICIAL_RELATIONSHIP', 161), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 200), ('SUPERFICIAL_RELATIONSHIP', 206), ('FULL_UNKNOWN', 227)]	9	[('CHEBI_26536', 'retinoic acid', 77, 'retinol'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 104, 'childbearing'), ('CHEBI_33290', 'food', 286, 'food'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin A')]
S90-PMC4997421	PMC4997421	8/2016	S90-PMC4997421	['OUR STUDY SHOWS that lower poverty status and race increase the risk of suboptimal Vitamin A stores in women of Childbearing age in the united states.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 10)]	2	[('CHEBI_27300', 'vitamin D', 83, 'vitamin A'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 112, 'childbearing')]
S100-PMC4997421	PMC4997421	8/2016	S100-PMC4997421	['our results also SUPPORT the FINDING that there is not an even distribution of Vitamin A status across ethnic, racial, and socioeconomic strata.']	[('INCOMPLETE_EVIDENCE', 17), ('INCOMPLETE_EVIDENCE', 29)]	2	[('CHEBI_27300', 'vitamin D', 79, 'vitamin A')]
S123-PMC4997421	PMC4997421	8/2016	S123-PMC4997421	['we also INVESTIGATED the IMPACT of OTHER socioeconomic indicators on Vitamin A status that have not been WELL explored, including Food insecurity and Snap use.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 35), ('FUTURE_WORK', 105)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin A'), ('CHEBI_33290', 'food', 130, 'food'), ('PR_000015329', 'stannin', 150, 'SNAP')]
S135-PMC4997421	PMC4997421	8/2016	S135-PMC4997421	['Serum Retinol levels are also under tight Homeostatic Control and MAY not be reliable indicators of the Vitamin A status of an Individual [44].']	[('INCOMPLETE_EVIDENCE', 66)]	1	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_26536', 'retinoic acid', 6, 'retinol'), ('GO_0042592', 'homeostatic process', 42, 'homeostatic'), ('GO_0065007', 'biological regulation', 54, 'control'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin A'), ('NCBITaxon_1', 'root', 127, 'individual')]
S136-PMC4997421	PMC4997421	8/2016	S136-PMC4997421	['our use of the who Retinol classifications, HOWEVER, does provide us with INFORMATION about the Vitamin A status of this IMPORTANT population [44], women of Childbearing age.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 44), ('INCOMPLETE_EVIDENCE', 74), ('IMPORTANT_CONSIDERATION', 121)]	3	[('CHEBI_26536', 'retinoic acid', 19, 'retinol'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin A'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 157, 'childbearing')]
S6-PMC4997567	PMC4997567	8/2016	S6-PMC4997567	['the RISK FACTORS were low socioeconomic status, insufficient family income, poor housing conditions, lack of exposure to sunlight DUE TO cultural practices, sole Breast feeding, and inadequate supplementation of Vitamin D to the children and the Pregnant women.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('PROBLEM_COMPLICATION', 130)]	2	[('UBERON_0000310', 'breast', 162, 'breast'), ('CHEBI_27300', 'vitamin D', 212, 'vitamin D'), ('GO_0007565', 'female pregnancy', 246, 'pregnant')]
S11-PMC4997567	PMC4997567	8/2016	S11-PMC4997567	['the risk factors contributing to Vitamin D deficiency rickets in the egyptian children include the low socioeconomic status, the limited exposure to sunlight due TO housing conditions and cultural practices, and the exclusive or prolonged Breast-feeding without Vitamin D supplements.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 162)]	1	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('UBERON_0000310', 'breast', 239, 'breast'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin D')]
S15-PMC4997567	PMC4997567	8/2016	S15-PMC4997567	['the study was DESIGNED to compare affected versus unaffected children in egypt taking into CONSIDERATION the socioeconomic status, housing and nutritional history, clinical examination, laboratory biochemical serum calcium, phosphorus, alkaline phosphatase, and active Vitamin D 1,25(Oh)2D levels, and radiographic findings.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('IMPORTANT_CONSIDERATION', 91)]	2	"[('CHEBI_27300', 'vitamin D', 269, 'vitamin D'), ('CHEBI_66212', ""5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone"", 281, '25(OH)2D')]"
S101-PMC4997567	PMC4997567	8/2016	S101-PMC4997567	['the RISK FACTORS included low socioeconomic status, nutritionally Vitamin D deficient mothers, and prolonged Breast Feeding without Vitamin D supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 4)]	1	[('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('GO_0007567', 'parturition', 109, 'breast'), ('GO_0007631', 'feeding behavior', 116, 'feeding'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
S103-PMC4997567	PMC4997567	8/2016	S103-PMC4997567	['several RISK FACTORS had IMPORTANT CONTRIBUTIONS, including low socio-economic status represented by low family income, low standard of education, poor housing conditions, lack of exposure to sunlight, nutritional status of mother, and prolonged Breast-Feeding without Vitamin D supplementation.']	[('SUPERFICIAL_RELATIONSHIP', 8), ('IMPORTANT_CONSIDERATION', 25), ('SUPERFICIAL_RELATIONSHIP', 35)]	3	[('GO_0007567', 'parturition', 246, 'breast-'), ('UBERON_0000310', 'breast', 246, 'breast'), ('GO_0007631', 'feeding behavior', 253, 'feeding'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D')]
S18-PMC4998950	PMC4998950	4/2016	S18-PMC4998950	['we first calculated frequencies and means of case status and other characteristics ACCORDING to lifetime maternal Vitamin D deficiency, with pearson’s chi-square tests to compute the difference between proportions and t -tests to test the difference between means.']	[('SUPERFICIAL_RELATIONSHIP', 83)]	1	[('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
S37-PMC4998950	PMC4998950	4/2016	S37-PMC4998950	['second, maternal Vitamin D status was IDENTIFIED from secondary care records, and THEREFORE under-ascertained and PERHAPS DIFFERENTIALLY so with regard to asd RISK FACTORS.']	[('INCOMPLETE_EVIDENCE', 38), ('PROBABLE_UNDERSTANDING', 82), ('INCOMPLETE_EVIDENCE', 114), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122), ('SUPERFICIAL_RELATIONSHIP', 159)]	5	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D')]
S38-PMC4998950	PMC4998950	4/2016	S38-PMC4998950	['indeed, diagnosed maternal Vitamin D deficiency CO-OCCURRED with such FACTORS including parental psychiatric histories10(including depression, a PROXY also for in utero exposure to Antidepressants, shown to, RATHER than the underlying disorder, increase the risk of asd),11immigration status3and disadvantageous social position.8hence, residual CONFOUNDING CANNOT BE ruled out.']	[('SUPERFICIAL_RELATIONSHIP', 48), ('IMPORTANT_CONSIDERATION', 50), ('SUPERFICIAL_RELATIONSHIP', 51), ('SUPERFICIAL_RELATIONSHIP', 70), ('SUPERFICIAL_RELATIONSHIP', 145), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 208), ('PROBLEM_COMPLICATION', 345), ('DIFFICULT_TASK', 357)]	8	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_35475', 'non-steroidal anti-inflammatory drug', 181, 'antidepressants')]
S45-PMC4998950	PMC4998950	4/2016	S45-PMC4998950	['there are, HOWEVER, biological UNDERPINNINGS of a TRUE ASSOCIATION AS experimental studies INDICATE CRITICAL ROLES of Vitamin D in the Development and functioning Of the Brain.4\nIN SUMMARY, our results SUPPORT, BUT DO NOT PROVE, the HYPOTHESIS that maternal Vitamin D status is IMPLICATED in the aetiology of asd with comorbid intellectual disability.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('SUPERFICIAL_RELATIONSHIP', 31), ('PROBABLE_UNDERSTANDING', 50), ('SUPERFICIAL_RELATIONSHIP', 55), ('PROBABLE_UNDERSTANDING', 67), ('INCOMPLETE_EVIDENCE', 91), ('IMPORTANT_CONSIDERATION', 100), ('SUPERFICIAL_RELATIONSHIP', 109), ('INCOMPLETE_EVIDENCE', 178), ('INCOMPLETE_EVIDENCE', 202), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 211), ('FULL_UNKNOWN', 215), ('INCOMPLETE_EVIDENCE', 233), ('SUPERFICIAL_RELATIONSHIP', 278)]	14	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0050887', 'determination of sensory modality', 135, 'development ... of ... brain'), ('UBERON_0000955', 'brain', 170, 'brain'), ('CHEBI_27300', 'vitamin D', 258, 'vitamin D')]
S6-PMC5014971	PMC5014971	8/2016	S6-PMC5014971	['ONLY one in four (25.8%) routinely screen their Pregnant patients for Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('GO_0007565', 'female pregnancy', 48, 'pregnant'), ('CHEBI_27300', 'vitamin D', 70, 'vitamin D')]
S7-PMC5014971	PMC5014971	8/2016	S7-PMC5014971	['physicians who indicated that Vitamin D status was a PROBLEM in their patient population were more LIKELY to screen routinely (32.8% versus 9.7%, p = 0.002) and believe their patients would BENEFIT from supplementation (91.2% versus 16.1%, p = 0.001).']	[('IMPORTANT_CONSIDERATION', 53), ('PROBABLE_UNDERSTANDING', 99), ('IMPORTANT_CONSIDERATION', 190)]	3	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D')]
S16-PMC5014971	PMC5014971	8/2016	S16-PMC5014971	['POOR Vitamin D status is a RISK FACTOR for POOR Skeletal Development and fractures in newborns [3].']	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 27), ('IMPORTANT_CONSIDERATION', 43)]	3	[('CHEBI_27300', 'vitamin D', 5, 'vitamin D'), ('GO_0001501', 'skeletal system development', 48, 'skeletal development'), ('UBERON_0004288', 'skeleton', 48, 'skeletal')]
S18-PMC5014971	PMC5014971	8/2016	S18-PMC5014971	['fetal and neonatal Vitamin D status is largely DEPENDENT upon maternal status [11], and maternal Vitamin D deficiency/insufficiency is distressingly prevalent in the united states.']	[('SUPERFICIAL_RELATIONSHIP', 47)]	1	[('CHEBI_27300', 'vitamin D', 19, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
S19-PMC5014971	PMC5014971	8/2016	S19-PMC5014971	['as many as 30% of Pregnant women in the us MAY have INADEQUATE Vitamin D status [12].']	[('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 52)]	2	[('GO_0007565', 'female pregnancy', 18, 'pregnant'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
S20-PMC5014971	PMC5014971	8/2016	S20-PMC5014971	['in SOME populations, especially during the winter months in higher latitudes, the proportion of Pregnant women with INADEQUATE Vitamin D status MAY exceed 50% [13], DEPENDING ON whose definition of INADEQUATE is used.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 116), ('INCOMPLETE_EVIDENCE', 144), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 165), ('PROBLEM_COMPLICATION', 198)]	5	[('GO_0007565', 'female pregnancy', 96, 'pregnant'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
S21-PMC5014971	PMC5014971	8/2016	S21-PMC5014971	['there is SOME uncertainty over the extent of the us population that has INADEQUATE Vitamin D status DUE TO DISAGREEMENTS between experts as to WHAT constitutes INADEQUATE status.']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 72), ('PROBLEM_COMPLICATION', 100), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 107), ('EXPLICIT_QUESTION', 143), ('IMPORTANT_CONSIDERATION', 160)]	6	[('CHEBI_27300', 'vitamin D', 83, 'vitamin D')]
S22-PMC5014971	PMC5014971	8/2016	S22-PMC5014971	['the main storage form of Vitamin D in Blood is 25-Hydroxyvitamin D (25-Oh-D) which makes this vitamin d metabolite the BEST indicator of nutritional status [2].']	[('IMPORTANT_CONSIDERATION', 119)]	1	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0000178', 'blood', 38, 'blood'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 47, '25-hydroxyvitamin D'), ('CHEBI_46744', 'DDT-2,3-dihydrodiol', 68, '25-OH-D')]
S29-PMC5014971	PMC5014971	8/2016	S29-PMC5014971	['OBSERVATIONAL studies have CONSISTENTLY FOUND an ASSOCIATION with low maternal Vitamin D status and INCREASED risk of neonatal infectious disease and later inflammatory and atopic disease in offspring [21].']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 27), ('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 49), ('IMPORTANT_CONSIDERATION', 100)]	5	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
S32-PMC5014971	PMC5014971	8/2016	S32-PMC5014971	['screening for Vitamin D status is relatively easy and accurate [19], though there is a NONTRIVIAL cost.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 87)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D')]
S35-PMC5014971	PMC5014971	8/2016	S35-PMC5014971	['HOWEVER, CONSENSUS on WHAT constitutes adequate Vitamin D status during Pregnancy and the most efficacious means to prevent and treat Vitamin D deficiency/insufficiency in Pregnant women has yet to be reached, leading to DIFFERING assessments of this PUBLIC HEALTH ISSUE [14,19].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBABLE_UNDERSTANDING', 9), ('EXPLICIT_QUESTION', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 221), ('IMPORTANT_CONSIDERATION', 251), ('IMPORTANT_CONSIDERATION', 265)]	6	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('GO_0007565', 'female pregnancy', 72, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007565', 'female pregnancy', 172, 'pregnant')]
S37-PMC5014971	PMC5014971	8/2016	S37-PMC5014971	['the PURPOSE of THIS STUDY was TO ASSESS the practice, knowledge, and opinions of practicing obstetrician-gynecologists regarding screening for Vitamin D status and Vitamin D supplementation of their Pregnant patients.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 30)]	3	[('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('GO_0007565', 'female pregnancy', 199, 'pregnant')]
S77-PMC5014971	PMC5014971	8/2016	S77-PMC5014971	['patient factors that would increase the LIKELIHOOD that a physician would screen for Vitamin D status included evidence of malabsorption syndrome (82.2%), Gastric bypass surgery (79.2%), family history of osteoporosis (75.8%), and evidence of Alcohol abuse (56.4%).']	[('PROBABLE_UNDERSTANDING', 40)]	1	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('UBERON_0001844', 'cochlea', 155, 'gastric'), ('CHEBI_30879', 'alcohol', 243, 'alcohol')]
S94-PMC5014971	PMC5014971	8/2016	S94-PMC5014971	['discussion\nthe results of THIS STUDY SUGGEST that practicing obstetrician-gynecologists GENERALLY are SOMEWHAT CONCERNED about the Vitamin D status of their Pregnant patients and consider Vitamin D supplementation during Pregnancy to be SAFE.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('INCOMPLETE_EVIDENCE', 37), ('PROBABLE_UNDERSTANDING', 88), ('INCOMPLETE_EVIDENCE', 102), ('IMPORTANT_CONSIDERATION', 111), ('IMPORTANT_CONSIDERATION', 237)]	6	[('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('GO_0007565', 'female pregnancy', 157, 'pregnant'), ('CHEBI_27300', 'vitamin D', 188, 'vitamin D'), ('GO_0007565', 'female pregnancy', 221, 'pregnancy')]
S95-PMC5014971	PMC5014971	8/2016	S95-PMC5014971	"[""the greater the CONCERN is over their patients' Vitamin D status, the more LIKELY the physician is to RECOMMEND supplementation.""]"	[('PROBLEM_COMPLICATION', 16), ('PROBABLE_UNDERSTANDING', 75), ('FUTURE_WORK', 102)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
S97-PMC5014971	PMC5014971	8/2016	S97-PMC5014971	['the responding physicians were GENERALLY not supportive of screening all Pregnant women for Vitamin D status; EVEN among physicians that expressed a CONCERN regarding their patient population, less than half would screen most Pregnant patients.']	[('PROBABLE_UNDERSTANDING', 31), ('ANOMALY_CURIOUS_FINDING', 110), ('IMPORTANT_CONSIDERATION', 149), ('PROBLEM_COMPLICATION', 149)]	4	[('GO_0007565', 'female pregnancy', 73, 'pregnant'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 226, 'pregnant')]
S111-PMC5014971	PMC5014971	8/2016	S111-PMC5014971	['a RECENT STUDY on a mother-offspring cohort in singapore FOUND NO EVIDENCE for an effect of Vitamin D status on Birth outcome, THOUGH the authors CAUTION that the population had a low prevalence of Vitamin D deficiency/insufficiency and THUS they MAY NOT HAVE BEEN able to detect small EFFECTS [29].']	[('INCOMPLETE_EVIDENCE', 2), ('INCOMPLETE_EVIDENCE', 57), ('INCOMPLETE_EVIDENCE', 63), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 127), ('ANOMALY_CURIOUS_FINDING', 127), ('INCOMPLETE_EVIDENCE', 146), ('PROBABLE_UNDERSTANDING', 237), ('INCOMPLETE_EVIDENCE', 247), ('INCOMPLETE_EVIDENCE', 255), ('SUPERFICIAL_RELATIONSHIP', 286)]	10	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007567', 'parturition', 112, 'birth'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D')]
S123-PMC5014971	PMC5014971	8/2016	S123-PMC5014971	['the majority of respondents would consider screening for specific patient conditions (e.g., Gastric bypass surgery); a lesser proportion would consider screening BECAUSE of obesity or for african american women DESPITE both of these patient characteristics being KNOWN RISK FACTORS for INADEQUATE Vitamin D status.']	[('PROBLEM_COMPLICATION', 162), ('ANOMALY_CURIOUS_FINDING', 211), ('INCOMPLETE_EVIDENCE', 263), ('SUPERFICIAL_RELATIONSHIP', 269), ('IMPORTANT_CONSIDERATION', 286)]	5	[('UBERON_0001844', 'cochlea', 92, 'gastric'), ('CHEBI_27300', 'vitamin D', 297, 'vitamin D')]
S124-PMC5014971	PMC5014971	8/2016	S124-PMC5014971	['dark skin pigmentation, AS OPPOSED TO african heritage per se, is a RISK FACTOR for poor Vitamin D status, especially in higher latitudes where sun intensity decreases outside of the summer months.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 24), ('SUPERFICIAL_RELATIONSHIP', 68)]	2	[('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
S130-PMC5014971	PMC5014971	8/2016	S130-PMC5014971	['conclusions\nus obstetricians APPEAR cognizant of the IMPORTANCE of maternal Vitamin D status during Pregnancy.']	[('ANOMALY_CURIOUS_FINDING', 29), ('IMPORTANT_CONSIDERATION', 53)]	2	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('GO_0007565', 'female pregnancy', 100, 'pregnancy')]
S132-PMC5014971	PMC5014971	8/2016	S132-PMC5014971	['ALTHOUGH few screen most of their Pregnant patients for Vitamin D status, most would RECOMMEND Vitamin D supplementation EVEN without screening.']	[('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 85), ('ANOMALY_CURIOUS_FINDING', 121)]	3	[('GO_0007565', 'female pregnancy', 34, 'pregnant'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
S156-PMC5024513	PMC5024513	9/2016	S156-PMC5024513	['the pooled mean for Vitamin D status as reflected in Blood 25 (Oh)D in THIS REVIEW was significantly below recommended levels across all trimesters.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 71)]	1	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('UBERON_0000178', 'blood', 53, 'blood'), ('CHEBI_71657', 'versiconol acetate', 59, '25 (OH)D'), ('PR_000008838', 'serine protease HTRA1', 59, '25 (OH ... D')]
S157-PMC5024513	PMC5024513	9/2016	S157-PMC5024513	['it was NOT POSSIBLE to conduct analysis of Vitamin D status by ethnicity or exposure to sunlight, however, which are FACTORS KNOWN to have a significant IMPACT on Vitamin D status [51–53].']	[('DIFFICULT_TASK', 7), ('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 125), ('SUPERFICIAL_RELATIONSHIP', 153)]	4	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
S80-PMC5030591	PMC5030591	9/2016	S80-PMC5030591	"[""caption (table-wrap): table 4\n\nthemes and elements relating to specific Conception and Pregnancy information for women with rheumatoid arthritis and their familiessaying : information that should be discussed by health professionals doing : actions that SHOULD BE undertaken by health professionals review of current Medications in relation to safety during Conception and Pregnancy (100%) prior to Conception and Pregnancy, review current Medication(s) and discuss:\nmedications vary with respect to their SAFETY during Pregnancy and RISKS related to Fertility, Ovulation, Conception and Miscarriage\nSOME Medicines used in ra care MAY have EFFECTS on Fertility, Conception and Pregnancy process, for example, regular Nsaids MAY impair fertility and ASSOCIATED RISKS with fetus\nit is IMPORTANT to time Conceptionprovide GUIDANCE as to WHERE to obtain reliable information about SAFETY of Medicines in Pregnancywhere current Medication(s) is (are) contraindicated for Conception/Pregnancy the following SHOULD BE discussed with the patient:\nthere are SAFE Medication options pre, during (including Delivery) and Postpregnancy (including Breast feeding)\ntiming is IMPORTANT in RELATION to ceasing or switching of current Medications and allowing for washout periods prior to Conception\nthere is a need for close supervision/monitoring by a rheumatologist when discontinuing current Medications prior to Pregnancy, including CONSIDERING POTENTIAL NEED for disease stabilisation on new treatment prior to Conception and Pregnancydiscuss IMPACT of ra pathology on Pregnancy and Pregnancy on ra (100%) there are DIFFERENT SCENARIOS regarding ra disease activity during Pregnancy (eg, POSSIBLE remission/low disease activity)discuss: ra-related pain management options during Pregnancyconception MAY take longer compared with women who do not have rathere is a need to balance disease Control with maternal and fetal health and safetyra MAY AFFECT Pregnancy and Pregnancy MAY AFFECT ra, and there are POSSIBLE adverse outcomes where risks are identified (eg, Prematurity)there are significant risks ASSOCIATED with active or uncontrolled ra for the mother and baby, ESPECIALLY irreversible Joint damage and functional impairmentpregnancy MAY change a patient’s health outlook in the futurethe size of the baby MAY BE smaller than women without ra and MAY also be Delivered pre-term discuss IMPORTANT elements of Preconception care RELEVANT to patient (97.1%) it is IMPORTANT to achieve optimal disease control prior to considering Pregnancy—Planning Conception is preferable after patients achieve and maintain low disease activityencourage and facilitate early discussions with all health practitioners involved in care about family planning to allow for adequate preparationthere is a CRITICAL need for a planned Pregnancy RATHER than an unplanned Pregnancyreview Prenatal nutrition, including need for dietary/vitamin supplements (ie, Folic Acid, calcium, Vitamin D, Iodine, iron)history of previous Attempts To Conceive/Pregnancies or Pregnancy-related complications (eg, Miscarriage) and other relevant patient history (such as smoking/Illicit Drug use history, family history of hereditary issues) MAY AFFECT Pregnancyundertake RELEVANT health checks such as immunisation status (eg, rubella, varicella, pertussis), Sexually Transmitted disease screening, pap test, screening for other Autoimmune disorders that MAY IMPACT on Pregnancyweight management and appropriate exercise are very IMPORTANTCONSIDER the NEED for review of diabetes or impaired Glucose tolerance if RISK factors are present (eg, on Steroid medication or overweight/obese)it is IMPORTANT to manage comorbid conditions, such as diabetes and hypertensionsome women MAY NEED to avoid Conception during a flarera disease activity MAY or MAY not improve with Pregnancy and there is a LIKELIHOOD of Postpartum flares importance of maintaining optimistic outlook and providing positive messages (97.1%) Pregnancy and Breast feeding success rates are near normal in women with mild to moderate ra nowadays (where appropriate for the patient's clinical status)ra is not a BARRIER to Pregnancystrategies to address anxiety, stress and depression (if relevant) are IMPORTANT, such as mindfulness meditation need for close monitoring of a patient prior to and during Pregnancy, where indicated (94.1%) it is IMPORTANCE to have a healthcare team with expertise in Autoimmune disorders for SOME women with radetermine THE NEED for high-level obstetric care during a Pregnancy (where indicated), including the need for Anaesthetic inputsome women REQUIRE closer monitoring of their Pregnancy and this is USUALLY proportional to disease activity, comorbidities and maternal historyassess the REQUIREMENTS for any extra treatment or monitoring prior to, or during, Pregnancyit is IMPORTANT to develop a Pregnancy plan, which includes different options for management of ra and support for different scenariosvaginal Delivery MAY NOT always BE POSSIBLE, depending on condition of the patient's Hips.""]"	[('FUTURE_WORK', 254), ('IMPORTANT_CONSIDERATION', 506), ('IMPORTANT_CONSIDERATION', 534), ('INCOMPLETE_EVIDENCE', 600), ('INCOMPLETE_EVIDENCE', 631), ('SUPERFICIAL_RELATIONSHIP', 640), ('INCOMPLETE_EVIDENCE', 724), ('SUPERFICIAL_RELATIONSHIP', 749), ('IMPORTANT_CONSIDERATION', 760), ('IMPORTANT_CONSIDERATION', 783), ('FUTURE_WORK', 819), ('EXPLICIT_QUESTION', 834), ('IMPORTANT_CONSIDERATION', 877), ('FUTURE_WORK', 1001), ('IMPORTANT_CONSIDERATION', 1049), ('IMPORTANT_CONSIDERATION', 1161), ('SUPERFICIAL_RELATIONSHIP', 1174), ('FUTURE_WORK', 1421), ('IMPORTANT_CONSIDERATION', 1421), ('INCOMPLETE_EVIDENCE', 1433), ('SUPERFICIAL_RELATIONSHIP', 1532), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1605), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1615), ('INCOMPLETE_EVIDENCE', 1677), ('INCOMPLETE_EVIDENCE', 1788), ('INCOMPLETE_EVIDENCE', 1929), ('SUPERFICIAL_RELATIONSHIP', 1933), ('INCOMPLETE_EVIDENCE', 1964), ('SUPERFICIAL_RELATIONSHIP', 1968), ('INCOMPLETE_EVIDENCE', 1993), ('SUPERFICIAL_RELATIONSHIP', 2091), ('IMPORTANT_CONSIDERATION', 2158), ('INCOMPLETE_EVIDENCE', 2230), ('INCOMPLETE_EVIDENCE', 2302), ('INCOMPLETE_EVIDENCE', 2343), ('IMPORTANT_CONSIDERATION', 2382), ('SUPERFICIAL_RELATIONSHIP', 2423), ('IMPORTANT_CONSIDERATION', 2457), ('IMPORTANT_CONSIDERATION', 2779), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2817), ('INCOMPLETE_EVIDENCE', 3196), ('SUPERFICIAL_RELATIONSHIP', 3200), ('IMPORTANT_CONSIDERATION', 3226), ('INCOMPLETE_EVIDENCE', 3410), ('SUPERFICIAL_RELATIONSHIP', 3414), ('IMPORTANT_CONSIDERATION', 3485), ('INCOMPLETE_EVIDENCE', 3507), ('SUPERFICIAL_RELATIONSHIP', 3568), ('IMPORTANT_CONSIDERATION', 3646), ('INCOMPLETE_EVIDENCE', 3731), ('FUTURE_WORK', 3735), ('IMPORTANT_CONSIDERATION', 3735), ('INCOMPLETE_EVIDENCE', 3794), ('INCOMPLETE_EVIDENCE', 3801), ('PROBABLE_UNDERSTANDING', 3847), ('DIFFICULT_TASK', 4131), ('IMPORTANT_CONSIDERATION', 4222), ('IMPORTANT_CONSIDERATION', 4364), ('INCOMPLETE_EVIDENCE', 4444), ('INCOMPLETE_EVIDENCE', 4472), ('IMPORTANT_CONSIDERATION', 4600), ('INCOMPLETE_EVIDENCE', 4657), ('IMPORTANT_CONSIDERATION', 4744), ('IMPORTANT_CONSIDERATION', 4831), ('INCOMPLETE_EVIDENCE', 4976), ('DIFFICULT_TASK', 4980)]	66	[('GO_0007631', 'feeding behavior', 72, 'conception ...'), ('GO_0007565', 'female pregnancy', 87, 'pregnancy'), ('CHEBI_25441', 'mycothiols', 317, 'medications'), ('GO_0007620', 'copulation', 358, 'conception'), ('GO_0007565', 'female pregnancy', 373, 'pregnancy'), ('GO_0007620', 'copulation', 399, 'conception'), ('GO_0007565', 'female pregnancy', 414, 'pregnancy'), ('CHEBI_60211', 'compound Z', 440, 'medication'), ('GO_0007565', 'female pregnancy', 520, 'pregnancy'), ('GO_0009566', 'fertilization', 551, 'fertility'), ('GO_0030728', 'ovulation', 562, 'ovulation'), ('GO_0007620', 'copulation', 573, 'conception'), ('GO_0046660', 'female sex differentiation', 588, 'miscarriage'), ('CHEBI_25179', 'melanins', 605, 'medicines'), ('GO_0009566', 'fertilization', 651, 'fertility'), ('GO_0007620', 'copulation', 662, 'conception'), ('GO_0007565', 'female pregnancy', 677, 'pregnancy'), ('CHEBI_16039', 'ITP', 717, 'NSAIDs'), ('GO_0070268', 'cornification', 801, 'conceptionProvide'), ('CHEBI_25179', 'melanins', 887, 'medicines'), ('GO_0000712', 'resolution of meiotic recombination intermediates', 900, 'pregnancyWhere'), ('CHEBI_60211', 'compound Z', 923, 'medication'), ('GO_0007620', 'copulation', 966, 'conception'), ('GO_0007565', 'female pregnancy', 977, 'pregnancy'), ('CHEBI_60211', 'compound Z', 1054, 'medication'), ('GO_0007567', 'parturition', 1096, 'delivery'), ('GO_0007565', 'female pregnancy', 1110, 'postpregnancy'), ('UBERON_0000310', 'breast', 1135, 'breast'), ('CHEBI_25441', 'mycothiols', 1218, 'medications'), ('GO_0007620', 'copulation', 1272, 'conception'), ('CHEBI_25441', 'mycothiols', 1379, 'medications'), ('GO_0007565', 'female pregnancy', 1400, 'pregnancy'), ('GO_0007620', 'copulation', 1500, 'conception'), ('GO_0006915', 'apoptotic process', 1515, 'pregnancyDiscuss'), ('GO_0007565', 'female pregnancy', 1558, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1572, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1662, 'pregnancy'), ('GO_0007602', 'phototransduction', 1768, 'pregnancyConception'), ('GO_0065007', 'biological regulation', 1877, 'control'), ('GO_0007565', 'female pregnancy', 1940, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1954, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2051, 'prematurity'), ('UBERON_0004905', 'articulation', 2182, 'joint'), ('GO_0007567', 'parturition', 2355, 'delivered'), ('GO_0007565', 'female pregnancy', 2404, 'preconception'), ('GO_0007565', 'female pregnancy', 2523, 'pregnancy'), ('GO_0006260', 'DNA replication', 2533, 'planning'), ('GO_0007620', 'copulation', 2542, 'conception'), ('GO_0007565', 'female pregnancy', 2807, 'pregnancy'), ('GO_0006412', 'translation', 2842, 'pregnancyReview'), ('GO_0007565', 'female pregnancy', 2858, 'prenatal'), ('CHEBI_30751', 'formic acid', 2930, 'folic acid'), ('CHEBI_27300', 'vitamin D', 2951, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 2962, 'iodine'), ('GO_0000380', 'alternative mRNA splicing, via spliceosome', 2995, 'attempts to conceive'), ('GO_0007565', 'female pregnancy', 3016, 'pregnancies'), ('GO_0007565', 'female pregnancy', 3031, 'pregnancy'), ('GO_0046660', 'female sex differentiation', 3068, 'miscarriage'), ('CHEBI_35704', 'N(2)-acetyl-L-lysine', 3133, 'illicit drug'), ('GO_0051610', 'serotonin uptake', 3207, 'pregnancyUndertake'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 3314, 'sexually transmitted'), ('UBERON_0001442', 'skeleton of manus', 3384, 'autoimmune'), ('GO_0006412', 'translation', 3424, 'pregnancyWeight'), ('CHEBI_17234', 'glucose', 3547, 'glucose'), ('CHEBI_35341', 'steroid', 3601, 'steroid'), ('GO_0007620', 'copulation', 3749, 'conception'), ('GO_0007565', 'female pregnancy', 3822, 'pregnancy'), ('GO_0007565', 'female pregnancy', 3861, 'postpartum'), ('GO_0007565', 'female pregnancy', 3964, 'Pregnancy'), ('UBERON_0000310', 'breast', 3978, 'breast'), ('GO_0006915', 'apoptotic process', 4142, 'pregnancyStrategies'), ('GO_0007565', 'female pregnancy', 4323, 'pregnancy'), ('UBERON_0001442', 'skeleton of manus', 4419, 'autoimmune'), ('GO_0007565', 'female pregnancy', 4520, 'pregnancy'), ('CHEBI_38867', 'anaesthetic', 4572, 'anaesthetic'), ('GO_0007565', 'female pregnancy', 4635, 'pregnancy'), ('GO_0007565', 'female pregnancy', 4816, 'pregnancyIt'), ('GO_0007565', 'female pregnancy', 4854, 'pregnancy'), ('GO_0007567', 'parturition', 4967, 'delivery'), ('UBERON_0000988', 'pons', 5044, 'hips')]
S1-PMC5039809	PMC5039809	10/2016	S1-PMC5039809	['TO OUR KNOWLEDGE, the ASSOCIATIONS between maternal Vitamin A status and offspring Bone Development have NOT previously BEEN ELUCIDATED.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 22), ('FULL_UNKNOWN', 105)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin A'), ('GO_0048539', 'bone marrow development', 83, 'bone development')]
S103-PMC5039809	PMC5039809	10/2016	S103-PMC5039809	['in the final analyses, maternal Vitamin D status in late Pregnancy was included in the MODELS.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 87)]	1	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 57, 'pregnancy')]
S104-PMC5039809	PMC5039809	10/2016	S104-PMC5039809	['adjusting for Vitamin D status made little difference; the pattern of ASSOCIATIONS OBSERVED between Serum Retinol and Β-Carotene concentrations and neonatal bone indexes REMAINED the same (data not shown).']	[('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 83), ('INCOMPLETE_EVIDENCE', 170)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0001977', 'blood serum', 100, 'serum'), ('CHEBI_26536', 'retinoic acid', 106, 'retinol'), ('CHEBI_28064', 'cyanidin 3-O-rutinoside', 118, 'β-carotene')]
S112-PMC5039809	PMC5039809	10/2016	S112-PMC5039809	['there are FEW STUDIES to OUR KNOWLEDGE that have RELATED maternal Vitamin A status to offspring Bone Development.']	[('INCOMPLETE_EVIDENCE', 10), ('PROBABLE_UNDERSTANDING', 25), ('SUPERFICIAL_RELATIONSHIP', 49)]	3	[('CHEBI_27300', 'vitamin D', 66, 'vitamin A'), ('GO_0048539', 'bone marrow development', 96, 'bone development')]
S0-PMC5042197	PMC5042197	9/2016	S0-PMC5042197	['prevalence and RISK FACTORS for low Vitamin D status among breastfeeding mother–infant dyads in an environment with abundant sunshine\n\nabstract\n\npurpose\nevaluation of Vitamin D (vd) status and RISK FACTORS for low vd among breastfeeding mother–infant dyads in a population at high RISK for vd deficiency.']	[('SUPERFICIAL_RELATIONSHIP', 15), ('SUPERFICIAL_RELATIONSHIP', 193), ('IMPORTANT_CONSIDERATION', 281)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D')]
S17-PMC5045784	PMC5045784	10/2016	S17-PMC5045784	['in addition, Animal studies SUPPORT the HYPOTHESIS that Vitamin D status MIGHT AFFECT the RISK of bpd GIVEN that both Vitamin D and the Vitamin D receptor (vdr) have IMPORTANT ROLES in Perinatal Lung Development.7,8thus, we SPECULATED that Vitamin D deficiency MIGHT predispose to and/or have a ROLE in the pathogenesis of bpd.']	[('INCOMPLETE_EVIDENCE', 28), ('INCOMPLETE_EVIDENCE', 40), ('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 79), ('IMPORTANT_CONSIDERATION', 90), ('PROBABLE_UNDERSTANDING', 102), ('IMPORTANT_CONSIDERATION', 166), ('SUPERFICIAL_RELATIONSHIP', 176), ('INCOMPLETE_EVIDENCE', 224), ('INCOMPLETE_EVIDENCE', 261), ('SUPERFICIAL_RELATIONSHIP', 295)]	11	[('NCBITaxon_33208', 'Metazoa', 13, 'animal'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('GO_0036268', 'swimming', 185, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 185, 'perinatal'), ('GO_0030324', 'lung development', 195, 'lung development'), ('UBERON_0002048', 'lung', 195, 'lung'), ('CHEBI_27300', 'vitamin D', 240, 'vitamin D')]
S58-PMC5045784	PMC5045784	10/2016	S58-PMC5045784	"[""our study is IN AGREEMENT with a study by onwuneme et al.16in which, in a cohort of 94 preterm infants (<32 weeks' Gestation), there was no association with bpd or other morbidities of Prematurity although the authors FOUND an ASSOCIATION between Vitamin D status and acute Respiratory morbidity (AS defined by differences in duration of positive pressure ventilation and highest oxygen concentration required in the delivery room and the odds of requiring assisted ventilation).""]"	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 218), ('SUPERFICIAL_RELATIONSHIP', 227), ('PROBABLE_UNDERSTANDING', 297)]	4	[('GO_0007565', 'female pregnancy', 115, 'gestation'), ('GO_0007565', 'female pregnancy', 185, 'prematurity'), ('CHEBI_27300', 'vitamin D', 247, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 274, 'respiratory')]
S59-PMC5045784	PMC5045784	10/2016	S59-PMC5045784	['SIMILARLY, a RECENT interventional TRIAL of three dosing regimens for Vitamin D supplementation in extremely preterm infants FOUND no association between Vitamin D status and Respiratory outcomes.17\nthe IMPORTANCE of Vitamin D status in pediatric Respiratory health is SUPPORTED by large epidemiologic studies of term infants SHOWING an ASSOCIATION between suboptimal Vitamin D status and wheezing.4,18in addition, Animal studies demonstrate an IMPORTANT biologic ROLE for Vitamin D in Lung Development and Maturation, including Differentiation Of Type Ii Pneumocytes, Surfactant Phospholipid synthesis and secretion,19as well as an immunomodulatory ROLE in Epithelial Cells, Neutrophils and Macrophages.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 125), ('IMPORTANT_CONSIDERATION', 203), ('INCOMPLETE_EVIDENCE', 269), ('INCOMPLETE_EVIDENCE', 326), ('SUPERFICIAL_RELATIONSHIP', 337), ('IMPORTANT_CONSIDERATION', 445), ('SUPERFICIAL_RELATIONSHIP', 464), ('SUPERFICIAL_RELATIONSHIP', 650)]	10	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 175, 'respiratory'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 247, 'respiratory'), ('CHEBI_27300', 'vitamin D', 368, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 415, 'animal'), ('CHEBI_27300', 'vitamin D', 473, 'vitamin D'), ('GO_0035180', 'larval wandering behavior', 486, 'lung development ... maturation'), ('UBERON_0002048', 'lung', 486, 'lung'), ('GO_0007620', 'copulation', 529, 'differentiation of ...'), ('CL_0002063', 'type II pneumocyte', 548, 'type II pneumocytes'), ('CHEBI_53015', 'N(6)-carboxymethyl-L-lysine residue', 569, 'surfactant phospholipid'), ('CL_0000066', 'epithelial cell', 658, 'epithelial cells'), ('UBERON_0000483', 'epithelium', 658, 'epithelial'), ('CL_0000775', 'neutrophil', 676, 'neutrophils'), ('CL_0000235', 'macrophage', 692, 'macrophages')]
S60-PMC5045784	PMC5045784	10/2016	S60-PMC5045784	['finally, interventional Animal and Human studies provide STRONG EVIDENCE for a beneficial ROLE of Vitamin D supplementation in Pulmonary outcomes.7,20\nthe ROLE of Vitamin D status in the development of bpd REMAINS incompletely understood.']	[('INCOMPLETE_EVIDENCE', 57), ('PROBABLE_UNDERSTANDING', 57), ('SUPERFICIAL_RELATIONSHIP', 90), ('SUPERFICIAL_RELATIONSHIP', 155), ('INCOMPLETE_EVIDENCE', 206)]	5	[('NCBITaxon_33208', 'Metazoa', 24, 'animal'), ('NCBITaxon_9606', 'Homo sapiens', 35, 'human'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('UBERON_0002048', 'lung', 127, 'pulmonary'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
S66-PMC5045784	PMC5045784	10/2016	S66-PMC5045784	['given that Vitamin D has IMPORTANT ROLES in early Lung Development and Innate Immunity, the LACK OF ASSOCIATION between Vitamin D status and development of bpd SUPPORTS the multifactorial etiology of and POSSIBLE Genetic predisposition to bpd.']	[('IMPORTANT_CONSIDERATION', 25), ('SUPERFICIAL_RELATIONSHIP', 35), ('INCOMPLETE_EVIDENCE', 92), ('SUPERFICIAL_RELATIONSHIP', 100), ('INCOMPLETE_EVIDENCE', 160), ('INCOMPLETE_EVIDENCE', 204)]	6	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0030324', 'lung development', 50, 'lung development'), ('UBERON_0002048', 'lung', 50, 'lung'), ('GO_0045087', 'innate immune response', 71, 'innate immunity'), ('CHEBI_27300', 'vitamin D', 120, 'vitamin D'), ('SO_0000704', 'gene', 213, 'genetic')]
S77-PMC5045784	PMC5045784	10/2016	S77-PMC5045784	[', wagner et al.30,31and others have DEMONSTRATED that Vitamin D status at Birth is modifiable through maternal supplementation during Pregnancy.']	[('INCOMPLETE_EVIDENCE', 36)]	1	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007567', 'parturition', 74, 'birth'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy')]
S79-PMC5045784	PMC5045784	10/2016	S79-PMC5045784	['HOWEVER, these studies DID NOT address the ROLE of Vitamin D status in bpd, wheezing and asthma among preterm infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 43)]	3	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D')]
S91-PMC5045784	PMC5045784	10/2016	S91-PMC5045784	['in CONCLUSION, we FOUND that low 25(Oh)D levels (<30\u2009ng\u2009ml−1) are frequent and MODIFIABLE among preterm infants at Birth, HOWEVER, in our study samples we did not detect any association between Vitamin D status and Pulmonary or other morbidities of prematurity.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 122)]	4	[('CHEBI_71657', 'versiconol acetate', 33, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 39, 'D'), ('GO_0007567', 'parturition', 115, 'birth'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('UBERON_0002048', 'lung', 215, 'pulmonary')]
S15-PMC5051327	PMC5051327	9/2016	S15-PMC5051327	['ONLY one Blood sample drawn from each mother gives us a snapshot of the Vitamin D status in early Pregnancy.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('UBERON_0000178', 'blood', 9, 'blood'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007565', 'female pregnancy', 98, 'pregnancy')]
S20-PMC5051327	PMC5051327	9/2016	S20-PMC5051327	['the primary AIM of this PILOT STUDY was TO INVESTIGATE 25-Oh Vitamin D, the main MARKER of Vitamin D status, in women who underwent caesarean section DUE to suspected fetal distress COMPARED TO those who did not.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 40), ('SUPERFICIAL_RELATIONSHIP', 81), ('IMPORTANT_CONSIDERATION', 150), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182)]	6	[('CHEBI_86198', '1,2-di-[(11Z)-eicosenoyl]-sn-glycero-3-phosphocholine', 55, '25-OH'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
S72-PMC5051327	PMC5051327	9/2016	S72-PMC5051327	['the fact that there was ONLY one Blood sample drawn from each mother just gives us a snapshot of the Vitamin D status in early Pregnancy.']	[('INCOMPLETE_EVIDENCE', 24)]	1	[('UBERON_0000178', 'blood', 33, 'blood'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 127, 'pregnancy')]
S13-PMC5062906	PMC5062906	10/2016	S13-PMC5062906	['conclusions\nTHESE FINDINGS DEMONSTRATE that maternal Vitamin D status plays a ROLE in determining Dna Methylation state in the germline and Soma.']	[('INCOMPLETE_EVIDENCE', 12), ('QUESTION_ANSWERED_BY_THIS_WORK', 27), ('SUPERFICIAL_RELATIONSHIP', 78)]	3	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0006306', 'DNA methylation', 98, 'DNA methylation'), ('GO_0044297', 'cell body', 140, 'soma')]
S68-PMC5062906	PMC5062906	10/2016	S68-PMC5062906	['the INFLUENCE of grandmaternal Vitamin D status on phenotypic and epigenetic outcomes DEMONSTRATES inheritance of perturbed epigenetic landscapes.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 86)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D')]
S163-PMC5064894	PMC5064894	10/2016	S163-PMC5064894	['THIS will TEST the core mechanistic HYPOTHESIS that IMPROVEMENTS in Vitamin D status via maternal Vitamin D supplementation reduce the RISK of ari among infants in dhaka.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('INCOMPLETE_EVIDENCE', 36), ('FUTURE_WORK', 52), ('IMPORTANT_CONSIDERATION', 135)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
S129-PMC5084016	PMC5084016	10/2016	S129-PMC5084016	['the season of Birth, ethnicity, and maternal prophylaxis during Pregnancy AFFECT the Vitamin D status of infants.']	[('SUPERFICIAL_RELATIONSHIP', 74)]	1	[('GO_0007567', 'parturition', 14, 'birth'), ('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D')]
S0-PMC5084041	PMC5084041	10/2016	S0-PMC5084041	['Vitamin D status during Pregnancy in a multi-ethnic population-representative swedish cohort\n\nabstract\nthere is currently LITTLE INFORMATION on changes in Vitamin D status during Pregnancy and its PREDICTORS.']	[('INCOMPLETE_EVIDENCE', 122), ('SUPERFICIAL_RELATIONSHIP', 197)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 24, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('GO_0007565', 'female pregnancy', 179, 'pregnancy')]
S1-PMC5084041	PMC5084041	10/2016	S1-PMC5084041	['the AIM was TO STUDY the DETERMINANTS of change in Vitamin D status during Pregnancy and of Vitamin D deficiency (<30 nmol/l) in early Pregnancy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 12), ('SUPERFICIAL_RELATIONSHIP', 25)]	3	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 135, 'pregnancy')]
S12-PMC5084041	PMC5084041	10/2016	S12-PMC5084041	['among them, the DETERMINANTS of both Vitamin D deficiency and change in season-corrected Vitamin D status were fewer, INDICATING a smaller EFFECT of sun exposure.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 139)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 89, 'vitamin D')]
S17-PMC5084041	PMC5084041	10/2016	S17-PMC5084041	['POOR maternal Vitamin D status during Pregnancy is ASSOCIATED with lower bone Mineral density and muscle strength in the infant [2].']	[('IMPORTANT_CONSIDERATION', 0), ('SUPERFICIAL_RELATIONSHIP', 51)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 38, 'pregnancy'), ('CHEBI_46662', 'mineral', 78, 'mineral')]
S18-PMC5084041	PMC5084041	10/2016	S18-PMC5084041	['POOR maternal Vitamin D status HAS also BEEN ASSOCIATED with Pregnancy COMPLICATIONS such as Preeclampsia [3], premature Birth [4] and infants Born small for Gestational age [5].']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 45), ('PROBLEM_COMPLICATION', 71)]	4	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 93, 'preeclampsia'), ('GO_0007567', 'parturition', 121, 'birth'), ('GO_0007567', 'parturition', 143, 'born'), ('GO_0007565', 'female pregnancy', 158, 'gestational')]
S22-PMC5084041	PMC5084041	10/2016	S22-PMC5084041	['SINCE data on Gestational Vitamin D status in populations living at latitudes without seasonality in cutaneous Vitamin D Synthesis are SCARCE, a season-corrected analysis is a way of investigating changes in 25(Oh)D during Pregnancy per se.']	[('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 135)]	2	[('GO_0007565', 'female pregnancy', 14, 'gestational'), ('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 111, 'vitamin D synthesis'), ('CHEBI_71657', 'versiconol acetate', 208, '25(OH)D'), ('GO_0007565', 'female pregnancy', 223, 'pregnancy')]
S23-PMC5084041	PMC5084041	10/2016	S23-PMC5084041	['such analyses of 25(Oh)D concentrations during Pregnancy SHOW that Vitamin D status between early and late Pregnancy tracks moderately and that change DEPENDS ON supplement use, Gestational weight gain and physical activity [12].']	[('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 151)]	2	[('CHEBI_71657', 'versiconol acetate', 17, '25(OH)D'), ('GO_0007565', 'female pregnancy', 47, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007565', 'female pregnancy', 107, 'pregnancy'), ('GO_0007565', 'female pregnancy', 178, 'gestational')]
S31-PMC5084041	PMC5084041	10/2016	S31-PMC5084041	['population-representative data on Vitamin D status during Pregnancy IS NEEDED to evaluate the POTENTIAL NEED for new PUBLIC-HEALTH policies and to provide reliable data on potential RISK groups for Vitamin D deficiency.']	[('FUTURE_WORK', 68), ('INCOMPLETE_EVIDENCE', 94), ('FUTURE_WORK', 104), ('IMPORTANT_CONSIDERATION', 117), ('IMPORTANT_CONSIDERATION', 124), ('SUPERFICIAL_RELATIONSHIP', 182)]	6	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin D')]
S32-PMC5084041	PMC5084041	10/2016	S32-PMC5084041	['FEW STUDIES have investigated Vitamin D status longitudinally in a large cohort of Pregnant women, and knowledge of change in Vitamin D status during Pregnancy and its DETERMINANTS are LACKING.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 168), ('FULL_UNKNOWN', 185)]	3	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 83, 'pregnant'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('GO_0007565', 'female pregnancy', 150, 'pregnancy')]
S37-PMC5084041	PMC5084041	10/2016	S37-PMC5084041	['materials and methods\nthe gravid study was DESIGNED TO INVESTIGATE the ASSOCIATION of Vitamin D status during Pregnancy with Preeclampsia and Pregnancy-induced hypertension.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('QUESTION_ANSWERED_BY_THIS_WORK', 52), ('SUPERFICIAL_RELATIONSHIP', 71)]	3	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('GO_0007565', 'female pregnancy', 110, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 125, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 142, 'pregnancy')]
S107-PMC5084041	PMC5084041	10/2016	S107-PMC5084041	['Gestational weight gain, bmi and age were not significantly associated with change in 25(Oh)D. in the subgroup of women Born in africa and asia, only Vitamin D supplementation at t3 was a DETERMINANT of season-corrected change in Vitamin D status during Pregnancy (adjusted r2= 0.115) (table 3).']	[('SUPERFICIAL_RELATIONSHIP', 188)]	1	[('GO_0007565', 'female pregnancy', 0, 'Gestational'), ('CHEBI_71657', 'versiconol acetate', 86, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 86, '25(OH)D'), ('GO_0007567', 'parturition', 120, 'born'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('GO_0007565', 'female pregnancy', 254, 'pregnancy')]
S118-PMC5084041	PMC5084041	10/2016	S118-PMC5084041	['FEW STUDIES have PREVIOUSLY investigated changes in Vitamin D status during Pregnancy and results were CONFLICTING.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103)]	3	[('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy')]
S136-PMC5084041	PMC5084041	10/2016	S136-PMC5084041	['we FOUND that DETERMINANTS of change in season-corrected Vitamin D status were RELATED to sun exposure (sun-Seeking behaviour, clothing style, and travel <35° n), Vitamin D intake (dietary and supplementary) and origin.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 14), ('SUPERFICIAL_RELATIONSHIP', 79)]	3	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0007568', 'aging', 107, '-seeking'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D')]
S143-PMC5084041	PMC5084041	10/2016	S143-PMC5084041	['a LIMITATION of THIS STUDY is that sampling was overrepresented during autumn and spring, when Vitamin D status is highest and lowest, respectively.']	[('INCOMPLETE_EVIDENCE', 2), ('QUESTION_ANSWERED_BY_THIS_WORK', 16)]	2	[('CHEBI_27300', 'vitamin D', 95, 'vitamin D')]
S145-PMC5084041	PMC5084041	10/2016	S145-PMC5084041	['HOWEVER, this was, IN PART, overcome by the season-correction of change in Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 19)]	2	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
S156-PMC5084041	PMC5084041	10/2016	S156-PMC5084041	['among women Born in africa and asia, the DETERMINANTS of both Vitamin D deficiency and change in season-corrected Vitamin D status were fewer, INDICATING a smaller EFFECT of sun exposure.']	[('SUPERFICIAL_RELATIONSHIP', 41), ('INCOMPLETE_EVIDENCE', 143), ('SUPERFICIAL_RELATIONSHIP', 164)]	3	[('GO_0007567', 'parturition', 12, 'born'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
S68-PMC5085625	PMC5085625	9/2016	S68-PMC5085625	['taking into account INCONCLUSIVE results of cross-sectional and cohort studies analyzing the ASSOCIATION between Vitamin D status and occurrence of Pregnancy pathologies [28,29], the AIM of OUR STUDY was to asses 25(Oh)D status in women with Gestational hypertension (gh).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 20), ('SUPERFICIAL_RELATIONSHIP', 93), ('QUESTION_ANSWERED_BY_THIS_WORK', 183), ('QUESTION_ANSWERED_BY_THIS_WORK', 190)]	4	[('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 213, '25(OH)D'), ('GO_0007565', 'female pregnancy', 242, 'gestational')]
S71-PMC5085625	PMC5085625	9/2016	S71-PMC5085625	['[13] who DEMONSTRATED that Vitamin D status CORRELATES significantly with Blood pressure during the first trimester and Gestational systolic Blood pressure trajectory, BUT NOT with the prevalence of gh.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 44), ('ANOMALY_CURIOUS_FINDING', 168)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('UBERON_0000178', 'blood', 74, 'blood'), ('GO_0007565', 'female pregnancy', 120, 'gestational'), ('UBERON_0000178', 'blood', 141, 'blood')]
S72-PMC5085625	PMC5085625	9/2016	S72-PMC5085625	['the RELATIONSHIP between Vitamin D status and gh HAS also BEEN a subject of OTHER STUDIES.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 49), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76), ('INCOMPLETE_EVIDENCE', 76)]	4	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D')]
S74-PMC5085625	PMC5085625	9/2016	S74-PMC5085625	['ANALYZED ASSOCIATIONS between Vitamin D status, Blood pressure at the onset of Pregnancy and occurrence of a mid-Pregnancy decrease in the latter parameters.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 9)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('UBERON_0000178', 'blood', 48, 'blood'), ('GO_0007565', 'female pregnancy', 79, 'pregnancy'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy')]
S75-PMC5085625	PMC5085625	9/2016	S75-PMC5085625	['moreover, the authors searched for a POTENTIAL mechanism EXPLAINING the ASSOCIATION between Vitamin D status and Pregnancy-related hypertensive disorders.']	[('INCOMPLETE_EVIDENCE', 37), ('PROBABLE_UNDERSTANDING', 57), ('SUPERFICIAL_RELATIONSHIP', 72)]	3	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0007565', 'female pregnancy', 113, 'pregnancy')]
S76-PMC5085625	PMC5085625	9/2016	S76-PMC5085625	['SIMILAR TO OUR STUDY, they FOUND no association between Vitamin D status, prevalence of gh, Blood pressure at early Gestation and mid-Pregnancy decrease in this parameter [30].']	[('INCOMPLETE_EVIDENCE', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 27)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('UBERON_0000178', 'blood', 92, 'blood'), ('GO_0007565', 'female pregnancy', 116, 'gestation'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy')]
S90-PMC5085625	PMC5085625	9/2016	S90-PMC5085625	['ACCORDING to barebring et al., AT LEAST a 30 nmol/l increase in Serum 25(Oh)D concentration is ASSOCIATED with lower odds of pe, REGARDLESS OF Vitamin D status in early Pregnancy [13].']	[('SUPERFICIAL_RELATIONSHIP', 0), ('PROBABLE_UNDERSTANDING', 31), ('SUPERFICIAL_RELATIONSHIP', 95), ('INCOMPLETE_EVIDENCE', 129)]	4	[('UBERON_0001977', 'blood serum', 64, 'serum'), ('CHEBI_71657', 'versiconol acetate', 70, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 70, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D'), ('GO_0007565', 'female pregnancy', 169, 'pregnancy')]
S92-PMC5085625	PMC5085625	9/2016	S92-PMC5085625	['in OUR STUDY, we determined Vitamin D status at a single time point, shortly before Delivery.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3)]	1	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007567', 'parturition', 84, 'delivery')]
S83-PMC5095257	PMC5095257	11/2016	S83-PMC5095257	['TO EXPLORE the POSSIBLE EFFECT of uvb radiation exposure, which IS KNOWN to INFLUENCE Vitamin D status, on the seasonality pattern OBSERVED in aad, we compared monthly ors (supplemental figure 1) dividing the cohort into 2 groups according to geographical latitude.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 24), ('INCOMPLETE_EVIDENCE', 64), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 131)]	6	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
S85-PMC5095257	PMC5095257	11/2016	S85-PMC5095257	['FURTHER STUDIES ARE REQUIRED to investigate the ASSOCIATION of Perinatal Vitamin D status and the RISK for aad.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 8), ('IMPORTANT_CONSIDERATION', 20), ('SUPERFICIAL_RELATIONSHIP', 48), ('IMPORTANT_CONSIDERATION', 98)]	5	[('GO_0036268', 'swimming', 63, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 63, 'perinatal'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
S86-PMC5095257	PMC5095257	11/2016	S86-PMC5095257	['verifying Vitamin D deficiency and aad risk by ascertaining 25 (Oh)D status in infancy, HOWEVER, will be difficult given the RARITY of the condition and the fact that diagnosis is USUALLY made in Individuals in their third to fifth decade.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 88), ('DIFFICULT_TASK', 125), ('INCOMPLETE_EVIDENCE', 180)]	3	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 60, '25 (OH)D'), ('NCBITaxon_1', 'root', 196, 'individuals')]
S23-PMC5118763	PMC5118763	12/2016	S23-PMC5118763	['in THIS ARTICLE, our AIMS were to compare the effectiveness of different Prenatal Food and Micronutrient regimens as well as the efficacy per Micronutrient capsule in women’s Vitamin B-12, Folate, ferritin, and zinc status.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 21)]	2	[('GO_0007565', 'female pregnancy', 73, 'prenatal'), ('CHEBI_33290', 'food', 82, 'food'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 91, 'micronutrient'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 142, 'micronutrient'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 175, 'vitamin B-12'), ('CHEBI_30863', '5-azaorotic acid', 189, 'folate')]
S170-PMC5118763	PMC5118763	12/2016	S170-PMC5118763	['there is SOME EVIDENCE that high maternal Folate status in combination with low Vitamin B-12 status MAY increase the risk of obesity and Insulin resistance in the offspring (21).']	[('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 100)]	2	[('CHEBI_30863', '5-azaorotic acid', 42, 'folate'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 80, 'vitamin B-12'), ('PR_000045358', 'insulin family protein', 137, 'insulin')]
S173-PMC5118763	PMC5118763	12/2016	S173-PMC5118763	['FURTHER FOLLOW-up of this cohort will be helpful to evaluate the EFFECT of high Folate and low Vitamin B-12 status of mothers on their offspring.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 65)]	2	[('CHEBI_30863', '5-azaorotic acid', 80, 'folate'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin B'), ('PR_000017269', 'ventral anterior homeobox 2', 95, 'vitamin B-12')]
S7-PMC5129897	PMC5129897	10/2016	S7-PMC5129897	['NEVERTHELESS, national policy changes are JUSTIFIED to improve Vitamin D status of canadians through promotion of SAFE sun exposure messages, Vitamin D supplement use, and/or facilitation of Food fortification.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('IMPORTANT_CONSIDERATION', 42), ('IMPORTANT_CONSIDERATION', 42), ('IMPORTANT_CONSIDERATION', 114)]	4	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('CHEBI_33290', 'food', 191, 'food')]
S117-PMC5129897	PMC5129897	10/2016	S117-PMC5129897	"[""the annual economic BURDEN of crohn's disease in canada is $1.7\xa0billion, WHEREAS that of ulcerative colitis is $1.2\xa0billion.78several papers HAVE REPORTED inverse CORRELATIONS between Vitamin D status and incidence, prevalence, and/or severity of Inflammatory Bowel disease.79,80\nEVIDENCE is mounting that higher 25(Oh)D concentrations are ASSOCIATED with BETTER Pregnancy and Birth outcomes.""]"	[('IMPORTANT_CONSIDERATION', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 73), ('INCOMPLETE_EVIDENCE', 141), ('SUPERFICIAL_RELATIONSHIP', 163), ('INCOMPLETE_EVIDENCE', 280), ('SUPERFICIAL_RELATIONSHIP', 340), ('IMPORTANT_CONSIDERATION', 356)]	7	[('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('UBERON_0001782', 'pigmented layer of retina', 247, 'inflammatory bowel'), ('CHEBI_71657', 'versiconol acetate', 313, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 319, 'D'), ('GO_0007565', 'female pregnancy', 363, 'pregnancy'), ('GO_0007567', 'parturition', 377, 'birth')]
S150-PMC5129897	PMC5129897	10/2016	S150-PMC5129897	['estimate of reduction in economic BURDEN in canada if all inhabitants had 25(Oh)D concentrations >100\xa0nmol/l after several years.outcometotal economic burden in 2016 ($b)reduction due to improving Vitamin D status (%)reduction in economic BURDEN due to improving Vitamin D status ($b)deaths in canada in 201139reduction in deaths, using deaths for 2011cancer7.3151.172,47610,870cvd24.6143.460,9108530dementia16.271.110,000700dm15.7182.871941290ms3.7401.5500 ref.92200osteoporosis (Hip fractures)5.0221.1\xa0\xa0respiratory infections6.1251.557671440total78.615.912.5156,84723,030\nnote: total deaths in canada in 2011 were 242,07488\n$b, billions of dollars; cvd, cardiovascular disease; dm, diabetes mellitus; ms, multiple sclerosis.']	[('IMPORTANT_CONSIDERATION', 34), ('IMPORTANT_CONSIDERATION', 239)]	2	[('CHEBI_71657', 'versiconol acetate', 74, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 74, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 263, 'vitamin D'), ('UBERON_0001464', 'hip', 481, 'hip')]
S158-PMC5129897	PMC5129897	10/2016	S158-PMC5129897	['the ESTIMATES intable\xa09SHOW a POTENTIAL large BENEFIT of improving Vitamin D status in terms of reduction in economic BURDEN ($12.5billion) and premature deaths (23,000/yr) ON THE BASIS OF the types of disease for which EVIDENCE IS STRONG that higher 25(Oh)D concentrations have beneficial EFFECTS.']	[('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 30), ('IMPORTANT_CONSIDERATION', 46), ('IMPORTANT_CONSIDERATION', 118), ('INCOMPLETE_EVIDENCE', 173), ('INCOMPLETE_EVIDENCE', 220), ('SUPERFICIAL_RELATIONSHIP', 290)]	8	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 251, '25(OH)D')]
S17-PMC5133057	PMC5133057	10/2016	S17-PMC5133057	['its occurrence is classically ASSOCIATED with low Intake of Vitamin A from Food sources [5,12], BUT it MAY also be ASSOCIATED with OTHER FACTORS such as socioeconomic status, and inadequate sanitation and the presence of infection [13,14,15].']	[('SUPERFICIAL_RELATIONSHIP', 30), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 96), ('INCOMPLETE_EVIDENCE', 103), ('SUPERFICIAL_RELATIONSHIP', 115), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('SUPERFICIAL_RELATIONSHIP', 137)]	6	[('GO_0007631', 'feeding behavior', 50, 'intake'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin A'), ('CHEBI_33290', 'food', 75, 'food')]
S19-PMC5133057	PMC5133057	10/2016	S19-PMC5133057	['furthermore, TO OUR KNOWLEDGE, no research concomitantly evaluated the ASSOCIATION of diet, C-Reactive Protein levels, and social, nutritional, and Gestational variables with the Vitamin A status of this population.']	[('PROBABLE_UNDERSTANDING', 13), ('SUPERFICIAL_RELATIONSHIP', 71)]	2	[('CHEBI_59147', '3-[(4-methoxyphenylsulfonyloxy)methyl]-5,5-dimethylbutyrolactone', 92, 'C-reactive protein'), ('PR_000005890', 'crooked neck-like protein 1', 92, 'C-reactive protein'), ('GO_0007565', 'female pregnancy', 148, 'gestational'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin A')]
S116-PMC5133057	PMC5133057	10/2016	S116-PMC5133057	['[42], where the authors assessed the nutritional status of 75 Pregnant adolescents in venezuela, using the same cutoff points as in OUR STUDY and FOUND low weight in 34.6% of the sample, which also presented insufficient Intake of energy, protein, zinc, Calcium, and Vitamin A.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 132), ('INCOMPLETE_EVIDENCE', 146)]	2	[('GO_0007565', 'female pregnancy', 62, 'pregnant'), ('GO_0007631', 'feeding behavior', 221, 'intake'), ('CHEBI_22313', 'alkaline earth metal atom', 254, 'calcium'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin A')]
S128-PMC5133057	PMC5133057	10/2016	S128-PMC5133057	['moreover, considering the high prevalence of vad OBSERVED in THIS STUDY, as well as its IMPACT on the Pregnancy process, there is a NEED FOR regular assessment of the nutritional status of Prenatal Vitamin A in teens in order to achieve early diagnosis and proper management of this nutritional deficiency.']	[('INCOMPLETE_EVIDENCE', 49), ('QUESTION_ANSWERED_BY_THIS_WORK', 61), ('SUPERFICIAL_RELATIONSHIP', 88), ('FUTURE_WORK', 132)]	4	[('GO_0007565', 'female pregnancy', 102, 'pregnancy'), ('GO_0007565', 'female pregnancy', 189, 'prenatal'), ('CHEBI_27300', 'vitamin D', 198, 'vitamin A')]
S143-PMC5137891	PMC5137891	12/2016	S143-PMC5137891	['Retinol Binding protein (rbp- a marker of Vitamin A status) was also directly ASSOCIATED with hb (0.27 mg/dl) and with ferritin (0.09 mg/dl), WHEREAS hookworm infection was indirectly ASSOCIATED with hb (-0.11) through rbp and ferritin.']	[('SUPERFICIAL_RELATIONSHIP', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 142), ('SUPERFICIAL_RELATIONSHIP', 184)]	3	[('CHEBI_27810', 'resorcinol', 0, 'Retinol'), ('PR_000014379', 'ryanodine receptor 3', 0, 'Retinol Binding'), ('CHEBI_27300', 'vitamin D', 42, 'vitamin A')]
S1-PMC5146866	PMC5146866	12/2016	S1-PMC5146866	['THIS STUDY was DESIGNED TO DETERMINE the rate, maternal RISK FACTORS, and clinical outcomes in infants in ASSOCIATION with Vitamin D insufficient/deficient status at Birth.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 15), ('QUESTION_ANSWERED_BY_THIS_WORK', 24), ('SUPERFICIAL_RELATIONSHIP', 56), ('SUPERFICIAL_RELATIONSHIP', 106)]	5	[('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('GO_0007567', 'parturition', 166, 'birth')]
S10-PMC5146866	PMC5146866	12/2016	S10-PMC5146866	['OUR FINDINGS RAISE a QUESTION regarding the adequacy of the aap RECOMMENDED Vitamin D supplementation REQUIREMENTS without knowing the infant’s Vitamin D status at Birth.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('EXPLICIT_QUESTION', 13), ('EXPLICIT_QUESTION', 21), ('FUTURE_WORK', 64), ('IMPORTANT_CONSIDERATION', 102)]	5	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('GO_0007567', 'parturition', 164, 'birth')]
S11-PMC5146866	PMC5146866	12/2016	S11-PMC5146866	['background\ncharacterization of the Vitamin D status in the maternal-fetal-neonatal interface is clinically IMPORTANT BECAUSE of the increased rates of detection of Vitamin D insufficiency in Cord Blood (Cb) and the ASSOCIATED RISK for health COMPLICATIONS in infants and children [1,2], including but not limited to rickets [3], infectious and allergic diseases, and type 1 diabetes [4–6].']	[('IMPORTANT_CONSIDERATION', 107), ('PROBABLE_UNDERSTANDING', 117), ('PROBLEM_COMPLICATION', 117), ('SUPERFICIAL_RELATIONSHIP', 215), ('IMPORTANT_CONSIDERATION', 226), ('IMPORTANT_CONSIDERATION', 242)]	6	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 164, 'vitamin D'), ('UBERON_0009472', 'axilla', 191, 'cord blood'), ('UBERON_2005013', 'concurrent branch afferent branchial artery', 203, 'CB')]
S12-PMC5146866	PMC5146866	12/2016	S12-PMC5146866	['assessing Vitamin D status using cb is a CHALLENGE AS the OPTIMAL level of Vitamin D in children is STILL the subject of discussion [7].']	[('DIFFICULT_TASK', 41), ('PROBABLE_UNDERSTANDING', 51), ('IMPORTANT_CONSIDERATION', 58), ('IMPORTANT_CONSIDERATION', 100)]	4	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
S23-PMC5146866	PMC5146866	12/2016	S23-PMC5146866	['DIFFERENCES in the classification [8–10] used to assess the infants’ Vitamin D status and strong DEPENDENCE of their Vitamin D pool on maternal Vitamin D levels [18] MAY BE RESPONSIBLE for the wide VARIABILITY in the REPORTED rates of Vitamin D deficiency/insufficiency in infants at Birth.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 97), ('INCOMPLETE_EVIDENCE', 166), ('PROBABLE_UNDERSTANDING', 173), ('DIFFICULT_TASK', 198), ('INCOMPLETE_EVIDENCE', 217)]	6	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D'), ('GO_0007567', 'parturition', 284, 'birth')]
S24-PMC5146866	PMC5146866	12/2016	S24-PMC5146866	['DESPITE numerous publications that explored Vitamin D status in cb, FURTHER RESEARCH is REQUIRED to determine the LIKELIHOOD for detection of Vitamin D insufficiency in cb of infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FUTURE_WORK', 68), ('IMPORTANT_CONSIDERATION', 88), ('PROBABLE_UNDERSTANDING', 114)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D')]
S42-PMC5146866	PMC5146866	12/2016	S42-PMC5146866	['data presentation and statistical analyses\nthe results of [25(Oh) D] were analyzed as a continuous variable and were also stratified with respect to the aap’s definition of Vitamin D status [8,9] AS severe (<5\xa0ng/ml) or mild/moderate deficient (5–15\xa0ng/ml), insufficient (16–20\xa0ng/ml), and sufficient (21–100\xa0ng/ml).']	[('PROBABLE_UNDERSTANDING', 196)]	1	[('CHEBI_71657', 'versiconol acetate', 59, '25(OH) D'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D')]
S70-PMC5146866	PMC5146866	12/2016	S70-PMC5146866	['a comparable magnitude of the INDEPENDENT EFFECT of maternal age and gravidity on Vitamin D status was IDENTIFIED in each race/ethnicity model (data not presented).']	[('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 103)]	3	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
S78-PMC5146866	PMC5146866	12/2016	S78-PMC5146866	['caption (table-wrap): table 3\n\ncharacteristics of neonates during Birth hospitalization with respect to their cb Vitamin D statusparametricvitamin D satus p valuedeficiency n \u2009=\u200995insufficiency n \u2009=\u200979sufficiency n \u2009=\u200991gestational age (weeks)38.8(38.6–39.1)39.2(38.9–39.5)38.9(38.7–39.3)0.65birth weight (g)3301(3215–3387)3433(3322–3544)3306(3305–3406)0.35birth length (cm)48.8(48.1–49.6)49.5(49.0–50.0)48.3(47.2–49.5)0.53apgar 1\xa0min <72.1%(0.6–7.0)2.6%(0.7–8.9)6.5%(2.4–12.2)0.21nicu admission6.3%(0.87–11.7)5.1%(0–10.6)8.9%(2.4–15.3)0.62hypoglycemia (%)01.3%(0–4.4)1.1%(0–3.6)0.56neonatal jaundice (%)21.1%(12.6–29.6)13.9%(5.3–22.5)13.9%(6.4–21.4)0.27phototherapy (%)5.3%(0.3–10.3)1.3%(0–4.4)1.1%(0–3.6)0.13\ndata presented as mean or proportion (%) with 95% confidence intervals of mean or %\n\ndiscussion\nwe FOUND that up to 45% infants are AT RISK for deficient and 35% for INSUFFICIENT levels of Vitamin D. the APPROXIMATED probability of an infant being Born with a sufficient Vitamin D level as defined by the aap for children [8] is less than 40%.']	[('INCOMPLETE_EVIDENCE', 810), ('IMPORTANT_CONSIDERATION', 843), ('IMPORTANT_CONSIDERATION', 877), ('INCOMPLETE_EVIDENCE', 915)]	4	[('GO_0007567', 'parturition', 66, 'birth'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 147, 'D'), ('PR_000006444', 'diacylglycerol kinase delta', 147, 'D'), ('CHEBI_27300', 'vitamin D', 900, 'vitamin D'), ('GO_0007567', 'parturition', 959, 'born'), ('CHEBI_27300', 'vitamin D', 982, 'vitamin D')]
S85-PMC5146866	PMC5146866	12/2016	S85-PMC5146866	['moreover, the internal VALIDITY of the EXISTING STUDIES is a subject for discussion because the INDEPENDENT EFFECT of maternal race/ethnicity on the Vitamin D status was not controlled for and other maternal FACTORS MAY also have an ASSOCIATION with the development of Vitamin D deficiency/insufficiency in infants at Birth.']	[('IMPORTANT_CONSIDERATION', 23), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 96), ('SUPERFICIAL_RELATIONSHIP', 108), ('SUPERFICIAL_RELATIONSHIP', 208), ('INCOMPLETE_EVIDENCE', 216), ('SUPERFICIAL_RELATIONSHIP', 233)]	7	[('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 269, 'vitamin D'), ('GO_0007567', 'parturition', 318, 'birth')]
S91-PMC5146866	PMC5146866	12/2016	S91-PMC5146866	['COMPARABLE to PREVIOUS reports we FOUND no difference between the cb Vitamin D status and maternal multivitamin supplementation [30,32].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 34)]	3	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
S95-PMC5146866	PMC5146866	12/2016	S95-PMC5146866	['in the PRESENT STUDY, evaluation of the neonatal clinical data did NOT reveal any obvious association between cb Vitamin D levels and neonatal health status during the short period of Birth hospitalization.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 7), ('ANOMALY_CURIOUS_FINDING', 67)]	2	[('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('GO_0007567', 'parturition', 184, 'birth')]
S99-PMC5146866	PMC5146866	12/2016	S99-PMC5146866	['TO THE BEST OF OUR KNOWLEDGE, NO PRIOR STUDY has investigated the clinical status of neonates in ASSOCIATION with cb Vitamin D levels.']	[('PROBABLE_UNDERSTANDING', 0), ('FULL_UNKNOWN', 30), ('SUPERFICIAL_RELATIONSHIP', 97)]	3	[('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
S104-PMC5146866	PMC5146866	12/2016	S104-PMC5146866	['moreover, a review of the literature REVEALED that data obtained from questionnaires regarding the assessment of sunlight exposure do NOT precisely estimate Vitamin D status [37].']	[('INCOMPLETE_EVIDENCE', 37), ('ANOMALY_CURIOUS_FINDING', 134)]	2	[('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
S105-PMC5146866	PMC5146866	12/2016	S105-PMC5146866	['we would like to highlight the strengths of the PRESENT report that include: (i) prospective observation of a sufficient number and diverse population of mother-infant pairs, (ii) use of 95% confidence intervals to present the POTENTIAL variability in prevalence of Vitamin D deficiency/ insufficiency in cb, (iii) use of regression models for identifying maternal FACTORS that increase the risk for Vitamin D deficiency/insufficiency in infant at Birth, and (iv) reporting clinical characteristics of the neonates in ASSOCIATION with their Vitamin D status at Birth.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 48), ('INCOMPLETE_EVIDENCE', 227), ('SUPERFICIAL_RELATIONSHIP', 365), ('SUPERFICIAL_RELATIONSHIP', 518)]	4	[('CHEBI_27300', 'vitamin D', 266, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 400, 'vitamin D'), ('GO_0007567', 'parturition', 448, 'birth'), ('CHEBI_27300', 'vitamin D', 541, 'vitamin D'), ('GO_0007567', 'parturition', 561, 'birth')]
S108-PMC5146866	PMC5146866	12/2016	S108-PMC5146866	['moreover, DUE TO the high LIKELIHOOD of Vitamin D insufficiency/deficiency at Birth, FURTHER STUDIES MAY be REQUIRED to determine the ROLE of implementing Vitamin D supplementation with respect to the cb Vitamin D status.']	[('PROBLEM_COMPLICATION', 10), ('PROBABLE_UNDERSTANDING', 26), ('FUTURE_WORK', 85), ('INCOMPLETE_EVIDENCE', 101), ('IMPORTANT_CONSIDERATION', 108), ('SUPERFICIAL_RELATIONSHIP', 134)]	6	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0007567', 'parturition', 78, 'birth'), ('CHEBI_27300', 'vitamin D', 155, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin D')]
S20-PMC5155676	PMC5155676	12/2016	S20-PMC5155676	['ALTHOUGH Vitamin D supplementation CAN improve maternal 25(Oh)D status (10), LITTLE IS KNOWN about HOW maternal characteristics MIGHT INFLUENCE the 25(Oh)d achieved after supplementation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 35), ('FULL_UNKNOWN', 77), ('EXPLICIT_QUESTION', 99), ('INCOMPLETE_EVIDENCE', 128), ('SUPERFICIAL_RELATIONSHIP', 134)]	6	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 56, '25(OH)D'), ('CHEBI_30778', 'gallic acid', 148, '25(OH)')]
S53-PMC5155676	PMC5155676	12/2016	S53-PMC5155676	['additionally, maternal factors ASSOCIATED with achieving a Vitamin D replete status (>50 nmol/l) were determined using poisson regression with robust standard errors (21).']	[('SUPERFICIAL_RELATIONSHIP', 31)]	1	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
S75-PMC5155676	PMC5155676	12/2016	S75-PMC5155676	['percentage of women achieving Vitamin D replete status (>50 nmol/l) according to randomization group and season of Deliveryseason of Deliveryplacebo1000 iu/d Cholecalciferol p comparing randomization groupswinter (december–may)13.975.0<.001summer (june–november)54.290.1<.001 p comparing seasons<.001<.001\n\ndeterminants of maternal 25(Oh)D at 34 weeks of Gestation\nin univariate analysis, maternal age, baseline 25(Oh)D, season of Delivery and compliance with study Medication were significantly ASSOCIATED with 34 week 25(Oh)D in both the Placebo and Vitamin D supplementation groups (table 3).']	[('SUPERFICIAL_RELATIONSHIP', 496)]	1	[('CHEBI_28384', 'vitamin K', 30, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 30, 'Vitamin D'), ('GO_0006260', 'DNA replication', 115, 'DeliverySeason'), ('GO_0006260', 'DNA replication', 133, 'DeliveryPlacebo1000'), ('CHEBI_16113', 'cholesterol', 158, 'Cholecalciferol'), ('CHEBI_71657', 'versiconol acetate', 332, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 332, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 355, 'gestation'), ('CHEBI_71657', 'versiconol acetate', 412, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 415, 'OH ... D'), ('GO_0007567', 'parturition', 431, 'delivery'), ('CHEBI_60211', 'compound Z', 466, 'medication'), ('CHEBI_71657', 'versiconol acetate', 520, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 520, '25(OH)D'), ('CHEBI_26130', 'biological pigment', 540, 'placebo'), ('CHEBI_27300', 'vitamin D', 552, 'vitamin D')]
S84-PMC5155676	PMC5155676	12/2016	S84-PMC5155676	['when achievement of Vitamin D replete status at 34 weeks of Gestation was considered INSTEAD of absolute 25(Oh)D concentration, in multivariate analyses, Delivery in summer (relative risk [rr] = 1.20; 95%ci 1.09, 1.33; p< .001), white ethnicity (rr = 1.27; 95%ci 1.17, 1.37; p< .001), greater compliance with Medication (%) (rr = 1.01; 95%ci 1.00, 1.02; p = .03), and greater early Pregnancy 25(Oh)D concentration (nmol/l) (rr = 1.003; 95%ci 1.001, 1.006; p = .007) were significantly ASSOCIATED with achieving 25(Oh)D >50 nmol/l in the women randomized to Cholecalciferol.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 85), ('SUPERFICIAL_RELATIONSHIP', 485)]	2	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0007565', 'female pregnancy', 60, 'gestation'), ('CHEBI_71657', 'versiconol acetate', 105, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 111, 'D'), ('GO_0007567', 'parturition', 154, 'delivery'), ('CHEBI_60211', 'compound Z', 309, 'medication'), ('GO_0007565', 'female pregnancy', 382, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 392, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 511, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 511, '25(OH)D'), ('CHEBI_52550', 'theopalauamide', 557, 'cholecalciferol')]
S95-PMC5155676	PMC5155676	12/2016	S95-PMC5155676	['the maternal characteristics ASSOCIATED with 25(Oh)D at 34 weeks of Gestation and achieving Vitamin D replete status were SIMILAR TO those observed in the whole cohort.']	[('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 122)]	2	[('CHEBI_71657', 'versiconol acetate', 45, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 51, 'D'), ('GO_0007565', 'female pregnancy', 68, 'gestation'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
S100-PMC5155676	PMC5155676	12/2016	S100-PMC5155676	['HOWEVER, when Vitamin D replete status was considered as the outcome, ONLY non-white maternal ethnicity and Delivery in winter were significant PREDICTORS of Vitamin D nonreplete status after supplementation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 70), ('SUPERFICIAL_RELATIONSHIP', 144)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007567', 'parturition', 108, 'delivery'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D')]
S112-PMC5155676	PMC5155676	12/2016	S112-PMC5155676	['HOWEVER, it is NOTABLE that there were marked DIFFERENCES in baseline 25(Oh)D concentrations between these investigations, and we OBSERVED that initial 25(Oh)D status was positively ASSOCIATED with both the LIKELIHOOD of achieving Vitamin D replete status and absolute 25(Oh)D status at 34 weeks of Gestation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('ANOMALY_CURIOUS_FINDING', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('INCOMPLETE_EVIDENCE', 130), ('SUPERFICIAL_RELATIONSHIP', 182), ('PROBABLE_UNDERSTANDING', 207)]	7	[('CHEBI_71657', 'versiconol acetate', 70, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 76, 'D'), ('CHEBI_63056', 'zinc cation', 152, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 158, 'D'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 269, '25(OH)D'), ('GO_0007565', 'female pregnancy', 299, 'gestation')]
S117-PMC5155676	PMC5155676	12/2016	S117-PMC5155676	['similarly, non-white ethnicity was ASSOCIATED with a higher risk of not achieving Vitamin D replete status in the supplemented women.']	[('SUPERFICIAL_RELATIONSHIP', 35)]	1	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D')]
S127-PMC5155676	PMC5155676	12/2016	S127-PMC5155676	['as baseline 25(Oh)D was ASSOCIATED with the LIKELIHOOD of achieving Vitamin D replete status, it is LIKELY that women with very low levels of 25(Oh)D at baseline will require a higher supplementation dose to achieve Vitamin D repletion.']	[('SUPERFICIAL_RELATIONSHIP', 24), ('PROBABLE_UNDERSTANDING', 44), ('PROBABLE_UNDERSTANDING', 100)]	3	[('CHEBI_71657', 'versiconol acetate', 12, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 144, '(OH)D'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D')]
S138-PMC5223368	PMC5223368	12/2016	S138-PMC5223368	['THUS, IF the third trimester is in spring OR in summer, the status of maternal Vitamin D would be better than in OTHER seasons.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 113)]	4	[('CHEBI_27300', 'vitamin D', 79, 'vitamin D')]
S144-PMC5223368	PMC5223368	12/2016	S144-PMC5223368	['THEREFORE, the positive ASSOCIATION between high temperature at the third Trimester and increased Birth length in THIS STUDY MIGHT be PARTLY EXPLAINED by Vitamin D status of mothers [31].']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 24), ('QUESTION_ANSWERED_BY_THIS_WORK', 114), ('INCOMPLETE_EVIDENCE', 125), ('INCOMPLETE_EVIDENCE', 134), ('PROBABLE_UNDERSTANDING', 141)]	6	[('GO_0009294', 'DNA mediated transformation', 74, 'trimester'), ('GO_0007567', 'parturition', 98, 'birth'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
S185-PMC5223368	PMC5223368	12/2016	S185-PMC5223368	['one of the LIMITATIONS of THIS STUDY was that FACTORS which COULD AFFECT Birth size such as maternal dietary information and maternal Vitamin D status during Pregnancy were NOT available.']	[('INCOMPLETE_EVIDENCE', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 60), ('SUPERFICIAL_RELATIONSHIP', 66), ('ANOMALY_CURIOUS_FINDING', 173)]	6	[('GO_0007567', 'parturition', 73, 'birth'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007565', 'female pregnancy', 158, 'pregnancy')]
S106-PMC5264377	PMC5264377	7/2016	S106-PMC5264377	['both groups had equal distributions of causes of infertility, SUGGESTING the absence of an association with the Metabolism Of Vitamin D.\nto sum up with, women with deficient levels of 25(Oh)D3 measured in single follicles were significantly heavier REGARDLESS OF their infertility statuses.']	[('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 249)]	2	[('GO_0019458', 'methionine catabolic process via 2-oxobutanoate', 112, 'metabolism of vitamin D'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('CHEBI_62946', 'ammonium sulfate', 184, '25(OH)D3'), ('PR_000029655', '28S rRNA (cytosine-C(5))-methyltransferase', 184, '25(OH)D3')]
S0-PMC5273824	PMC5273824	1/2017	S0-PMC5273824	['investigation of the Vitamin D nutritional status in women with Gestational diabetes mellitus in beijing\n\nabstract\n\nbackground\nVitamin D deficiency is a common ISSUE, which has RELATION with gdm, during the Pregnant period.']	[('IMPORTANT_CONSIDERATION', 160), ('SUPERFICIAL_RELATIONSHIP', 177)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007565', 'female pregnancy', 64, 'gestational'), ('CHEBI_28384', 'vitamin K', 127, 'Vitamin D'), ('GO_0007565', 'female pregnancy', 207, 'pregnant')]
S37-PMC5310660	PMC5310660	1/2017	S37-PMC5310660	['the peak of Births for those who developed one of these diseases occurred in april and a trough in october, and the risk CORRELATED inversely with PREDICTED second-trimester uvb exposure and third-trimester Vitamin D status [7].']	[('SUPERFICIAL_RELATIONSHIP', 121), ('SUPERFICIAL_RELATIONSHIP', 147)]	2	[('GO_0007567', 'parturition', 12, 'births'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]
S5-PMC5318550	PMC5318550	2/2017	S5-PMC5318550	['we EXPLORED how adjusting for socioeconomic status and maternal iq, Childbirth outcomes, Pregnancy Vitamin D status, nutritional intake, exposure to infections, and child age relative to peers in class changed the RELATION between season of Birth and child iq.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('SUPERFICIAL_RELATIONSHIP', 214)]	2	[('GO_0007623', 'circadian rhythm', 68, 'childbirth'), ('GO_0007565', 'female pregnancy', 89, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('GO_0007567', 'parturition', 241, 'birth')]
S28-PMC5318550	PMC5318550	2/2017	S28-PMC5318550	['next, we determined in additional models WHETHER this ASSOCIATION COULD BE explained by specific variables—thereby testing DIFFERENT HYPOTHESES; (2) sociodemographic factors and maternal iq; (3) child Birth weight and Gestational duration; (4) Pregnancy Vitamin D plasma status; (5) maternal nutritional intake; (6) maternal exposure to fever during Pregnancy; and (7) child age relative to peers at school.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 41), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 66), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 123), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 133)]	5	[('GO_0007567', 'parturition', 201, 'birth'), ('GO_0007565', 'female pregnancy', 218, 'gestational'), ('GO_0007565', 'female pregnancy', 244, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('GO_0007565', 'female pregnancy', 350, 'pregnancy')]
S157-PMC5318550	PMC5318550	2/2017	S157-PMC5318550	['moreover, certain VARIABLES have MISSING values of over 20%, for example, maternal nutrition and Vitamin D status.']	[('SUPERFICIAL_RELATIONSHIP', 18), ('PROBLEM_COMPLICATION', 33)]	2	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D')]
S107-PMC5340372	PMC5340372	3/2017	S107-PMC5340372	['THEREFORE, drawing CONCLUSIONS about the EFFECTS of Perinatal and Postnatal Vitamin D status from these results can be DIFFICULT.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 19), ('SUPERFICIAL_RELATIONSHIP', 41), ('DIFFICULT_TASK', 119)]	4	[('GO_0036268', 'swimming', 52, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 52, 'perinatal'), ('GO_0007567', 'parturition', 66, 'postnatal'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
S118-PMC5340372	PMC5340372	3/2017	S118-PMC5340372	['the fetal Vitamin D status is DEPENDENT on the Placental-fetal circulation.']	[('SUPERFICIAL_RELATIONSHIP', 30)]	1	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0001987', 'placenta', 47, 'placental')]
S53-PMC5359891	PMC5359891	3/2017	S53-PMC5359891	['taken TOGETHER, there is strong SUPPORT for NEW intervention studies commencing before Pregnancy to provide myo-inositol and Probiotics, and to improve maternal Vitamin B6, Vitamin B12, Vitamin D and zinc status, AIMED at optimising maternal glycaemia and Glucose supply to the Feto-Placental Unit to promote healthy offspring growth and body composition.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 44), ('QUESTION_ANSWERED_BY_THIS_WORK', 213)]	4	[('GO_0007565', 'female pregnancy', 87, 'pregnancy'), ('CHEBI_26346', 'prostaglandins J', 125, 'probiotics'), ('CHEBI_33237', 'vitamin D4', 161, 'vitamin B6'), ('CHEBI_33229', 'vitamin (role)', 173, 'vitamin'), ('CHEBI_27778', 'abequose', 181, 'B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 181, 'B12'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('CHEBI_17234', 'glucose', 256, 'glucose'), ('UBERON_0000981', 'femur', 278, 'feto'), ('UBERON_0013765', 'digestive system element', 283, 'placental unit')]
S70-PMC5371920	PMC5371920	3/2017	S70-PMC5371920	['for example, maternal 25(oh)-Vitamin D [25(Oh)D] status INFLUENCES offspring bone mass at Birth.']	[('SUPERFICIAL_RELATIONSHIP', 56)]	1	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 40, '25(OH)D'), ('GO_0007567', 'parturition', 90, 'birth')]
S127-PMC5372327	PMC5372327	3/2017	S127-PMC5372327	['results from this study will LIKELY generate NOVEL EVIDENCE-BASED INFORMATION for improving Vitamin D status among the paediatric population worldwide.']	[('PROBABLE_UNDERSTANDING', 29), ('FULL_UNKNOWN', 45), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 66)]	4	[('CHEBI_27300', 'vitamin D', 92, 'vitamin D')]
S135-PMC5372327	PMC5372327	3/2017	S135-PMC5372327	['HOWEVER, DUE TO the randomised controlled study design our study will provide valuable data on the EFFECTS of Vitamin D substitution in populations with variable Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('PROBLEM_COMPLICATION', 9), ('SUPERFICIAL_RELATIONSHIP', 99)]	3	[('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 162, 'vitamin D')]
S2-PMC5385921	PMC5385921	4/2017	S2-PMC5385921	['AIMS\nTO DETERMINE the ASSOCIATION between Gestational Vitamin D status and asd.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 5), ('SUPERFICIAL_RELATIONSHIP', 22)]	3	[('GO_0007565', 'female pregnancy', 42, 'gestational'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D')]
S14-PMC5385921	PMC5385921	4/2017	S14-PMC5385921	['ONE STUDY compared neonatal Vitamin D status in children with asd v. their unaffected siblings ( n =58 sibling pairs).']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D')]
S18-PMC5385921	PMC5385921	4/2017	S18-PMC5385921	['we had the opportunity to explore the ASSOCIATION between developmental Vitamin D status and risk of asd, based on the same dutch Birth cohort in which we previously reported an ASSOCIATION between low mid-Gestational and neonatal Vitamin D concentrations and autistic traits.13within the cohort, we had access to an extensive set of POTENTIAL CONFOUNDING variables as well as the children’s individual-level Genome-wide genotype data.']	[('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 178), ('INCOMPLETE_EVIDENCE', 334), ('PROBLEM_COMPLICATION', 344)]	4	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0007567', 'parturition', 130, 'birth'), ('GO_0007565', 'female pregnancy', 206, 'gestational'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('SO_0001026', 'genome', 409, 'genome')]
S56-PMC5385921	PMC5385921	4/2017	S56-PMC5385921	['ancestry information and Genetic relatedness derived from observed common Genetic variants\nethnicity is strongly ASSOCIATED with Vitamin D status (darker skinned Individuals are more PRONE to Vitamin D deficiency and insufficiency).19genome-wide genotype data for the children allow us to build models that are BETTER able to account for variation in ethnic background (compared with register-based or self-ascribed ethnicity) and for Genetic relatedness between cohort members that MAY inflate an association statistic when Genes AFFECT the exposure or outcome variable.']	[('SUPERFICIAL_RELATIONSHIP', 113), ('PROBABLE_UNDERSTANDING', 183), ('INCOMPLETE_EVIDENCE', 311), ('INCOMPLETE_EVIDENCE', 483), ('SUPERFICIAL_RELATIONSHIP', 531)]	5	[('SO_0000704', 'gene', 25, 'genetic'), ('SO_0000704', 'gene', 74, 'genetic'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('NCBITaxon_1', 'root', 162, 'individuals'), ('CHEBI_27300', 'vitamin D', 192, 'vitamin D'), ('SO_0000704', 'gene', 435, 'genetic'), ('SO_0000704', 'gene', 525, 'genes')]
S69-PMC5385921	PMC5385921	4/2017	S69-PMC5385921	['main analyses\nlogistic regression analyses were applied to test the EFFECT of Vitamin D deficiency status on asd.']	[('SUPERFICIAL_RELATIONSHIP', 68)]	1	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
S120-PMC5385921	PMC5385921	4/2017	S120-PMC5385921	['ASSUMING that the variables of interest are causally RELATED and that other VARIABLES remain unchanged), optimising Vitamin D status of this sample COULD BE ASSOCIATED with a reduction in the prevalence of asd of APPROXIMATELY 10%.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 148), ('SUPERFICIAL_RELATIONSHIP', 157), ('INCOMPLETE_EVIDENCE', 213)]	6	[('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
S2-PMC5405075	PMC5405075	4/2017	S2-PMC5405075	['SINCE asthma is presented with high incidence in childhood and neonatal Vitamin D stores DEPEND on maternal Vitamin levels, a POSSIBLE programming EFFECT of maternal Vitamin D status during Gestation was SUGGESTED.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('SUPERFICIAL_RELATIONSHIP', 89), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 147), ('INCOMPLETE_EVIDENCE', 204)]	6	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 108, 'vitamin'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D'), ('GO_0007565', 'female pregnancy', 190, 'gestation')]
S9-PMC5405075	PMC5405075	4/2017	S9-PMC5405075	['SINCE asthma is presented with high incidence in childhood, a POSSIBLE programming EFFECT of maternal Vitamin D status during Gestation HAS BEEN PROPOSED.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBLEM_COMPLICATION', 0), ('INCOMPLETE_EVIDENCE', 62), ('SUPERFICIAL_RELATIONSHIP', 83), ('INCOMPLETE_EVIDENCE', 136), ('INCOMPLETE_EVIDENCE', 145)]	6	[('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('GO_0007565', 'female pregnancy', 126, 'gestation')]
S14-PMC5405075	PMC5405075	4/2017	S14-PMC5405075	['in THIS mini-REVIEW ARTICLE, we AIM to present the CURRENT KNOWLEDGE as it EMERGES from studies FOCUSED on the IMPACT of maternal Vitamin D status and Vitamin d supplementation on the Development Of Asthma in early childhood.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 75), ('QUESTION_ANSWERED_BY_THIS_WORK', 96), ('SUPERFICIAL_RELATIONSHIP', 111)]	7	[('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 151, 'vitamin'), ('GO_0009602', 'detection of symbiont', 184, 'development of asthma')]
S28-PMC5405075	PMC5405075	4/2017	S28-PMC5405075	['AS a result, Vitamin D deficiency during Pregnancy exerts SIGNIFICANT IMPACT on Vitamin D status of newborns and subsequently on early Childhood (9,28).']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 58), ('SUPERFICIAL_RELATIONSHIP', 70)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0007565', 'female pregnancy', 41, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('UBERON_0013628', 'pollical pad', 135, 'childhood')]
S29-PMC5405075	PMC5405075	4/2017	S29-PMC5405075	['the IMPACT of Vitamin D exposure in utero\nthe DEPENDENCE of the developing fetus on maternal Vitamin D status TOGETHER with the REPORTED extra Skeletal function of the hormone and Vitamin D deficiency EPIDEMIC during the last years led to FURTHER INVESTIGATION of the CONSEQUENCES of maternal Vitamin D insufficiency on Pregnancy outcomes (6,29,30).']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 46), ('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 128), ('IMPORTANT_CONSIDERATION', 201), ('FUTURE_WORK', 239), ('PROBLEM_COMPLICATION', 268)]	7	[('CHEBI_28384', 'vitamin K', 14, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('UBERON_0004288', 'skeleton', 143, 'skeletal'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D'), ('GO_0007565', 'female pregnancy', 320, 'pregnancy')]
S34-PMC5405075	PMC5405075	4/2017	S34-PMC5405075	['maternal Vitamin D status and ASSOCIATIONS with asthma in early Life\nthe PUTATIVE EFFECT of Prenatal exposure to Vitamin D on asthmatic phenotypes in early Life has been initially investigated via observational studies based on either maternal dietary Intake of Vitamin D or 25(Oh)D levels in Venous maternal and/or Cord Blood [reviewed in ref.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('PROBABLE_UNDERSTANDING', 73), ('SUPERFICIAL_RELATIONSHIP', 82)]	3	[('CHEBI_28384', 'vitamin K', 9, 'Vitamin D'), ('UBERON_0000104', 'life cycle', 64, 'Life'), ('GO_0007565', 'female pregnancy', 92, 'prenatal'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('UBERON_0000104', 'life cycle', 156, 'life'), ('GO_0007631', 'feeding behavior', 252, 'intake'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 275, '25(OH)D'), ('UBERON_0001638', 'vein', 293, 'venous'), ('UBERON_0002240', 'spinal cord', 316, 'cord'), ('UBERON_0000178', 'blood', 321, 'blood')]
S38-PMC5405075	PMC5405075	4/2017	S38-PMC5405075	['CONSEQUENTLY, longitudinal studies measuring 25(Oh)D levels, a POSSIBLE more objective INDICATOR of Vitamin D status, were DESIGNED TO explore the POSSIBLE IMPACT of Vitamin D on asthma-like symptoms or asthma.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 87), ('QUESTION_ANSWERED_BY_THIS_WORK', 123), ('QUESTION_ANSWERED_BY_THIS_WORK', 132), ('INCOMPLETE_EVIDENCE', 147), ('SUPERFICIAL_RELATIONSHIP', 156)]	7	[('CHEBI_71657', 'versiconol acetate', 45, '25(OH)D'), ('PR_000010220', 'mannose-binding protein C', 47, '('), ('PR_000006444', 'diacylglycerol kinase delta', 51, 'D'), ('CHEBI_27300', 'vitamin D', 100, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D')]
S42-PMC5405075	PMC5405075	4/2017	S42-PMC5405075	['INCONSISTENCIES across studies HAVE BEEN ATTRIBUTED to a plethora of FACTORS such as diverse study designs, MISSING significant follow-up, lack OF a clear definition of vitamin d sufficiency in Pregnancy, REMARKABLE fluctuations in populations in different latitudes, Genetic heterogeneity, the diversity of assays employed (69), low repeatability of Serum 25(Oh)D values (37), variety of Vitamin D status DETERMINANTS, multifactorial nature and phenotypical diversity of asthma, as well as imprecision in diagnosing asthma in early Life.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 41), ('SUPERFICIAL_RELATIONSHIP', 69), ('PROBLEM_COMPLICATION', 108), ('ANOMALY_CURIOUS_FINDING', 144), ('ANOMALY_CURIOUS_FINDING', 205), ('SUPERFICIAL_RELATIONSHIP', 406)]	8	[('GO_0007565', 'female pregnancy', 194, 'pregnancy'), ('SO_0000704', 'gene', 268, 'genetic'), ('UBERON_0001977', 'blood serum', 351, 'serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 360, 'OH)D'), ('CHEBI_27300', 'vitamin D', 389, 'vitamin D'), ('UBERON_0000104', 'life cycle', 533, 'life')]
S89-PMC5405075	PMC5405075	4/2017	S89-PMC5405075	['moreover, it HAS BEEN PROPOSED that studies SHOULD focus on Vitamin D status in early Pregnancy and supplementary administration SHOULD BE initiated from the first Trimester of Gestation in order to observe the OPTIMAL EFFECT on RISK of childhood asthma, THOUGH EVIDENCE from chawes et al.’s clinical trial DID NOT CONFIRM this NOTION (75).']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 22), ('FUTURE_WORK', 44), ('FUTURE_WORK', 129), ('IMPORTANT_CONSIDERATION', 211), ('SUPERFICIAL_RELATIONSHIP', 219), ('IMPORTANT_CONSIDERATION', 229), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 255), ('ANOMALY_CURIOUS_FINDING', 255), ('INCOMPLETE_EVIDENCE', 262), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 307), ('INCOMPLETE_EVIDENCE', 328)]	12	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 86, 'pregnancy'), ('GO_0009294', 'DNA mediated transformation', 164, 'trimester'), ('GO_0007565', 'female pregnancy', 177, 'gestation')]
S90-PMC5405075	PMC5405075	4/2017	S90-PMC5405075	['in addition, an INTERESTING REMARK is that study designs and analyses do not take into CONSIDERATION the starting maternal Vitamin D status and dose adequacy for the different body systems.']	[('ANOMALY_CURIOUS_FINDING', 16), ('ANOMALY_CURIOUS_FINDING', 28), ('IMPORTANT_CONSIDERATION', 87)]	3	[('CHEBI_27300', 'vitamin D', 123, 'vitamin D')]
S98-PMC5405075	PMC5405075	4/2017	S98-PMC5405075	['moreover, any intervention SHOULD BE individualized to initial maternal Vitamin D status and be followed up, SINCE a u -curve ASSOCIATION between Vitamin D circulating levels and IMPACT on allergy and Human health HAS BEEN also PROPOSED (83,84).']	[('FUTURE_WORK', 27), ('PROBABLE_UNDERSTANDING', 109), ('SUPERFICIAL_RELATIONSHIP', 126), ('SUPERFICIAL_RELATIONSHIP', 179), ('INCOMPLETE_EVIDENCE', 214), ('INCOMPLETE_EVIDENCE', 228)]	6	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 201, 'human')]
S103-PMC5405075	PMC5405075	4/2017	S103-PMC5405075	['any intervention SHOULD BE individualized to initial maternal Vitamin D status and be followed up.']	[('FUTURE_WORK', 17)]	1	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
S6-PMC5418719	PMC5418719	5/2017	S6-PMC5418719	['conclusion\nCONSIDERING the EFFICACY and SAFETY of Vitamin D supplementation in THIS STUDY, Vitamin D intake of 800\xa0iu/day MAY enhance Vitamin D status during early hospitalization in vlbw infants with 25 Ohd concentrations\u2009<\u200910\xa0ng/ml at Birth.']	[('PROBABLE_UNDERSTANDING', 11), ('SUPERFICIAL_RELATIONSHIP', 27), ('IMPORTANT_CONSIDERATION', 40), ('QUESTION_ANSWERED_BY_THIS_WORK', 79), ('INCOMPLETE_EVIDENCE', 122)]	5	"[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 201, '25 OHD'), ('GO_0007567', 'parturition', 237, 'birth')]"
S16-PMC5418719	PMC5418719	5/2017	S16-PMC5418719	['WHILE Breast Milk Feeding is currently RECOMMENDED as a source of early nutrition in full and preterm infants, an infant diet with Breast Milk alone does not contain enough Vitamin D. the definition of Vitamin D sufficiency in preterm infants is STILL CONTROVERSIAL; optimal Vitamin D status is BASED ON the Vitamin D concentrations for multiple health outcomes in Adults with a target value for 25(Oh)D levels >30\xa0ng/ml [8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 39), ('IMPORTANT_CONSIDERATION', 246), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 252), ('QUESTION_ANSWERED_BY_THIS_WORK', 295), ('SUPERFICIAL_RELATIONSHIP', 295)]	6	[('UBERON_0001348', 'brown adipose tissue', 6, 'breast milk'), ('GO_0007614', 'short-term memory', 13, 'milk'), ('GO_0007631', 'feeding behavior', 18, 'feeding'), ('UBERON_0001348', 'brown adipose tissue', 131, 'breast milk'), ('CHEBI_27300', 'vitamin D', 173, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 275, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D'), ('UBERON_0007023', 'adult organism', 365, 'adults'), ('CHEBI_71657', 'versiconol acetate', 396, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 396, '25(OH ... D')]
S41-PMC5418719	PMC5418719	5/2017	S41-PMC5418719	['TO EVALUATE the EFFECT of the course of prematurity on Vitamin D status, we EVALUATED Respiratory Distress syndrome (rds), patent Ductus Arteriosus (pda), necrotizing enterocolitis (nec\u2009≥\u2009grade 2), sepsis (clinical or proven), bronchopulmonary dysplasia (bpd, ≥ moderate), retinopathy of prematurity, Intraventricular hemorrhage (ivh\u2009≥\u2009grade 2), type of infant formula, ventilation days, hospital days and total parenteral nutrition days.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 16), ('QUESTION_ANSWERED_BY_THIS_WORK', 76)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('UBERON_0003495', 'respiratory system arteriole', 86, 'respiratory distress'), ('UBERON_0002254', 'thyroglossal duct', 130, 'ductus arteriosus'), ('UBERON_0006250', 'infundibular recess of 3rd ventricle', 301, 'intraventricular')]
S77-PMC5418719	PMC5418719	5/2017	S77-PMC5418719	['caption (table-wrap): table 2\n\nVitamin D statusvariablecord 25(Oh)D concentrations <10\xa0ng/mlcord 25(Oh)D concentrations ≥10\xa0ng/ml p at Birth\u2003n2029\u2003Serum 25(Oh)D levels8.3\u2009±\u20091.921.4\u2009±\u20098.5<0.001\u2003Vitamin D sufficiency (>30\xa0ng/ml)0 (0%)5 (17%)0.0732\u2009±\u20091\xa0weeks Postmenstrual age\u2003n1318\u2003Serum 25(Oh)d levels15.3\u2009±\u200910.124.1\u2009±\u20099.30.05\u2003Vitamin D sufficiency (>30\xa0ng/ml)3 (23%)4 (22%)1.0036\u2009±\u20091\xa0weeks Postmenstrual age\u2003n1726\u2003Serum 25(Oh)D levels43.1\u2009±\u200920.357.7\u2009±\u200921.90.03\u2003Vitamin D sufficiency (>30\xa0ng/ml)11 (65%)23 (88%)0.12\ndata are presented as n (%), median (range), or mean\u2009±\u2009sd\ntable\xa03presents the levels of Serum calcium, Phosphorous, alkaline phosphatase level at Birth, 32\u2009±\u20091\xa0weeks pma, and 36\u2009±\u20091\xa0weeks pma as MARKERS of Vitamin D status.']	[('SUPERFICIAL_RELATIONSHIP', 710)]	1	[('CHEBI_28384', 'vitamin K', 31, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 60, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 97, '25(OH)D'), ('GO_0007567', 'parturition', 135, 'birth'), ('UBERON_0001977', 'blood serum', 147, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 153, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 153, '25(OH)D'), ('CHEBI_28384', 'vitamin K', 193, 'Vitamin D'), ('GO_0008283', 'cell proliferation', 256, 'postmenstrual'), ('UBERON_0001977', 'blood serum', 280, 'Serum'), ('CHEBI_63056', 'zinc cation', 286, '25(OH'), ('CHEBI_28384', 'vitamin K', 326, 'Vitamin D'), ('GO_0008283', 'cell proliferation', 390, 'postmenstrual'), ('UBERON_0001977', 'blood serum', 414, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 420, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 420, '25(OH)D'), ('CHEBI_28384', 'vitamin K', 461, 'Vitamin D'), ('UBERON_0001977', 'blood serum', 603, 'serum'), ('CHEBI_30207', 'phosphorus(.)', 618, 'phosphorous'), ('GO_0007567', 'parturition', 661, 'birth'), ('CHEBI_27300', 'vitamin D', 721, 'vitamin D')]
S96-PMC5418719	PMC5418719	5/2017	S96-PMC5418719	['moreover, INADEQUATE Vitamin D levels in Cord Blood are ASSOCIATED with Immune status and the prevalence of SEVERE Respiratory Tract infections in the first year of Life, as well as reduced bone density during childhood [18–20].']	[('IMPORTANT_CONSIDERATION', 10), ('SUPERFICIAL_RELATIONSHIP', 56), ('IMPORTANT_CONSIDERATION', 108)]	3	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('UBERON_0009472', 'axilla', 41, 'cord blood'), ('UBERON_0002405', 'immune system', 72, 'immune'), ('UBERON_0000065', 'respiratory tract', 115, 'respiratory tract'), ('UBERON_0000104', 'life cycle', 165, 'life')]
S97-PMC5418719	PMC5418719	5/2017	S97-PMC5418719	['serial measurements of Serum 25(Oh)D to evaluate Vitamin D status during hospitalization MAY HELP to identify preterm infants AT RISK of Vitamin D deficiency.']	[('INCOMPLETE_EVIDENCE', 89), ('FUTURE_WORK', 93), ('IMPORTANT_CONSIDERATION', 126)]	3	[('UBERON_0001977', 'blood serum', 23, 'serum'), ('CHEBI_71657', 'versiconol acetate', 29, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 29, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
S101-PMC5418719	PMC5418719	5/2017	S101-PMC5418719	['preterm infants with radiologic evidence of rickets or high alkaline phosphatase (>800\xa0iu/l) are GENERALLY given the upper intake total of 800\xa0iu/day of Vitamin D. DESPITE Vitamin D supplementation, it is DIFFICULT to maintain the RECOMMENDED daily Vitamin D intake from dietary in preterm infants, and there are FEW EVIDENCE-based data to support Vitamin D supplementation to meet a desired Serum 25(Oh)D ACCORDING to Vitamin D status at Birth in preterm infants.']	[('PROBABLE_UNDERSTANDING', 97), ('ANOMALY_CURIOUS_FINDING', 164), ('DIFFICULT_TASK', 205), ('FUTURE_WORK', 231), ('INCOMPLETE_EVIDENCE', 313), ('SUPERFICIAL_RELATIONSHIP', 406)]	6	[('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('UBERON_0001977', 'blood serum', 392, 'serum'), ('CHEBI_71657', 'versiconol acetate', 398, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 401, 'OH ... D'), ('CHEBI_27300', 'vitamin D', 419, 'vitamin D'), ('GO_0007567', 'parturition', 439, 'birth')]
S122-PMC5418719	PMC5418719	5/2017	S122-PMC5418719	['the POTENTIAL risk of Vitamin D deficiency on Immune status of preterm infants at Birth has attracted much INTEREST RECENTLY [32].']	[('INCOMPLETE_EVIDENCE', 4), ('ANOMALY_CURIOUS_FINDING', 107), ('INCOMPLETE_EVIDENCE', 116)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0002405', 'immune system', 46, 'immune'), ('GO_0007567', 'parturition', 82, 'birth')]
S125-PMC5418719	PMC5418719	5/2017	S125-PMC5418719	['SIMILAR TO PREVIOUS REPORTS [34,35], in the PRESENT STUDY, women with gdm had a significantly INCREASED RISK of deficient Vitamin D status with cord 25(Oh)D concentrations\u2009≤\u200910\xa0ng/ml.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 20), ('QUESTION_ANSWERED_BY_THIS_WORK', 44), ('IMPORTANT_CONSIDERATION', 94)]	5	[('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('CHEBI_33010', 'chromide(1-)', 151, '(OH)D')]
S131-PMC5418719	PMC5418719	5/2017	S131-PMC5418719	['INTERESTINGLY, preterm morbidities INFLUENCING Vitamin D status had no significant differences between the groups in our patients.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 35)]	2	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D')]
S13-PMC5426325	PMC5426325	4/2017	S13-PMC5426325	['BASED ON Serum 25-Hydroxy Vitamin D3(25(Oh)D3) measurements, STUDIES HAVE SHOWN a pronounced seasonal variation in Vitamin D status in denmark and other countries with latitudes above 35° north and south(1,2), MOST LIKELY RELATED to insufficient actinic Vitamin D Synthesis during the darker part of the year in such countries.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 69), ('PROBABLE_UNDERSTANDING', 210), ('SUPERFICIAL_RELATIONSHIP', 222)]	5	[('UBERON_0001977', 'blood serum', 9, 'serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 15, '25-hydroxy'), ('CHEBI_33279', 'vitamin D5', 26, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 26, 'vitamin D3'), ('CHEBI_62946', 'ammonium sulfate', 37, '25(OH)D3'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('GO_0042368', 'vitamin D biosynthetic process', 254, 'vitamin D synthesis')]
S14-PMC5426325	PMC5426325	4/2017	S14-PMC5426325	['CONSEQUENTLY, the Vitamin D status will then depend more on diet, supplementation and/or fortification alone.']	[('PROBABLE_UNDERSTANDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D')]
S15-PMC5426325	PMC5426325	4/2017	S15-PMC5426325	['in denmark, the reintroduction of fortified Foods to improve the general population’s Vitamin D status is currently being CONSIDERED, and its justification is part of an ongoing international DEBATE.']	[('FUTURE_WORK', 122), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 192)]	2	[('CHEBI_33290', 'food', 44, 'foods'), ('CHEBI_27300', 'vitamin D', 86, 'vitamin D')]
S19-PMC5426325	PMC5426325	4/2017	S19-PMC5426325	['the EVIDENCE for LINKING maternal Vitamin D insufficiency to offspring fracture rates is SPARSE and is BASED ON results from Animal studies(5), as well as observational studies SUGGESTING that maternal Vitamin D status INFLUENCES fetal bone growth and mineralisation(6), and PERHAPS also long-term bone health among offspring(7–12).']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 17), ('INCOMPLETE_EVIDENCE', 89), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 177), ('SUPERFICIAL_RELATIONSHIP', 219), ('INCOMPLETE_EVIDENCE', 275)]	7	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 125, 'animal'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D')]
S135-PMC5426325	PMC5426325	4/2017	S135-PMC5426325	['the RELATIONSHIP between Vitamin D status during fetal Life and long-term bone health has not previously been widely examined, and results from earlier observational studies SHOWED EITHER no association or a direct association.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 174), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 181)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('UBERON_0000104', 'life cycle', 55, 'life')]
S136-PMC5426325	PMC5426325	4/2017	S136-PMC5426325	['in the avon longitudinal study of parents and children (alspac) study, uv-b-exposure during the third Trimester of Pregnancy was used as a PROXY for Vitamin D status, and the exposure was directly ASSOCIATED with bone Mineral content (bmc), bone area and bmd among 6955 children at age 9·9 years(8).']	[('SUPERFICIAL_RELATIONSHIP', 139), ('SUPERFICIAL_RELATIONSHIP', 197)]	2	[('GO_0009294', 'DNA mediated transformation', 102, 'trimester'), ('GO_0007565', 'female pregnancy', 115, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('CHEBI_46662', 'mineral', 218, 'mineral')]
S146-PMC5426325	PMC5426325	4/2017	S146-PMC5426325	['from systematic review and meta-analysis of randomised controlled trials, THERE IS EVIDENCE that Vitamin D-fortified Foods GENERALLY improve Vitamin D status among both children and Adults in a dose-DEPENDENT manner(57–59).']	[('INCOMPLETE_EVIDENCE', 74), ('PROBABLE_UNDERSTANDING', 123), ('SUPERFICIAL_RELATIONSHIP', 199)]	3	[('CHEBI_27300', 'vitamin D', 97, 'vitamin D'), ('CHEBI_33290', 'food', 117, 'foods'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('UBERON_0007023', 'adult organism', 182, 'adults')]
S152-PMC5426325	PMC5426325	4/2017	S152-PMC5426325	['UNFORTUNATELY, we LACK INFORMATION on Vitamin D status among danish women in the Reproductive age during the fortification period, BUT for comparision, a study SHOWED that among 850 Pregnant women recruited from the second-largest city in denmark in 1988–1989 (the period without fortification), only 6·3 of the Pregnant women had a Serum 25(Oh)D concentration ≤25 nmol/l(12); the median concentrations of 76·2 (95 % ci 23·0, 152·1) nmol/l were also above the ‘OPTIMAL level’ as STATED by the us Endocrine society(62,63).']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 23), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('INCOMPLETE_EVIDENCE', 160), ('IMPORTANT_CONSIDERATION', 461), ('INCOMPLETE_EVIDENCE', 479)]	7	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0000003', 'reproduction', 81, 'reproductive'), ('GO_0007565', 'female pregnancy', 182, 'pregnant'), ('GO_0007565', 'female pregnancy', 312, 'pregnant'), ('UBERON_0001977', 'blood serum', 333, 'serum'), ('CHEBI_71657', 'versiconol acetate', 339, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 339, '25(OH)D'), ('UBERON_0005063', 'left ventricular compact myocardium', 496, 'Endocrine')]
S140-PMC5452160	PMC5452160	4/2017	S140-PMC5452160	['APPROXIMATELY 80% of women had inadequate or marginal Vitamin A status.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 54, 'vitamin A')]
S40-PMC5474873	PMC5474873	6/2017	S40-PMC5474873	['given the LIMITED RESEARCH, the AIM of THIS STUDY is TO INVESTIGATE the ASSOCIATION between Adult Life sun exposure (AS a PROXY for Vitamin D status) and later pes.']	[('INCOMPLETE_EVIDENCE', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 32), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('QUESTION_ANSWERED_BY_THIS_WORK', 53), ('SUPERFICIAL_RELATIONSHIP', 72), ('PROBABLE_UNDERSTANDING', 117), ('SUPERFICIAL_RELATIONSHIP', 122)]	7	[('UBERON_0000113', 'post-juvenile adult stage', 92, 'adult life'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D')]
S161-PMC5474873	PMC5474873	6/2017	S161-PMC5474873	['we had NO biological DATA on Vitamin D levels, which COULD have established a clear LINK to Vitamin D, ALTHOUGH it is WELL KNOWN that sun exposure is the MOST IMPORTANT DETERMINANT of Vitamin D status (9,13).']	[('FULL_UNKNOWN', 7), ('INCOMPLETE_EVIDENCE', 53), ('SUPERFICIAL_RELATIONSHIP', 84), ('ANOMALY_CURIOUS_FINDING', 103), ('INCOMPLETE_EVIDENCE', 118), ('PROBABLE_UNDERSTANDING', 154), ('IMPORTANT_CONSIDERATION', 159), ('SUPERFICIAL_RELATIONSHIP', 169)]	8	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D')]
S75-PMC5485024	PMC5485024	3/2017	S75-PMC5485024	['parental smoking, bmi status, or diet (Vitamin D, Omega‐3 Fatty Acids, Omega‐6 Fatty Acids or dietary supplements) at age 8 years DID NOT influence the OBSERVED or and were not included in the final model.']	[('INCOMPLETE_EVIDENCE', 130), ('INCOMPLETE_EVIDENCE', 152)]	2	"[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('CHEBI_75908', ""5'-CTGC-3' dsDNA oligonucleotide"", 50, 'omega‐3 fatty acids'), ('CHEBI_75908', ""5'-CTGC-3' dsDNA oligonucleotide"", 71, 'omega‐6 fatty acids')]"
S0-PMC5489519	PMC5489519	6/2017	S0-PMC5489519	['Vitamin D MODULATION of Trail expression in Human Milk and Mammary Epithelial Cells\n\nabstract\nthe Vitamin D levels in mothers AFFECT the health status of both the mother and breastfeeding infant.']	[('SUPERFICIAL_RELATIONSHIP', 10), ('SUPERFICIAL_RELATIONSHIP', 126)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 24, 'TRAIL'), ('NCBITaxon_10088', 'Mus <genus>', 44, 'Human'), ('UBERON_0001913', 'milk', 50, 'Milk'), ('CL_0002458', 'langerin-positive dermal dendritic cell', 59, 'Mammary Epithelial Cells'), ('UBERON_0006918', 'parakeratinized epithelium of tongue', 59, 'Mammary Epithelial'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D')]
S2-PMC5489519	PMC5489519	6/2017	S2-PMC5489519	['WHILE Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (Trail) HAS BEEN IMPLICATED in Cellular growth/Apoptosis, Immune Cell function and Bone-Resorbing Osteoclast formation, the Expression of Trail in Human milk as a function of Vitamin D status in mothers REMAINS UNKNOWN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 79), ('FULL_UNKNOWN', 265)]	4	[('PR_000000035', 'BMP receptor type-1A', 6, 'tumor necrosis factor-related apoptosis inducing ligand'), ('GO_0006915', 'apoptotic process', 36, 'apoptosis'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 63, 'TRAIL'), ('GO_0006915', 'apoptotic process', 93, 'cellular ... apoptosis'), ('CL_0000738', 'leukocyte', 120, 'immune cell'), ('UBERON_0002405', 'immune system', 120, 'immune'), ('GO_0046849', 'bone remodeling', 145, 'bone-resorbing'), ('CL_0000092', 'osteoclast', 160, 'osteoclast'), ('GO_0010467', 'gene expression', 186, 'expression'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 200, 'TRAIL'), ('NCBITaxon_9606', 'Homo sapiens', 209, 'human'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin D')]
S8-PMC5489519	PMC5489519	6/2017	S8-PMC5489519	['our results INDICATE that Vitamin D status in mothers Modulates Trail Expression in Breast Milk, which MAY have IMPLICATIONS for both mother and infant health.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 103), ('IMPORTANT_CONSIDERATION', 112)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0065007', 'biological regulation', 54, 'modulates'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 64, 'TRAIL'), ('GO_0010467', 'gene expression', 70, 'expression'), ('UBERON_0001348', 'brown adipose tissue', 84, 'breast milk')]
S16-PMC5489519	PMC5489519	6/2017	S16-PMC5489519	['studies have SUGGESTED that the Vitamin D status of mother DETERMINES the Vitamin D levels of breastfeeding infant12–14.']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 59)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D')]
S17-PMC5489519	PMC5489519	6/2017	S17-PMC5489519	['evidently, randomized controlled clinical trials INDICATED the beneficial ROLE of maternal Vitamin D supplementation on the Vitamin D status of breastfed infants14,15.']	[('INCOMPLETE_EVIDENCE', 49), ('SUPERFICIAL_RELATIONSHIP', 74)]	2	[('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D')]
S36-PMC5489519	PMC5489519	6/2017	S36-PMC5489519	['Serum 25(Oh)D levels were measured to evaluate the active form of Vitamin D [1,25(Oh)2D] status in maternal blood as classified by the Endocrine society clinical practice GUIDELINE25.']	[('PROBABLE_UNDERSTANDING', 171)]	1	"[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 6, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 66, 'vitamin D'), ('CHEBI_37958', 'dye', 77, '1,'), ('CHEBI_66212', ""5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone"", 79, '25(OH)2D'), ('UBERON_0005063', 'left ventricular compact myocardium', 135, 'Endocrine')]"
S46-PMC5489519	PMC5489519	6/2017	S46-PMC5489519	['these results SUGGEST that Vitamin D status in mothers Modulate Trail Expression levels in Human Breast Milk.']	[('INCOMPLETE_EVIDENCE', 14)]	1	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0065007', 'biological regulation', 55, 'modulate'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 64, 'TRAIL'), ('GO_0010467', 'gene expression', 70, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 91, 'human'), ('UBERON_0000310', 'breast', 97, 'breast'), ('UBERON_0001913', 'milk', 104, 'milk')]
S87-PMC5489519	PMC5489519	6/2017	S87-PMC5489519	['THEREFORE, our results INDICATE that Trail\xa0is Expressed in Breast Milk as a FUNCTION of Vitamin D status in mothers.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 76)]	3	[('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 37, 'TRAIL'), ('GO_0010467', 'gene expression', 46, 'expressed'), ('UBERON_0001348', 'brown adipose tissue', 59, 'breast milk'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
S2-PMC5513133	PMC5513133	7/2017	S2-PMC5513133	['evidence of the ROLE of Vitamin D status and supplementation in the etiology and PREVENTION of pe is reviewed in THIS ARTICLE along with identification of research gaps to inform FUTURE STUDIES.']	[('SUPERFICIAL_RELATIONSHIP', 16), ('SUPERFICIAL_RELATIONSHIP', 81), ('QUESTION_ANSWERED_BY_THIS_WORK', 113), ('FUTURE_WORK', 179)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
S4-PMC5513133	PMC5513133	7/2017	S4-PMC5513133	['these sources were retrieved, collected, indexed, and ASSESSED for availability of Pregnancy-related data on pe and Vitamin D.\n\nresults\nseveral case-control studies and cross-sectional studies HAVE SHOWN an ASSOCIATION between Vitamin D status and pe, ALTHOUGH EVIDENCE HAS BEEN INCONSISTENT.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 54), ('INCOMPLETE_EVIDENCE', 193), ('SUPERFICIAL_RELATIONSHIP', 207), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 252), ('INCOMPLETE_EVIDENCE', 261), ('INCOMPLETE_EVIDENCE', 270), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 279)]	7	[('GO_0007565', 'female pregnancy', 83, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D')]
S42-PMC5513133	PMC5513133	7/2017	S42-PMC5513133	['RISK FACTORS that AFFECT Vitamin D status include season, time of the day, latitude, clothing and skin color [32].']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 18)]	2	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D')]
S138-PMC5513133	PMC5513133	7/2017	S138-PMC5513133	['OBSERVATIONAL studies which measured Vitamin D status after the onset of pe [53,82] near Delivery [83] or at Delivery [84,85] SUGGEST an inverse ASSOCIATION with pe.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 126), ('SUPERFICIAL_RELATIONSHIP', 145)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007567', 'parturition', 89, 'delivery'), ('GO_0007567', 'parturition', 109, 'delivery')]
S177-PMC5513133	PMC5513133	7/2017	S177-PMC5513133	['RETROSPECTIVELY ANALYZED Vitamin D status and the risk of pe in 697 nulliparous women with singleton Pregnancies in a randomized, placebo-controlled trial of vitamin c and e supplementation for the PREVENTION of pe.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 198)]	3	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 101, 'pregnancies')]
S237-PMC5513133	PMC5513133	7/2017	S237-PMC5513133	['additionally, investigators SHOULD ATTEMPT to assess Preconception and early Pregnancy dietary intake, sun exposure or baseline Vitamin D status.']	[('FUTURE_WORK', 28), ('DIFFICULT_TASK', 35)]	2	[('GO_0007565', 'female pregnancy', 53, 'preconception'), ('GO_0007565', 'female pregnancy', 77, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
S253-PMC5513133	PMC5513133	7/2017	S253-PMC5513133	['HOWEVER, women with a Serum Vitamin D status of ≥75\xa0nmol/l that was maintained from enrollment through late Pregnancy had a significantly lower RISK of pe versus women who had <75\xa0nmol/l ( p \xa0=\xa00.04).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 144)]	3	[('UBERON_0001977', 'blood serum', 22, 'serum'), ('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0007565', 'female pregnancy', 108, 'pregnancy')]
S269-PMC5513133	PMC5513133	7/2017	S269-PMC5513133	['FUTURE STUDIES SHOULD include follow up from the pre-Conception period until Delivery to ELUCIDATE the mechanisms and INTERACTIONS which DRIVE Vitamin D status, response, and onset of pe to inform population-specific dose RECOMMENDATIONS.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 15), ('FUTURE_WORK', 89), ('SUPERFICIAL_RELATIONSHIP', 118), ('SUPERFICIAL_RELATIONSHIP', 137), ('FUTURE_WORK', 222)]	6	[('GO_0007620', 'copulation', 53, 'conception'), ('GO_0007567', 'parturition', 77, 'delivery'), ('CHEBI_27300', 'vitamin D', 143, 'vitamin D')]
S17-PMC5524288	PMC5524288	7/2017	S17-PMC5524288	['multiple epidemiologic STUDIES have FOUND an ASSOCIATION between higher maternal Serum 25-Hydroxyvitamin D [25(Oh)D] concentration, the physiological measure of Vitamin D status, and lower ptb RISK [4–10].']	[('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 45), ('IMPORTANT_CONSIDERATION', 193)]	4	[('UBERON_0001977', 'blood serum', 81, 'serum'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 87, '25-hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 108, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin D')]
S111-PMC5524288	PMC5524288	7/2017	S111-PMC5524288	['THESE FINDINGS SHOW that higher Vitamin D status is significantly ASSOCIATED with lower ptb RISK for both ptb subtypes and that Vitamin D plays an IMPORTANT ROLE in the UNDERLYING causes of indicated ptb including maternal hypertension, pre-existing diabetes, and non-reassuring fetal status.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 66), ('IMPORTANT_CONSIDERATION', 92), ('IMPORTANT_CONSIDERATION', 147), ('SUPERFICIAL_RELATIONSHIP', 157), ('SUPERFICIAL_RELATIONSHIP', 169)]	7	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D')]
S112-PMC5524288	PMC5524288	7/2017	S112-PMC5524288	['IMPROVING the Vitamin D status of women with underlying conditions MAY AVERT the need for a medically indicated Preterm Delivery.']	[('FUTURE_WORK', 0), ('FUTURE_PREDICTION', 67), ('SUPERFICIAL_RELATIONSHIP', 71)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 112, 'preterm'), ('GO_0007567', 'parturition', 120, 'delivery')]
S116-PMC5524288	PMC5524288	7/2017	S116-PMC5524288	['THESE FINDINGS SUGGEST that IMPROVEMENTS in Vitamin D status MAY decrease the DISPARITY in ptb rates between race/ethnic groups.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('FUTURE_WORK', 28), ('FUTURE_PREDICTION', 61), ('IMPORTANT_CONSIDERATION', 78)]	5	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D')]
S117-PMC5524288	PMC5524288	7/2017	S117-PMC5524288	['additionally, for women with a prior ptb, the substantial decrease in recurrent ptb RISK (80%) for ≥40 ng/ml vs. <20 ng/ml INDICATES that IMPROVING Vitamin D status in this HIGH RISK subgroup COULD sizably reduce ptb rates.']	[('IMPORTANT_CONSIDERATION', 84), ('INCOMPLETE_EVIDENCE', 123), ('FUTURE_WORK', 138), ('IMPORTANT_CONSIDERATION', 173), ('FUTURE_PREDICTION', 192)]	5	[('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]
S118-PMC5524288	PMC5524288	7/2017	S118-PMC5524288	['among women with initial 25(Oh)D concentrations <40 ng/ml, the significantly lower ptb rate (60%) for those who achieved ≥40 ng/ml COMPARED TO those who did not reach the target concentration on a follow-up test SUGGESTS that maternal Vitamin D status is a MODIFIABLE RISK FACTOR that CAN be addressed during the Prenatal period.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 131), ('INCOMPLETE_EVIDENCE', 212), ('IMPORTANT_CONSIDERATION', 257), ('SUPERFICIAL_RELATIONSHIP', 268), ('INCOMPLETE_EVIDENCE', 285)]	5	[('CHEBI_71657', 'versiconol acetate', 25, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 25, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 235, 'vitamin D'), ('GO_0007565', 'female pregnancy', 313, 'prenatal')]
S120-PMC5524288	PMC5524288	7/2017	S120-PMC5524288	['this INDICATES that IMPROVING the Vitamin D status of non-white women, who are known to have PARTICULARLY low Vitamin D concentrations, COULD DRAMATICALLY decrease racial DISPARITIES in ptb rates.']	[('INCOMPLETE_EVIDENCE', 5), ('FUTURE_WORK', 20), ('IMPORTANT_CONSIDERATION', 93), ('FUTURE_PREDICTION', 136), ('ANOMALY_CURIOUS_FINDING', 142), ('IMPORTANT_CONSIDERATION', 171)]	6	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
S126-PMC5524288	PMC5524288	7/2017	S126-PMC5524288	['additionally, using Serum 25(Oh)D concentration is a BETTER INDICATOR of Vitamin D status and statistically more powerful than using reported Intake BECAUSE it ACCOUNTS FOR all Vitamin D input sources (sun exposure, Food, and Supplements) and makes provision for inter-Individual VARIABILITY in Vitamin D dose response.']	[('PROBABLE_UNDERSTANDING', 53), ('SUPERFICIAL_RELATIONSHIP', 60), ('PROBABLE_UNDERSTANDING', 149), ('INCOMPLETE_EVIDENCE', 160), ('DIFFICULT_TASK', 280)]	5	[('UBERON_0001977', 'blood serum', 20, 'serum'), ('CHEBI_71657', 'versiconol acetate', 26, '25(OH)D'), ('PR_000011040', 'nuclear receptor coactivator 1', 28, '(OH'), ('PR_000006444', 'diacylglycerol kinase delta', 32, 'D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('GO_0007631', 'feeding behavior', 142, 'intake'), ('CHEBI_27300', 'vitamin D', 177, 'vitamin D'), ('CHEBI_33290', 'food', 216, 'food'), ('CHEBI_33341', 'titanium atom', 226, 'supplements'), ('NCBITaxon_1', 'root', 269, 'individual'), ('CHEBI_27300', 'vitamin D', 295, 'vitamin D')]
S16-PMC5537904	PMC5537904	7/2017	S16-PMC5537904	['current Human EVIDENCE SUPPORTING the ASSOCIATION between Prenatal Vitamin D intake, neonatal Vitamin D status, and offspring adiposity is MIXED.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 139)]	4	[('NCBITaxon_9606', 'Homo sapiens', 8, 'human'), ('GO_0007565', 'female pregnancy', 58, 'prenatal'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
S23-PMC5537904	PMC5537904	7/2017	S23-PMC5537904	['in addition, FEW STUDIES EXAMINED WHETHER Gestational weight gain OR body mass index (bmi) modify the ASSOCIATIONS between Prenatal Vitamin D intake, neonatal Vitamin D status, and offspring adiposity.']	[('INCOMPLETE_EVIDENCE', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('SUPERFICIAL_RELATIONSHIP', 102)]	4	[('GO_0007565', 'female pregnancy', 42, 'gestational'), ('GO_0007565', 'female pregnancy', 123, 'prenatal'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D')]
S25-PMC5537904	PMC5537904	7/2017	S25-PMC5537904	['THUS, the PURPOSE of THIS analysis was TO EXAMINE the ASSOCIATIONS between Prenatal Vitamin D intake, neonatal Vitamin D status, and early Life body composition.']	[('PROBABLE_UNDERSTANDING', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('QUESTION_ANSWERED_BY_THIS_WORK', 39), ('SUPERFICIAL_RELATIONSHIP', 54)]	5	[('GO_0007565', 'female pregnancy', 75, 'prenatal'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('UBERON_0000104', 'life cycle', 139, 'life')]
S173-PMC5537904	PMC5537904	7/2017	S173-PMC5537904	['continued RESEARCH into the IMPLICATIONS of Cord Blood 25(Oh)D status IS NEEDED to guide RECOMMENDATIONS for Prenatal Vitamin D intake.']	[('FUTURE_WORK', 10), ('IMPORTANT_CONSIDERATION', 28), ('FUTURE_WORK', 70), ('FUTURE_WORK', 89)]	4	[('UBERON_0002240', 'spinal cord', 44, 'cord'), ('UBERON_0000178', 'blood', 49, 'blood'), ('CHEBI_71657', 'versiconol acetate', 55, '25(OH)D'), ('GO_0007565', 'female pregnancy', 109, 'prenatal'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D')]
S0-PMC5539754	PMC5539754	8/2017	S0-PMC5539754	['season and Vitamin D status are INDEPENDENTLY ASSOCIATED with Glucose Homeostasis in Pregnancy\n\nabstract\n\nbackground\nVitamin D status and season are intrinsically LINKED, and both have been PROPOSED to be ASSOCIATED with Glucose Homeostasis in Pregnancy, with CONFLICTING results.']	[('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 46), ('SUPERFICIAL_RELATIONSHIP', 163), ('INCOMPLETE_EVIDENCE', 190), ('SUPERFICIAL_RELATIONSHIP', 205), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 260)]	6	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_17234', 'glucose', 62, 'glucose'), ('GO_0042593', 'glucose homeostasis', 62, 'glucose homeostasis'), ('GO_0007565', 'female pregnancy', 85, 'pregnancy'), ('CHEBI_28384', 'vitamin K', 117, 'Vitamin D'), ('CHEBI_17234', 'glucose', 221, 'glucose'), ('GO_0042593', 'glucose homeostasis', 221, 'glucose homeostasis'), ('GO_0007565', 'female pregnancy', 244, 'pregnancy')]
S10-PMC5539754	PMC5539754	8/2017	S10-PMC5539754	['our NOVEL FINDINGS IMPLY that seasonal variation in Insulin resistance MAY NOT be fully EXPLAINED by differences in Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 19), ('INCOMPLETE_EVIDENCE', 71), ('PROBABLE_UNDERSTANDING', 88)]	4	[('PR_000045358', 'insulin family protein', 52, 'insulin'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
S14-PMC5539754	PMC5539754	8/2017	S14-PMC5539754	['background\nVitamin D status and season are intrinsically LINKED; upon exposure to natural ultraviolet solar radiation, endogenous skin Production Of Vitamin D occurs.']	[('SUPERFICIAL_RELATIONSHIP', 57)]	1	[('CHEBI_28384', 'vitamin K', 11, 'Vitamin D'), ('GO_0018240', 'protein S-linked glycosylation via cysteine', 135, 'production of vitamin D'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D')]
S105-PMC5539754	PMC5539754	8/2017	S105-PMC5539754	['GIVEN that the ASSOCIATION between early Gestation through extended winter and Insulin resistance is INDEPENDENT of Serum 25Ohd <30\xa0nmol/l, our NOVEL FINDINGS IMPLY that seasonal variation in Insulin resistance MAY NOT be fully EXPLAINED by differences in Vitamin D status.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 15), ('SUPERFICIAL_RELATIONSHIP', 101), ('INCOMPLETE_EVIDENCE', 144), ('PROBABLE_UNDERSTANDING', 159), ('INCOMPLETE_EVIDENCE', 211), ('PROBABLE_UNDERSTANDING', 228)]	7	"[('GO_0007565', 'female pregnancy', 41, 'gestation'), ('PR_000045358', 'insulin family protein', 79, 'insulin'), ('UBERON_0001977', 'blood serum', 116, 'serum'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 122, '25OHD'), ('PR_000045358', 'insulin family protein', 192, 'insulin'), ('CHEBI_27300', 'vitamin D', 256, 'vitamin D')]"
S15-PMC5546866	PMC5546866	8/2017	S15-PMC5546866	['furthermore, ASSOCIATIONS between maternal Vitamin D status and obstetric COMPLICATIONS (4) and offspring Musculoskeletal Development (5–7) HAVE BEEN REPORTED.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('PROBLEM_COMPLICATION', 74), ('INCOMPLETE_EVIDENCE', 140)]	3	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0061375', 'mammillotectal axonal tract development', 106, 'musculoskeletal development'), ('UBERON_0002204', 'musculoskeletal system', 106, 'musculoskeletal')]
S26-PMC5546866	PMC5546866	8/2017	S26-PMC5546866	['CONSIDERING this and the physiological changes to the Vitamin D pathway in Pregnancy, it is THEREFORE POSSIBLE that the Genetic variants ASSOCIATED with baseline Serum 25(Oh)d status and the response to supplementation also differ between the Pregnant and nonpregnant state.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 92), ('INCOMPLETE_EVIDENCE', 102), ('SUPERFICIAL_RELATIONSHIP', 137)]	4	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('SO_0000704', 'gene', 120, 'genetic'), ('UBERON_0001977', 'blood serum', 162, 'serum'), ('CHEBI_30778', 'gallic acid', 168, '25(OH)'), ('GO_0007565', 'female pregnancy', 243, 'pregnant')]
S27-PMC5546866	PMC5546866	8/2017	S27-PMC5546866	['we THEREFORE undertook THIS STUDY TO DETERMINE WHETHER Snps within the Vitamin D Metabolism pathway KNOWN to modify Vitamin D status are also ASSOCIATED with the response to Antenatal Vitamin d supplementation.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 23), ('QUESTION_ANSWERED_BY_THIS_WORK', 34), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 47), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 142)]	6	[('SO_0000694', 'SNP', 55, 'SNPs'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 71, 'vitamin D metabolism'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007567', 'parturition', 174, 'antenatal'), ('CHEBI_33229', 'vitamin (role)', 184, 'vitamin')]
S118-PMC5546866	PMC5546866	8/2017	S118-PMC5546866	['discussion\nTHIS STUDY ASSESSED the RELATIONSHIPS between common Genetic variants and the response to Vitamin D supplementation in Pregnancy; rs12785878 in dhcr7 was ASSOCIATED with 25(Oh)D status in early Pregnancy prior to Vitamin D supplementation, WHEREAS rs10741657 in Cyp2R1 and rs2282679 in gc were ASSOCIATED with both the achieved and change in 25(Oh)D concentration following supplementation with 1000 iu/d Cholecalciferol.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 22), ('SUPERFICIAL_RELATIONSHIP', 35), ('SUPERFICIAL_RELATIONSHIP', 165), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 251), ('SUPERFICIAL_RELATIONSHIP', 305)]	6	[('SO_0000704', 'gene', 64, 'genetic'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 130, 'pregnancy'), ('CHEBI_30778', 'gallic acid', 181, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 187, 'D'), ('GO_0007565', 'female pregnancy', 205, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 224, 'vitamin D'), ('PR_000006110', 'cytochrome P450 27, mitochondrial', 273, 'CYP2R1'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 356, 'OH)D'), ('CHEBI_52550', 'theopalauamide', 416, 'cholecalciferol')]
S132-PMC5546866	PMC5546866	8/2017	S132-PMC5546866	['we FOUND that the rs10741657 Snp was not associated with baseline 25(Oh)D BUT was ASSOCIATED with the response to Gestational Vitamin D supplementation, THEREFORE SUGGESTING that this Snp ONLY modifies 25(Oh)D status when the substrate is more readily available and that at the baseline measurement, saturation of the enzyme had not been reached.']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 74), ('SUPERFICIAL_RELATIONSHIP', 82), ('PROBABLE_UNDERSTANDING', 153), ('INCOMPLETE_EVIDENCE', 163), ('ANOMALY_CURIOUS_FINDING', 188)]	6	[('SO_0000694', 'SNP', 29, 'SNP'), ('CHEBI_71657', 'versiconol acetate', 66, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 66, '25(OH ... D'), ('GO_0007565', 'female pregnancy', 114, 'gestational'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('SO_0000694', 'SNP', 184, 'SNP'), ('CHEBI_71657', 'versiconol acetate', 202, '25(OH)D')]
S26-PMC5634602	PMC5634602	10/2017	S26-PMC5634602	['preterm infants2008[2]Endocrine society healthy infants 0–1 year400–1000 iu>75 nmol/l (for non-Skeletal benefits)0–1 Vitamin D deficient (<50 nmol/l) 2000 iu/D for 6 weeks followed by maintenance dosing2011[9]\nvery LITTLE data is available regarding response to Vitamin D supplementation in the smallest and youngest infants (<1200 grams at Birth), a population that MIGHT see the most BENEFIT from normalized Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 215), ('INCOMPLETE_EVIDENCE', 367), ('IMPORTANT_CONSIDERATION', 386)]	3	[('UBERON_0005063', 'left ventricular compact myocardium', 22, 'Endocrine'), ('UBERON_0004288', 'skeleton', 95, 'skeletal'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 158, 'D'), ('CHEBI_27300', 'vitamin D', 262, 'vitamin D'), ('GO_0007567', 'parturition', 341, 'birth'), ('CHEBI_27300', 'vitamin D', 410, 'vitamin D')]
S32-PMC5634602	PMC5634602	10/2017	S32-PMC5634602	['it is LIKELY that preterm infants will have a compromised Vitamin D status at Birth.']	[('PROBABLE_UNDERSTANDING', 6)]	1	[('CHEBI_27300', 'vitamin D', 58, 'vitamin D'), ('GO_0007567', 'parturition', 78, 'birth')]
S33-PMC5634602	PMC5634602	10/2017	S33-PMC5634602	['MANY STUDIES in the united states and abroad have DOCUMENTED maternal status to be SUBOPTIMAL and have CALLED for national programs to improve maternal Vitamin D status with increased supplementation dose and frequency [18–26].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 50), ('IMPORTANT_CONSIDERATION', 83), ('IMPORTANT_CONSIDERATION', 103), ('IMPORTANT_CONSIDERATION', 103)]	5	[('CHEBI_27300', 'vitamin D', 152, 'vitamin D')]
S36-PMC5634602	PMC5634602	10/2017	S36-PMC5634602	['IMPORTANTLY, SEVERAL STUDIES have DOCUMENTED an ASSOCIATION with decreasing 25(Oh)D levels and lower Gestational age at Delivery allowing for a situation where preterm infants are a highly vulnerable population at Birth with regards to their Vitamin D status [15,28,30].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 48)]	4	[('CHEBI_71657', 'versiconol acetate', 76, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 82, 'D'), ('GO_0007565', 'female pregnancy', 101, 'gestational'), ('GO_0007567', 'parturition', 120, 'delivery'), ('GO_0007567', 'parturition', 214, 'birth'), ('CHEBI_27300', 'vitamin D', 242, 'vitamin D')]
S38-PMC5634602	PMC5634602	10/2017	S38-PMC5634602	['preterm infants have a smaller size, leading to decreased volume Intake, and OFTEN have a compromised nutritional status during the initial hospitalization and are EVEN less LIKELY to get adequate Vitamin D intake from diet [15].']	[('PROBABLE_UNDERSTANDING', 77), ('ANOMALY_CURIOUS_FINDING', 164), ('PROBABLE_UNDERSTANDING', 174)]	3	[('GO_0007631', 'feeding behavior', 65, 'intake'), ('CHEBI_27300', 'vitamin D', 197, 'vitamin D')]
S84-PMC5634602	PMC5634602	10/2017	S84-PMC5634602	['we SHOWED significant improvements in Vitamin D status between the groups supplemented with 400 iu and 800 iu at four weeks of age.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D')]
S98-PMC5634602	PMC5634602	10/2017	S98-PMC5634602	['improving Vitamin D ALONE is not adequate to prevent POOR bone mineralization; this physiology is also DEPENDENT on delivery of appropriate amounts and ratios of Calcium and Phosphorus in the parenteral and enteral diet, as well as a patient’s over all nutrition status [21].']	[('ANOMALY_CURIOUS_FINDING', 20), ('IMPORTANT_CONSIDERATION', 53), ('SUPERFICIAL_RELATIONSHIP', 103)]	3	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 162, 'calcium'), ('CHEBI_35885', 'secondary phosphine', 174, 'phosphorus')]
S131-PMC5634602	PMC5634602	10/2017	S131-PMC5634602	['these infants are the HIGHEST RISK infants and are in need of additional evaluation of Vitamin D status and response to supplementation.']	[('IMPORTANT_CONSIDERATION', 22)]	1	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
S132-PMC5634602	PMC5634602	10/2017	S132-PMC5634602	['our dexa scan evaluation of these infants at term corrected age is an IMPORTANT INDICATOR of both short term and long-term benefits of improvement in Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 70), ('SUPERFICIAL_RELATIONSHIP', 80)]	2	[('CHEBI_27300', 'vitamin D', 150, 'vitamin D')]
S146-PMC5634602	PMC5634602	10/2017	S146-PMC5634602	['ALTERNATIVELY, the risks of RECOMMENDATION of too low a dose MAY have significant IMPACT on Individual and population health with disease outcomes ASSOCIATED with low Vitamin D status, including hypocalcemic seizures, growth restriction, fractures, and elevation of Serum Parathyroid hormone [53–55].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 28), ('INCOMPLETE_EVIDENCE', 61), ('SUPERFICIAL_RELATIONSHIP', 82), ('SUPERFICIAL_RELATIONSHIP', 147)]	5	[('NCBITaxon_1', 'root', 92, 'individual'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin D'), ('UBERON_0001977', 'blood serum', 266, 'serum'), ('UBERON_0001132', 'parathyroid gland', 272, 'parathyroid')]
S147-PMC5634602	PMC5634602	10/2017	S147-PMC5634602	['IN FACT, SOME authors, including heaney, have ARGUED that a physiological reference for optimal Vitamin D status would be between 100 and 130 nmol/l stating that BASED ON physiological outcomes such as normalization of pth and adequate Vitamin D supply in Breast Milk this level is SAFE for disease prevention without ASSOCIATION of toxicity [56].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 46), ('PROBABLE_UNDERSTANDING', 162), ('SUPERFICIAL_RELATIONSHIP', 162), ('IMPORTANT_CONSIDERATION', 282), ('SUPERFICIAL_RELATIONSHIP', 318)]	7	[('CHEBI_27300', 'vitamin D', 96, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D'), ('UBERON_0001348', 'brown adipose tissue', 256, 'breast milk')]
S148-PMC5634602	PMC5634602	10/2017	S148-PMC5634602	['OTHER authors have RECOMMENDED loading doses to more quickly improve Vitamin D status in AT RISK populations, a STRATEGY that MERITS FURTHER INVESTIGATION [57].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('FUTURE_WORK', 19), ('IMPORTANT_CONSIDERATION', 89), ('FUTURE_WORK', 112), ('IMPORTANT_CONSIDERATION', 126), ('FUTURE_WORK', 133)]	6	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
S149-PMC5634602	PMC5634602	10/2017	S149-PMC5634602	['our results AGREE with PREVIOUS EVIDENCE that SUPPORTS an ASSOCIATION between Vitamin D status, Gestational age, and growth in premature infants.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 23), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 58)]	4	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0007565', 'female pregnancy', 96, 'gestational')]
S19-PMC5638722	PMC5638722	8/2017	S19-PMC5638722	['current studies investigate the RELATIONSHIP between Cord Blood Vitamin D status and in vitro measures of Human Monocyte function.']	[('SUPERFICIAL_RELATIONSHIP', 32)]	1	[('UBERON_0009472', 'axilla', 53, 'cord blood'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('NCBITaxon_9606', 'Homo sapiens', 106, 'human'), ('CL_0000576', 'monocyte', 112, 'monocyte')]
S22-PMC5659607	PMC5659607	10/2017	S22-PMC5659607	['we THEREFORE conducted a combined analysis of the two trials including the primary end-point asthma/recurrent wheeze by age 3 years as well as the secondary end-points specific Ige, total Ige, eczema and Lower Respiratory Tract infections (lrti) and did 25(Oh)D level-based analyses to determine WHETHER nutritional status at entry to the trials INFLUENCED the EFFECT of Vitamin D.\n\nmethods\nvdaart: monitored by nhlbi and copsac: approved by the ethics committee for copenhagen.']	[('PROBABLE_UNDERSTANDING', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 296), ('SUPERFICIAL_RELATIONSHIP', 346), ('SUPERFICIAL_RELATIONSHIP', 361)]	4	[('GO_0071743', 'IgE immunoglobulin complex, circulating', 177, 'IgE'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 188, 'IgE'), ('UBERON_0004905', 'articulation', 204, 'lower respiratory tract'), ('CHEBI_71657', 'versiconol acetate', 254, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 254, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 371, 'vitamin D')]
S150-PMC5659607	PMC5659607	10/2017	S150-PMC5659607	['it has already been shown that maternal Vitamin D status is ASSOCIATED with OTHER Immune-mediated diseases such as pre-eclampsia[34] and type i diabetes in the offspring[35].']	[('SUPERFICIAL_RELATIONSHIP', 60), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 76)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('UBERON_0002405', 'immune system', 82, 'immune')]
S121-PMC5664622	PMC5664622	9/2017	S121-PMC5664622	['the ASSOCIATION between Vitamin D consumption and financial status WAS NOT INVESTIGATED, which is one of the LIMITATIONS of OUR STUDY BECAUSE that FACTOR MIGHT have AFFECTED the diet of the investigated population.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 67), ('QUESTION_ANSWERED_BY_THIS_WORK', 75), ('INCOMPLETE_EVIDENCE', 109), ('QUESTION_ANSWERED_BY_THIS_WORK', 124), ('PROBLEM_COMPLICATION', 134), ('SUPERFICIAL_RELATIONSHIP', 147), ('INCOMPLETE_EVIDENCE', 154), ('SUPERFICIAL_RELATIONSHIP', 165)]	9	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
S15-PMC5679631	PMC5679631	11/2017	S15-PMC5679631	['given that Intestinal Microbiotic Homeostasis MAY BE an IMPORTANT FACTOR in the PREVENTION of Immune mediated diseases and that Vitamin D status is a MODIFIABLE FACTOR, FURTHER INVESTIGATION of the IMPACT of Postnatal Vitamin D supplementation SHOULD BE conducted in older infants.']	[('INCOMPLETE_EVIDENCE', 46), ('IMPORTANT_CONSIDERATION', 56), ('SUPERFICIAL_RELATIONSHIP', 66), ('SUPERFICIAL_RELATIONSHIP', 80), ('IMPORTANT_CONSIDERATION', 150), ('SUPERFICIAL_RELATIONSHIP', 161), ('FUTURE_WORK', 169), ('SUPERFICIAL_RELATIONSHIP', 198), ('FUTURE_WORK', 244)]	9	[('UBERON_0000160', 'intestine', 11, 'intestinal'), ('CHEBI_75293', 'methyltrioctylammonium', 22, 'microbiotic'), ('GO_0055074', 'calcium ion homeostasis', 22, 'microbiotic homeostasis'), ('UBERON_0002405', 'immune system', 94, 'immune'), ('CHEBI_27300', 'vitamin D', 128, 'vitamin D'), ('GO_0007567', 'parturition', 208, 'postnatal'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D')]
S22-PMC5679631	PMC5679631	11/2017	S22-PMC5679631	['in addition, a study of sepsis patients DEMONSTRATED a positive ASSOCIATION between Vitamin D status and Plasma Cathelicidin concentrations [10].']	[('INCOMPLETE_EVIDENCE', 40), ('SUPERFICIAL_RELATIONSHIP', 64)]	2	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('UBERON_0001969', 'blood plasma', 105, 'plasma'), ('CHEBI_3364', 'Canthiumine', 112, 'cathelicidin'), ('PR_000006009', 'alpha-catulin', 112, 'cathelicidin')]
S26-PMC5679631	PMC5679631	11/2017	S26-PMC5679631	['GIVEN that Vitamin D status is a MODIFIABLE FACTOR which MAY INFLUENCE Intestinal Microbiotic Homeostasis, which in turn is INDICATED to be IMPORTANT in the prevention of Immune mediated diseases, we INVESTIGATED WHETHER maternal use of multivitamin supplements containing Vitamin D, maternal Vitamin D status (25 Hydroxyvitamin D (25(Oh)D), OR administration of Vitamin D supplement to the baby INFLUENCES the presence and abundance of several key bacterial taxa of the infant Gut microbiota.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 33), ('SUPERFICIAL_RELATIONSHIP', 44), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 124), ('IMPORTANT_CONSIDERATION', 140), ('QUESTION_ANSWERED_BY_THIS_WORK', 200), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 213), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 342), ('SUPERFICIAL_RELATIONSHIP', 396)]	11	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('UBERON_0000160', 'intestine', 71, 'intestinal'), ('CHEBI_75293', 'methyltrioctylammonium', 82, 'microbiotic'), ('GO_0055074', 'calcium ion homeostasis', 82, 'microbiotic homeostasis'), ('UBERON_0002405', 'immune system', 171, 'immune'), ('CHEBI_27300', 'vitamin D', 273, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 293, 'vitamin D'), ('CHEBI_67828', 'rel-(3aR,4S,6aS,7R,9aR,10aS)-10a-Hydroxy-7-isopropyl-1,4,9a-trimethyl-4,5,6,6a,7,8,9,9a,10,10a-decahydro-3aH-dicyclopenta[a,d]cycloocten-3-one', 311, '25 hydroxyvitamin D'), ('CHEBI_71657', 'versiconol acetate', 332, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 363, 'vitamin D'), ('UBERON_0001555', 'digestive tract', 478, 'gut')]
S122-PMC5679631	PMC5679631	11/2017	S122-PMC5679631	['the function of Vitamin D in Regulating Amp Production, THEREFORE, SUGGESTS that Vitamin D status COULD INFLUENCE the composition of the Intestinal microbiota.']	[('PROBABLE_UNDERSTANDING', 56), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 98), ('SUPERFICIAL_RELATIONSHIP', 104)]	4	"[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0065007', 'biological regulation', 29, 'regulating'), ('CHEBI_16027', ""adenosine 5'-monophosphate"", 40, 'AMP'), ('GO_0006754', 'ATP biosynthetic process', 40, 'AMP production'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('UBERON_0000160', 'intestine', 137, 'intestinal')]"
S131-PMC5679631	PMC5679631	11/2017	S131-PMC5679631	['investigations studying the EFFECT of Vitamin D status on the composition of the Intestinal microbiota are FEW; ONE STUDY was performed in Vitamin D deficient Mice and two investigations in Humans examined the ROLE of Vitamin D as secondary questions.']	[('SUPERFICIAL_RELATIONSHIP', 28), ('INCOMPLETE_EVIDENCE', 107), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 210)]	4	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0000160', 'intestine', 81, 'intestinal'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('NCBITaxon_10088', 'Mus <genus>', 159, 'mice'), ('NCBITaxon_9606', 'Homo sapiens', 190, 'humans'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D')]
S46-PMC5682869	PMC5682869	11/2017	S46-PMC5682869	['HOWEVER, still a well-balanced ovo-lacto vegetarian diet USUALLY enables good Nutrient status in Pregnancy, when supplemented with Vitamin D, Folic Acid, Iodine, iron, Vitamin B12 and zinc, and, in cases of a fish-free diet, with Dha [19].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 57)]	2	[('CHEBI_33284', 'nutrient', 78, 'nutrient'), ('GO_0007565', 'female pregnancy', 97, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('CHEBI_30751', 'formic acid', 142, 'folic acid'), ('CHEBI_24859', 'iodine atom', 154, 'iodine'), ('CHEBI_33279', 'vitamin D5', 168, 'vitamin B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 176, 'B12'), ('CHEBI_17874', 'dihydrozeatin', 230, 'DHA')]
S7-PMC5685050	PMC5685050	10/2014	S7-PMC5685050	"[""latitude is an IMPORTANT determinant of Vitamin D status since the amount of uvb that penetrates the earth's surface decreases markedly with increasing latitude[8].""]"	[('IMPORTANT_CONSIDERATION', 15)]	1	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
S18-PMC5706533	PMC5706533	11/2017	S18-PMC5706533	['beyond its established INFLUENCE on bone growth and Calcium Homeostasis,1vitamin D and its RELATED Metabolites have HYPOTHESISED EFFECTS on the risk of Cardiovascular diseases,2cancer,3respiratory infections,4asthma,5conditions RELATED to Pregnancy (such as pre-eclampsia, Gestational diabetes), and Birth outcomes.6concern that Vitamin D deficiency is a global PUBLIC HEALTH PROBLEM HAS BEEN sparked by numerous REPORTS of the high proportion of Individuals in studies throughout the world who have relatively low Serum/Plasma concentrations of 25-hydroxyvitamin d (25(Oh)D),7the conventional circulating BIOMARKER of Vitamin D status.8there HAS BEEN particular ATTENTION to the high prevalence of vitamin d deficiency in Pregnant women and newborns.7\nin 2010, dietary reference intakes for Vitamin D for canada and the us from the institute of medicine were based solely on bone health—particularly in young children (for instance, rickets) and older Adults (for instance, osteoporosis).1considerable SKEPTICISM was cast onto the LINK between Vitamin D and Extraskeletal health conditions or the POTENTIAL benefits (versus risks) of intakes larger than the recommended dietary allowance (600 iu/day for MOST children and Adults).1THE institute’s report DID NOT RECOMMEND higher intakes during Pregnancy and Lactation.1a 2016 update of the cochrane collaboration systematic review and meta-analysis of trials of Vitamin D in Pregnancy (versus placebo or no Supplement), HOWEVER, TENTATIVELY CONCLUDED that Prenatal Vitamin D supplementation “MAY reduce the risk of pre-eclampsia, low birthweight and Preterm Birth.”6other RECENT systematic reviews that included trials with active control arms (in which participants received Vitamin D) ACKNOWLEDGED the POTENTIAL EFFECT of Vitamin D on fetal growth910but DID NOT FIND evidence of EFFECTS on OTHER maternal, fetal, or infant outcomes.91011citing the 2016 cochrane review,6the world health organization guidelines for Antenatal care ADVISE against routine Vitamin D supplementation in Pregnancy.12dietary and supplementation RECOMMENDATIONS, HOWEVER, vary widely across other professional organisations (appendix 1), and there REMAINS a LACK OF CONSENSUS on target health outcomes, indications for Prenatal supplementation, or EVIDENCE BASED regimens for supplement dose (or fortification STRATEGIES).']	[('SUPERFICIAL_RELATIONSHIP', 23), ('SUPERFICIAL_RELATIONSHIP', 91), ('INCOMPLETE_EVIDENCE', 116), ('SUPERFICIAL_RELATIONSHIP', 129), ('SUPERFICIAL_RELATIONSHIP', 228), ('IMPORTANT_CONSIDERATION', 362), ('IMPORTANT_CONSIDERATION', 376), ('PROBLEM_COMPLICATION', 376), ('INCOMPLETE_EVIDENCE', 384), ('INCOMPLETE_EVIDENCE', 413), ('SUPERFICIAL_RELATIONSHIP', 606), ('INCOMPLETE_EVIDENCE', 643), ('IMPORTANT_CONSIDERATION', 663), ('INCOMPLETE_EVIDENCE', 663), ('IMPORTANT_CONSIDERATION', 1003), ('SUPERFICIAL_RELATIONSHIP', 1032), ('INCOMPLETE_EVIDENCE', 1098), ('PROBABLE_UNDERSTANDING', 1205), ('INCOMPLETE_EVIDENCE', 1231), ('INCOMPLETE_EVIDENCE', 1255), ('FUTURE_WORK', 1263), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1471), ('INCOMPLETE_EVIDENCE', 1480), ('INCOMPLETE_EVIDENCE', 1492), ('INCOMPLETE_EVIDENCE', 1543), ('INCOMPLETE_EVIDENCE', 1623), ('INCOMPLETE_EVIDENCE', 1738), ('PROBABLE_UNDERSTANDING', 1738), ('INCOMPLETE_EVIDENCE', 1755), ('SUPERFICIAL_RELATIONSHIP', 1765), ('INCOMPLETE_EVIDENCE', 1807), ('SUPERFICIAL_RELATIONSHIP', 1832), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1843), ('FUTURE_WORK', 1983), ('FUTURE_WORK', 2075), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2092), ('ANOMALY_CURIOUS_FINDING', 2092), ('INCOMPLETE_EVIDENCE', 2177), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2187), ('INCOMPLETE_EVIDENCE', 2187), ('INCOMPLETE_EVIDENCE', 2277), ('FUTURE_WORK', 2339)]	42	[('GO_0055073', 'cadmium ion homeostasis', 52, 'calcium homeostasis'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 81, 'D'), ('CHEBI_25212', 'metabolite', 99, 'metabolites'), ('UBERON_0004535', 'cardiovascular system', 152, 'cardiovascular'), ('GO_0007565', 'female pregnancy', 239, 'pregnancy'), ('GO_0007565', 'female pregnancy', 273, 'gestational'), ('GO_0007567', 'parturition', 300, 'birth'), ('CHEBI_27300', 'vitamin D', 329, 'vitamin D'), ('NCBITaxon_1', 'root', 447, 'individuals'), ('UBERON_0001977', 'blood serum', 515, 'serum'), ('UBERON_0001969', 'blood plasma', 521, 'plasma'), ('CHEBI_71657', 'versiconol acetate', 567, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 619, 'vitamin D'), ('GO_0007565', 'female pregnancy', 723, 'pregnant'), ('CHEBI_27300', 'vitamin D', 792, 'vitamin D'), ('UBERON_0007023', 'adult organism', 953, 'adults'), ('CHEBI_27300', 'vitamin D', 1045, 'vitamin D'), ('UBERON_0001431', 'distal carpal bone 2', 1059, 'extraskeletal'), ('UBERON_0007023', 'adult organism', 1223, 'adults'), ('GO_0007565', 'female pregnancy', 1295, 'pregnancy'), ('GO_0007595', 'lactation', 1309, 'lactation'), ('CHEBI_27300', 'vitamin D', 1413, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1426, 'pregnancy'), ('CHEBI_16158', 'steroid sulfate', 1458, 'supplement'), ('GO_0007565', 'female pregnancy', 1507, 'prenatal'), ('CHEBI_27300', 'vitamin D', 1516, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1601, 'preterm birth'), ('CHEBI_27300', 'vitamin D', 1727, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1775, 'vitamin D'), ('GO_0007567', 'parturition', 1968, 'antenatal'), ('CHEBI_27300', 'vitamin D', 2006, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2035, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2248, 'prenatal')]
S46-PMC5706533	PMC5706533	11/2017	S46-PMC5706533	['when multiple comparisons from the same trial were included in the same meta-analysis, we divided the control group sample size corresponding to each comparison by the number of intervention arms to avoid double counting participants.14\nwe conducted subgroup meta-analyses according to a priori defined sources of potential clinical and methodological heterogeneity17: control arm type (Placebo versus Vitamin D containing active control); dosing frequency (regular versus bolus); baseline Vitamin D status categorised as low (mean 25(Oh)D <30 nmol/l) versus sufficient (≥30 nmol/l), based on maternal mean 25(Oh)D in the control group at enrolment (“initial baseline”) or at/near delivery (“modified baseline,” which THEORETICALLY takes into account the effect of active control supplementation); intervention dose (among regular dose trials), defined as low (<2000 iu/day) versus high (≥2000 iu/day).']	[('INCOMPLETE_EVIDENCE', 718)]	1	[('CHEBI_26130', 'biological pigment', 387, 'placebo'), ('CHEBI_27300', 'vitamin D', 402, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 490, 'vitamin D'), ('CHEBI_63056', 'zinc cation', 532, '25(OH'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 538, 'D'), ('CHEBI_71657', 'versiconol acetate', 607, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 613, 'D')]
S76-PMC5706533	PMC5706533	11/2017	S76-PMC5706533	['there was substantial clinical and methodological heterogeneity between trials (table 1), including wide VARIATION in baseline maternal Vitamin D status (fig 3; table b in Appendix 5).']	[('DIFFICULT_TASK', 105)]	1	[('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('UBERON_0001154', 'vermiform appendix', 172, 'appendix')]
S77-PMC5706533	PMC5706533	11/2017	S77-PMC5706533	['among regular dose trials, effective doses were no higher in populations with lower baseline Vitamin D status, and placebo controlled trials DID NOT consistently use higher effective doses nor were they more LIKELY to be conducted in populations deficient in Vitamin D compared with active control trials (fig 3).']	[('INCOMPLETE_EVIDENCE', 141), ('PROBABLE_UNDERSTANDING', 208)]	2	[('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D')]
S80-PMC5706533	PMC5706533	11/2017	S80-PMC5706533	['figures are number (percentage) unless stated otherwisecharacteristicall trialsregular dose trials*Bolus dose trials*trials4337†8†intervention arms55469participants enrolled:\u2003total840676871031\u2003median within individual trials (min-max)133 (16-1134)133 (16-1134)118 (50-235)meta-analyses to which each trial contributed:\u2003median maternal outcomes (min-max)2 (0-6)2 (0-6)2 (0-4)\u2003median newborn/infant outcomes (min-max)3 (0-17)3 (0-17)4 (0-7)\u2003trials that DID not contribute data to any meta-analyses2 (4.7)2 (5.4)0 (0.0)geographical region:\u2003europe7 (16.3)7 (18.9)2 (25.0)\u2003south east asia6 (14.0)2 (5.4)4 (50.0)\u2003americas5 (11.6)5 (13.5)0 (0.0)\u2003eastern mediterranean21 (48.8)19 (51.4)2 (25.0)\u2003western pacific4 (9.3)4 (10.8)0 (0.0)health status at enrolment:\u2003generally healthy37 (86.0)33 (89.2)6 (75.0)\u2003Gestational diabetes4 (9.3)2 (5.4)2 (25.0)\u2003hypocalcaemia1 (2.3)1 (2.7)\u2003multiple sclerosis1 (2.3)1 (2.7)0 (0.0)baseline Vitamin D status‡:\u2003mean 25(Oh)D <30 nmol/l10 (23.3)9 (24.3)2 (25.0)\u2003mean 25(Oh)D ≥30 nmol/l23 (53.5)20 (54.1)3 (37.5)\u2003not reported10 (23.3)8 (21.6)3 (37.5)type of Vitamin D§:\u2003d24 (7.3)3 (6.5)1 (11.1)\u2003d348 (87.3)40 (87.0)8 (88.9)\u2003not reported3 (5.5)3 (6.5)0 (0.0)supplementation frequency§:\u2003daily31 (56.4)31 (67.4)—\u2003weekly5 (9.1)5 (10.9)—\u2003every 2 weeks6 (10.9)6 (13.0)—\u2003monthly3 (5.5)3 (6.5)—\u2003 every 2 months1 (1.8)1 (2.2)—\u2003single dose3 (5.5)—3 (33.3)\u2003two doses4 (7.3)—4 (44.4)\u2003other2 (3.6)—2 (22.2)intervention dose§¶:\u2003median (min-max)2000 (200-7543)2000 (200-7543)—\u2003regular dose <2000 iu/day24 (52.2)24 (52.2)—\u2003regular dose ≥2000 iu/day22 (47.8)22 (47.8)—control intervention type:\u2003placebo29 (67.4)23 (62.2)8 (100.0)\u2003active14 (32.6)14 (37.8)0 (0.0)median Vitamin D dose in active control arms (min-max)400 (200-600)400 (200-600)—timing of initiation of supplementation§:\u20031st trimester19 (34.5)18 (39.1)1 (11.1)\u20032nd trimester30 (54.5)24 (52.2)6 (66.7)\u20033rd trimester5 (9.1)3 (6.5)2 (22.2)\u2003not reported1 (1.8)1 (2.2)0 (0.0)\n*regular dosing refers to regimens in which Supplement was administered at least three times at regular frequency throughout Pregnancy (daily, weekly, every 2 weeks, monthly, or every 2 months ); bolus dosing refers to interventions administered either once or twice during intervention period.']	[('ANOMALY_CURIOUS_FINDING', 451)]	1	[('NCBITaxon_10088', 'Mus <genus>', 99, 'Bolus'), ('GO_0007565', 'female pregnancy', 796, 'Gestational'), ('CHEBI_27300', 'vitamin D', 915, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 939, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 988, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 1078, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 1671, 'vitamin D'), ('CHEBI_16158', 'steroid sulfate', 1981, 'supplement'), ('GO_0007565', 'female pregnancy', 2062, 'pregnancy')]
S114-PMC5706533	PMC5706533	11/2017	S114-PMC5706533	['in a post hoc analysis of the EFFECT on Birth weight that took into account both effective dose and baseline Vitamin D status, there was a significant dose-response effect in trials in which mean baseline 25(Oh)D was 30-50 nmol/l but no association in trials with mean 25(Oh)d <30 nmol/l (fig s29 in appendix 10).']	[('SUPERFICIAL_RELATIONSHIP', 30)]	1	[('GO_0007567', 'parturition', 40, 'birth'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 205, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 269, '25(OH')]
S132-PMC5706533	PMC5706533	11/2017	S132-PMC5706533	['caption (fig)\n\nfig 5 \xa0proportion of all participants (n=8406) enrolled in eligible trials for which maternal and neonatal/infant outcomes were reported and met criteria for case definition and method of ascertainment; reported but did not meet minimum criteria; reported, but in manner that prevented inclusion of data in meta-analysis; missing because of loss of follow-up in trials for which outcome was reported for some participants or BECAUSE of apparent incomplete reporting of planned outcomes; or MISSING BECAUSE outcome was not assessed or not mentioned in published reports\n\nfuture projections of evidence based on registered ongoing/planned trials\nwe identified 35 registered trials of Prenatal Vitamin D with a total target enrolment of 12\u2009530 participants, of which 19 (54%) were completed but unpublished, 11 (31%) were ongoing or planned, and five (14%) had indeterminate status (fig 2; table a and fig a in appendix 11).']	[('PROBLEM_COMPLICATION', 440), ('PROBLEM_COMPLICATION', 505), ('PROBLEM_COMPLICATION', 513)]	3	[('GO_0007565', 'female pregnancy', 697, 'prenatal'), ('CHEBI_27300', 'vitamin D', 706, 'vitamin D')]
S146-PMC5706533	PMC5706533	11/2017	S146-PMC5706533	['although data COULD BE statistically pooled for several outcomes, irreconcilable heterogeneity between trials (such as variable baseline Vitamin D status) rendered most inferences DIFFICULT to interpret or apply.']	[('INCOMPLETE_EVIDENCE', 14), ('DIFFICULT_TASK', 180)]	2	[('CHEBI_27300', 'vitamin D', 137, 'vitamin D')]
S154-PMC5706533	PMC5706533	11/2017	S154-PMC5706533	['two trials INDICATED that Vitamin D COULD enhance Postnatal linear growth, an outcome RELATED to growth plates for which a HYPOTHESISED ROLE of Vitamin D is logical,26and which is the primary focus of our AS YET unpublished trial in bangladesh.27in the FEW STUDIES reporting EFFECTS on infant bone mass, results were MIXED; the largest of these trials—the mavidos study in the uk, which excluded women with 25(Oh)D concentrations <25 nmol/l28—has scheduled follow-up of children at age 4 years.29infant rickets was NOT REPORTED in any trials; THOUGH RARE, this is one of the MOST LIKELY paediatric conditions to be directly caused by poor maternal and early infant Vitamin D status.30adverse events were infrequently REPORTED, resulting in unreliable meta-analyses.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 36), ('SUPERFICIAL_RELATIONSHIP', 86), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 136), ('INCOMPLETE_EVIDENCE', 205), ('ANOMALY_CURIOUS_FINDING', 208), ('INCOMPLETE_EVIDENCE', 253), ('SUPERFICIAL_RELATIONSHIP', 275), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 317), ('INCOMPLETE_EVIDENCE', 515), ('ANOMALY_CURIOUS_FINDING', 543), ('INCOMPLETE_EVIDENCE', 550), ('PROBABLE_UNDERSTANDING', 575), ('PROBABLE_UNDERSTANDING', 580), ('INCOMPLETE_EVIDENCE', 717)]	16	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0007567', 'parturition', 50, 'postnatal'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 407, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 413, 'D'), ('CHEBI_27300', 'vitamin D', 665, 'vitamin D')]
S159-PMC5706533	PMC5706533	11/2017	S159-PMC5706533	['the INTERPRETATION of Micronutrient intervention trials, HOWEVER, is COMPLEX BECAUSE all Individuals have some Vitamin D intake or Endogenous production.35the EFFECT of a given dose depends on the difference between the intervention and control doses (or the difference in mean 25(Oh)D in the intervention versus control group at/near delivery) as well as baseline Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 4), ('PROBABLE_UNDERSTANDING', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 57), ('DIFFICULT_TASK', 69), ('PROBABLE_UNDERSTANDING', 77), ('SUPERFICIAL_RELATIONSHIP', 159)]	6	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 22, 'micronutrient'), ('NCBITaxon_1', 'root', 89, 'individuals'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D'), ('GO_0009790', 'embryo development', 131, 'endogenous'), ('CHEBI_71657', 'versiconol acetate', 278, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 278, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 365, 'vitamin D')]
S160-PMC5706533	PMC5706533	11/2017	S160-PMC5706533	['populations without Vitamin D deficiency MIGHT have little to gain from any dose, BUT deficient populations MIGHT require relatively high doses to raise Vitamin D status to an optimal range ASSOCIATED with clinical BENEFITS.35in this FRAMEWORK, the DISTINCTION between placebo versus active control trials is ONLY INFORMATIVE insofar as an active control dose increases the baseline status to which the intervention dose is compared (as such, we considered a “modified” baseline status to be reflected by the mean 25(Oh)d at Delivery in the control group).']	[('INCOMPLETE_EVIDENCE', 41), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 190), ('IMPORTANT_CONSIDERATION', 215), ('INCOMPLETE_EVIDENCE', 234), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 249), ('INCOMPLETE_EVIDENCE', 309), ('INCOMPLETE_EVIDENCE', 314)]	9	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 153, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 514, '25(OH)'), ('GO_0007567', 'parturition', 525, 'delivery')]
S13-PMC5707701	PMC5707701	11/2017	S13-PMC5707701	['since infants are Born with very low reserves of Vitamin A in the Liver REGARDLESS of the mother’s nutritional status [3], they rely entirely on Breast Milk to support growth and build up Liver storage.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 72)]	1	[('GO_0007567', 'parturition', 18, 'born'), ('CHEBI_27300', 'vitamin D', 49, 'vitamin A'), ('UBERON_0002107', 'liver', 66, 'liver'), ('UBERON_0000310', 'breast', 145, 'breast'), ('UBERON_0001913', 'milk', 152, 'milk'), ('UBERON_0002107', 'liver', 188, 'liver')]
S183-PMC5707701	PMC5707701	11/2017	S183-PMC5707701	['secondly, LITTLE IS KNOWN about the levels of Vitamins A and E in maternal Plasma ASSOCIATED with the corresponding Milk, which would be better than dietary Intake to assess maternal Nutrient status, DUE TO the IMPOSSIBILITY to collect such samples in our research.']	[('FULL_UNKNOWN', 10), ('SUPERFICIAL_RELATIONSHIP', 82), ('PROBLEM_COMPLICATION', 200), ('PROBLEM_COMPLICATION', 211)]	4	[('CHEBI_27300', 'vitamin D', 46, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 46, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 61, 'E'), ('UBERON_0001969', 'blood plasma', 75, 'plasma'), ('UBERON_0001913', 'milk', 116, 'milk'), ('GO_0007631', 'feeding behavior', 157, 'intake'), ('CHEBI_33284', 'nutrient', 183, 'nutrient')]
S10-PMC5716389	PMC5716389	9/2017	S10-PMC5716389	['maternal nutritional status, and exposure during fetal Life to an inadequately nurturing environment, COULD THUS IMPACT fetal Immune Development [3,4], in particular, Micronutrients including zinc, iron, Vitamin A and protein energy malnutrition (pem).']	[('INCOMPLETE_EVIDENCE', 102), ('PROBABLE_UNDERSTANDING', 108), ('SUPERFICIAL_RELATIONSHIP', 113)]	3	[('UBERON_0000104', 'life cycle', 55, 'life'), ('GO_0001822', 'kidney development', 126, 'immune development'), ('UBERON_0002405', 'immune system', 126, 'immune'), ('CHEBI_33839', 'macromolecule', 167, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 204, 'vitamin A')]
S43-PMC5716389	PMC5716389	9/2017	S43-PMC5716389	['there is NO INFORMATION on the ASSOCIATION between maternal Vitamin A status during Pregnancy and infant Immune Response.']	[('FULL_UNKNOWN', 9), ('SUPERFICIAL_RELATIONSHIP', 31)]	2	[('CHEBI_27300', 'vitamin D', 60, 'vitamin A'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('GO_0006955', 'immune response', 105, 'immune response'), ('UBERON_0002405', 'immune system', 105, 'immune')]
S0-PMC5732505	PMC5732505	12/2017	S0-PMC5732505	['maternal Vitamin D status, Gestational diabetes and infant Birth size\n\nabstract\n\nbackground\nmaternal Vitamin D status HAS BEEN ASSOCIATED with both Gestational diabetes mellitus (gdm) and fetal growth restriction, HOWEVER, the EVIDENCE is INCONSISTENT.']	[('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 127), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 214), ('INCOMPLETE_EVIDENCE', 227), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 239)]	5	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 27, 'gestational'), ('GO_0007567', 'parturition', 59, 'birth'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('GO_0007565', 'female pregnancy', 148, 'gestational')]
S1-PMC5732505	PMC5732505	12/2017	S1-PMC5732505	['in finland, maternal Vitamin D status has improved CONSIDERABLY DUE TO national health policies.']	[('ANOMALY_CURIOUS_FINDING', 51), ('PROBABLE_UNDERSTANDING', 64)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
S14-PMC5732505	PMC5732505	12/2017	S14-PMC5732505	['ASSOCIATIONS between maternal Vitamin D status and Birth size were INCONSISTENT.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 67)]	2	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007567', 'parturition', 51, 'birth')]
S15-PMC5732505	PMC5732505	12/2017	S15-PMC5732505	['a sufficient maternal Vitamin D status, specified AS 25(Oh)D above 50\xa0nmol/l, MAY BE a threshold above which the physiological REQUIREMENTS of Pregnancy are achieved.']	[('PROBABLE_UNDERSTANDING', 50), ('INCOMPLETE_EVIDENCE', 78), ('IMPORTANT_CONSIDERATION', 127)]	3	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 53, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 59, 'D'), ('GO_0007565', 'female pregnancy', 143, 'pregnancy')]
S26-PMC5732505	PMC5732505	12/2017	S26-PMC5732505	['POOR maternal Vitamin D status HAS BEEN RELATED to fetal growth restriction [15] BUT it is UNKNOWN WHETHER maternal Vitamin D status ASSOCIATES with Birth size in infants with normal Birth weight.']	[('IMPORTANT_CONSIDERATION', 0), ('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 40), ('ANOMALY_CURIOUS_FINDING', 81), ('FULL_UNKNOWN', 91), ('EXPLICIT_QUESTION', 99), ('SUPERFICIAL_RELATIONSHIP', 133)]	7	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D'), ('GO_0007567', 'parturition', 149, 'birth'), ('GO_0007567', 'parturition', 183, 'birth')]
S48-PMC5732505	PMC5732505	12/2017	S48-PMC5732505	['we employed ucb 25(Oh)D to REFLECT both the maternal Vitamin D status at the end of Pregnancy and the newborn’s Vitamin D status at Birth [1].']	[('PROBABLE_UNDERSTANDING', 27)]	1	[('CHEBI_71657', 'versiconol acetate', 16, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0007565', 'female pregnancy', 84, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 112, 'vitamin D'), ('GO_0007567', 'parturition', 132, 'birth')]
S50-PMC5732505	PMC5732505	12/2017	S50-PMC5732505	['suboptimal Vitamin D status was DEFINED AS 25(Oh)D\u2009<\u200980\xa0nmol/l, and optimal Vitamin D status AS 25(Oh)D\u2009≥\u200980\xa0nmol/l, AS HAS BEEN SUGGESTED BASED ON calcium absorption STUDIES [18].']	[('PROBABLE_UNDERSTANDING', 32), ('PROBABLE_UNDERSTANDING', 40), ('PROBABLE_UNDERSTANDING', 93), ('PROBABLE_UNDERSTANDING', 117), ('INCOMPLETE_EVIDENCE', 120), ('INCOMPLETE_EVIDENCE', 139), ('INCOMPLETE_EVIDENCE', 167)]	7	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 43, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 96, '25(OH)D')]
S132-PMC5732505	PMC5732505	12/2017	S132-PMC5732505	['abbreviations: gwg, Gestational weight gain; gdm, Gestational diabetes mellitus; 25(Oh)D, 25-Hydroxy Vitamin D; suboptimal, ucb, Umbilical Cord Blood; 25(Oh)D\u2009<\u200980\xa0nmol/l; optimal 25(Oh)D\u2009≥\u200980\xa0nmol/l\n\ndiscussion\nthe primary FOCUS of this work was TO DETERMINE WHETHER 25(Oh)D concentration differs between mothers with AND without gdm, and WHETHER Vitamin D status AFFECTS Birth size in normal-Birth-weight infants.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 224), ('QUESTION_ANSWERED_BY_THIS_WORK', 247), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 260), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 340), ('SUPERFICIAL_RELATIONSHIP', 365)]	5	[('GO_0007565', 'female pregnancy', 20, 'gestational'), ('GO_0007565', 'female pregnancy', 50, 'gestational'), ('CHEBI_71657', 'versiconol acetate', 81, '25(OH)D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 90, '25-hydroxy vitamin D'), ('UBERON_0002331', 'umbilical cord', 129, 'umbilical cord'), ('UBERON_0000178', 'blood', 144, 'blood'), ('CHEBI_71657', 'versiconol acetate', 151, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 180, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 268, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 348, 'vitamin D'), ('GO_0007567', 'parturition', 373, 'birth'), ('GO_0007567', 'parturition', 394, 'birth')]
S134-PMC5732505	PMC5732505	12/2017	S134-PMC5732505	['ALMOST ALL mother-child pairs (97%) were Vitamin D sufficient [25(Oh)D\u2009≥\u200950\xa0nmol/l], and ABOUT half of the mother-child pairs had optimal Vitamin D status [25(Oh)D\u2009≥\u200980\xa0nmol/l].']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 89)]	2	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 63, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 156, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 162, 'D')]
S136-PMC5732505	PMC5732505	12/2017	S136-PMC5732505	['INTERESTINGLY, Pregnancy Vitamin D status ASSOCIATED positively with Birth weight, BUT an inverse ASSOCIATION was OBSERVED between newborn Vitamin D status and Head circumference at Birth.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 42), ('ANOMALY_CURIOUS_FINDING', 83), ('SUPERFICIAL_RELATIONSHIP', 98), ('INCOMPLETE_EVIDENCE', 114)]	5	[('GO_0007565', 'female pregnancy', 15, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007567', 'parturition', 69, 'birth'), ('CHEBI_27300', 'vitamin D', 139, 'vitamin D'), ('UBERON_0000033', 'head', 160, 'head'), ('GO_0007567', 'parturition', 182, 'birth')]
S148-PMC5732505	PMC5732505	12/2017	S148-PMC5732505	['furthermore, SOME of these FACTORS are RELATED to or CO-EXIST with POOR Vitamin D status [24,25], which further increases the CHALLENGE when dissecting INDEPENDENT EFFECT.']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 27), ('SUPERFICIAL_RELATIONSHIP', 39), ('SUPERFICIAL_RELATIONSHIP', 53), ('IMPORTANT_CONSIDERATION', 67), ('DIFFICULT_TASK', 126), ('SUPERFICIAL_RELATIONSHIP', 152), ('SUPERFICIAL_RELATIONSHIP', 164)]	8	[('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
S151-PMC5732505	PMC5732505	12/2017	S151-PMC5732505	['ALTHOUGH a biological mechanism between low Vitamin D status and diabetes is PLAUSIBLE [29], ONLY a FEW INTERVENTIONS have been conducted, and these HAVE NOT proved an EFFECT of Vitamin D supplementation on RISK of gdm [30].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 93), ('INCOMPLETE_EVIDENCE', 100), ('SUPERFICIAL_RELATIONSHIP', 104), ('INCOMPLETE_EVIDENCE', 149), ('SUPERFICIAL_RELATIONSHIP', 168), ('IMPORTANT_CONSIDERATION', 207)]	8	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D')]
S152-PMC5732505	PMC5732505	12/2017	S152-PMC5732505	['maternal Vitamin D status ASSOCIATED with Birth size: Pregnancy 25(Oh)D SHOWED a positive ASSOCIATION towards Birth weight, BUT ucb 25(Oh)D an inverse ASSOCIATION with Head circumference, WHILE ONLY the inverse ASSOCIATION with Head circumference was VERIFIED with linear model.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 72), ('SUPERFICIAL_RELATIONSHIP', 90), ('ANOMALY_CURIOUS_FINDING', 124), ('SUPERFICIAL_RELATIONSHIP', 151), ('ANOMALY_CURIOUS_FINDING', 188), ('ANOMALY_CURIOUS_FINDING', 194), ('SUPERFICIAL_RELATIONSHIP', 211), ('INCOMPLETE_EVIDENCE', 251)]	9	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007567', 'parturition', 42, 'birth'), ('GO_0007565', 'female pregnancy', 54, 'pregnancy'), ('CHEBI_71657', 'versiconol acetate', 64, '25(OH)D'), ('GO_0007567', 'parturition', 110, 'birth'), ('CHEBI_71657', 'versiconol acetate', 132, '25(OH)D'), ('UBERON_0000033', 'head', 168, 'head'), ('UBERON_0000033', 'head', 228, 'head')]
S154-PMC5732505	PMC5732505	12/2017	S154-PMC5732505	['(2014) CONCLUDED that MODEST EVIDENCE exist for a positive RELATION between maternal Vitamin D status and Birth weight [31].']	[('INCOMPLETE_EVIDENCE', 7), ('INCOMPLETE_EVIDENCE', 22), ('SUPERFICIAL_RELATIONSHIP', 59)]	3	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007567', 'parturition', 106, 'birth')]
S157-PMC5732505	PMC5732505	12/2017	S157-PMC5732505	['HOWEVER, the clinical RELEVANCE, if any, of the inverse RELATIONSHIP between maternal Vitamin D status and Head circumference at Birth REMAINS UNEXPLAINED.']	[('ANOMALY_CURIOUS_FINDING', 0), ('IMPORTANT_CONSIDERATION', 22), ('SUPERFICIAL_RELATIONSHIP', 56), ('INCOMPLETE_EVIDENCE', 135), ('INCOMPLETE_EVIDENCE', 143)]	5	[('CHEBI_27300', 'vitamin D', 86, 'vitamin D'), ('UBERON_0000033', 'head', 107, 'head'), ('GO_0007567', 'parturition', 129, 'birth')]
S160-PMC5732505	PMC5732505	12/2017	S160-PMC5732505	['a POSSIBLE EXPLANATION for this MIGHT be a u-shaped ASSOCIATION between maternal Vitamin D concentration and fetal outcomes in a population with sufficient Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 2), ('PROBABLE_UNDERSTANDING', 11), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 52)]	4	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D')]
S163-PMC5732505	PMC5732505	12/2017	S163-PMC5732505	['in MANY previous STUDIES, participants had various ethnic backgrounds which COULD AFFECT both Vitamin D status and their RISK of gdm [7,38].']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 76), ('SUPERFICIAL_RELATIONSHIP', 82), ('IMPORTANT_CONSIDERATION', 121)]	4	[('CHEBI_27300', 'vitamin D', 94, 'vitamin D')]
S166-PMC5732505	PMC5732505	12/2017	S166-PMC5732505	['a CHALLENGE in PREVIOUS STUDIES on Vitamin D status and gdm HAS BEEN the LACK OF RELEVANT adjustments, for example adjustments for bmi and smoking status [6].']	[('DIFFICULT_TASK', 2), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 60), ('PROBLEM_COMPLICATION', 73), ('IMPORTANT_CONSIDERATION', 81)]	5	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D')]
S176-PMC5732505	PMC5732505	12/2017	S176-PMC5732505	['sufficient maternal Vitamin D status, specified AS 25(Oh)D above 50\xa0nmol/l, SEEMS a threshold value, above which the physiological REQUIREMENTS of Pregnancy are achieved.']	[('PROBABLE_UNDERSTANDING', 48), ('PROBABLE_UNDERSTANDING', 76), ('IMPORTANT_CONSIDERATION', 131)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 51, '25(OH)D'), ('GO_0007565', 'female pregnancy', 147, 'pregnancy')]
S0-PMC5758521	PMC5758521	1/2018	S0-PMC5758521	['vitamin a and e nutritional status in RELATION to leptin, adiponectin, Igf-I and Igf-Ii in early Life - a Birth cohort study\n\nabstract\nthe Metabolic health EFFECTS of Vitamin A and E nutritional status in early Life are largely UNKNOWN.']	[('SUPERFICIAL_RELATIONSHIP', 38), ('SUPERFICIAL_RELATIONSHIP', 156), ('FULL_UNKNOWN', 228)]	3	[('PR_000008919', 'interferon alpha-6', 71, 'IGF-I'), ('PR_000002046', 'interferon regulatory factor 4', 81, 'IGF-II'), ('UBERON_0000104', 'life cycle', 97, 'Life'), ('GO_0007567', 'parturition', 106, 'Birth'), ('GO_0008152', 'metabolic process', 139, 'metabolic'), ('CHEBI_27300', 'vitamin D', 167, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 181, 'E'), ('UBERON_0000104', 'life cycle', 211, 'life')]
S1-PMC5758521	PMC5758521	1/2018	S1-PMC5758521	['we ASSESSED WHETHER Vitamin A and Vitamin E nutritional status MAY AFFECT circulating leptin, adiponectin, Insulin-Like Growth Factor (Igf)-I and Igf-Ii levels in early Life in Humans.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 12), ('INCOMPLETE_EVIDENCE', 63), ('SUPERFICIAL_RELATIONSHIP', 67)]	4	[('CHEBI_27300', 'vitamin D', 20, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin E'), ('PR_000008929', 'interferon-related developmental regulator 1', 107, 'insulin-like growth factor ...'), ('PR_000008954', 'insulin-like growth factor-binding protein-like 1', 135, 'IGF)-I'), ('PR_000002046', 'interferon regulatory factor 4', 146, 'IGF-II'), ('UBERON_0000104', 'life cycle', 169, 'life'), ('NCBITaxon_9606', 'Homo sapiens', 177, 'humans')]
S9-PMC5758521	PMC5758521	1/2018	S9-PMC5758521	['however, the Metabolic health EFFECTS of Vitamin A and E nutritional status in early Life remain largely UNKNOWN.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('FULL_UNKNOWN', 105)]	2	[('GO_0008152', 'metabolic process', 13, 'metabolic'), ('CHEBI_27300', 'vitamin D', 41, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 55, 'E'), ('UBERON_0000104', 'life cycle', 85, 'life')]
S20-PMC5758521	PMC5758521	1/2018	S20-PMC5758521	['HOWEVER, there is a LACK OF DATA on WHETHER Vitamin A and E nutritional status MAY BE ASSOCIATED with Metabolic health BIOMARKERS in early Life in Humans.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 20), ('INCOMPLETE_EVIDENCE', 20), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 36), ('INCOMPLETE_EVIDENCE', 79), ('SUPERFICIAL_RELATIONSHIP', 86), ('SUPERFICIAL_RELATIONSHIP', 119)]	7	[('CHEBI_27300', 'vitamin D', 44, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 58, 'E'), ('GO_0008152', 'metabolic process', 102, 'metabolic'), ('UBERON_0000104', 'life cycle', 139, 'life'), ('NCBITaxon_9606', 'Homo sapiens', 147, 'humans')]
S21-PMC5758521	PMC5758521	1/2018	S21-PMC5758521	['to fill this IMPORTANT research data gap, we SOUGHT TO EVALUATE WHETHER Vitamin A and e nutritional status in neonates are ASSOCIATED with circulating concentrations of leptin, adiponectin, Igf-I and Igf-Ii which are IMPORTANT BIOMARKERS of fetal growth and Metabolic health15,16.']	[('IMPORTANT_CONSIDERATION', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 45), ('QUESTION_ANSWERED_BY_THIS_WORK', 52), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 64), ('SUPERFICIAL_RELATIONSHIP', 123), ('IMPORTANT_CONSIDERATION', 217), ('SUPERFICIAL_RELATIONSHIP', 227)]	7	[('CHEBI_27300', 'vitamin D', 72, 'vitamin A'), ('PR_000008919', 'interferon alpha-6', 190, 'IGF-I'), ('PR_000002046', 'interferon regulatory factor 4', 200, 'IGF-II'), ('GO_0008152', 'metabolic process', 258, 'metabolic')]
S22-PMC5758521	PMC5758521	1/2018	S22-PMC5758521	['we HYPOTHESIZED that Vitamin A and E nutritional status MAY AFFECT fetal circulating leptin, adiponectin, Igf-I and Igf-Ii levels.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 56), ('SUPERFICIAL_RELATIONSHIP', 60)]	3	[('CHEBI_27300', 'vitamin D', 21, 'vitamin A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 35, 'E'), ('PR_000008919', 'interferon alpha-6', 106, 'IGF-I'), ('PR_000002046', 'interferon regulatory factor 4', 116, 'IGF-II')]
S119-PMC5758521	PMC5758521	1/2018	S119-PMC5758521	['these observations SUGGEST that Vitamin E and a nutritional status MAY matter for Metabolic health in early Life in Humans.']	[('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 67)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin E'), ('GO_0008152', 'metabolic process', 82, 'metabolic'), ('UBERON_0000104', 'life cycle', 108, 'life'), ('NCBITaxon_9606', 'Homo sapiens', 116, 'humans')]
S0-PMC5784894	PMC5784894	1/2018	S0-PMC5784894	['early Life Vitamin D depletion alters the Postnatal response to Skeletal loading in Growing and mature bone\n\nabstract\nthere is INCREASING EVIDENCE of persistent EFFECTS of early Life Vitamin D exposure on later Skeletal health; LINKING low levels in early Life to smaller bone size in childhood as well as increased fracture risk later in Adulthood, INDEPENDENTLY of later Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 161), ('SUPERFICIAL_RELATIONSHIP', 228), ('SUPERFICIAL_RELATIONSHIP', 350)]	4	[('UBERON_0000104', 'life cycle', 6, 'life'), ('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007567', 'parturition', 42, 'postnatal'), ('UBERON_0004288', 'skeleton', 64, 'skeletal'), ('GO_0040007', 'growth', 84, 'growing'), ('UBERON_0000104', 'life cycle', 178, 'life'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('UBERON_0004288', 'skeleton', 211, 'skeletal'), ('UBERON_0000104', 'life cycle', 256, 'life'), ('UBERON_0000113', 'post-juvenile adult stage', 339, 'adulthood'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D')]
S7-PMC5784894	PMC5784894	1/2018	S7-PMC5784894	['THESE FINDINGS SUGGEST early Life Vitamin D status MAY, IN PART, determine the propensity to osteoporosis and fracture that blights later Life in many Individuals.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 51), ('INCOMPLETE_EVIDENCE', 56)]	4	[('UBERON_0000104', 'life cycle', 29, 'life'), ('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('UBERON_0000104', 'life cycle', 138, 'life'), ('NCBITaxon_1', 'root', 151, 'individuals')]
S15-PMC5784894	PMC5784894	1/2018	S15-PMC5784894	['in addition, lower maternal Vitamin D status is ASSOCIATED with reduced bone Mineral content and area persisting into childhood[8] and young Adulthood[9].']	[('SUPERFICIAL_RELATIONSHIP', 48)]	1	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('CHEBI_46662', 'mineral', 77, 'mineral'), ('UBERON_0000113', 'post-juvenile adult stage', 141, 'adulthood')]
S21-PMC5784894	PMC5784894	1/2018	S21-PMC5784894	['we HYPOTHESISE that Antenatal Vitamin D status MAY BE RESPONSIBLE for altered bone responsiveness to Postnatal mechanical loading, a major anabolic INFLUENCE on bone size, mass and strength, and thus act as a DETERMINANT of later Skeletal ill-health.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 47), ('PROBABLE_UNDERSTANDING', 54), ('SUPERFICIAL_RELATIONSHIP', 148), ('SUPERFICIAL_RELATIONSHIP', 209)]	5	[('GO_0007567', 'parturition', 20, 'antenatal'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007567', 'parturition', 101, 'postnatal'), ('UBERON_0004288', 'skeleton', 230, 'skeletal')]
S144-PMC5784894	PMC5784894	1/2018	S144-PMC5784894	['that these changes are present in Mice that, following weaning, are Vitamin D replete throughout Life INDICATES that early Life, AS OPPOSED TO current, Vitamin D status is the cause of these differences.']	[('INCOMPLETE_EVIDENCE', 102), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 129)]	2	[('NCBITaxon_10088', 'Mus <genus>', 34, 'mice'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0000104', 'life cycle', 97, 'life'), ('UBERON_0000104', 'life cycle', 123, 'life'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin D')]
S148-PMC5784894	PMC5784894	1/2018	S148-PMC5784894	['THESE FINDINGS are CONSISTENT with multiple data sources that LINK early Life Vitamin D status to later bone size[4,8,9,25], structure[6,26], mass[8,9,26,27] and risk of fracture[9].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 19), ('SUPERFICIAL_RELATIONSHIP', 62)]	3	[('UBERON_0000104', 'life cycle', 73, 'life'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
S0-PMC5812027	PMC5812027	2/2018	S0-PMC5812027	['trajectory of Vitamin D status during Pregnancy in RELATION to neonatal Birth size and fetal survival: a prospective cohort study\n\nabstract\n\nbackground\nwe INVESTIGATED the ASSOCIATIONS between Vitamin D status in early and late Pregnancy with neonatal small for Gestational age (sga), low Birth weight (lbw) and Preterm Delivery.']	[('SUPERFICIAL_RELATIONSHIP', 51), ('QUESTION_ANSWERED_BY_THIS_WORK', 155), ('SUPERFICIAL_RELATIONSHIP', 172)]	3	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0007565', 'female pregnancy', 38, 'pregnancy'), ('GO_0007567', 'parturition', 72, 'birth'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('GO_0007565', 'female pregnancy', 228, 'pregnancy'), ('GO_0007565', 'female pregnancy', 262, 'gestational'), ('GO_0007567', 'parturition', 289, 'birth'), ('GO_0007565', 'female pregnancy', 312, 'preterm'), ('GO_0007567', 'parturition', 320, 'delivery')]
S1-PMC5812027	PMC5812027	2/2018	S1-PMC5812027	['furthermore, ASSOCIATIONS between Vitamin D status and Pregnancy loss were studied.']	[('SUPERFICIAL_RELATIONSHIP', 13)]	1	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('GO_0007565', 'female pregnancy', 55, 'pregnancy')]
S14-PMC5812027	PMC5812027	2/2018	S14-PMC5812027	['THUS, both higher Vitamin D status in late Pregnancy and Gestational Vitamin D status trajectory CAN be SUSPECTED to play a ROLE in healthy Pregnancy.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 97), ('PROBABLE_UNDERSTANDING', 104), ('SUPERFICIAL_RELATIONSHIP', 124)]	4	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 43, 'pregnancy'), ('GO_0007565', 'female pregnancy', 57, 'gestational'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007565', 'female pregnancy', 140, 'pregnancy')]
S19-PMC5812027	PMC5812027	2/2018	S19-PMC5812027	['we have PREVIOUSLY SHOWN that higher Vitamin D status in late Pregnancy and larger increase in Vitamin D status during Pregnancy is ASSOCIATED with lower risk of Preeclampsia [3].']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 132)]	2	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0007565', 'female pregnancy', 62, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 95, 'vitamin D'), ('GO_0007565', 'female pregnancy', 119, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 162, 'preeclampsia')]
S24-PMC5812027	PMC5812027	2/2018	S24-PMC5812027	['THUS, the ASSOCIATION between Vitamin D status and neonatal Birth size is NOT CLEAR and WARRANTS FURTHER INVESTIGATION.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('FULL_UNKNOWN', 74), ('FUTURE_WORK', 88)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007567', 'parturition', 60, 'birth')]
S28-PMC5812027	PMC5812027	2/2018	S28-PMC5812027	['lower Vitamin D status HAS also BEEN ASSOCIATED with a medical history of recurrent Miscarriage [12] BUT ONLY two prospective studies have INVESTIGATED this, without finding that lower 25Ohd concentrations increases the risk of Pregnancy Loss [5,13].']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 37), ('ANOMALY_CURIOUS_FINDING', 101), ('QUESTION_ANSWERED_BY_THIS_WORK', 139)]	4	"[('CHEBI_27300', 'vitamin D', 6, 'vitamin D'), ('GO_0046660', 'female sex differentiation', 84, 'miscarriage'), ('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 185, '25OHD'), ('GO_0006508', 'proteolysis', 228, 'pregnancy loss')]"
S30-PMC5812027	PMC5812027	2/2018	S30-PMC5812027	['THUS, the ASSOCIATION between Vitamin D status and risk of Miscarriage NEEDS FURTHER INVESTIGATION.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 10), ('FUTURE_WORK', 71), ('FUTURE_WORK', 77)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0046660', 'female sex differentiation', 59, 'miscarriage')]
S33-PMC5812027	PMC5812027	2/2018	S33-PMC5812027	['our OBJECTIVES were to study the ASSOCIATIONS between Vitamin D status in both early and late Pregnancy, as well as change in Vitamin D status during Pregnancy with neonatal sga, lbw and Preterm Delivery.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('SUPERFICIAL_RELATIONSHIP', 33)]	2	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0007565', 'female pregnancy', 94, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('GO_0007565', 'female pregnancy', 150, 'pregnancy'), ('GO_0007565', 'female pregnancy', 187, 'preterm'), ('GO_0007567', 'parturition', 195, 'delivery')]
S34-PMC5812027	PMC5812027	2/2018	S34-PMC5812027	['ASSOCIATIONS between Vitamin D status in early Pregnancy and Pregnancy loss WERE also STUDIED.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 76)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0007565', 'female pregnancy', 47, 'pregnancy'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy')]
S62-PMC5812027	PMC5812027	2/2018	S62-PMC5812027	['season was coded as a binary variable, since this EXPLAINED 30% of Vitamin D status in a PREVIOUS STUDY in Pregnant women at the same latitude [16].']	[('PROBABLE_UNDERSTANDING', 50), ('INCOMPLETE_EVIDENCE', 89)]	2	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('GO_0007565', 'female pregnancy', 107, 'pregnant')]
S65-PMC5812027	PMC5812027	2/2018	S65-PMC5812027	['these groups were chosen to study WHETHER Vitamin D insufficiency (30–50\xa0nmol/l), sufficiency (≥\u200950\xa0nmol/l) or high status (≥\u200975 or ≥\u2009100\xa0nmol/l) was ASSOCIATED with the outcomes studied, COMPARED to Vitamin D deficiency (<\u200930\xa0nmol/l).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('SUPERFICIAL_RELATIONSHIP', 150)]	2	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
S108-PMC5812027	PMC5812027	2/2018	S108-PMC5812027	['discussion\nwe FOUND that higher Vitamin D status among women in late, BUT NOT early, Pregnancy was ASSOCIATED with lower probability of sga and lbw.']	[('INCOMPLETE_EVIDENCE', 14), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 70), ('SUPERFICIAL_RELATIONSHIP', 99)]	3	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007565', 'female pregnancy', 85, 'pregnancy')]
S111-PMC5812027	PMC5812027	2/2018	S111-PMC5812027	['we also FOUND that lower Vitamin D status in early Pregnancy was RELATED to Pregnancy loss.']	[('INCOMPLETE_EVIDENCE', 8), ('SUPERFICIAL_RELATIONSHIP', 65)]	2	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('GO_0007565', 'female pregnancy', 51, 'pregnancy'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy')]
S115-PMC5812027	PMC5812027	2/2018	S115-PMC5812027	['THUS, preeclampsia does not SEEM to MEDIATE the ASSOCIATIONS between Vitamin D status trajectory and neonatal Birth size or Preterm Birth.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 28), ('SUPERFICIAL_RELATIONSHIP', 36), ('SUPERFICIAL_RELATIONSHIP', 48)]	4	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('GO_0007567', 'parturition', 110, 'birth'), ('GO_0007565', 'female pregnancy', 124, 'preterm birth')]
S118-PMC5812027	PMC5812027	2/2018	S118-PMC5812027	['AS the results between change in 25Ohd and neonatal Birth size and Preterm Delivery REMAINED after adjustment for season of Conception, origin and Vitamin D supplementation, Vitamin D status trajectory CAN be SUSPECTED to play a ROLE in healthy Pregnancy.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 84), ('INCOMPLETE_EVIDENCE', 202), ('PROBABLE_UNDERSTANDING', 209), ('SUPERFICIAL_RELATIONSHIP', 229)]	5	"[('CHEBI_72652', ""7,2'-dihydroxy-4'-methoxyisoflavan-4-ylium cation"", 33, '25OHD'), ('GO_0007567', 'parturition', 52, 'birth'), ('GO_0007565', 'female pregnancy', 67, 'preterm'), ('GO_0007567', 'parturition', 75, 'delivery'), ('GO_0007620', 'copulation', 124, 'conception'), ('CHEBI_27300', 'vitamin D', 147, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('GO_0007565', 'female pregnancy', 245, 'pregnancy')]"
S121-PMC5812027	PMC5812027	2/2018	S121-PMC5812027	['it is also POSSIBLE that the ASSOCIATIONS between fetal growth and maternal Vitamin D status are DUE TO residual CONFOUNDING or REVERSE CAUSATION.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 29), ('PROBLEM_COMPLICATION', 97), ('PROBLEM_COMPLICATION', 113), ('PROBLEM_COMPLICATION', 128)]	5	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
S127-PMC5812027	PMC5812027	2/2018	S127-PMC5812027	['this COULD BE INTERPRETED AS SUPPORT of our finding that late RATHER than early Pregnancy Vitamin D status is the stronger PREDICTOR of fetal growth restriction.']	[('INCOMPLETE_EVIDENCE', 5), ('PROBABLE_UNDERSTANDING', 14), ('INCOMPLETE_EVIDENCE', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 62), ('SUPERFICIAL_RELATIONSHIP', 123)]	5	[('GO_0007565', 'female pregnancy', 80, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D')]
S131-PMC5812027	PMC5812027	2/2018	S131-PMC5812027	['we DID NOT SEE a u-shaped ASSOCIATION between early Pregnancy Vitamin D status and sga, as PREVIOUSLY INDICATED [9].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 3), ('SUPERFICIAL_RELATIONSHIP', 26), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 102)]	4	[('GO_0007565', 'female pregnancy', 52, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D')]
S136-PMC5812027	PMC5812027	2/2018	S136-PMC5812027	['supplementation CAN THEREFORE ONLY PARTLY EXPLAIN the large proportion with high Vitamin D status, and OTHER LIKELY CONTRIBUTORS are Pregnancy associated Endocrine changes and POSSIBLY lifestyle FACTORS.']	[('INCOMPLETE_EVIDENCE', 16), ('PROBABLE_UNDERSTANDING', 20), ('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 35), ('PROBABLE_UNDERSTANDING', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 103), ('PROBABLE_UNDERSTANDING', 109), ('SUPERFICIAL_RELATIONSHIP', 116), ('INCOMPLETE_EVIDENCE', 176), ('SUPERFICIAL_RELATIONSHIP', 195)]	10	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0007565', 'female pregnancy', 133, 'pregnancy'), ('GO_0006397', 'mRNA processing', 154, 'endocrine')]
S137-PMC5812027	PMC5812027	2/2018	S137-PMC5812027	['TO OUR KNOWLEDGE, ours is one of the FIRST studies to find ASSOCIATIONS between Vitamin D status and Pregnancy loss.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 37), ('SUPERFICIAL_RELATIONSHIP', 59)]	3	[('CHEBI_27300', 'vitamin D', 80, 'vitamin D'), ('GO_0007565', 'female pregnancy', 101, 'pregnancy')]
S141-PMC5812027	PMC5812027	2/2018	S141-PMC5812027	['one earlier study, from denmark, FOUND that lower Vitamin D status in early Pregnancy was ASSOCIATED with Pregnancy loss in the first trimester [24].']	[('INCOMPLETE_EVIDENCE', 33), ('SUPERFICIAL_RELATIONSHIP', 90)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy')]
S143-PMC5812027	PMC5812027	2/2018	S143-PMC5812027	['AS most women with high Vitamin D status were Born in sweden and THUS more LIKELY to be familiar with the swedish Health-Care System, IT IS POSSIBLE that they registered earlier for Antenatal Care and were more LIKELY to report Pregnancy Loss.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 65), ('PROBABLE_UNDERSTANDING', 75), ('INCOMPLETE_EVIDENCE', 134), ('PROBABLE_UNDERSTANDING', 211)]	5	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0007567', 'parturition', 46, 'born'), ('UBERON_0001008', 'renal system', 114, 'health-care system'), ('GO_0007608', 'sensory perception of smell', 182, 'antenatal care'), ('GO_0006508', 'proteolysis', 228, 'pregnancy loss')]
S152-PMC5812027	PMC5812027	2/2018	S152-PMC5812027	['in addition, Vitamin D status among women who Terminated the Pregnancy WAS NOT ASSESSED.']	[('INCOMPLETE_EVIDENCE', 71), ('QUESTION_ANSWERED_BY_THIS_WORK', 79)]	2	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0042778', 'tRNA end turnover', 46, 'terminated'), ('GO_0007565', 'female pregnancy', 61, 'pregnancy')]
S160-PMC5812027	PMC5812027	2/2018	S160-PMC5812027	['INTERESTINGLY, Vitamin D status at t1- around the time the maternal Blood flow of the Placenta is fully developed- is ONLY RELATED to Pregnancy loss.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 123)]	3	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('UBERON_0000178', 'blood', 68, 'blood'), ('UBERON_0001987', 'placenta', 86, 'placenta'), ('GO_0007565', 'female pregnancy', 134, 'pregnancy')]
S162-PMC5812027	PMC5812027	2/2018	S162-PMC5812027	['high Vitamin D status in late, BUT NOT early, Pregnancy was ASSOCIATED with lower odds of sga and lbw.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('SUPERFICIAL_RELATIONSHIP', 60)]	2	[('CHEBI_27300', 'vitamin D', 5, 'vitamin D'), ('GO_0007565', 'female pregnancy', 46, 'pregnancy')]
S164-PMC5812027	PMC5812027	2/2018	S164-PMC5812027	['both higher late Pregnancy Vitamin D status and Gestational Vitamin D status trajectory CAN be SUSPECTED to play a ROLE in healthy Pregnancy.']	[('INCOMPLETE_EVIDENCE', 88), ('PROBABLE_UNDERSTANDING', 95), ('SUPERFICIAL_RELATIONSHIP', 115)]	3	[('GO_0007565', 'female pregnancy', 17, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0007565', 'female pregnancy', 48, 'gestational'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('GO_0007565', 'female pregnancy', 131, 'pregnancy')]
S9-PMC5827025	PMC5827025	2/2018	S9-PMC5827025	['in conclusion, pre-Pregnancy bmi, seasonality and multivitamin use are INFLUENT FACTORS of Gestational Vitamin D status.']	[('SUPERFICIAL_RELATIONSHIP', 71), ('SUPERFICIAL_RELATIONSHIP', 80)]	2	[('GO_0007565', 'female pregnancy', 19, 'pregnancy'), ('GO_0007565', 'female pregnancy', 91, 'gestational'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin D')]
S15-PMC5827025	PMC5827025	2/2018	S15-PMC5827025	['ALTHOUGH SOME POTENTIAL INFLUENT FACTORS for Vitamin D status, such as seasonality, age, smoking, race and ethnicity HAVE BEEN IDENTIFIED in SEVERAL case-control STUDIES6–8, research REPORTS on the INFLUENT FACTORS for Gestational Vitamin D status in a population-based cohort are LACKING.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 24), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 117), ('INCOMPLETE_EVIDENCE', 127), ('INCOMPLETE_EVIDENCE', 141), ('INCOMPLETE_EVIDENCE', 162), ('INCOMPLETE_EVIDENCE', 183), ('SUPERFICIAL_RELATIONSHIP', 198), ('SUPERFICIAL_RELATIONSHIP', 207), ('FULL_UNKNOWN', 281), ('INCOMPLETE_EVIDENCE', 281)]	15	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0007565', 'female pregnancy', 219, 'gestational'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D')]
S35-PMC5827025	PMC5827025	2/2018	S35-PMC5827025	['influence of demographic characteristics on Gestational Serum 25(Oh)D concentration\nthe demographic characteristics for INFLUENCING Gestational Vitamin D status were analyzed.']	[('SUPERFICIAL_RELATIONSHIP', 120)]	1	[('GO_0007565', 'female pregnancy', 44, 'gestational'), ('UBERON_0001977', 'blood serum', 56, 'serum'), ('CHEBI_71657', 'versiconol acetate', 62, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 62, '25(OH)D'), ('GO_0007565', 'female pregnancy', 132, 'gestational'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D')]
S74-PMC5827025	PMC5827025	2/2018	S74-PMC5827025	['discussion\nthe PRESENT STUDY analyzed Vitamin D status among 3598 Pregnant women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 15)]	1	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('GO_0007565', 'female pregnancy', 66, 'pregnant')]
S78-PMC5827025	PMC5827025	2/2018	S78-PMC5827025	['a report DEMONSTRATED that socio-economic status INFLUENCES Gestational Vitamin D status26.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 49)]	2	[('GO_0007565', 'female pregnancy', 60, 'gestational'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D')]
S81-PMC5827025	PMC5827025	2/2018	S81-PMC5827025	['results SHOW that these factors did not affect Gestational Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 8)]	1	[('GO_0007565', 'female pregnancy', 47, 'gestational'), ('CHEBI_27300', 'vitamin D', 59, 'vitamin D')]
S90-PMC5827025	PMC5827025	2/2018	S90-PMC5827025	['SEVERAL STUDIES SHOWED that multivitamin use CAN improve their Vitamin D status29,30.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 45)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
S94-PMC5827025	PMC5827025	2/2018	S94-PMC5827025	['NUMEROUS STUDIES SHOWED that season is a MAJOR INFLUENT FACTOR for Vitamin D status31,32.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('IMPORTANT_CONSIDERATION', 41), ('SUPERFICIAL_RELATIONSHIP', 47), ('SUPERFICIAL_RELATIONSHIP', 56)]	5	[('CHEBI_27300', 'vitamin D', 67, 'vitamin D')]
S102-PMC5827025	PMC5827025	2/2018	S102-PMC5827025	['the INCONSISTENCY of PAST FINDINGS MAY BE RELATED to following REASONS: first, cohort among Pregnant women with relatively Vitamin D replete, with a history of Preterm Delivery or at high risk for Preeclampsia; second, Gestational Vitamin D status is a LINK to ethnic DISPARITIES in adverse Birth outcomes24.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 4), ('INCOMPLETE_EVIDENCE', 4), ('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 35), ('SUPERFICIAL_RELATIONSHIP', 42), ('PROBABLE_UNDERSTANDING', 63), ('SUPERFICIAL_RELATIONSHIP', 253), ('IMPORTANT_CONSIDERATION', 268)]	9	[('GO_0007565', 'female pregnancy', 92, 'pregnant'), ('CHEBI_27300', 'vitamin D', 123, 'vitamin D'), ('GO_0007565', 'female pregnancy', 160, 'preterm'), ('GO_0007567', 'parturition', 168, 'delivery'), ('GO_0007128', 'meiotic prophase I', 197, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 219, 'gestational'), ('CHEBI_27300', 'vitamin D', 231, 'vitamin D'), ('GO_0007567', 'parturition', 291, 'birth')]
S103-PMC5827025	PMC5827025	2/2018	S103-PMC5827025	['ALTHOUGH a RECENT STUDY in northeast china DEMONSTRATED that vdd was more PREVALENT in the SEVERE preterm group than in the mildly preterm group and the in-term group, they DID NOT analyze the ASSOCIATION between vdd and an INCREASED RISK of Preterm Delivery BECAUSE Vitamin D status at prior to labor cannot be used to assess risk of Preterm Delivery39.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 43), ('IMPORTANT_CONSIDERATION', 74), ('IMPORTANT_CONSIDERATION', 91), ('INCOMPLETE_EVIDENCE', 173), ('SUPERFICIAL_RELATIONSHIP', 193), ('IMPORTANT_CONSIDERATION', 224), ('PROBLEM_COMPLICATION', 259)]	10	[('GO_0007565', 'female pregnancy', 242, 'preterm'), ('GO_0007567', 'parturition', 250, 'delivery'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('GO_0007565', 'female pregnancy', 335, 'preterm'), ('GO_0007567', 'parturition', 343, 'delivery39')]
S104-PMC5827025	PMC5827025	2/2018	S104-PMC5827025	['the PRESENT STUDY analyzed the ASSOCIATION between Vitamin D status during first- and second-Trimester and Preterm Delivery in chinese population.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('SUPERFICIAL_RELATIONSHIP', 31)]	2	[('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0009294', 'DNA mediated transformation', 93, 'trimester'), ('GO_0007565', 'female pregnancy', 107, 'preterm'), ('GO_0007567', 'parturition', 115, 'delivery')]
S1-PMC5838372	PMC5838372	3/2018	S1-PMC5838372	['the AIM of THIS STUDY was TO EVALUATE maternal Vitamin D status and its EFFECT on neonatal Vitamin D concentrations after a support programme for Pregnant women was introduced.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 72)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0007565', 'female pregnancy', 146, 'pregnant')]
S27-PMC5838372	PMC5838372	3/2018	S27-PMC5838372	['the AIM of THIS STUDY was TO EVALUATE maternal Vitamin D status and its EFFECT on neonatal Vitamin D status, following the introduction of the support programme for pregnant women.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 4), ('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 72)]	4	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D')]
S106-PMC5838372	PMC5838372	3/2018	S106-PMC5838372	['limited sun exposure, regular use of sunscreens, living in northern latitudes, dark skin, obesity, extensive clothing cover, Aging, poor nutritional status, malabsorption syndromes and Medications HAVE BEEN REPORTED as RISK FACTORS for Vitamin D deficiency (1,19).']	[('INCOMPLETE_EVIDENCE', 197), ('SUPERFICIAL_RELATIONSHIP', 219)]	2	[('GO_0007568', 'aging', 125, 'aging'), ('CHEBI_25441', 'mycothiols', 185, 'medications'), ('CHEBI_27300', 'vitamin D', 236, 'vitamin D')]
S107-PMC5838372	PMC5838372	3/2018	S107-PMC5838372	['in PREVIOUS STUDIES in turkey, winter season, low socioeconomic status, low educational status and covered clothing style were REPORTED as RISK FACTORS for Vitamin D deficiency in mothers (31,34,35).']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 127), ('SUPERFICIAL_RELATIONSHIP', 139)]	3	[('CHEBI_27300', 'vitamin D', 156, 'vitamin D')]
S28-PMC5941617	PMC5941617	5/2018	S28-PMC5941617	['it is the BEST MARKER to monitor for Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 10), ('SUPERFICIAL_RELATIONSHIP', 15)]	2	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
S32-PMC5941617	PMC5941617	5/2018	S32-PMC5941617	['caption (table-wrap): table 2\n\ndefinition of Vitamin D status according to several societies and organizations in the last 10\xa0yearssociety/organizationyearsevere deficiencydeficiencyinsufficiencysufficiency/adequacycanadian pediatric society [8]2007–<\u2009 10\xa0ng/ml10–29\xa0ng/ml≥ 30\xa0ng/mllawson wilkins pediatric Endocrine society [9]2008<\u2009 5\xa0ng/ml5–14\xa0ng/ml15–19\xa0ng/ml≥ 20\xa0ng/mlinstitute of medicine [10]2011–<\u2009 12\xa0ng/ml12–20\xa0ng/mla≥ 20\xa0ng/mlthe Endocrine society [11]2011–<\u2009 20\xa0ng/ml21–29\xa0ng/ml≥ 30\xa0ng/mlbritish paediatric and adolescent bone group [12]2012–<\u200910\xa0ng/ml10–19\xa0ng/ml≥ 20\xa0ng/mlfrench society of paediatrics [13]2012–<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlasociación espanola de pediatría (spain) [14]2012–<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlfederal commission for nutrition (switzerland) [15]2012<\u200910\xa0ng/ml<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlnordic nutrition recommendations [16]2012–<\u2009 12\xa0ng/ml12–20\xa0ng/ml≥ 20\xa0ng/mlgerman nutrition society [17]2012–––≥ 20\xa0ng/mlhealth council of the netherlands [18]2012–––≥ 12\xa0ng/mleuropean society for paediatric gastroenterology hepatology and nutrition [19]2013<\u200910\xa0ng/ml<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mlcentral europe [20]2013–< 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mlsociety for adolescent health and medicine [21]2013–<\u2009 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mlaustralia/new zealand [22]2013<\u2009 5\xa0ng/ml5–11\xa0ng/ml12–19\xa0ng/ml≥ 20\xa0ng/mlamerican academy of pediatrics [23]2014–<\u2009 20\xa0ng/ml–≥ 20\xa0ng/mljapanese society for bone and Mineral research, japan Endocrine societyb[24]2015–<\u2009 20\xa0ng/ml––scientific advisory committee on nutrition [25]2016–––≥ 10\xa0ng/mleuropean Food safety authority [26]2016–––≥ 20\xa0ng/mlunited arab emirates [27]2016–<\u2009 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mlglobal consensus for rickets [28]2016–<\u2009 12\xa0ng/ml12–19\xa0ng/ml≥ 20\xa0ng/mljapanese society for bone and Mineral research, japan Endocrine societyc[29]2017–<\u2009 20\xa0ng/ml20–29\xa0ng/ml≥ 30\xa0ng/mleuropean academy of pediatrics [30]2017definition of Vitamin D status is UNCLEAR DUE TO a lack OF consensus\navitamin D inadequacy\nbdiagnostic criteria for rickets\ncassessment criteria for Vitamin D deficiency/insufficiency (authors REPORTED that DIFFERENT criteria MAY BE needed for children)\nsevere Vitamin D deficiency is DEFINED as 25(Oh)d levels <\u200910\xa0ng/ml by SEVERAL authors and societies BECAUSE the risk of rickets is high below this cut-off also in presence of an adequate Calcium intake [31–33] (see chapter “nutritional rickets”).']	[('FULL_UNKNOWN', 1894), ('PROBLEM_COMPLICATION', 1902), ('ANOMALY_CURIOUS_FINDING', 1916), ('ANOMALY_CURIOUS_FINDING', 1916), ('INCOMPLETE_EVIDENCE', 2053), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2067), ('INCOMPLETE_EVIDENCE', 2086), ('PROBABLE_UNDERSTANDING', 2145), ('INCOMPLETE_EVIDENCE', 2185), ('PROBABLE_UNDERSTANDING', 2215)]	10	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 307, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 441, 'Endocrine'), ('CHEBI_46662', 'mineral', 1396, 'Mineral'), ('GO_0009790', 'embryo development', 1420, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 1420, 'Endocrine'), ('CHEBI_33290', 'food', 1533, 'Food'), ('CHEBI_46662', 'mineral', 1738, 'Mineral'), ('GO_0009790', 'embryo development', 1762, 'Endocrine'), ('UBERON_0005063', 'left ventricular compact myocardium', 1762, 'Endocrine'), ('CHEBI_27300', 'vitamin D', 1874, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1938, 'D'), ('CHEBI_27300', 'vitamin D', 2009, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2121, 'vitamin D'), ('CHEBI_30778', 'gallic acid', 2156, '25(OH)'), ('CHEBI_22313', 'alkaline earth metal atom', 2302, 'calcium')]
S44-PMC5941617	PMC5941617	5/2018	S44-PMC5941617	['based ON the above CONSIDERATIONS, we SUGGEST to define Vitamin D status as reported in table\xa03.']	[('ANOMALY_CURIOUS_FINDING', 6), ('IMPORTANT_CONSIDERATION', 19), ('INCOMPLETE_EVIDENCE', 38)]	3	[('CHEBI_27300', 'vitamin D', 56, 'vitamin D')]
S45-PMC5941617	PMC5941617	5/2018	S45-PMC5941617	['caption (table-wrap): table 3\n\ncut-off points for the definition of Vitamin D status based on circulating levels of 25(Oh)Dsevere deficiencydeficiencyinsufficiencysufficiency25(Oh)D< 10\xa0ng/ml (< 25\xa0nmol/l)< 20\xa0ng/ml (< 50\xa0nmol/l)20–29\xa0ng/ml (50–74\xa0nmol/l)≥ 30\xa0ng/ml (≥ 75\xa0nmol/l)\nconversion factor: ng/ml\u2009=\u2009nmol/l*0.401; nmol/l\u2009=\u2009ng/ml*2.496\nVitamin D status is DEFINED by the measurement of 25(Oh)D concentrations.']	[('PROBABLE_UNDERSTANDING', 362)]	1	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('CHEBI_77894', 'aci-nitroethane', 116, '25(OH)DSevere'), ('CHEBI_33010', 'chromide(1-)', 176, '(OH)D'), ('CHEBI_28384', 'vitamin K', 342, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 392, '25(OH)D')]
S47-PMC5941617	PMC5941617	5/2018	S47-PMC5941617	['1,25(Oh)2D measurement does not reflect Vitamin D status, OWING to the short half-life (4–6\xa0h) and the lower concentration (pg/ml vs. ng/ml).']	[('PROBLEM_COMPLICATION', 58)]	1	"[('CHEBI_66212', ""5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone"", 2, '25(OH)2D'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]"
S92-PMC5941617	PMC5941617	5/2018	S92-PMC5941617	['THUS, during this period an adequate Vitamin D status can be maintained only from endogenous stores accumulated during previous summer or by exogenous supplementation.']	[('PROBABLE_UNDERSTANDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D')]
S109-PMC5941617	PMC5941617	5/2018	S109-PMC5941617	['caption (table-wrap): table 5\n\ndietary reference values of Vitamin D in infants, children, and adolescents as PROPOSED by various organizations and societiesorganization/societyyearcountry/countriesdietary reference value for Vitamin D0–12\xa0months, iu/day1–18\xa0years, iu/dayeuropean Food safety authority [26]2016europeai400 (7–11\xa0months)600 (1–17\xa0years)scientific advisory committee on nutrition [25]2016united kingdomsafe intake (<\u20094\xa0years)340–400400rni (4–18\xa0years)nordic nutrition recommendations [16]2012denmark, finland, iceland, norway, sweden, faroe islands, greenland, åland islandsri400400german nutrition society [17]2012germany, austria, switzerlandai400 (infants)800a(children)health council of the netherlands [18]2012the netherlandsai400400italian society of nutrition [89]2012italyai (<\u2009 12\xa0months)400 (6–12\xa0months)600pri (1–18\xa0years)institute of medicine [10]2011north america, canadaai (<\u2009 12\xa0months)400600rda (1–18\xa0years)the Endocrine society [11]2011worldwidedaily requirementb400–1000600–1000\nai adequate intake, the average observed daily level of Intake by a population group of apparently healthy People that is ASSUMED to be adequate\nsafe intake , a level or range of intakes considered to pose no risk of deficiency and below a level where there is a risk of undesirable EFFECTS\nrni reference Nutrient intake, the amount of a Nutrient that is LIKELY to meet the needs of 97.5% of the population\nri recommended intake, the amount of a Nutrient that meets the known REQUIREMENT and maintains good nutritional status among practically all (97–98%) healthy Individuals in a particular Life Stage or gender group\npri population reference intake, the level of Nutrient intake sufficient to satisfy the needs of ALMOST all (97.5%) healthy subjects in one specific population group\nrda recommended dietary allowance, the estimated intake capable of satisfying the needs of 97.5% of the population\naadequate intake with missing Endogenous Synthesis Of Vitamin D\nbrecommended REQUIREMENTS for subjects at risk of Vitamin D deficiency\nin accordance with the european society for paediatric gastroenterology hepatology and nutrition [espghan] [19] and the european academy of pediatrics [30], we endorsed tolerable upper intake levels of Vitamin D proposed by efsa in 2012 (1000\xa0iu/day for infants: 2000\xa0iu/day for children ages 1 to 10\xa0years; 4000\xa0iu/day for children and adolescents ages 11 to 17\xa0years) [90].']	[('INCOMPLETE_EVIDENCE', 110), ('PROBABLE_UNDERSTANDING', 1134), ('SUPERFICIAL_RELATIONSHIP', 1295), ('PROBABLE_UNDERSTANDING', 1367), ('IMPORTANT_CONSIDERATION', 1488), ('ANOMALY_CURIOUS_FINDING', 1729), ('IMPORTANT_CONSIDERATION', 1990)]	7	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_33279', 'vitamin D5', 226, 'vitamin D0'), ('PR_000017299', 'VIP peptides', 226, 'vitamin D0'), ('CHEBI_33290', 'food', 281, 'Food'), ('UBERON_0005063', 'left ventricular compact myocardium', 942, 'Endocrine'), ('GO_0007631', 'feeding behavior', 1068, 'intake'), ('NCBITaxon_10088', 'Mus <genus>', 1119, 'people'), ('CHEBI_33284', 'nutrient', 1317, 'Nutrient'), ('CHEBI_33284', 'nutrient', 1350, 'nutrient'), ('CHEBI_33284', 'nutrient', 1458, 'nutrient'), ('NCBITaxon_1', 'root', 1577, 'individuals'), ('UBERON_0000105', 'life cycle stage', 1605, 'life stage'), ('CHEBI_33284', 'nutrient', 1678, 'nutrient'), ('GO_0009790', 'embryo development', 1943, 'endogenous'), ('GO_0030474', 'spindle pole body duplication', 1954, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 1967, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 1975, 'D'), ('CHEBI_27300', 'vitamin D', 2027, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 2250, 'vitamin D')]
S110-PMC5941617	PMC5941617	5/2018	S110-PMC5941617	['Vitamin D supplementation\n\n0–12\xa0months\nvitamin D supplementation in the first year of Life is ESSENTIAL to ensure an adequate Vitamin D status and to prevent nutritional rickets.']	[('IMPORTANT_CONSIDERATION', 94)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 47, 'D'), ('UBERON_0000104', 'life cycle', 86, 'life'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D')]
S113-PMC5941617	PMC5941617	5/2018	S113-PMC5941617	['moreover, newborns from deficient mothers are at INCREASED RISK for Vitamin D deficiency AS Cord Blood and neonatal 25(Oh)D levels highly CORRELATE with maternal Vitamin d status during Gestation [92,93].']	[('IMPORTANT_CONSIDERATION', 49), ('PROBABLE_UNDERSTANDING', 89), ('SUPERFICIAL_RELATIONSHIP', 138)]	3	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0002240', 'spinal cord', 92, 'cord'), ('UBERON_0000178', 'blood', 97, 'blood'), ('CHEBI_71657', 'versiconol acetate', 116, '25(OH)D'), ('CHEBI_33229', 'vitamin (role)', 162, 'vitamin'), ('GO_0007565', 'female pregnancy', 186, 'gestation')]
S115-PMC5941617	PMC5941617	5/2018	S115-PMC5941617	['SOME STUDIES evaluated the EFFECT of daily Vitamin D supplementation at variable dosages (ranging from 200 to 1600\xa0iu/day) on Vitamin D status in children during the first year of Life [52,62,97–107].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 27)]	2	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 126, 'vitamin D'), ('UBERON_0000104', 'life cycle', 180, 'life')]
S123-PMC5941617	PMC5941617	5/2018	S123-PMC5941617	['these societies also agree that the administration of 400\xa0iu/day is SAFE and effective to prevent rickets and ensure an adequate Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 68)]	1	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]
S139-PMC5941617	PMC5941617	5/2018	S139-PMC5941617	['in addition to optimize bone mineralization during fetal Life, Vitamin D status HAS BEEN ASSOCIATED with acute Respiratory morbidity in preterm infants Born <\u200932\xa0weeks Gestation [124].']	[('INCOMPLETE_EVIDENCE', 80), ('SUPERFICIAL_RELATIONSHIP', 89)]	2	[('UBERON_0000104', 'life cycle', 57, 'life'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 111, 'respiratory'), ('GO_0007567', 'parturition', 152, 'born'), ('GO_0007565', 'female pregnancy', 168, 'gestation')]
S152-PMC5941617	PMC5941617	5/2018	S152-PMC5941617	['RECENTLY RECOMMENDED Vitamin D supplementation at 800\xa0iu/day to enhance Vitamin D status during early hospitalization in vlbw infants with Serum 25(Oh)D levels <\u200910\xa0ng/ml at Birth [142].']	[('INCOMPLETE_EVIDENCE', 0), ('FUTURE_WORK', 9)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('UBERON_0001977', 'blood serum', 139, 'serum'), ('CHEBI_71657', 'versiconol acetate', 145, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 145, '25 ... OH ... D'), ('GO_0007567', 'parturition', 174, 'birth')]
S159-PMC5941617	PMC5941617	5/2018	S159-PMC5941617	['1–18\xa0years\nthe promotion of an adequate Vitamin D status is IMPORTANT for older children and adolescents, AS nutritional rickets MAY develop during the entire pediatric age [28] and Vitamin D deficiency MAY negatively AFFECT bone health [25,26].']	[('IMPORTANT_CONSIDERATION', 60), ('PROBABLE_UNDERSTANDING', 106), ('INCOMPLETE_EVIDENCE', 129), ('INCOMPLETE_EVIDENCE', 203), ('SUPERFICIAL_RELATIONSHIP', 218)]	5	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 182, 'vitamin D')]
S160-PMC5941617	PMC5941617	5/2018	S160-PMC5941617	['VARIOUS STUDIES evaluated DIFFERENT regimens of Vitamin D supplementation, BUT comparison of results is COMPLEX DUE TO HETEROGENEITY in Vitamin D administration (dose, interval, and length of supplementation) and population enrolled (age, gender, ethnicity, body mass index, latitude of the country of residence, season of enrolment, and basal Vitamin D status).']	[('INCOMPLETE_EVIDENCE', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 75), ('PROBLEM_COMPLICATION', 75), ('DIFFICULT_TASK', 104), ('PROBLEM_COMPLICATION', 112), ('DIFFICULT_TASK', 119)]	7	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 136, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 344, 'vitamin D')]
S182-PMC5941617	PMC5941617	5/2018	S182-PMC5941617	['these data SUGGEST that wintry Vitamin D status DEPENDS ON the amount of Vitamin D produced and stored during the previous summer [181].']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 48)]	2	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 73, 'vitamin D')]
S199-PMC5941617	PMC5941617	5/2018	S199-PMC5941617	['particularly, Vitamin D status SHOULD BE monitored AT LEAST yearly in subjects that REQUIRE supplementation during the whole year BECAUSE AFFECTED from pathological conditions or receiving Drugs AFFECTING vitamin D Metabolism (table\xa07) (see “Extraskeletal actions of Vitamin D” for specific RECOMMENDATIONS).']	[('FUTURE_WORK', 31), ('IMPORTANT_CONSIDERATION', 31), ('PROBABLE_UNDERSTANDING', 51), ('IMPORTANT_CONSIDERATION', 84), ('PROBABLE_UNDERSTANDING', 130), ('SUPERFICIAL_RELATIONSHIP', 138), ('SUPERFICIAL_RELATIONSHIP', 195), ('FUTURE_WORK', 291)]	8	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CHEBI_23888', 'drug', 189, 'drugs'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 213, 'D'), ('GO_0018977', '1,1,1-trichloro-2,2-bis-(4-chlorophenyl)ethane metabolic process', 213, 'D metabolism'), ('UBERON_0001431', 'distal carpal bone 2', 242, 'Extraskeletal'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D')]
S243-PMC5941617	PMC5941617	5/2018	S243-PMC5941617	['bone health\nbone mass acquisition is INFLUENCED by both genetics and lifestyle-related FACTORS, such as Vitamin D status, physical activity and Calcium intake [23,53].']	[('SUPERFICIAL_RELATIONSHIP', 37), ('SUPERFICIAL_RELATIONSHIP', 87)]	2	[('CHEBI_27300', 'vitamin D', 104, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 144, 'calcium')]
S250-PMC5941617	PMC5941617	5/2018	S250-PMC5941617	['a FEW STUDIES evaluated the RELATIONSHIP between Vitamin D status and bone mass during this period of Life [52,62,97,104,201–203].']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 28)]	2	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0000104', 'life cycle', 102, 'life')]
S251-PMC5941617	PMC5941617	5/2018	S251-PMC5941617	['among these, three italian STUDIES assessed bone Mineral status in infants using quantitative ultrasound [201–203], SUGGESTING that Vitamin D supplementation is IMPORTANT to provide an adequate Bone Development, PARTICULARLY in exclusively breastfed infants.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 116), ('IMPORTANT_CONSIDERATION', 161), ('ANOMALY_CURIOUS_FINDING', 212), ('IMPORTANT_CONSIDERATION', 212)]	5	[('CHEBI_46662', 'mineral', 49, 'mineral'), ('CHEBI_27300', 'vitamin D', 132, 'vitamin D'), ('GO_0048539', 'bone marrow development', 194, 'bone development')]
S254-PMC5941617	PMC5941617	5/2018	S254-PMC5941617	['INTERESTINGLY, higher Vitamin D status from infancy through to 3\xa0years of age was ASSOCIATED with leaner body composition [205].']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 82)]	2	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D')]
S256-PMC5941617	PMC5941617	5/2018	S256-PMC5941617	['SEVERAL STUDIES evaluated the ASSOCIATION between Vitamin D status and bone mass in children and adolescents, USUALLY SEARCHING for a CORRELATION between actual Serum 25(Oh)D levels and bone mass.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 118), ('SUPERFICIAL_RELATIONSHIP', 134)]	5	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('UBERON_0001977', 'blood serum', 161, 'serum'), ('CHEBI_71657', 'versiconol acetate', 167, '25(OH)D')]
S257-PMC5941617	PMC5941617	5/2018	S257-PMC5941617	['results of these studies are HETEROGENEOUS, because SOME DEMONSTRATED that Vitamin D status was significantly RELATED to bone mass [41,42,54,206–208] WHILE others DID NOT FIND any association [44,209–211].']	[('DIFFICULT_TASK', 29), ('INCOMPLETE_EVIDENCE', 52), ('INCOMPLETE_EVIDENCE', 57), ('SUPERFICIAL_RELATIONSHIP', 110), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 150), ('INCOMPLETE_EVIDENCE', 163)]	6	[('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
S261-PMC5941617	PMC5941617	5/2018	S261-PMC5941617	['moreover, Vitamin D status was DEMONSTRATED to be a significant DETERMINANT of pbm in young Adults [214,215].']	[('INCOMPLETE_EVIDENCE', 31), ('SUPERFICIAL_RELATIONSHIP', 64)]	2	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('UBERON_0007023', 'adult organism', 92, 'adults')]
S264-PMC5941617	PMC5941617	5/2018	S264-PMC5941617	['HOWEVER, the EFFECT of supplementation became significant on total body bmc and Lumbar Spine bmd by dividing the sample into two groups, depending on Vitamin D status [25(Oh)D levels <\u200914\xa0ng/ml vs. ≥ 14\xa0ng/ml], SUGGESTING that Vitamin D supplementation MAY result in a clinically significant increase in bone mass in subjects with Vitamin D deficiency.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 211), ('INCOMPLETE_EVIDENCE', 253)]	4	[('UBERON_0006074', 'lumbar region of vertebral column', 80, 'lumbar spine'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 168, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 168, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 227, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 331, 'vitamin D')]
S272-PMC5941617	PMC5941617	5/2018	S272-PMC5941617	['maternal Vitamin D status during Pregnancy MAY significantly INFLUENCE fetal and neonatal bone mass, as RECENTLY CONFIRMED by the sacn [25].']	[('INCOMPLETE_EVIDENCE', 43), ('SUPERFICIAL_RELATIONSHIP', 61), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 113)]	4	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0007565', 'female pregnancy', 33, 'pregnancy')]
S275-PMC5941617	PMC5941617	5/2018	S275-PMC5941617	['these results CONFIRMED that maternal Vitamin D status MAY AFFECT bone Mineral accrual during the Intrauterine Period and INFLUENCE bone size [230].']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 55), ('SUPERFICIAL_RELATIONSHIP', 59), ('SUPERFICIAL_RELATIONSHIP', 122)]	4	[('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('CHEBI_46662', 'mineral', 71, 'mineral'), ('UBERON_0006351', 'principal vein of forelimb', 98, 'intrauterine period')]
S276-PMC5941617	PMC5941617	5/2018	S276-PMC5941617	['moreover, Postnatal Vitamin D supplementation (follow-up 14\xa0months) MAY ONLY PARTLY eliminate the differences in bone variables induced by maternal Vitamin D status during the Fetal Period [231].']	[('INCOMPLETE_EVIDENCE', 68), ('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 77)]	3	[('GO_0007567', 'parturition', 10, 'postnatal'), ('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D'), ('UBERON_0002375', 'cricoid cartilage', 176, 'fetal period')]
S283-PMC5941617	PMC5941617	5/2018	S283-PMC5941617	['HOWEVER, the most RECENT STUDY SUGGESTED that Vitamin D status during childhood MIGHT be more RELEVANT for bone health that maternal 25(Oh)D levels during fetal Life [237].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 80), ('IMPORTANT_CONSIDERATION', 94), ('SUPERFICIAL_RELATIONSHIP', 94)]	6	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D'), ('UBERON_0000104', 'life cycle', 161, 'life')]
S285-PMC5941617	PMC5941617	5/2018	S285-PMC5941617	['a RELATIONSHIP between Vitamin D status and the incidence or the severity of Respiratory infections in children HAS BEEN FOUND in MANY observational STUDIES, most with a case-control or cross sectional design, both in developing and in westernized countries.']	[('SUPERFICIAL_RELATIONSHIP', 2), ('INCOMPLETE_EVIDENCE', 112), ('INCOMPLETE_EVIDENCE', 130)]	3	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 77, 'respiratory')]
S300-PMC5941617	PMC5941617	5/2018	S300-PMC5941617	['taken TOGETHER, all these data INDICATE that Vitamin D status MIGHT have SOME INFLUENCE on conditioning the incidence and severity of SOME but not all type of Respiratory infections and that more information are REQUIRED before drawing any firm conclusion on THIS topic.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 73), ('SUPERFICIAL_RELATIONSHIP', 78), ('INCOMPLETE_EVIDENCE', 134), ('FUTURE_WORK', 212), ('IMPORTANT_CONSIDERATION', 212), ('QUESTION_ANSWERED_BY_THIS_WORK', 259)]	9	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 159, 'respiratory')]
S302-PMC5941617	PMC5941617	5/2018	S302-PMC5941617	['furthermore, SOME ROLE from vdr polymorphisms or OTHER Genetic factors MIGHT play a ROLE in determining the INFLUENCE of Vitamin D status on Respiratory morbidity [257,258].']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 49), ('INCOMPLETE_EVIDENCE', 71), ('SUPERFICIAL_RELATIONSHIP', 84), ('SUPERFICIAL_RELATIONSHIP', 108)]	6	[('SO_0000704', 'gene', 55, 'genetic'), ('CHEBI_27300', 'vitamin D', 121, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 141, 'respiratory')]
S324-PMC5941617	PMC5941617	5/2018	S324-PMC5941617	['the Vitamin D status CAN be INFLUENCED by the infection itself but also by Antiretroviral therapy.']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 28)]	2	[('CHEBI_27300', 'vitamin D', 4, 'vitamin D'), ('CHEBI_65417', '(+)-aplysinillin', 75, 'antiretroviral')]
S333-PMC5941617	PMC5941617	5/2018	S333-PMC5941617	['an italian rct was performed TO TEST WHETHER Vitamin D3Supplementation (oral 100000\xa0iu every 3\xa0months for 4 doses) COULD improve Vitamin D status and AFFECT the t-Cell phenotype in hiv-infected patients aged 8 to 26\xa0years with Serum 25(Oh) D\u2009<\u200930\xa0ng/ml.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 29), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 37), ('INCOMPLETE_EVIDENCE', 115), ('SUPERFICIAL_RELATIONSHIP', 150)]	4	[('CHEBI_52915', 'phosphatediyl group', 45, 'vitamin D3supplementation'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CL_0000622', 'acinar cell', 162, '-cell'), ('UBERON_0001977', 'blood serum', 227, 'serum'), ('CHEBI_71657', 'versiconol acetate', 233, '25(OH) D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 233, '25(OH) D')]
S336-PMC5941617	PMC5941617	5/2018	S336-PMC5941617	['in a pilot study in botswana, Vitamin D3Supplementation (4000–7000\xa0iu/day for 12\xa0weeks) was SAFE and improved Vitamin D status, growth and hiv status [289].']	[('IMPORTANT_CONSIDERATION', 92)]	1	[('CHEBI_52915', 'phosphatediyl group', 30, 'vitamin D3supplementation'), ('PR_000006649', 'zinc finger protein neuro-d4', 38, 'D3supplementation'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D')]
S346-PMC5941617	PMC5941617	5/2018	S346-PMC5941617	['DID NOT FIND an ASSOCIATION between tubercular infection and Vitamin D status in a large population of internationally adopted children, although results DEMONSTRATED a high prevalence (about 75%) of hypovitaminosis d in this population [182].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 16), ('INCOMPLETE_EVIDENCE', 154)]	3	[('CHEBI_27300', 'vitamin D', 61, 'vitamin D')]
S348-PMC5941617	PMC5941617	5/2018	S348-PMC5941617	['the same authors had PREVIOUSLY DEMONSTRATED a RELATION between tubercular disease and Vitamin D status [301].']	[('INCOMPLETE_EVIDENCE', 21), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 47)]	3	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D')]
S423-PMC5941617	PMC5941617	5/2018	S423-PMC5941617	['CONVERSELY, neonatal Vitamin D status SEEMS TO BE ASSOCIATED to the RISK of t1dm in some [382] BUT NOT all the populations [383].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 38), ('SUPERFICIAL_RELATIONSHIP', 50), ('IMPORTANT_CONSIDERATION', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 95)]	5	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D')]
S449-PMC5941617	PMC5941617	5/2018	S449-PMC5941617	['FOUND that two regimens of weekly Vitamin D3Administration (5000\xa0iu/10 kg/week, maximum weekly dose of 25000\xa0iu and maximum cumulative dose of 150000\xa0iu vs. 10000\xa0iu/10 kg/week, maximum weekly dose of 50000\xa0iu and maximum cumulative dose of 300000\xa0iu) for 6\xa0weeks were SAFE and EFFECTIVE in normalizing Vitamin D status in ibd children and adolescents with hypovitaminosis D [411].']	[('INCOMPLETE_EVIDENCE', 0), ('IMPORTANT_CONSIDERATION', 269), ('SUPERFICIAL_RELATIONSHIP', 278)]	3	[('CHEBI_63455', 'tetronic acid derivative', 34, 'vitamin D3administration'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 34, 'vitamin D3administration'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 373, 'D')]
S452-PMC5941617	PMC5941617	5/2018	S452-PMC5941617	['Vitamin D supplementation at 800–1000\xa0iu/day is SUGGESTED to maintain optimal Vitamin D status [403].']	[('INCOMPLETE_EVIDENCE', 48)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D')]
S461-PMC5941617	PMC5941617	5/2018	S461-PMC5941617	['ON THE CONTRARY, maternal Vitamin D supplementation, maternal and neonatal Vitamin D status were not related to the risk of childhood cd [415,416].']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 75, 'vitamin D')]
S470-PMC5941617	PMC5941617	5/2018	S470-PMC5941617	['spontaneous recovery of Vitamin D status following gluten free diet HAS BEEN SUGGESTED [417], BUT it is still DEBATED.']	[('INCOMPLETE_EVIDENCE', 68), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 94), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110)]	3	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
S471-PMC5941617	PMC5941617	5/2018	S471-PMC5941617	['strict adherence to gluten free diet itself MAY REPRESENTS a DETERMINANT of Vitamin D status, BECAUSE it HAS BEEN DEMONSTRATED that sweden cd children on gluten free diet had low Vitamin D intake compared with nordic nutrition recommendation and lower Nutrient density of Vitamin D than healthy children [431].']	[('INCOMPLETE_EVIDENCE', 44), ('PROBABLE_UNDERSTANDING', 48), ('SUPERFICIAL_RELATIONSHIP', 48), ('SUPERFICIAL_RELATIONSHIP', 61), ('PROBABLE_UNDERSTANDING', 94), ('INCOMPLETE_EVIDENCE', 105), ('INCOMPLETE_EVIDENCE', 114)]	7	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 179, 'vitamin D'), ('CHEBI_33284', 'nutrient', 252, 'nutrient'), ('CHEBI_27300', 'vitamin D', 272, 'vitamin D')]
S493-PMC5941617	PMC5941617	5/2018	S493-PMC5941617	['SHOWED no difference in Vitamin D status between obese with or without impaired Glucose Homeostasis [450].']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_17234', 'glucose', 80, 'glucose'), ('GO_0042593', 'glucose homeostasis', 80, 'glucose homeostasis')]
S517-PMC5941617	PMC5941617	5/2018	S517-PMC5941617	['AT PRESENT, CONSIDERING that obese italian children have higher prevalence of Vitamin D deficiency and insufficiency then normal weight Individuals, we SUGGEST in obese children and adolescents vitamin D supplementation at higher doses THAN those RECOMMENDED for age (1000–1500\xa0iu/day) from the end of fall to the beginning of spring (november–april) to ensure an adequate Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 0), ('PROBABLE_UNDERSTANDING', 12), ('INCOMPLETE_EVIDENCE', 152), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 236), ('FUTURE_WORK', 247)]	5	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('NCBITaxon_1', 'root', 136, 'individuals'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 202, 'D'), ('CHEBI_27300', 'vitamin D', 373, 'vitamin D')]
S533-PMC5941617	PMC5941617	5/2018	S533-PMC5941617	['FOUND no differences in Vitamin D status and bone density among adolescents AFFECTED by major depression and healthy controls [493].']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 76)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D')]
S538-PMC5941617	PMC5941617	5/2018	S538-PMC5941617	['Pregnancy and breastfeeding\nthe high prevalence of Vitamin D deficiency in Pregnant women is a worldwide health PROBLEM REGARDLESS OF latitude, Food Intake or socio-economic status [93].']	[('IMPORTANT_CONSIDERATION', 112), ('INCOMPLETE_EVIDENCE', 120)]	2	[('GO_0007565', 'female pregnancy', 0, 'Pregnancy'), ('CHEBI_27300', 'vitamin D', 51, 'vitamin D'), ('GO_0007565', 'female pregnancy', 75, 'pregnant'), ('CHEBI_33290', 'food', 144, 'food'), ('GO_0007631', 'feeding behavior', 144, 'food intake')]
S539-PMC5941617	PMC5941617	5/2018	S539-PMC5941617	['data about Vitamin D intake and status in Pregnant women are relatively SCARCE but CONFIRM THIS scenario.']	[('INCOMPLETE_EVIDENCE', 72), ('INCOMPLETE_EVIDENCE', 83), ('QUESTION_ANSWERED_BY_THIS_WORK', 91)]	3	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0007565', 'female pregnancy', 42, 'pregnant')]
S545-PMC5941617	PMC5941617	5/2018	S545-PMC5941617	['during Pregnancy Vitamin D Metabolism changes so that maternal Serum 1,25(Oh)2D levels significantly rise to meet increased calcium REQUIREMENTS for Fetal Skeleton mineralization, WHEREAS fetal Vitamin D stores are exclusively DEPENDENT on maternal Vitamin D status.']	[('IMPORTANT_CONSIDERATION', 132), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 180), ('SUPERFICIAL_RELATIONSHIP', 227)]	3	"[('GO_0007565', 'female pregnancy', 7, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 17, 'vitamin D metabolism'), ('UBERON_0001977', 'blood serum', 63, 'serum'), ('CHEBI_37958', 'dye', 69, '1,'), ('CHEBI_66212', ""5,7,3',4'-tetrahydroxy-2'-(3,3-dimethylallyl)isoflavone"", 71, '25(OH)2D'), ('UBERON_0000922', 'embryo', 149, 'fetal'), ('UBERON_0004288', 'skeleton', 155, 'skeleton'), ('CHEBI_27300', 'vitamin D', 194, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 249, 'vitamin D')]"
S572-PMC5941617	PMC5941617	5/2018	S572-PMC5941617	['after completion of treatment, Serum 25(Oh)D concentrations SHOULD BE revaluated, AS it is not unusual for a second course of treatment to be necessary to achieve adequate Vitamin D status [23].']	[('FUTURE_WORK', 60), ('PROBABLE_UNDERSTANDING', 82)]	2	[('UBERON_0001977', 'blood serum', 31, 'serum'), ('CHEBI_71657', 'versiconol acetate', 37, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 37, '25 ... OH ... D'), ('CHEBI_27300', 'vitamin D', 172, 'vitamin D')]
S609-PMC5941617	PMC5941617	5/2018	S609-PMC5941617	['moreover, the RECENTLY SUGGESTED ROLE of Vitamin D in the development of other non-Skeletal diseases reinforced the interest in the promotion of an adequate Vitamin D status during pediatric age.']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 33)]	3	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('UBERON_0004288', 'skeleton', 83, 'skeletal'), ('CHEBI_27300', 'vitamin D', 157, 'vitamin D')]
S614-PMC5941617	PMC5941617	5/2018	S614-PMC5941617	['summary of RECOMMENDATIONS\n\ndefinition of Vitamin D status\n\nindividual Vitamin D status can be assessed evaluating Serum circulating 25(Oh)D levels.']	[('FUTURE_WORK', 11)]	1	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0001977', 'blood serum', 115, 'serum'), ('CHEBI_71657', 'versiconol acetate', 133, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 139, 'D')]
S615-PMC5941617	PMC5941617	5/2018	S615-PMC5941617	['DEPENDING ON 25(Oh)D levels, Vitamin D status can be defined as follows:\nsufficiency ≥30\xa0ng/ml\ninsufficiency 20–29\xa0ng/ml\ndeficiency <\u200920\xa0ng/ml\nsevere deficiency <\u200910\xa0ng/ml\nthe term hypovitaminosis D refers to Serum 25(Oh)D levels <\u200930\xa0ng/ml.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_71657', 'versiconol acetate', 13, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 197, 'D'), ('UBERON_0001977', 'blood serum', 209, 'serum'), ('CHEBI_71657', 'versiconol acetate', 215, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 215, '25(OH)D')]
S616-PMC5941617	PMC5941617	5/2018	S616-PMC5941617	['evaluation of Vitamin D status\n\nthe isotope dilution- lc-ms/ms is CONSIDERED the PREFERRED method for measuring Serum 25(Oh)D levels, especially in the Neonatal Period.']	[('INCOMPLETE_EVIDENCE', 66), ('PROBABLE_UNDERSTANDING', 81)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0001977', 'blood serum', 112, 'serum'), ('CHEBI_71657', 'versiconol acetate', 118, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 118, '25(OH ... D'), ('UBERON_0007221', 'neonate stage', 152, 'neonatal period')]
S619-PMC5941617	PMC5941617	5/2018	S619-PMC5941617	['adolescents are PARTICULARLY AT RISK of hypovitaminosis d.\nVitamin D status of newborns is INFLUENCED by ethnicity, season of Birth, and maternal Vitamin D status during Pregnancy.']	[('IMPORTANT_CONSIDERATION', 16), ('IMPORTANT_CONSIDERATION', 29), ('SUPERFICIAL_RELATIONSHIP', 91)]	3	[('CHEBI_28384', 'vitamin K', 59, 'Vitamin D'), ('GO_0007567', 'parturition', 126, 'birth'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('GO_0007565', 'female pregnancy', 170, 'pregnancy')]
S621-PMC5941617	PMC5941617	5/2018	S621-PMC5941617	['Vitamin D supplementation\n\n0–12\xa0months\n\nwe RECOMMEND Vitamin D supplementation in the first year of Life to ensure an adequate Vitamin D status and to prevent nutritional rickets.']	[('FUTURE_WORK', 43)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('UBERON_0000104', 'life cycle', 100, 'life'), ('CHEBI_27300', 'vitamin D', 127, 'vitamin D')]
S648-PMC5941617	PMC5941617	5/2018	S648-PMC5941617	['Vitamin D status SHOULD BE monitored AT LEAST yearly in subjects that REQUIRE supplementation during the whole year BECAUSE AFFECTED from pathological conditions or receiving Drugs AFFECTING Vitamin D Metabolism (table\xa07).']	[('FUTURE_WORK', 17), ('IMPORTANT_CONSIDERATION', 17), ('PROBABLE_UNDERSTANDING', 37), ('IMPORTANT_CONSIDERATION', 70), ('PROBABLE_UNDERSTANDING', 116), ('SUPERFICIAL_RELATIONSHIP', 124), ('SUPERFICIAL_RELATIONSHIP', 181)]	7	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_23888', 'drug', 175, 'drugs'), ('CHEBI_27300', 'vitamin D', 191, 'vitamin D'), ('GO_0008152', 'metabolic process', 201, 'metabolism')]
S661-PMC5941617	PMC5941617	5/2018	S661-PMC5941617	['RECENT STUDIES SUGGEST a RELATIONSHIP between maternal Vitamin D status during Pregnancy and bone mass of the fetus and the newborn.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('SUPERFICIAL_RELATIONSHIP', 25)]	3	[('CHEBI_27300', 'vitamin D', 55, 'vitamin D'), ('GO_0007565', 'female pregnancy', 79, 'pregnancy')]
S672-PMC5941617	PMC5941617	5/2018	S672-PMC5941617	['we SUGGEST the evaluation of Vitamin D status ONLY in patients affected by tuberculosis or hiv infection, AS they MAY BENEFIT from Vitamin D supplementation, in particular due to concomitant treatments that INFLUENCE Vitamin D Metabolism.']	[('FUTURE_WORK', 3), ('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 46), ('PROBABLE_UNDERSTANDING', 106), ('INCOMPLETE_EVIDENCE', 114), ('IMPORTANT_CONSIDERATION', 118), ('SUPERFICIAL_RELATIONSHIP', 207)]	7	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 131, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('GO_0008152', 'metabolic process', 227, 'metabolism')]
S674-PMC5941617	PMC5941617	5/2018	S674-PMC5941617	['HOWEVER, as FEW STUDIES SHOWED that Vitamin D supplementation improves clinical parameters in patients with active tuberculosis or hiv infection, MORE rigorous and extensive STUDIES ARE NEEDED to EVALUATE the ROLE of Vitamin D supplementation in infectious diseases, CONSIDERING also the setting of care, children’s age and nutritional status, POTENTIAL co-infections and compliance with Anti-infective therapy.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 24), ('ANOMALY_CURIOUS_FINDING', 146), ('FUTURE_WORK', 174), ('QUESTION_ANSWERED_BY_THIS_WORK', 196), ('SUPERFICIAL_RELATIONSHIP', 209), ('IMPORTANT_CONSIDERATION', 267), ('INCOMPLETE_EVIDENCE', 344)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D'), ('CHEBI_59132', 'antigen', 388, 'anti')]
S686-PMC5941617	PMC5941617	5/2018	S686-PMC5941617	['in presence of documented Vitamin D deficiency, we RECOMMENDED adequate treatment to restore Vitamin D status, followed by supplementation at doses RECOMMENDED for age.']	[('FUTURE_WORK', 51), ('FUTURE_WORK', 148)]	2	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D')]
S700-PMC5941617	PMC5941617	5/2018	S700-PMC5941617	['we SUGGEST against further 25(Oh)D evaluations in case of sufficient 25(Oh)D levels or documented normalization of Vitamin D status and strict adherence to the gluten-free diet.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_71657', 'versiconol acetate', 27, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 115, 'vitamin D')]
S707-PMC5941617	PMC5941617	5/2018	S707-PMC5941617	['we SUGGEST Vitamin D supplementation at higher doses THAN those RECOMMENDED for age (1000–1500\xa0iu/day) from the end of fall to the beginning of spring (november–april) in obese children and adolescents to ensure an adequate Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 53), ('FUTURE_WORK', 64)]	3	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 224, 'vitamin D')]
S725-PMC5941617	PMC5941617	5/2018	S725-PMC5941617	['management of asymptomatic Vitamin D deficiency and insufficiency\n\nin children and adolescents with asymptomatic Vitamin D deficiency [25(Oh)D\u2009<\u2009\xa020\xa0ng/ml] we RECOMMEND the administration of 2000\xa0iu/day or 50000\xa0iu/week of Vitamin D2Or d3for 6–8\xa0weeks (8\xa0weeks in adolescents) in order to obtain a sufficient Vitamin D status [25(Oh)D\u2009≥\u200930\xa0ng/ml].']	[('FUTURE_WORK', 159)]	1	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 113, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 135, '25(OH)D'), ('PR_000009880', 'Lon protease, mitochondrial', 135, '25 ... OH ... D'), ('CHEBI_27329', 'xanthosine phosphate', 223, 'vitamin D2or'), ('PR_000017209', 'utrophin', 223, 'vitamin D2or'), ('CHEBI_27300', 'vitamin D', 309, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 327, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 333, 'D')]
S727-PMC5941617	PMC5941617	5/2018	S727-PMC5941617	['in presence of adequate Vitamin D status [25(Oh)D\u2009≥\u200930\xa0ng/ml], we RECOMMEND to continue Vitamin D supplementation as RECOMMENDED for age.']	[('FUTURE_WORK', 66), ('FUTURE_WORK', 117)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 42, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 42, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]
S16-PMC5952272	PMC5952272	5/2018	S16-PMC5952272	['there is also a GROWING body of RESEARCH that SUGGESTS that Vitamin D status EITHER in utero OR early in Life MAY BE a RISK for autism.']	[('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 32), ('INCOMPLETE_EVIDENCE', 46), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('INCOMPLETE_EVIDENCE', 110), ('IMPORTANT_CONSIDERATION', 119)]	6	[('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('UBERON_0000104', 'life cycle', 105, 'life')]
S82-PMC5952272	PMC5952272	5/2018	S82-PMC5952272	['THUS, Vitamin E status CAN be considered AS quite satisfactory.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 23), ('PROBABLE_UNDERSTANDING', 41)]	3	[('CHEBI_27300', 'vitamin D', 6, 'vitamin E')]
S92-PMC5952272	PMC5952272	5/2018	S92-PMC5952272	['the status of Vitamin E was better in Lactating women from the gaza strip, ALTHOUGH not significant.']	[('ANOMALY_CURIOUS_FINDING', 75)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin E'), ('GO_0007594', 'puparial adhesion', 38, 'lactating')]
S141-PMC5952272	PMC5952272	5/2018	S141-PMC5952272	['methionine MAY then be activated by methionine adenosyltransferase to form S-Adenosylmethionine (sam), the primary Methyl Donor for most cellular methyltransferase reactions, including the methylation of dna, rna, proteins, Phospholipids, and Neurotransmitters.34\n\nVitamin D status as a risk factor for autism\nthe main source of Vitamin D is the solar uv-b radiation–RELATED Conversion Of 7-Dehydrocholesterol to Previtamin D3 in the skin and a lesser amount of Vitamin D from Food.35there is a GROWING BODY of RESEARCH that SUGGESTS that Vitamin D status EITHER in utero OR early in Life MAY BE a risk of autism.36moreover, epidemiologic EVIDENCE SUPPORTS the ROLE of maternal Vitamin D deficiency AS a RISK FACTOR for the development of infantile autism.37maternal status of Vitamin D IS CONSIDERED INSUFFICIENT not ONLY in countries where solar radiation is low but also in very sunny places such saudi arabia, uae, iran, and jordan.38\nVitamin D functions in the body have been extensively studied by researchers.']	[('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 367), ('INCOMPLETE_EVIDENCE', 495), ('INCOMPLETE_EVIDENCE', 525), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 556), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 572), ('INCOMPLETE_EVIDENCE', 589), ('INCOMPLETE_EVIDENCE', 639), ('INCOMPLETE_EVIDENCE', 648), ('SUPERFICIAL_RELATIONSHIP', 661), ('PROBABLE_UNDERSTANDING', 699), ('SUPERFICIAL_RELATIONSHIP', 704), ('INCOMPLETE_EVIDENCE', 787), ('PROBLEM_COMPLICATION', 801), ('INCOMPLETE_EVIDENCE', 818)]	15	[('CHEBI_50770', 'N,N-dihydroxypentahomomethionine', 75, 'S-adenosylmethionine'), ('CHEBI_81933', 'methasulfocarb', 115, 'methyl donor'), ('CHEBI_16247', 'phospholipid', 224, 'phospholipids'), ('CHEBI_25512', 'neurotransmitter', 243, 'neurotransmitters'), ('CHEBI_28384', 'vitamin K', 265, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 329, 'vitamin D'), ('GO_0048669', 'collateral sprouting in absence of injury', 375, 'conversion of ... dehydrocholesterol'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 389, '7-dehydrocholesterol'), ('PR_000014709', 'neuroserpin', 413, 'previtamin D3'), ('CHEBI_29238', 'tritium atom', 424, 'D3'), ('CHEBI_27300', 'vitamin D', 462, 'vitamin D'), ('CHEBI_33290', 'food', 477, 'food'), ('CHEBI_27300', 'vitamin D', 539, 'vitamin D'), ('UBERON_0000104', 'life cycle', 584, 'life'), ('CHEBI_27300', 'vitamin D', 678, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 777, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 939, 'Vitamin D')]
S6-PMC5956785	PMC5956785	5/2018	S6-PMC5956785	['conclusion\nthe data INDICATE SUBOPTIMAL Vitamin D status in children with chronic arthritis.']	[('INCOMPLETE_EVIDENCE', 20), ('IMPORTANT_CONSIDERATION', 29)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D')]
S14-PMC5956785	PMC5956785	5/2018	S14-PMC5956785	['Vitamin D status is POTENTIALLY GOVERNED by these same FACTORS; Vitamin D receptor genotype, ethnically RELATED skin tone and clothing, environmental variations in exposure to ultraviolet b radiation RELATING to the latitude of residence and season, and Vitamin D nutritional intake are FACTORS that Modulate Vitamin D concentrations.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 200), ('SUPERFICIAL_RELATIONSHIP', 287)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('GO_0065007', 'biological regulation', 300, 'modulate'), ('CHEBI_27300', 'vitamin D', 309, 'vitamin D')]
S24-PMC5956785	PMC5956785	5/2018	S24-PMC5956785	['an updated, systematic analysis of pertinent literature SHOULD help to FURTHER REFINE understanding of the RELATIONSHIPS between Vitamin D and juvenile arthritis, contribute to optimizing management of vitamin d status in children with arthritis, and CLARIFY Vitamin D’s POTENTIAL ROLE in MEDIATING disease pathogenesis.']	[('FUTURE_WORK', 56), ('FUTURE_WORK', 71), ('SUPERFICIAL_RELATIONSHIP', 107), ('FUTURE_WORK', 251), ('INCOMPLETE_EVIDENCE', 271), ('SUPERFICIAL_RELATIONSHIP', 281), ('SUPERFICIAL_RELATIONSHIP', 289)]	7	[('CHEBI_27300', 'vitamin D', 129, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 259, 'vitamin D')]
S30-PMC5956785	PMC5956785	5/2018	S30-PMC5956785	['HERE we report the results of a Vitamin D- jia scoping review that summarizes, synthesizes, evaluates, and interprets pertinent EVIDENCE from the literature to address the following research questions: 1) WHAT is the RELATIONSHIP between Vitamin D status and the occurrence of jia?']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 128), ('EXPLICIT_QUESTION', 205), ('SUPERFICIAL_RELATIONSHIP', 217), ('EXPLICIT_QUESTION', 280)]	5	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 238, 'vitamin D')]
S31-PMC5956785	PMC5956785	5/2018	S31-PMC5956785	['2) WHAT is the RELATIONSHIP between Vitamin D status and childhood arthritis activity?']	[('EXPLICIT_QUESTION', 3), ('SUPERFICIAL_RELATIONSHIP', 15), ('EXPLICIT_QUESTION', 85)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
S32-PMC5956785	PMC5956785	5/2018	S32-PMC5956785	['3) WHAT is the RELATIONSHIP between Vitamin D status in jia and medication use?']	[('EXPLICIT_QUESTION', 3), ('SUPERFICIAL_RELATIONSHIP', 15), ('EXPLICIT_QUESTION', 78)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
S33-PMC5956785	PMC5956785	5/2018	S33-PMC5956785	['4) WHAT is the RELATIONSHIP between Vitamin D status and geographic and demographic characteristics in children with jia?']	[('EXPLICIT_QUESTION', 3), ('SUPERFICIAL_RELATIONSHIP', 15), ('EXPLICIT_QUESTION', 120)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D')]
S62-PMC5956785	PMC5956785	5/2018	S62-PMC5956785	['defining Vitamin D status\nvitamin D deficiency is DEFINED AS a Serum 25(Oh)D concentration less than 30\xa0nmol/l, a 25(Oh)D concentration between 30 and 50\xa0nmol/l IS CONSIDERED insufficient, greater than 50\xa0nmol/l IS CONSIDERED sufficient and a 25(Oh)D status greater than 125\xa0nmol/l IS CONSIDERED AT RISK of adverse EFFECTS [19].']	[('PROBABLE_UNDERSTANDING', 50), ('PROBABLE_UNDERSTANDING', 58), ('INCOMPLETE_EVIDENCE', 161), ('INCOMPLETE_EVIDENCE', 212), ('INCOMPLETE_EVIDENCE', 282), ('IMPORTANT_CONSIDERATION', 296), ('SUPERFICIAL_RELATIONSHIP', 315)]	7	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 34, 'D'), ('UBERON_0001977', 'blood serum', 63, 'serum'), ('CHEBI_71657', 'versiconol acetate', 69, '25(OH)D'), ('CHEBI_30778', 'gallic acid', 114, '25(OH)'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 120, 'D'), ('CHEBI_71657', 'versiconol acetate', 243, '25(OH)D')]
S81-PMC5956785	PMC5956785	5/2018	S81-PMC5956785	['2008 37°n [54]children with arthritis n \u2009=\u2009183–1582.1\u2009±\u200938.7supplemental Vitamin D improved status, BUT supplemental Vitamin D or calcium did not improve bone mass.kansas, usa warady et al.']	[('ANOMALY_CURIOUS_FINDING', 100)]	1	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D')]
S134-PMC5956785	PMC5956785	5/2018	S134-PMC5956785	['ONLY nine children had acceptable Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 0)]	1	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D')]
S140-PMC5956785	PMC5956785	5/2018	S140-PMC5956785	['the 2013, systematic literature review of 19 childhood arthritis STUDIES REPORTED Vitamin D status (14 reporting 25(Oh)D and 11 reporting 1,25(Oh)D) SUGGESTED that at that time there was NO CLEAR LINK between Vitamin D status and children with chronic arthritis [12].']	[('INCOMPLETE_EVIDENCE', 65), ('INCOMPLETE_EVIDENCE', 73), ('INCOMPLETE_EVIDENCE', 149), ('FULL_UNKNOWN', 187), ('SUPERFICIAL_RELATIONSHIP', 196)]	5	[('CHEBI_27300', 'vitamin D', 82, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 113, '25(OH)D'), ('PR_000012046', 'oxysterol-binding protein-related protein 11', 116, 'OH ... D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 143, 'OH)D'), ('CHEBI_27300', 'vitamin D', 209, 'vitamin D')]
S156-PMC5956785	PMC5956785	5/2018	S156-PMC5956785	['INTERESTINGLY, the RELATIONSHIP between reduced Vitamin D status and increased disease activity also APPEARS TO BE present and follow a north-south gradient (fig.']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 19), ('ANOMALY_CURIOUS_FINDING', 101)]	3	[('CHEBI_27300', 'vitamin D', 48, 'vitamin D')]
S188-PMC5956785	PMC5956785	5/2018	S188-PMC5956785	['active disease or frequent relapse was ASSOCIATED with reduced Vitamin D status COMPARED TO patients with no active disease or frequent flare-ups.']	[('SUPERFICIAL_RELATIONSHIP', 39), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 80)]	2	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D')]
S201-PMC5956785	PMC5956785	5/2018	S201-PMC5956785	['Vitamin D intake and status was SIMILAR for two jia patient groups [23,26], and lower intake resulted in lower Vitamin D status in the third group [31].']	[('SUPERFICIAL_RELATIONSHIP', 32)]	1	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 111, 'vitamin D')]
S211-PMC5956785	PMC5956785	5/2018	S211-PMC5956785	['by exploring the factors that INFLUENCE Vitamin D status (genetics, environment, and nutrition), we will be BETTER able to discern an ASSOCIATION between Vitamin D and jia.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 134)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 154, 'vitamin D')]
S238-PMC5956785	PMC5956785	5/2018	S238-PMC5956785	['WHILE THIS REVIEW FOCUSED on Vitamin D status in children with jia, Vitamin D MAY BE INVOLVED in both disease development and subsequent disease activity status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('QUESTION_ANSWERED_BY_THIS_WORK', 6), ('QUESTION_ANSWERED_BY_THIS_WORK', 18), ('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 85)]	5	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D')]
S239-PMC5956785	PMC5956785	5/2018	S239-PMC5956785	['exploring elements of Vitamin D status that MAY have a ROLE in disease development such as early Life and Gestational Vitamin D status as well as Genes in the Vitamin D pathway will help TO CLARIFY the ROLE of Vitamin D.\nseason of Birth HAS BEEN SUGGESTED to have an IMPACT on the risk of developing a number of Autoimmune diseases such as multiple sclerosis, type 1 diabetes and celiac disease [78].']	[('INCOMPLETE_EVIDENCE', 44), ('SUPERFICIAL_RELATIONSHIP', 55), ('FUTURE_WORK', 187), ('SUPERFICIAL_RELATIONSHIP', 202), ('INCOMPLETE_EVIDENCE', 237), ('SUPERFICIAL_RELATIONSHIP', 267)]	6	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('UBERON_0000104', 'life cycle', 97, 'life'), ('GO_0007565', 'female pregnancy', 106, 'gestational'), ('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('SO_0000704', 'gene', 146, 'genes'), ('CHEBI_27300', 'vitamin D', 159, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 210, 'vitamin D'), ('GO_0007567', 'parturition', 231, 'birth'), ('UBERON_0001442', 'skeleton of manus', 312, 'autoimmune')]
S244-PMC5956785	PMC5956785	5/2018	S244-PMC5956785	['season of Birth MAY BE a MARKER for Vitamin D status in utero with children Born in the non-Vitamin D synthesizing periods being exposed to less Vitamin D during their time in utero THAN those who are Born during the Vitamin D synthesizing seasons.']	[('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 25), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182)]	3	[('GO_0007567', 'parturition', 10, 'birth'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0007567', 'parturition', 76, 'born'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 145, 'vitamin D'), ('GO_0007567', 'parturition', 201, 'born'), ('CHEBI_27300', 'vitamin D', 217, 'vitamin D')]
S257-PMC5956785	PMC5956785	5/2018	S257-PMC5956785	['INVESTIGATING Genetic, nutritional and environmental factors that INFLUENCE Vitamin D in jia COULD HELP inform ways in which Vitamin D status INFLUENCES the occurrence and activity of jia.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 66), ('INCOMPLETE_EVIDENCE', 93), ('FUTURE_WORK', 99), ('SUPERFICIAL_RELATIONSHIP', 142)]	5	[('SO_0000704', 'gene', 14, 'genetic'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
S265-PMC5956785	PMC5956785	5/2018	S265-PMC5956785	['these variables CAN make it DIFFICULT to interpret the RELATIONSHIP between Vitamin D and disease activity in RELATION to both inflammation status and risk of relapse.']	[('INCOMPLETE_EVIDENCE', 16), ('DIFFICULT_TASK', 28), ('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 110)]	4	[('CHEBI_27300', 'vitamin D', 76, 'vitamin D')]
S271-PMC5956785	PMC5956785	5/2018	S271-PMC5956785	['this review was UNABLE TO explore the RELATIONSHIP between Vitamin D status and ethnicity, Vitamin D receptor Genes or OTHER Genes that INFLUENCE Vitamin D Metabolism.']	[('DIFFICULT_TASK', 16), ('SUPERFICIAL_RELATIONSHIP', 38), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 119), ('SUPERFICIAL_RELATIONSHIP', 136)]	4	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('SO_0000704', 'gene', 110, 'genes'), ('SO_0000704', 'gene', 125, 'genes'), ('CHEBI_27300', 'vitamin D', 146, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 146, 'vitamin D metabolism')]
S272-PMC5956785	PMC5956785	5/2018	S272-PMC5956785	['conclusion\nTHIS is the FIRST scoping review to summarize research RELATING to Vitamin D and jia in the context of Vitamin D status, latitude, disease activity.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 11), ('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 66)]	3	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 114, 'vitamin D')]
S277-PMC5956785	PMC5956785	5/2018	S277-PMC5956785	['further, the RELATIONSHIP between Vitamin D status and disease activity in children with jia is STILL UNCLEAR.']	[('SUPERFICIAL_RELATIONSHIP', 13), ('FULL_UNKNOWN', 96)]	2	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D')]
S280-PMC5956785	PMC5956785	5/2018	S280-PMC5956785	['we do not, HOWEVER, know the optimal Vitamin D status for children with jia, WHETHER reduced Vitamin D is caused by increased utilization OR reduced Vitamin D status in children with jia, the IMPACT of Vitamin D in disease activity or the ROLE of Vdr polymorphisms with jia.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 77), ('EXPLICIT_QUESTION', 77), ('SUPERFICIAL_RELATIONSHIP', 192), ('SUPERFICIAL_RELATIONSHIP', 239)]	5	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 93, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 149, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 202, 'vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 247, 'VDR')]
S282-PMC5956785	PMC5956785	5/2018	S282-PMC5956785	['the RELATIONSHIP between Vitamin D status and jia over time in newly diagnosed Individuals has YET to be investigated.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('ANOMALY_CURIOUS_FINDING', 95)]	2	[('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('NCBITaxon_1', 'root', 79, 'individuals')]
S284-PMC5956785	PMC5956785	5/2018	S284-PMC5956785	['being able to SUGGEST specific TARGETS for Vitamin D status AS a POTENTIAL adjunct therapy in the treatment of jia and understanding HOW Genetic variants increase the RISK of disease development will enhance the quality of Life of patients and their families.']	[('INCOMPLETE_EVIDENCE', 14), ('FUTURE_WORK', 31), ('PROBABLE_UNDERSTANDING', 60), ('INCOMPLETE_EVIDENCE', 65), ('EXPLICIT_QUESTION', 133), ('IMPORTANT_CONSIDERATION', 167)]	6	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('SO_0000704', 'gene', 137, 'genetic'), ('UBERON_0000104', 'life cycle', 223, 'life')]
S34-PMC5995352	PMC5995352	6/2018	S34-PMC5995352	['ALTHOUGH maternal Vitamin D status during Pregnancy has no impact on foetal Bone mineralisation IF Calcium supply is adequate, observational studies have LINKED low maternal Vitamin D levels with smaller child bone mass and impaired linear growth in the first 12 months of Life [18–20].']	[('ANOMALY_CURIOUS_FINDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 96), ('SUPERFICIAL_RELATIONSHIP', 154)]	3	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0007565', 'female pregnancy', 42, 'pregnancy'), ('GO_0007567', 'parturition', 76, 'bone'), ('CHEBI_22313', 'alkaline earth metal atom', 99, 'calcium'), ('CHEBI_27300', 'vitamin D', 174, 'vitamin D'), ('UBERON_0000104', 'life cycle', 273, 'life')]
S147-PMC5995352	PMC5995352	6/2018	S147-PMC5995352	['Breastfed infants MAY BE at a higher RISK of rickets [36], BUT this DID NOT apply to our cohort with a general high Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 18), ('IMPORTANT_CONSIDERATION', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 59), ('INCOMPLETE_EVIDENCE', 68)]	4	[('UBERON_0001224', 'renal pelvis', 0, 'Breastfed'), ('CHEBI_27300', 'vitamin D', 116, 'vitamin D')]
S152-PMC5995352	PMC5995352	6/2018	S152-PMC5995352	['this was IN KEEPING WITH OUR FINDINGS, SUPPORTING that early Pregnancy Vitamin D status does not affect offspring linear growth.']	[('INCOMPLETE_EVIDENCE', 9), ('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('INCOMPLETE_EVIDENCE', 39)]	3	[('GO_0007565', 'female pregnancy', 61, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D')]
S187-PMC5995352	PMC5995352	6/2018	S187-PMC5995352	['in conclusion, early Life Vitamin D status had no clinically IMPORTANT associations with linear growth in a generally healthy population of infants.']	[('IMPORTANT_CONSIDERATION', 61)]	1	[('UBERON_0000104', 'life cycle', 21, 'life'), ('CHEBI_27300', 'vitamin D', 26, 'vitamin D')]
S2-PMC6011374	PMC6011374	6/2018	S2-PMC6011374	['we AIMED to compare Vitamin D status in two distinct populations of Pregnant women in australia and new zealand and TO INVESTIGATE the RELATIONSHIP between Vitamin D status and Pregnancy outcome.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 116), ('SUPERFICIAL_RELATIONSHIP', 135)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnant'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0007565', 'female pregnancy', 177, 'pregnancy')]
S10-PMC6011374	PMC6011374	6/2018	S10-PMC6011374	['a POSSIBLE ASSOCIATION between fetal sex, Vitamin D status and gdm provides FURTHER QUESTIONS and ENCOURAGES continual RESEARCH and discussion into the ROLE of Vitamin D in Pregnancy, particularly in Vitamin D replete populations.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 76), ('EXPLICIT_QUESTION', 84), ('FUTURE_WORK', 98), ('SUPERFICIAL_RELATIONSHIP', 152)]	6	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 160, 'vitamin D'), ('GO_0007565', 'female pregnancy', 173, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D')]
S27-PMC6011374	PMC6011374	6/2018	S27-PMC6011374	['in the case of Preterm Delivery, Vitamin D status measured closer to the Delivery date was more significantly ASSOCIATED with Preterm Delivery than earlier measures [26].']	[('SUPERFICIAL_RELATIONSHIP', 110)]	1	[('GO_0007565', 'female pregnancy', 15, 'preterm'), ('GO_0007567', 'parturition', 23, 'delivery'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0007567', 'parturition', 73, 'delivery'), ('GO_0007565', 'female pregnancy', 126, 'preterm'), ('GO_0007567', 'parturition', 134, 'delivery')]
S29-PMC6011374	PMC6011374	6/2018	S29-PMC6011374	['using a robust, validated chemiluminescent-based assay to measure Serum 25(Oh)D [27], we AIMED TO INVESTIGATE the DIFFERENCES between Vitamin D status in early Pregnancy in two distinct populations of Nulliparous women from australia and new zealand.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 89), ('QUESTION_ANSWERED_BY_THIS_WORK', 95), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 114)]	3	[('UBERON_0001977', 'blood serum', 66, 'serum'), ('CHEBI_71657', 'versiconol acetate', 72, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 72, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('GO_0007565', 'female pregnancy', 160, 'pregnancy'), ('GO_0046662', 'regulation of oviposition', 201, 'nulliparous')]
S30-PMC6011374	PMC6011374	6/2018	S30-PMC6011374	['we also AIMED TO EXAMINE the RELATIONSHIP between Serum 25(Oh)D at 15\u2009±\u20091\xa0weeks’ Gestation and the risk of an adverse Pregnancy outcome and included determining the EFFECT modification of fetal sex on the ASSOCIATION between maternal Vitamin D status and Pregnancy outcome.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('QUESTION_ANSWERED_BY_THIS_WORK', 14), ('SUPERFICIAL_RELATIONSHIP', 29), ('SUPERFICIAL_RELATIONSHIP', 165), ('SUPERFICIAL_RELATIONSHIP', 205)]	5	[('UBERON_0001977', 'blood serum', 50, 'serum'), ('CHEBI_71657', 'versiconol acetate', 56, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 56, '25(OH)D'), ('GO_0007565', 'female pregnancy', 81, 'gestation'), ('GO_0007565', 'female pregnancy', 118, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 234, 'vitamin D'), ('GO_0007565', 'female pregnancy', 255, 'pregnancy')]
S50-PMC6011374	PMC6011374	6/2018	S50-PMC6011374	['given that the month in which the Serum was sampled heavily INFLUENCES Vitamin D status, “standardised” Serum 25(Oh)D concentrations were calculated as previously described [34] in order to normalise against seasonal VARIATION.']	[('SUPERFICIAL_RELATIONSHIP', 60), ('DIFFICULT_TASK', 217)]	2	[('UBERON_0001977', 'blood serum', 34, 'serum'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('UBERON_0001977', 'blood serum', 104, 'serum'), ('CHEBI_71657', 'versiconol acetate', 110, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 110, '25(OH ... D')]
S62-PMC6011374	PMC6011374	6/2018	S62-PMC6011374	['given that all these factors significantly INFLUENCED Serum 25(Oh)D in the linear regression model, it was unsurprising that Vitamin D status of the women was significantly different between the two recruitment sites.']	[('SUPERFICIAL_RELATIONSHIP', 43)]	1	[('UBERON_0001977', 'blood serum', 54, 'serum'), ('CHEBI_71657', 'versiconol acetate', 60, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 60, '25(OH ... D'), ('CHEBI_27300', 'vitamin D', 125, 'vitamin D')]
S63-PMC6011374	PMC6011374	6/2018	S63-PMC6011374	['HOWEVER, after adjusting for maternal age, bmi, sei, smoking status and Alcohol consumption at 15\u2009±\u20091\xa0weeks’ Gestation, ethnicity, recreational walking and season, the women recruited in adelaide STILL had significantly lower Serum 25(Oh)D when compared with those in auckland (adelaide: 58.4\u2009±\u200950.3 vs. auckland: 70.2\u2009±\u200954.5\xa0nmol/l, p\u2009<\u20090.001) INDICATING the INFLUENCE of OTHER CONFOUNDERS not measured as part of the study on Vitamin D status.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 196), ('INCOMPLETE_EVIDENCE', 345), ('SUPERFICIAL_RELATIONSHIP', 360), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 373), ('PROBLEM_COMPLICATION', 379)]	6	[('CHEBI_30879', 'alcohol', 72, 'alcohol'), ('GO_0007565', 'female pregnancy', 109, 'gestation'), ('UBERON_0001977', 'blood serum', 226, 'serum'), ('CHEBI_71657', 'versiconol acetate', 232, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 232, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 428, 'vitamin D')]
S64-PMC6011374	PMC6011374	6/2018	S64-PMC6011374	['caption (table-wrap): table 1\n\nparticipant characteristics and comparison of characteristics between women recruited at the adelaide and auckland scope centresall women (n = 2800)adelaide (n = 1156)auckland (n = 1644) p value*age yrs , mean (sd)28 (6)23.73 (5.11)30.44 (4.82)<0.0001bmi kg/m2, mean (sd)25.8 (5.44)27.04 (6.56)24.88 (4.26)<0.0001ethnicity<0.0001\u2003caucasian2449 (87)1060 (92)1389 (84)\u2003non caucasian351 (13)96 (8)255 (16)smoking status, n (%)<0.0001\u2003no2152 (77)704 (61)1448 (88)\u2003quit during Pregnancy306 (11)175 (15)131 (8)\u2003smoking342 (12)277 (24)65 (4)Alcohol consumption, n (%)<0.0001\u2003no1480 (53)708 (61)772 (47)\u2003stopped during pregnancy1185 (42)397 (34)788 (48)\u2003consuming Alcohol135 (5)51 (4)84 (5)fruit intake, n (%)<0.0001\u2003≥1x per day2032 (73)586 (51)1446 (88)\u20033-6x per week405 (14)272 (24)133 (8)\u20031-2x per week223 (8)181 (16)42 (3)\u20031-3x per month or less140 (5)117 (10)23 (1)recreational walking<0.0001\u2003never428 (15)265 (23)163 (10)\u20031-3 times/week1773 (63)668 (58)1105 (68)\u2003≥4 times/week590 (22)221 (19)369 (23)time watching tv<0.0001\u2003<5 hours per day2404 (86)901 (78)1503 (92)\u2003≥5 hours per day387 (14)253 (22)134 (8)season Serum was sampled0.3213\u2003summer636 (23)278 (24)358 (22)\u2003autumn705 (25)273 (24)432 (26)\u2003winter727 (26)300 (26)427 (26)\u2003spring732 (26)305 (26)427 (26)Serum 25(Oh)D nmol/l , mean (sd)68.09 (27.14)60.06 (23.68)73.74 (27.99)<0.0001vitamin D status<0.0001\u2003<25 nmol/l99 (4)48 (4)51 (3)\u200325-50 nmol/l673 (24)375 (32)298 (18)\u200350-75 nmol/l928 (33)422 (37)506 (31)\u2003>75 nmol/l1098 (39)311 (27)787 (48)\n* p values for continuous variables were determined using a welch’s t-test and categorical variables a fisher’s exact test comparing adelaide and auckland women\n\nstandardising Serum 25(Oh)D based on seasonal variation\nAS EXPECTED, there was a seasonal INFLUENCE on Serum 25(Oh)D and THUS, “standardised” Vitamin D concentrations were calculated to account for the month of Serum collection.']	[('INCOMPLETE_EVIDENCE', 1748), ('SUPERFICIAL_RELATIONSHIP', 1782), ('PROBABLE_UNDERSTANDING', 1813)]	3	[('GO_0007602', 'phototransduction', 503, 'pregnancy306'), ('CHEBI_30879', 'alcohol', 565, 'Alcohol'), ('CHEBI_78635', 'fatty alcohol 16:1', 687, 'alcohol135'), ('UBERON_0001977', 'blood serum', 1142, 'serum'), ('UBERON_0001977', 'blood serum', 1289, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 1295, '25(OH)D'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 1375, 'D'), ('UBERON_0001977', 'blood serum', 1706, 'serum'), ('CHEBI_71657', 'versiconol acetate', 1712, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1712, '25(OH)D'), ('UBERON_0001977', 'blood serum', 1795, 'serum'), ('CHEBI_71657', 'versiconol acetate', 1801, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1801, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 1834, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1903, 'serum')]
S77-PMC6011374	PMC6011374	6/2018	S77-PMC6011374	['HOWEVER, when each Pregnancy complication was analysed separately, a 53% decreased risk for gdm was observed with high Vitamin D status when compared to moderate-high status (arr: 0.47; 95% ci: 0.23, 0.96).']	[('ANOMALY_CURIOUS_FINDING', 0)]	1	[('GO_0007565', 'female pregnancy', 19, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin D')]
S80-PMC6011374	PMC6011374	6/2018	S80-PMC6011374	['caption (table-wrap): table 2\n\nadjusted relative risks (arr) of Pregnancy complications from any complication, Preeclampsia (pe), Gestational hypertension (gh), Gestational diabetes mellitus (gdm), spontaneous Preterm Birth (sptb) and small-for-Gestational age (sga) according to Vitamin D status categorised based on standardised quartiles and clinical definitions of Vitamin D statuspregnancy complicationsall womenany complicationpeghgdmsptbsga n (%) n (%)arr*(95% ci) n (%)arr*(95% ci) n (%)arr*(95% ci) n (%)arr*(95% ci) n (%)arr*(95% ci) n (%)arr*(95% ci)standardised quartiles**\u2003low711 (25)328 (46)0.95 (0.85, 1.07)46 (6)1.02 (0.66, 1.57))57 (8)0.97 (0.67, 1.42)28 (4)0.79 (0.47, 1.30)36 (5)0.83 (0.54, 1.29)84 (12)1.02 (0.75, 1.39)\u2003low-moderate755 (27)318 (42)1.00 (0.90, 1.12)42 (6)1.07 (0.69, 1.64)65 (9)1.06 (0.74, 1.52)25 (3)0.67 (0.39, 1.16)33 (4)0.87 (0.56, 1.3572 (10)0.98 (0.73, 1.32)\u2003moderate-high702 (25)309 (44)1.0†37 (5)1.0†50 (7)1.0†28 (4)1.0†39 (6)1.0†81 (12)1.0†\u2003high630 (23)258 (41)0.93 (0.82, 1.06)†35 (6)1.24 (0.78, 1.96)40 (6)0.87 (0.58, 1.30)10 (2) 0.47(0.23, 0.96) 30 (5)0.77 (0.48, 1.25)60 (10)0.80 (0.57, 1.11)Vitamin d status\u2003<25 nmol/l99 (4)51 (52)1.10 (0.89, 1.36)8 (8)1.44 (0.68, 3.03))6 (6)0.70 (0.32, 1.52)5 (5)0.98 (0.38, 2.52)7 (7)1.44 (0.68, 3.04)13 (13)1.15 (0.66, 2.01)\u200325-50 nmol/l673 (24)301 (45)0.93 (0.83, 1.03)45 (7)1.18 (0.80, 1.75)59 (9)0.97 (0.71, 1.34)26 (4)0.89 (0.54, 1.47)29 (4)0.75 (0.48, 1.16)74 (11)0.93 (0.69, 1.24)\u2003>50-75 nmol/l928 (33)428 (46)1.0†48 (5)1.0†80 (9)1.0†35 (4)1.0†52 (6)1.0†107 (12)1.0†\u2003>75 nmol/l1098 (39)435 (40)0.95 (0.86, 1.04)60 (5)1.28 (0.87, 1.87)67 (6)0.82 (0.59, 1.12)†26 (2)0.78 (0.48, 1.28)51 (5)0.86 (0.59, 1.26)104 (9)0.86 (0.67, 1.12)\n*relative risks compared to all women were adjusted for age, maternal body mass index, ethnicity (non caucasian vs. caucasian), smoking status at 15\u2009±\u20091\xa0weeks’ Gestation (no vs. yes), Alcohol consumption at 15\u2009±\u20091\xa0weeks’ (no vs yes), recreational walking (1-3×/week and\u2009≥\u20094×/week vs. never) and recruitment site (auckland vs. adelaide)\n**Serum 25(Oh)D was standardised for month that Serum was sampled based as previously described [34]\n†reference category\n\nSerum 25(Oh)D, Pregnancy outcome and fetal sex\nas THERE IS EVIDENCE to SUGGEST that Vitamin D Metabolism within the Placenta MAY DIFFER with respect to fetal sex [35] THUS, we ASSESSED the EFFECT of “standardised” Vitamin D status on Pregnancy outcome stratified by fetal sex (table\xa03).']	[('INCOMPLETE_EVIDENCE', 2230), ('INCOMPLETE_EVIDENCE', 2251), ('INCOMPLETE_EVIDENCE', 2305), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2309), ('PROBABLE_UNDERSTANDING', 2347), ('QUESTION_ANSWERED_BY_THIS_WORK', 2356), ('SUPERFICIAL_RELATIONSHIP', 2369)]	7	[('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 111, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 130, 'gestational'), ('GO_0007565', 'female pregnancy', 161, 'gestational'), ('GO_0007565', 'female pregnancy', 210, 'preterm birth'), ('GO_0007565', 'female pregnancy', 245, 'gestational'), ('CHEBI_27300', 'vitamin D', 280, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 369, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 1141, 'Vitamin'), ('GO_0007565', 'female pregnancy', 1882, 'gestation'), ('CHEBI_30879', 'alcohol', 1906, 'alcohol'), ('UBERON_0001977', 'blood serum', 2060, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 2066, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 2066, '25(OH)D'), ('UBERON_0001977', 'blood serum', 2106, 'serum'), ('UBERON_0001977', 'blood serum', 2180, 'Serum'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 2189, 'OH)D'), ('GO_0007565', 'female pregnancy', 2195, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 2264, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 2264, 'vitamin D metabolism'), ('UBERON_0001987', 'placenta', 2296, 'placenta'), ('CHEBI_27300', 'vitamin D', 2394, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2414, 'pregnancy')]
S86-PMC6011374	PMC6011374	6/2018	S86-PMC6011374	['caption (table-wrap): table 3\n\nadjusted relative risks (arr) of Pregnancy complications from any complication, Preeclampsia (pe), Gestational hypertension (gh), Gestational diabetes mellitus (gdm), spontaeous Preterm Birth (sptb) and small-for-Gestational age (sga) according to Vitamin D status and stratified by fetal sexpregnancy complicationsall womenany complicationpeghgdmsptbsga n (%) n (%)arr* (95% ci) n (%)arr* (95% ci) n (%)arr* (95% ci) n (%)arr* (95% ci) n (%)arr* (95% ci) n (%)arr* (95% ci)standardised quartiles**males\u2003low367 (26)173 (47)1.00 (0.85, 1.18)24 (7)1.24 (0.65, 2.34)31 (8)1.11 (0.64, 1.94)18 (5)1.25 (0.58, 2.68)22 (6)1.09 (0.60, 1.98)43 (12)1.14 (0.73, 1.79)\u2003low-moderate364 (26)163 (45)1.01 (0.86, 1.19))20 (5)1.11 (0.58, 2.12)32 (9)1.25 (0.73, 2.13)13 (4)1.06 (0.48, 2.38)18 (5)0.93 (0.49, 1.76)45 (12)1.23 (0.80, 1.88)\u2003moderate-high359 (25)152 (42)1.0†16 (4)1.0†23 (6)1.0†11 (3)1.0†18 (5)1.0†35 (10)1.0†\u2003high325 (23)111 (34)0.86 (0.71, 1.04)15 (5)1.18 (0.59, 2.36)17 (5)0.90 (0.50, 1.62)4 (1)0.45 (0.15, 1.38)15 (5)0.97 (0.50, 1.88)26 (8)0.77 (0.47, 1.26)females\u2003low380 (28)169 (44)0.91 (0.77, 1.06)23 (6)0.85 (0.47, 1.55)30 (8)0.87 (0.52, 1.45)13 (3)0.51 (0.25, 1.04)14 (4)0.61 (0.31, 1.18)45 (12)0.88 (0.58, 1.35)\u2003low-moderate353 (26)168 (48)0.99 (0.85, 1.15)24 (7)1.03 (0.57, 1.85)31 (9)0.92 (0.57, 1.50)9 (3) 0.44(0.20, 0.97) 18 (5)0.79 (0.43, 1.45)33 (9)0.74 (0.48, 1.13)\u2003moderate-high334 (24)149 (45)1.0†19 (6)1.0†28 (8)1.0†17 (5)1.0†21 (6)1.0†31 (9)1.0†\u2003high314 (23)128 (41)1.00 (0.84, 1.19)19 (6)1.29 (0.70, 2.35)20 (6)0.85 (0.49, 1.46)6 (2)0.48 (0.19, 1.23)12 (4)0.60 (0.30, 1.21)29 (9)0.82 (0.53, 1.28)\n*relative risks compared to all women were adjusted for age, maternal body mass index, ethnicity (non caucasian vs. caucasian), smoking status at 15\u2009±\u20091\xa0weeks’ Gestation (no vs. yes), Alcohol consumption at 15\u2009±\u20091\xa0weeks’ (no vs yes), recreational walking (1-3×/week and\u2009≥\u20094×/week vs. never) and recruitment site (auckland vs. adelaide)\n**Serum 25(Oh)D was standardised for month that serum was sampled based as previously described [34]\n†reference category\n\ndiscussion\nthis study ADDS TO THE current body of LITERATURE on Vitamin D status in a population of Pregnant australian and new zealand women and provides INSIGHT into normal circulating levels of 25(Oh)D in early Pregnancy.']	[('INCOMPLETE_EVIDENCE', 2125), ('INCOMPLETE_EVIDENCE', 2258)]	2	[('GO_0007565', 'female pregnancy', 64, 'pregnancy'), ('GO_0007128', 'meiotic prophase I', 111, 'preeclampsia'), ('GO_0007565', 'female pregnancy', 130, 'gestational'), ('GO_0007565', 'female pregnancy', 161, 'gestational'), ('GO_0007565', 'female pregnancy', 209, 'preterm birth'), ('GO_0007565', 'female pregnancy', 244, 'gestational'), ('CHEBI_27300', 'vitamin D', 279, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1805, 'gestation'), ('CHEBI_30879', 'alcohol', 1829, 'alcohol'), ('UBERON_0001977', 'blood serum', 1983, 'Serum'), ('CHEBI_71657', 'versiconol acetate', 1989, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1989, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 2167, 'vitamin D'), ('GO_0007565', 'female pregnancy', 2203, 'pregnant'), ('CHEBI_71657', 'versiconol acetate', 2300, '25(OH)D'), ('GO_0007565', 'female pregnancy', 2317, 'pregnancy')]
S87-PMC6011374	PMC6011374	6/2018	S87-PMC6011374	['it is the largest prospective cohort study TO ASSESS Vitamin D status within the international scope cohort, comparing and combining two distinct populations of Pregnant women living at similar latitude and provides a GREATER UNDERSTANDING of Vitamin D deficiency and the risk of adverse Pregnancy outcomes.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 43), ('INCOMPLETE_EVIDENCE', 218)]	2	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0007565', 'female pregnancy', 161, 'pregnant'), ('CHEBI_27300', 'vitamin D', 243, 'vitamin D'), ('GO_0007565', 'female pregnancy', 288, 'pregnancy')]
S91-PMC6011374	PMC6011374	6/2018	S91-PMC6011374	['furthermore, there MAY BE POSSIBLE fetal sex specific DIFFERENCES in Vitamin D status WORTH CONSIDERING in FUTURE STUDIES.']	[('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 26), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 54), ('IMPORTANT_CONSIDERATION', 86), ('FUTURE_WORK', 107)]	5	[('CHEBI_27300', 'vitamin D', 69, 'vitamin D')]
S94-PMC6011374	PMC6011374	6/2018	S94-PMC6011374	['PREVIOUS STUDIES HAVE SHOWN a positive ASSOCIATION between socioeconomic status and Vitamin D in both Pregnant and non-Pregnant women [36,37].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 39)]	3	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0007565', 'female pregnancy', 102, 'pregnant'), ('GO_0007565', 'female pregnancy', 119, 'pregnant')]
S97-PMC6011374	PMC6011374	6/2018	S97-PMC6011374	['HOWEVER, after adjusting for factors shown to be ASSOCIATED with Vitamin D status including bmi and recreational walking, serum 25(Oh)D remained significantly lower in the women recruited in adelaide SUGGESTING the INFLUENCE of OTHER factors not measured as part of scope for example, hours spent outside in the sun.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 200), ('SUPERFICIAL_RELATIONSHIP', 215), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 228)]	5	[('CHEBI_27300', 'vitamin D', 65, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 128, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 130, '(OH ... D')]
S98-PMC6011374	PMC6011374	6/2018	S98-PMC6011374	['as INDICATED by the seasonal variation in Serum 25(Oh)D, amongst women recruited in adelaide, Vitamin D status declined significantly from february to april WHILST in the women recruited in auckland, Serum 25(Oh)D in march and april remained elevated before declining.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 157)]	2	[('UBERON_0001977', 'blood serum', 42, 'serum'), ('CHEBI_71657', 'versiconol acetate', 48, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 48, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 94, 'vitamin D'), ('UBERON_0001977', 'blood serum', 200, 'serum'), ('CHEBI_71657', 'versiconol acetate', 206, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 206, '25(OH)D')]
S102-PMC6011374	PMC6011374	6/2018	S102-PMC6011374	['this is also CONSISTENT with another study that observed an increased risk of gdm with Vitamin D deficiency in early Pregnancy (aor: 3.40; 95% ci: 2.03–4.98 [17]) and offers POTENTIAL physiological CONNECTIONS between Vitamin D status and the progression of Insulin resistance in Pregnant women.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 174), ('SUPERFICIAL_RELATIONSHIP', 198)]	3	[('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('GO_0007565', 'female pregnancy', 117, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D'), ('PR_000045358', 'insulin family protein', 258, 'insulin'), ('GO_0007565', 'female pregnancy', 280, 'pregnant')]
S107-PMC6011374	PMC6011374	6/2018	S107-PMC6011374	['in THIS STUDY, we observed marginal sex-specific DIFFERENCES between early Pregnancy Vitamin D status and Pregnancy outcome where by high Vitamin D status and carrying a male fetus was moderately ASSOCIATED with decreasing the risk of having any Pregnancy complication.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 49), ('SUPERFICIAL_RELATIONSHIP', 196)]	3	[('GO_0007565', 'female pregnancy', 75, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0007565', 'female pregnancy', 106, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('GO_0007565', 'female pregnancy', 246, 'pregnancy')]
S108-PMC6011374	PMC6011374	6/2018	S108-PMC6011374	['CONVERSELY, high Vitamin D status and carrying a female fetus was not associated with changing the risk of having any Pregnancy complication.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0)]	1	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0007565', 'female pregnancy', 118, 'pregnancy')]
S109-PMC6011374	PMC6011374	6/2018	S109-PMC6011374	['indeed, for the risk of gdm an OPPOSITE EFFECT of Vitamin D status in early Pregnancy was observed DEPENDING ON fetal sex.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 31), ('SUPERFICIAL_RELATIONSHIP', 40), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 99)]	3	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0007565', 'female pregnancy', 76, 'pregnancy')]
S110-PMC6011374	PMC6011374	6/2018	S110-PMC6011374	['this is similar to that which has PREVIOUSLY been shown in the RELATIONSHIP between Vitamin D status at ≤26\xa0weeks’ Gestation and Placental pathology in Pregnancy [51] SUGGESTING that male and female fetuses respond differently to maternal Vitamin D status.']	[('INCOMPLETE_EVIDENCE', 34), ('SUPERFICIAL_RELATIONSHIP', 63), ('INCOMPLETE_EVIDENCE', 167)]	3	[('CHEBI_27300', 'vitamin D', 84, 'vitamin D'), ('GO_0007565', 'female pregnancy', 115, 'gestation'), ('UBERON_0001987', 'placenta', 129, 'placental'), ('GO_0007565', 'female pregnancy', 152, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 239, 'vitamin D')]
S112-PMC6011374	PMC6011374	6/2018	S112-PMC6011374	['indeed many of the studies that have assessed the ASSOCIATION between Vitamin D status and adverse Pregnancy outcome that have reported statistically significant differences HAVE BEEN in populations with higher rates of Vitamin D deficiency [2,4].']	[('SUPERFICIAL_RELATIONSHIP', 50), ('INCOMPLETE_EVIDENCE', 174)]	2	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0007565', 'female pregnancy', 99, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 220, 'vitamin D')]
S118-PMC6011374	PMC6011374	6/2018	S118-PMC6011374	['during Gestation, fetal demand for Calcium increases and it is IMPERATIVE that maternal Vitamin D status remain adequate to support increased Calcium absorption from the Gut [54].']	[('IMPORTANT_CONSIDERATION', 63)]	1	[('GO_0007565', 'female pregnancy', 7, 'gestation'), ('CHEBI_22313', 'alkaline earth metal atom', 35, 'calcium'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 142, 'calcium'), ('UBERON_0001555', 'digestive tract', 170, 'gut')]
S119-PMC6011374	PMC6011374	6/2018	S119-PMC6011374	['THEREFORE, Vitamin D status MAY BE IMPORTANT in populations where dietary Calcium intake is low which is UNLIKELY in the population of women studied HERE.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 28), ('IMPORTANT_CONSIDERATION', 35), ('PROBABLE_UNDERSTANDING', 105), ('QUESTION_ANSWERED_BY_THIS_WORK', 149)]	5	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_22313', 'alkaline earth metal atom', 74, 'calcium')]
S121-PMC6011374	PMC6011374	6/2018	S121-PMC6011374	['HOWEVER, DIFFERENCES in Vitamin D status between the women recruited in adelaide and those recruited in auckland reflect obvious DIFFICULTIES in studying HOW Vitamin D MAY support healthy Pregnancies.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 9), ('DIFFICULT_TASK', 129), ('EXPLICIT_QUESTION', 154), ('INCOMPLETE_EVIDENCE', 168)]	5	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 158, 'vitamin D'), ('GO_0007565', 'female pregnancy', 188, 'pregnancies')]
S122-PMC6011374	PMC6011374	6/2018	S122-PMC6011374	['a POSSIBLE CONNECTION between fetal sex, Vitamin D status and Pregnancy complications REVEALS FURTHER QUESTIONS and ENCOURAGES continual RESEARCH and discussion into the ROLE of Vitamin D in Pregnancy, particularly in Vitamin D replete populations.']	[('INCOMPLETE_EVIDENCE', 2), ('SUPERFICIAL_RELATIONSHIP', 11), ('INCOMPLETE_EVIDENCE', 86), ('FUTURE_WORK', 94), ('FUTURE_WORK', 116), ('SUPERFICIAL_RELATIONSHIP', 170)]	6	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0007565', 'female pregnancy', 62, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 178, 'vitamin D'), ('GO_0007565', 'female pregnancy', 191, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 218, 'vitamin D')]
